Citrus Sinensis ID: 038002
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 702 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.296 | 0.25 | 0.474 | 8e-56 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.301 | 0.255 | 0.454 | 3e-47 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.407 | 0.348 | 0.354 | 8e-45 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.306 | 0.246 | 0.422 | 3e-43 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.356 | 0.242 | 0.383 | 3e-41 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.297 | 0.252 | 0.432 | 2e-40 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.346 | 0.235 | 0.393 | 3e-40 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.283 | 0.249 | 0.426 | 1e-39 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.310 | 0.25 | 0.389 | 3e-39 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.282 | 0.310 | 0.401 | 1e-38 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 219 bits (557), Expect = 8e-56, Method: Compositional matrix adjust.
Identities = 103/217 (47%), Positives = 148/217 (68%), Gaps = 9/217 (4%)
Query: 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
L+ + + +++VYEF+ +G+LA+ LF RP W DR IA+ +ARG+LYLH+EC Q
Sbjct: 594 LIGFCNEGQSQMIVYEFLPQGTLANFLFR-RPRPSWEDRKNIAVAIARGILYLHEECSEQ 652
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITV 593
IIHCDIK +NIL+D+ + +ISDFGLAKLL+ NQT + +RG++GY+APEW + IT
Sbjct: 653 IIHCDIKPQNILLDEYYTPRISDFGLAKLLLMNQTYTLTNIRGTKGYVAPEWFRNSPITS 712
Query: 594 KSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI--- 650
K DVYS+GV+LLEI+CC+ V D V+L W Y+CF G L E++ + +
Sbjct: 713 KVDVYSYGVMLLEIVCCKK----AVDLEDNVILINWAYDCFRQGRLEDLTEDDSEAMNDM 768
Query: 651 -TLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686
T+ER VK + CIQ+E +RP+M+NV MLEG +++
Sbjct: 769 ETVERYVKIAIWCIQEEHGMRPNMRNVTQMLEGVIQV 805
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (483), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 101/222 (45%), Positives = 138/222 (62%), Gaps = 10/222 (4%)
Query: 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECE 531
L+ + + +LLVYEFM GSL + LF ++ W R IAL A+G+ YLH+EC
Sbjct: 542 LIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECR 601
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGL 590
I+HCDIK NIL+DD++ AK+SDFGLAKLL P ++ VRG+RGY+APEW +
Sbjct: 602 DCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLP 661
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV------E 644
IT KSDVYS+G+VLLE++ + NF+V+ T + S W Y F G ++ +
Sbjct: 662 ITSKSDVYSYGMVLLELVSGKRNFDVSEKT-NHKKFSIWAYEEFEKGNTKAILDTRLSED 720
Query: 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686
+ VD + RMVKT CIQ++P RP+M V+ MLEG EI
Sbjct: 721 QTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEI 762
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 8e-45, Method: Compositional matrix adjust.
Identities = 110/310 (35%), Positives = 172/310 (55%), Gaps = 24/310 (7%)
Query: 406 PLMFATKD-QYASAILFIKWSSGQANLSTHRIAPPIGN-------DKVNDKRKLLTVLAG 457
P+ FA KD Q A+ +K G S + P G+ + + +K
Sbjct: 480 PIRFAYKDLQSATNNFSVKLGQGGFG-SVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVS 538
Query: 458 CLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL---WRDRVR 514
+GSI L + L + + +LL YEF+SKGSL +F + + W R
Sbjct: 539 IIGSIHHLHLV----RLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFN 594
Query: 515 IALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGV 574
IAL A+GL YLH++C+ +I+HCDIK NIL+DD++ AK+SDFGLAKL+ Q+ + +
Sbjct: 595 IALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTM 654
Query: 575 RGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF 634
RG+RGY+APEW + I+ KSDVYS+G+VLLE+I R N++ + T+++ ++ +
Sbjct: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKM 713
Query: 635 VAGEFNKLVEEEVDKIT-----LERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPIL 689
G+ +V+ ++ + ++R +KT L CIQ++ RPSM V+ MLEG P++
Sbjct: 714 EEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVF--PVV 771
Query: 690 AFPPLSHVNS 699
P S + S
Sbjct: 772 QPPSSSTMGS 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 177 bits (449), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 95/225 (42%), Positives = 139/225 (61%), Gaps = 10/225 (4%)
Query: 477 YKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPL--WRDRVRIALDVARGLLYLHDECEVQ 533
Y S +LLVYE+M GSL +F+ E T L WR R IA+ A+G+ Y H++C +
Sbjct: 592 YCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNR 651
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITV 593
IIHCDIK NIL+DD++ K+SDFGLAK++ + +V +RG+RGY+APEW ++ ITV
Sbjct: 652 IIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPITV 711
Query: 594 KSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653
K+DVYS+G++LLEI+ R N +++ A++ W Y G K V++ + + E
Sbjct: 712 KADVYSYGMLLLEIVGGRRNLDMSYD-AEDFFYPGWAYKELTNGTSLKAVDKRLQGVAEE 770
Query: 654 RMV----KTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPPL 694
V K CIQDE ++RPSM V+ +LEGT + + PP+
Sbjct: 771 EEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSD--EINLPPM 813
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 105/274 (38%), Positives = 151/274 (55%), Gaps = 24/274 (8%)
Query: 439 PIGNDKVNDKR----KLLTVLAGCLGSITFLCFLIAISSLLVYKHRS-----------SK 483
P+ K+ND R KLL+V G F+ ++AIS++ +HR+
Sbjct: 706 PVYKGKLNDGREVAVKLLSV-GSRQGKGQFVAEIVAISAV---QHRNLVKLYGCCYEGEH 761
Query: 484 KLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
+LLVYE++ GSL LF +T L W R I L VARGL+YLH+E ++I+H D+K
Sbjct: 762 RLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEICLGVARGLVYLHEEARLRIVHRDVKAS 821
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
NIL+D K+SDFGLAKL +T I V G+ GY+APE+ G +T K+DVY+FGV
Sbjct: 822 NILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGV 881
Query: 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE---RMVKTG 659
V LE++ R N + N+ LL W +N G +L++ ++ + +E RM+
Sbjct: 882 VALELVSGRPNSDENLEDEKRYLLE-WAWNLHEKGREVELIDHQLTEFNMEEGKRMIGIA 940
Query: 660 LLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPP 693
LLC Q LRP M V+ ML G +E+ + P
Sbjct: 941 LLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKP 974
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 167 bits (424), Expect = 2e-40, Method: Compositional matrix adjust.
Identities = 96/222 (43%), Positives = 135/222 (60%), Gaps = 13/222 (5%)
Query: 482 SKKLLVYEFMSKGSLADLLF--NLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHC 537
SKKLLVY++M GSL LF +E + + W+ R +IAL ARGL YLHDEC IIHC
Sbjct: 559 SKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHC 618
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDV 597
DIK NIL+D + K++DFGLAKL+ + + ++ +RG+RGY+APEW + IT K+DV
Sbjct: 619 DIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADV 678
Query: 598 YSFGVVLLEIICCRSNFEVNVSTADEV-LLSTWVYNCFVA-GEFNKLVEE--EVDKITLE 653
YS+G++L E++ R N E S ++V +W G+ LV+ E D + +E
Sbjct: 679 YSYGMMLFELVSGRRNTE--QSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIE 736
Query: 654 ---RMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFP 692
R K CIQDE + RP+M V+ +LEG +E+ FP
Sbjct: 737 EVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 167 bits (422), Expect = 3e-40, Method: Compositional matrix adjust.
Identities = 105/267 (39%), Positives = 148/267 (55%), Gaps = 24/267 (8%)
Query: 439 PIGNDKVNDKR----KLLTVLAGCLGSITFLCFLIAISSLLVYKHRS-----------SK 483
P+ +ND R KLL+V G F+ ++AISS+L HR+
Sbjct: 707 PVYKGNLNDGRVVAVKLLSV-GSRQGKGQFVAEIVAISSVL---HRNLVKLYGCCFEGEH 762
Query: 484 KLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
++LVYE++ GSL LF +T L W R I L VARGL+YLH+E V+I+H D+K
Sbjct: 763 RMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGVARGLVYLHEEASVRIVHRDVKAS 822
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
NIL+D +ISDFGLAKL +T I V G+ GY+APE+ G +T K+DVY+FGV
Sbjct: 823 NILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIGYLAPEYAMRGHLTEKTDVYAFGV 882
Query: 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE---RMVKTG 659
V LE++ R N + N+ + LL W +N +L+++++ +E RM+
Sbjct: 883 VALELVSGRPNSDENLEEEKKYLLE-WAWNLHEKSRDIELIDDKLTDFNMEEAKRMIGIA 941
Query: 660 LLCIQDEPNLRPSMKNVILMLEGTMEI 686
LLC Q LRP M V+ ML G +EI
Sbjct: 942 LLCTQTSHALRPPMSRVVAMLSGDVEI 968
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 165 bits (418), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 90/211 (42%), Positives = 123/211 (58%), Gaps = 12/211 (5%)
Query: 484 KLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
+LLVY++M +GSL+ L + L W R RIAL A+G+ YLH+ C IIHCDIK
Sbjct: 530 RLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKGIAYLHEGCRDCIIHCDIKPE 589
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
NIL+D + AK+SDFGLAKLL + + ++A +RG+ GY+APEW + IT K+DVYSFG+
Sbjct: 590 NILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVAPEWISGLPITTKADVYSFGM 649
Query: 603 VLLEIICCRSNFEVNVSTADEV-------LLSTWVYNCFVAGEFNKLVEE----EVDKIT 651
LLE+I R N VN T E W + G + +V+ E +
Sbjct: 650 TLLELIGGRRNVIVNSDTLGEKETEPEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEE 709
Query: 652 LERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682
+ RM + CIQD +RP+M V+ MLEG
Sbjct: 710 VTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 164 bits (414), Expect = 3e-39, Method: Compositional matrix adjust.
Identities = 95/244 (38%), Positives = 138/244 (56%), Gaps = 26/244 (10%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCD 538
R + LLVYE+M+ GSL LF+ L W++R IAL ARGL YLH C+ +IIHCD
Sbjct: 580 RGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCD 639
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
+K NIL+ D ++ KISDFGL+KLL ++ + +RG+RGY+APEW + I+ K+DVY
Sbjct: 640 VKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVY 699
Query: 599 SFGVVLLEIICCRSN--FEVNVSTADE----------------VLLSTWVYNCFVAGEFN 640
S+G+VLLE++ R N F ++ E V + + G +
Sbjct: 700 SYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHEQGRYM 759
Query: 641 KL----VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPPLSH 696
+L +E V E++V+ L C+ +EP LRP+M V+ M EG+ IP L P +
Sbjct: 760 ELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGS--IP-LGNPRMES 816
Query: 697 VNSL 700
+N L
Sbjct: 817 LNFL 820
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 162 bits (409), Expect = 1e-38, Method: Compositional matrix adjust.
Identities = 84/209 (40%), Positives = 129/209 (61%), Gaps = 11/209 (5%)
Query: 482 SKKLLVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
++KLLVY +MS GS+A ++ +P+ W R RIA+ ARGL+YLH++C+ +IIH D+
Sbjct: 380 TEKLLVYPYMSNGSVAS---RMKAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDV 436
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
K NIL+DD A + DFGLAKLL + + VRG+ G++APE+ ++G + K+DV+
Sbjct: 437 KAANILLDDYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFG 496
Query: 600 FGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV------DKITLE 653
FG++LLE++ + FE + + ++ WV + LV++E+ D+I L+
Sbjct: 497 FGILLLELVTGQRAFEFGKAANQKGVMLDWVKKIHQEKKLELLVDKELLKKKSYDEIELD 556
Query: 654 RMVKTGLLCIQDEPNLRPSMKNVILMLEG 682
MV+ LLC Q P RP M V+ MLEG
Sbjct: 557 EMVRVALLCTQYLPGHRPKMSEVVRMLEG 585
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 702 | ||||||
| 147811984 | 739 | hypothetical protein VITISV_011721 [Viti | 0.938 | 0.891 | 0.353 | 1e-103 | |
| 359477048 | 792 | PREDICTED: G-type lectin S-receptor-like | 0.669 | 0.593 | 0.469 | 1e-103 | |
| 125529231 | 723 | hypothetical protein OsI_05328 [Oryza sa | 0.924 | 0.897 | 0.336 | 1e-100 | |
| 224116056 | 776 | predicted protein [Populus trichocarpa] | 0.649 | 0.587 | 0.435 | 8e-97 | |
| 224116040 | 781 | predicted protein [Populus trichocarpa] | 0.618 | 0.555 | 0.455 | 7e-96 | |
| 225431567 | 762 | PREDICTED: G-type lectin S-receptor-like | 0.611 | 0.562 | 0.45 | 7e-96 | |
| 224073224 | 699 | predicted protein [Populus trichocarpa] | 0.903 | 0.907 | 0.335 | 3e-95 | |
| 147782422 | 762 | hypothetical protein VITISV_038481 [Viti | 0.611 | 0.562 | 0.445 | 5e-95 | |
| 225431571 | 762 | PREDICTED: G-type lectin S-receptor-like | 0.606 | 0.559 | 0.445 | 2e-93 | |
| 224143661 | 691 | predicted protein [Populus trichocarpa] | 0.864 | 0.878 | 0.335 | 4e-91 |
| >gi|147811984|emb|CAN59770.1| hypothetical protein VITISV_011721 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 382 bits (981), Expect = e-103, Method: Compositional matrix adjust.
Identities = 257/728 (35%), Positives = 374/728 (51%), Gaps = 69/728 (9%)
Query: 21 AQNHQLKSTISLGSSLSPSGQHSW-NSSSGLFQFGFYKQGSG-YSLGIWLVTSPNITVVW 78
+ + Q+ + GSSL +S+ S +G F FGF + GSG + L IW P TVVW
Sbjct: 33 SSDAQISRNFTSGSSLIARDNNSFLASPNGDFAFGFQQVGSGGFLLAIWFNKVPERTVVW 92
Query: 79 TANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSN 138
+AN D + + + + LT DG+ +L + K+ ADL ++A+MLD+GNFVL +
Sbjct: 93 SANXDSL-VQTGSRVQLTTDGEFMLNDPKGKQMWKADLN-STGVAYAAMLDTGNFVLAGH 150
Query: 139 RSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNM- 197
S +W+SF+ PTDTIL Q L L++ +E N S+GRF L +Q DGN+VLY +
Sbjct: 151 NSTYLWQSFNHPTDTILPTQILNQXSKLVARFSEVNYSSGRFMLILQTDGNLVLYTTDFP 210
Query: 198 LNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVI 257
++ A AYWA T ++ + +G + L+ N+ + S K
Sbjct: 211 MDSANSAYWATAT-----VGIGFQVIYNESGDIYLIGNNRRK---LSDVLSNKEPTGEFY 262
Query: 258 YRTTLDSDGILRLYSHHFKNDGNSTVGIEWSAL-----EKQCV------VKGFCGLNSYC 306
R L+ DG+ R Y H S + WS L E C G CG NSYC
Sbjct: 263 QRAILEYDGVFRQYVH--PKSAGSGPPMAWSPLSAFIPENICTNITASTGSGACGFNSYC 320
Query: 307 STSTNISTKGDCHCFRGFNFINPKMKFLGCYRNFSDE---EGCKRKMPAEFYNITSLKIT 363
+ + + C C G+ F++P + GC ++F E EG +F +T+ +
Sbjct: 321 TLGDH--QRPICKCPPGYTFLDPHNEVKGCRQDFYPEICDEGSHETGRFDFERMTN--VD 376
Query: 364 WLGGLPYAKLSV-SKKDCSKSCLNDCYFGAAFYSDGACSKHKFPLMFATKDQYASAILFI 422
W Y + + ++ DC K+CL DC+ A + DG C K K PL K + +
Sbjct: 377 WPTS-DYDRFQLFTEDDCRKACLEDCFCAVAIFRDGDCWKKKIPLSNGRKPAIIESQQVM 435
Query: 423 KWSSGQANLSTHRIAPPIGNDKVN-DKRKLLTVLAG-CLGSITFLC------------FL 468
+ Q+ + H + K K TV G C G++ + F
Sbjct: 436 VGRNLQS-FTYHELEEATNGFKDELGKGAFGTVYKGSCNGNLVAVKKLERMVKEGEREFE 494
Query: 469 IAISSLLVYKHRSS-----------KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIAL 517
+S+++ H++ +LLVYEFMS GSLA LF +RP W R++I L
Sbjct: 495 TEVSAIVRTNHKNLVQLLGFCNEGLHRLLVYEFMSNGSLATFLFG-SSRPKWHQRIQIIL 553
Query: 518 DVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS 577
A+GLLYLH+EC +Q IHCDIK +NIL+DDS A+ISDFGLAK L +QT + G+RG+
Sbjct: 554 GTAKGLLYLHEECSIQTIHCDIKPQNILLDDSLTARISDFGLAKFLKTDQTRTMTGIRGT 613
Query: 578 RGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG 637
+GY+APEW + ITVK DVYSFG+VLLE+I CR NFE V+L+ Y C+ G
Sbjct: 614 KGYVAPEWFKTVPITVKVDVYSFGIVLLELIFCRKNFEAEAEDKSPVVLAELAYYCYKEG 673
Query: 638 EFNKLVEEEVDKIT----LERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPP 693
+ + L++ + + + LE+ V CIQD+P+ RP MK V MLEG +E+ + PP
Sbjct: 674 KLDMLLDNDEEALEDMERLEKFVMIAFWCIQDDPHQRPGMKKVTQMLEGAIEV---SSPP 730
Query: 694 LSHVNSLS 701
S +LS
Sbjct: 731 DSSSFTLS 738
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477048|ref|XP_002275811.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 381 bits (978), Expect = e-103, Method: Compositional matrix adjust.
Identities = 228/486 (46%), Positives = 297/486 (61%), Gaps = 16/486 (3%)
Query: 1 MASVSVALILLFTVSEIIRAAQNHQLKSTISLGSSLSP--SGQHSWNSSSGLFQFGFYKQ 58
MASV L + + +L ISL SSLSP W S SGLF FGFY Q
Sbjct: 1 MASVWFVFFLPLLCVGVRAQPEKAKL---ISLNSSLSPKYGSPMGWASPSGLFAFGFYPQ 57
Query: 59 GSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVF 118
GSG+S+GIWLV + TVVWTANRD+ P +NA L T DGKL+L+TEE E I D
Sbjct: 58 GSGFSVGIWLVGTDENTVVWTANRDDPPASANAKLYFTEDGKLLLQTEEGSEISITD--G 115
Query: 119 DEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTG 178
PA ASMLDSG+FVLY +IW SFS PTDT+LGGQ+L++ + ++SS + +N S+G
Sbjct: 116 SGPAVAASMLDSGSFVLYDQNLSVIWNSFSYPTDTLLGGQNLDSNKKMVSSESRSNHSSG 175
Query: 179 RFCLNMQEDGNIVLYPRNMLNKALEAYWANGTDIQSEYP-YSVKLNLSPNGVLQLLSGNK 237
F L MQ DGN+V YP N ++ ++YW++GT S YS +L+L+ G L L SG
Sbjct: 176 WFFLAMQGDGNLVSYPVNSSGESDDSYWSSGTSSASRLNFYSTQLSLNTEGALYLSSGMS 235
Query: 238 TQKI-LFRSSYSLKSMNETVIYRTTLDSDGILRLYSHHFKNDGNSTVGIEWSALEKQCVV 296
+ I FR+S S S N+T IYR T D DGI RLYSH F+N+G+S I WS+L QC V
Sbjct: 236 SLIIQTFRNS-SNPSKNKTTIYRATFDPDGIFRLYSHRFENNGSSNESIVWSSLSDQCDV 294
Query: 297 KGFCGLNSYCSTSTNISTKGDCHCFRGFNFINPKMKFLGCYRNFSDEEGCKRKMPAEFYN 356
KGFCG NSYCS N K +CHC GF F NP K GC R F+ ++ K YN
Sbjct: 295 KGFCGFNSYCS---NPGAKAECHCLPGFAFNNPSEKIRGCSRIFNGDDCSKMNNQLISYN 351
Query: 357 ITSLKITWLGGLPYAKLSVSKKDCSKSCLNDCYFGAAFYSDGACSKHKFPLMFATKDQYA 416
IT+L+ T G PY K S+ ++CSK CL+DC GAA Y +G+C K+K P+ + ++
Sbjct: 352 ITTLENTGWGDYPYYKKSMKMEECSKFCLDDCNCGAALYRNGSCYKYKLPVRYGRINRNE 411
Query: 417 SAILFIKWSSGQANLSTHRIAP-PIGND-KVNDKRKLLTVLAGCLGSITFLCFLIAISSL 474
+A +K Q S +R P P+ + K++ K+ L+ VL+ LGSI FLC +IAISS
Sbjct: 412 TATALLK-GHLQRVKSAYRPPPAPMNTEVKIDGKKTLILVLSLSLGSIAFLCLVIAISSF 470
Query: 475 LVYKHR 480
VY+H+
Sbjct: 471 WVYRHQ 476
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125529231|gb|EAY77345.1| hypothetical protein OsI_05328 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 372 bits (956), Expect = e-100, Method: Compositional matrix adjust.
Identities = 239/711 (33%), Positives = 359/711 (50%), Gaps = 62/711 (8%)
Query: 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQP 86
++ ++ G+S+ W+S SG F FGFY G ++G+WL T+P+ITV WTA+R++ P
Sbjct: 26 QTNVTSGASVQAVAGAGWSSPSGHFVFGFYATDGGLAVGVWLATAPSITVTWTASRNDTP 85
Query: 87 MPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146
A L LT DG+L+ +++ +A A+M D GNFVLY+ + + W +
Sbjct: 86 ATGGA-LRLTYDGRLLWTGANGQDRTVAAPPQPA--VAAAMRDDGNFVLYAANATVAWST 142
Query: 147 FSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQ-EDGNIVLYPRNMLNKALEAY 205
F+ PTDT+L GQ L G L SSV+ T+ +TG++ L Q DGN+V+YP +N A AY
Sbjct: 143 FAAPTDTLLAGQDLAPGAQLFSSVSATSRATGKYRLTNQLNDGNLVMYPAGTMNVAAAAY 202
Query: 206 WANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSD 265
W GT Q +P +++L+ S GVL L+ N + + + +++ + +R TLD D
Sbjct: 203 WDTGT-FQIGFPLTLRLDAS--GVLYLVGNNGSYTKNLTKASAAQAVEQAHYHRVTLDPD 259
Query: 266 GILRLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYCSTSTNISTKGDCHCFRGFN 325
G+LR Y H + G +EW +C VKG CG NSYC + + C C GF+
Sbjct: 260 GVLRSYRHGLLSSGGWKTDVEWIGPSDRCHVKGACGFNSYCVLDRD--AQPSCLCPPGFD 317
Query: 326 FINPKMKFLGCYRNFSDEE--GCKRKMPAEFYNITSLKITWLGGLPYAKLSV--SKKDCS 381
I+ GC + E +R P T ++W P L+ S DC
Sbjct: 318 LIDAGDAAGGCTASSGAGECTAGQRADPGSSM-ATMQNVSW-ADTPCGVLAAGTSAADCQ 375
Query: 382 KSCLNDCYFGAAFY--SDGACSKHKFPLMFATKDQYASAILFIKWSSGQANLSTHRIAPP 439
+C++DC+ AA +DG C+K + PL + +F+K +
Sbjct: 376 AACMSDCFCVAALLDTNDGTCTKQQLPLRYGRAG--GGYTMFVKTGGAASPALGGGGGGN 433
Query: 440 IGNDKVNDKRKLLTVLAGCLGSITF--LCFLIAISSLLVYKHRSSKKLLV---------- 487
+ ++ R+ TV C+G +TF LC L+A + LL R ++ +
Sbjct: 434 HHHHRL---RRASTVALVCVGLLTFVALCALLASARLLWLNQRMVRRRVALADAEALDEE 490
Query: 488 ---------------YEF---MSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLH 527
Y F + +G+ + R R R+ V G
Sbjct: 491 APLRSYSYEELEHATYSFRHHLGRGAFGTVFKGTLRRGGERTVAVKRLEKLVEDGEREFQ 550
Query: 528 DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW-Q 586
E + ++IHCD+K +NIL+D + AKISDFGLAKLL P+ T VRG+RGY+APEW +
Sbjct: 551 RELDSRVIHCDVKPQNILMDAAGTAKISDFGLAKLLQPDHTRTFTSVRGTRGYLAPEWYR 610
Query: 587 NSGLITVKSDVYSFGVVLLEIICC-RSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV-- 643
+G +TVK+DVYS+GVVLLE + C RS + +E L+ W Y + K
Sbjct: 611 GAGPVTVKADVYSYGVVLLETVACRRSMEMEEAAGEEERTLAEWAYELLLVKSEAKSAMS 670
Query: 644 -EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPP 693
+E V+ +ER+V+ + C+Q EP RPSM VILML+G +E+P FPP
Sbjct: 671 SDETVEAAEVERVVRVAMWCVQVEPQSRPSMDGVILMLQGRLEVP---FPP 718
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116056|ref|XP_002332037.1| predicted protein [Populus trichocarpa] gi|222875262|gb|EEF12393.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 361 bits (926), Expect = 8e-97, Method: Compositional matrix adjust.
Identities = 212/487 (43%), Positives = 292/487 (59%), Gaps = 31/487 (6%)
Query: 8 LILLFTVSEIIRAAQNHQLKSTISLGSSLSPSGQ-HSWNSSSGLFQFGFYKQGSGYSLGI 66
+L+ + + + + QNH + ISLGSS+S + Q SW S SG F FGFY QGSG+ +GI
Sbjct: 9 FLLVICIYKPVSSQQNHS--NLISLGSSISTNVQPTSWRSPSGTFAFGFYPQGSGFIVGI 66
Query: 67 WLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFAS 126
WLV P + WTA RD+ P+PSNATL LT++GKL+L+T + + E A+ AS
Sbjct: 67 WLVCKPADIITWTAYRDDPPVPSNATLELTINGKLLLRTYSANNEA-------EIAASAS 119
Query: 127 MLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQE 186
MLDSGNFVLYS S +IW+SF PTDTIL GQ+L + + L+SSV+ +N S+GRF L MQE
Sbjct: 120 MLDSGNFVLYSG-SSVIWQSFDYPTDTILVGQNLTDFDKLVSSVSSSNHSSGRFFLAMQE 178
Query: 187 DGNIVLYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSS 246
DGN+V YP N ++++AYWA+ T ++ + L L+ G L + + +K +L SS
Sbjct: 179 DGNLVAYPTNSAGESVDAYWASSTTGDNK---GLSLYLNQQGFLSMDTVSKKPVLLASSS 235
Query: 247 YSLKSMNETVIYRTTLDSDGILRLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYC 306
Y N+T I+R TLD+DGI RLYSH +N + +V IEWSAL QC V GFC NSYC
Sbjct: 236 YPCN--NKTTIFRATLDADGIFRLYSHCLENKTSRSVHIEWSALNNQCNVHGFCDFNSYC 293
Query: 307 STSTNISTKGDCHCFRGFNFINPKMKFLGCYRNFSDEEGCKRKMPAEFYNITSLKITWLG 366
S + T DC C+ GF F +P KF GCY+N + E C+ E Y++ +++
Sbjct: 294 S---GMGTNFDCSCYPGFAFNDPSEKFSGCYKNVT-ESFCRGTKEGEMYDVKAVENILFE 349
Query: 367 GLPYAKLSVSKKDCSKSCLNDCYFGAAFYSDGACSKHKFPLMFATKDQYASAILFIKWSS 426
PY+ L V K++C SCL DC A Y + C K+ P+ + KD S+I F K +
Sbjct: 350 RFPYSVLHVKKENCGLSCLEDCLCDVALYMNEKCEKYAAPIRYGLKDINISSIAFFKVKA 409
Query: 427 GQANLSTHRIAPPIGND-KVNDKRKLLTVLAGCLGSITFLCFLIAISSLLVYKHRSSKKL 485
APP+ + K+ LL LA GS+T LCF+IAIS+ VY+ R+
Sbjct: 410 ASP------AAPPMSPTIIIESKKSLLVFLAIAFGSVTLLCFVIAISTFCVYRDRA---- 459
Query: 486 LVYEFMS 492
+YE +S
Sbjct: 460 FLYEKLS 466
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116040|ref|XP_002332033.1| predicted protein [Populus trichocarpa] gi|222875258|gb|EEF12389.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 358 bits (918), Expect = 7e-96, Method: Compositional matrix adjust.
Identities = 207/454 (45%), Positives = 278/454 (61%), Gaps = 20/454 (4%)
Query: 30 ISLGSSLSP-SGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMP 88
I LGS LSP S +SW S SG F FGFY QG+G+++GIW++ PN TVVWTANRD++P+
Sbjct: 29 IHLGSQLSPISNLNSWQSPSGNFAFGFYSQGNGFAVGIWMMGQPNNTVVWTANRDDEPVS 88
Query: 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFS 148
NAT+ L+ +GKL+L+TE+ E IA++ E A+ ASMLDSGNFVLY N S +IW+SF
Sbjct: 89 FNATIHLSEEGKLLLRTEQGNENLIANV--SEIAASASMLDSGNFVLY-NGSSVIWQSFD 145
Query: 149 TPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWAN 208
PTDTIL GQ+L + L+SSV+ +N S+GRF L MQ DGN+V YP N +++AYWA+
Sbjct: 146 YPTDTILVGQNLTYSDKLVSSVSSSNHSSGRFFLAMQADGNLVAYPTNSAGLSVDAYWAS 205
Query: 209 GTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGIL 268
T S+ S+ N G L + + +K +L RSSY N+T I+R TLD+DGI
Sbjct: 206 NTYKDSKKGLSLYFN--HQGFLFMDTVSKKPVLLARSSYPCN--NKTTIFRATLDADGIF 261
Query: 269 RLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYCSTSTNISTKGDCHCFRGFNFIN 328
RLYSH +N + +V IEWSAL C V+GFC NSYCS + T DC C+ GF F +
Sbjct: 262 RLYSHCLENKTSRSVHIEWSALNNTCNVRGFCDFNSYCS---GMGTNADCSCYPGFAFND 318
Query: 329 PKMKFLGCYRNFSDEEGCKRKMPAEFYNITSLKITWLGGLPYAKLSVSKKDCSKSCLNDC 388
P KF GCY+N E C + ++ +++ PY+ L K++C SCL DC
Sbjct: 319 PSEKFSGCYKNVP-ESFCTDTKDGQMNDVITVENILFERYPYSVLDEKKENCGLSCLEDC 377
Query: 389 YFGAAFYSDGACSKHKFPLMFATKDQYASAILFIKWSSGQANLSTHRIAPPIG-NDKVND 447
A Y + C K+ P+ + KD AS+I F K A APP+ +
Sbjct: 378 LCDVALYMNERCEKYTAPIRYGIKDINASSIAFFKVKPTPA-------APPMSLTIIIES 430
Query: 448 KRKLLTVLAGCLGSITFLCFLIAISSLLVYKHRS 481
K+ LL LA GS+TFLCF+IAIS+ VY+ R+
Sbjct: 431 KKSLLVFLAIAFGSVTFLCFVIAISTFCVYRDRA 464
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431567|ref|XP_002276274.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 358 bits (918), Expect = 7e-96, Method: Compositional matrix adjust.
Identities = 207/460 (45%), Positives = 282/460 (61%), Gaps = 31/460 (6%)
Query: 30 ISLGSSLSPS-GQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMP 88
I LGSSLSP+ G SW S SG F FGFY Q +G+++G+WLV TVVWTANRD+ P+
Sbjct: 13 IELGSSLSPTNGSSSWVSPSGHFAFGFYPQDTGFAVGVWLVGQSGKTVVWTANRDDPPVS 72
Query: 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYS-NRSGIIWESF 147
SN L T +GKL+L+T +E IAD+ E ++ ASMLDSGNFVL+ N S IIW+SF
Sbjct: 73 SNTALEFTRNGKLLLRTGPGEEVSIADVA--ESSASASMLDSGNFVLFGDNSSFIIWQSF 130
Query: 148 STPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWA 207
PTDT+LGGQ+L N +LSS +S+ G F L++Q G IV YP NM + + YW
Sbjct: 131 QHPTDTLLGGQNLSN---ILSSSKTESSAIGGFFLSLQSGGRIVSYPYNM-GVSEDPYWT 186
Query: 208 NGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGI 267
D + +L+ G+L L + S + NET+IYR TLD DG+
Sbjct: 187 --VDAR---------DLNDKGLLSSYDATSNVLTLASNISSDDAKNETIIYRATLDVDGV 235
Query: 268 LRLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYCSTSTNISTKGDCHCFRGFNFI 327
RLYSH F N S+V I WSA + C VKG CG+N CS++ T +C C GF I
Sbjct: 236 FRLYSHSFGNSNISSVSIMWSAFKNPCDVKGLCGVNGLCSSN---GTNANCSCVPGFVSI 292
Query: 328 NPKMKFLGCYRNFSDEEGCKRKMPAEFYNITSLK-ITWLGGLPYAKL-SVSKKDCSKSCL 385
N + K+ GCYR+F++EEGC+ + P YNIT+L+ ++W G PY+ L S++++ CS+SCL
Sbjct: 293 N-REKYSGCYRSFNNEEGCRGQEPESLYNITTLRNVSWEGANPYSALTSLNEQGCSRSCL 351
Query: 386 NDCYFGAAFYSDGACSKHKFPLMFATKDQYASAILFIKWSSGQANLSTHRIAPPIGNDKV 445
DC AA+Y +G C ++K PL+ +Q S I F+K S G A + I P KV
Sbjct: 352 QDCNCWAAYYFNGTCRRYKLPLVHGIANQNESGITFLKMSLGTAYVGDD-IPAPRNQTKV 410
Query: 446 --NDKRKLLTVLAGCLGSITFLCFLIAISSLLVYK---HR 480
++K++L+ +LA LGSI FLC L+A+SS +Y+ HR
Sbjct: 411 IESNKKELILILASSLGSIAFLCALVAVSSFFIYRSQVHR 450
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224073224|ref|XP_002304031.1| predicted protein [Populus trichocarpa] gi|222841463|gb|EEE79010.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 355 bits (912), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 248/739 (33%), Positives = 371/739 (50%), Gaps = 105/739 (14%)
Query: 25 QLKSTISLGSSLSPSGQH-SWNSSSGLFQFGFYK--QGSGYSLGIWLVTSPNITVVWTA- 80
Q + +G+S++ + SW S+SG F FGF + + L IW P TVVW A
Sbjct: 5 QTNGRVPVGASITATDDSPSWLSASGEFAFGFRQLENKDYFLLSIWYEKIPEKTVVWYAI 64
Query: 81 ---NRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDE-----PASFASMLDSGN 132
D+ +P + + LT D L+L P +L++ S M D+GN
Sbjct: 65 GEDPTDDPAVPRGSKVELTDDRGLLLA------DPQGNLIWTSRILLGAVSSGVMNDTGN 118
Query: 133 FVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVL 192
FVL + S +WESF+ PTDT+L Q +E G + S TETN S GRF L + ++GN+VL
Sbjct: 119 FVLQNRNSERLWESFNNPTDTLLPTQIMEAGGVVSSRRTETNFSLGRFQLRLLDNGNLVL 178
Query: 193 YPRNMLNK-ALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKS 251
N+ K A + Y+ +GT S S N ++LF S
Sbjct: 179 NSMNLSTKFAYDDYYRSGTSDASN------------------SSNTGYRLLFNES----- 215
Query: 252 MNETVIYRTTLDSDGILRLYSHHFKNDGNSTVGIEWSALEKQCV------VKGFCGLNSY 305
+++R ++ H+ ++ S+V WS + CV G CG NS
Sbjct: 216 --GYILWRPPPSPSSLISADIHYIQS--WSSV---WSKPDDICVNMGADLGSGACGYNSI 268
Query: 306 CSTSTNISTKGDCHCFRGFNFINPKMKFLGCYRNFSDEEGCK----RKMPAEFYNITSLK 361
C+ + + +C C +GF+ ++ K+ C +F E C+ ++ + +
Sbjct: 269 CNLKAD--KRPECKCPQGFSLLDQNDKYGSCIPDF--ELSCRDDGLNSTEDQYDFVELIN 324
Query: 362 ITWLGGLPYAKLSVSKKDCSKSCLNDCYFGAAFYSDGACSKHKFPLMFATKDQYASAILF 421
+ W +++ +C KSCLNDC A + DG C K K PL D + F
Sbjct: 325 VDWPTSDYERYKPINEDECRKSCLNDCLCSVAIFRDG-CWKKKLPLSNGRFDIGMNGKAF 383
Query: 422 IKWSSGQANLS--THRIAPPIGND-----------------------KVNDKRKLLTVLA 456
+K+ G NL T++ ND +V +KL V+
Sbjct: 384 LKFPKGYTNLRYFTYKELAEATNDFKDEVGRGGFGVVYKGTIQAGSTRVVAVKKLDKVVQ 443
Query: 457 GCLGSITFLCFLIAISS--------LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL 508
G F + I LL + +LLVYEF+S G+LA+ LF ++P
Sbjct: 444 D--GEKEFKTEVQVIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGC-SKPN 500
Query: 509 WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568
W+ R +IA +ARGLLYLH+EC QIIHCDIK +NIL+D+ + A+ISDFGLAKLL+ +Q+
Sbjct: 501 WKQRTQIAFGIARGLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQS 560
Query: 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628
+RG++GY+APEW + ITVK DVYSFGV+LLEIICCR N ++ + + +L+
Sbjct: 561 KTQTAIRGTKGYVAPEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTD 620
Query: 629 WVYNCFVAGEFNKLV----EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684
W Y+C++ G + L+ E + D TLER++K G+ CIQ++P+LRP+M+ V MLEG +
Sbjct: 621 WAYDCYMDGSLDVLIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVV 680
Query: 685 EIPILAFP-PLSHVNSLSH 702
E+P P P S ++ SH
Sbjct: 681 EVPAAPNPFPYSSISKYSH 699
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147782422|emb|CAN72833.1| hypothetical protein VITISV_038481 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 355 bits (911), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 205/460 (44%), Positives = 280/460 (60%), Gaps = 31/460 (6%)
Query: 30 ISLGSSLSPS-GQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMP 88
I LGSSLSP+ G SW S SG F FGFY Q +G+++G+WLV TVVWTANRD+ P+
Sbjct: 13 IELGSSLSPTNGSSSWVSPSGHFAFGFYPQDTGFAVGVWLVGQSGKTVVWTANRDDPPVS 72
Query: 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYS-NRSGIIWESF 147
SN L T +GKL+L+T +E IAD+ E + ASMLDSGNFVL+ N S IIW+SF
Sbjct: 73 SNTALEFTRNGKLLLRTGPGEEVSIADVA--ESXASASMLDSGNFVLFGDNSSFIIWQSF 130
Query: 148 STPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWA 207
PTBT+LGGQ+L N +LSS + + G F L++Q G IV YP NM + + YW
Sbjct: 131 QHPTBTLLGGQNLSN---ILSSSKTESXAIGGFFLSLQSGGRIVSYPYNM-GVSEDPYWT 186
Query: 208 NGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGI 267
D + +L+ G+L L + S + NET+IYR TLD DG+
Sbjct: 187 --VDAR---------DLNDKGLLSSYDATSNVLTLASNISSDDAKNETIIYRATLDVDGV 235
Query: 268 LRLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYCSTSTNISTKGDCHCFRGFNFI 327
RLYSH F N S+V I WSA + C VKG CG+N CS++ T +C C GF I
Sbjct: 236 FRLYSHSFGNSNISSVSIMWSAFKNPCDVKGLCGVNGLCSSN---GTNANCSCVPGFVSI 292
Query: 328 NPKMKFLGCYRNFSDEEGCKRKMPAEFYNITSLK-ITWLGGLPYAKL-SVSKKDCSKSCL 385
N + K+ GCYR+F++EEGC+ + P YNIT+L+ ++W G PY+ L S++++ CS+SCL
Sbjct: 293 N-REKYSGCYRSFNNEEGCRGQEPESLYNITTLRNVSWEGANPYSALTSLNEQGCSRSCL 351
Query: 386 NDCYFGAAFYSDGACSKHKFPLMFATKDQYASAILFIKWSSGQANLSTHRIAPPIGNDKV 445
DC AA+Y +G C ++K PL+ +Q S I F+K S G A + I P KV
Sbjct: 352 QDCNCWAAYYFNGTCRRYKLPLVHGIANQNESGITFLKMSLGTAYVGDD-IPAPRNQTKV 410
Query: 446 --NDKRKLLTVLAGCLGSITFLCFLIAISSLLVYK---HR 480
++K++L+ +LA LGSI FLC L+A+SS +Y+ HR
Sbjct: 411 IESNKKELILILASSLGSIAFLCALVAVSSFFIYRSQVHR 450
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431571|ref|XP_002276322.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 350 bits (897), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 209/469 (44%), Positives = 285/469 (60%), Gaps = 43/469 (9%)
Query: 30 ISLGSSLSP-SGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMP 88
I LGSSL P +G SW S SG F FGFY QG+G+++G+WLV+ TVVWTANRD+ +
Sbjct: 13 IKLGSSLFPHNGSSSWVSPSGHFAFGFYPQGTGFAVGVWLVSQSGNTVVWTANRDKPLVS 72
Query: 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYS-NRSGIIWESF 147
N TL T +GKL+L+T ++ IAD+ E A+ ASMLDSGNFVL+ N S IIW+SF
Sbjct: 73 FNTTLEFTTNGKLLLRTGPGEQITIADVA--ESAASASMLDSGNFVLFGDNSSSIIWQSF 130
Query: 148 STPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWA 207
PTDT+LGGQ+ G+ L S TE+ + G F L+ DG IV YP N L + + YW
Sbjct: 131 QYPTDTLLGGQNFSTGDILSSRKTES-PAIGDFYLSTS-DGQIVSYPYN-LAVSEDPYWT 187
Query: 208 ------NGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTT 261
N + S Y + L L+ N + S + NET+IYR T
Sbjct: 188 VDARDLNDMGLLSSYD-AFTLTLASNNI-----------------SSDDAKNETIIYRAT 229
Query: 262 LDSDGILRLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYCSTSTNISTKGDCHCF 321
LD DGI RLYSH F N STV I WSA++ C VKG CG+N+ CS++ T +C C
Sbjct: 230 LDVDGIFRLYSHSFGNSNISTVSIMWSAIKNPCDVKGLCGVNALCSSN---GTNANCSCV 286
Query: 322 RGFNFINPKMKFLGCYRNFSDEEGCKRKMPAEFYNITSLK-ITWLGGLPYAKL-SVSKKD 379
GF IN + K+ GCYR+F++EEGC+ + P YNIT+L+ ++W PY+ + S+++KD
Sbjct: 287 PGFVSIN-REKYSGCYRSFNNEEGCRGQEPESIYNITTLRNVSWKDANPYSGIKSLNEKD 345
Query: 380 CSKSCLNDCYFGAAFYSDGACSKHKFPLMFATKDQYASAILFIKWSSGQANLSTHRIAPP 439
CS+SCL DC AA+Y +G C ++K PL++ +Q S I F+K S G A + + I P
Sbjct: 346 CSRSCLQDCNCWAAYYFNGTCRRYKLPLVYGIANQNESGITFLKMSLGTAYVGDN-IPAP 404
Query: 440 IGNDKV--NDKRKLLTVLAGCLGSITFLCFLIAISSLLVYK---HRSSK 483
KV ++K++L+ +LA LGSI FLC L+A+SS +Y+ HR K
Sbjct: 405 RNQTKVIESNKKELILILASSLGSIAFLCALVAMSSFFIYRSQVHRYRK 453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143661|ref|XP_002336066.1| predicted protein [Populus trichocarpa] gi|222869874|gb|EEF07005.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 342 bits (877), Expect = 4e-91, Method: Compositional matrix adjust.
Identities = 242/721 (33%), Positives = 361/721 (50%), Gaps = 114/721 (15%)
Query: 43 SWNSSSGLFQFGF----YKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMD 98
SW SSSG F FGF YK + L IW P T+VW AN D P P + + L D
Sbjct: 18 SWLSSSGEFAFGFQPLEYKDH--FLLSIWYAKIPEKTIVWYANGD-NPAPRESKVELRGD 74
Query: 99 GKLILKTEESKEKPIADLVFDEPA-----SFASMLDSGNFVLYSNRSGIIWESFSTPTDT 153
L+L P +L++ + S M D+GNFVL ++ S +WESFS PTDT
Sbjct: 75 SGLVLT------DPQGNLIWSSGSLLGTVSSGVMNDTGNFVLQNSNSFRLWESFSNPTDT 128
Query: 154 ILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKAL--EAYWANGTD 211
+L Q +E G + S TETN S GRF L + ++GN+VL N+ K + + Y + +D
Sbjct: 129 LLPTQIMEVGGVVSSRRTETNFSLGRFQLRLLDNGNLVLNYMNLPTKFVYDDYYSSETSD 188
Query: 212 IQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLY 271
+ +L + +G + +L N + L +++ L +++ +R TL+ D L
Sbjct: 189 ASNSSNSGYRLIFNESGYMYILRRNGLIEDLTKTA--LPTID--FYHRATLNFDADLG-- 242
Query: 272 SHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYCSTSTNISTKGDCHCFRGFNFINPKM 331
G CG NS C+ + + +C C +GF+ ++
Sbjct: 243 -------------------------SGACGYNSICNLKAD--KRPECKCPQGFSLLDQND 275
Query: 332 KFLGCYRNFSDEEGCK----RKMPAEFYNITSLKITWLGGLPYAKLSVSKKDCSKSCLND 387
K+ C +F E C+ ++ + + + W +++ +C KSCLND
Sbjct: 276 KYGSCIPDF--ELSCRDDGLNSTEDQYDFVELINVDWPTSDYERYKPINEDECRKSCLND 333
Query: 388 CYFGAAFYSDGACSKHKFPLMFATKDQYASAILFIKWSSG-------------QANLS-- 432
C A + DG C K K PL D + F+K+ G + NL
Sbjct: 334 CLCSVAIFRDG-CWKKKLPLSNGRFDIGMNGKAFLKFPKGYKTEKVKEGGSGLETNLRYF 392
Query: 433 THRIAPPIGND-----------------------KVNDKRKLLTVLAGCLGSITFLCFLI 469
T++ ND +V +KL V+ G F +
Sbjct: 393 TYKELAEATNDFKDEVGRGGFGVVYKGTIQAGSTRVVAVKKLDKVVQD--GEKEFKTEVQ 450
Query: 470 AISS--------LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR 521
I LL + +LLVYEF+S G+LA+ LF ++P W+ R +IA +AR
Sbjct: 451 VIGQTHHKNLVRLLGFCDEGQNRLLVYEFLSNGTLANFLFGC-SKPNWKQRTQIAFGIAR 509
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYM 581
GLLYLH+EC QIIHCDIK +NIL+D+ + A+ISDFGLAKLL+ +Q+ +RG++GY+
Sbjct: 510 GLLYLHEECGTQIIHCDIKPQNILLDNYYNARISDFGLAKLLVMDQSKTQTAIRGTKGYV 569
Query: 582 APEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641
APEW + ITVK DVYSFGV+LLEIICCR N ++ + + +L+ W Y+C++ G +
Sbjct: 570 APEWFRNRPITVKVDVYSFGVMLLEIICCRRNVDLEIGEVENPVLTDWAYDCYMDGSLDV 629
Query: 642 LV----EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFP-PLSH 696
L+ E + D TLER++K G+ CIQ++P+LRP+M+ V MLEG +E+P P P S
Sbjct: 630 LIGDDTEAKNDISTLERLLKVGIWCIQEDPSLRPTMRKVTQMLEGVVEVPAAPNPFPYSS 689
Query: 697 V 697
+
Sbjct: 690 I 690
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 702 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.297 | 0.252 | 0.432 | 2.2e-59 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.301 | 0.255 | 0.463 | 1.9e-55 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.400 | 0.342 | 0.359 | 1.7e-50 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.190 | 0.153 | 0.503 | 2.9e-48 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.289 | 0.250 | 0.388 | 6.2e-46 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.292 | 0.254 | 0.374 | 8.3e-46 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.293 | 0.248 | 0.406 | 1.4e-45 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.296 | 0.265 | 0.384 | 2.9e-45 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.292 | 0.241 | 0.394 | 4.3e-45 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.320 | 0.279 | 0.385 | 8.8e-45 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 416 (151.5 bits), Expect = 2.2e-59, Sum P(2) = 2.2e-59
Identities = 96/222 (43%), Positives = 135/222 (60%)
Query: 482 SKKLLVYEFMSKGSLADLLF--NLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHC 537
SKKLLVY++M GSL LF +E + + W+ R +IAL ARGL YLHDEC IIHC
Sbjct: 559 SKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHC 618
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDV 597
DIK NIL+D + K++DFGLAKL+ + + ++ +RG+RGY+APEW + IT K+DV
Sbjct: 619 DIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITAKADV 678
Query: 598 YSFGVVLLEIICCRSNFEVNVSTADEV-LLSTWVYNCFVA-GEFNKLVEE--EVDKITLE 653
YS+G++L E++ R N E S ++V +W G+ LV+ E D + +E
Sbjct: 679 YSYGMMLFELVSGRRNTEQ--SENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVDIE 736
Query: 654 ---RMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFP 692
R K CIQDE + RP+M V+ +LEG +E+ FP
Sbjct: 737 EVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFP 778
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 1.9e-55, Sum P(2) = 1.9e-55
Identities = 103/222 (46%), Positives = 139/222 (62%)
Query: 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECE 531
L+ + + +LLVYEFM GSL + LF ++ W R IAL A+G+ YLH+EC
Sbjct: 542 LIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECR 601
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGL 590
I+HCDIK NIL+DD++ AK+SDFGLAKLL P ++ VRG+RGY+APEW +
Sbjct: 602 DCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLP 661
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN-----KLVEE 645
IT KSDVYS+G+VLLE++ + NF+V+ T + S W Y F G +L E+
Sbjct: 662 ITSKSDVYSYGMVLLELVSGKRNFDVSEKT-NHKKFSIWAYEEFEKGNTKAILDTRLSED 720
Query: 646 E-VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686
+ VD + RMVKT CIQ++P RP+M V+ MLEG EI
Sbjct: 721 QTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEI 762
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 1.7e-50, Sum P(2) = 1.7e-50
Identities = 110/306 (35%), Positives = 171/306 (55%)
Query: 406 PLMFATKD-QYASAILFIKWSSGQANLSTHRIAPPIGN-------DKVNDKRKLLTVLAG 457
P+ FA KD Q A+ +K G S + P G+ + + +K
Sbjct: 480 PIRFAYKDLQSATNNFSVKLGQGGFG-SVYEGTLPDGSRLAVKKLEGIGQGKKEFRAEVS 538
Query: 458 CLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL---WRDRVR 514
+GSI L L+ + + +LL YEF+SKGSL +F + + W R
Sbjct: 539 IIGSIHHL-HLVRLRGFCA---EGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFN 594
Query: 515 IALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGV 574
IAL A+GL YLH++C+ +I+HCDIK NIL+DD++ AK+SDFGLAKL+ Q+ + +
Sbjct: 595 IALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTM 654
Query: 575 RGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF 634
RG+RGY+APEW + I+ KSDVYS+G+VLLE+I R N++ + T+++ ++ +
Sbjct: 655 RGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPS-ETSEKCHFPSFAFKKM 713
Query: 635 VAGEFNKLVEEEVDKITL-----ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPIL 689
G+ +V+ ++ + + +R +KT L CIQ++ RPSM V+ MLEG P++
Sbjct: 714 EEGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVF--PVV 771
Query: 690 AFPPLS 695
PP S
Sbjct: 772 Q-PPSS 776
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 345 (126.5 bits), Expect = 2.9e-48, Sum P(3) = 2.9e-48
Identities = 68/135 (50%), Positives = 94/135 (69%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCD 538
R + LLVYE+M+ GSL LF+ L W++R IAL ARGL YLH C+ +IIHCD
Sbjct: 580 RGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQKIIHCD 639
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
+K NIL+ D ++ KISDFGL+KLL ++ + +RG+RGY+APEW + I+ K+DVY
Sbjct: 640 VKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISEKADVY 699
Query: 599 SFGVVLLEIICCRSN 613
S+G+VLLE++ R N
Sbjct: 700 SYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 6.2e-46, Sum P(2) = 6.2e-46
Identities = 82/211 (38%), Positives = 119/211 (56%)
Query: 483 KKLLVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLH-DECEVQIIHCDI 539
++LLVYEF+ SL LF+ R W R I +ARGL YLH D C +++IH D+
Sbjct: 564 ERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSC-LRVIHRDL 622
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQ-TGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
K+ NIL+D+ KISDFGLA++ + V G+ GYMAPE+ +G+ + KSD+Y
Sbjct: 623 KVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIY 682
Query: 599 SFGVVLLEIICCRSNFEVNVSTADEVLLS-TWVYNCFVAGE--FNKLVEEEVDKITLERM 655
SFGV+LLEII + + LL+ W C G +K V + + +ER
Sbjct: 683 SFGVILLEIITGEKISRFSYGRQGKTLLAYAWESWCESGGIDLLDKDVADSCHPLEVERC 742
Query: 656 VKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686
V+ GLLC+Q +P RP+ ++ ML T ++
Sbjct: 743 VQIGLLCVQHQPADRPNTMELLSMLTTTSDL 773
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 343 (125.8 bits), Expect = 8.3e-46, Sum P(2) = 8.3e-46
Identities = 79/211 (37%), Positives = 121/211 (57%)
Query: 483 KKLLVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540
+KLL+YEFM SL LF+ R W R+ I +ARG+ YLH + +++IH D+K
Sbjct: 562 EKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLDIIQGIARGIHYLHRDSHLKVIHRDLK 621
Query: 541 LRNILIDDSWRAKISDFGLAKLLMPNQ-TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
+ NIL+D+ KISDFGLA++ + V G+ GYMAPE+ +G+ + KSD+YS
Sbjct: 622 VSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTLGYMAPEYAWTGMFSEKSDIYS 681
Query: 600 FGVVLLEIICCRSNFEVNVSTADEVLLS-TWVYNCFVAGE--FNKLVEEEVDKITLERMV 656
FGV++LEII + ++ L++ W C G +K V + + +ER V
Sbjct: 682 FGVLMLEIISGEKISRFSYGKEEKTLIAYAWESWCDTGGIDLLDKDVADSCRPLEVERCV 741
Query: 657 KTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687
+ GLLC+Q +P RP+ ++ ML T ++P
Sbjct: 742 QIGLLCVQHQPADRPNTLELLSMLTTTSDLP 772
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 358 (131.1 bits), Expect = 1.4e-45, Sum P(2) = 1.4e-45
Identities = 87/214 (40%), Positives = 124/214 (57%)
Query: 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFN-LETRPL-WRDRVRIALDVARGLLYLHDECE 531
LL + +++LVYEFM + L LF+ ++ R L W+ R I + RGL+YLH +
Sbjct: 571 LLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSR 630
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGL 590
++IIH D+K NIL+D++ KISDFGLA++ N+ + V G+ GYMAPE+ GL
Sbjct: 631 LKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGL 690
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE----EE 646
+ KSDV+S GV+LLEI+ R N + LS + + + GE LV+ EE
Sbjct: 691 FSEKSDVFSLGVILLEIVSGRRNSSF-YNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEE 749
Query: 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680
+ + R V GLLC+QD N RPS+ VI ML
Sbjct: 750 CFENEIRRCVHVGLLCVQDHANDRPSVATVIWML 783
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 356 (130.4 bits), Expect = 2.9e-45, Sum P(2) = 2.9e-45
Identities = 85/221 (38%), Positives = 130/221 (58%)
Query: 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETR-PL-WRDRVRIALDVARGLLYLHDECE 531
+L Y +++L+YE+ SL +F+ E R L W RV I +ARG+LYLH++
Sbjct: 524 ILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSR 583
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGL 590
++IIH D+K N+L+D AKISDFGLA+ L ++T V G+ GYM+PE+Q G
Sbjct: 584 LRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGY 643
Query: 591 ITVKSDVYSFGVVLLEIICCRSN--FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
++KSDV+SFGV++LEI+ R N F N +L W F+ + ++++E V+
Sbjct: 644 FSLKSDVFSFGVLVLEIVSGRRNRGFR-NEEHKLNLLGHAW--RQFLEDKAYEIIDEAVN 700
Query: 649 KITLE-----RMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684
+ + R++ GLLC+Q +P RP+M V+LML M
Sbjct: 701 ESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEM 741
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 356 (130.4 bits), Expect = 4.3e-45, Sum P(2) = 4.3e-45
Identities = 86/218 (39%), Positives = 127/218 (58%)
Query: 483 KKLLVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540
+K+LVYE+M SL LF+ + L W+ R I +ARGLLYLH + ++IIH D+K
Sbjct: 597 EKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLK 656
Query: 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
+ N+L+D KISDFG+A++ NQ V G+ GYM+PE+ GL +VKSDVYS
Sbjct: 657 VSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYS 716
Query: 600 FGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE-----R 654
FGV+LLEI+ + N + S ++ W Y + G +LV+ ++ ++T R
Sbjct: 717 FGVLLLEIVSGKRNTSLRSSEHGSLIGYAW-Y-LYTHGRSEELVDPKI-RVTCSKREALR 773
Query: 655 MVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFP 692
+ +LC+QD RP+M +V+LMLE + LA P
Sbjct: 774 CIHVAMLCVQDSAAERPNMASVLLMLES--DTATLAAP 809
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 345 (126.5 bits), Expect = 8.8e-45, Sum P(2) = 8.8e-45
Identities = 91/236 (38%), Positives = 131/236 (55%)
Query: 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFN--LETRPLWRDRVRIALDVARGLLYLHDECE 531
LL Y +KLL+YEFM SL +F+ L+ W R I +ARGLLYLH +
Sbjct: 547 LLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRDSR 606
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-TGIVAGVRGSRGYMAPEWQNSGL 590
+++IH D+K+ NIL+DD KISDFGLA++ Q V G+ GYM+PE+ +GL
Sbjct: 607 LRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWAGL 666
Query: 591 ITVKSDVYSFGVVLLEIICCR--SNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
+ KSD+YSFGV++LEII + S F + + +L TW C G N L + D
Sbjct: 667 FSEKSDIYSFGVLMLEIISGKRISRF-IYGDESKGLLAYTWDSWCETGGS-NLLDRDLTD 724
Query: 649 K---ITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPPLSHVNSLS 701
+ R V+ GLLC+Q E RP+ V+ ML ++P+ P+ V++L+
Sbjct: 725 TCQAFEVARCVQIGLLCVQHEAVDRPNTLQVLSMLTSATDLPVPK-QPIFAVHTLN 779
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00024697001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (729 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 702 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-34 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-28 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-21 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 5e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-15 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 6e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-14 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-13 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-13 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-09 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-09 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-07 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-07 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-06 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 5e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-04 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 0.003 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.003 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 6e-34
Identities = 51/124 (41%), Positives = 73/124 (58%), Gaps = 6/124 (4%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E+ GSL DLL E + + +RI L + GL YLH IIH D+K NIL
Sbjct: 68 LVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENIL 124
Query: 546 ID-DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKSDVYSFGVV 603
+D D+ + K++DFGL+KLL + ++ + G+ YMAPE G + KSD++S GV+
Sbjct: 125 LDSDNGKVKLADFGLSKLL-TSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVI 183
Query: 604 LLEI 607
L E+
Sbjct: 184 LYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 41/130 (31%), Positives = 61/130 (46%), Gaps = 6/130 (4%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E+ G L DLL + + L YLH + I+H D+K NIL
Sbjct: 74 LVMEYCEGGDLFDLLKKRGRLSE-DEARFYLRQILSALEYLHSK---GIVHRDLKPENIL 129
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+D+ K++DFGLA+ L P + + G+ YMAPE D++S GV+L
Sbjct: 130 LDEDGHVKLADFGLARQLDPGEK--LTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILY 187
Query: 606 EIICCRSNFE 615
E++ + F
Sbjct: 188 ELLTGKPPFP 197
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 8e-29
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 23/200 (11%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+M G L L + D + AL +ARG+ YL + IH D+ RN
Sbjct: 77 YIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNC 133
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG----VRGSRGYMAPEWQNSGLITVKSDVYSF 600
L+ ++ KISDFGL++ L + G +R +MAPE G T KSDV+SF
Sbjct: 134 LVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR----WMAPESLKEGKFTSKSDVWSF 189
Query: 601 GVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGL 660
GV+L EI +S + V G ++ + M++
Sbjct: 190 GVLLWEIFTLGEQPYPGMSNEE-------VLEYLKNGYRLPQPPNCPPEL-YDLMLQ--- 238
Query: 661 LCIQDEPNLRPSMKNVILML 680
C ++P RP+ ++ +L
Sbjct: 239 -CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 26/202 (12%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++V E+M G L D L + L D + AL +ARG+ YL + IH D+ RN
Sbjct: 77 MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARN 133
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAG----VRGSRGYMAPEWQNSGLITVKSDVYS 599
L+ ++ KISDFGL++ L + V G +R +MAPE G T KSDV+S
Sbjct: 134 CLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIR----WMAPESLKEGKFTSKSDVWS 189
Query: 600 FGVVLLEII-CCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKT 658
FGV+L EI + +S A+ V G ++ + M++
Sbjct: 190 FGVLLWEIFTLGEEPYP-GMSNAE-------VLEYLKKGYRLPKPPNCPPEL-YKLMLQ- 239
Query: 659 GLLCIQDEPNLRPSMKNVILML 680
C ++P RP+ ++ +L
Sbjct: 240 ---CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 51/133 (38%), Positives = 68/133 (51%), Gaps = 8/133 (6%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHC 537
LV E+ G L D L PL + +IAL + RGL YLH IIH
Sbjct: 68 EDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLHSN---GIIHR 122
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL-ITVKSD 596
D+K NIL+D++ KI+DFGLAK L+ + + G+ YMAPE G K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 597 VYSFGVVLLEIIC 609
V+S GV+L E++
Sbjct: 182 VWSLGVILYELLT 194
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 44/130 (33%), Positives = 68/130 (52%), Gaps = 12/130 (9%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+M G L D L + +D +++AL +A+G+ YL +H D+ RN
Sbjct: 77 YIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNC 133
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNSGLITVKSDVYS 599
L+ ++ KISDFGL++ + + G ++ +MAPE G T KSDV+S
Sbjct: 134 LVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPESLKDGKFTSKSDVWS 189
Query: 600 FGVVLLEIIC 609
FGV+L EI
Sbjct: 190 FGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 485 LLVYEFMSKGSLADLL--------FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIH 536
LV E+M G L D L ++ +D + A+ +A+G+ YL + +H
Sbjct: 72 YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVH 128
Query: 537 CDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNSGLI 591
D+ RN L+ + KISDFGL++ + + +R +MAPE G+
Sbjct: 129 RDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----WMAPESLKDGIF 184
Query: 592 TVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
T KSDV+SFGV+L EI + + +S + V G E D++
Sbjct: 185 TSKSDVWSFGVLLWEIFTLGATPYP-GLSNEE-------VLEYLRKGYRLPKPEYCPDEL 236
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
E M L C Q +P RP+ ++ LE
Sbjct: 237 Y-ELM----LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 46/124 (37%), Positives = 64/124 (51%), Gaps = 9/124 (7%)
Query: 489 EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
E++S GSL+ LL F P+ R R + GL YLH I+H DIK NIL+
Sbjct: 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTR---QILEGLAYLHSN---GIVHRDIKGANILV 134
Query: 547 DDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
D K++DFG AK L +TG G VRG+ +MAPE +D++S G ++
Sbjct: 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVI 194
Query: 606 EIIC 609
E+
Sbjct: 195 EMAT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 50/124 (40%), Positives = 73/124 (58%), Gaps = 4/124 (3%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+MSKGSL D L + E + L V +A +A G+ YL IH D+ RNI
Sbjct: 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNI 134
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ ++ KI+DFGLA+L+ ++ G + + APE N G T+KSDV+SFG++L
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILL 194
Query: 605 LEII 608
EI+
Sbjct: 195 TEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 5e-20
Identities = 40/111 (36%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 73 NITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPI--ADLVFDEPASFASMLDS 130
N TVVW ANR S+ TL L DG L+L + + + ++ A + D
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVL--YDGNGRVVWSSNTSGKGSGCVAVLQDD 58
Query: 131 GNFVLYSNRSGIIWESFSTPTDTILGGQSLEN----GEHLLSS-VTETNSS 176
GN VLY N ++W+SF PTDT+L GQ N G L+S + T+ S
Sbjct: 59 GNLVLYDNSGKVLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 46/124 (37%), Positives = 66/124 (53%), Gaps = 8/124 (6%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
+V E+M+KGSL D L + + ++ ALDV G+ YL E +H D+ RN
Sbjct: 76 YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARN 132
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
+L+ + AK+SDFGLAK Q V+ + APE + KSDV+SFG++
Sbjct: 133 VLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK----WTAPEALREKKFSTKSDVWSFGIL 188
Query: 604 LLEI 607
L EI
Sbjct: 189 LWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 47/221 (21%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L+ E++ GSL D L + + + + + +G+ YL + + IH D+ RNI
Sbjct: 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNI 140
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
L++ KISDFGLAK+L ++ G Y APE + + SDV+SFG
Sbjct: 141 LVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFG 199
Query: 602 VVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMV---K 657
V L E+ + EF +++ ++ + R++ K
Sbjct: 200 VTLYELFTYGDPS-------------------QSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 658 TG-----------------LLCIQDEPNLRPSMKNVILMLE 681
G LC + EP RPS ++IL+++
Sbjct: 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 43/126 (34%), Positives = 67/126 (53%), Gaps = 6/126 (4%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQ-IIHCDIKLR 542
+V E M GSL + L R L + +A VA G+ YL E Q IH D+ R
Sbjct: 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL----EAQNYIHRDLAAR 132
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
N+L+ ++ K++DFGLA+++ + G + + APE ++KSDV+SFG+
Sbjct: 133 NVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192
Query: 603 VLLEII 608
+L EI+
Sbjct: 193 LLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 43/125 (34%), Positives = 62/125 (49%), Gaps = 13/125 (10%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V EF S GSL DLL + L ++ + ++ +GL YLH IIH DIK NI
Sbjct: 74 IVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANI 129
Query: 545 LIDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
L+ K+ DFGL+ L T + G+ +MAPE N K+D++S G
Sbjct: 130 LLTSDGEVKLIDFGLSAQLSDTKARNTMV-----GTPYWMAPEVINGKPYDYKADIWSLG 184
Query: 602 VVLLE 606
+ +E
Sbjct: 185 ITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 50/124 (40%), Positives = 73/124 (58%), Gaps = 4/124 (3%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+MSKGSL D L + E R L + V +A VA G+ Y+ + IH D++ NI
Sbjct: 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANI 133
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ D KI+DFGLA+L+ N+ G + + APE G T+KSDV+SFG++L
Sbjct: 134 LVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193
Query: 605 LEII 608
E++
Sbjct: 194 TELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 44/125 (35%), Positives = 71/125 (56%), Gaps = 4/125 (3%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++ E+M GSL D L E L ++ + +A +A G+ ++ IH D++ N
Sbjct: 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAAN 132
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+ ++ KI+DFGLA+L+ N+ G + + APE N G T+KSDV+SFG++
Sbjct: 133 ILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 192
Query: 604 LLEII 608
L EI+
Sbjct: 193 LTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 84.4 bits (207), Expect = 2e-17
Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 15/219 (6%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLHD 528
I L + LV E++ GSL DLL + + + I + L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH- 118
Query: 529 ECEVQIIHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQT-----GIVAGVRGSRGYMA 582
IIH DIK NIL+D D K+ DFGLAKLL + + + G+ GYMA
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 583 PEW---QNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639
PE + + SD++S G+ L E++ FE +++ +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE-LPTPSL 235
Query: 640 NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678
+ ++ + + +P R S + +
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 61/224 (27%), Positives = 91/224 (40%), Gaps = 49/224 (21%)
Query: 480 RSSKKLLVYEFMSKGSLADLL---------FNLETRPLWRDRVRIALDVARGLLYLHDEC 530
L+V E M+KG L L P + +++A ++A G+ YL
Sbjct: 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA--- 136
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLA-------------KLLMPNQTGIVAGVRGS 577
+ +H D+ RN ++ + KI DFG+ K L+P VR
Sbjct: 137 AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP--------VR-- 186
Query: 578 RGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG 637
+MAPE G+ T KSDV+SFGVVL E+ +S +EVL + G
Sbjct: 187 --WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVL------KFVIDG 237
Query: 638 EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
L E LE M +C Q P +RP+ ++ L+
Sbjct: 238 GHLDL-PENCPDKLLELM----RMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 46/123 (37%), Positives = 66/123 (53%), Gaps = 8/123 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLHDECEVQIIHCDIKLRN 543
+V E+M GSLADLL + + V IA + +GL YLH + IIH DIK N
Sbjct: 76 IVLEYMDGGSLADLL---KKVGKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSN 130
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
+LI+ KI+DFG++K+L V G+ YM+PE + +D++S G+
Sbjct: 131 LLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAADIWSLGLT 189
Query: 604 LLE 606
LLE
Sbjct: 190 LLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 5e-17
Identities = 44/124 (35%), Positives = 73/124 (58%), Gaps = 4/124 (3%)
Query: 486 LVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E+M+KGSL D L + E + L + + +A G+ Y+ + IH D++ N+
Sbjct: 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANV 134
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ +S KI+DFGLA+++ N+ G + + APE N G T+KSDV+SFG++L
Sbjct: 135 LVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 194
Query: 605 LEII 608
EI+
Sbjct: 195 YEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 15/188 (7%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547
EFM GSL + + P+ + + +IA+ V GL YL++ +I+H DIK NIL++
Sbjct: 83 EFMDCGSLDRIY--KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVN 138
Query: 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
+ K+ DFG++ L+ I G+ YM+PE G TVKSDV+S G+ ++E+
Sbjct: 139 SRGQIKLCDFGVSGELI---NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIEL 195
Query: 608 ICCRSNFEVNVSTADEVLLSTWVYN---CFVAGEFNKLVEEEVDKITLERMVKTGLLCIQ 664
+ F + D + + V +L + + L V C+
Sbjct: 196 ALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPED-LRDFVD---ACLL 251
Query: 665 DEPNLRPS 672
+P RP+
Sbjct: 252 KDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 48/133 (36%), Positives = 68/133 (51%), Gaps = 5/133 (3%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+ G L LL RPL D+V R + + GL +LH + +I+H DIK N+
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNL 132
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+D KI D G+AKLL N T + G+ Y++PE KSDV++ GVVL
Sbjct: 133 FLDAYDNVKIGDLGVAKLLSDN-TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVL 191
Query: 605 LEIICCRSNFEVN 617
E + F+ N
Sbjct: 192 YECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 43/128 (33%), Positives = 69/128 (53%), Gaps = 15/128 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E M KGSL L + E + L + +A VA G+ YL ++ IH D+ RNI
Sbjct: 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNI 135
Query: 545 LIDDSWRAKISDFGLAKLL-----MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
L+ + K++DFGLA+L+ + + I + + APE + G + KSDV+S
Sbjct: 136 LVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYK----WTAPEAASHGTFSTKSDVWS 189
Query: 600 FGVVLLEI 607
FG++L E+
Sbjct: 190 FGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 38/208 (18%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V EFM KGSL D L + + L + V +A +A G+ Y+ + IH D++ NI
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANI 133
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ D+ KI+DFGLA+L+ N+ G + + APE G T+KSDV+SFG++L
Sbjct: 134 LVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 193
Query: 605 LEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK-----------ITLE 653
E++ T V G N+ V E+V++ +L
Sbjct: 194 TELV-----------TKGRVPYP---------GMVNREVLEQVERGYRMPCPQGCPESLH 233
Query: 654 RMVKTGLLCIQDEPNLRPSMKNVILMLE 681
++K LC + +P+ RP+ + + LE
Sbjct: 234 ELMK---LCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 4e-16
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 33/161 (20%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGY 580
L YLH +I+H DIK +NI + + K+ DFG++K+L + T +A V G+ Y
Sbjct: 115 ALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVL--SSTVDLAKTVVGTPYY 169
Query: 581 MAPE-WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639
++PE QN KSD++S G VL E+ + FE + +L
Sbjct: 170 LSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFE-----GENLL-----------ELA 212
Query: 640 NKLVEEEVDKIT------LERMVKTGLLCIQDEPNLRPSMK 674
K+++ + I L +V + +Q +P RPS+
Sbjct: 213 LKILKGQYPPIPSQYSSELRNLVSS---LLQKDPEERPSIA 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 44/124 (35%), Positives = 72/124 (58%), Gaps = 4/124 (3%)
Query: 486 LVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ EFM+KGSL D L + E ++ + + +A G+ ++ IH D++ NI
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANI 133
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ S KI+DFGLA+++ N+ G + + APE N G T+KSDV+SFG++L
Sbjct: 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 193
Query: 605 LEII 608
+EI+
Sbjct: 194 MEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 43/119 (36%), Positives = 69/119 (57%), Gaps = 5/119 (4%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548
E+M GSL +L ++ R R +IA+ V +GL YLH++ +IIH D+K NIL++
Sbjct: 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNS 136
Query: 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
+ K+ DFG++ L+ + G + YMAPE +VKSD++S G+ L+E+
Sbjct: 137 RGQIKLCDFGVSGQLVNSLAKTFVG---TSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 45/124 (36%), Positives = 70/124 (56%), Gaps = 6/124 (4%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWR--DRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
+V E+MSKGSL D L E R V +A +A G+ Y+ + +H D++ N
Sbjct: 77 IVTEYMSKGSLLDFLKG-EMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAAN 132
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+ ++ K++DFGLA+L+ N+ G + + APE G T+KSDV+SFG++
Sbjct: 133 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 192
Query: 604 LLEI 607
L E+
Sbjct: 193 LTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-15
Identities = 41/121 (33%), Positives = 55/121 (45%), Gaps = 9/121 (7%)
Query: 34 SSLSPSGQHSWNSSSGLFQFGFYKQG--SGYSLGIWLVTSPNITVVWTANRDEQPMPSNA 91
S+ SGQ SS LF+ GF+K S I S TVVW ANRD P S+
Sbjct: 1 SNPLSSGQTLV-SSGSLFELGFFKLIMQSRDYNLILYKGSSR-TVVWVANRDN-PSGSSC 57
Query: 92 TLALTMDGKLILKTEESKEKPI--ADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149
TL L DG L++ + + ++ +LD GN VLY + +W+SF
Sbjct: 58 TLTLQSDGNLVI--YDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDY 115
Query: 150 P 150
P
Sbjct: 116 P 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 55/192 (28%), Positives = 88/192 (45%), Gaps = 21/192 (10%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRV------RIALDVARGLLYLHDECEVQIIHCDIKLR 542
E+ GSL + ++ R R+ +IA V +GL YLH +IIH DIK
Sbjct: 81 EYCEGGSLDSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPS 134
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
NIL+ + K+ DFG++ L+ + G G + YMAPE ++ SDV+S G+
Sbjct: 135 NILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQGKPYSITSDVWSLGL 191
Query: 603 VLLEIICCRSNFEVNVS-TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGL- 660
LLE+ R F + L +++ N +L +E + I K +
Sbjct: 192 TLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP----ELKDEPGNGIKWSEEFKDFIK 247
Query: 661 LCIQDEPNLRPS 672
C++ +P RP+
Sbjct: 248 QCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 4/130 (3%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+S +++ E+M GSL L + + V + +A G+ YL + V H D+
Sbjct: 76 KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDL 132
Query: 540 KLRNILIDDSWRAKISDFGLAKLL-MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
RNIL++ + K+SDFGL++ L T G + + APE T SDV+
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVW 192
Query: 599 SFGVVLLEII 608
SFG+V+ E++
Sbjct: 193 SFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 41/136 (30%), Positives = 69/136 (50%), Gaps = 10/136 (7%)
Query: 479 HRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIH 536
+S L ++ E+ GSL ++ P V + + V +GL YLH++ +IH
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQ---GVIH 122
Query: 537 CDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKS 595
DIK NIL K++DFG+A + + + A V G+ +MAPE + SG + S
Sbjct: 123 RDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTAS 180
Query: 596 DVYSFGVVLLEIICCR 611
D++S G ++E++
Sbjct: 181 DIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 2e-14
Identities = 35/112 (31%), Positives = 53/112 (47%), Gaps = 8/112 (7%)
Query: 39 SGQHSWNSSSGLFQFGFYK-QGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTM 97
SGQ + S + LF+ GF+ I +S TVVW ANRD P+ + TL L
Sbjct: 6 SGQ-TLVSGNSLFELGFFTLIMQNDYNLILYKSSSR-TVVWVANRDN-PVSDSCTLTLQS 62
Query: 98 DGKLILKTEESKEKPI--ADLVFDEPASFASMLDSGNFVLYSNRSGIIWESF 147
DG L+L + + + ++ +LD GN V+Y + +W+SF
Sbjct: 63 DGNLVL--YDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 45/132 (34%), Positives = 66/132 (50%), Gaps = 12/132 (9%)
Query: 480 RSSKKLLVY-EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIH 536
R L ++ E + GSLA LL + P+ R R L GL YLHD +H
Sbjct: 72 REEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL---GLEYLHDR---NTVH 125
Query: 537 CDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKS 595
DIK NIL+D + K++DFG+AK ++ +GS +MAPE G + +
Sbjct: 126 RDIKGANILVDTNGVVKLADFGMAKQVVEF--SFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 596 DVYSFGVVLLEI 607
D++S G +LE+
Sbjct: 184 DIWSLGCTVLEM 195
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 44/138 (31%), Positives = 70/138 (50%), Gaps = 10/138 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV+EFM G L+D L + + + LDV G+ YL +IH D+ RN L
Sbjct: 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCL 132
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+ ++ K+SDFG+ + ++ +Q G + + +PE + + KSDV+SFGV++
Sbjct: 133 VGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMW 192
Query: 606 EIIC-------CRSNFEV 616
E+ RSN EV
Sbjct: 193 EVFSEGKTPYENRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 26/161 (16%)
Query: 462 ITFLCFLIAISSLLVYKHRSSKKLL----------VYEFMSKGSLADLL-----FNLETR 506
+T FL + + H++ +LL V E MSKG+L + L +
Sbjct: 41 VTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVI 100
Query: 507 PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566
L ++ +LDVA G+ YL + +++H D+ RNIL+ + AK+SDFGLA++
Sbjct: 101 QL----LQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---G 150
Query: 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
G V + + APE + KSDV+S+GV+L E+
Sbjct: 151 SMG-VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 3e-14
Identities = 40/131 (30%), Positives = 63/131 (48%), Gaps = 20/131 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E+M GSL D++ R + +V +GL YLH + +IH DIK NIL
Sbjct: 92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNIL 148
Query: 546 IDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLIT-----VKSDV 597
+ K++DFG A L + +V G+ +MAPE +I K D+
Sbjct: 149 LSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYWMAPE-----VIKRKDYGPKVDI 199
Query: 598 YSFGVVLLEII 608
+S G++ +E+
Sbjct: 200 WSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 7/142 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEV 532
L Y + L LV M+ G L ++N+ R A + GL +LH
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
+I++ D+K N+L+DD +ISD GLA + + I G+ GYMAPE +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVYD 172
Query: 593 VKSDVYSFGVVLLEIICCRSNF 614
D ++ G L E+I RS F
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 48/138 (34%), Positives = 69/138 (50%), Gaps = 15/138 (10%)
Query: 479 HRSSKKLLVY-EFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEVQIIH 536
HR K+ ++ E+ S G+L +LL + R L +R+ L + GL YLH I+H
Sbjct: 70 HRE--KVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLH---SHGIVH 122
Query: 537 CDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG---YMAPEWQNSGLITV 593
DIK NI +D + K+ DFG A L N T + V+ G YMAPE G
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 594 K---SDVYSFGVVLLEII 608
+D++S G V+LE+
Sbjct: 183 HGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 40/128 (31%), Positives = 65/128 (50%), Gaps = 12/128 (9%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E + GSL L + R + ++++LD A G+ YL + IH D+ RN
Sbjct: 68 YIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNC 124
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNSGLITVKSDVYS 599
L+ ++ KISDFG+++ + G + V + APE N G T +SDV+S
Sbjct: 125 LVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWS 180
Query: 600 FGVVLLEI 607
+G++L E
Sbjct: 181 YGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 41/129 (31%), Positives = 69/129 (53%), Gaps = 4/129 (3%)
Query: 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540
SS+ L+ + M G L D + N + + + + +A+G+ YL E +++H D+
Sbjct: 80 SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLA 136
Query: 541 LRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
RN+L+ KI+DFGLAKLL ++ G + +MA E + T KSDV+S
Sbjct: 137 ARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWS 196
Query: 600 FGVVLLEII 608
+GV + E++
Sbjct: 197 YGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 44/123 (35%), Positives = 64/123 (52%), Gaps = 8/123 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+M+KGSL D L + L D ++ +LDV + YL +H D+ RN+
Sbjct: 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNV 133
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ + AK+SDFGL K Q V+ + APE + KSDV+SFG++L
Sbjct: 134 LVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSDVWSFGILL 189
Query: 605 LEI 607
EI
Sbjct: 190 WEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 480 RSSKKLLVYEFMSKGSL-ADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHC 537
R S+K+ S G+ + L N + R L D + A ++RG+ YL E++++H
Sbjct: 95 RESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHR 151
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNSGLIT 592
D+ RN+L+ + + KISDFGL++ + + V+ S+G +MA E + T
Sbjct: 152 DLAARNVLVAEGRKMKISDFGLSRDVYEED----SYVKRSKGRIPVKWMAIESLFDHIYT 207
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652
+SDV+SFGV+L EI+ N ++ ++N G E +
Sbjct: 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPER-------LFNLLKTGY-----RMERPENCS 255
Query: 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684
E M L C + EP+ RP+ ++ LE M
Sbjct: 256 EEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 40/140 (28%), Positives = 65/140 (46%), Gaps = 10/140 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETR-PLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRN 543
LV + + G DL ++L + ++V+ ++ L YLH IIH DIK N
Sbjct: 77 LVVDLLLGG---DLRYHLSQKVKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDN 130
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+D+ I+DF +A + P+ + G+ GYMAPE +V D +S GV
Sbjct: 131 ILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVT 188
Query: 604 LLEIICCRSNFEVNVSTADE 623
E + + + + T +
Sbjct: 189 AYECLRGKRPYRGHSRTIRD 208
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 50/196 (25%), Positives = 90/196 (45%), Gaps = 24/196 (12%)
Query: 486 LVYEFMSKGSLADLLFNLET--RPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLR 542
+V E+ G L+ + + + + + RI + + RGL LH++ +I+H D+K
Sbjct: 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSA 132
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKSDVYSFG 601
NIL+ + KI D G++K+L N G + YMAPE W+ + KSD++S G
Sbjct: 133 NILLVANDLVKIGDLGISKVLKKNMAKTQIG---TPHYMAPEVWKGRPY-SYKSDIWSLG 188
Query: 602 VVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLL 661
+L E+ FE S D + G++ + L+ +++
Sbjct: 189 CLLYEMATFAPPFEAR-SMQD-------LRYKVQRGKYPPIPPIYSQD--LQNFIRS--- 235
Query: 662 CIQDEPNLRPSMKNVI 677
+Q +P LRP+ ++
Sbjct: 236 MLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 44/124 (35%), Positives = 62/124 (50%), Gaps = 5/124 (4%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E++ GSL D L R R + A + +G+ YL + +H D+ RNIL
Sbjct: 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNIL 140
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG--YMAPEWQNSGLITVKSDVYSFGVV 603
++ R KI DFGL K+L ++ G + APE +V SDV+SFGVV
Sbjct: 141 VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVV 200
Query: 604 LLEI 607
L E+
Sbjct: 201 LYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 48/127 (37%), Positives = 69/127 (54%), Gaps = 13/127 (10%)
Query: 489 EFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
E++ GS+A LL N L R+ VR L +GL YLH+ IIH DIK NIL+
Sbjct: 86 EYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYLHNR---GIIHRDIKGANILV 139
Query: 547 DDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNSGLITVKSDVYSFG 601
D+ KISDFG++K L N ++GS +MAPE T K+D++S G
Sbjct: 140 DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLG 199
Query: 602 VVLLEII 608
+++E++
Sbjct: 200 CLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 41/127 (32%), Positives = 71/127 (55%), Gaps = 6/127 (4%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L+V +M G L + + + P +D + L VA+G+ YL + + +H D+ RN
Sbjct: 73 LVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNC 129
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQNSGLITVKSDVYSFG 601
++D+S+ K++DFGLA+ + + V G++ +MA E + T KSDV+SFG
Sbjct: 130 MLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFG 189
Query: 602 VVLLEII 608
V+L E++
Sbjct: 190 VLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 48/140 (34%), Positives = 73/140 (52%), Gaps = 30/140 (21%)
Query: 489 EFMSKGSLADLLFN---LETRPLW------------RDRVRIALDVARGLLYLHDECEVQ 533
E+ G+L D L LET P + + ++ A DVA G+ YL ++ Q
Sbjct: 83 EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---Q 139
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNS 588
IH D+ RN+L+ ++ +KI+DFGL++ G V+ + G +MA E N
Sbjct: 140 FIHRDLAARNVLVGENLASKIADFGLSR-------GEEVYVKKTMGRLPVRWMAIESLNY 192
Query: 589 GLITVKSDVYSFGVVLLEII 608
+ T KSDV+SFGV+L EI+
Sbjct: 193 SVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 6e-13
Identities = 45/141 (31%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
L Y ++ +KL LV E+ G L L R R A ++ L YLH +
Sbjct: 58 LHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAA-EIVLALEYLH---SLG 113
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITV 593
II+ D+K NIL+D K++DFGLAK L + G+ Y+APE
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 594 KSDVYSFGVVLLEIICCRSNF 614
D +S GV+L E++ + F
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPF 193
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 40/138 (28%), Positives = 65/138 (47%), Gaps = 10/138 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E+M+ G L + L + + + + DV + YL IH D+ RN L
Sbjct: 76 IVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCL 132
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+ + K+SDFGLA+ ++ +Q G + + PE + + KSDV+SFGV++
Sbjct: 133 VGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMW 192
Query: 606 EIICC-------RSNFEV 616
E+ SN EV
Sbjct: 193 EVFSEGKMPYERFSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 43/128 (33%), Positives = 66/128 (51%), Gaps = 19/128 (14%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
V E + DL L +RPL + ++ + RGL Y+H ++H D+K NI
Sbjct: 87 FVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNI 139
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE----WQNSGLITVKSDVYSF 600
LI+++ KI DFGLA++ P TG V+ +R Y APE WQ V+ D++S
Sbjct: 140 LINENCDLKICDFGLARIQDPQMTGYVS----TRYYRAPEIMLTWQKYD---VEVDIWSA 192
Query: 601 GVVLLEII 608
G + E++
Sbjct: 193 GCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 42/116 (36%), Positives = 64/116 (55%), Gaps = 8/116 (6%)
Query: 497 ADLLFNLETRPLW----RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRA 552
+D +T W D +R + VA+G+ +L + IH D+ RN+L+ D A
Sbjct: 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVA 251
Query: 553 KISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
KI DFGLA+ +M + +V G R +MAPE + TV+SDV+S+G++L EI
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 35/97 (36%), Positives = 56/97 (57%), Gaps = 11/97 (11%)
Query: 514 RIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL---MPNQTGI 570
+I++ V RGL YL ++ +I+H D+K NIL++ K+ DFG++ L M N
Sbjct: 103 KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--- 157
Query: 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
G+R YM+PE TV+SD++S G+ L+E+
Sbjct: 158 ---FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 57/223 (25%)
Query: 485 LLVYEFMSKGSLADLLFNLETR---------PLWRDRVRIALDVARGLLYLHDECEVQII 535
L+V E M+ G L L +L P ++ +++A ++A G+ YL+ + + +
Sbjct: 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFV 141
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNSGL 590
H D+ RN ++ + KI DFG+ + + +G +G +MAPE G+
Sbjct: 142 HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGV 197
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
T SD++SFGVVL EI S A++ + L E+V K
Sbjct: 198 FTTSSDMWSFGVVLWEI----------TSLAEQ--------------PYQGLSNEQVLKF 233
Query: 651 TL------------ERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
+ ER+ +C Q P +RP+ ++ +L+
Sbjct: 234 VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 51/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 485 LLVYEFMSKGSLADLLF-NLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
L++ E+ G L + L E+ D + + VA+G+ +L + IH D+ RN
Sbjct: 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 171
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+L+ KI DFGLA+ +M + +V G R +MAPE + + T +SDV+S+G+
Sbjct: 172 VLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 231
Query: 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLC 662
+L EI F + + + + + Y G + E + M C
Sbjct: 232 LLWEI------FSLGSNPYPGMPVDSKFYKLIKEG-YRMAQPEHAPAEIYDIMKT----C 280
Query: 663 IQDEPNLRPSMKNVILMLE 681
+P RP+ K ++ ++
Sbjct: 281 WDADPLKRPTFKQIVQLIG 299
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 50/157 (31%), Positives = 73/157 (46%), Gaps = 39/157 (24%)
Query: 477 YKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR----GLLYLHDECEV 532
+ H ++L+ EFM GSL E + ++ DVAR G+ YLH
Sbjct: 141 FDHNGEIQVLL-EFMDGGSL-------EGTHIADEQF--LADVARQILSGIAYLHRR--- 187
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT--------GIVAGVRGSRGYMAPE 584
I+H DIK N+LI+ + KI+DFG++++L QT G +A YM+PE
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIA-------YMSPE 238
Query: 585 WQNSGLITVK-----SDVYSFGVVLLEIICCRSNFEV 616
N+ L D++S GV +LE R F V
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 485 LLVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLR 542
V EF++ G DL+F+++ +R R R A ++ L++LHD+ II+ D+KL
Sbjct: 72 FFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLD 125
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKSDV 597
N+L+D K++DFG+ K GI G G+ Y+APE L D
Sbjct: 126 NVLLDHEGHCKLADFGMCK------EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 598 YSFGVVLLEIICCRSNFEVNVST-------ADEVLLSTWV 630
++ GV+L E++C + FE DEV+ TW+
Sbjct: 180 WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 44/125 (35%), Positives = 61/125 (48%), Gaps = 8/125 (6%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+LV E G L L P+ D +A VA G+ YL +H D+ RN+
Sbjct: 71 MLVMELAPLGPLLKYLKKRREIPV-SDLKELAHQVAMGMAYLE---SKHFVHRDLAARNV 126
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
L+ + +AKISDFG+++ L A G + Y APE N G + KSDV+S+G
Sbjct: 127 LLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY-APECINYGKFSSKSDVWSYG 185
Query: 602 VVLLE 606
V L E
Sbjct: 186 VTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-12
Identities = 43/123 (34%), Positives = 60/123 (48%), Gaps = 24/123 (19%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI-----DDSWRAKISDFGLAKLLMP 565
+ + I LDVA+G +YL + IH D+ RN L+ D KI DFGLA+ +
Sbjct: 107 ELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK 163
Query: 566 NQTGIVAG-----VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-------CRSN 613
+ G VR +MAPE G T +SDV+SFGV++ EI+ +N
Sbjct: 164 SDYYRKEGEGLLPVR----WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219
Query: 614 FEV 616
EV
Sbjct: 220 QEV 222
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 48/143 (33%), Positives = 71/143 (49%), Gaps = 12/143 (8%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
L Y + K L LV E++ G LA LL N+ + R+ IA ++ L YLH
Sbjct: 58 LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNG 113
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKL-LMPNQTGIVAG------VRGSRGYMAPEWQ 586
IIH D+K NILID + K++DFGL+K+ L+ Q + + G+ Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 587 NSGLITVKSDVYSFGVVLLEIIC 609
+ D +S G +L E +
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 5e-12
Identities = 38/156 (24%), Positives = 57/156 (36%), Gaps = 39/156 (25%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
V E+ G L + R + R L YLH IIH
Sbjct: 79 FVLEYAPNGELLQYI---------RKYGSLDEKCTRFYAAEILLALEYLHS---KGIIHR 126
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLL----MPNQTGIVAGVRGSRG-------------- 579
D+K NIL+D KI+DFG AK+L P A S+
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186
Query: 580 -YMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614
Y++PE N SD+++ G ++ +++ + F
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 44/150 (29%), Positives = 66/150 (44%), Gaps = 41/150 (27%)
Query: 486 LVYEFMSKGSLADLL---------------FNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+V E+ + G+L D L E +D V A VARG+ +L +
Sbjct: 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK- 151
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRG-------SRG---- 579
+ IH D+ RN+L+ + KI+DFGLA+ + + G
Sbjct: 152 --KCIHRDLAARNVLVTEDHVMKIADFGLAR-----------DIHHIDYYRKTTNGRLPV 198
Query: 580 -YMAPEWQNSGLITVKSDVYSFGVVLLEII 608
+MAPE + T +SDV+SFGV+L EI
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 7e-12
Identities = 41/144 (28%), Positives = 69/144 (47%), Gaps = 31/144 (21%)
Query: 486 LVYEFMSKGSL----------ADLLFNLETR----PLWR-DRVRIALDVARGLLYLHDEC 530
+++E+++ G L +D+ L D + IA+ +A G+ YL
Sbjct: 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH- 143
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL-------MPNQTGIVAGVRGSRGYMAP 583
+H D+ RN L+ + KISDFGL++ + + +++ + VR +M P
Sbjct: 144 --HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS--LLPVR----WMPP 195
Query: 584 EWQNSGLITVKSDVYSFGVVLLEI 607
E G T +SD++SFGVVL EI
Sbjct: 196 EAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 51/164 (31%), Positives = 71/164 (43%), Gaps = 48/164 (29%)
Query: 484 KLLVYEFMSKGSLADLLFNLETRP--------LWRDRVRIALDVARGLLYLHDECEVQII 535
+ ++ E M+ G L L E RP +D + A DVA+G YL E I
Sbjct: 84 RFILLELMAGGDLKSFL--RENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFI 138
Query: 536 HCDIKLRNILIDD---SWRAKISDFGLA-------------KLLMPNQTGIVAGVRGSRG 579
H DI RN L+ AKI+DFG+A + ++P +
Sbjct: 139 HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK------------ 186
Query: 580 YMAPEWQNSGLITVKSDVYSFGVVLLEIIC-------CRSNFEV 616
+M PE G+ T K+DV+SFGV+L EI R+N EV
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 9e-12
Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 30/143 (20%)
Query: 486 LVYEFMSKGSLADLLFN---LETRPLW------------RDRVRIALDVARGLLYLHDEC 530
L E+ G+L D L LET P + + + A DVARG+ YL
Sbjct: 73 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS--- 129
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEW 585
+ Q IH D+ RNIL+ +++ AKI+DFGL++ G V+ + G +MA E
Sbjct: 130 QKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIES 182
Query: 586 QNSGLITVKSDVYSFGVVLLEII 608
N + T SDV+S+GV+L EI+
Sbjct: 183 LNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 44/136 (32%), Positives = 71/136 (52%), Gaps = 19/136 (13%)
Query: 487 VYEFMSKGSLADLLFNLET-RPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRNI 544
V E+++ G DL+F+++ R R A ++ GL +LH+ II+ D+KL N+
Sbjct: 74 VMEYVNGG---DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNV 127
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKSDVYS 599
L+D KI+DFG+ K GI+ GV G+ Y+APE + D ++
Sbjct: 128 LLDSEGHIKIADFGMCK------EGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWA 181
Query: 600 FGVVLLEIICCRSNFE 615
GV+L E++ +S FE
Sbjct: 182 LGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 50/143 (34%), Positives = 73/143 (51%), Gaps = 30/143 (20%)
Query: 486 LVYEFMSKGSLADLLFN---LETRPLW------------RDRVRIALDVARGLLYLHDEC 530
L E+ G+L D L LET P + + + A DVARG+ YL +
Sbjct: 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK- 143
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEW 585
Q IH D+ RNIL+ +++ AKI+DFGL++ G V+ + G +MA E
Sbjct: 144 --QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIES 194
Query: 586 QNSGLITVKSDVYSFGVVLLEII 608
N + T SDV+S+GV+L EI+
Sbjct: 195 LNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 34/98 (34%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 514 RIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573
+IA+ + + L YLH + V IH D+K N+LI+ + + K+ DFG++ L+ + +
Sbjct: 107 KIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 574 VRGSRGYMAPEW----QNSGLITVKSDVYSFGVVLLEI 607
G + YMAPE N VKSDV+S G+ ++E+
Sbjct: 165 --GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 7/146 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
L Y ++ KL L+ ++++ G L L+ E RV IA ++ L +LH ++
Sbjct: 70 LHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA-EIVLALDHLH---QLG 125
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITV 593
II+ DIKL NIL+D ++DFGL+K + + G+ YMAPE G
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185
Query: 594 KS--DVYSFGVVLLEIICCRSNFEVN 617
D +S GV+ E++ S F V+
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEV 532
L Y + + L LV M+ G L ++N+ +R A ++ GL LH E
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE--- 121
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
+I++ D+K NIL+DD +ISD GLA + +T + G G+ GYMAPE + T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYT 179
Query: 593 VKSDVYSFGVVLLEIICCRSNFE 615
D + G ++ E+I +S F
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 39/122 (31%), Positives = 63/122 (51%), Gaps = 3/122 (2%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E+MS G L + L R + + DV G+ YL + Q IH D+ RN L
Sbjct: 76 IVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCL 132
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+DD K+SDFGL++ ++ ++ G + + PE + KSDV++FGV++
Sbjct: 133 VDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMW 192
Query: 606 EI 607
E+
Sbjct: 193 EV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 44/143 (30%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEV 532
L Y S L LV M+ G L ++N+ R L +RV + + G+L+LH +
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
I++ D+K N+L+DD ++SD GLA L +T + G+ GYMAPE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172
Query: 593 VKSDVYSFGVVLLEIICCRSNFE 615
D ++ G + E++ R+ F+
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 27/216 (12%)
Query: 480 RSSK-KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
RS K L++E++ +L+++L NL W R +IA+ +A+ L +LH C ++ +
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRNLS----WERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
+ I+ID + L LL + + S Y+APE + + IT KSD+Y
Sbjct: 809 LSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-----SSAYVAPETRETKDITEKSDIY 862
Query: 599 SFGVVLLEIICCRS----NFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK---IT 651
FG++L+E++ +S F V+ S + W C+ + ++ + +
Sbjct: 863 GFGLILIELLTGKSPADAEFGVHGS------IVEWARYCYSDCHLDMWIDPSIRGDVSVN 916
Query: 652 LERMVKT---GLLCIQDEPNLRPSMKNVILMLEGTM 684
+V+ L C +P RP +V+ LE
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 14/127 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
+V E+ GS++D++ + + L IA +GL YLH + IH DIK
Sbjct: 75 IVMEYCGAGSVSDIM-KITNKTL--TEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAG 128
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPE-WQNSGLITVKSDVYSF 600
NIL+++ +AK++DFG++ L T V G+ +MAPE Q G K+D++S
Sbjct: 129 NILLNEEGQAKLADFGVSGQL--TDTMAKRNTVIGTPFWMAPEVIQEIGYNN-KADIWSL 185
Query: 601 GVVLLEI 607
G+ +E+
Sbjct: 186 GITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 35/202 (17%)
Query: 486 LVYEFMSKGSLADLL-FNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKL 541
LV ++S GSL D++ + L D IA +V +GL YLH IH DIK
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGL--DEAIIATVLKEVLKGLEYLHSN---GQIHRDIKA 130
Query: 542 RNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR----GSRGYMAPE--WQNSGLITVKS 595
NIL+ + KI+DFG++ L VR G+ +MAPE Q G K+
Sbjct: 131 GNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVMEQVHGY-DFKA 188
Query: 596 DVYSFGVVLLEIICCRSNFEVNVST--ADEVLLSTWVYNCFVAGEFNKLVEEEVDKI--- 650
D++SFG+ +E+ + + S +VL+ T + + L K
Sbjct: 189 DIWSFGITAIELATGAAPY----SKYPPMKVLMLT------LQNDPPSLETGADYKKYSK 238
Query: 651 TLERMVKTGLLCIQDEPNLRPS 672
+ +M+ LC+Q +P+ RP+
Sbjct: 239 SFRKMIS---LCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 465 LCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLL---------FNLETRPLWRDRVRI 515
+ LI +S K R +++ FM G L L F L + L VR
Sbjct: 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTL----VRF 118
Query: 516 ALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR 575
+D+A G+ YL + IH D+ RN +++++ ++DFGL+K I +G
Sbjct: 119 MIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK-------KIYSGDY 168
Query: 576 GSRG--------YMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627
+G ++A E + T SDV++FGV + EI+ V ++
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----- 223
Query: 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
+YN + G K + ++ + E M + C EP RPS +++ LE
Sbjct: 224 --IYNYLIKGNRLKQPPDCLEDV-YELMCQ----CWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 66/244 (27%), Positives = 112/244 (45%), Gaps = 45/244 (18%)
Query: 443 DKVNDKRKLLTVLAGCLGSITFLCFLIAISSLLVYKH-----RSSKKLLVYEFMSKGSLA 497
D++ D ++ +TVL+ C S V K+ + +K ++ E++ GS
Sbjct: 44 DEIEDIQQEITVLSQC-------------DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL 90
Query: 498 DLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKI 554
DLL E PL D +IA ++ +GL YLH E + IH DIK N+L+ + K+
Sbjct: 91 DLL---EPGPL--DETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKL 142
Query: 555 SDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614
+DFG+A L Q V G+ +MAPE K+D++S G+ +E+ +
Sbjct: 143 ADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIWSLGITAIEL--AKGEP 199
Query: 615 EVNVSTADEVLLSTWVYN-CFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM 673
+ +VL N + G ++K ++E V+ C+ EP+ RP+
Sbjct: 200 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA------------CLNKEPSFRPTA 247
Query: 674 KNVI 677
K ++
Sbjct: 248 KELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 48/143 (33%), Positives = 73/143 (51%), Gaps = 7/143 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEV 532
L Y + + L LV M+ G L ++++ R V A ++ GL LH E
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
+I++ D+K NIL+DD +ISD GLA + QT + G G+ GYMAPE + T
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYT 179
Query: 593 VKSDVYSFGVVLLEIICCRSNFE 615
D ++ G +L E+I +S F+
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 25/146 (17%)
Query: 480 RSSKKLLVYEFMSKGSLADLL------FNL------ETRPLWR-DRVRIALDVARGLLYL 526
++V+E+M G L L L ++IA+ +A G++YL
Sbjct: 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYL 138
Query: 527 HDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYM 581
+ +H D+ RN L+ KI DFG+++ + V G +R +M
Sbjct: 139 ASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR----WM 191
Query: 582 APEWQNSGLITVKSDVYSFGVVLLEI 607
PE T +SDV+SFGVVL EI
Sbjct: 192 PPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 37/98 (37%), Positives = 56/98 (57%), Gaps = 11/98 (11%)
Query: 515 IALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGV 574
IA+ + L YL +E ++IIH D+K NIL+D + K+ DFG++ L+ + +A
Sbjct: 112 IAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS----IAKT 165
Query: 575 R--GSRGYMAPEWQNSGLIT---VKSDVYSFGVVLLEI 607
R G R YMAPE + V+SDV+S G+ L E+
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 21/137 (15%)
Query: 485 LLVYEFMSKGSLADLLFNLETR---------PLWRDRVRIALDVARGLLYLHDECEVQII 535
L++ E M++G L L +L P + +++A ++A G+ YL+ + +
Sbjct: 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFV 141
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNSGL 590
H D+ RN ++ + + KI DFG+ + + +G +G +M+PE G+
Sbjct: 142 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGV 197
Query: 591 ITVKSDVYSFGVVLLEI 607
T SDV+SFGVVL EI
Sbjct: 198 FTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 9e-11
Identities = 45/129 (34%), Positives = 67/129 (51%), Gaps = 16/129 (12%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRVRIA--LDVARGLLYLHDECEVQIIHCDIKLRNILI 546
E+M+ GS++ LL +++ V I + RGL YLH+ QIIH D+K N+LI
Sbjct: 83 EWMAGGSVSHLLSKYGA---FKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLI 136
Query: 547 DDSWR-AKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNSGLITVKSDVYSF 600
D + + +I+DFG A L TG AG + G+ +MAPE DV+S
Sbjct: 137 DSTGQRLRIADFGAAARLAAKGTG--AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSV 194
Query: 601 GVVLLEIIC 609
G V++E+
Sbjct: 195 GCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 6/100 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV E+M L+++L + E RPL +V+ + +G+ Y+H I+H D+K N+
Sbjct: 76 LVMEYMP-SDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANL 130
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE 584
LI KI+DFGLA+L + + + +R Y APE
Sbjct: 131 LISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 62/239 (25%), Positives = 107/239 (44%), Gaps = 35/239 (14%)
Query: 443 DKVNDKRKLLTVLAGCLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFN 502
D++ D ++ +TVL+ C ++ + +K ++ E++ GS DLL
Sbjct: 44 DEIEDIQQEITVLSQCDSPY--------VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-- 93
Query: 503 LETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559
P D +IA ++ +GL YLH E + IH DIK N+L+ + K++DFG+
Sbjct: 94 -RAGPF--DEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGV 147
Query: 560 AKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVS 619
A L Q V G+ +MAPE K+D++S G+ +E+ + +
Sbjct: 148 AGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKADIWSLGITAIEL--AKGEPPNSDM 204
Query: 620 TADEVLLSTWVYNC-FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
VL N + GEF+K +E +D C+ +P+ RP+ K ++
Sbjct: 205 HPMRVLFLIPKNNPPTLTGEFSKPFKEFIDA------------CLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 60/215 (27%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCD 538
R LV E+ GS +D+L + +PL + I +GL YLH IH D
Sbjct: 86 REHTAWLVMEY-CLGSASDIL-EVHKKPLQEVEIAAICHGALQGLAYLHSHER---IHRD 140
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---WQNSGLITVKS 595
IK NIL+ + K++DFG A L+ P + + G+ +MAPE + G K
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKV 195
Query: 596 DVYSFGVVLLEIICCRSN-FEVNVSTA-------DEVLLST--WVYNCFVAGEFNKLVEE 645
DV+S G+ +E+ + F +N +A D LS+ W + F V+
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW------SDYFRNFVDS 249
Query: 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680
+ KI +R + ++ LR VI+ L
Sbjct: 250 CLQKIPQDRP--SSEELLKHRFVLRERPPTVIIDL 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 42/139 (30%), Positives = 70/139 (50%), Gaps = 12/139 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V EFM G L + L + + L +D + + DV G+ YL IH D+ RN
Sbjct: 76 IVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNC 131
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ + K+SDFG+ + ++ ++ +G + + PE N + KSDV+SFGV++
Sbjct: 132 LVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLM 191
Query: 605 LEIIC-------CRSNFEV 616
E+ +SN+EV
Sbjct: 192 WEVFTEGKMPFEKKSNYEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 38/124 (30%), Positives = 66/124 (53%), Gaps = 6/124 (4%)
Query: 486 LVYEFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++ EFM+ G+L D L N + + +A ++ + YL + IH D+ RN
Sbjct: 79 IITEFMTYGNLLDYLRECNRQEVNAVV-LLYMATQISSAMEYLEKK---NFIHRDLAARN 134
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
L+ ++ K++DFGL++L+ + AG + + APE ++KSDV++FGV+
Sbjct: 135 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194
Query: 604 LLEI 607
L EI
Sbjct: 195 LWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 16/166 (9%)
Query: 443 DKVNDKRKLLTVLAGCLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFN 502
D++ D ++ +TVL+ C + S L + +K ++ E++ GS DLL
Sbjct: 44 DEIEDIQQEITVLSQCDSPYITRYY----GSYL----KGTKLWIIMEYLGGGSALDLL-- 93
Query: 503 LETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
+ PL + L ++ +GL YLH E + IH DIK N+L+ + K++DFG+A
Sbjct: 94 -KPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149
Query: 562 LLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
L Q V G+ +MAPE K+D++S G+ +E+
Sbjct: 150 QLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 46/142 (32%), Positives = 72/142 (50%), Gaps = 7/142 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEV 532
L Y + + L LV M+ G L ++N+ +R A ++ GL LH E
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE--- 121
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
++ D+K NIL+DD +ISD GLA + +P + + G G+ GYMAPE N+ T
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLA-VKIP-EGESIRGRVGTVGYMAPEVLNNQRYT 179
Query: 593 VKSDVYSFGVVLLEIICCRSNF 614
+ D + G ++ E+I +S F
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 40/124 (32%), Positives = 70/124 (56%), Gaps = 8/124 (6%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547
E M GSL +L E + + + + ++++ V RGL YL ++ QI+H D+K NIL++
Sbjct: 83 EHMDGGSLDQVL--KEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVN 138
Query: 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
K+ DFG++ L+ + + G+R YM+PE +V+SD++S G+ L+E+
Sbjct: 139 SRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
Query: 608 ICCR 611
R
Sbjct: 196 AIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 40/124 (32%), Positives = 63/124 (50%), Gaps = 10/124 (8%)
Query: 489 EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
E+M GS+ D L + T + R R L+ G+ YLH I+H DIK NIL
Sbjct: 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILE---GVEYLHSN---MIVHRDIKGANILR 137
Query: 547 DDSWRAKISDFGLAKLL--MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
D + K+ DFG +K L + + + V G+ +M+PE + K+DV+S G +
Sbjct: 138 DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTV 197
Query: 605 LEII 608
+E++
Sbjct: 198 VEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 51/156 (32%), Positives = 84/156 (53%), Gaps = 13/156 (8%)
Query: 454 VLAGCLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRV 513
V+AG +GS ++C L+ I +S LV + M G L D + + R +D +
Sbjct: 62 VMAG-VGS-PYVCRLLGIC-------LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 514 RIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA- 572
+ +A+G+ YL EV+++H D+ RN+L+ KI+DFGLA+LL ++T A
Sbjct: 113 NWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 169
Query: 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608
G + +MA E T +SDV+S+GV + E++
Sbjct: 170 GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 3e-10
Identities = 40/134 (29%), Positives = 67/134 (50%), Gaps = 7/134 (5%)
Query: 480 RSSKKL-LVYEFMSKGSLADLLFNL--ETRPLWRDRV-RIALDVARGLLYLH--DECEVQ 533
RS++ L +V E+ G LA L+ E + + + + RI + L H +
Sbjct: 71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT 130
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITV 593
++H D+K NI +D + K+ DFGLAK+L + + G+ YM+PE N
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFGLAKIL-GHDSSFAKTYVGTPYYMSPEQLNHMSYDE 189
Query: 594 KSDVYSFGVVLLEI 607
KSD++S G ++ E+
Sbjct: 190 KSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 45/139 (32%), Positives = 66/139 (47%), Gaps = 11/139 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E+++ G A L+ L P + IA +V G+ LH IIH DIK N+L
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLHQR---GIIHRDIKPENLL 129
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
ID + K++DFGL++ + N+ + G+ Y+APE SD +S G V+
Sbjct: 130 IDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETILGVGDDKMSDWWSLGCVIF 184
Query: 606 EIICCRSNFEVNVSTADEV 624
E + F T D V
Sbjct: 185 EFLFGYPPFHAE--TPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 53/174 (30%), Positives = 83/174 (47%), Gaps = 28/174 (16%)
Query: 442 NDKVNDKRKLLTVLAGCLGS-IT--FLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLAD 498
D++ D ++ + L+ C IT + FL + SK ++ E+ GS D
Sbjct: 40 EDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----------KGSKLWIIMEYCGGGSCLD 88
Query: 499 LLFNLETRPLWRDRVRIA---LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555
LL + L D IA +V GL YLH+E IH DIK NIL+ + K++
Sbjct: 89 LL---KPGKL--DETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLA 140
Query: 556 DFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKSDVYSFGVVLLEII 608
DFG++ L + V G+ +MAPE + SG K+D++S G+ +E+
Sbjct: 141 DFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDE-KADIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 6/131 (4%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCD 538
+ ++V E GSL D L + A+ +A G+ YL + + IH D
Sbjct: 66 LTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRD 122
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSD 596
+ RNIL+ + KI DFGL + L N+ V ++ + APE + + SD
Sbjct: 123 LAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASD 182
Query: 597 VYSFGVVLLEI 607
V+ FGV L E+
Sbjct: 183 VWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 40/119 (33%), Positives = 63/119 (52%), Gaps = 11/119 (9%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548
EFM GSL D+ + L R IA+ V +GL YL ++I+H D+K N+L++
Sbjct: 79 EFMDGGSL-DVYRKIPEHVLGR----IAVAVVKGLTYLWS---LKILHRDVKPSNMLVNT 130
Query: 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
+ K+ DFG++ L+ I G+ YMAPE + + SDV+S G+ +E+
Sbjct: 131 RGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570
D + + VARG+ +L + IH D+ RNIL+ ++ KI DFGLA+ + + +
Sbjct: 174 DLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230
Query: 571 VAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
G R +MAPE + T +SDV+SFGV+L EI
Sbjct: 231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 47/142 (33%), Positives = 71/142 (50%), Gaps = 7/142 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEV 532
L Y + + L LV M+ G L ++N+ R + A ++ GL L E
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE--- 121
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
+I++ D+K NIL+DD +ISD GLA + +T V G G+ GYMAPE N+ T
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNEKYT 179
Query: 593 VKSDVYSFGVVLLEIICCRSNF 614
D + G ++ E+I +S F
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 44/137 (32%), Positives = 66/137 (48%), Gaps = 23/137 (16%)
Query: 491 MSKGSLADLLFN-------------LETRPLWR------DRVRIALDVARGLLYLHDECE 531
+ A +LF+ ET LW+ D + + VARG+ +L
Sbjct: 136 RIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR-- 193
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEWQNSGL 590
+ IH D+ RNIL+ ++ KI DFGLA+ + + + G R +MAPE +
Sbjct: 194 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252
Query: 591 ITVKSDVYSFGVVLLEI 607
T +SDV+SFGV+L EI
Sbjct: 253 YTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 468 LIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLF--NLETRPLW---RDRVRIALDVARG 522
LI + + K +++ FM G L L L P + ++ +D+A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 523 LLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN----QTGIVAGVRGSR 578
+ YL + IH D+ RN ++ + ++DFGL+K + Q I +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI---AKMPV 179
Query: 579 GYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
++A E + T KSDV++FGV + EI
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 5/131 (3%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+S ++V E+M GSL L + + V + +A G+ YL D + +H D+
Sbjct: 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDL 132
Query: 540 KLRNILIDDSWRAKISDFGLAKLLM--PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDV 597
RNIL++ + K+SDFGL+++L P G + + APE T SDV
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDV 192
Query: 598 YSFGVVLLEII 608
+S+G+V+ E++
Sbjct: 193 WSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 37/125 (29%), Positives = 62/125 (49%), Gaps = 10/125 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E + G L R ++ +++ + A G+ YL + IH D+ RN L
Sbjct: 70 IVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCL 126
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR----GYMAPEWQNSGLITVKSDVYSFG 601
+ + KISDFG+++ + G+ A G + + APE N G + +SDV+SFG
Sbjct: 127 VTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFG 183
Query: 602 VVLLE 606
++L E
Sbjct: 184 ILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 47/148 (31%), Positives = 67/148 (45%), Gaps = 10/148 (6%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
L Y + L LV E+ G L LL N D + L A +L +H ++
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYL--AELVLAIHSVHQMG 122
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS----- 588
+H DIK N+LID + K++DFG A L N+ G+ Y+APE +
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 589 -GLITVKSDVYSFGVVLLEIICCRSNFE 615
G V+ D +S GV+ E+I RS F
Sbjct: 183 KGTYGVECDWWSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 40/137 (29%), Positives = 67/137 (48%), Gaps = 13/137 (9%)
Query: 481 SSKKLLVYEFMSKGSLADLLFNLETRPLW-------RDRVRIALDVARGLLYLHDECEVQ 533
++Y +M+ G+L L + V +A+ +A G+ YLH +
Sbjct: 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRG 137
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR--GYMAPEWQNSGLI 591
+IH DI RN +ID+ + KI+D L++ L P + G +R +MA E +
Sbjct: 138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCL-GDNENRPVKWMALESLVNKEY 196
Query: 592 TVKSDVYSFGVVLLEII 608
+ SDV+SFGV+L E++
Sbjct: 197 SSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 19/134 (14%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV M ADL ++ + L D ++ + + RGL Y+H IIH D+K NI
Sbjct: 97 LVTHLMG----ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNI 149
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE----WQNSGLITVKSDVYSF 600
+++ KI DFGLA+ TG VA +R Y APE W + D++S
Sbjct: 150 AVNEDCELKILDFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMH---YNQTVDIWSV 202
Query: 601 GVVLLEIICCRSNF 614
G ++ E++ ++ F
Sbjct: 203 GCIMAELLTGKTLF 216
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 23/172 (13%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570
D + + VA+G+ +L + IH D+ RNIL+ ++ KI DFGLA+ + + +
Sbjct: 180 DLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 236
Query: 571 VAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629
G R +MAPE + T++SDV+SFGV+L EI F + S V +
Sbjct: 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI------FSLGASPYPGVKIDE- 289
Query: 630 VYNCFVAGEFNKLVEE----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
EF + ++E T M +T L C EP+ RP+ ++
Sbjct: 290 --------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 44/130 (33%), Positives = 72/130 (55%), Gaps = 9/130 (6%)
Query: 487 VYEFMSKGSLADLLFNLETRPLWRD-RVRI-ALDVARGLLYLHDECEVQIIHCDIKLRNI 544
V E+++ G DL+F++++ + + R R A ++ GL +LH + II+ D+KL N+
Sbjct: 74 VMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNV 127
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+D KI+DFG+ K M N G + G+ Y+APE D +SFGV+L
Sbjct: 128 LLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLL 186
Query: 605 LEIICCRSNF 614
E++ +S F
Sbjct: 187 YEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 45/130 (34%), Positives = 68/130 (52%), Gaps = 19/130 (14%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDR---VRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
E+M GSL D L+ RI V +GL +L +E IIH D+K N+L
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVL 135
Query: 546 IDDSWRAKISDFGLAKLLMPN--QTGIVAGVRGSRGYMAPEWQNSG------LITVKSDV 597
++ + + K+ DFG++ L+ + +T I G + YMAPE SG TV+SDV
Sbjct: 136 VNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQNPTYTVQSDV 190
Query: 598 YSFGVVLLEI 607
+S G+ +LE+
Sbjct: 191 WSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 15/159 (9%)
Query: 467 FLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLL 524
FL+ + S S+ V E+++ G DL+F+++ R L + R + +++ L
Sbjct: 57 FLVGLHSCF---QTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 525 YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL-LMPNQTGIVAGVRGSRGYMAP 583
YLH E II+ D+KL N+L+D K++D+G+ K L P T + G+ Y+AP
Sbjct: 111 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAP 165
Query: 584 EWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD 622
E D ++ GV++ E++ RS F++ V ++D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI-VGSSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 41/134 (30%), Positives = 68/134 (50%), Gaps = 9/134 (6%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+S +++ EFM G+L L + + V + +A G+ YL E+ +H D+
Sbjct: 76 KSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYVHRDL 132
Query: 540 KLRNILIDDSWRAKISDFGLAKLLM-----PNQTGIVAGVRGSRGYMAPEWQNSGLITVK 594
RNIL++ + K+SDFGL++ L P T + G R + APE T
Sbjct: 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIR-WTAPEAIAYRKFTSA 191
Query: 595 SDVYSFGVVLLEII 608
SDV+S+G+V+ E++
Sbjct: 192 SDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 46/138 (33%), Positives = 70/138 (50%), Gaps = 19/138 (13%)
Query: 486 LVYEFMSKGSLADLL-----------FNLETRPL----WRDRVRIALDVARGLLYLHDEC 530
++ E+ SKG+L + L +N P ++D V A VARG+ YL +
Sbjct: 101 VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK- 159
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAK-LLMPNQTGIVAGVRGSRGYMAPEWQNSG 589
+ IH D+ RN+L+ + KI+DFGLA+ + + R +MAPE
Sbjct: 160 --KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR 217
Query: 590 LITVKSDVYSFGVVLLEI 607
+ T +SDV+SFGV+L EI
Sbjct: 218 IYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 42/132 (31%), Positives = 63/132 (47%), Gaps = 7/132 (5%)
Query: 486 LVYEFMSKGSLADLLFNL-ETRPLWRD--RVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
LV M+ G L ++N+ E P + + + GL +LH +II+ D+K
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPE 126
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
N+L+D+ +ISD GLA L Q+ G G+ G+MAPE D ++ GV
Sbjct: 127 NVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDFSVDYFALGV 185
Query: 603 VLLEIICCRSNF 614
L E+I R F
Sbjct: 186 TLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-09
Identities = 39/126 (30%), Positives = 67/126 (53%), Gaps = 5/126 (3%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+++ E+M G+L L + + V + +A G+ YL D + +H D+ RNI
Sbjct: 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNI 138
Query: 545 LIDDSWRAKISDFGLAKLL--MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
L++ + K+SDFGL+++L P T +G + + APE T SDV+SFG+
Sbjct: 139 LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 198
Query: 603 VLLEII 608
V+ E++
Sbjct: 199 VMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 19/157 (12%)
Query: 525 YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE 584
Y+H + I+H DIK NI + + K+ DFG++K ++ ++ + V G+ YM+PE
Sbjct: 116 YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETVVGTPYYMSPE 171
Query: 585 WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644
KSD+++ G VL E++ + F+ A L V G +
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFD-----ATNPLNLVVK---IVQGNY----T 219
Query: 645 EEVDKITLE-RMVKTGLLCIQDEPNLRPSMKNVILML 680
V + E + LL Q +P RP+ V+
Sbjct: 220 PVVSVYSSELISLVHSLL--QQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 39/128 (30%), Positives = 62/128 (48%), Gaps = 17/128 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E + G L + + V+ ALD A G+ YL + IH D+ RN L
Sbjct: 69 IVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCL 125
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-------YMAPEWQNSGLITVKSDVY 598
+ ++ KISDFG+++ + G+ S G + APE N G + +SDV+
Sbjct: 126 VGENNVLKISDFGMSR----QEDD---GIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 599 SFGVVLLE 606
S+G++L E
Sbjct: 179 SYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 467 FLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLL 524
FL+ + S +S+ LV E+++ G DL+F+++ R L + R A ++ L
Sbjct: 57 FLVGLHSCF---QTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAEICIALN 110
Query: 525 YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL-LMPNQTGIVAGVRGSRGYMAP 583
+LH E II+ D+KL N+L+D K++D+G+ K L P T + G+ Y+AP
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAP 165
Query: 584 EWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD 622
E D ++ GV++ E++ RS F++ D
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 26/136 (19%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR------IALDVARGLLYLHDECEVQIIHCDI 539
LV E GS+ DL+ L + R++ I + RGL YLH+ ++IH DI
Sbjct: 86 LVMELCGGGSVTDLVKGLRKKG---KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDI 139
Query: 540 KLRNILIDDSWRAKISDFG----LAKLLMPNQTGIVAGVRGSRGYMAPE-----WQNSGL 590
K +NIL+ + K+ DFG L L T I G+ +MAPE Q
Sbjct: 140 KGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-----GTPYWMAPEVIACDEQPDAS 194
Query: 591 ITVKSDVYSFGVVLLE 606
+SDV+S G+ +E
Sbjct: 195 YDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 24/157 (15%)
Query: 475 LVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQ 533
+V H SS +Y +++K +RPL + I + GL YLH + +
Sbjct: 134 MVLPHYSSD---LYTYLTK----------RSRPLPIDQALIIEKQILEGLRYLHAQ---R 177
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAK--LLMPNQTGIVAGVRGSRGYMAPEWQNSGLI 591
IIH D+K NI I+D + I D G A+ ++ P G+ V + APE
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETN----APEVLARDKY 233
Query: 592 TVKSDVYSFGVVLLEIICCRSN-FEVNVSTADEVLLS 627
K+D++S G+VL E++ S FE ST +E + S
Sbjct: 234 NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 43/140 (30%), Positives = 69/140 (49%), Gaps = 23/140 (16%)
Query: 486 LVYEFMSKGSL-----------ADLLFNLETRP----LWRDRVRIALDVARGLLYLHDEC 530
++ E+ +KG+L D F++ P ++D V A VARG+ YL
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR- 153
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQN 587
+ IH D+ RN+L+ + KI+DFGLA+ + + R +MAPE
Sbjct: 154 --RCIHRDLAARNVLVTEDNVMKIADFGLARGV--HDIDYYKKTSNGRLPVKWMAPEALF 209
Query: 588 SGLITVKSDVYSFGVVLLEI 607
+ T +SDV+SFG+++ EI
Sbjct: 210 DRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 37/126 (29%), Positives = 66/126 (52%), Gaps = 12/126 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V EF+ G+L D++ TR + L V + L +LH + +IH DIK +IL
Sbjct: 93 VVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSIL 147
Query: 546 IDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+ R K+SDFG + +P + +V G+ +MAPE + + D++S G+
Sbjct: 148 LTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGI 203
Query: 603 VLLEII 608
+++E++
Sbjct: 204 MVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 46/149 (30%), Positives = 66/149 (44%), Gaps = 32/149 (21%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRP--LWRDRVR-IALDVARGLLYLHDEC 530
L R +L LV+E++ + LL LE P L D VR + + + Y H
Sbjct: 65 LKEAFRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH- 119
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL----MPNQTGIVAGVRGSRGYMAPEWQ 586
IIH DIK NIL+ +S K+ DFG A+ L T VA +R Y APE
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA----TRWYRAPE-- 171
Query: 587 NSGLITVKS-------DVYSFGVVLLEII 608
+ V DV++ G ++ E++
Sbjct: 172 ----LLVGDTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 46/138 (33%), Positives = 72/138 (52%), Gaps = 19/138 (13%)
Query: 486 LVYEFMSKGSLADLL---------FNLETRPL------WRDRVRIALDVARGLLYLHDEC 530
++ E+ SKG+L + L ++ +T L ++D V A VARG+ YL +
Sbjct: 95 VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ- 153
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP-NQTGIVAGVRGSRGYMAPEWQNSG 589
+ IH D+ RN+L+ + KI+DFGLA+ + + R +MAPE
Sbjct: 154 --KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR 211
Query: 590 LITVKSDVYSFGVVLLEI 607
+ T +SDV+SFGV+L EI
Sbjct: 212 VYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 8e-09
Identities = 40/126 (31%), Positives = 67/126 (53%), Gaps = 12/126 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V EF+ G+L D++ TR + L V R L YLH++ +IH DIK +IL
Sbjct: 96 VVMEFLEGGALTDIV--THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSIL 150
Query: 546 IDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+ R K+SDFG + +P + +V G+ +MAPE + + D++S G+
Sbjct: 151 LTSDGRIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGI 206
Query: 603 VLLEII 608
+++E+I
Sbjct: 207 MVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 37/126 (29%), Positives = 64/126 (50%), Gaps = 13/126 (10%)
Query: 489 EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
EF+ GS++ +L F P++ + LD G+ YLH+ C ++H DIK N+++
Sbjct: 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILD---GVAYLHNNC---VVHRDIKGNNVML 135
Query: 547 DDSWRAKISDFGLAKLLM-----PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
+ K+ DFG A+ L + ++ + G+ +MAPE N KSD++S G
Sbjct: 136 MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIG 195
Query: 602 VVLLEI 607
+ E+
Sbjct: 196 CTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 44/140 (31%), Positives = 71/140 (50%), Gaps = 23/140 (16%)
Query: 486 LVYEFMSKGSLADLL-----------FNLETRP----LWRDRVRIALDVARGLLYLHDEC 530
++ E+ SKG+L + L +++ P ++D V VARG+ YL +
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ- 156
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQN 587
+ IH D+ RN+L+ ++ KI+DFGLA+ + N R +MAPE
Sbjct: 157 --KCIHRDLAARNVLVTENNVMKIADFGLARDV--NNIDYYKKTTNGRLPVKWMAPEALF 212
Query: 588 SGLITVKSDVYSFGVVLLEI 607
+ T +SDV+SFGV++ EI
Sbjct: 213 DRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 39/145 (26%), Positives = 61/145 (42%), Gaps = 18/145 (12%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET--RPLWRDRVR-IALDVARGLLYLH 527
I LL LV+EFM DL ++ R L ++ + +GL + H
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 528 DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ---TGIVAGVRGSRGYMAPE 584
I+H D+K N+LI+ K++DFGLA+ T V +R Y APE
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPE 168
Query: 585 -WQNSGLITVKSDVYSFGVVLLEII 608
+ D++S G + E++
Sbjct: 169 LLLGDKGYSTPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 29/91 (31%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 519 VARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV-AGVRGS 577
+A+G+ YL + ++H ++ RNIL+ +I+DFG+A LL P+ + +
Sbjct: 118 IAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTP 174
Query: 578 RGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608
+MA E G T +SDV+S+GV + E++
Sbjct: 175 IKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 20/135 (14%)
Query: 484 KLLVY-EFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKL 541
KL + EF G+L ++ LE R L ++R + + L +LH ++IH D+K
Sbjct: 76 KLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKA 131
Query: 542 RNILIDDSWRAKISDFGL-AKLLMPNQ---TGIVAGVRGSRGYMAPEWQN-----SGLIT 592
NIL+ K++DFG+ AK Q T I G+ +MAPE
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-----GTPYWMAPEVVACETFKDNPYD 186
Query: 593 VKSDVYSFGVVLLEI 607
K+D++S G+ L+E+
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 37/127 (29%), Positives = 65/127 (51%), Gaps = 9/127 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ EF+ GSL + L + + + +++ A+ + +G+ YL Q +H D+ RN+L
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVL 141
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG----YMAPEWQNSGLITVKSDVYSFG 601
++ + KI DFGL K + ++ V+ + APE + SDV+SFG
Sbjct: 142 VESEHQVKIGDFGLTKAIETDKEYYT--VKDDLDSPVFWYAPECLIQSKFYIASDVWSFG 199
Query: 602 VVLLEII 608
V L E++
Sbjct: 200 VTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 19/116 (16%)
Query: 514 RIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573
++ + + + L YL ++ +IH D+K NIL+D S K+ DFG++ L+ ++ A
Sbjct: 118 KMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK----AK 171
Query: 574 VR--GSRGYMAPEW----QNSGLITVKSDVYSFGVVLLEIIC-------CRSNFEV 616
R G YMAPE + +++DV+S G+ L+E+ C++ FEV
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV 227
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 51/192 (26%), Positives = 78/192 (40%), Gaps = 45/192 (23%)
Query: 440 IGNDKVN----DKRKLLTV----------LAGCLGSITFLCFLIAISSLLVYKHRSSKKL 485
I D+V +KR T L C + +CF
Sbjct: 38 IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF------------------ 79
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRNI 544
V E+ + G DL+ ++ T R A V GL YLH+ +I++ D+KL N+
Sbjct: 80 -VMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNL 132
Query: 545 LIDDSWRAKISDFGLAKLLM--PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
L+D KI+DFGL K M ++T G+ ++APE T D + GV
Sbjct: 133 LLDTEGFVKIADFGLCKEGMGFGDRTSTFC---GTPEFLAPEVLTETSYTRAVDWWGLGV 189
Query: 603 VLLEIICCRSNF 614
++ E++ S F
Sbjct: 190 LIYEMLVGESPF 201
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 14/103 (13%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP----- 565
+++ IA VA G+ YL + + +H D+ RN L+ ++ KI+DFGL++ +
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 566 -NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
++ + +R +M PE T +SDV+++GVVL EI
Sbjct: 188 ASENDAIP-IR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 47/143 (32%), Positives = 68/143 (47%), Gaps = 32/143 (22%)
Query: 490 FMSK---GSLADLLFNLETR--PLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKL 541
FM + GSL+ LL ++ PL + I + GL YLHD QI+H DIK
Sbjct: 83 FMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKG 136
Query: 542 RNILIDD-SWRAKISDFGLAKLLMPNQTGIVAGV-------RGSRGYMAPEWQNSGL--I 591
N+L++ S KISDFG +K L AG+ G+ YMAPE + G
Sbjct: 137 DNVLVNTYSGVVKISDFGTSKRL--------AGINPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 592 TVKSDVYSFGVVLLEIICCRSNF 614
+D++S G ++E+ + F
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 19/148 (12%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNL-ETRPLWRDRVRI-ALDVARGLLYLHDECE 531
L Y ++ +L V E+ + G +L F+L R DR R ++ L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQ 586
V ++ D+KL N+++D KI+DFGL K GI G G+ Y+APE
Sbjct: 117 V--VYRDLKLENLMLDKDGHIKITDFGLCK------EGIKDGATMKTFCGTPEYLAPEVL 168
Query: 587 NSGLITVKSDVYSFGVVLLEIICCRSNF 614
D + GVV+ E++C R F
Sbjct: 169 EDNDYGRAVDWWGLGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 43/129 (33%), Positives = 65/129 (50%), Gaps = 16/129 (12%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV E+ + LA LL N+ P +V+ + L + RGL YLH+ IIH D+K+ N+
Sbjct: 85 LVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNL 139
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR----GYMAPEWQ-NSGLITVKSDVYS 599
L+ D KI+DFGLA+ G+ A + Y APE T D+++
Sbjct: 140 LLTDKGCLKIADFGLART-----YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWA 194
Query: 600 FGVVLLEII 608
G +L E++
Sbjct: 195 VGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 37/125 (29%), Positives = 70/125 (56%), Gaps = 10/125 (8%)
Query: 514 RIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573
++++ V +GL YL ++ +I+H D+K NIL++ K+ DFG++ L+ + +
Sbjct: 107 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANS 161
Query: 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC 633
G+R YM+PE +V+SD++S G+ L+E+ R + + A E+ L ++ C
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR--YPIPPPDAKELEL---MFGC 216
Query: 634 FVAGE 638
V G+
Sbjct: 217 PVEGD 221
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 37/129 (28%), Positives = 61/129 (47%), Gaps = 13/129 (10%)
Query: 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
V+E++ +L ++L P + R+ L V L H++ I+H D+K +NI++
Sbjct: 57 VFEYVPGRTLREVLAADGALPA-GETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112
Query: 547 ---DDSWRAKISDFGLAKLL-----MPNQTGIVAG-VRGSRGYMAPEWQNSGLITVKSDV 597
AK+ DFG+ LL T V G+ Y APE +T SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 598 YSFGVVLLE 606
Y++G++ LE
Sbjct: 173 YAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 45/148 (30%), Positives = 68/148 (45%), Gaps = 20/148 (13%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNL-ETRPLWRDRVRI-ALDVARGLLYLHDECE 531
L Y ++ +L V E+ + G +L F+L R +R R ++ L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR-- 114
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQ 586
+++ DIKL N+++D KI+DFGL K GI G G+ Y+APE
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTPEYLAPEVL 167
Query: 587 NSGLITVKSDVYSFGVVLLEIICCRSNF 614
D + GVV+ E++C R F
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 46/137 (33%), Positives = 72/137 (52%), Gaps = 13/137 (9%)
Query: 478 KHRSSKKLLVY-EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQI 534
+ R+ K L ++ E+M GS+ D L + T + R R L+ G+ YLH I
Sbjct: 74 RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE---GMSYLHSN---MI 127
Query: 535 IHCDIKLRNILIDDSWRAKISDFGLAKLLMP---NQTGIVAGVRGSRGYMAPEWQNSGLI 591
+H DIK NIL D + K+ DFG +K L + TGI + V G+ +M+PE +
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVISGEGY 186
Query: 592 TVKSDVYSFGVVLLEII 608
K+DV+S G ++E++
Sbjct: 187 GRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 42/140 (30%), Positives = 75/140 (53%), Gaps = 27/140 (19%)
Query: 487 VYEFMSKGSLADLLFNLETRPLWRDRVRI--ALDVARGLLYLHDECEVQIIHCDIKLRNI 544
V E+++ G DL+++++ +++ + A ++A GL +LH + II+ D+KL N+
Sbjct: 79 VMEYVNGG---DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNV 132
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPE---WQNSGLITVKS- 595
++D KI+DFG+ K I G G+ Y+APE +Q G KS
Sbjct: 133 MLDAEGHIKIADFGMCK------ENIFGGKTTRTFCGTPDYIAPEIIAYQPYG----KSV 182
Query: 596 DVYSFGVVLLEIICCRSNFE 615
D ++FGV+L E++ + F+
Sbjct: 183 DWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 519 VARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS- 577
V+ G+ YL E +H D+ RN+L+ AKISDFGL+K L ++ A G
Sbjct: 104 VSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160
Query: 578 -RGYMAPEWQNSGLITVKSDVYSFGVVLLE 606
+ APE N + KSDV+SFGV++ E
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 37/124 (29%), Positives = 66/124 (53%), Gaps = 4/124 (3%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ + M G L D + + + + + +A+G+ YL + +++H D+ RN+L
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVL 141
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVA-GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ KI+DFGLAKLL ++ A G + +MA E + T +SDV+S+GV +
Sbjct: 142 VKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201
Query: 605 LEII 608
E++
Sbjct: 202 WELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 43/134 (32%), Positives = 68/134 (50%), Gaps = 13/134 (9%)
Query: 481 SSKKLLVY-EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHC 537
KKL ++ E+M GS+ D L + T + R R + +G+ YLH I+H
Sbjct: 77 EEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR---QILQGVSYLHSN---MIVHR 130
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMP---NQTGIVAGVRGSRGYMAPEWQNSGLITVK 594
DIK NIL D + K+ DFG +K + + TGI V G+ +M+PE + K
Sbjct: 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI-KSVTGTPYWMSPEVISGEGYGRK 189
Query: 595 SDVYSFGVVLLEII 608
+DV+S ++E++
Sbjct: 190 ADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 14/153 (9%)
Query: 467 FLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLL 524
FL+ + S S+ V EF+S G DL+F+++ R L + R + +++ L
Sbjct: 57 FLVGLHSCF---QTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLALN 110
Query: 525 YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL-LMPNQTGIVAGVRGSRGYMAP 583
+LH E II+ D+KL N+L+D K++D+G+ K + P T + G+ Y+AP
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAP 165
Query: 584 EWQNSGLITVKSDVYSFGVVLLEIICCRSNFEV 616
E D ++ GV++ E++ RS F++
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 44/133 (33%), Positives = 68/133 (51%), Gaps = 11/133 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E M DL ++T+ L D ++ L + RGL Y+H ++H D+K N+
Sbjct: 85 IVQELME----TDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNL 137
Query: 545 LIDDSWRAKISDFGLAKLLMPN--QTGIVAGVRGSRGYMAPEWQ-NSGLITVKSDVYSFG 601
L++ + KI DFGLA++ P TG + +R Y APE NS T D++S G
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG 197
Query: 602 VVLLEIICCRSNF 614
+L E++ R F
Sbjct: 198 CILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-08
Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 523 LLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-GSRGYM 581
LL +H +IH DIK NIL+ + K+ DFG +K+ + V G+ Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 582 APEWQNSGLITVKSDVYSFGVVLLEIICCRSNFE-VNVSTADEVLLSTWVYNCFVAGEFN 640
APE + K+D++S GV+L E++ + F+ N+ +EV+ T +AG ++
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---EEVMHKT------LAGRYD 263
Query: 641 KLVEEEVDKITLE-RMVKTGLLCIQDEPNLRPSMKNVI------LMLEGTMEI 686
L I+ E + + T LL +P RPS ++ L + G +EI
Sbjct: 264 PL----PPSISPEMQEIVTALLS--SDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570
D + VARG+ +L + +H D+ RN+L+ KI DFGLA+ +M + +
Sbjct: 238 DLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYV 294
Query: 571 VAGVRG-SRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629
G +MAPE L T SDV+S+G++L EI F + + +++ +
Sbjct: 295 SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI------FSLGGTPYPGMIVDST 348
Query: 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNV 676
YN +G + + + + MVK C EP RPS ++
Sbjct: 349 FYNKIKSG-YRMAKPDHATQEVYDIMVK----CWNSEPEKRPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 44/147 (29%), Positives = 63/147 (42%), Gaps = 34/147 (23%)
Query: 479 HRSSK-KLLVY---EFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYL 526
+R+ K K +Y E+ G L +L RDR AR YL
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTIL---------RDRGLFDEYTARFYIACVVLAFEYL 109
Query: 527 HDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ---TGIVAGVRGSRGYMAP 583
H+ II+ D+K N+L+D + K+ DFG AK L Q T G+ Y+AP
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC-----GTPEYVAP 161
Query: 584 E-WQNSGLITVKSDVYSFGVVLLEIIC 609
E N G D +S G++L E++
Sbjct: 162 EIILNKGY-DFSVDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 41/118 (34%), Positives = 60/118 (50%), Gaps = 10/118 (8%)
Query: 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAK 553
+ D L N + D V + VA G+ +L + +H D+ RN+LI + K
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVK 279
Query: 554 ISDFGLAKLLMPNQTGIVAGVRGSR----GYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
I DFGLA+ +M + I +GS +MAPE + L T SDV+SFG++L EI
Sbjct: 280 ICDFGLARDIMRDSNYI---SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 45/219 (20%)
Query: 485 LLVYEFMSKGSL--------ADLLFNLETRPLWRD-------RVRIALDVARGLLYLHDE 529
++V+E+M G L D + ++ +P + IA +A G++YL +
Sbjct: 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ 142
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPE 584
+H D+ RN L+ + KI DFG+++ + V G +R +M PE
Sbjct: 143 ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----WMPPE 195
Query: 585 WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG---EFNK 641
T +SDV+SFGV+L EI +S +T V C G E +
Sbjct: 196 SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTEVIECITQGRVLERPR 248
Query: 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680
+ +EV I L C Q EP R ++K + +L
Sbjct: 249 VCPKEVYDIMLG--------CWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 5/113 (4%)
Query: 507 PLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565
PL D V++ L + RGL YLH I+H DIK N+L++ + KI DFGLA++ P
Sbjct: 99 PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155
Query: 566 NQTGIVAGVRGSRGYMAPE-WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617
+++ + ++ Y APE S T D++S G + E++ R F+
Sbjct: 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQ 208
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 42/217 (19%)
Query: 485 LLVYEFMSKGSLADLLF------------NLETRPLWRDRVRIALDVARGLLYLHDECEV 532
++V+E+M G L L N + IA +A G++YL +
Sbjct: 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ--- 139
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQN 587
+H D+ RN L+ ++ KI DFG+++ + V G +R +M PE
Sbjct: 140 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----WMPPESIM 195
Query: 588 SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG---EFNKLVE 644
T +SDV+S GVVL EI +S + V C G + +
Sbjct: 196 YRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECITQGRVLQRPRTCP 248
Query: 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
+EV + L C Q EP++R ++K + +L+
Sbjct: 249 KEVYDLMLG--------CWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 4e-08
Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 22/99 (22%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ------TGIVAGV 574
RGL YLH +IH D+K NIL++ + KI DFGLA+ + P++ T V
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-- 168
Query: 575 RGSRGYMAPE----WQN-SGLITVKSDVYSFGVVLLEII 608
+R Y APE + I D++S G + E++
Sbjct: 169 --TRWYRAPELLLSSSRYTKAI----DIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 40/128 (31%), Positives = 65/128 (50%), Gaps = 10/128 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV EF GS+ DL+ N + L + + I ++ RGL +LH ++IH DIK +N+
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNV 142
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-----WQNSGLITVKSDVYS 599
L+ ++ K+ DFG++ L G G+ +MAPE KSD++S
Sbjct: 143 LLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201
Query: 600 FGVVLLEI 607
G+ +E+
Sbjct: 202 LGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 6e-08
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 28/109 (25%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL--------MPNQTGIVA 572
+ L Y+H +IH D+K NIL++ R K++DFGLA+ L P T VA
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGV-------VLLEIICCRSNF 614
+R Y APE I + S Y+ GV +L E++ + F
Sbjct: 175 ----TRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGKPLF 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570
D + + VA+G+ +L + IH D+ RNIL+ KI DFGLA+ + + +
Sbjct: 215 DLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271
Query: 571 VAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
V G R +MAPE + + T +SDV+S+G++L EI
Sbjct: 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 29/98 (29%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 517 LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRG 576
+ +A L YLH++ I+H D+K +N+ + + K+ D G+A++L NQ + + + G
Sbjct: 109 VQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIG 164
Query: 577 SRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614
+ YM+PE ++ KSDV++ G + E+ + F
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 42/130 (32%), Positives = 59/130 (45%), Gaps = 15/130 (11%)
Query: 485 LLVYEFMSKGSLADLL----FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540
L+ E++ GSL D L NL L+ A + G+ YLH + IH D+
Sbjct: 84 QLIMEYVPLGSLRDYLPKHKLNLAQLLLF------AQQICEGMAYLHSQ---HYIHRDLA 134
Query: 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG--YMAPEWQNSGLITVKSDVY 598
RN+L+D+ KI DFGLAK + G + A E + SDV+
Sbjct: 135 ARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVW 194
Query: 599 SFGVVLLEII 608
SFGV L E++
Sbjct: 195 SFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 7e-08
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 12/102 (11%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN---- 566
D + IA+ +A G+ YL +H D+ RNILI + KISD GL++ +
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 567 -QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
Q + +R +M PE G + SD++SFGVVL EI
Sbjct: 182 VQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 43/135 (31%), Positives = 71/135 (52%), Gaps = 15/135 (11%)
Query: 485 LLVYEFMSKGSLADLLFNLETR---PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541
V EF++ G DL+F+++ + L+R A ++ GL +LH + II+ D+KL
Sbjct: 72 FFVMEFLNGG---DLMFHIQDKGRFDLYRATF-YAAEIVCGLQFLHSK---GIIYRDLKL 124
Query: 542 RNILIDDSWRAKISDFGLAK--LLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
N+++D KI+DFG+ K + N+ G+ Y+APE T D +S
Sbjct: 125 DNVMLDRDGHIKIADFGMCKENVFGDNRASTFC---GTPDYIAPEILQGLKYTFSVDWWS 181
Query: 600 FGVVLLEIICCRSNF 614
FGV+L E++ +S F
Sbjct: 182 FGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 8e-08
Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 5/124 (4%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+LV E S G L L + + V + V+ G+ YL +H D+ RN+
Sbjct: 70 MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNV 126
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS--RGYMAPEWQNSGLITVKSDVYSFGV 602
L+ + AKISDFGL+K L + + A G + APE N + +SDV+S+G+
Sbjct: 127 LLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGI 186
Query: 603 VLLE 606
+ E
Sbjct: 187 TMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 32/93 (34%), Positives = 56/93 (60%), Gaps = 4/93 (4%)
Query: 517 LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA-GVR 575
+ +A+G++YL E +++H D+ RN+L+ KI+DFGLA+LL ++ A G +
Sbjct: 116 VQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 576 GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608
+MA E + T +SDV+S+GV + E++
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 42/138 (30%), Positives = 66/138 (47%), Gaps = 21/138 (15%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQII 535
R K +V E+ GSL D+ + + PL + IA + +GL YLH E I
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDI-YQVTRGPLSELQ--IAYVCRETLKGLAYLH---ETGKI 123
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPN----QTGIVAGVRGSRGYMAPEW---QNS 588
H DIK NIL+ + K++DFG++ L ++ I G+ +MAPE +
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVERK 178
Query: 589 GLITVKSDVYSFGVVLLE 606
G K D+++ G+ +E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 36/126 (28%), Positives = 66/126 (52%), Gaps = 12/126 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
++ EF+ G+L D++ +TR + V + L YLH + +IH DIK +IL
Sbjct: 95 VLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSIL 149
Query: 546 IDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+ R K+SDFG + +P + +V G+ +MAPE + + D++S G+
Sbjct: 150 LTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISRTPYGTEVDIWSLGI 205
Query: 603 VLLEII 608
+++E++
Sbjct: 206 MVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/126 (33%), Positives = 63/126 (50%), Gaps = 14/126 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV E+ GS +DLL + +PL + I +GL YLH +IH DIK NI
Sbjct: 98 LVMEY-CLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNI 152
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---WQNSGLITVKSDVYSFG 601
L+ + + K++DFG A P + + G+ +MAPE + G K DV+S G
Sbjct: 153 LLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLG 207
Query: 602 VVLLEI 607
+ +E+
Sbjct: 208 ITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 40/123 (32%), Positives = 62/123 (50%), Gaps = 15/123 (12%)
Query: 497 ADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555
ADL ++ + L D V+ + + RGL Y+H IIH D+K N+ +++ KI
Sbjct: 106 ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162
Query: 556 DFGLAKLLMPNQTGIVAGVRGSRGYMAPE----WQNSGLITVKSDVYSFGVVLLEIICCR 611
DFGLA+ TG VA +R Y APE W + D++S G ++ E++ R
Sbjct: 163 DFGLARHTDDEMTGYVA----TRWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGR 215
Query: 612 SNF 614
+ F
Sbjct: 216 TLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 42/142 (29%), Positives = 64/142 (45%), Gaps = 26/142 (18%)
Query: 485 LLVYEFMSKGSL----------ADLLFNLETRPLWR----DRVRIALDVARGLLYLHDEC 530
L+V+E+M G L A +L E + + IA +A G++YL
Sbjct: 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---A 139
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEW 585
+ +H D+ RN L+ KI DFG+++ + V G +R +M PE
Sbjct: 140 SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----WMPPES 195
Query: 586 QNSGLITVKSDVYSFGVVLLEI 607
T +SD++SFGVVL EI
Sbjct: 196 ILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 40/128 (31%), Positives = 65/128 (50%), Gaps = 10/128 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV EF GS+ DL+ N + L D + I ++ RGL +LH ++IH DIK +N+
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNV 152
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-----WQNSGLITVKSDVYS 599
L+ ++ K+ DFG++ L G G+ +MAPE +SD++S
Sbjct: 153 LLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 600 FGVVLLEI 607
G+ +E+
Sbjct: 212 LGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 10/143 (6%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNL-ETRPLWRDRVRI-ALDVARGLLYLHDECE 531
L Y ++ +L V E+++ G +L F+L R DR R ++ L YLH
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGG---ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG-- 114
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI 591
+I++ D+KL N+++D KI+DFGL K + + + G+ Y+APE
Sbjct: 115 -KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCGTPEYLAPEVLEDNDY 172
Query: 592 TVKSDVYSFGVVLLEIICCRSNF 614
D + GVV+ E++C R F
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 45/112 (40%), Positives = 56/112 (50%), Gaps = 18/112 (16%)
Query: 480 RSSKKL-LVYEFMSKGSLADLLFNLETRP--LWRDRVRIAL-DVARGLLYLHDECEVQII 535
R K+L LV+EF+ L DL E P L RVR L + RG+ + H II
Sbjct: 70 RRKKRLYLVFEFVDHTVLDDL----EKYPNGLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLM-PNQ--TGIVAGVRGSRGYMAPE 584
H DIK NIL+ S K+ DFG A+ L P + T VA +R Y APE
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA----TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 22/140 (15%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRVRIALD-VARGLLYLHDECEVQIIHCDIKLRNILID 547
E++ GS+ L VR + V GL YLH + I+H D+K N+L+D
Sbjct: 88 EYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVD 142
Query: 548 DSWRAKISDFGLAKLLMPNQTGIVAG------VRGSRGYMAPEW-QNSGL-ITVKSDVYS 599
KISDFG++K ++ + ++GS +MAPE + + K D++S
Sbjct: 143 ADGICKISDFGISK-----KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWS 197
Query: 600 FGVVLLEIICCR---SNFEV 616
G V+LE+ R S+ E
Sbjct: 198 LGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 32/87 (36%), Positives = 49/87 (56%), Gaps = 5/87 (5%)
Query: 523 LLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMA 582
L Y+H +V +IH DIK NIL+ ++ K+ DFG+A LL N + V G+ +MA
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMA 169
Query: 583 PEWQNSG-LITVKSDVYSFGVVLLEII 608
PE G K+D++S G+ + E+
Sbjct: 170 PEVITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 24/156 (15%)
Query: 467 FLIAISSLLVYKHRSSKKL-LVYEFMSKGSLADLLFNL-ETRPLWRDRVRI-ALDVARGL 523
FL A L Y ++ +L V E+ + G +L F+L R DR R ++ L
Sbjct: 56 FLTA----LKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSR 578
YLH C+ +++ D+KL N+++D KI+DFGL K GI G G+
Sbjct: 109 GYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK------EGISDGATMKTFCGTP 159
Query: 579 GYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614
Y+APE D + GVV+ E++C R F
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 8/106 (7%)
Query: 502 NLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
+W V++ L L YLH E +I+H D+ NI++ + + I+DFGLAK
Sbjct: 109 RFTEERIWNIFVQMVL----ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
Query: 562 LLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
P + V G+ Y PE + K+DV++FG +L ++
Sbjct: 163 QKQPESK--LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 41/139 (29%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALD-------VARGLLYLHDECEVQIIHC 537
++V E+ G+LA+ + + R LD + LL LH I+H
Sbjct: 75 MIVMEYAPGGTLAEYI---------QKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 538 DIKLRNILIDDSWRA-KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSD 596
D+K +NIL+D KI DFG++K+L V G+ Y++PE KSD
Sbjct: 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKSD 183
Query: 597 VYSFGVVLLEIICCRSNFE 615
+++ G VL E+ + FE
Sbjct: 184 IWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 31/212 (14%)
Query: 485 LLVYEFMSKGSLADLLFN----LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540
LLV EF G L + L + + R+A +VA GLL+LH + IH D+
Sbjct: 71 LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLA 127
Query: 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNS------- 588
LRN + KI D+GLA P I +R ++APE
Sbjct: 128 LRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR----WLAPELVEIRGQDLLP 183
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
T KS+++S GV + E+ ++S V V + KL + ++D
Sbjct: 184 KDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVREQDIKLPKPQLD 236
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILML 680
+R + C D P RP+ + V +L
Sbjct: 237 LKYSDRWYEVMQFCWLD-PETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 35/106 (33%), Positives = 58/106 (54%), Gaps = 9/106 (8%)
Query: 513 VRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR-AKISDFGLAKLLMPNQTGIV 571
V+I+L GL ++HD +I+H DIK +NI + + AK+ DFG+A+ L + +
Sbjct: 108 VQISL----GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELA 159
Query: 572 AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617
G+ Y++PE + K+D++S G VL E+ + FE N
Sbjct: 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 12/126 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
+V E+++ GSL D++ ET D +IA + + L +LH Q+IH DIK
Sbjct: 93 VVMEYLAGGSLTDVV--TETC---MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSD 144
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
NIL+ K++DFG + P Q+ V G+ +MAPE K D++S G+
Sbjct: 145 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 603 VLLEII 608
+ +E++
Sbjct: 204 MAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 25/144 (17%)
Query: 479 HRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIH 536
R + +L V+E+M +G+L L+ + + +P +R I + +GL ++H H
Sbjct: 67 FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFH 122
Query: 537 CDIKLRNILIDDSWRAKISDFGLAKLL--MPNQTGIVAGVRGSRGYMAPEWQNSGLITVK 594
D+K N+L+ KI+DFGLA+ + P T V +R Y APE I ++
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV----STRWYRAPE------ILLR 172
Query: 595 SDVYS-------FGVVLLEIICCR 611
S YS G ++ E+ R
Sbjct: 173 STSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 2e-07
Identities = 43/132 (32%), Positives = 65/132 (49%), Gaps = 14/132 (10%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCD 538
R LV E+ GS +DLL + +PL + I +GL YLH +IH D
Sbjct: 96 REHTAWLVMEY-CLGSASDLL-EVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRD 150
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---WQNSGLITVKS 595
IK NIL+ + + K++DFG A + P + + G+ +MAPE + G K
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDEGQYDGKV 205
Query: 596 DVYSFGVVLLEI 607
DV+S G+ +E+
Sbjct: 206 DVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 43/140 (30%), Positives = 74/140 (52%), Gaps = 16/140 (11%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSL-----ADLLFNLETRPLWRDRVRIALDVARGLLYLHD 528
L Y ++ KL L+ +F+ G L +++F E + + +ALD +LH
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD------HLHS 116
Query: 529 ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS 588
+ II+ D+K NIL+D+ K++DFGL+K + ++ + G+ YMAPE N
Sbjct: 117 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNR 172
Query: 589 GLITVKSDVYSFGVVLLEII 608
T +D +SFGV++ E++
Sbjct: 173 RGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 44/179 (24%)
Query: 447 DKRKLLTVLAGCLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETR 506
DK LT L C ++ L F V E+++ G DL+++++
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYF-------------------VMEYVNGG---DLMYHIQQV 95
Query: 507 PLWRD--RVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564
+++ V A +++ GL +LH II+ D+KL N+++D KI+DFG+ K M
Sbjct: 96 GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152
Query: 565 PNQTGIVAGVR-----GSRGYMAPE---WQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
V GV G+ Y+APE +Q G D +++GV+L E++ + F+
Sbjct: 153 ------VDGVTTRTFCGTPDYIAPEIIAYQPYGK---SVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYM 581
G+ Y+H + +I+H D+K +NI + ++ KI DFG+++LLM + G+ YM
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLM-GSCDLATTFTGTPYYM 172
Query: 582 APEWQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
+PE KSD++S G +L E+ C FE
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 47/198 (23%), Positives = 85/198 (42%), Gaps = 25/198 (12%)
Query: 486 LVYEFMSKGSLADLLFN-------LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
+V E G L+ ++ + + R +W+ V++ L ++H +I+H D
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMH---SKRIMHRD 131
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
IK N+ I + K+ D GL + T + V G+ YM+PE + KSD++
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIW 190
Query: 599 SFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKT 658
S G +L E+ +S F D++ L + + ++ L + + L +V
Sbjct: 191 SLGCLLYEMAALQSPFY-----GDKMNLYS-LCKKIEKCDYPPLPADHYSE-ELRDLVS- 242
Query: 659 GLLCIQDEPNLRPSMKNV 676
CI +P RP + V
Sbjct: 243 --RCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 44/141 (31%), Positives = 76/141 (53%), Gaps = 27/141 (19%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRD--RVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
V E+++ G DL++ ++ +++ V A ++A GL +LH + II+ D+KL N
Sbjct: 78 FVMEYVNGG---DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDN 131
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPE---WQNSGLITVKS 595
+++D KI+DFG+ K + GV G+ Y+APE +Q G KS
Sbjct: 132 VMLDSEGHIKIADFGMCK------ENMWDGVTTKTFCGTPDYIAPEIIAYQPYG----KS 181
Query: 596 -DVYSFGVVLLEIICCRSNFE 615
D ++FGV+L E++ ++ FE
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 41/125 (32%), Positives = 63/125 (50%), Gaps = 12/125 (9%)
Query: 489 EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
E M GS+ D L + T + R R L+ G+ YLH I+H DIK NIL
Sbjct: 86 EHMPGGSIKDQLKSYGALTENVTRKYTRQILE---GVSYLHSN---MIVHRDIKGANILR 139
Query: 547 DDSWRAKISDFGLAKLLMP---NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
D K+ DFG +K L + TG+ + V G+ +M+PE + K+D++S G
Sbjct: 140 DSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVISGEGYGRKADIWSVGCT 198
Query: 604 LLEII 608
++E++
Sbjct: 199 VVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 39/127 (30%), Positives = 65/127 (51%), Gaps = 12/127 (9%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKL 541
+V E+++ GSL D++ ET D +IA + + L +LH Q+IH DIK
Sbjct: 92 FVVMEYLAGGSLTDVV--TET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKS 143
Query: 542 RNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
N+L+ K++DFG + P Q+ V G+ +MAPE K D++S G
Sbjct: 144 DNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 602 VVLLEII 608
++ +E++
Sbjct: 203 IMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 41/126 (32%), Positives = 65/126 (51%), Gaps = 12/126 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
+V E+++ GSL D++ ET D +IA + + L +LH Q+IH DIK
Sbjct: 94 VVMEYLAGGSLTDVV--TET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSD 145
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
NIL+ K++DFG + P Q+ V G+ +MAPE K D++S G+
Sbjct: 146 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGI 204
Query: 603 VLLEII 608
+ +E+I
Sbjct: 205 MAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 29/178 (16%)
Query: 467 FLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLL 524
FL A+ K R V E+++ G DL+F ++ +R R R A +V L+
Sbjct: 57 FLTALHCCFQTKDRL---FFVMEYVNGG---DLMFQIQRSRKFDEPRSRFYAAEVTLALM 110
Query: 525 YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRG 579
+LH +I+ D+KL NIL+D K++DFG+ K GI+ GV G+
Sbjct: 111 FLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK------EGILNGVTTTTFCGTPD 161
Query: 580 YMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA-------DEVLLSTWV 630
Y+APE D ++ GV++ E++ + FE + D+VL W+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWL 219
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 14/132 (10%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCD 538
R LV E+ GS +DLL + +PL + + +GL YLH +IH D
Sbjct: 86 REHTAWLVMEY-CLGSASDLL-EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRD 140
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---WQNSGLITVKS 595
+K NIL+ + K+ DFG A ++ P + G+ +MAPE + G K
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQYDGKV 195
Query: 596 DVYSFGVVLLEI 607
DV+S G+ +E+
Sbjct: 196 DVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 19/137 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV FM DL ++ L DR++ + + +GL Y+H IIH D+K N+
Sbjct: 97 LVMPFMG----TDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNL 149
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE----WQNSGLITVKSDVYSF 600
+++ KI DFGLA+ TG V +R Y APE W + T D++S
Sbjct: 150 AVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRAPEVILNWMH---YTQTVDIWSV 202
Query: 601 GVVLLEIICCRSNFEVN 617
G ++ E++ + F+ +
Sbjct: 203 GCIMAEMLTGKPLFKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (124), Expect = 5e-07
Identities = 29/85 (34%), Positives = 46/85 (54%), Gaps = 11/85 (12%)
Query: 481 SSKKL-LVYEFMSKGSLADL--LFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIH 536
+ +KL LV+E+ DL + PL + ++ I + RGL Y H +I+H
Sbjct: 69 TERKLYLVFEYCDM----DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILH 121
Query: 537 CDIKLRNILIDDSWRAKISDFGLAK 561
D+K +NILI+ K++DFGLA+
Sbjct: 122 RDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 37/126 (29%), Positives = 65/126 (51%), Gaps = 12/126 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V EF+ G+L D++ TR + L V + L LH + +IH DIK +IL
Sbjct: 94 VVMEFLEGGALTDIV--THTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSIL 148
Query: 546 IDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+ R K+SDFG + +P + +V G+ +MAPE + + D++S G+
Sbjct: 149 LTHDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPELISRLPYGPEVDIWSLGI 204
Query: 603 VLLEII 608
+++E++
Sbjct: 205 MVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 5e-07
Identities = 38/134 (28%), Positives = 59/134 (44%), Gaps = 28/134 (20%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
LV E++ G L L R R VAR L YLH I++
Sbjct: 78 LVMEYVPGGELFSHL---------RKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYR 125
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKS- 595
D+K N+L+D KI+DFG AK + + G+ Y+APE + G K+
Sbjct: 126 DLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSKG--YGKAV 179
Query: 596 DVYSFGVVLLEIIC 609
D ++ G+++ E++
Sbjct: 180 DWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 15/96 (15%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-------TGIVAG 573
RGL Y+H +IH D+K N+L+++ +I DFG+A+ L + T VA
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA- 173
Query: 574 VRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEII 608
+R Y APE S T D++S G + E++
Sbjct: 174 ---TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 6e-07
Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 12/126 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
+V E+++ GSL D++ ET D +IA + + L +LH Q+IH DIK
Sbjct: 93 VVMEYLAGGSLTDVV--TET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSD 144
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
NIL+ K++DFG + P Q+ V G+ +MAPE K D++S G+
Sbjct: 145 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGI 203
Query: 603 VLLEII 608
+ +E++
Sbjct: 204 MAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 31/142 (21%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK--------L 562
D V I +A G+ +L ++H D+ RN+L+ D KISD GL +
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 563 LMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII-------CCRSNFE 615
LM N + +R +M+PE G ++ SD++S+GVVL E+ C SN +
Sbjct: 182 LMGNS---LLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234
Query: 616 V-NVSTADEVLL-----STWVY 631
V + +VL WVY
Sbjct: 235 VIEMIRNRQVLPCPDDCPAWVY 256
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 39/143 (27%), Positives = 65/143 (45%), Gaps = 24/143 (16%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLW-----------RDRVRIALDVARGLLYLHDECEVQI 534
++ E+M G L L E + + + +A+ +A G+ YL +
Sbjct: 94 MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNF 150
Query: 535 IHCDIKLRNILIDDSWRAKISDFGLAKLLMPN-----QTGIVAGVRGSRGYMAPEWQNSG 589
+H D+ RN L+ + + KI+DFG+++ L Q V +R +MA E G
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMAWESILLG 206
Query: 590 LITVKSDVYSFGVVLLEI-ICCR 611
T SDV++FGV L E+ C+
Sbjct: 207 KFTTASDVWAFGVTLWEMFTLCK 229
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 18/148 (12%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEV 532
L Y ++ KL L+ +++S G + L+ + D VR ++ L +LH ++
Sbjct: 70 LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALEHLH---KL 124
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
I++ DIKL NIL+D ++DFGL+K + + G+ YMAPE +I
Sbjct: 125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-----IIR 179
Query: 593 VKS------DVYSFGVVLLEIICCRSNF 614
K D +S G+++ E++ S F
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 7/92 (7%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN---QTGIVAGVRGS 577
GL Y+H ++H D+K N+L++ KI DFGLA+ N G + +
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 578 RGYMAPEWQNSGLITVKS-DVYSFGVVLLEII 608
R Y APE S K+ DV+S G +L E++
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 30/97 (30%), Positives = 54/97 (55%), Gaps = 6/97 (6%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYM 581
G+ ++H++ +++H DIK +NI + + + K+ DFG A+LL + G+ Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-TSPGAYACTYVGTPYYV 167
Query: 582 APE-WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617
PE W+N KSD++S G +L E+ + F+ N
Sbjct: 168 PPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 35/126 (27%), Positives = 54/126 (42%), Gaps = 9/126 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRI---ALDVARGLLYLHDECEVQIIHCDIKLR 542
+V E G L L + D + + ++ L YL + +H DI R
Sbjct: 83 IVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAAR 136
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
N+L+ K+ DFGL++ L + + +MAPE N T SDV+ FGV
Sbjct: 137 NVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGV 196
Query: 603 VLLEII 608
+ EI+
Sbjct: 197 CMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 49/152 (32%), Positives = 68/152 (44%), Gaps = 13/152 (8%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEV 532
L+Y + + L L E++ G LL NL L D R + ++ + LH E+
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV--LSEDHARFYMAEMFEAVDALH---EL 120
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
IH D+K N LID S K++DFGL+K V GS YMAPE
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRGKGYD 176
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624
D +S G +L E +C F + ST +E
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPF--SGSTPNET 206
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 28/108 (25%), Positives = 49/108 (45%), Gaps = 27/108 (25%)
Query: 512 RVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK---------- 561
+V + +A G+ +L + + +H D+ RN L+ K+S L+K
Sbjct: 119 KVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKL 175
Query: 562 --LLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
L+P +R ++APE + KSDV+SFGV++ E+
Sbjct: 176 RNALIP--------LR----WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 2e-06
Identities = 35/101 (34%), Positives = 48/101 (47%), Gaps = 25/101 (24%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVA---------- 520
I L V+ H+S+ L V+EFM DL + +D+ I L A
Sbjct: 65 IGLLDVFGHKSNINL-VFEFME----TDL------EKVIKDK-SIVLTPADIKSYMLMTL 112
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
RGL YLH I+H D+K N+LI K++DFGLA+
Sbjct: 113 RGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 43/135 (31%), Positives = 71/135 (52%), Gaps = 15/135 (11%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVR---IALDVARGLLYLHDECEVQIIHCDIKL 541
V E+++ G DL+F++++ + D R A ++ GL +LH + I++ D+KL
Sbjct: 72 FFVMEYLNGG---DLMFHIQSCHKF-DLPRATFYAAEIICGLQFLHSK---GIVYRDLKL 124
Query: 542 RNILIDDSWRAKISDFGLAK--LLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
NIL+D KI+DFG+ K +L +T G+ Y+APE D +S
Sbjct: 125 DNILLDTDGHIKIADFGMCKENMLGDAKTCTFC---GTPDYIAPEILLGQKYNTSVDWWS 181
Query: 600 FGVVLLEIICCRSNF 614
FGV+L E++ +S F
Sbjct: 182 FGVLLYEMLIGQSPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 38/131 (29%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 485 LLVYEFMSKGSLADLLF--NLETRPLW---RDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+++ FM G L L L P + + V+ D+A G+ YL + IH D+
Sbjct: 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDL 138
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPN---QTGIVAGVRGSRGYMAPEWQNSGLITVKSD 596
RN +++++ ++DFGL+K + + G +A + ++A E + T KSD
Sbjct: 139 AARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA--KMPVKWIAIESLADRVYTTKSD 196
Query: 597 VYSFGVVLLEI 607
V+SFGV + EI
Sbjct: 197 VWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 41/135 (30%), Positives = 66/135 (48%), Gaps = 17/135 (12%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHC 537
R K LV+E + + LA L L + ++ + + RG+ +LH I+H
Sbjct: 76 DRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHR 131
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPE--WQNSGLIT 592
D+K +NIL+ + KI+DFGLA++ M T +V + Y APE Q+S
Sbjct: 132 DLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVV----TLWYRAPEVLLQSSYATP 186
Query: 593 VKSDVYSFGVVLLEI 607
V D++S G + E+
Sbjct: 187 V--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 32/95 (33%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGV-RGSRGY 580
L ++HD +I+H DIK +NI + K+ DFG+A++L N T +A G+ Y
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYY 167
Query: 581 MAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
++PE + KSD+++ G VL E+ + FE
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 3e-06
Identities = 20/40 (50%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
GL YLH I+H DIK NILI++ K++DFGLA+
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 12/100 (12%)
Query: 513 VRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN-----Q 567
+ +A +A G+ YL + +H D+ RN L+ ++ KI+DFG+++ L + Q
Sbjct: 133 LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
+R +MA E G T KSDV++FGV L EI
Sbjct: 190 GRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 11/148 (7%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDR-VRIAL-DVARGLLYLHDECE 531
L Y ++ KL L+ ++++ G +L +L R ++++ V+I ++ L +LH +
Sbjct: 70 LHYAFQTDTKLHLILDYINGG---ELFTHLSQRERFKEQEVQIYSGEIVLALEHLH---K 123
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI 591
+ II+ DIKL NIL+D + ++DFGL+K ++ G+ YMAP+ G
Sbjct: 124 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDG 183
Query: 592 TVKS--DVYSFGVVLLEIICCRSNFEVN 617
D +S GV++ E++ S F V+
Sbjct: 184 GHDKAVDWWSMGVLMYELLTGASPFTVD 211
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 4e-06
Identities = 24/81 (29%), Positives = 39/81 (48%), Gaps = 7/81 (8%)
Query: 245 SSYSLKSMNETVIYRTTLDSDGILRLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNS 304
Y+ + N ++ R TL S+G L ++ + + WSA + QC V G CG
Sbjct: 34 VYYTYRMTNNSIYSRLTLSSEGSLERFTW---IPNSQDWNLFWSAPKDQCDVYGRCGPYG 90
Query: 305 YCSTSTNISTKGDCHCFRGFN 325
YC +++T C+C +GF
Sbjct: 91 YC----DVNTSPKCNCIKGFV 107
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 44/140 (31%), Positives = 66/140 (47%), Gaps = 24/140 (17%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E++ G A LL N+ P+ R+ A V L YLH+ I+H D+K N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-ALEYLHN---YGIVHRDLKPDNLL 133
Query: 546 IDDSWRAKISDFGLAKL-LMPNQTGIVAG-------------VRGSRGYMAPE---WQNS 588
I K++DFGL+K+ LM T + G V G+ Y+APE Q
Sbjct: 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY 193
Query: 589 GLITVKSDVYSFGVVLLEII 608
G D ++ G++L E +
Sbjct: 194 G---KPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 32/101 (31%), Positives = 44/101 (43%), Gaps = 20/101 (19%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL-----MPNQTGIVA---- 572
G+ YLH+ I+H DIK NILID+ KI+DFGLA+ P G
Sbjct: 127 GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 573 -GVRGSRGYMAPE----WQNSGLITVKSDVYSFGVVLLEII 608
+ +R Y PE + T D++ G V E+
Sbjct: 184 TNLVVTRWYRPPELLLGERR---YTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 18/112 (16%)
Query: 480 RSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRV---RIALDVARGLLYLHDECEVQII 535
R +KL LV+E+ +L LE P +I + + + H I
Sbjct: 70 RRKRKLHLVFEYCDH----TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCI 122
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMP---NQTGIVAGVRGSRGYMAPE 584
H D+K NILI + K+ DFG A++L + T VA +R Y APE
Sbjct: 123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA----TRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 45/201 (22%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 486 LVYEFMSKGSLADLLFNLET-------RPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
+V E G L+ ++ + R +W+ V++ + ++H +++H D
Sbjct: 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEHMHSR---RVMHRD 131
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
IK N+ I + K+ D GL + ++T + G+ YM+PE + KSD++
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190
Query: 599 SFGVVLLEIICCRSNF---EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERM 655
S G +L E+ +S F ++N+ + L + C ++ L E E++
Sbjct: 191 SLGCLLYEMAALQSPFYGDKMNLFS-----LCQKIEQC----DYPPLPTEHYS----EKL 237
Query: 656 VKTGLLCIQDEPNLRPSMKNV 676
+ +CI +P+ RP + V
Sbjct: 238 RELVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 13/106 (12%)
Query: 513 VRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN-----Q 567
+ +AL +A G+ YL + +H D+ RN L+ ++ KI+DFG+++ L Q
Sbjct: 141 LHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQ 197
Query: 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII-CCRS 612
V +R +MA E G T SDV++FGV L EI+ C+
Sbjct: 198 GRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 40/137 (29%), Positives = 69/137 (50%), Gaps = 10/137 (7%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRD-RVRI-ALDVARGLLYLHDECE 531
L Y ++++KL V ++++ G +L F+L+ + + R R A +VA + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGG---ELFFHLQRERCFLEPRARFYAAEVASAIGYLH---S 114
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI 591
+ II+ D+K NIL+D ++DFGL K + + + G+ Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTSTFCGTPEYLAPEVLRKEPY 173
Query: 592 TVKSDVYSFGVVLLEII 608
D + G VL E++
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 23/182 (12%)
Query: 444 KVNDKRKLL----TVLAGCLGSITFLCFLIAISSLLVYKH-----------RSSKKLLVY 488
K+ KR+L T+ AGC FL +L + H R + ++V
Sbjct: 27 KLPSKRELPVAIHTLRAGCSDK-QRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVT 85
Query: 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548
E+MS G+L L E + + + + +A G+ YL E+ +H + +L++
Sbjct: 86 EYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNS 142
Query: 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRG--YMAPEWQNSGLITVKSDVYSFGVVLLE 606
KIS F +L I + G + APE + SDV+SFG+V+ E
Sbjct: 143 DLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWE 200
Query: 607 II 608
++
Sbjct: 201 VM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 40/139 (28%), Positives = 70/139 (50%), Gaps = 12/139 (8%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDR-VRI-ALDVARGLLYLHDECEVQIIH 536
H K + + M+ G DL ++L ++ ++ +R A ++ GL ++H+ +++
Sbjct: 67 HTPDKLCFILDLMNGG---DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVY 120
Query: 537 CDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKS 595
D+K NIL+D+ +ISD GLA + A V G+ GYMAPE Q +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGTAYDSSA 177
Query: 596 DVYSFGVVLLEIICCRSNF 614
D +S G +L +++ S F
Sbjct: 178 DWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 14/92 (15%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGY 580
RGL Y+H IIH D+K N+ +++ +I DFGLA+ TG VA +R Y
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA----TRWY 181
Query: 581 MAPE----WQNSGLITVKSDVYSFGVVLLEII 608
APE W + TV D++S G ++ E++
Sbjct: 182 RAPEIMLNWMHYNQ-TV--DIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 33/136 (24%), Positives = 64/136 (47%), Gaps = 15/136 (11%)
Query: 486 LVYEFMSKGSLADLLFNLET-------RPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
+V E G L+ ++ + + + +W+ V++ L ++H +++H D
Sbjct: 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMHSR---RVMHRD 131
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
IK N+ I + K+ D GL + ++T + G+ YM+PE + KSD++
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 190
Query: 599 SFGVVLLEIICCRSNF 614
S G +L E+ +S F
Sbjct: 191 SLGCLLYEMAALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 42/158 (26%), Positives = 62/158 (39%), Gaps = 46/158 (29%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-------IALDVARGLLYLHDECEVQIIHCD 538
LV E+M G L +LL + P + R +ALD L + IH D
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFP--EETARFYIAELVLALDSVHKLGF---------IHRD 126
Query: 539 IKLRNILIDDSWRAKISDFGLAK---------------LLMPNQTGIVAGVR-------- 575
IK NILID K++DFGL K + + ++ R
Sbjct: 127 IKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVR 186
Query: 576 -----GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608
G+ Y+APE ++ D +S GV+L E++
Sbjct: 187 ANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 38/132 (28%), Positives = 65/132 (49%), Gaps = 19/132 (14%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLRNI 544
++ EF + G++ ++ LE RPL ++R+ L YLH+ +IIH D+K NI
Sbjct: 79 ILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNI 134
Query: 545 LIDDSWRAKISDFGLA----KLLMPNQTGIVAGVRGSRGYMAP-----EWQNSGLITVKS 595
L K++DFG++ + + + I G+ +MAP E K+
Sbjct: 135 LFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSKDRPYDYKA 189
Query: 596 DVYSFGVVLLEI 607
DV+S G+ L+E+
Sbjct: 190 DVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 12/138 (8%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDEC 530
L Y ++++KL V +F++ G +L F+L+ + P R R A ++A L YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+ I++ D+K NIL+D ++DFGL K + Q+ G+ Y+APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 591 ITVKSDVYSFGVVLLEII 608
D + G VL E++
Sbjct: 173 YDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 13/145 (8%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLW--RDRVRIALDVARGLLYLHDECE 531
+ Y + KL + + M+ G DL ++L ++ + A ++ GL ++H+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF- 117
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI 591
+++ D+K NIL+D+ +ISD GLA + A V G+ GYMAPE G+
Sbjct: 118 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQKGVA 172
Query: 592 TVKS-DVYSFGVVLLEIICCRSNFE 615
S D +S G +L +++ S F
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 16/135 (11%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCD 538
R K + EF GSL D+ T PL ++ ++ + +GL YLH + + +H D
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETLQGLYYLHSKGK---MHRD 131
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR---GSRGYMAPE---WQNSGLIT 592
IK NIL+ D+ K++DFG++ + T +A + G+ +MAPE + G
Sbjct: 132 IKGANILLTDNGHVKLADFGVSAQI----TATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187
Query: 593 VKSDVYSFGVVLLEI 607
D+++ G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 21/139 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRD----RVRIALDVARGLLYLHDECEVQIIHCDIKL 541
+V E+M G L +L+ N + W V +ALD + +IH D+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSM---------GLIHRDVKP 170
Query: 542 RNILIDDSWRAKISDFGLAKLLMPNQTGIVA--GVRGSRGYMAPEWQNS----GLITVKS 595
N+L+D K++DFG + ++TG+V G+ Y++PE S G +
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKM--DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 596 DVYSFGVVLLEIICCRSNF 614
D +S GV L E++ + F
Sbjct: 229 DWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 42/151 (27%), Positives = 70/151 (46%), Gaps = 32/151 (21%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVA----------RGLLYLHD 528
H +K +LV+E+M K DL ++T VR ALD +G+ + H+
Sbjct: 68 HTENKLMLVFEYMDK----DLKKYMDTHG-----VRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 529 ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR----GYMAPE 584
+++H D+K +N+LI+ K++DFGLA+ GI + Y AP+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAF-----GIPVNTFSNEVVTLWYRAPD 170
Query: 585 -WQNSGLITVKSDVYSFGVVLLEIICCRSNF 614
S + D++S G ++ E+I R F
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLF 201
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 44/197 (22%), Positives = 88/197 (44%), Gaps = 19/197 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ E+ ++G L ++L E ++ ++ +A+D +GL L+ + ++ + L
Sbjct: 99 LILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFL 155
Query: 546 IDDSWRAKISDFGLAKLL-MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ ++++ KI GL K+L P + V S + + T+K D+YS GVVL
Sbjct: 156 VTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSE---YTIKDDIYSLGVVL 212
Query: 605 LEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQ 664
EI + FE N++T + +Y+ + NK ++ + C
Sbjct: 213 WEIFTGKIPFE-NLTTKE-------IYDLII----NKNNSLKLPLDCPLEIKCIVEACTS 260
Query: 665 DEPNLRPSMKNVILMLE 681
+ RP++K ++ L
Sbjct: 261 HDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 8e-05
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 15/143 (10%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRN 543
+L+ +++ G L DLL L V+ I + L LH IIH DIKL N
Sbjct: 85 VLIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLEN 139
Query: 544 ILIDDS-WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+L D + R + D+GL K + G+ Y +PE V D ++ GV
Sbjct: 140 VLYDRAKDRIYLCDYGLCK--IIGTPSC---YDGTLDYFSPEKIKGHNYDVSFDWWAVGV 194
Query: 603 VLLEIICCRSNFEVNVSTADEVL 625
+ E++ + F+ + DE L
Sbjct: 195 LTYELLTGKHPFKEDE---DEEL 214
|
Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 12/138 (8%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLLYLHDECE 531
L + +++ KL V ++++ G +L ++L+ R R R A ++A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLH---S 114
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKL-LMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+ I++ D+K NIL+D ++DFGL K + N G + G+ Y+APE +
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQP 172
Query: 591 ITVKSDVYSFGVVLLEII 608
D + G VL E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 42/138 (30%), Positives = 69/138 (50%), Gaps = 12/138 (8%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLLYLHDECE 531
L Y +++ KL V ++++ G +L F+L+ R R R A ++A L YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGYLH---S 114
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM-PNQTGIVAGVRGSRGYMAPEWQNSGL 590
+ II+ D+K NIL+D ++DFGL K + ++T + G+ Y+APE
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 591 ITVKSDVYSFGVVLLEII 608
D + G VL E++
Sbjct: 173 YDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 22/138 (15%)
Query: 486 LVYEFMSKGSLADLLFNLE----------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535
++ E+M G L L E + + +A +A G+ YL + +
Sbjct: 96 MITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFV 152
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPN-----QTGIVAGVRGSRGYMAPEWQNSGL 590
H D+ RN L+ ++ KI+DFG+++ L Q V +R +M+ E G
Sbjct: 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR----WMSWESILLGK 208
Query: 591 ITVKSDVYSFGVVLLEII 608
T SDV++FGV L EI+
Sbjct: 209 FTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 34/97 (35%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 516 ALDVARGLL----YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA-KLLMPNQTGI 570
A+ + R LL YLH IIH D+K NI +D+ A + DFG A KL T
Sbjct: 187 AITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243
Query: 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
G G+ +PE K+D++S G+VL E+
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRP---LWRDRVR-IALDVARGLLYLHDECEVQII 535
R +K LV+E + + DL L+ P + + ++ + + RGL +LH +++
Sbjct: 80 RETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVV 132
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKS 595
H D+K +NIL+ S + K++DFGLA++ + + V + Y APE
Sbjct: 133 HRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLLQSSYATPV 190
Query: 596 DVYSFGVVLLEIICCRSNFEVNVSTADEV 624
D++S G + E+ + F + S D++
Sbjct: 191 DLWSVGCIFAEMFRRKPLFRGS-SDVDQL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGY 580
GL Y+H IIH D+K N+ +++ KI DFGLA+ TG V +R Y
Sbjct: 128 CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWY 180
Query: 581 MAPE----WQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
APE W + D++S G ++ E++ ++ F+
Sbjct: 181 RAPEVILNWMH---YNQTVDIWSVGCIMAEMLTGKTLFK 216
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 40/135 (29%), Positives = 64/135 (47%), Gaps = 6/135 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
L + +S +KL LV F++ G +L +L+ + D R A L L + +
Sbjct: 58 LKFSFQSPEKLYLVLAFINGG---ELFHHLQREGRF-DLSRARFYTAELLCALENLHKFN 113
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITV 593
+I+ D+K NIL+D + DFGL KL M + G+ Y+APE T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 594 KSDVYSFGVVLLEII 608
D ++ GV+L E++
Sbjct: 173 AVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 15/96 (15%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLL-----FNLETRPLWRDRVRIALDVARGLLYLHD 528
L Y +S+ + LV E++ G + LL F+ E + V +ALD YLH
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHR 122
Query: 529 ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564
IIH D+K N+LI + K++DFGL+K+ +
Sbjct: 123 H---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 40/139 (28%), Positives = 64/139 (46%), Gaps = 21/139 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLW----RDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541
+V E+M G L +L+ N + W V +ALD + + IH D+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---------IHRDVKP 170
Query: 542 RNILIDDSWRAKISDFGLAKLLMPNQTGIVA--GVRGSRGYMAPEWQNS----GLITVKS 595
N+L+D S K++DFG + N+ G+V G+ Y++PE S G +
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKM--NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGREC 228
Query: 596 DVYSFGVVLLEIICCRSNF 614
D +S GV L E++ + F
Sbjct: 229 DWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 26/79 (32%), Positives = 43/79 (54%), Gaps = 10/79 (12%)
Query: 486 LVYEFMSKGSLADLLFNLETRP--LWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLR 542
LV+E++ DL ++ L VR+ L + RGL Y H +++H D+K +
Sbjct: 80 LVFEYLDT----DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQ 132
Query: 543 NILIDDSWRAKISDFGLAK 561
N+LI + K++DFGLA+
Sbjct: 133 NLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 25/88 (28%), Positives = 39/88 (44%), Gaps = 27/88 (30%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
HR +K++ + M K LL+ + L+ G+ YLH ++H D
Sbjct: 97 HRQAKRVSIPPSMVK----SLLWQI-------------LN---GVHYLHSN---WVLHRD 133
Query: 539 IKLRNILI----DDSWRAKISDFGLAKL 562
+K NIL+ + KI D GLA+L
Sbjct: 134 LKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 45/149 (30%), Positives = 69/149 (46%), Gaps = 19/149 (12%)
Query: 468 LIAISSLLVYKHRSSKK--LLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIAL-DVARGL 523
+IAI ++ HR + +VYE M DL + ++ L D + L + RGL
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMD----TDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ---TGIVAGVRGSRGY 580
Y+H ++H D+K N+L++ + KI DFGLA+ T V +R Y
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV----TRWY 174
Query: 581 MAPE-WQNSGLITVKSDVYSFGVVLLEII 608
APE N T DV+S G + E++
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 18/136 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETR---PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
LV ++MS G +L ++L+ R + IA ++ L +LH + I++ D+K
Sbjct: 73 LVTDYMSGG---ELFWHLQKEGRFSEDRAKFYIA-ELVLALEHLH---KYDIVYRDLKPE 125
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPE--WQNSGLITVKSDVY 598
NIL+D + + DFGL+K N T G+ Y+APE G T D +
Sbjct: 126 NILLDATGHIALCDFGLSK---ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKHVDFW 181
Query: 599 SFGVVLLEIICCRSNF 614
S GV++ E+ C S F
Sbjct: 182 SLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 38/132 (28%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRP---LWRDRVR-IALDVARGLLYLHDECEVQII 535
R +K LV+E + + DL L+ P L + ++ + RGL +LH C I+
Sbjct: 78 RETKVTLVFEHVDQ----DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IV 130
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKS 595
H D+K NIL+ + K++DFGLA++ + V + Y APE
Sbjct: 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPV 188
Query: 596 DVYSFGVVLLEI 607
D++S G + E+
Sbjct: 189 DMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 33/102 (32%), Positives = 48/102 (47%), Gaps = 15/102 (14%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM---PNQ---TGIVAGV 574
R L Y+H + H D+K +NIL + + KI DFGLA++ P T VA
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA-- 168
Query: 575 RGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNF 614
+R Y APE S T D++S G + E++ + F
Sbjct: 169 --TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 43/143 (30%), Positives = 65/143 (45%), Gaps = 31/143 (21%)
Query: 485 LLVYEFMSKGSLADLLF------NLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
LLV EF G L L + P R+A ++A GLL+LH IH D
Sbjct: 71 LLVMEFCPLGDLKGYLRSCRKAELMTPDP--TTLQRMACEIALGLLHLHKN---NFIHSD 125
Query: 539 IKLRNILIDDSWRAKISDFGLAKL-------LMPNQTGIVAGVRGSRGYMAPEWQN---S 588
+ LRN L+ KI D+GL+ + P+Q + +R ++APE +
Sbjct: 126 LALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLR----WIAPELVDEVHG 179
Query: 589 GLITV----KSDVYSFGVVLLEI 607
L+ V +S+V+S GV + E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 47/211 (22%), Positives = 88/211 (41%), Gaps = 34/211 (16%)
Query: 439 PIGNDKVNDKRKLLTVLAGCLGS--ITFLCFLIAISSLLVYKHRSSKKL----------L 486
+ + + ++V+ LGS L F S + H+ KL +
Sbjct: 18 VQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDENIM 77
Query: 487 VYEFMSKGSLADLLFNLETRPLWRD-RVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
V E++ G L D+ + E + ++ +A +A L YL D+ +++H ++ +NIL
Sbjct: 78 VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNIL 133
Query: 546 -IDDSWR------AKISDFGLAKLLMPNQTGIVAGVRGSRG-YMAPEWQNSGL--ITVKS 595
K+SD G+ ++ + R R ++APE +G +T+ +
Sbjct: 134 VARYGLNEGYVPFIKLSDPGIPITVLSRE------ERVERIPWIAPECIRNGQASLTIAA 187
Query: 596 DVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626
D +SFG LLE IC ++ ++ E
Sbjct: 188 DKWSFGTTLLE-ICSNGEEPLSTLSSSEKER 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 30/95 (31%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRP---LWRDRVRIAL-DVARGLLYL 526
I LL H +K LV+EF+ DL +++ P L ++ L + +G+ Y
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 527 HDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
H +++H D+K +N+LID K++DFGLA+
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 29/86 (33%), Positives = 47/86 (54%), Gaps = 10/86 (11%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRP--LWRDRVRIAL-DVARGLLYLHDECEVQII 535
H LV+E++ DL ++ P L + V++ L + RGL Y+H I+
Sbjct: 73 HTKETLTLVFEYVH----TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YIL 125
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAK 561
H D+K +N+LI D+ K++DFGLA+
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 2e-04
Identities = 15/81 (18%), Positives = 27/81 (33%), Gaps = 6/81 (7%)
Query: 346 CKRKMPA-EFYNITSLKITWLGGLPYAKLSVSKKDCSKSCLNDCYFGAAFY--SDGACSK 402
C F + L A ++S ++C ++CL++C A Y G C
Sbjct: 5 CGGDGSTDGFLKLPD---VKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLL 61
Query: 403 HKFPLMFATKDQYASAILFIK 423
L L+++
Sbjct: 62 WNGLLNNLRSLSSGGGTLYLR 82
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 12/96 (12%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRP----LWRDRVRIAL-DVARGLLY 525
I L + S+ L++EF+S DL L++ P + + V+ L + +G+L+
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116
Query: 526 LHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
H +++H D+K +N+LID+ K++DFGLA+
Sbjct: 117 CHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 7/84 (8%)
Query: 525 YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE 584
YLH II+ D+K N+L+D+ K++DFG AK + P++T + G+ Y+APE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTFTLC---GTPEYLAPE 185
Query: 585 WQNSGLITVKSDVYSFGVVLLEII 608
S D ++ GV+L E I
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 35/106 (33%), Positives = 47/106 (44%), Gaps = 4/106 (3%)
Query: 511 DRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570
D + I V R + YLH+ +IIH DIK NI I+ + DFG A +
Sbjct: 183 DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239
Query: 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCR-SNFE 615
G G+ APE D++S G+VL E+ C S FE
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285
|
Length = 391 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 28/82 (34%), Positives = 43/82 (52%), Gaps = 9/82 (10%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+M DL LE PL + R+ + RGL Y+H ++H D+K N+
Sbjct: 93 IVQEYME----TDLANVLEQGPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANV 145
Query: 545 LID-DSWRAKISDFGLAKLLMP 565
I+ + KI DFGLA+++ P
Sbjct: 146 FINTEDLVLKIGDFGLARIVDP 167
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 6/127 (4%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E + GS+ +L+ L D I+ + LL L +IIH D+K NIL
Sbjct: 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNIL 160
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAP-----EWQNSGLITVKSDVYSF 600
+ K+ DFG++ L + V G+ +MAP E Q + DV+S
Sbjct: 161 LTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSL 219
Query: 601 GVVLLEI 607
G+ +E+
Sbjct: 220 GITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 35/136 (25%), Positives = 55/136 (40%), Gaps = 21/136 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
+V M+ GS DLL L + IA DV L Y+H + IH +K
Sbjct: 76 VVSPLMAYGSCEDLLKTHFPEGL--PELAIAFILKDVLNALDYIHSK---GFIHRSVKAS 130
Query: 543 NILIDDSWRAKISDFGLAKLLMPN---QTGIVAGVRGSRG---YMAPE--WQNSGLITVK 594
+IL+ + +S + ++ + Q + + S +++PE QN K
Sbjct: 131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEK 190
Query: 595 SDVYSFGVVLLEIICC 610
SD+YS G I C
Sbjct: 191 SDIYSVG-----ITAC 201
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 38/134 (28%), Positives = 62/134 (46%), Gaps = 8/134 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV ++ G L LL E R L D R L A ++ + ++ +H DIK NIL
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFYL--AEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW-----QNSGLITVKSDVYSF 600
+D + +++DFG LM + T + G+ Y++PE G + D +S
Sbjct: 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSL 194
Query: 601 GVVLLEIICCRSNF 614
GV + E++ + F
Sbjct: 195 GVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 19/152 (12%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIAL------DVARGLL 524
I LL H +K LV+EF+ + DL ++ PL + + L + +GL
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ----DLKKFMDASPL--SGIPLPLIKSYLFQLLQGLA 114
Query: 525 YLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL-MPNQTGIVAGVRGSRGYMAP 583
+ H +++H D+K +N+LI+ K++DFGLA+ +P +T V + Y AP
Sbjct: 115 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAP 169
Query: 584 E-WQNSGLITVKSDVYSFGVVLLEIICCRSNF 614
E + D++S G + E++ R+ F
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 36/115 (31%), Positives = 51/115 (44%), Gaps = 9/115 (7%)
Query: 497 ADLLFNLETRPLWRDRVRIALDVARGLL----YLHDECEVQIIHCDIKLRNILIDDSWRA 552
+DL L R ++ VAR LL Y+H E IIH DIK N+L++
Sbjct: 244 SDLYTYLGARLRPLGLAQVTA-VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDI 299
Query: 553 KISDFGLAKLLMPN-QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLE 606
+ DFG A + T G+ G+ APE T D++S G+V+ E
Sbjct: 300 CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 22/145 (15%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRD----RVRIALDVARGLLYLHDE 529
L Y + K L +V E+M G L +L+ N + W V +ALD + +
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGF---- 163
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQN 587
IH D+K N+L+D S K++DFG + + G+V G+ Y++PE
Sbjct: 164 -----IHRDVKPDNMLLDKSGHLKLADFGTCMKM--DANGMVRCDTAVGTPDYISPEVLK 216
Query: 588 S----GLITVKSDVYSFGVVLLEII 608
S G + D +S GV L E++
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 32/122 (26%), Positives = 58/122 (47%), Gaps = 8/122 (6%)
Query: 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
+Y FM + F+ + RPL + I + + Y+HD+ ++IH DIKL NI +
Sbjct: 249 LYSFMYDEA-----FDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300
Query: 547 DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLE 606
+ + + DFG A + G G+ +PE +D++S G++LL+
Sbjct: 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLD 360
Query: 607 II 608
++
Sbjct: 361 ML 362
|
Length = 501 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 40/135 (29%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 481 SSKKLLV-YEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCD 538
S +KL + E+ GSL D+ T PL ++ + + +GL YLH + + +H D
Sbjct: 77 SREKLWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETLQGLAYLHSKGK---MHRD 131
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR---GSRGYMAPE---WQNSGLIT 592
IK NIL+ D+ K++DFG+A + T +A + G+ +MAPE + +G
Sbjct: 132 IKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187
Query: 593 VKSDVYSFGVVLLEI 607
D+++ G+ +E+
Sbjct: 188 QLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 18/41 (43%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562
GL Y H + +H DIK NIL+++ + K++DFGLA+L
Sbjct: 128 GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 5/87 (5%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
L Y + ++ L L+ EF+ G L +L +T D R + A +L + ++
Sbjct: 66 LYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT--FSEDVTRFYM--AECVLAIEAVHKLG 121
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLA 560
IH DIK NILID K+SDFGL+
Sbjct: 122 FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV ++ G L LL E R L D R +A +L +H ++ +H DIK N+L
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDR-LPEDMARFY--IAEMVLAIHSIHQLHYVHRDIKPDNVL 134
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSF 600
+D + +++DFG + + T + G+ Y++PE + G + D +S
Sbjct: 135 LDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL 194
Query: 601 GVVLLEIICCRSNF 614
GV + E++ + F
Sbjct: 195 GVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 36/127 (28%), Positives = 56/127 (44%), Gaps = 6/127 (4%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E + GS+ DL+ R + IA + L+ L + IH D+K NIL
Sbjct: 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNIL 156
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAP-----EWQNSGLITVKSDVYSF 600
+ K+ DFG++ L + V G+ +MAP E Q + DV+S
Sbjct: 157 LTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSL 215
Query: 601 GVVLLEI 607
G+ +E+
Sbjct: 216 GITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 42/134 (31%), Positives = 65/134 (48%), Gaps = 15/134 (11%)
Query: 480 RSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHC 537
R + +L LV+E M +L +L+ RPL RV+ + + + L ++H I H
Sbjct: 70 RKTGRLALVFELMD-MNLYELIKG-RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHR 124
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPE-WQNSGLITVK 594
DIK NILI D K++DFG + + T ++ +R Y APE G K
Sbjct: 125 DIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS----TRWYRAPECLLTDGYYGPK 179
Query: 595 SDVYSFGVVLLEII 608
D+++ G V EI+
Sbjct: 180 MDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 40/136 (29%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIA----LDVARGLLYLHDECEVQII 535
S K+L LV+E++ DL ++++ P + R+ + RG+ Y H +++
Sbjct: 72 SEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVL 124
Query: 536 HCDIKLRNILIDDSWRA-KISDFGLAKLL-MPNQTGIVAGVRGSRGYMAPE-WQNSGLIT 592
H D+K +N+LID A K++DFGLA+ +P +T V + Y APE S +
Sbjct: 125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGSRHYS 182
Query: 593 VKSDVYSFGVVLLEII 608
D++S G + E++
Sbjct: 183 TPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 19/147 (12%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDE 529
I LL + K ++ EF G++ ++ L+ R L +++ I + L YLH
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH-- 127
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLA----KLLMPNQTGIVAGVRGSRGYMAP-- 583
++IIH D+K N+L+ K++DFG++ K L + I G+ +MAP
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEV 181
Query: 584 ---EWQNSGLITVKSDVYSFGVVLLEI 607
E K+D++S G+ L+E+
Sbjct: 182 VMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 18/41 (43%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
RGL Y H + +I+H D+K +N+LI++ K++DFGLA+
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 8/111 (7%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL-LMPNQTGIVAGVRGSRG 579
RGL Y+H + I+H D+K +N+LI K++DFGLA+ +P+QT V +
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLW 168
Query: 580 YMAPE-WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629
Y P+ + + D++ G + +E++ + F VS E L W
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFP-GVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.004
Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 4/76 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV+EF LA LL N + + ++ + GL Y+H +I+H D+K NIL
Sbjct: 96 LVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANIL 151
Query: 546 IDDSWRAKISDFGLAK 561
I K++DFGLA+
Sbjct: 152 ITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 702 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.98 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.98 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.96 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.96 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.96 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.96 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.96 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.96 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.96 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.96 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.96 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.96 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.95 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.95 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.95 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.94 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.93 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.93 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.93 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.93 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.92 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.92 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.92 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.92 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.92 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.92 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.92 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.91 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.9 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.9 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.9 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.89 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.88 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.87 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.86 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.86 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.86 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.86 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.85 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.85 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.8 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.64 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.64 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.64 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.61 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.6 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.59 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.57 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.55 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.52 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.45 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.44 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.41 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.25 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.24 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.23 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.19 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.14 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.14 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.08 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.07 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.04 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.02 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.97 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.89 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 98.87 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.83 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.77 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.74 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.68 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.53 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.49 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.41 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.34 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.29 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.26 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 97.96 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 97.94 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.86 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.51 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.87 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.79 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.69 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.57 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.5 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 96.3 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.76 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.56 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 95.56 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.2 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.56 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.53 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 93.44 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.4 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 92.96 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 92.72 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 91.96 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.21 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 89.9 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 89.46 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.24 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 89.21 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 88.97 | |
| smart00223 | 79 | APPLE APPLE domain. Four-fold repeat in plasma kal | 88.59 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 88.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 86.92 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 86.74 | |
| PF14295 | 51 | PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A. | 85.41 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 84.99 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 84.99 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 84.24 | |
| PF00024 | 79 | PAN_1: PAN domain This Prosite entry concerns appl | 82.98 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 82.59 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=330.86 Aligned_cols=238 Identities=37% Similarity=0.614 Sum_probs=202.6
Q ss_pred ccceEEEeEE--EEEeeeeh-hhhHhh---------------------------eeeEEEEEecCC-eeEEEEecCCCCC
Q 038002 447 DKRKLLTVLA--GCLGSITF-LCFLIA---------------------------ISSLLVYKHRSS-KKLLVYEFMSKGS 495 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~-~~~avk---------------------------i~~l~~~~~~~~-~~~lV~e~~~~gs 495 (702)
....||+|+| ||+|.+.. ..|||| +++|++|+.+++ +.+||||||++|+
T Consensus 79 ~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGs 158 (361)
T KOG1187|consen 79 ESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGS 158 (361)
T ss_pred hhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCC
Confidence 3467888877 88888777 677777 888999999888 5999999999999
Q ss_pred HHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeece
Q 038002 496 LADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGV 574 (702)
Q Consensus 496 L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 574 (702)
|.++|+.... .++|..+++|+.++|+||+|||+.+.+.||||||||+|||+|+++++||+|||+|+....... .....
T Consensus 159 L~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~-~~~~~ 237 (361)
T KOG1187|consen 159 LEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDT-SVSTT 237 (361)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcccc-ceeee
Confidence 9999998776 789999999999999999999999888899999999999999999999999999976543111 11222
Q ss_pred -eccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc-----C
Q 038002 575 -RGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV-----D 648 (702)
Q Consensus 575 -~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 648 (702)
.||.+|+|||++..+..+.|+|||||||+++||++|+.|.+... ...+..+..|....+..+.+.+++|+.+ .
T Consensus 238 ~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~ 316 (361)
T KOG1187|consen 238 VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYP 316 (361)
T ss_pred cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCC-CcccccHHHHHHHHHHCcchhheeCCCccCCCCC
Confidence 79999999999999999999999999999999999999887653 2334447788888888888888888742 2
Q ss_pred H-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 649 K-ITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 649 ~-~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
. ....++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 317 ~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 317 DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 2 5788899999999999999999999999999766544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=312.20 Aligned_cols=194 Identities=28% Similarity=0.395 Sum_probs=161.2
Q ss_pred eeeEEEEEecCC-eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSS-KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~ 548 (702)
|+.+++.|..+. .+.|+||||++|||++++...+ ++++....+|+.+|++||.|||+ + +||||||||+|||++.
T Consensus 139 IV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNs 214 (364)
T KOG0581|consen 139 IVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNS 214 (364)
T ss_pred eeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeecc
Confidence 899998888888 5999999999999999998774 79999999999999999999996 6 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
.|.+||+|||.+..+... ....+.||..|||||.+.+..|+.++||||||++++|+.+|+.|+......... ..+
T Consensus 215 kGeVKicDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~--~~~ 289 (364)
T KOG0581|consen 215 KGEVKICDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD--IFE 289 (364)
T ss_pred CCCEEeccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC--HHH
Confidence 999999999999877544 346688999999999999999999999999999999999999999764111111 111
Q ss_pred HHHHhhhccccccccccccCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDK-ITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....+..+.- +.++. ..++++.+++..||++||.+||+++|+++.
T Consensus 290 -Ll~~Iv~~pp-----P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 290 -LLCAIVDEPP-----PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -HHHHHhcCCC-----CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111122111 12333 478899999999999999999999999863
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.59 Aligned_cols=217 Identities=24% Similarity=0.292 Sum_probs=184.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..+++.+.||+|+| +|.+.... ..||+| |++++.+|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45677889999999 88888743 778877 999999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
|+|+.++|.++++. +..+++.+++.+++||+.||.|||++ +|+|||||..|++++++.++||+|||+|..+..+.
T Consensus 98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 99999999999984 44899999999999999999999999 99999999999999999999999999999885443
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
+...+.+|||.|+|||++.....+..+||||+|||+|.||.|++||+...- +-.+..++..+ -..+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~~------Y~~P 238 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLNE------YSMP 238 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhcC------cccc
Confidence 335568999999999999999999999999999999999999999975411 11222222211 1234
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...+....+||.++|+.||.+|||+++|+.
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 456778889999999999999999999996
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=311.69 Aligned_cols=223 Identities=22% Similarity=0.219 Sum_probs=179.2
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------------eeeEEEEEecCC
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------------ISSLLVYKHRSS 482 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------------i~~l~~~~~~~~ 482 (702)
+++.+...+.+|.|+| |-++..+. ..|||| |+++.++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4555556677888877 44444433 566766 999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC---CcEEEecccc
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS---WRAKISDFGL 559 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~ 559 (702)
..|+||||++||+|.+++...+ .+.+..-..++.|++.|+.|||++ ||+||||||+|||+..+ -.+||+|||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 9999999999999999998765 677888889999999999999999 99999999999999665 6799999999
Q ss_pred eeecCCCCCceeeceeccccccCcccccCCC---CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc
Q 038002 560 AKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL---ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA 636 (702)
Q Consensus 560 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 636 (702)
|+... ....+.+.+|||.|.|||++.++. +..++||||+||+||-+++|.+||....... . ..+++..
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---s----l~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---S----LKEQILK 396 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---c----HHHHHhc
Confidence 99875 344577899999999999997653 3358899999999999999999997542221 0 1222333
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 637 GEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+.. .+.+......+++.+++|.+||+.||++|||++|+++
T Consensus 397 G~y--~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRY--AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ccc--cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 332 2233445678899999999999999999999999886
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=303.04 Aligned_cols=168 Identities=28% Similarity=0.359 Sum_probs=151.7
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
.+...++||.|+| ||+|..+. ..|||| |+.++++.+.++.+||||||
T Consensus 11 ~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEy 90 (429)
T KOG0595|consen 11 DYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEY 90 (429)
T ss_pred cceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEe
Confidence 4455566999999 99999876 778887 99999999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC------CcEEEecccceeecC
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS------WRAKISDFGLAKLLM 564 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~------~~~kl~Dfg~a~~~~ 564 (702)
|+||+|.++|+..+ ++++..+..++.||+.||++||++ +||||||||+|||++.. -.+||+|||+|+.+.
T Consensus 91 C~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 91 CNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred CCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 99999999998876 899999999999999999999999 99999999999999664 568999999999875
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
. .....+.+|++.|||||++....|+.|+|+||+|+|+|++++|+.||+..
T Consensus 167 ~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 167 P--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred c--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 3 33356789999999999999999999999999999999999999999754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.55 Aligned_cols=218 Identities=23% Similarity=0.266 Sum_probs=181.6
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
++-.+.+|+|++ |+++.... ..+||| |++|+..|+++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 344568888888 88877654 677776 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++|+|.++|.+.+ .+++..++.++.||+.||+|||++ |||||||||||||+|+++++||+|||.|+.+......
T Consensus 155 ~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred ecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 999999999999886 899999999999999999999999 9999999999999999999999999999987543211
Q ss_pred ------------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcc
Q 038002 570 ------------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG 637 (702)
Q Consensus 570 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 637 (702)
....++||..|.+||++.....+..+|||+||||||+|+.|.+||... .+...+... ..
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~---NeyliFqkI-----~~- 301 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA---NEYLIFQKI-----QA- 301 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc---cHHHHHHHH-----HH-
Confidence 114588999999999999999999999999999999999999999644 111111111 10
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 638 EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 638 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
++-++++..++.+.+|+.+.|..||.+|+|.++|.+..
T Consensus 302 -----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 -----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -----hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 11234445567888999999999999999999998754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.33 Aligned_cols=220 Identities=32% Similarity=0.400 Sum_probs=177.4
Q ss_pred eEEEeEE--EEEeeeehhh-hHhh-----------------------------eeeEEEEEecCC-eeEEEEecCCCCCH
Q 038002 450 KLLTVLA--GCLGSITFLC-FLIA-----------------------------ISSLLVYKHRSS-KKLLVYEFMSKGSL 496 (702)
Q Consensus 450 ~l~~g~~--v~~~~~~~~~-~avk-----------------------------i~~l~~~~~~~~-~~~lV~e~~~~gsL 496 (702)
.+|.|++ ||++...... |||| |+++++...+.. ...|||||+++|+|
T Consensus 48 ~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL 127 (362)
T KOG0192|consen 48 VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSL 127 (362)
T ss_pred hcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcH
Confidence 3666666 7777766644 6665 777888888877 79999999999999
Q ss_pred HHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCC-eEecCCCCCcEEEeCCC-cEEEecccceeecCCCCCceeec
Q 038002 497 ADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQ-IIHCDIKLRNILIDDSW-RAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 497 ~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
.+++... ...+++..++.++.||++||.|||++ + ||||||||+|||++.++ ++||+|||+++...... ...+.
T Consensus 128 ~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~~~ 203 (362)
T KOG0192|consen 128 SVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSMTS 203 (362)
T ss_pred HHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccccC
Confidence 9999883 55799999999999999999999999 8 99999999999999997 99999999998764332 23344
Q ss_pred eeccccccCccccc--CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 574 VRGSRGYMAPEWQN--SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 574 ~~gt~~y~aPE~~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
..||+.|||||++. ...++.|+|||||||++|||+||+.||..... ... .......+ ..+.++...
T Consensus 204 ~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~---~~~v~~~~-----~Rp~~p~~~ 271 (362)
T KOG0192|consen 204 VAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQV---ASAVVVGG-----LRPPIPKEC 271 (362)
T ss_pred CCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHH---HHHHHhcC-----CCCCCCccC
Confidence 67999999999999 56999999999999999999999999975521 111 11111111 122333346
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...+..++.+||+.||++||++.+++.+|+.+..
T Consensus 272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 7788999999999999999999999999997543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=294.27 Aligned_cols=212 Identities=21% Similarity=0.215 Sum_probs=174.4
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV 487 (702)
.+.++..+.||+|+| |+...... ..+|+| |+.+...||+++++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 355666789999998 77766554 667776 89999999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
+||+.||.|..+|.+.+ .+++..+.-++.+|+.||.|||+. |||||||||+|||+|++|+++|+|||+++......
T Consensus 104 ld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999999998776 899999999999999999999999 99999999999999999999999999999653332
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
....+++||+.|||||++.+..|+.++|+||||+++|||++|.+||....... .++.+..+.. ...
T Consensus 180 -~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~-----~~~ 245 (357)
T KOG0598|consen 180 -DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKL-----PLP 245 (357)
T ss_pred -CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcC-----CCC
Confidence 23455899999999999999999999999999999999999999997552111 1122222221 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRP 671 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RP 671 (702)
+.-.+.+.++++.++|+.||++|.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhc
Confidence 223566788899999999999995
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=303.11 Aligned_cols=225 Identities=27% Similarity=0.324 Sum_probs=185.0
Q ss_pred cccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCCCCH
Q 038002 446 NDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL 496 (702)
+..++||+|-| |+.|.... ..||+| |+++++....++.+|||||||+.|+|
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 34567888887 88888777 477776 99999999998999999999999999
Q ss_pred HHHhhc-CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeecee
Q 038002 497 ADLLFN-LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR 575 (702)
Q Consensus 497 ~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 575 (702)
.++|+. .+..+...+.+.++.||++|++||+++ ++|||||...||||+++..+||+|||+|+....+.........
T Consensus 289 l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~k 365 (468)
T KOG0197|consen 289 LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGK 365 (468)
T ss_pred HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCC
Confidence 999997 455789999999999999999999999 9999999999999999999999999999966555443444444
Q ss_pred ccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHH
Q 038002 576 GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLER 654 (702)
Q Consensus 576 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (702)
-+..|.|||.+....++.|+|||||||+||||+| |+.|+..... . + +.+.+.++.. -..+...++.
T Consensus 366 fPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-~------e-v~~~le~GyR-----lp~P~~CP~~ 432 (468)
T KOG0197|consen 366 FPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-E------E-VLELLERGYR-----LPRPEGCPDE 432 (468)
T ss_pred CCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-H------H-HHHHHhccCc-----CCCCCCCCHH
Confidence 5678999999999999999999999999999998 8888865411 1 1 1122222211 1234556788
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 655 MVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 655 l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
+.++|..||+.+|++|||++.+...|+.....
T Consensus 433 vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 433 VYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999886543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=275.05 Aligned_cols=206 Identities=22% Similarity=0.220 Sum_probs=173.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.+...+.+|.|+| |.+..... ..+|+| ++++...+++.+.+|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 44556778888888 66555443 455555 788889999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||++||.|..++++.+ ++++..++-++.||+.||+|||+. +|++|||||||||+|.+|.+||+|||+|+....
T Consensus 124 eyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--- 196 (355)
T ss_pred eccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence 9999999999998876 899999999999999999999999 999999999999999999999999999997633
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
...+.+|||.|+|||+++.+.+..++|.|||||++|||+.|.+||..... ...++.+.++.+ ..+
T Consensus 197 -rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~KI~~~~v------~fP 261 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYEKILEGKV------KFP 261 (355)
T ss_pred -cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHHHHHhCcc------cCC
Confidence 24568899999999999999999999999999999999999999976522 124444444443 234
Q ss_pred HHHHHHHHHHHHHcccCCCCCC
Q 038002 649 KITLERMVKTGLLCIQDEPNLR 670 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~R 670 (702)
.-....+.+|+...|+.|-.+|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 4556688889999999999999
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.93 Aligned_cols=233 Identities=21% Similarity=0.201 Sum_probs=183.2
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCC-eeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSS-KKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~-~~~lV 487 (702)
-+.|...+++|.|.| |+++.... ..|||| |++|.+.+.+.+ .+|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 355667789999998 88888655 778988 888887777766 99999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
||||+. +|.+++++.+..+++.++..|+.||++||+|+|++ |+.|||+||||||+..+..+||+|||+|+.+....
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 999976 99999999877799999999999999999999999 99999999999999999999999999999875544
Q ss_pred CceeeceeccccccCcccc-cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH-------------Hh
Q 038002 568 TGIVAGVRGSRGYMAPEWQ-NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY-------------NC 633 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------------~~ 633 (702)
. .+..+.|+.|+|||++ +...|+.+.|||++|||++|+.+-++.|.+..+.++...+-+.+. ..
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 4566789999999966 567899999999999999999999999976532222111111110 00
Q ss_pred hhcccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 634 FVAGEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 634 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
...-.++..... .+-+..+.++.++|.+|+++||++|||++|++++-
T Consensus 243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000011111111 22233788899999999999999999999999853
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.62 Aligned_cols=219 Identities=24% Similarity=0.283 Sum_probs=177.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
.++....++|+|.. ||.+.... ..|||| |+.++..|..++++++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45556677888876 77776554 667776 666666666689999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
+||+|.|.+... .+++.++..|++++++||+|||.+ ||+|||||.+|||+..+|.+||+|||++..+..... ..
T Consensus 353 ~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-KR 426 (550)
T KOG0578|consen 353 EGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-KR 426 (550)
T ss_pred CCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC-cc
Confidence 999999999654 599999999999999999999999 999999999999999999999999999998866554 34
Q ss_pred eceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 572 AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
....|||.|||||++....|++|+||||||++++||+-|++||-.... ... .+.....+. ..+ ..+...
T Consensus 427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P-----lrA--lyLIa~ng~-P~l---k~~~kl 495 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP-----LRA--LYLIATNGT-PKL---KNPEKL 495 (550)
T ss_pred ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh-----HHH--HHHHhhcCC-CCc---CCcccc
Confidence 567899999999999999999999999999999999999999964311 111 111111111 111 224456
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+..+.+++.+||+.|+++||++.|||+
T Consensus 496 S~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 SPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 788999999999999999999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=278.29 Aligned_cols=226 Identities=19% Similarity=0.252 Sum_probs=177.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEE-EEecCCe-eEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLV-YKHRSSK-KLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~-~~~~~~~-~~lV 487 (702)
..++..++||+|.| ||++.... ..+|.| |++++. -+.++.. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 34556788999999 88877654 667766 666664 4444444 9999
Q ss_pred EecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCC-CeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 488 YEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEV-QIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~-~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
||+|..|+|...++. .+..+++..+++++.|++.||.++|..... -|+||||||.||+++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999864 344699999999999999999999994221 3999999999999999999999999999988
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
.... .......|||.||+||.+....|+.|+||||+||++|||+.-++||... .... ....+..++.+.+.
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~----L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLS----LCKKIEQGDYPPLP 249 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHH----HHHHHHcCCCCCCc
Confidence 5443 3455688999999999999999999999999999999999999999765 1111 22333444433221
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
....+..+..+|..|+..||+.||+.-.++..+.
T Consensus 250 ----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 ----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 2467888889999999999999998555555443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=296.86 Aligned_cols=198 Identities=25% Similarity=0.334 Sum_probs=167.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|.++++.+++.+++|||.||+++|.|.+++...+ ++++.++++++.||+.|+.|+|.. +|+||||||+|+|+|.++
T Consensus 74 Vl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~ 149 (786)
T KOG0588|consen 74 VLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKN 149 (786)
T ss_pred eeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhccc
Confidence 8899999999999999999999999999998876 899999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCC-ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT-VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
++||+|||+|.+-.. .....+.+|+|.|.+||++.+.+|. .++||||.|||||.||+|+.||+.. ++. .
T Consensus 150 nIKIADFGMAsLe~~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-------Nir-~ 219 (786)
T KOG0588|consen 150 NIKIADFGMASLEVP--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-------NIR-V 219 (786)
T ss_pred CEeeeccceeecccC--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-------cHH-H
Confidence 999999999987533 3345677999999999999998875 7999999999999999999999733 111 1
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCCcCCCC
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGTMEIPI 688 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~~~~~~ 688 (702)
+......|.+ +.+...+.++.+|+.+||..||++|.|++||++. |.+-..++.
T Consensus 220 LLlKV~~G~f------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~ 274 (786)
T KOG0588|consen 220 LLLKVQRGVF------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPS 274 (786)
T ss_pred HHHHHHcCcc------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCCh
Confidence 2333344433 3345667789999999999999999999999984 455444443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=286.49 Aligned_cols=220 Identities=23% Similarity=0.301 Sum_probs=170.3
Q ss_pred cceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCC--eeEEEEecCCCC
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSS--KKLLVYEFMSKG 494 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~--~~~lV~e~~~~g 494 (702)
.+.+|+|.+ |+++.... ...||| |+++++...... .+++.|||+++|
T Consensus 22 ~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~G 101 (313)
T KOG0198|consen 22 GKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGG 101 (313)
T ss_pred hccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCC
Confidence 356777776 77776654 555555 566665433333 799999999999
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-CCcEEEecccceeecCC--CCCcee
Q 038002 495 SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-SWRAKISDFGLAKLLMP--NQTGIV 571 (702)
Q Consensus 495 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~--~~~~~~ 571 (702)
+|.+++.+.+.++++..+..+.+||++||+|||++ ||+||||||+|||++. ++.+||+|||++..... ......
T Consensus 102 sL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~ 178 (313)
T KOG0198|consen 102 SLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSE 178 (313)
T ss_pred cHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccccccc
Confidence 99999998766799999999999999999999999 9999999999999999 79999999999987653 222233
Q ss_pred eceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 572 AGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
....||+.|||||++..+ ....++|||||||++.||+||..||.... ............... +.++..
T Consensus 179 ~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~~~-----P~ip~~ 247 (313)
T KOG0198|consen 179 LSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGREDSL-----PEIPDS 247 (313)
T ss_pred ccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccCCC-----CCCCcc
Confidence 457899999999999853 33459999999999999999999997530 011111111122211 245556
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.+....+++.+|++.||++|||++++++..-
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 7788999999999999999999999998653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.16 Aligned_cols=189 Identities=26% Similarity=0.386 Sum_probs=159.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS- 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~- 549 (702)
|++++.+++...+.|+||||+.||+|.+++.+ ..++.+.++..+++|++.|++|+|++ ||+||||||+|||++.+
T Consensus 82 I~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~ 157 (370)
T KOG0583|consen 82 IIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNE 157 (370)
T ss_pred EeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCC
Confidence 89999999999999999999999999999998 55899999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCC-CC-ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL-IT-VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
+++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+... ...
T Consensus 158 ~~~Kl~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~----~~~-- 230 (370)
T KOG0583|consen 158 GNLKLSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN----VPN-- 230 (370)
T ss_pred CCEEEeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc----HHH--
Confidence 999999999999874 3334466789999999999998876 75 78999999999999999999997531 111
Q ss_pred HHHHHhhhccccccccccccCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKIT-LERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+..+..+.. .++... +..+..++.+||+.||.+|+++.++++
T Consensus 231 --l~~ki~~~~~------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 231 --LYRKIRKGEF------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred --HHHHHhcCCc------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111222221 122223 788999999999999999999999993
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=291.29 Aligned_cols=223 Identities=17% Similarity=0.140 Sum_probs=177.9
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV 487 (702)
.+.+..-+.||+|+| |+++..+. ..+|+| |++|+..|++.+.+|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 345566689999999 88888765 677877 99999999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC-
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN- 566 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~- 566 (702)
|||++||++..+|.+.+ .+++..+..++.+++.|++.||+. |+|||||||+|+|||..|++||+|||++.-+...
T Consensus 220 MEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 99999999999998776 799999999999999999999999 9999999999999999999999999999633110
Q ss_pred -------------------C--Cc-----ee-------------------eceeccccccCcccccCCCCCccccccchh
Q 038002 567 -------------------Q--TG-----IV-------------------AGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601 (702)
Q Consensus 567 -------------------~--~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 601 (702)
. .. .. ....|||.|+|||++.+..|+..+|+||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 00 00 124599999999999999999999999999
Q ss_pred HhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 038002 602 VVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS---MKNVIL 678 (702)
Q Consensus 602 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl~ 678 (702)
||+||||.|.+||......+.-..+..|.... ........+.+..+||.+||. ||++|.- ++||-+
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l----------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETL----------KFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc----------cCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 99999999999998764333222333322111 111122334788999999999 9999975 666655
Q ss_pred H
Q 038002 679 M 679 (702)
Q Consensus 679 ~ 679 (702)
+
T Consensus 445 H 445 (550)
T KOG0605|consen 445 H 445 (550)
T ss_pred C
Confidence 3
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=274.49 Aligned_cols=229 Identities=19% Similarity=0.186 Sum_probs=174.7
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
++..-.++|+|+. |++...+. +.|||| ++.|++.|+...+.+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4455567888876 66655443 667776 67777888889999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
|+. ++.+-|......++.+.+.+++.|+++|+.|+|++ ++|||||||||||++.++.+||+|||+|+.+.. ....
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 977 66666777777899999999999999999999999 999999999999999999999999999998854 3445
Q ss_pred eeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHH--------hhhc-cccc
Q 038002 571 VAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYN--------CFVA-GEFN 640 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~--------~~~~-~~~~ 640 (702)
.+....|..|+|||.+.+ .+|...+||||+||++.||++|.+.|.+.. .-++......... .+.. +.+.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S-DiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS-DIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc-hHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 667778999999998876 689999999999999999999999997663 2222221111111 0000 1111
Q ss_pred ccccc---------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 641 KLVEE---------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 641 ~~~~~---------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+.-+ .--+..+.-++++++.||+.||++|++-+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11111 112334567899999999999999999999874
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=289.73 Aligned_cols=217 Identities=27% Similarity=0.292 Sum_probs=183.8
Q ss_pred ceEEEeEE--EEEeeeehhhhHhh--------------------eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCC
Q 038002 449 RKLLTVLA--GCLGSITFLCFLIA--------------------ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETR 506 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~~~~avk--------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~ 506 (702)
.-+|.|+. ||+|.+..+.|||| |+.+.+.+-...-++||||||..|-|...|+... .
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~-~ 208 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR-P 208 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC-c
Confidence 35677765 99999999999998 8899999999999999999999999999998765 7
Q ss_pred CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccc
Q 038002 507 PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ 586 (702)
Q Consensus 507 ~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~ 586 (702)
+.......|..+|+.|+.|||.+ .|||||||.-||||..+..+||+|||-++..... .....+.||..|||||++
T Consensus 209 itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGTVaWMAPEvI 283 (904)
T KOG4721|consen 209 ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGTVAWMAPEVI 283 (904)
T ss_pred cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhhHhhhCHHHh
Confidence 88888899999999999999999 9999999999999999999999999998865433 334568899999999999
Q ss_pred cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCC
Q 038002 587 NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDE 666 (702)
Q Consensus 587 ~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~d 666 (702)
++.+.++|+|||||||+|||||||+.||....... ++-+.-...+.-.++...++-+.-|+++||+-.
T Consensus 284 rnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA------------IIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sK 351 (904)
T KOG4721|consen 284 RNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA------------IIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSK 351 (904)
T ss_pred hcCCcccccceehhHHHHHHHHhcCCCccccchhe------------eEEeccCCcccccCcccCchHHHHHHHHHHhcC
Confidence 99999999999999999999999999996432211 111111122222455667778888999999999
Q ss_pred CCCCCCHHHHHHHHhCC
Q 038002 667 PNLRPSMKNVILMLEGT 683 (702)
Q Consensus 667 P~~RPt~~evl~~Le~~ 683 (702)
|..||++.+++..|+=.
T Consensus 352 pRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 352 PRNRPSFRQILLHLDIA 368 (904)
T ss_pred CCCCccHHHHHHHHhhc
Confidence 99999999999999743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=277.18 Aligned_cols=227 Identities=24% Similarity=0.287 Sum_probs=181.0
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEE
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..+.++-...||.|.. ||++.... ..|||| |+.++..|-.+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3455666678888866 88887654 788888 888889999999999999
Q ss_pred ecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 489 EFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 489 e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
.||.+||+.++++.. ...+++..+..|++++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+....
T Consensus 104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999999865 34689999999999999999999999 99999999999999999999999999987665443
Q ss_pred Ccee---eceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc--
Q 038002 568 TGIV---AGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN-- 640 (702)
Q Consensus 568 ~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 640 (702)
.... ..+.||+.|||||++.. ..|+.|+||||||++..||.+|..||..... -+..+.+ ..+..+
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~t------Lqn~pp~~ 252 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLLT------LQNDPPTL 252 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHHH------hcCCCCCc
Confidence 2221 45789999999998543 4789999999999999999999999975411 1111111 111111
Q ss_pred --cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 641 --KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 641 --~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...+.+........+.+++..||+.||.+|||++++++
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 12223344555668889999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=281.05 Aligned_cols=233 Identities=19% Similarity=0.178 Sum_probs=179.6
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEE--ecCCeeEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYK--HRSSKKLL 486 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~--~~~~~~~l 486 (702)
.+.+....+||+|.+ ||++.... ..||+| |++|.+.- .....+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 345566778999988 99888765 668877 66666332 23689999
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
|+|||+. +|.-++....-++++.++..++.||+.||+|+|.+ ||+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999977 99999988877899999999999999999999999 9999999999999999999999999999998877
Q ss_pred CCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH----HHhhhccccc-
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV----YNCFVAGEFN- 640 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~~- 640 (702)
.....+..+-|..|+|||.+.+ ..|+.++|+||.||||.||+.|++.|......++-..+.+.- ...|....++
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 7766777888999999998766 489999999999999999999999998663222111111000 0001111111
Q ss_pred -ccccc---------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 641 -KLVEE---------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 641 -~~~~~---------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+.+ +.-.......++|+..+|..||.+|.|+.++++
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111 112233556788899999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-32 Score=288.38 Aligned_cols=199 Identities=26% Similarity=0.376 Sum_probs=153.4
Q ss_pred eeeEEEEEec-CCeeEEEEecCCCCCHHHHhhcCC---------------------------------------------
Q 038002 471 ISSLLVYKHR-SSKKLLVYEFMSKGSLADLLFNLE--------------------------------------------- 504 (702)
Q Consensus 471 i~~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------- 504 (702)
|+++++.+.. ++..++||||+++|+|.+++....
T Consensus 73 iv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (338)
T cd05102 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPS 152 (338)
T ss_pred eeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccc
Confidence 5666665544 456899999999999999997532
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 505 ----------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 505 ----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~ 229 (338)
T cd05102 153 TSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 229 (338)
T ss_pred cCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc
Confidence 1366788899999999999999999 999999999999999999999999999986543322
Q ss_pred c-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 569 G-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 569 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... . .......+... .
T Consensus 230 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~-----~~~~~~~~~~~-----~ 297 (338)
T cd05102 230 YVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--E-----FCQRLKDGTRM-----R 297 (338)
T ss_pred hhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--H-----HHHHHhcCCCC-----C
Confidence 1 1223345678999999988899999999999999999997 999997542211 1 11111111111 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+...+..+.+++.+||+.||++|||+.||+++|+.+.
T Consensus 298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12234567889999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=259.13 Aligned_cols=230 Identities=20% Similarity=0.164 Sum_probs=180.1
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+...+++|+|.+ ||+|.... +.|||| |+.|.+.|...+..-||+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 455678899987 88888765 788887 788888899999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
+. +|+..|++....++..++..++.++++||+|||++ .|+||||||.|+|++++|.+||+|||+|+.+........
T Consensus 84 ~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 84 PT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred cc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 76 99999999887899999999999999999999999 999999999999999999999999999999865554332
Q ss_pred eceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc------
Q 038002 572 AGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE------ 644 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 644 (702)
...-|..|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+.. .-++....-.+........+++...
T Consensus 160 -~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s-DidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 160 -HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS-DIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred -cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc-hHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 3367999999997765 689999999999999999999887776542 2222211111111111111111110
Q ss_pred ---------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 645 ---------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 645 ---------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
..+-........+++..|+..||.+|+++.|++++=
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 012344566779999999999999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-32 Score=290.34 Aligned_cols=208 Identities=23% Similarity=0.267 Sum_probs=173.0
Q ss_pred cccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEEEec
Q 038002 446 NDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
.-.+.||+|.| |.++.... ..+||| ++.++..|++.+++|+||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 34578999999 88888765 778887 78889999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+.||++..+++ ...+++..+.-++..|+.||.|||++ |||+||||.+|||+|.+|++||+|||+++.-... ...
T Consensus 451 ~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~~ 524 (694)
T KOG0694|consen 451 VAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GDR 524 (694)
T ss_pred cCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-CCc
Confidence 99999554443 23699999999999999999999999 9999999999999999999999999999864322 235
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
..+++|||.|+|||++.+..|+.++|.|||||+||||+.|+.||.... ++..+ ..+... +..++.-
T Consensus 525 TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---Eee~F-----dsI~~d------~~~yP~~ 590 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---EEEVF-----DSIVND------EVRYPRF 590 (694)
T ss_pred cccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHH-----HHHhcC------CCCCCCc
Confidence 678999999999999999999999999999999999999999997552 11111 111111 1234556
Q ss_pred HHHHHHHHHHHcccCCCCCCCCH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
.+.+.+.++.++|..+|++|.-+
T Consensus 591 ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 591 LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ccHHHHHHHHHHhccCcccccCC
Confidence 67889999999999999999765
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=261.98 Aligned_cols=192 Identities=26% Similarity=0.366 Sum_probs=160.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.+.+.++.+...++|+|.|+.|.|.|+|...- .+++.+..+|++|+.+|++|||.+ +|+||||||+|||++++.
T Consensus 85 II~l~D~yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~ 160 (411)
T KOG0599|consen 85 IIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNM 160 (411)
T ss_pred EEEeeeeccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecccc
Confidence 8999999999999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc------CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN------SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
++||+|||++..+..... ....+|||+|+|||.++ ...|+..+|+|++|||+|.|+.|.+||... .+.
T Consensus 161 ~i~isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----kQm 234 (411)
T KOG0599|consen 161 NIKISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----KQM 234 (411)
T ss_pred ceEEeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH----HHH
Confidence 999999999998755443 56789999999999774 346788999999999999999999999643 111
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ....+.++...- ..+.-.+.+....+||.+||+.||.+|.|++|+++
T Consensus 235 l----MLR~ImeGkyqF--~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 L----MLRMIMEGKYQF--RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred H----HHHHHHhccccc--CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1 122223333221 11223356778899999999999999999999886
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=269.88 Aligned_cols=189 Identities=22% Similarity=0.318 Sum_probs=161.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.+++.|++.+.++|||||..+|.|.|++.+.+ .+++.++..+++||..|+.|+|++ +++|||||.+|||+|.++
T Consensus 115 II~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~ 190 (668)
T KOG0611|consen 115 IIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNN 190 (668)
T ss_pred eeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCC
Confidence 8999999999999999999999999999998776 899999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCC-ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT-VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
++||+|||++..+.... ..++++|++-|.+||++.+.+|. +.+|.|||||+||.|+.|..||++.+. ..
T Consensus 191 NiKIADFGLSNly~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~---- 260 (668)
T KOG0611|consen 191 NIKIADFGLSNLYADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KR---- 260 (668)
T ss_pred Ceeeeccchhhhhcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HH----
Confidence 99999999999875433 46789999999999999998874 889999999999999999999986521 11
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
...++..+...+ ++.+....-||+|||..||++|.|+++|....
T Consensus 261 lvrQIs~GaYrE-------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 261 LVRQISRGAYRE-------PETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred HHHHhhcccccC-------CCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 122223333221 22344567789999999999999999998754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=280.82 Aligned_cols=217 Identities=23% Similarity=0.214 Sum_probs=177.5
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
.+.....||+|.| ||+|.... ..||+| |.++++.+-.+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 3444578999999 99998765 788888 334455566688999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
.||++.+.|+... .+++.++.-++++++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+.......
T Consensus 94 ~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred cCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 9999999997654 458888888999999999999999 99999999999999999999999999998875544433
Q ss_pred eceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 572 AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
..+.||+.|||||+++...|+.|+||||||++.+||++|.+|+.......-. -.+.+...+.++...
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------------flIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------------FLIPKSAPPRLDGDF 235 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------------EeccCCCCCcccccc
Confidence 6788999999999999889999999999999999999999999654221100 011222223334466
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+..+.+++..||.+||+.||++.++++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 778999999999999999999999886
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=274.69 Aligned_cols=194 Identities=26% Similarity=0.299 Sum_probs=154.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+.+...+.+++..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~ 138 (285)
T cd05631 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDR 138 (285)
T ss_pred EEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCC
Confidence 7778888889999999999999999998886543 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.+||+|||++....... ......|++.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 139 ~~~kl~Dfg~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---- 212 (285)
T cd05631 139 GHIRISDLGLAVQIPEGE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE---- 212 (285)
T ss_pred CCEEEeeCCCcEEcCCCC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH----
Confidence 999999999998753322 22345689999999999999999999999999999999999999975422111111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 679 (702)
......... ...+...+..+.+++.+||+.||++||+ ++++++.
T Consensus 213 ~~~~~~~~~------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 213 VDRRVKEDQ------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHhhccc------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 111111110 1223345668889999999999999997 7888873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=275.42 Aligned_cols=194 Identities=21% Similarity=0.292 Sum_probs=155.0
Q ss_pred eeeEEEEEec----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYKHR----SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIl 545 (702)
|+++++++.+ ....++||||+++|+|.+++.+.. .+++.....++.|++.||+|||+ . +++||||||+||+
T Consensus 80 Iv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~---~~~Hrdlkp~nil 155 (283)
T PHA02988 80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYT---NKPYKNLTSVSFL 155 (283)
T ss_pred EEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcC---CCCCCcCChhhEE
Confidence 7888877755 457899999999999999998754 68899999999999999999997 4 7889999999999
Q ss_pred EeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 546 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
+++++.+||+|||+++...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... .+
T Consensus 156 l~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~ 229 (283)
T PHA02988 156 VTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KE 229 (283)
T ss_pred ECCCCcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HH
Confidence 9999999999999988653322 23457889999999876 6889999999999999999999999974411 11
Q ss_pred hhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 624 VLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
........... ...+...++.+.+++.+||+.||++|||++|+++.|+...
T Consensus 230 ------~~~~i~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 230 ------IYDLIINKNNS----LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ------HHHHHHhcCCC----CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 11111111111 1122234667899999999999999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=283.06 Aligned_cols=213 Identities=22% Similarity=0.294 Sum_probs=178.0
Q ss_pred ccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 447 DKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
.-..||+|.| ||+|.... ..||+| |+.++++|++..+.++|.||+.|
T Consensus 6 v~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g 85 (808)
T KOG0597|consen 6 VYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG 85 (808)
T ss_pred HHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh
Confidence 3456777877 88887665 566665 88889999999999999999987
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
+|..+|...+ .++++.+..++.+++.||.|||++ +|+|||+||.|||++..+.+|++|||+|+.+.. .+...+.
T Consensus 86 -~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~vlts 159 (808)
T KOG0597|consen 86 -DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSVLTS 159 (808)
T ss_pred -hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cceeeee
Confidence 9999998766 899999999999999999999999 999999999999999999999999999998754 3445677
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
+.|||-|||||...+++|+..+|+||+|||+||+.+|++||... .+.. ....+.... + ..+...+.
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-------si~~-Lv~~I~~d~----v--~~p~~~S~ 225 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-------SITQ-LVKSILKDP----V--KPPSTASS 225 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-------HHHH-HHHHHhcCC----C--CCcccccH
Confidence 89999999999999999999999999999999999999999643 1111 111111111 1 23446788
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+.+++...|++||.+|.+..+++..
T Consensus 226 ~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 226 SFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred HHHHHHHHHhhcChhhcccHHHHhcC
Confidence 89999999999999999999998863
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=281.05 Aligned_cols=189 Identities=22% Similarity=0.292 Sum_probs=154.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++...++.++..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 57 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~ 132 (323)
T cd05571 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDG 132 (323)
T ss_pred CCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCC
Confidence 6778888999999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... .
T Consensus 133 ~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~-~---- 203 (323)
T cd05571 133 HIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEK-L---- 203 (323)
T ss_pred CEEEeeCCCCcccccCC-CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHH-H----
Confidence 99999999987532221 22334679999999999998899999999999999999999999996431 111 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
......... ..+......+.+++.+||+.||++|| +++++++
T Consensus 204 ~~~~~~~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 204 FELILMEEI------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHcCCC------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111111111 12334566788999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=280.39 Aligned_cols=195 Identities=19% Similarity=0.243 Sum_probs=154.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~ 142 (332)
T cd05614 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEG 142 (332)
T ss_pred cccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCC
Confidence 6777788899999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++...............||+.|+|||.+.+. .++.++|||||||++|||++|+.||.............
T Consensus 143 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~-- 220 (332)
T cd05614 143 HVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS-- 220 (332)
T ss_pred CEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--
Confidence 999999999986544333333456799999999988765 47889999999999999999999997542222111111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
...... +...+......+.+++.+||+.||++|| +++++++.
T Consensus 221 --~~~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 221 --RRILKC------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --HHHhcC------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111111 1122233456788999999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=281.62 Aligned_cols=195 Identities=24% Similarity=0.251 Sum_probs=155.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..|+||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~ 138 (333)
T cd05600 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASG 138 (333)
T ss_pred CccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCC
Confidence 7778889999999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++..... ......|++.|+|||++.+..++.++|||||||++|||++|..||...........+..
T Consensus 139 ~~kL~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-- 212 (333)
T cd05600 139 HIKLTDFGLSKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY-- 212 (333)
T ss_pred CEEEEeCcCCccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh--
Confidence 999999999986533 22345689999999999988999999999999999999999999975421110000000
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. ................+..+.+++.+||+.+|++||+++++++.
T Consensus 213 ---~-~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 213 ---W-KETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---c-cccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 00000000001112346788899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-31 Score=274.14 Aligned_cols=204 Identities=20% Similarity=0.190 Sum_probs=152.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||++++.|..+.. ....+++..+..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~ 137 (287)
T cd07848 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHND 137 (287)
T ss_pred ccchhhhEecCCEEEEEEecCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCC
Confidence 6777788888999999999999887765544 334689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++...............|++.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (287)
T cd07848 138 VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217 (287)
T ss_pred cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999998764333323334568999999999988889999999999999999999999997542111100000000
Q ss_pred -------HHh-hhcccccccccc----------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 -------YNC-FVAGEFNKLVEE----------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 -------~~~-~~~~~~~~~~~~----------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... ...........+ ......+..+.+++.+||+.||++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 218 GPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 000000000000 011224567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=270.19 Aligned_cols=197 Identities=20% Similarity=0.235 Sum_probs=157.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..+++.++||||+++|+|.+++......+++.+++.++.||+.||+|||++ +++||||||+||+++.++
T Consensus 68 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~ 144 (266)
T cd05064 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDL 144 (266)
T ss_pred cCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCC
Confidence 78888899999999999999999999999987665789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+|++|||.+...............++..|+|||.+.+..++.++||||||+++||+++ |+.||...... ..
T Consensus 145 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~--- 217 (266)
T cd05064 145 VCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DV--- 217 (266)
T ss_pred cEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HH---
Confidence 99999999876532222111112334678999999988899999999999999999775 99999643111 11
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
......+.. ...+...+..+.+++.+||+.+|++||++++|++.|+++
T Consensus 218 -~~~~~~~~~-----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 -IKAVEDGFR-----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -HHHHHCCCC-----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111111111 112233456788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=272.62 Aligned_cols=187 Identities=20% Similarity=0.322 Sum_probs=163.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE-eCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI-DDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll-~~~ 549 (702)
|++|++...+...+|||+|.-++|+|.++|.++...+.++.+.+++.||+.|+.|+|+. .+|||||||+|+.+ ..-
T Consensus 79 iVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKl 155 (864)
T KOG4717|consen 79 IVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKL 155 (864)
T ss_pred eeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeec
Confidence 99999999999999999999999999999999988999999999999999999999999 99999999999876 677
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCC-ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT-VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
|.+||.|||++..+...+. ....+|+..|.|||++.+..|+ +++||||||||||.|++|+.||+.....+.
T Consensus 156 GlVKLTDFGFSNkf~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------ 227 (864)
T KOG4717|consen 156 GLVKLTDFGFSNKFQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------ 227 (864)
T ss_pred CceEeeeccccccCCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------
Confidence 8999999999987755443 5677899999999999998886 678999999999999999999975522211
Q ss_pred HHHHhhhcccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEE--EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+..+++- .++...+.++.+||..||+.||.+|.+.+||+.
T Consensus 228 ----------LTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 228 ----------LTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----------hhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1122333 457788999999999999999999999999875
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=280.17 Aligned_cols=194 Identities=24% Similarity=0.260 Sum_probs=154.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++|+|.+++......+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~ 139 (330)
T cd05601 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTG 139 (330)
T ss_pred CcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCC
Confidence 67777888899999999999999999999988755799999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc------CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN------SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
.+||+|||++...............||+.|+|||++. ...++.++|||||||++|||++|+.||.......
T Consensus 140 ~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--- 216 (330)
T cd05601 140 HIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--- 216 (330)
T ss_pred CEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---
Confidence 9999999999876544433333456899999999876 4567899999999999999999999996442111
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ...+.... ..............+.+++..||+ +|++||+++++++
T Consensus 217 ~-----~~~i~~~~--~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 217 T-----YNNIMNFQ--RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred H-----HHHHHcCC--CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 11111110 001111112345678889999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=277.86 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=153.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++...++.++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 57 iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~ 132 (328)
T cd05593 57 LTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDG 132 (328)
T ss_pred CcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCC
Confidence 6777888999999999999999999999987654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .+ .
T Consensus 133 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--~~--~---- 203 (328)
T cd05593 133 HIKITDFGLCKEGITDA-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EK--L---- 203 (328)
T ss_pred cEEEecCcCCccCCCcc-cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--HH--H----
Confidence 99999999987532221 223345689999999999888899999999999999999999999964311 11 0
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
........ ...+......+.+++.+||+.||++|| +++|+++.
T Consensus 204 ~~~~~~~~------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 204 FELILMED------IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHhccCC------ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 11111111 112233456788999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.37 Aligned_cols=189 Identities=23% Similarity=0.340 Sum_probs=152.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 58 i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~ 133 (316)
T cd05592 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDG 133 (316)
T ss_pred ccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCC
Confidence 6778888899999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ...
T Consensus 134 ~~kL~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~----- 204 (316)
T cd05592 134 HIKIADFGMCKENMNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DEL----- 204 (316)
T ss_pred CEEEccCcCCeECCCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHH-----
Confidence 99999999998643222 223345689999999999988899999999999999999999999975411 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMK-NVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~ 678 (702)
....... ....+......+.+++.+||+.||++||++. ++++
T Consensus 205 ~~~i~~~------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 205 FDSILND------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHcC------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1111111 0112233456778899999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=276.55 Aligned_cols=189 Identities=22% Similarity=0.223 Sum_probs=152.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+.+++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 55 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~ 130 (312)
T cd05585 55 IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQG 130 (312)
T ss_pred EeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCC
Confidence 7888889999999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .. .
T Consensus 131 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~---~~-----~ 201 (312)
T cd05585 131 HIALCDFGLCKLNMKDD-DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV---NE-----M 201 (312)
T ss_pred cEEEEECcccccCccCC-CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH---HH-----H
Confidence 99999999987543222 223345689999999999988999999999999999999999999964311 11 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS---MKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl~ 678 (702)
......... ..+......+.+++.+||+.||++||+ +.|++.
T Consensus 202 ~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 202 YRKILQEPL------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred HHHHHcCCC------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111111111 122344567889999999999999986 455543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=266.74 Aligned_cols=197 Identities=25% Similarity=0.410 Sum_probs=157.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+..++..++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.+
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~ 139 (261)
T cd05072 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSES 139 (261)
T ss_pred eeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCC
Confidence 788888888999999999999999999999754 34588899999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++...............++..|+|||.+....++.++||||||+++|+|++ |..||...... ....
T Consensus 140 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~ 215 (261)
T cd05072 140 LMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMS 215 (261)
T ss_pred CcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHH
Confidence 999999999998764333222223345678999999988889999999999999999998 99999643111 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
. .... .. .+.....+..+.+++.+||+.+|++||++++++++|++.
T Consensus 216 ~----~~~~-~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 216 A----LQRG-YR----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred H----HHcC-CC----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1 1111 00 111122456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=276.46 Aligned_cols=184 Identities=24% Similarity=0.365 Sum_probs=150.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++..+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 58 iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~ 133 (320)
T cd05590 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEG 133 (320)
T ss_pred hhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCC
Confidence 6778888999999999999999999999987654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... . . .
T Consensus 134 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~-~----~ 204 (320)
T cd05590 134 HCKLADFGMCKEGIFNG-KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---D-D----L 204 (320)
T ss_pred cEEEeeCCCCeecCcCC-CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---H-H----H
Confidence 99999999987542222 123345689999999999988999999999999999999999999964411 1 1 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
...+..... ..+......+.+++.+||+.||++||++
T Consensus 205 ~~~i~~~~~------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 205 FEAILNDEV------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHhcCCC------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 111111111 1122345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=282.37 Aligned_cols=199 Identities=27% Similarity=0.406 Sum_probs=155.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----------------------------------------------
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------------------------------------- 504 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------- 504 (702)
|+++++.+..++..++||||+++|+|.+++....
T Consensus 104 Iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (374)
T cd05106 104 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVE 183 (374)
T ss_pred eeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccc
Confidence 7888889999999999999999999999986421
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 505 -----------------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 505 -----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
..+++.+++.++.||++||+|||++ +|+||||||+||++++++.+||+|||++.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~ 260 (374)
T cd05106 184 MRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR 260 (374)
T ss_pred cCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeee
Confidence 1367788899999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccc
Q 038002 562 LLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639 (702)
Q Consensus 562 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (702)
......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||....... .. ......+ .
T Consensus 261 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~----~~~~~~~-~ 332 (374)
T cd05106 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KF----YKMVKRG-Y 332 (374)
T ss_pred eccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HH----HHHHHcc-c
Confidence 654332211 122335668999999988899999999999999999997 999996542111 11 1111111 1
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 640 NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 640 ~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
. ...+...+..+.+++.+||+.||++||++++|+++|+++.
T Consensus 333 ~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 333 Q----MSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred C----ccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0 0111123467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=275.90 Aligned_cols=188 Identities=23% Similarity=0.318 Sum_probs=151.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++++++.|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 58 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~ 133 (316)
T cd05620 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDG 133 (316)
T ss_pred ccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCC
Confidence 6778888999999999999999999999987654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||..... .. .
T Consensus 134 ~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~-~---- 204 (316)
T cd05620 134 HIKIADFGMCKENVFG-DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DE-L---- 204 (316)
T ss_pred CEEeCccCCCeecccC-CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HH-H----
Confidence 9999999998753221 1223446789999999999988999999999999999999999999964311 11 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMK-NVI 677 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl 677 (702)
....... ....+......+.+++.+||+.||++||++. +++
T Consensus 205 ~~~~~~~------~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 205 FESIRVD------TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHhC------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111111 0111223456788999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=269.42 Aligned_cols=203 Identities=20% Similarity=0.223 Sum_probs=151.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.+++..++||||+++ +|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 65 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~ 140 (288)
T cd07871 65 IVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKG 140 (288)
T ss_pred EeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCC
Confidence 78888889999999999999975 99999877665688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++....... .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||...............
T Consensus 141 ~~kl~DfG~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (288)
T cd07871 141 ELKLADFGLARAKSVPT-KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL 219 (288)
T ss_pred CEEECcCcceeeccCCC-ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999997653222 12234567899999998765 56899999999999999999999999754221111000000
Q ss_pred -------HHHhhh-cccccccccc--------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 -------VYNCFV-AGEFNKLVEE--------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 -------~~~~~~-~~~~~~~~~~--------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+.... ...+.....+ .........+++++.+||+.||.+|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 220 LGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 0000000000 001123457889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=273.13 Aligned_cols=191 Identities=20% Similarity=0.325 Sum_probs=151.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.++..++..+..++||||+++|+|.+++...+ .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 58 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~ 133 (327)
T cd05617 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADG 133 (327)
T ss_pred EeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCC
Confidence 7788889999999999999999999999887654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~ 211 (327)
T cd05617 134 HIKLTDYGMCKEGLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYL 211 (327)
T ss_pred CEEEeccccceeccCCC-CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHH
Confidence 99999999987532221 223346789999999999989999999999999999999999999965322111 1111112
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
......... ..+...+..+.+++.+||+.||++||++
T Consensus 212 ~~~~~~~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 212 FQVILEKPI------RIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHhCCC------CCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 222221111 1222345677899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=275.68 Aligned_cols=189 Identities=22% Similarity=0.315 Sum_probs=150.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 138 (324)
T cd05587 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEG 138 (324)
T ss_pred eeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCC
Confidence 5667788888999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 139 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~----- 209 (324)
T cd05587 139 HIKIADFGMCKENIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DEL----- 209 (324)
T ss_pred CEEEeecCcceecCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHH-----
Confidence 99999999987532221 123345689999999999988999999999999999999999999964311 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM-----KNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~ 678 (702)
........ ...+......+.+++.+||+.||.+|++. +++++
T Consensus 210 ~~~i~~~~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 210 FQSIMEHN------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred HHHHHcCC------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11111111 11222345678899999999999999986 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=274.78 Aligned_cols=192 Identities=19% Similarity=0.319 Sum_probs=151.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||+++|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 58 iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~ 133 (329)
T cd05618 58 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEG 133 (329)
T ss_pred CCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCC
Confidence 7788888999999999999999999999887654 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcc-hhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD-EVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~ 629 (702)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ......+
T Consensus 134 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05618 134 HIKLTDYGMCKEGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212 (329)
T ss_pred CEEEeeCCccccccCCC-CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH
Confidence 99999999987532221 123346789999999999998999999999999999999999999964311111 1111122
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
.......... .++......+.+++.+||+.||++||++
T Consensus 213 ~~~~i~~~~~------~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 213 LFQVILEKQI------RIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHhcCCC------CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2222222111 1233445678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=276.65 Aligned_cols=190 Identities=21% Similarity=0.286 Sum_probs=153.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..|+||||+++++|.+.+.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 58 i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~ 133 (321)
T cd05591 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEG 133 (321)
T ss_pred ccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 6778889999999999999999999999987654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ...
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~----- 204 (321)
T cd05591 134 HCKLADFGMCKEGILNG-VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDL----- 204 (321)
T ss_pred CEEEeecccceecccCC-ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHH-----
Confidence 99999999987543222 223345689999999999988999999999999999999999999975421 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-------SMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-------t~~evl~~ 679 (702)
......... ..+......+.+++.+||+.||++|| +++++++.
T Consensus 205 ~~~i~~~~~------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 205 FESILHDDV------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHcCCC------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 111111111 11222356788999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=271.59 Aligned_cols=203 Identities=20% Similarity=0.209 Sum_probs=149.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.++.+++..++||||++ ++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 65 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 140 (303)
T cd07869 65 IVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTG 140 (303)
T ss_pred cCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence 6777888999999999999995 688888877666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++....... .......+++.|+|||++.+ ..++.++|||||||++|||++|..||.......+.......
T Consensus 141 ~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 219 (303)
T cd07869 141 ELKLADFGLARAKSVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFL 219 (303)
T ss_pred CEEECCCCcceeccCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHH
Confidence 99999999987543222 12234567899999998765 46789999999999999999999999754221111110000
Q ss_pred HHHhhhcc--------------cccccccccc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVAG--------------EFNKLVEEEV-----DKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~--------------~~~~~~~~~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ .......... .......+.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 220 VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 0000000000 0012356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=270.15 Aligned_cols=203 Identities=24% Similarity=0.304 Sum_probs=153.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE------------------TRPLWRDRVRIALDVARGLLYLHDECEV 532 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~ 532 (702)
|+++++++.+.+..++||||+++++|.+++.... ..+++.++..++.||+.||+|||+.
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 8888999999999999999999999999986432 1357788899999999999999999
Q ss_pred CeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh--
Q 038002 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-- 609 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-- 609 (702)
+|+||||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 9999999999999999999999999999865333221 1223445778999999888889999999999999999987
Q ss_pred CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 610 CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 610 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
+..||..... .+ .. ............. .....+...+..+.+++.+||+.||++|||+++|.+.|++
T Consensus 238 ~~~p~~~~~~--~~-~~-~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 238 KEQPYGELTD--EQ-VI-ENAGEFFRDQGRQ--VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCCcCCH--HH-HH-HHHHHHhhhcccc--ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5567754311 11 11 1111111111000 0011122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=275.39 Aligned_cols=213 Identities=22% Similarity=0.219 Sum_probs=168.1
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEec
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+...+.||+|++ ||++.... ..+|+| |++++..+..++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 444567787776 77666543 444444 77888899999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 100 VVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred CCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 99999999998654 688899999999999999999999 99999999999999999999999999998763322
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .. .......+.. ..+..
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~----~~----~~~~i~~~~~------~~p~~ 237 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP----FR----IYEKILAGRL------KFPNW 237 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH----HH----HHHHHhcCCc------CCCCC
Confidence 235689999999999988899999999999999999999999964311 11 1111222211 11222
Q ss_pred HHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPS-----MKNVILM 679 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 679 (702)
....+.+++.+||+.||++||+ ++++++.
T Consensus 238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 3457889999999999999997 6777743
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=274.94 Aligned_cols=214 Identities=22% Similarity=0.186 Sum_probs=170.4
Q ss_pred cccccceEEEeEE--EEEeeeeh---hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF---LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~---~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
.+...+.||+|++ ||++.... ..+|+| |+++++++.+++..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 3445678888887 77775432 234544 788889999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 111 Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-- 184 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-- 184 (340)
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence 9999999999997655 688999999999999999999999 9999999999999999999999999999875322
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
.....||+.|+|||++.+..++.++|||||||++|||++|..||..... .. .......+.. ..+
T Consensus 185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~----~~~~i~~~~~------~~p 248 (340)
T PTZ00426 185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LL----IYQKILEGII------YFP 248 (340)
T ss_pred --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HH----HHHHHhcCCC------CCC
Confidence 2345689999999999888899999999999999999999999964311 11 1111222211 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
......+.+++.+||+.||++|+ +++++++.
T Consensus 249 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 23345678999999999999995 89988775
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=274.29 Aligned_cols=197 Identities=19% Similarity=0.309 Sum_probs=154.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 58 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~ 133 (329)
T cd05588 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEG 133 (329)
T ss_pred CCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCC
Confidence 7788889999999999999999999999887654 799999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcc-hhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD-EVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~~ 629 (702)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+
T Consensus 134 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05588 134 HIKLTDYGMCKEGIRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212 (329)
T ss_pred CEEECcCccccccccCC-CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH
Confidence 99999999987432211 223346789999999999988999999999999999999999999974321110 1111122
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS------MKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt------~~evl~ 678 (702)
.......... ..+......+.+++.+||+.||.+||+ ++++++
T Consensus 213 ~~~~~~~~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 213 LFQVILEKQI------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHcCCC------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 2222222211 122234567889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=274.60 Aligned_cols=200 Identities=25% Similarity=0.338 Sum_probs=154.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++
T Consensus 65 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~ 141 (331)
T cd06649 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRG 141 (331)
T ss_pred CCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCC
Confidence 7888888999999999999999999999997654 6889999999999999999999851 699999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... +....
T Consensus 142 ~~kl~Dfg~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~ 214 (331)
T cd06649 142 EIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIF 214 (331)
T ss_pred cEEEccCcccccccccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHh
Confidence 99999999987653322 234568999999999998899999999999999999999999996432110 00000
Q ss_pred HHhhhcc----------------------------------cccccc---cc-ccCHHHHHHHHHHHHHcccCCCCCCCC
Q 038002 631 YNCFVAG----------------------------------EFNKLV---EE-EVDKITLERMVKTGLLCIQDEPNLRPS 672 (702)
Q Consensus 631 ~~~~~~~----------------------------------~~~~~~---~~-~~~~~~~~~l~~li~~cL~~dP~~RPt 672 (702)
....... ...... .+ .........+.+++.+||+.||++|||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt 294 (331)
T cd06649 215 GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD 294 (331)
T ss_pred cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC
Confidence 0000000 000000 00 001134567999999999999999999
Q ss_pred HHHHHHHH
Q 038002 673 MKNVILML 680 (702)
Q Consensus 673 ~~evl~~L 680 (702)
++||++..
T Consensus 295 ~~ell~h~ 302 (331)
T cd06649 295 LKMLMNHT 302 (331)
T ss_pred HHHHhcCh
Confidence 99998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=280.79 Aligned_cols=194 Identities=23% Similarity=0.261 Sum_probs=154.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++++++.++||||+++++|.+++... ..+++..+..++.||+.||+|||++ ||+||||||+||+++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~ 138 (350)
T cd05573 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADG 138 (350)
T ss_pred ccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 667777888899999999999999999999876 4789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCC----------------------------CceeeceeccccccCcccccCCCCCccccccchhH
Q 038002 551 RAKISDFGLAKLLMPNQ----------------------------TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 602 (702)
.+||+|||++....... ........||+.|+|||.+.+..++.++|||||||
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 218 (350)
T cd05573 139 HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218 (350)
T ss_pred CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecch
Confidence 99999999998664332 11223456899999999999999999999999999
Q ss_pred hHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 038002 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-MKNVILM 679 (702)
Q Consensus 603 il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~ 679 (702)
++|||++|+.||....... ....+.... ...........+..+.+++.+||+ ||.+||+ ++++++.
T Consensus 219 il~ell~g~~Pf~~~~~~~--------~~~~i~~~~--~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 219 ILYEMLYGFPPFYSDTLQE--------TYNKIINWK--ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred hhhhhccCCCCCCCCCHHH--------HHHHHhccC--CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 9999999999997542110 011111100 000001111146778889999998 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=275.14 Aligned_cols=184 Identities=24% Similarity=0.332 Sum_probs=149.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~ 138 (323)
T cd05616 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEG 138 (323)
T ss_pred EeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCC
Confidence 5667788899999999999999999999987654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 139 ~~kL~DfG~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~----- 209 (323)
T cd05616 139 HIKIADFGMCKENMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DEL----- 209 (323)
T ss_pred cEEEccCCCceecCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHH-----
Confidence 99999999987543222 123345689999999999999999999999999999999999999964311 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
...+..... ..+......+.+++.+||+.||++|++.
T Consensus 210 ~~~i~~~~~------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 210 FQSIMEHNV------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHhCCC------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111111111 1223345678899999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=264.74 Aligned_cols=215 Identities=25% Similarity=0.249 Sum_probs=176.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..++..+.||+|+| ||....+. ..+|.| |+.+.-.|++.+.++|||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 34556789999999 77666654 777876 888889999999999999
Q ss_pred ecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 489 EFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
..|.||+|.-+|.+.+. .+++..++-++.+|+.||++||.+ +||.|||||+|||+|+.|+++|+|+|+|..+...+
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~ 341 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK 341 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCC
Confidence 99999999999988754 588999999999999999999999 99999999999999999999999999999886555
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
. .....||.+|||||++.+..|+...|.|||||++|||+.|+.||........ .+-+.+...+ ...++
T Consensus 342 ~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----~eEvdrr~~~------~~~ey 409 (591)
T KOG0986|consen 342 P--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----REEVDRRTLE------DPEEY 409 (591)
T ss_pred c--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----HHHHHHHHhc------chhhc
Confidence 4 3344799999999999999999999999999999999999999975421110 0011111111 11245
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPS 672 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt 672 (702)
+...++++..+....|+.||++|.-
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhcc
Confidence 6677888889988999999999953
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=275.60 Aligned_cols=189 Identities=23% Similarity=0.298 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 57 i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 132 (323)
T cd05595 57 LTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDG 132 (323)
T ss_pred CcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCC
Confidence 6778888999999999999999999999887654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ....
T Consensus 133 ~~kL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~---- 204 (323)
T cd05595 133 HIKITDFGLCKEGISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLF---- 204 (323)
T ss_pred CEEecccHHhccccCCC-CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHH----
Confidence 99999999987532221 122345689999999999988999999999999999999999999964311 1111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
........ ..+......+.+++.+||+.||++|| ++.++++
T Consensus 205 -~~~~~~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 205 -ELILMEEI------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -HHHhcCCC------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 11111111 12233456788999999999999998 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-30 Score=263.65 Aligned_cols=195 Identities=24% Similarity=0.358 Sum_probs=155.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.++..++..++||||+++|+|.+++......+++..+..++.|++.||+|||++ +|+|+||||+||+++.++
T Consensus 61 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~ 137 (256)
T cd05114 61 LVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTG 137 (256)
T ss_pred ceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCC
Confidence 78888899999999999999999999999976555688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||.+...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .....
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~----~~~~~- 212 (256)
T cd05114 138 VVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN----YEVVE- 212 (256)
T ss_pred eEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHH-
Confidence 99999999987653322222222335568999999988889999999999999999999 8999964311 11111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
....+.. . ..+......+.+++.+||+.+|++||++++++++|.
T Consensus 213 ---~i~~~~~--~---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 213 ---MISRGFR--L---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred ---HHHCCCC--C---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111110 0 111223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=278.97 Aligned_cols=195 Identities=21% Similarity=0.236 Sum_probs=148.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++++++.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++
T Consensus 63 iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~ 138 (381)
T cd05626 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDG 138 (381)
T ss_pred eeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCC
Confidence 8888899999999999999999999999997654 688889999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC----------------------------------------------ceeeceeccccccCcc
Q 038002 551 RAKISDFGLAKLLMPNQT----------------------------------------------GIVAGVRGSRGYMAPE 584 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~----------------------------------------------~~~~~~~gt~~y~aPE 584 (702)
++||+|||++..+..... .......||+.|+|||
T Consensus 139 ~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 218 (381)
T cd05626 139 HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218 (381)
T ss_pred CEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHH
Confidence 999999999764311000 0012356999999999
Q ss_pred cccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHH--c
Q 038002 585 WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLL--C 662 (702)
Q Consensus 585 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--c 662 (702)
.+.+..++.++|||||||++|||++|+.||.............. ...... . ........++.+++.+ |
T Consensus 219 ~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~------~~~~~~--~--~~~~~~s~~~~dli~~ll~ 288 (381)
T cd05626 219 VLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVIN------WENTLH--I--PPQVKLSPEAVDLITKLCC 288 (381)
T ss_pred HHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHc------cccccC--C--CCCCCCCHHHHHHHHHHcc
Confidence 99888899999999999999999999999975421111110000 000000 0 0111234566777776 4
Q ss_pred ccCCCCCCCCHHHHHHH
Q 038002 663 IQDEPNLRPSMKNVILM 679 (702)
Q Consensus 663 L~~dP~~RPt~~evl~~ 679 (702)
+..+|..||+++++++.
T Consensus 289 ~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 289 SAEERLGRNGADDIKAH 305 (381)
T ss_pred CcccccCCCCHHHHhcC
Confidence 56666679999999874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=250.96 Aligned_cols=192 Identities=27% Similarity=0.306 Sum_probs=148.5
Q ss_pred CCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecc
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDF 557 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 557 (702)
.+..||+++|+..|+|.+.+... +..+++.+++.|+.+|++||++||+. .+.+.||||||.|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 56799999999999999998754 33589999999999999999999998 223999999999999999999999999
Q ss_pred cceeecCCCCCc--------eeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 558 GLAKLLMPNQTG--------IVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 558 g~a~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
|.+......-.. .......|..|+|||.+. +...++++|||||||+||+|+.|..||+..........+
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL 253 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL 253 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE
Confidence 999765321111 112345799999999764 557789999999999999999999999754222111111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.. ..+.+ .-.-....++.+.+++++||+.||.+||++.+++..++..
T Consensus 254 Av------~n~q~----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 254 AV------QNAQI----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ee------ecccc----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 10 01111 0011223788999999999999999999999999998865
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=276.28 Aligned_cols=190 Identities=22% Similarity=0.294 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++...+..++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||+ . +|+||||||+|||++.+
T Consensus 57 i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~ 132 (325)
T cd05594 57 LTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKD 132 (325)
T ss_pred CCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCC
Confidence 6778888999999999999999999999887654 68999999999999999999997 7 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +. .
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~-~--- 204 (325)
T cd05594 133 GHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EK-L--- 204 (325)
T ss_pred CCEEEecCCCCeecCCCCc-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HH-H---
Confidence 9999999999875432221 22345689999999999888999999999999999999999999964311 11 0
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
......... ..+......+.+++.+||+.||++|+ ++.++++.
T Consensus 205 -~~~i~~~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 205 -FELILMEEI------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred -HHHHhcCCC------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111111111 11223456788999999999999996 89998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-30 Score=278.37 Aligned_cols=230 Identities=18% Similarity=0.119 Sum_probs=169.3
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh---------------------eeeEEEEEecCCeeEEEEecCCCCCHHH
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------ISSLLVYKHRSSKKLLVYEFMSKGSLAD 498 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~ 498 (702)
.+...++||+|++ ||++.... ..||+| |+++++.+..+...++|||++. ++|.+
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~ 171 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYC 171 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHH
Confidence 4555677888877 77666543 455555 8889999999999999999995 68998
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceeccc
Q 038002 499 LLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR 578 (702)
Q Consensus 499 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~ 578 (702)
++.... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...............||+
T Consensus 172 ~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~ 247 (391)
T PHA03212 172 YLAAKR-NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTI 247 (391)
T ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCcc
Confidence 887654 688999999999999999999999 9999999999999999999999999999754332222334467999
Q ss_pred cccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcc----hhhhHHHHHH---------------------h
Q 038002 579 GYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD----EVLLSTWVYN---------------------C 633 (702)
Q Consensus 579 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~~~~~---------------------~ 633 (702)
.|+|||++.+..++.++|||||||++|||++|..||........ ...+...... .
T Consensus 248 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~ 327 (391)
T PHA03212 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIG 327 (391)
T ss_pred CCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHH
Confidence 99999999888999999999999999999999988754321110 0000000000 0
Q ss_pred hhcccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 634 FVAGEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 634 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
............ .........+.+++.+||+.||++|||++|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 328 LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 001134567889999999999999999999986
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=273.87 Aligned_cols=187 Identities=24% Similarity=0.265 Sum_probs=151.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+.+++..++||||+++++|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~ 138 (291)
T cd05612 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEG 138 (291)
T ss_pred HhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCC
Confidence 5666677778999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++...... .....|++.|+|||++.+..++.++||||||+++|||++|+.||..... . . .
T Consensus 139 ~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~---~-~----~ 206 (291)
T cd05612 139 HIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP---F-G----I 206 (291)
T ss_pred CEEEEecCcchhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H-H----H
Confidence 9999999999865322 2234689999999999988899999999999999999999999965311 0 0 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 679 (702)
......+.. ..+......+.+++.+||+.||.+||+ ++++++.
T Consensus 207 ~~~i~~~~~------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 207 YEKILAGKL------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHhCCc------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111111 122233567889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=265.04 Aligned_cols=197 Identities=26% Similarity=0.360 Sum_probs=156.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+..++..++||||+++++|.+++.... ..+++..++.++.|+++||+|||++ +++||||||+||+++++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~ 140 (263)
T cd05052 64 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 140 (263)
T ss_pred hhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCC
Confidence 6777888888999999999999999999997643 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... ++
T Consensus 141 ~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~----- 213 (263)
T cd05052 141 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQ----- 213 (263)
T ss_pred CcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HH-----
Confidence 999999999998764332211122234567999999988889999999999999999998 9999864311 11
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
........ . ..+.+...+..+.+++.+||+.||++||++.+++++|+.+
T Consensus 214 -~~~~~~~~-~----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 214 -VYELLEKG-Y----RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -HHHHHHCC-C----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11111111 1 1122233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=279.83 Aligned_cols=198 Identities=25% Similarity=0.347 Sum_probs=155.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----------------------------------------------
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------------------------------------- 504 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------- 504 (702)
|+++++++..++..++||||+++|+|.+++....
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 180 (375)
T cd05104 101 IVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVP 180 (375)
T ss_pred eeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccc
Confidence 7888889999999999999999999999986432
Q ss_pred ----------------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 505 ----------------------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 505 ----------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~D 257 (375)
T cd05104 181 TKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICD 257 (375)
T ss_pred cccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEec
Confidence 1367788899999999999999999 999999999999999999999999
Q ss_pred ccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhh
Q 038002 557 FGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCF 634 (702)
Q Consensus 557 fg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 634 (702)
||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||....... ..... .
T Consensus 258 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~~~~~----~ 330 (375)
T cd05104 258 FGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---KFYKM----I 330 (375)
T ss_pred CccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---HHHHH----H
Confidence 99998664332211 122335667999999998899999999999999999998 888986431111 11111 1
Q ss_pred hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 635 VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
..+. .. ..+.....++.+++.+||+.||++||++.||+++|++.
T Consensus 331 ~~~~-~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 331 KEGY-RM----LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HhCc-cC----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111 00 11112345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=271.57 Aligned_cols=197 Identities=20% Similarity=0.198 Sum_probs=150.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.++..+++++..++||||+++|+|.+++.+....+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~ 139 (332)
T cd05623 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNG 139 (332)
T ss_pred EeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCC
Confidence 67777888999999999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.+||+|||++...............||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..
T Consensus 140 ~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~ 216 (332)
T cd05623 140 HIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ET 216 (332)
T ss_pred CEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HH
Confidence 9999999999765433332333457999999999875 346789999999999999999999999643110 01
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNL--RPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 679 (702)
............+ +......+..+.+++.+||..++++ |++++|+++.
T Consensus 217 -----~~~i~~~~~~~~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 217 -----YGKIMNHKERFQF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----HHHHhCCCccccC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111111100001 1111234567788888888654444 6899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-31 Score=263.50 Aligned_cols=228 Identities=24% Similarity=0.225 Sum_probs=173.8
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEec--CC---eeEEEEecCC
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHR--SS---KKLLVYEFMS 492 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~--~~---~~~lV~e~~~ 492 (702)
+...+.+|.|+| ||.|.+.. ..|||| |++|..+|.. ++ ...||||||+
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 445688999999 99998766 789998 8888866543 22 4568999998
Q ss_pred CCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-CcEEEecccceeecCCCCC
Q 038002 493 KGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS-WRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 493 ~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~~ 568 (702)
. +|.+.++.. +.+++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||+|||.|+.+...+.
T Consensus 106 ~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep 181 (364)
T KOG0658|consen 106 E-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP 181 (364)
T ss_pred H-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC
Confidence 7 999999852 44688888888999999999999999 99999999999999876 8999999999999866655
Q ss_pred ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHh--------hh----
Q 038002 569 GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC--------FV---- 635 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------~~---- 635 (702)
. .....|+.|+|||.+.+ ..|+.+.||||.||++.||+.|++-|.+.. ..++......+... +.
T Consensus 182 n--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 182 N--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred c--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 3 44567999999997765 589999999999999999999999998753 22222211111100 00
Q ss_pred cccccccccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 636 AGEFNKLVEE----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 636 ~~~~~~~~~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+...+.+... -.......+.++++.++|+++|.+|.++.|++..
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 0111111111 1234456788999999999999999999998863
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=273.77 Aligned_cols=185 Identities=22% Similarity=0.227 Sum_probs=149.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++.+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 58 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~ 133 (323)
T cd05575 58 LVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQG 133 (323)
T ss_pred CCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCC
Confidence 6778888899999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..... .. .
T Consensus 134 ~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~-----~ 204 (323)
T cd05575 134 HVVLTDFGLCKEGIEH-SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT---AE-----M 204 (323)
T ss_pred cEEEeccCCCcccccC-CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH---HH-----H
Confidence 9999999998753222 1223345689999999999988999999999999999999999999964311 10 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMK 674 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ 674 (702)
......... .........+.+++.+||+.||++||++.
T Consensus 205 ~~~i~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 205 YDNILNKPL------RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHcCCC------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111111111 11223466788999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=277.31 Aligned_cols=195 Identities=19% Similarity=0.234 Sum_probs=147.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++++...|+||||+++|+|.+++.+.. .+++.++..++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~ 138 (363)
T cd05628 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKG 138 (363)
T ss_pred cceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCC
Confidence 6778888999999999999999999999997654 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC----------------------------------ceeeceeccccccCcccccCCCCCcccc
Q 038002 551 RAKISDFGLAKLLMPNQT----------------------------------GIVAGVRGSRGYMAPEWQNSGLITVKSD 596 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 596 (702)
.+||+|||+++.+..... .......||+.|+|||++.+..++.++|
T Consensus 139 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~D 218 (363)
T cd05628 139 HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218 (363)
T ss_pred CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchh
Confidence 999999999875432110 0012356999999999999889999999
Q ss_pred ccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHccc--CCCCCCCCHH
Q 038002 597 VYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQ--DEPNLRPSMK 674 (702)
Q Consensus 597 iwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~--~dP~~RPt~~ 674 (702)
||||||++|||++|+.||....... ....+........+.+. ....+.+.+++.+++. .++..||+++
T Consensus 219 vwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ 288 (363)
T cd05628 219 WWSLGVIMYEMLIGYPPFCSETPQE--------TYKKVMNWKETLIFPPE--VPISEKAKDLILRFCCEWEHRIGAPGVE 288 (363)
T ss_pred hhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcCChhhcCCCCCHH
Confidence 9999999999999999996542111 11111111000011111 1124456666666543 3344568999
Q ss_pred HHHHH
Q 038002 675 NVILM 679 (702)
Q Consensus 675 evl~~ 679 (702)
||++.
T Consensus 289 ei~~h 293 (363)
T cd05628 289 EIKTN 293 (363)
T ss_pred HHhCC
Confidence 99875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=275.11 Aligned_cols=224 Identities=22% Similarity=0.289 Sum_probs=177.7
Q ss_pred cceEEEeEE--EEEeeeehhhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCCCCCH
Q 038002 448 KRKLLTVLA--GCLGSITFLCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL 496 (702)
..+||+|.| ||+|.... .|||| |+-+++++-+... .||+.+|+|-+|
T Consensus 397 ~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSL 474 (678)
T KOG0193|consen 397 GERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSL 474 (678)
T ss_pred cceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchh
Confidence 357999998 88887653 35555 6767788877777 999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC-CCceeecee
Q 038002 497 ADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN-QTGIVAGVR 575 (702)
Q Consensus 497 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~ 575 (702)
..+|+..+.+++....+.|++||++|+.|||.+ +|||+|||..||++.++++|||+|||++..-..- .........
T Consensus 475 Y~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~ 551 (678)
T KOG0193|consen 475 YTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPH 551 (678)
T ss_pred hhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCc
Confidence 999999888899999999999999999999999 9999999999999999999999999999764332 222334566
Q ss_pred ccccccCcccccC---CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 576 GSRGYMAPEWQNS---GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 576 gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
|..-|||||+++. .+|+..+||||||+++|||++|..||... ..+++... .-++.+..-+. .......
T Consensus 552 gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIifm------VGrG~l~pd~s-~~~s~~p 622 (678)
T KOG0193|consen 552 GSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIFM------VGRGYLMPDLS-KIRSNCP 622 (678)
T ss_pred cchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEEE------ecccccCccch-hhhccCH
Confidence 8889999998863 47899999999999999999999999732 22222111 11111111000 2234556
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.++.+|+..||..++++||.+.+|+.+|+.+..
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 788999999999999999999999999988765
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=272.50 Aligned_cols=189 Identities=24% Similarity=0.317 Sum_probs=151.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 58 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~ 133 (316)
T cd05619 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDG 133 (316)
T ss_pred CcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCC
Confidence 6778888999999999999999999999997653 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~----- 204 (316)
T cd05619 134 HIKIADFGMCKENMLGD-AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EEL----- 204 (316)
T ss_pred CEEEccCCcceECCCCC-CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHH-----
Confidence 99999999987542221 123345689999999999988999999999999999999999999964311 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMK-NVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~-evl~ 678 (702)
........ ...+......+.+++.+||+.||++||++. ++++
T Consensus 205 ~~~i~~~~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 205 FQSIRMDN------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHhCC------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11111110 111223456788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=265.78 Aligned_cols=197 Identities=25% Similarity=0.379 Sum_probs=158.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|++++.++...+..+++|||+++++|.+++.... ..+++.++..++.|++.||+|||++ +++
T Consensus 70 i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~ 146 (283)
T cd05048 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFV 146 (283)
T ss_pred cceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 7788888889999999999999999999997542 3477889999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
|+||||+||++++++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 147 H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p 226 (283)
T cd05048 147 HRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226 (283)
T ss_pred ccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999986533221 12233456788999999988889999999999999999998 9999
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
|...... + ....+..+... ..+...+.++.+++.+||+.||++||+++||+++|+++
T Consensus 227 ~~~~~~~--~------~~~~i~~~~~~-----~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 227 YYGFSNQ--E------VIEMIRSRQLL-----PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred CCCCCHH--H------HHHHHHcCCcC-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 9643211 1 11111222111 12334567899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=270.99 Aligned_cols=197 Identities=19% Similarity=0.192 Sum_probs=151.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..|+||||+++|+|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 63 i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~ 139 (331)
T cd05624 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNG 139 (331)
T ss_pred EeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCC
Confidence 67788889999999999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.+||+|||++...............|++.|+|||++.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 140 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~- 215 (331)
T cd05624 140 HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---E- 215 (331)
T ss_pred CEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH---H-
Confidence 99999999998765443333334569999999998865 46788999999999999999999999643111 0
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNL--RPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 679 (702)
.............+.. .....++.+.+++.+||..++++ |++++++++.
T Consensus 216 ----~~~~i~~~~~~~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 216 ----TYGKIMNHEERFQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----HHHHHHcCCCcccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 1111111110000111 11224567888899999866544 4678888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-31 Score=275.34 Aligned_cols=192 Identities=23% Similarity=0.344 Sum_probs=163.8
Q ss_pred eeeEEEEEecCCe-eEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSSK-KLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~-~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+.+...|..++. .+|||+|++||+|.+.|.+.+ ..++++.+..++.|++.|+.|||++ .|+|||||+.||++..
T Consensus 65 iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk 141 (426)
T KOG0589|consen 65 IVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTK 141 (426)
T ss_pred eeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccc
Confidence 8888888888887 999999999999999998876 4588999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
++.|||.|||+|+.+.... .......||+.|+.||++.+.+|..|+|||||||++|||++-+++|....... +
T Consensus 142 ~~~VkLgDfGlaK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----L-- 214 (426)
T KOG0589|consen 142 DKKVKLGDFGLAKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----L-- 214 (426)
T ss_pred cCceeecchhhhhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----H--
Confidence 9999999999999886544 23456789999999999999999999999999999999999999997552211 1
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...+.+. .-..++..++.++..++..||+.+|+.||++.+++.+
T Consensus 215 --i~ki~~~-----~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 215 --ILKINRG-----LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --HHHHhhc-----cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111111 1234566788899999999999999999999999875
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=276.06 Aligned_cols=166 Identities=27% Similarity=0.262 Sum_probs=144.6
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~lV 487 (702)
++.....||+|.| |.++.... +.|||| +++++++|...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 4556678999999 77777665 788988 89999999999999999
Q ss_pred EecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC--cEEEecccceeecC
Q 038002 488 YEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW--RAKISDFGLAKLLM 564 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~a~~~~ 564 (702)
+|.+.. +|.++|+...- .++...++.|+.||+.||.+||+. +|||+|||||||||.+-. .+||+|||.+....
T Consensus 267 fELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 267 FELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred ehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999954 99999987653 488999999999999999999999 999999999999995543 69999999998653
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
.. ......++.|+|||++.+.+|+.+.||||||||+.||++|.+.|.+.
T Consensus 343 q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 343 QR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred Cc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 22 23566789999999999999999999999999999999998888655
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-30 Score=261.92 Aligned_cols=195 Identities=24% Similarity=0.356 Sum_probs=156.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++...+..++||||+++++|.+++......+++.+++.++.||+.||+|||+. +++|+||||+||+++.++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~ 137 (256)
T cd05113 61 LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQG 137 (256)
T ss_pred eeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCC
Confidence 78888889889999999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||.++..............++..|+|||.+.+..++.++||||||+++|||++ |..||...... .
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~---- 209 (256)
T cd05113 138 CVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS----E---- 209 (256)
T ss_pred CEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----H----
Confidence 99999999988664333222222345678999999988889999999999999999998 99998643211 0
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.......+... ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 210 ~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 210 TVEKVSQGLRL-----YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHhcCCCC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11111111111 111223578899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.49 Aligned_cols=196 Identities=25% Similarity=0.370 Sum_probs=156.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++.++..++..++||||+++++|.+++.... ..+++.++..++.|++.||.+||+. +|+|+||||+||+++++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 139 (261)
T cd05068 63 LIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGEN 139 (261)
T ss_pred ccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCC
Confidence 7778888899999999999999999999997654 4588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++................+..|+|||.+.+..++.++||||||+++|||++ |+.||.... ....
T Consensus 140 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~--- 213 (261)
T cd05068 140 NICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEV--- 213 (261)
T ss_pred CCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHH---
Confidence 999999999998765322211222223457999999988889999999999999999999 999996431 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
....... .. ...+......+.+++.+||+.+|++||+++++++.||.
T Consensus 214 --~~~~~~~-~~----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 214 --LQQVDQG-YR----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --HHHHHcC-CC----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111111 00 11122345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-30 Score=272.10 Aligned_cols=188 Identities=21% Similarity=0.213 Sum_probs=151.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||+++|+|..++.... .+++.++..++.||+.||+|||+. ||+||||||+|||++.++
T Consensus 58 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~ 133 (325)
T cd05604 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQG 133 (325)
T ss_pred CccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCC
Confidence 7788889999999999999999999999887654 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++...... ........|++.|+|||.+.+..++.++|||||||++|||++|..||..... .. .
T Consensus 134 ~~kL~DfG~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~-----~ 204 (325)
T cd05604 134 HVVLTDFGLCKEGIAQ-SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV---AE-----M 204 (325)
T ss_pred CEEEeecCCcccCCCC-CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH---HH-----H
Confidence 9999999998753221 1223346689999999999998999999999999999999999999964311 11 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl 677 (702)
......... ...+.....+.+++.+||+.+|.+||++.+.+
T Consensus 205 ~~~~~~~~~------~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 205 YDNILHKPL------VLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred HHHHHcCCc------cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 111111111 11223456778899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-30 Score=274.15 Aligned_cols=189 Identities=22% Similarity=0.267 Sum_probs=151.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||+++++|.+++.... .+.+..+..++.||++||+|||++ ||+||||||+|||++.++
T Consensus 58 Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~ 133 (325)
T cd05602 58 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQG 133 (325)
T ss_pred CCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCC
Confidence 7788889999999999999999999999997654 678888889999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||..... ...
T Consensus 134 ~~kl~DfG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~----- 204 (325)
T cd05602 134 HIVLTDFGLCKENIEHN-GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEM----- 204 (325)
T ss_pred CEEEccCCCCcccccCC-CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHH-----
Confidence 99999999987542222 223346789999999999998999999999999999999999999964311 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......... .........+.+++.+||+.||.+||++.+.+.
T Consensus 205 ~~~i~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 205 YDNILNKPL------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHHHhCCc------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 111111111 122234567889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=264.78 Aligned_cols=194 Identities=29% Similarity=0.415 Sum_probs=149.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++++.+.+..++||||+++|+|.++|... ...+++.++..|+.||++||+|||++ +++|++|+++||+++++
T Consensus 63 i~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~ 139 (259)
T PF07714_consen 63 IVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSN 139 (259)
T ss_dssp BE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccc
Confidence 899999999888899999999999999999887 55799999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 550 WRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
+.+||+|||++........ ...........|+|||.+....++.++||||||+++|||++ |+.||... . ....
T Consensus 140 ~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--~--~~~~- 214 (259)
T PF07714_consen 140 GQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--D--NEEI- 214 (259)
T ss_dssp TEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--C--HHHH-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--c--cccc-
Confidence 9999999999987632222 12233456778999999988889999999999999999999 78888543 1 1111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
......+... ..+...+..+.+++.+||+.||++||++++|++.|
T Consensus 215 ---~~~~~~~~~~-----~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 215 ---IEKLKQGQRL-----PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---HHHHHTTEET-----TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cccccccccc-----eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111122111 11223456788999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-31 Score=248.23 Aligned_cols=192 Identities=20% Similarity=0.266 Sum_probs=156.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS- 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~- 549 (702)
|++|.....+++..|||+|+|.|++|..-|-.. .-.++..+-..++||+++|.|+|.+ +|||||+||+|+++...
T Consensus 72 IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~ 147 (355)
T KOG0033|consen 72 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKA 147 (355)
T ss_pred EeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeecc
Confidence 888888888899999999999999998776544 2578888899999999999999999 99999999999999443
Q ss_pred --CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 550 --WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 550 --~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.-+||+|||+|..+. .........|||+|+|||+++..+|+..+|||+.|||||-|+.|..||.... +.
T Consensus 148 ~~A~vKL~~FGvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~----~~--- 218 (355)
T KOG0033|consen 148 KGAAVKLADFGLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QH--- 218 (355)
T ss_pred CCCceeecccceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc----HH---
Confidence 359999999999876 3334556789999999999999999999999999999999999999997531 11
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+++.+..+...- +...-....+...+|+.+||..||.+|.|+.|.++
T Consensus 219 -rlye~I~~g~yd~--~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 219 -RLYEQIKAGAYDY--PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -HHHHHHhccccCC--CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 2344444443321 12223345778899999999999999999998775
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-30 Score=272.12 Aligned_cols=189 Identities=22% Similarity=0.297 Sum_probs=153.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.++..++.++||||+++++|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 58 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~ 133 (318)
T cd05570 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEG 133 (318)
T ss_pred ccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCC
Confidence 6778888999999999999999999999987654 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||.... ... .
T Consensus 134 ~~kl~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~-----~ 204 (318)
T cd05570 134 HIKIADFGMCKEGILGG-VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDE-----L 204 (318)
T ss_pred cEEecccCCCeecCcCC-CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHH-----H
Confidence 99999999987532222 12234568999999999999999999999999999999999999996431 111 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM-----KNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~ 678 (702)
......... ..+......+.+++.+||+.||++||++ .++++
T Consensus 205 ~~~i~~~~~------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 205 FQSILEDEV------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHHHcCCC------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111111111 1122345678899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=261.94 Aligned_cols=195 Identities=25% Similarity=0.372 Sum_probs=155.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.++...+..++||||+++++|.+++......+++..+..++.|++.||+|||+. +|+|+||||+||+++.++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~ 137 (256)
T cd05059 61 LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDN 137 (256)
T ss_pred EEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCC
Confidence 77888888999999999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||...... + ..
T Consensus 138 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~--~~-- 211 (256)
T cd05059 138 VVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--E--VV-- 211 (256)
T ss_pred cEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--H--HH--
Confidence 99999999988654322211122223457999999988889999999999999999999 89999643111 1 11
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
...... .....+...+..+.+++.+||+.+|++|||++|+++.|.
T Consensus 212 --~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 212 --ESVSAG-----YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred --HHHHcC-----CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 111111 011112234668999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=283.96 Aligned_cols=225 Identities=26% Similarity=0.320 Sum_probs=187.0
Q ss_pred ccceEEEeEE--EEEeeeeh-------hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 447 DKRKLLTVLA--GCLGSITF-------LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~-------~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+++||+|.| ||+|.... ..|||| |++|++.+.+++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 3578999999 88887654 578998 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 490 FMSKGSLADLLFNLE-------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
||..|||.+||.... ..++..+.+.|+.|||.|++||-++ .+|||||-..|.||.++..|||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecc
Confidence 999999999997432 1267889999999999999999999 999999999999999999999999
Q ss_pred ccceeecCCCCCceee-ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhh
Q 038002 557 FGLAKLLMPNQTGIVA-GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCF 634 (702)
Q Consensus 557 fg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 634 (702)
||+++.+-........ .-.-..+|||||.+..++++.++|||||||+|||+++ |+.|+...... .+.+.+
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~--------EVIe~i 718 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ--------EVIECI 718 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH--------HHHHHH
Confidence 9999876544433322 3345678999999999999999999999999999998 89999754211 133334
Q ss_pred hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 635 VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
..+.+. +.+...+.++.+||..||+.+|.+||++.||-.+|+...+..
T Consensus 719 ~~g~lL-----~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 719 RAGQLL-----SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HcCCcc-----cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 444441 335567789999999999999999999999999999876544
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=274.00 Aligned_cols=194 Identities=21% Similarity=0.214 Sum_probs=152.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 105 iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~ 179 (370)
T cd05596 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (370)
T ss_pred cceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCC
Confidence 777888899999999999999999999998653 578888999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC----CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG----LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.+||+|||++...............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .
T Consensus 180 ~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~-- 254 (370)
T cd05596 180 HLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---G-- 254 (370)
T ss_pred CEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---H--
Confidence 999999999987643332223345799999999987643 4789999999999999999999999754211 1
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNL--RPSMKNVILM 679 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 679 (702)
.+..+......... ......+..+.+++.+||+.+|++ ||+++|+++.
T Consensus 255 ---~~~~i~~~~~~~~~--~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 255 ---TYSKIMDHKNSLTF--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ---HHHHHHcCCCcCCC--CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111111100000 111234678889999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=261.37 Aligned_cols=197 Identities=24% Similarity=0.328 Sum_probs=158.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++......+++.++..++.|++.||+|||++ +|+|+||||+||++++++
T Consensus 67 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~ 143 (266)
T cd05033 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNL 143 (266)
T ss_pred cceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 77888888899999999999999999999987666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... . ...
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~-~~~- 218 (266)
T cd05033 144 VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---Q-DVI- 218 (266)
T ss_pred CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---H-HHH-
Confidence 9999999999877422221 1112334678999999988889999999999999999998 9999854311 1 111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
........ ...+...+..+.+++.+||+.+|++||+++||+++|+++
T Consensus 219 ---~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 219 ---KAVEDGYR-----LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---HHHHcCCC-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111100 011223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=260.84 Aligned_cols=219 Identities=19% Similarity=0.156 Sum_probs=174.8
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEec
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
++..++||.|.. ||++.+.. ..+|+| +..|+..|+.++..+|||||
T Consensus 79 f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~mey 158 (459)
T KOG0610|consen 79 FRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEY 158 (459)
T ss_pred HHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEec
Confidence 445577888755 88888876 667776 78899999999999999999
Q ss_pred CCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC----
Q 038002 491 MSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP---- 565 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~---- 565 (702)
|+||+|..+++++.. .+++..++-++.+++-||+|||.. |||.||||||||||.++|++.|+||.++.....
T Consensus 159 CpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 159 CPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred CCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999988754 489999999999999999999999 999999999999999999999999998754310
Q ss_pred -----------------------------C-CC---------------------ceeeceeccccccCcccccCCCCCcc
Q 038002 566 -----------------------------N-QT---------------------GIVAGVRGSRGYMAPEWQNSGLITVK 594 (702)
Q Consensus 566 -----------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~~~~ 594 (702)
. .. .....++||-.|+|||++++...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 00 01123669999999999999999999
Q ss_pred ccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC--
Q 038002 595 SDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-- 672 (702)
Q Consensus 595 ~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-- 672 (702)
+|+|+|||++|||+.|..||.+....+ .+...+.+ .. .-.-.+..+..+.+||+++|.+||.+|.-
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~---Tl~NIv~~-----~l----~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKE---TLRNIVGQ-----PL----KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchh---hHHHHhcC-----CC----cCCCCCcchhHHHHHHHHHhccChhhhhccc
Confidence 999999999999999999998763322 12221111 11 00112256788999999999999999988
Q ss_pred --HHHHHH
Q 038002 673 --MKNVIL 678 (702)
Q Consensus 673 --~~evl~ 678 (702)
+.||-+
T Consensus 384 rGA~eIK~ 391 (459)
T KOG0610|consen 384 RGAAEIKR 391 (459)
T ss_pred cchHHhhc
Confidence 777765
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=276.61 Aligned_cols=194 Identities=19% Similarity=0.198 Sum_probs=150.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~ 138 (364)
T cd05599 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKG 138 (364)
T ss_pred CcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCC
Confidence 7778889999999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCc-------------------------------------eeeceeccccccCcccccCCCCCc
Q 038002 551 RAKISDFGLAKLLMPNQTG-------------------------------------IVAGVRGSRGYMAPEWQNSGLITV 593 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 593 (702)
.+||+|||++..+...... ......||+.|+|||++....++.
T Consensus 139 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 218 (364)
T cd05599 139 HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK 218 (364)
T ss_pred CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCC
Confidence 9999999998764321100 011245899999999998889999
Q ss_pred cccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-
Q 038002 594 KSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS- 672 (702)
Q Consensus 594 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt- 672 (702)
++|||||||++|||++|..||...... + .. .............. ....++.+.+++.+|+. +|.+|++
T Consensus 219 ~~DiwSlG~il~el~~G~~Pf~~~~~~--~-~~-----~~i~~~~~~~~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~ 287 (364)
T cd05599 219 ECDWWSLGVIMYEMLVGYPPFCSDNPQ--E-TY-----RKIINWKETLQFPD--EVPLSPEAKDLIKRLCC-EAERRLGN 287 (364)
T ss_pred eeeeecchhHHHHhhcCCCCCCCCCHH--H-HH-----HHHHcCCCccCCCC--CCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence 999999999999999999999644211 0 00 11111000000011 11235677888888997 9999998
Q ss_pred --HHHHHHH
Q 038002 673 --MKNVILM 679 (702)
Q Consensus 673 --~~evl~~ 679 (702)
++|+++.
T Consensus 288 ~~~~~ll~h 296 (364)
T cd05599 288 NGVNEIKSH 296 (364)
T ss_pred CCHHHHhcC
Confidence 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=271.32 Aligned_cols=189 Identities=22% Similarity=0.250 Sum_probs=153.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..|+||||+++++|.+++.... .+.+..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~ 137 (323)
T cd05584 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQG 137 (323)
T ss_pred hhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCC
Confidence 7788888999999999999999999999997654 678888999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... .. .
T Consensus 138 ~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~-----~ 208 (323)
T cd05584 138 HVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KK-----T 208 (323)
T ss_pred CEEEeeCcCCeecccCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HH-----H
Confidence 999999999875432222 22345689999999999888899999999999999999999999965321 11 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
......+.. ..+......+.+++.+||+.||++|| +++++++
T Consensus 209 ~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 209 IDKILKGKL------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred HHHHHcCCC------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111111111 12233456788999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=273.86 Aligned_cols=190 Identities=25% Similarity=0.335 Sum_probs=146.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++++++.++..++||||+++++|.+.. ...+..+..++.||+.||+|||++ +|+||||||+|||+++++
T Consensus 134 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 205 (353)
T PLN00034 134 VVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAK 205 (353)
T ss_pred cceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCC
Confidence 778888899999999999999999986532 356778889999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.+||+|||++..+..... ......|+..|+|||.+.. ...+.++|||||||++|||++|+.||...........
T Consensus 206 ~~kL~DfG~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 284 (353)
T PLN00034 206 NVKIADFGVSRILAQTMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284 (353)
T ss_pred CEEEcccccceecccccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH
Confidence 999999999987643221 1234568999999998743 2345689999999999999999999974321111111
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... .... ............+.+++.+||+.||++||+++|+++.
T Consensus 285 ~~~-----~~~~-----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 285 MCA-----ICMS-----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHH-----Hhcc-----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000 0112233456678999999999999999999999985
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-30 Score=277.57 Aligned_cols=193 Identities=19% Similarity=0.213 Sum_probs=146.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g 138 (382)
T cd05625 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDG 138 (382)
T ss_pred CCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 7888899999999999999999999999997654 688899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCC----------------------------------------------CceeeceeccccccCcc
Q 038002 551 RAKISDFGLAKLLMPNQ----------------------------------------------TGIVAGVRGSRGYMAPE 584 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~----------------------------------------------~~~~~~~~gt~~y~aPE 584 (702)
.+||+|||++..+.... ........||+.|+|||
T Consensus 139 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 218 (382)
T cd05625 139 HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218 (382)
T ss_pred CEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHH
Confidence 99999999975321000 00012346899999999
Q ss_pred cccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHccc
Q 038002 585 WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQ 664 (702)
Q Consensus 585 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~ 664 (702)
++.+..++.++|||||||++|||++|+.||............. . ...... ........+.+.+++.+|+.
T Consensus 219 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~----~--~~~~~~----~p~~~~~s~~~~~li~~l~~ 288 (382)
T cd05625 219 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI----N--WQTSLH----IPPQAKLSPEASDLIIKLCR 288 (382)
T ss_pred HhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHH----c--cCCCcC----CCCcccCCHHHHHHHHHHcc
Confidence 9998899999999999999999999999997542111100000 0 000000 01112234566677777664
Q ss_pred CCCCCCCC---HHHHHH
Q 038002 665 DEPNLRPS---MKNVIL 678 (702)
Q Consensus 665 ~dP~~RPt---~~evl~ 678 (702)
+|++|++ ++|+++
T Consensus 289 -~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 289 -GPEDRLGKNGADEIKA 304 (382)
T ss_pred -CHhHcCCCCCHHHHhc
Confidence 9999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=273.62 Aligned_cols=200 Identities=25% Similarity=0.368 Sum_probs=154.1
Q ss_pred eeeEEEEE-ecCCeeEEEEecCCCCCHHHHhhcCC---------------------------------------------
Q 038002 471 ISSLLVYK-HRSSKKLLVYEFMSKGSLADLLFNLE--------------------------------------------- 504 (702)
Q Consensus 471 i~~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------- 504 (702)
|+++++.+ ..+...++||||+++++|.+++....
T Consensus 73 iv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (337)
T cd05054 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKS 152 (337)
T ss_pred hhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcc
Confidence 55565544 45677899999999999999986432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 505 ---------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 505 ---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~ 229 (337)
T cd05054 153 LSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229 (337)
T ss_pred hhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcch
Confidence 1468889999999999999999999 9999999999999999999999999999876433221
Q ss_pred e-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 570 I-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 570 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .+ ......+.. ...
T Consensus 230 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~-----~~~ 297 (337)
T cd05054 230 VRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EF----CRRLKEGTR-----MRA 297 (337)
T ss_pred hhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HH----HHHHhccCC-----CCC
Confidence 1 223445678999999999999999999999999999998 999996431111 11 111111111 111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+......+.+++.+||+.+|++||+++||+++|+.+.+
T Consensus 298 ~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22345678999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=274.70 Aligned_cols=221 Identities=18% Similarity=0.162 Sum_probs=166.3
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.++..+.||+|++ ||++.... ..+|+| |++++..+++++..|+|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 4455567888877 66665432 334443 7788889999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.........
T Consensus 124 y~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 124 YMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred CCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 99999999999654 578899999999999999999999 9999999999999999999999999999876433322
Q ss_pred eeeceeccccccCcccccCC----CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 570 IVAGVRGSRGYMAPEWQNSG----LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ... ...+.........
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~---~~~-----~~~i~~~~~~~~~-- 268 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL---VGT-----YSKIMDHKNSLNF-- 268 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH---HHH-----HHHHHhCCcccCC--
Confidence 23456799999999988653 378899999999999999999999965421 111 1111111100000
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNL--RPSMKNVILM 679 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 679 (702)
......+..+.+++.+||+.++.+ ||+++|+++.
T Consensus 269 p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111234667788888899865544 8899999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=283.77 Aligned_cols=192 Identities=20% Similarity=0.277 Sum_probs=155.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|++++++++.+++.||||||+++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++
T Consensus 127 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~ 203 (478)
T PTZ00267 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLM 203 (478)
T ss_pred EeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEEC
Confidence 899999999999999999999999999988642 23578899999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 548 DSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..
T Consensus 204 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~-- 278 (478)
T PTZ00267 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---RE-- 278 (478)
T ss_pred CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HH--
Confidence 999999999999987643322 123346699999999999988999999999999999999999999964311 10
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......+... ..+...+..+.+++.+||+.||++||++++++.
T Consensus 279 ---~~~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 279 ---IMQQVLYGKYD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---HHHHHHhCCCC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11111111111 112234567899999999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=264.21 Aligned_cols=195 Identities=23% Similarity=0.284 Sum_probs=154.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|+++...+..++..++||||+++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+||+++
T Consensus 55 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~ 131 (280)
T cd05608 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLD 131 (280)
T ss_pred EeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEC
Confidence 777888888999999999999999999887542 23588999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++.+||+|||++..+..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...........
T Consensus 132 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~-- 208 (280)
T cd05608 132 NDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE-- 208 (280)
T ss_pred CCCCEEEeeCccceecCCCCc-cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHH--
Confidence 999999999999986543322 22345689999999999999999999999999999999999999975422111111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
......... ...+...+..+.+++.+||+.||++|| +++++++.
T Consensus 209 --~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 209 --LKQRILNDS------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --HHHhhcccC------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 111111110 122334567788999999999999999 77888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=270.86 Aligned_cols=188 Identities=24% Similarity=0.303 Sum_probs=150.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++++++.++..|+||||+++++|..++.. ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 64 i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~ 138 (324)
T cd05589 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEG 138 (324)
T ss_pred hhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCC
Confidence 67788889999999999999999999988854 3689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ....
T Consensus 139 ~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~---- 210 (324)
T cd05589 139 FVKIADFGLCKEGMGFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVF---- 210 (324)
T ss_pred cEEeCcccCCccCCCCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHH----
Confidence 99999999987532221 223346789999999999988999999999999999999999999964411 1111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
........ ..+......+.+++.+||+.||++|| +++++++
T Consensus 211 -~~i~~~~~------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 211 -DSIVNDEV------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -HHHHhCCC------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11111111 11223456788999999999999999 5666665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=283.75 Aligned_cols=227 Identities=22% Similarity=0.245 Sum_probs=176.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEE-Ee-----c-CCe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVY-KH-----R-SSK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~-~~-----~-~~~ 483 (702)
.....++.|-+|+| ||++.... ..+|+| ||.+++. .. + .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 34456788999998 99888765 566666 7777752 11 1 357
Q ss_pred eEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 484 KLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.+|.||||+||.|-|++... ..++++.++++|+.++++|+++||.. ...|||||||.|||||..+++.||||||.+..
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 89999999999999999754 33599999999999999999999997 44699999999999999999999999999975
Q ss_pred cCCCCCceee--------ceeccccccCcccc---cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH
Q 038002 563 LMPNQTGIVA--------GVRGSRGYMAPEWQ---NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY 631 (702)
Q Consensus 563 ~~~~~~~~~~--------~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 631 (702)
.....+.... ...-|+.|+|||.+ .+..+++|+|||+|||+||.|+....||+..... .+
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l--aI------- 266 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL--AI------- 266 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--eE-------
Confidence 4333311100 12358999999955 6789999999999999999999999999754111 00
Q ss_pred HhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 632 NCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
..+.. .-...+.++.++.+||..||+.||++||++-+|++.+-.+...
T Consensus 267 ---lng~Y----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 267 ---LNGNY----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ---Eeccc----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11111 1112357899999999999999999999999999988776543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=278.33 Aligned_cols=194 Identities=20% Similarity=0.199 Sum_probs=148.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~ 138 (376)
T cd05598 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDG 138 (376)
T ss_pred cceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCC
Confidence 7778889999999999999999999999997654 688889999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCC------------------------------------------CceeeceeccccccCcccccC
Q 038002 551 RAKISDFGLAKLLMPNQ------------------------------------------TGIVAGVRGSRGYMAPEWQNS 588 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~ 588 (702)
.+||+|||++..+.... ........||+.|+|||++.+
T Consensus 139 ~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 218 (376)
T cd05598 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218 (376)
T ss_pred CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC
Confidence 99999999975331000 000113469999999999998
Q ss_pred CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCC
Q 038002 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPN 668 (702)
Q Consensus 589 ~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~ 668 (702)
..++.++|||||||++|||++|+.||........... ...... ..........+..+.+++.+|+ .+|.
T Consensus 219 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~--------i~~~~~--~~~~~~~~~~s~~~~~li~~l~-~~p~ 287 (376)
T cd05598 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLK--------VINWET--TLHIPSQAKLSREASDLILRLC-CGAE 287 (376)
T ss_pred CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHH--------HhccCc--cccCCCCCCCCHHHHHHHHHHh-cCHh
Confidence 8999999999999999999999999975421111000 000000 0000111123456677777766 4999
Q ss_pred CCC---CHHHHHHH
Q 038002 669 LRP---SMKNVILM 679 (702)
Q Consensus 669 ~RP---t~~evl~~ 679 (702)
+|+ +++|+++.
T Consensus 288 ~R~~~~t~~ell~h 301 (376)
T cd05598 288 DRLGKNGADEIKAH 301 (376)
T ss_pred hcCCCCCHHHHhCC
Confidence 999 88888865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-30 Score=271.89 Aligned_cols=216 Identities=26% Similarity=0.253 Sum_probs=178.2
Q ss_pred cceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecCCCCCH
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL 496 (702)
+-.+|+|.. ||.|.... ..+||| |+++++.+.+++++-+.||.++||||
T Consensus 580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 346888876 99888765 566776 88999999999999999999999999
Q ss_pred HHHhhcCCCCC--CHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE-eCCCcEEEecccceeecCCCCCceeec
Q 038002 497 ADLLFNLETRP--LWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI-DDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 497 ~~~l~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll-~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
.++|+..-+++ ++..+-.+..||++||.|||++ .|||||||-+|+|+ .-.|.+||+|||-++.+.. -.....+
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 99998875555 7888888999999999999999 99999999999999 4688999999999987643 2334556
Q ss_pred eeccccccCcccccCC--CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 574 VRGSRGYMAPEWQNSG--LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
+.||..|||||++..+ .|..++|||||||++.||.||++||-......... +.-+. --..++++.+.
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM---------FkVGm--yKvHP~iPeel 804 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM---------FKVGM--YKVHPPIPEEL 804 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh---------hhhcc--eecCCCCcHHH
Confidence 7899999999998654 68899999999999999999999996542221111 11111 12345778889
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+.+...+|++|+.+||.+||++.++++
T Consensus 805 saeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 SAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 999999999999999999999999986
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=272.79 Aligned_cols=223 Identities=18% Similarity=0.167 Sum_probs=166.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.+...+.||+|++ ||++.... ..+|+| |++++..+++++..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34455677888877 77665532 334443 677888899999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 123 Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 123 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred cCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 999999999999654 478888999999999999999999 999999999999999999999999999987644333
Q ss_pred ceeeceeccccccCcccccCC----CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQNSG----LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.......||+.|+|||++... .++.++|||||||++|||++|+.||..... .. ....+..... ...
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~-----~~~~i~~~~~--~~~ 267 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VG-----TYSKIMNHKN--SLT 267 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH---HH-----HHHHHHcCCC--ccc
Confidence 233456799999999988653 378999999999999999999999975311 11 1111111100 000
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNL--RPSMKNVILML 680 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~L 680 (702)
.......+..+.+++.+||+.++.+ ||+++|+++..
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 1112235667888999999844433 78999988853
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=247.23 Aligned_cols=199 Identities=23% Similarity=0.264 Sum_probs=158.5
Q ss_pred eeeEEEEEec----CCeeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYKHR----SSKKLLVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 545 (702)
|+.+++.|++ .+.+.+|||.|+||.|.+.+.+.+. .++++++..|+.||..|+.|||+. +|.||||||+|+|
T Consensus 117 iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLL 193 (400)
T KOG0604|consen 117 IVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLL 193 (400)
T ss_pred eEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhhee
Confidence 7888766554 6788999999999999999987764 489999999999999999999999 9999999999999
Q ss_pred EeC---CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcc
Q 038002 546 IDD---SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD 622 (702)
Q Consensus 546 l~~---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 622 (702)
... +..+||+|||+|+.-.. .....+.+.|+.|.|||++....|+...|+||+||++|-|++|.+||.......
T Consensus 194 yt~t~~na~lKLtDfGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a- 270 (400)
T KOG0604|consen 194 YTTTSPNAPLKLTDFGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA- 270 (400)
T ss_pred eecCCCCcceEecccccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-
Confidence 954 55799999999996543 233556788999999999999999999999999999999999999998653211
Q ss_pred hhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 623 EVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
+..-....+..+... + ..+.-...++...++|+.+|..+|.+|.|+++++..-
T Consensus 271 ---ispgMk~rI~~gqy~-F-P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 271 ---ISPGMKRRIRTGQYE-F-PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred ---CChhHHhHhhccCcc-C-CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 111112222222221 1 1122345688899999999999999999999998753
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=258.89 Aligned_cols=196 Identities=22% Similarity=0.303 Sum_probs=154.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++......+++.++..++.|++.||+|||++ +|+|+||||+||+++.++
T Consensus 55 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~ 131 (252)
T cd05084 55 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKN 131 (252)
T ss_pred cceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCC
Confidence 78888899999999999999999999999976655689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee-eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV-AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||++........... .....+..|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 132 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~-- 205 (252)
T cd05084 132 VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QT-- 205 (252)
T ss_pred cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HH--
Confidence 999999999875432211111 11123456999999988889999999999999999998 88888543110 00
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
....... . ....+...+..+.+++.+||+.+|++||++++|+++|+.
T Consensus 206 --~~~~~~~-~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 206 --REAIEQG-V----RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred --HHHHHcC-C----CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 0111110 0 111222345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=269.67 Aligned_cols=185 Identities=22% Similarity=0.226 Sum_probs=149.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++.+..++||||+++++|...+.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 58 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~ 133 (321)
T cd05603 58 LVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQG 133 (321)
T ss_pred ccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCC
Confidence 7788888999999999999999999999887644 688889999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++...... ........|++.|+|||.+.+..++.++|||||||++|||++|..||..... .. .
T Consensus 134 ~~kl~Dfg~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~----~ 204 (321)
T cd05603 134 HVVLTDFGLCKEGVEP-EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQ----M 204 (321)
T ss_pred CEEEccCCCCccCCCC-CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----HH----H
Confidence 9999999998753222 1223345689999999999888899999999999999999999999964311 11 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMK 674 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ 674 (702)
......... ..+......+.+++.+||+.||.+||++.
T Consensus 205 ~~~i~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 205 YDNILHKPL------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHhcCCC------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111111 12233456788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.17 Aligned_cols=184 Identities=22% Similarity=0.323 Sum_probs=148.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++...++.++..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~ 138 (323)
T cd05615 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEG 138 (323)
T ss_pred hhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 4556678888999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .. .
T Consensus 139 ~ikL~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~-----~ 209 (323)
T cd05615 139 HIKIADFGMCKEHMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DE-----L 209 (323)
T ss_pred CEEEeccccccccCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HH-----H
Confidence 99999999987543222 122345689999999999888899999999999999999999999965411 11 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
......... ..+...+..+.+++.+||+.+|.+|++.
T Consensus 210 ~~~i~~~~~------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 210 FQSIMEHNV------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHhCCC------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111111 1222345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=264.69 Aligned_cols=199 Identities=22% Similarity=0.250 Sum_probs=148.9
Q ss_pred eeeEEEEEe-----cCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKH-----RSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~-----~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++++.+. .+...++||||++ ++|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||
T Consensus 66 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Ni 141 (290)
T cd07862 66 VVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNI 141 (290)
T ss_pred cceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHE
Confidence 566665553 4567999999996 59999987643 3588999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+++.++.+||+|||++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 142 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--- 216 (290)
T cd07862 142 LVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--- 216 (290)
T ss_pred EEcCCCCEEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---
Confidence 9999999999999999875433 22334568999999999988889999999999999999999999997542211
Q ss_pred hhHHHHHHhh--hcccccc-------cccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCF--VAGEFNK-------LVEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~--~~~~~~~-------~~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+........ ....+.. .... ...+.....+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1111110000 0000000 0000 111234567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=275.01 Aligned_cols=194 Identities=21% Similarity=0.191 Sum_probs=148.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~ 138 (377)
T cd05629 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGG 138 (377)
T ss_pred cceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCC
Confidence 7888899999999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCc----------------------------------------------eeeceeccccccCcc
Q 038002 551 RAKISDFGLAKLLMPNQTG----------------------------------------------IVAGVRGSRGYMAPE 584 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~----------------------------------------------~~~~~~gt~~y~aPE 584 (702)
.+||+|||+++.+...... ......||+.|+|||
T Consensus 139 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 218 (377)
T cd05629 139 HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218 (377)
T ss_pred CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHH
Confidence 9999999998643210000 001246899999999
Q ss_pred cccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHccc
Q 038002 585 WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQ 664 (702)
Q Consensus 585 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~ 664 (702)
++.+..++.++|||||||++|||++|..||...... + .. ..+.... ..+.-.........+.+++.+||+
T Consensus 219 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--~-~~-----~~i~~~~--~~~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 219 IFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSH--E-TY-----RKIINWR--ETLYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred HHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHH--H-HH-----HHHHccC--CccCCCCCCCCCHHHHHHHHHHhc
Confidence 998889999999999999999999999999654211 1 11 1111100 000000011234578888999998
Q ss_pred CCCCCC---CCHHHHHHH
Q 038002 665 DEPNLR---PSMKNVILM 679 (702)
Q Consensus 665 ~dP~~R---Pt~~evl~~ 679 (702)
+|.+| +++.|+++.
T Consensus 289 -~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 289 -NAENRLGRGGAHEIKSH 305 (377)
T ss_pred -CHhhcCCCCCHHHHhcC
Confidence 66665 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=257.28 Aligned_cols=196 Identities=23% Similarity=0.290 Sum_probs=156.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+...+..++||||+++++|.+++......+++..+..++.|++.+|.|||++ +++|+||||+||+++.++
T Consensus 54 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~ 130 (250)
T cd05085 54 IVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENN 130 (250)
T ss_pred cCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCC
Confidence 77888888999999999999999999999977655688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++...............++..|+|||++....++.++||||||+++|++++ |..||...... ...
T Consensus 131 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~-- 204 (250)
T cd05085 131 VLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAR-- 204 (250)
T ss_pred eEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHH--
Confidence 99999999987643322211122234567999999988889999999999999999998 99999643111 111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
....... ....+...+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus 205 --~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 250 (250)
T cd05085 205 --EQVEKGY-----RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250 (250)
T ss_pred --HHHHcCC-----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhcC
Confidence 1111111 111122345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=261.48 Aligned_cols=197 Identities=21% Similarity=0.283 Sum_probs=154.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++...++++.+.++||||+++++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 55 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~ 131 (277)
T cd05607 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQ 131 (277)
T ss_pred EEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCC
Confidence 7888889999999999999999999999886543 3588899999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... .
T Consensus 132 ~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~---~- 205 (277)
T cd05607 132 GNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE---E- 205 (277)
T ss_pred CCEEEeeceeeeecCCCc--eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH---H-
Confidence 999999999998764322 2234568999999999988889999999999999999999999996432211111 1
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
............ ........+.+++.+||+.||++||+++|+++.+.
T Consensus 206 ~~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 206 LKRRTLEDEVKF-----EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHhhcccccc-----ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 111111111110 11234567899999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=274.64 Aligned_cols=199 Identities=26% Similarity=0.355 Sum_probs=157.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----------------------------------------------
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------------------------------------- 504 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------- 504 (702)
|+++++++.+++..||||||+++|+|.++|....
T Consensus 103 Iv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (400)
T cd05105 103 IVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQ 182 (400)
T ss_pred eeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccc
Confidence 7888999999999999999999999999886421
Q ss_pred -------------------------------------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 505 -------------------------------------------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 505 -------------------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
..+++.++..++.||++||+|||+. +|+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iv 259 (400)
T cd05105 183 ADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCV 259 (400)
T ss_pred ccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 1366778889999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
|+||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 260 H~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P 339 (400)
T cd05105 260 HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP 339 (400)
T ss_pred CCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999999865433221 1223346778999999988889999999999999999997 9999
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
|....... . .......+. ....+...+..+.+++.+||+.||++||++.+|.++|+.+.
T Consensus 340 ~~~~~~~~--~-----~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 340 YPGMIVDS--T-----FYNKIKSGY-----RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred CcccchhH--H-----HHHHHhcCC-----CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 86431111 0 111111111 11122334667899999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=259.76 Aligned_cols=194 Identities=27% Similarity=0.305 Sum_probs=154.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+.++..+..++..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+. +|+|+||||+||+++++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDY 138 (285)
T ss_pred EeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCC
Confidence 7777888888999999999999999999886543 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||++........ .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||....... .. ..
T Consensus 139 ~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~-~~ 212 (285)
T cd05605 139 GHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KR-EE 212 (285)
T ss_pred CCEEEeeCCCceecCCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HH-HH
Confidence 9999999999987533222 233468999999999988889999999999999999999999997542111 10 00
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
........ ....+...+..+.+++.+||+.||++|| +++++++.
T Consensus 213 ~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 213 VERRVKED------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHhhhc------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11111110 1122334567788999999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=263.16 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=159.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++++..++..++||||+++++|.+++.... ..+++..++.++.||+.||+|||++ +|+
T Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~ 145 (291)
T cd05094 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFV 145 (291)
T ss_pred cceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 7888899999999999999999999999997532 2478899999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
||||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 146 H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 225 (291)
T cd05094 146 HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225 (291)
T ss_pred ecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976533221 11223446788999999988889999999999999999999 9999
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
|...... . ..+....+.... .....+..+.+++.+||+.||++||++++|+++|+++..
T Consensus 226 ~~~~~~~---~-----~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 226 WFQLSNT---E-----VIECITQGRVLE-----RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred CCCCCHH---H-----HHHHHhCCCCCC-----CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 8643111 0 111112222111 122345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=269.27 Aligned_cols=202 Identities=23% Similarity=0.344 Sum_probs=151.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.++++.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.. +|+|+||||+||+++.++
T Consensus 65 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~ 141 (333)
T cd06650 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRG 141 (333)
T ss_pred ccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCC
Confidence 7888899999999999999999999999997654 6888999999999999999999741 799999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .....|+..|+|||.+.+..++.++|||||||++|||++|+.||................
T Consensus 142 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 218 (333)
T cd06650 142 EIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPV 218 (333)
T ss_pred CEEEeeCCcchhhhhhc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcc
Confidence 99999999987553221 233468999999999988889999999999999999999999996432111000000000
Q ss_pred HHh-------------------hhcc-----c---ccc-ccc---ccc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNC-------------------FVAG-----E---FNK-LVE---EEV-DKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~-------------------~~~~-----~---~~~-~~~---~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... .... . ... ... +.. ......++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 219 EGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000 0000 0 000 000 000 0113467889999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-30 Score=273.36 Aligned_cols=227 Identities=26% Similarity=0.303 Sum_probs=181.3
Q ss_pred cccceEEEeEE--EEEeeeehh-----h-hHhh------------------------------eeeEEEEEecCCeeEEE
Q 038002 446 NDKRKLLTVLA--GCLGSITFL-----C-FLIA------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~~-----~-~avk------------------------------i~~l~~~~~~~~~~~lV 487 (702)
...++||+|+| |+.|.+... . |||| |++++++...+..++||
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 33489999999 999998751 2 6777 99999999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
||+|+||+|.++|++.+..++..+...++.+.+.||+|||++ ++|||||-.+|+|+..++.+||+|||+++.-....
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 999999999999999887799999999999999999999999 99999999999999999999999999987542111
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
. ......-+..|+|||.+....++.++|||||||++||+.+ |..||...... . +...+..... ...
T Consensus 317 ~-~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~----~----v~~kI~~~~~----r~~ 383 (474)
T KOG0194|consen 317 M-KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY----E----VKAKIVKNGY----RMP 383 (474)
T ss_pred e-ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH----H----HHHHHHhcCc----cCC
Confidence 1 1111234678999999999999999999999999999998 88898654211 1 1111111111 112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCCC
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPI 688 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~~ 688 (702)
.+...+..+..++.+|++.||++||+|.++.+.|+.+.....
T Consensus 384 ~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 384 IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 223446677788889999999999999999999988655433
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=259.75 Aligned_cols=196 Identities=28% Similarity=0.404 Sum_probs=157.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++.++..++..++||||+++++|.+++.+.. ..+++.++..++.||+.||+|||++ +|+|+||||+||+++++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~ 140 (261)
T cd05148 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGED 140 (261)
T ss_pred hhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCC
Confidence 6777888899999999999999999999998643 3578999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||.+........ ......++..|+|||.+....++.++||||||+++|+|++ |+.||..... .....
T Consensus 141 ~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~- 215 (261)
T cd05148 141 LVCKVADFGLARLIKEDVY-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYD- 215 (261)
T ss_pred ceEEEccccchhhcCCccc-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHH-
Confidence 9999999999986643221 1223345678999999988889999999999999999998 8999964321 11111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
....+ .....+...++.+.+++.+||+.||++|||++++++.|+++
T Consensus 216 ----~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 216 ----QITAG-----YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ----HHHhC-----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11111 01112234456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=256.37 Aligned_cols=200 Identities=24% Similarity=0.281 Sum_probs=153.9
Q ss_pred eeeEEEEEecCC------eeEEEEecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCC
Q 038002 471 ISSLLVYKHRSS------KKLLVYEFMSKGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541 (702)
Q Consensus 471 i~~l~~~~~~~~------~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 541 (702)
|+.|++.+.+++ ..++|+||++. +|..++.... ..++...+..++.||++||+|||++ +|+||||||
T Consensus 73 iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKP 148 (323)
T KOG0594|consen 73 IVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKP 148 (323)
T ss_pred eEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCc
Confidence 788887777766 89999999965 9999998776 3577788999999999999999999 999999999
Q ss_pred CcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCC
Q 038002 542 RNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVST 620 (702)
Q Consensus 542 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 620 (702)
+|||++++|.+||+|||+|+.+.-.. ...++..+|..|+|||++.+. .|+...||||+|||+.||++++.-|.....
T Consensus 149 QNlLi~~~G~lKlaDFGlAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se- 226 (323)
T KOG0594|consen 149 QNLLISSSGVLKLADFGLARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE- 226 (323)
T ss_pred ceEEECCCCcEeeeccchHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-
Confidence 99999999999999999999664332 235566789999999988765 899999999999999999999999976532
Q ss_pred cchhhhHHHHHHhh---hcccccccc---------cc-----cc---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 621 ADEVLLSTWVYNCF---VAGEFNKLV---------EE-----EV---DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 621 ~~~~~~~~~~~~~~---~~~~~~~~~---------~~-----~~---~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.++. ..+.... .+..++... .. .. .+.......+++.+||+.+|.+|.|++.++++
T Consensus 227 ~~ql---~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 227 IDQL---FRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred HHHH---HHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111 1111111 001111100 00 01 11112478889999999999999999999986
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=265.84 Aligned_cols=196 Identities=20% Similarity=0.202 Sum_probs=149.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.++..++++++.|+||||+++|+|.+++.+....+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~ 139 (331)
T cd05597 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNG 139 (331)
T ss_pred CCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCC
Confidence 67777888999999999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.+||+|||++...............||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ..
T Consensus 140 ~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~---~~ 216 (331)
T cd05597 140 HIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV---ET 216 (331)
T ss_pred CEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH---HH
Confidence 99999999997664433322333568999999998863 45788999999999999999999999643110 00
Q ss_pred hHHHHHHhhhc-cccccccccccCHHHHHHHHHHHHHcccCCC--CCCCCHHHHHHH
Q 038002 626 LSTWVYNCFVA-GEFNKLVEEEVDKITLERMVKTGLLCIQDEP--NLRPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP--~~RPt~~evl~~ 679 (702)
...... ..... +.. .....++.+.+++.+||..++ ..||+++++++.
T Consensus 217 -----~~~i~~~~~~~~-~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 217 -----YGKIMNHKEHFQ-FPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----HHHHHcCCCccc-CCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011111 10001 111 111245667778888775533 347899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=261.66 Aligned_cols=199 Identities=24% Similarity=0.301 Sum_probs=153.4
Q ss_pred eeeEEEEEe--cCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKH--RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|++|++.-. +.+++|||+|||..|.+...=.... .+++.++++++++++.||+|||.+ |||||||||+|+|+++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~ 245 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS 245 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence 899987764 5889999999999888765432221 388999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCC----CCceeeceeccccccCcccccCC----CCCccccccchhHhHHHhhhCCcCCcCCCCC
Q 038002 549 SWRAKISDFGLAKLLMPN----QTGIVAGVRGSRGYMAPEWQNSG----LITVKSDVYSFGVVLLEIICCRSNFEVNVST 620 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 620 (702)
+|++||+|||.+..+... .........|||.|+|||...++ ..+.+.||||+||+||.|+.|+.||-...
T Consensus 246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-- 323 (576)
T KOG0585|consen 246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-- 323 (576)
T ss_pred CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch--
Confidence 999999999999876322 11223347799999999977652 23578899999999999999999996431
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+. ..+..+....+ .-...+++.+++.+||++||++||++|.+..+|....--...
T Consensus 324 --~~----~l~~KIvn~pL----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 324 --EL----ELFDKIVNDPL----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred --HH----HHHHHHhcCcc----cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 11 12222222221 112233567889999999999999999999999887755443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=250.96 Aligned_cols=228 Identities=18% Similarity=0.174 Sum_probs=170.5
Q ss_pred cccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEE--EEEecCCeeEEEEec
Q 038002 446 NDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLL--VYKHRSSKKLLVYEF 490 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~--~~~~~~~~~~lV~e~ 490 (702)
..-.+|++|.+ ||++.... +.||.| |+.+- ....+-+.+|+||||
T Consensus 79 e~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~ 158 (419)
T KOG0663|consen 79 EKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEY 158 (419)
T ss_pred HHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHH
Confidence 34456777776 77777654 667766 44443 344557779999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
|+. +|..++...+.++...++..++.|+++|++|||.+ .|+||||||+|+|+.+.|.+||+|||+|+.+... ...
T Consensus 159 ~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~ 233 (419)
T KOG0663|consen 159 VEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKP 233 (419)
T ss_pred HHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-ccc
Confidence 977 99999998888899999999999999999999999 9999999999999999999999999999988544 334
Q ss_pred eeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc-----
Q 038002 571 VAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE----- 644 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 644 (702)
.+...-|..|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+.... ++....-.......+..++.+..
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-DQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-HHHHHHHHHhCCCccccCCCccccchhh
Confidence 566778999999997765 57999999999999999999999999765222 22211110100001111111000
Q ss_pred -------------cccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 645 -------------EEVDKI-TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 645 -------------~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..+... ..+.-.+|+..+|..||.+|.|++|.++.
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 011111 34677888999999999999999998753
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=260.44 Aligned_cols=198 Identities=23% Similarity=0.311 Sum_probs=155.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++. +...++|+||+++|+|.+++......+++..+..++.||+.||+|||++ +++|+||||+||++++++
T Consensus 71 iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~ 146 (279)
T cd05111 71 IVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDS 146 (279)
T ss_pred cceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCC
Confidence 677777664 5567899999999999999987666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....
T Consensus 147 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~~~~ 222 (279)
T cd05111 147 IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----EVPD 222 (279)
T ss_pred cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence 999999999987643322 12233456778999999988889999999999999999998 99999644111 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
. ...+... .. +......+.+++.+||..||++|||+.|+++.|+.+.+
T Consensus 223 ~----~~~~~~~--~~---~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 223 L----LEKGERL--AQ---PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred H----HHCCCcC--CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1 1111111 01 11123467788999999999999999999999988664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=255.18 Aligned_cols=234 Identities=20% Similarity=0.215 Sum_probs=171.8
Q ss_pred cceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEe-----cCCeeEEEEe
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKH-----RSSKKLLVYE 489 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~-----~~~~~~lV~e 489 (702)
.+.+|+|++ |+.+.... ..||+| |+.+...+. +-+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 567888887 67666554 778887 555554443 4678999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC-CC
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN-QT 568 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-~~ 568 (702)
+| +-+|...|+.+. .++...+..++.||++||+|+|+. +|+||||||+|++++.+..+||+|||+|+..... ..
T Consensus 107 lM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred HH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 99 559999998764 588888999999999999999999 9999999999999999999999999999987543 12
Q ss_pred ceeeceeccccccCccccc-CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH-------HHHhhhccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW-------VYNCFVAGEFN 640 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 640 (702)
...+....|..|.|||++. ...|+.+.||||+|||+.||++|+.-|.+...-.+-..+.+. ....+......
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 3346677899999999764 568999999999999999999999999765322111111000 00001100000
Q ss_pred cccc----------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCCcCC
Q 038002 641 KLVE----------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGTMEI 686 (702)
Q Consensus 641 ~~~~----------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~~~~ 686 (702)
..+. ...-+......++|+.+||+.||.+|+|++|.++. |+....+
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 0100 02223456678999999999999999999999873 4554433
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=261.78 Aligned_cols=199 Identities=24% Similarity=0.372 Sum_probs=158.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~d 538 (702)
|+++++++..++..++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +++|||
T Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~d 145 (288)
T cd05093 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRD 145 (288)
T ss_pred cceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 7888889999999999999999999999997432 2478999999999999999999999 999999
Q ss_pred CCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcC
Q 038002 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEV 616 (702)
Q Consensus 539 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~ 616 (702)
|||+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 146 lkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 146 LATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred cCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999865332211 1122345678999999988889999999999999999998 8999864
Q ss_pred CCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 617 NVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
... .. .......+.... .+...+..+.+++.+||+.||.+|||++++++.|+++..
T Consensus 226 ~~~---~~-----~~~~i~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 226 LSN---NE-----VIECITQGRVLQ-----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred CCH---HH-----HHHHHHcCCcCC-----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 321 11 111112221111 112234578999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=269.99 Aligned_cols=190 Identities=23% Similarity=0.262 Sum_probs=149.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.++..+++++..|+||||+++|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||++.++
T Consensus 58 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~ 133 (330)
T cd05586 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATG 133 (330)
T ss_pred CcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCC
Confidence 6777788999999999999999999999987654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++....... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..... ..
T Consensus 134 ~~kl~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~---~~----- 204 (330)
T cd05586 134 HIALCDFGLSKANLTDN-KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT---QQ----- 204 (330)
T ss_pred CEEEecCCcCcCCCCCC-CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH---HH-----
Confidence 99999999987542222 123346689999999988654 578999999999999999999999964311 11
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP----SMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP----t~~evl~ 678 (702)
....+..+... + . .......+.+++.+||+.||++|| +++++++
T Consensus 205 ~~~~i~~~~~~-~-~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 205 MYRNIAFGKVR-F-P---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHcCCCC-C-C---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11111111110 0 0 112356778899999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=270.56 Aligned_cols=186 Identities=24% Similarity=0.237 Sum_probs=151.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..|+||||+++|+|.+++.+.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 60 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 135 (318)
T cd05582 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEG 135 (318)
T ss_pred cccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCC
Confidence 7888899999999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++....... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...
T Consensus 136 ~~kL~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~---- 206 (318)
T cd05582 136 HIKLTDFGLSKESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KET---- 206 (318)
T ss_pred cEEEeeccCCcccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHH----
Confidence 99999999987653322 123346789999999999888889999999999999999999999964311 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKN 675 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e 675 (702)
......... ..+......+.+++.+||+.||++||++.+
T Consensus 207 ~~~i~~~~~------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 207 MTMILKAKL------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHcCCC------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111111111 122334567889999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-30 Score=241.51 Aligned_cols=215 Identities=21% Similarity=0.214 Sum_probs=176.0
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEec
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+...+.+|+|-| ||.+.... -.||+| |.+++.+|.++...||++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 344567777776 88777654 344554 78899999999999999999
Q ss_pred CCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 491 MSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
...|+|...|...+. ++++.....++.|++.||.|+|.. +||||||||+|+|++..+.+||+|||.+..-. ..
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 999999999985543 589999999999999999999999 99999999999999999999999999998654 23
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....+||..|++||...+..++..+|+|++|++.||++.|.+||+.....+ .+..+..-+ -..+.
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--------tYkrI~k~~------~~~p~ 243 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--------TYKRIRKVD------LKFPS 243 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--------HHHHHHHcc------ccCCc
Confidence 3456789999999999999999999999999999999999999997653111 111111111 12234
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..+....++|.+|+..+|.+|.+..|+++.
T Consensus 244 ~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 244 TISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 566788899999999999999999999864
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=255.81 Aligned_cols=193 Identities=26% Similarity=0.299 Sum_probs=152.0
Q ss_pred eeeEEEE-EecCCeeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVY-KHRSSKKLLVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~-~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
++++++. +..++..++||||+++++|.+++.+... .+++..+..++.|++.||+|||++ +|+||||||+||++++
T Consensus 61 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~ 137 (256)
T cd05082 61 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSE 137 (256)
T ss_pred eeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcC
Confidence 6666654 4567789999999999999999976543 478899999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++....... ....++..|+|||++.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 138 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~----~~~- 208 (256)
T cd05082 138 DNVAKVSDFGLTKEASSTQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KDV- 208 (256)
T ss_pred CCcEEecCCccceeccccC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH----HHH-
Confidence 9999999999987643222 12234568999999988889999999999999999997 9999864311 011
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
......+. ........+..+.+++.+||+.+|++|||+++++++|+.+
T Consensus 209 ---~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 209 ---VPRVEKGY-----KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred ---HHHHhcCC-----CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11111111 1112223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=260.81 Aligned_cols=220 Identities=19% Similarity=0.224 Sum_probs=165.8
Q ss_pred ccccceEEEeEE--EEEeeeeh-hhhHhh------------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 445 VNDKRKLLTVLA--GCLGSITF-LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~-~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+...++||.|+. ||+..... ..+|.| |++|++|.-.++.+|+||||-
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 444578888887 88776554 333433 999999999999999999998
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
+ .+|.++|.+....++...+..+..|++.|+.++|++ ||||.||||.|+|+- .|.+||+|||.|..+..+.+...
T Consensus 443 d-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~ 517 (677)
T KOG0596|consen 443 D-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIV 517 (677)
T ss_pred c-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccCcccccee
Confidence 5 499999988765555457888999999999999999 999999999999985 46899999999998877665543
Q ss_pred -eceeccccccCcccccCC-----------CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccc
Q 038002 572 -AGVRGSRGYMAPEWQNSG-----------LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639 (702)
Q Consensus 572 -~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (702)
...+||+.||+||.+... ..++++||||||||||+|+.|+.||.... .... ....+..+..
T Consensus 518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------n~~a-Kl~aI~~P~~ 590 (677)
T KOG0596|consen 518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------NQIA-KLHAITDPNH 590 (677)
T ss_pred eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------HHHH-HHHhhcCCCc
Confidence 357899999999976421 25689999999999999999999996331 0000 0111111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 640 NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 640 ~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. +--+..+. ..+++++++.||+.||.+||+..|||+.
T Consensus 591 ~-Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 591 E-IEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred c-ccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 0 00011111 1229999999999999999999999863
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=280.08 Aligned_cols=226 Identities=15% Similarity=0.142 Sum_probs=161.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhhe--------------------------------eeEEEEEec-CCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIAI--------------------------------SSLLVYKHR-SSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avki--------------------------------~~l~~~~~~-~~~~~ 485 (702)
..++..++||+|+| ||++.... ..||||+ +++..++.. .++.+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 34555678888887 88776543 5566663 334455554 46889
Q ss_pred EEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCC--------------
Q 038002 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSW-------------- 550 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~-------------- 550 (702)
+|||++ +++|.+++.+.. .+++.++..++.||+.||+|||+ . +|+||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~ 283 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPD 283 (467)
T ss_pred EEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCC
Confidence 999998 778999887654 68999999999999999999997 6 999999999999998765
Q ss_pred --cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 551 --RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 --~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +......
T Consensus 284 ~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~ 358 (467)
T PTZ00284 284 PCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL-EHLHLME 358 (467)
T ss_pred CceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHH
Confidence 49999999875432 1223467899999999999999999999999999999999999999754221 1111000
Q ss_pred HHHH----hhh--------------cccccccccc-----------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WVYN----CFV--------------AGEFNKLVEE-----------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~~~----~~~--------------~~~~~~~~~~-----------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... .+. .+.+.....+ .........+.+||.+||+.||++|||++|+++
T Consensus 359 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 359 KTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 0000 000 0000000000 001112456789999999999999999999997
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=258.41 Aligned_cols=196 Identities=26% Similarity=0.428 Sum_probs=153.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC---------CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET---------RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 541 (702)
|+++++++..+...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++|+||||
T Consensus 71 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp 147 (277)
T cd05062 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAA 147 (277)
T ss_pred eeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcch
Confidence 78888889999999999999999999999975321 256788899999999999999999 999999999
Q ss_pred CcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCC
Q 038002 542 RNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVS 619 (702)
Q Consensus 542 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 619 (702)
+||++++++.++|+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 148 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 148 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred heEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999987653322211 112335678999999988889999999999999999999 7888864311
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
+. ............ .+......+.+++.+||+.||++|||+.|++++|++
T Consensus 228 ---~~-----~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 228 ---EQ-----VLRFVMEGGLLD-----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---HH-----HHHHHHcCCcCC-----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 111111111111 122335678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=280.99 Aligned_cols=221 Identities=21% Similarity=0.247 Sum_probs=167.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhhee-----------------------------eEEEEEecC--------
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIAIS-----------------------------SLLVYKHRS-------- 481 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avki~-----------------------------~l~~~~~~~-------- 481 (702)
.++...+.||+|++ ||++.... ..||+|++ ++...+...
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 45666788999988 78776543 66777733 222222211
Q ss_pred CeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccc
Q 038002 482 SKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFG 558 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 558 (702)
...++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 1478999999999999998653 23578999999999999999999999 99999999999999999999999999
Q ss_pred ceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcc
Q 038002 559 LAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG 637 (702)
Q Consensus 559 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 637 (702)
+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... . . .......+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~---~----~-~~~~~~~~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM---E----E-VMHKTLAG 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH---H----H-HHHHHhcC
Confidence 9987643222 223346799999999999988999999999999999999999999964311 0 1 11111111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 638 EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 638 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... ..+......+.+++.+||+.||++||++.++++.
T Consensus 261 ~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1233446678999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=288.41 Aligned_cols=223 Identities=29% Similarity=0.389 Sum_probs=181.5
Q ss_pred ccceEEEeEE--EEEeeeeh-------hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 447 DKRKLLTVLA--GCLGSITF-------LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~-------~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
..+.||+|.| ||.|.... ..|||| |+++++..-+....+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 3467999999 99999875 236776 9999988888999999999
Q ss_pred cCCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 490 FMSKGSLADLLFNL------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 490 ~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
||++|+|..+|++. ...+...+.+.++.|||+|+.|||++ ++|||||..+|+|++....+||+|||+|+.+
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999987 55688999999999999999999999 9999999999999999999999999999955
Q ss_pred CCCCCceeec-eeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 564 MPNQTGIVAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 564 ~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
.......... ..-...|||||.++.+.++.|+|||||||++||++| |..||...... + +...+.++. .
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~--~------v~~~~~~gg--R 922 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF--E------VLLDVLEGG--R 922 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH--H------HHHHHHhCC--c
Confidence 4433322222 234568999999999999999999999999999999 88898654111 1 111122222 1
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+ +.+...++.+.++|..||+.+|++||++..|++.++.+..
T Consensus 923 L---~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 923 L---DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred c---CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 1 2244567788899999999999999999999999987644
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=255.97 Aligned_cols=195 Identities=30% Similarity=0.403 Sum_probs=153.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
+++++.++. +...++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +|+|+||||+||+++++
T Consensus 63 i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~ 138 (260)
T cd05070 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDG 138 (260)
T ss_pred eEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCC
Confidence 666766664 566899999999999999997643 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+|||++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~ 214 (260)
T cd05070 139 LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN----REVLE 214 (260)
T ss_pred ceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Confidence 999999999998764433222223345668999999888889999999999999999999 8899964311 11111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
..... .....+...+..+.+++.+||+.+|++|||++++.+.|+.
T Consensus 215 ----~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 215 ----QVERG-----YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ----HHHcC-----CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11111 0111223445679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=274.85 Aligned_cols=231 Identities=18% Similarity=0.128 Sum_probs=167.4
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh---------------------eeeEEEEEecCCeeEEEEecCCCCCHHHH
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------ISSLLVYKHRSSKKLLVYEFMSKGSLADL 499 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~~ 499 (702)
+...+.||+|++ ||++.... ..||+| |++++.++..++..++|||++. ++|.++
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~ 249 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTY 249 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHH
Confidence 334566777766 67766543 445554 7888899999999999999995 699998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccc
Q 038002 500 LFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSR 578 (702)
Q Consensus 500 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~ 578 (702)
+......+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........ ......||+
T Consensus 250 l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~ 326 (461)
T PHA03211 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326 (461)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCc
Confidence 876655799999999999999999999999 9999999999999999999999999999876433221 123456999
Q ss_pred cccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch----hhhHHHHHHh-hhcccccccc----------
Q 038002 579 GYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE----VLLSTWVYNC-FVAGEFNKLV---------- 643 (702)
Q Consensus 579 ~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~---------- 643 (702)
.|+|||++.+..++.++|||||||++|||++|..|+......... ..+...+... .....+....
T Consensus 327 ~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~ 406 (461)
T PHA03211 327 DTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRH 406 (461)
T ss_pred CCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHh
Confidence 999999999889999999999999999999988765332111110 0111111100 0000000000
Q ss_pred ------cc-----cc--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 644 ------EE-----EV--DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 644 ------~~-----~~--~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. .. .......+.+|+.+||+.||++|||+.|+++.
T Consensus 407 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 407 RAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00 00123468889999999999999999999974
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=256.72 Aligned_cols=196 Identities=29% Similarity=0.402 Sum_probs=153.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+. ++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++++
T Consensus 63 i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~ 138 (262)
T cd05071 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGEN 138 (262)
T ss_pred cceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCC
Confidence 666666554 566899999999999999997643 3578999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||.+..+............++..|+|||...+..++.++||||||+++|||++ |..||...... + .
T Consensus 139 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~--~-~--- 212 (262)
T cd05071 139 LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--E-V--- 212 (262)
T ss_pred CcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH--H-H---
Confidence 999999999998764433222223446678999999988889999999999999999999 88888643111 1 1
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
........ ........+..+.+++.+|++.||++||+++++++.|+..
T Consensus 213 --~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 213 --LDQVERGY-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred --HHHHhcCC-----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11111110 0112234566788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=255.79 Aligned_cols=195 Identities=28% Similarity=0.434 Sum_probs=153.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+ ..+..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||+++++
T Consensus 63 i~~~~~~~-~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~ 138 (260)
T cd05067 63 LVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSET 138 (260)
T ss_pred eeeEEEEE-ccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCC
Confidence 66666665 4567899999999999999987543 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+|||++...............++..|+|||.+....++.++||||||+++|||++ |+.||...... ...
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~- 213 (260)
T cd05067 139 LCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP----EVI- 213 (260)
T ss_pred CCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH----HHH-
Confidence 999999999998765333222223445678999999988889999999999999999999 99999643211 011
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
....... ....+...+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 214 ---~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 214 ---QNLERGY-----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---HHHHcCC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 1111110 011222345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=255.99 Aligned_cols=200 Identities=20% Similarity=0.292 Sum_probs=158.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|+++++++...+..++||||+++++|.+++... ...+++.++..++.|++.||+|||++ +++|+||||+||+++
T Consensus 64 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~ 140 (267)
T cd08228 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEc
Confidence 777888888899999999999999999988642 23478899999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||......... .
T Consensus 141 ~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~--~- 216 (267)
T cd08228 141 ATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS--L- 216 (267)
T ss_pred CCCCEEECccccceeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH--H-
Confidence 999999999999887643221 122345788999999998888899999999999999999999999643211111 1
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.......... +.........+.+++.+||+.+|++||+++++++.|+++.
T Consensus 217 ---~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 217 ---CQKIEQCDYP----PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ---HHHHhcCCCC----CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111111111 1112345577899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=260.84 Aligned_cols=198 Identities=29% Similarity=0.378 Sum_probs=156.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---------------ETRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++++..++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +|+
T Consensus 78 i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~iv 154 (293)
T cd05053 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCI 154 (293)
T ss_pred eeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 778888889999999999999999999999642 23578899999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
|+||||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 155 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 234 (293)
T cd05053 155 HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234 (293)
T ss_pred ccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCC
Confidence 99999999999999999999999998764322111 122334668999999988889999999999999999997 9999
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
|..... .+ .......+... ..+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 235 ~~~~~~--~~------~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 235 YPGIPV--EE------LFKLLKEGYRM-----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCCCH--HH------HHHHHHcCCcC-----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 864311 11 11111111111 122234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-29 Score=255.51 Aligned_cols=193 Identities=21% Similarity=0.249 Sum_probs=154.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++++++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++
T Consensus 66 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~ 141 (263)
T cd06625 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAG 141 (263)
T ss_pred eeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 7888899999999999999999999999997654 588899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee--eceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
.++|+|||++........... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~--- 215 (263)
T cd06625 142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AA--- 215 (263)
T ss_pred CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HH---
Confidence 999999999986533221111 2345788999999998888999999999999999999999999643111 00
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ..... ....+......+.+++.+||+.+|++|||++++++.
T Consensus 216 -~~~~-~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 216 -IFKI-ATQPT----NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -HHHH-hccCC----CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 0110 11111 112233456678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=272.05 Aligned_cols=194 Identities=20% Similarity=0.234 Sum_probs=147.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 63 iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~ 138 (360)
T cd05627 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKG 138 (360)
T ss_pred EeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCC
Confidence 6778889999999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC----------------------------------ceeeceeccccccCcccccCCCCCcccc
Q 038002 551 RAKISDFGLAKLLMPNQT----------------------------------GIVAGVRGSRGYMAPEWQNSGLITVKSD 596 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D 596 (702)
.+||+|||++........ .......||+.|+|||++.+..++.++|
T Consensus 139 ~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~D 218 (360)
T cd05627 139 HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218 (360)
T ss_pred CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcce
Confidence 999999999875422110 0012346899999999999999999999
Q ss_pred ccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC---H
Q 038002 597 VYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS---M 673 (702)
Q Consensus 597 iwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~ 673 (702)
||||||++|||++|+.||....... .............+.+. ......+.+++.+++. ||.+|++ +
T Consensus 219 iwSlGvilyel~tG~~Pf~~~~~~~--------~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~ 287 (360)
T cd05627 219 WWSLGVIMYEMLIGYPPFCSETPQE--------TYRKVMNWKETLVFPPE--VPISEKAKDLILRFCT-DSENRIGSNGV 287 (360)
T ss_pred eccccceeeecccCCCCCCCCCHHH--------HHHHHHcCCCceecCCC--CCCCHHHHHHHHHhcc-ChhhcCCCCCH
Confidence 9999999999999999996542111 01111110000001111 1235567778877765 9999986 5
Q ss_pred HHHHHH
Q 038002 674 KNVILM 679 (702)
Q Consensus 674 ~evl~~ 679 (702)
+|+++.
T Consensus 288 ~ei~~h 293 (360)
T cd05627 288 EEIKSH 293 (360)
T ss_pred HHHhcC
Confidence 666553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=256.41 Aligned_cols=194 Identities=26% Similarity=0.323 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++++++ ++..++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||.||+++.++
T Consensus 58 i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~ 132 (257)
T cd05116 58 IVRMIGICE-AESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQH 132 (257)
T ss_pred cceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCC
Confidence 677777664 557799999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee--eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++........... ....++..|+|||.+....++.++||||||+++|||++ |..||..... ....
T Consensus 133 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~ 208 (257)
T cd05116 133 YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVT 208 (257)
T ss_pred eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHH
Confidence 999999999987644332111 12234578999999888888999999999999999998 9999964311 1111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
.....+.. ...+...+..+.+++.+||+.||++||++++|.++|++
T Consensus 209 ----~~i~~~~~-----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 209 ----QMIESGER-----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred ----HHHHCCCC-----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11111111 11222345678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=258.51 Aligned_cols=196 Identities=25% Similarity=0.416 Sum_probs=155.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 541 (702)
|+++++++..++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||
T Consensus 71 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p 147 (277)
T cd05032 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAA 147 (277)
T ss_pred eeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCh
Confidence 7888999999999999999999999999996532 1367889999999999999999999 999999999
Q ss_pred CcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCC
Q 038002 542 RNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVS 619 (702)
Q Consensus 542 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 619 (702)
+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||.....
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred heEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 9999999999999999998765433221 1223346788999999988889999999999999999998 9999864311
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
..... ....+... ..+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 228 ----~~~~~----~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 228 ----EEVLK----FVIDGGHL-----DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----HHHHH----HHhcCCCC-----CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111 11111111 1122236788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=267.65 Aligned_cols=204 Identities=19% Similarity=0.239 Sum_probs=145.6
Q ss_pred eeeEEEEEec-----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYKHR-----SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 545 (702)
|+++++++.. ....|+||||+. ++|.+++.... .+++..+..++.||++||+|||++ +|+||||||+|||
T Consensus 61 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 135 (338)
T cd07859 61 IVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNIL 135 (338)
T ss_pred EeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeE
Confidence 5555554432 235899999995 69999987654 689999999999999999999999 9999999999999
Q ss_pred EeCCCcEEEecccceeecCCCCC--ceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCc
Q 038002 546 IDDSWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA 621 (702)
Q Consensus 546 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 621 (702)
++.++.+||+|||+++....... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 136 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 136 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred ECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 99999999999999986532221 11234568999999998865 678999999999999999999999996542110
Q ss_pred chhhhHHH-------HHHhhhccccccc---ccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 622 DEVLLSTW-------VYNCFVAGEFNKL---VEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 622 ~~~~~~~~-------~~~~~~~~~~~~~---~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
........ ....+........ +.. ...+.....+.+++.+||+.||++|||++|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000 0000000000000 000 0011234567899999999999999999999974
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=253.96 Aligned_cols=197 Identities=24% Similarity=0.349 Sum_probs=157.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+.+...+..++||||+++++|.+++......+++.++..++.|++.||+|||+. +++|+||||+||+++.++
T Consensus 68 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~ 144 (268)
T cd05063 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNL 144 (268)
T ss_pred eeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCC
Confidence 77888899999999999999999999999987666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceee--ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVA--GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++............ ....+..|+|||.+....++.++||||||+++|||++ |+.||..... ..
T Consensus 145 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~--- 218 (268)
T cd05063 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HE--- 218 (268)
T ss_pred cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HH---
Confidence 9999999999866433221111 1223457999999988889999999999999999997 9999964311 11
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
....+.... ...........+.+++.+||+.+|++||++++|++.|+++
T Consensus 219 --~~~~i~~~~-----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 219 --VMKAINDGF-----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --HHHHHhcCC-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111111110 0111123456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=269.32 Aligned_cols=164 Identities=23% Similarity=0.258 Sum_probs=136.8
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh---------------------eeeEEEEEecCCeeEEEEecCCCCCHHHH
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------ISSLLVYKHRSSKKLLVYEFMSKGSLADL 499 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~~ 499 (702)
++..+.||+|++ ||++.... ..||+| |++++.++..++..++|||++. ++|.++
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~ 146 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTY 146 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHH
Confidence 445567777776 77766543 445555 7888888899999999999995 589998
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceecccc
Q 038002 500 LFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG 579 (702)
Q Consensus 500 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 579 (702)
+......+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ......||+.
T Consensus 147 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~ 221 (357)
T PHA03209 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAGTVE 221 (357)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--cccccccccc
Confidence 877666799999999999999999999999 99999999999999999999999999987532221 2234568999
Q ss_pred ccCcccccCCCCCccccccchhHhHHHhhhCCcCC
Q 038002 580 YMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614 (702)
Q Consensus 580 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 614 (702)
|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 222 y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 99999999889999999999999999999866554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=263.36 Aligned_cols=203 Identities=19% Similarity=0.244 Sum_probs=151.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++ +|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 66 iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~ 141 (309)
T cd07872 66 IVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERG 141 (309)
T ss_pred cceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence 78888899999999999999975 89988877665688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+........
T Consensus 142 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 220 (309)
T cd07872 142 ELKLADFGLARAKSVPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRL 220 (309)
T ss_pred CEEECccccceecCCCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999976433221 2233457899999998754 56889999999999999999999999754221111000000
Q ss_pred -------HHHhhhc------ccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 -------VYNCFVA------GEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 -------~~~~~~~------~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+..... ......... .........+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000 000000000 011224567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.5e-29 Score=254.49 Aligned_cols=195 Identities=30% Similarity=0.443 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
+++++.++. ++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||||+||+++++
T Consensus 63 i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~ 138 (260)
T cd05069 63 LVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDN 138 (260)
T ss_pred eeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCC
Confidence 566666654 567899999999999999997643 3478999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+|||++...............++..|+|||...+..++.++||||||+++|||++ |..||..... ...
T Consensus 139 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~--- 212 (260)
T cd05069 139 LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REV--- 212 (260)
T ss_pred CeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH---
Confidence 999999999998764333222223345678999999988889999999999999999999 8999864311 111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
....... . ....+...+..+.+++.+||+.||++||++++|++.|+.
T Consensus 213 --~~~~~~~-~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 213 --LEQVERG-Y----RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --HHHHHcC-C----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111111 1 111223446778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=262.68 Aligned_cols=201 Identities=28% Similarity=0.358 Sum_probs=155.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++.+...+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+
T Consensus 65 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iv 141 (297)
T cd05089 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFI 141 (297)
T ss_pred hhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 6677888888999999999999999999996532 2477889999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNF 614 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf 614 (702)
||||||+||++++++.+||+|||++........ ......+..|+|||.+....++.++||||||+++|||++ |..||
T Consensus 142 H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf 219 (297)
T cd05089 142 HRDLAARNVLVGENLASKIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY 219 (297)
T ss_pred cCcCCcceEEECCCCeEEECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999999999864321111 111223457999999988889999999999999999997 99999
Q ss_pred cCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCCCC
Q 038002 615 EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPIL 689 (702)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~~p 689 (702)
...... . .......+. ....+...+..+.+++.+||+.+|.+||++++++++|+.+.+...+
T Consensus 220 ~~~~~~--~------~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 220 CGMTCA--E------LYEKLPQGY-----RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred CCCCHH--H------HHHHHhcCC-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 643111 0 111111111 1112223456788999999999999999999999999887654444
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=253.67 Aligned_cols=200 Identities=21% Similarity=0.312 Sum_probs=158.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|++++..+..++..++||||+++++|.+++... ...+++.++..++.|++.||+|||+. +|+|+||+|+||+++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~ 140 (267)
T cd08224 64 VIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFIT 140 (267)
T ss_pred eeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEEC
Confidence 777888888899999999999999999998642 33478999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..
T Consensus 141 ~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~ 214 (267)
T cd08224 141 ATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LY 214 (267)
T ss_pred CCCcEEEeccceeeeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HH
Confidence 999999999999886543221 123345788999999998888999999999999999999999999644211 00
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
. .......+.... .........+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 215 ~-~~~~~~~~~~~~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 215 S-LCKKIEKCDYPP----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred H-HHhhhhcCCCCC----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 111111111111 111245667889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=257.91 Aligned_cols=200 Identities=25% Similarity=0.326 Sum_probs=156.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.. ...+++|||+++|+|.+++......+++.++..++.|++.||+|||++ +|+||||||+||++++++
T Consensus 71 i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~ 146 (279)
T cd05109 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPN 146 (279)
T ss_pred CceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCC
Confidence 6666666654 457899999999999999987665789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||+++......... .....++..|+|||...+..++.++||||||+++|||++ |..||..... .....
T Consensus 147 ~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~ 222 (279)
T cd05109 147 HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPD 222 (279)
T ss_pred cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 99999999998764333211 112234678999999988889999999999999999998 8999864311 11111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
. ...+.. ...+......+.+++.+||+.||++||++.++++.|+.+...+
T Consensus 223 ~----~~~~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 223 L----LEKGER-----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred H----HHCCCc-----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 1 111111 0112234567889999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=264.75 Aligned_cols=192 Identities=24% Similarity=0.280 Sum_probs=162.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC--
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-- 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-- 548 (702)
|+.+...|++.+..++|||++.||.|.+.+... .+++.++..++.|++.+++|||+. ||+||||||+|+|+..
T Consensus 98 iv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~ 172 (382)
T KOG0032|consen 98 IVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD 172 (382)
T ss_pred EEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence 889999999999999999999999999999876 399999999999999999999999 9999999999999943
Q ss_pred --CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 549 --SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
++.+|++|||++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||..........
T Consensus 173 ~~~~~ik~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-- 248 (382)
T KOG0032|consen 173 EGSGRIKLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-- 248 (382)
T ss_pred CCCCcEEEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--
Confidence 35799999999998765 445677899999999999999999999999999999999999999997653221111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+..+++ .+..+.-...+..+.+++..||..||.+|+|+.++++.
T Consensus 249 ------~i~~~~~--~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 ------AILRGDF--DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ------HHHcCCC--CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 2223322 22223344568889999999999999999999999985
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=259.12 Aligned_cols=196 Identities=23% Similarity=0.370 Sum_probs=155.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEec
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHC 537 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~ 537 (702)
|++++.++..+...++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +++|+
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~ 146 (280)
T cd05049 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHR 146 (280)
T ss_pred chheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceecc
Confidence 7778888889999999999999999999997542 2467889999999999999999999 99999
Q ss_pred CCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCc
Q 038002 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFE 615 (702)
Q Consensus 538 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~ 615 (702)
||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 147 dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~ 226 (280)
T cd05049 147 DLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY 226 (280)
T ss_pred ccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCC
Confidence 9999999999999999999999976532221 11223345778999999998999999999999999999998 999986
Q ss_pred CCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 616 VNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
..... .. ......+... ..+...+..+.+++.+||+.||++||+++||+++|++
T Consensus 227 ~~~~~----~~----~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 227 GLSNE----EV----IECITQGRLL-----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred CCCHH----HH----HHHHHcCCcC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 43111 11 1111122111 1122345678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=257.92 Aligned_cols=196 Identities=27% Similarity=0.343 Sum_probs=152.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|++++.++.+.+..++||||+++++|.+++.... ..+++.+++.++.||+.||+|||++ +++|+||||+||
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~ni 147 (277)
T cd05036 71 IVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNC 147 (277)
T ss_pred EeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheE
Confidence 7888888888899999999999999999997653 2478899999999999999999999 999999999999
Q ss_pred EEeCCC---cEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCC
Q 038002 545 LIDDSW---RAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVS 619 (702)
Q Consensus 545 ll~~~~---~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 619 (702)
+++.++ .+||+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 148 l~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 148 LLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred EEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 998765 59999999998763222111 112223567999999988889999999999999999997 9999964321
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
. + .... ...... ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus 228 ~--~--~~~~----~~~~~~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 228 Q--E--VMEF----VTGGGR-----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred H--H--HHHH----HHcCCc-----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1 1 1111 111100 01122335678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-29 Score=253.95 Aligned_cols=195 Identities=26% Similarity=0.424 Sum_probs=155.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+......++||||+++++|.+++......++++.+..++.|++.+|+|||+. +++|+||||+||+++.++
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~ 137 (256)
T cd05112 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQ 137 (256)
T ss_pred eeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCC
Confidence 77888889999999999999999999999987665688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..... .. .
T Consensus 138 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~-~--- 210 (256)
T cd05112 138 VVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SE-V--- 210 (256)
T ss_pred eEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HH-H---
Confidence 99999999998654332221222334678999999988889999999999999999998 9999964311 11 1
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
......+ ... ..+....+.+.+++.+||+.+|++||++++++++|.
T Consensus 211 -~~~~~~~-~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 211 -VETINAG-FRL----YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -HHHHhCC-CCC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1111111 000 111223567999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=253.94 Aligned_cols=195 Identities=29% Similarity=0.422 Sum_probs=158.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL--------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
|++++.++.+++..++||||+++++|.+++... ...+++.++..++.|++.||+|||++ +++|+||||+
T Consensus 58 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~ 134 (262)
T cd00192 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAAR 134 (262)
T ss_pred hheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcc
Confidence 677888888899999999999999999999876 35789999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVST 620 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 620 (702)
||+++.++.+||+|||.+........ .......++..|+|||.+....++.++||||||+++|||++ |..||.....
T Consensus 135 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~- 213 (262)
T cd00192 135 NCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN- 213 (262)
T ss_pred eEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999987654331 11233457889999999888889999999999999999999 6999965411
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.. .......+. ....+...+.++.+++.+||+.+|++||+++|+++.|+
T Consensus 214 ---~~----~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 214 ---EE----VLEYLRKGY-----RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---HH----HHHHHHcCC-----CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11 111111111 11222334678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=254.26 Aligned_cols=196 Identities=23% Similarity=0.283 Sum_probs=154.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.++ .+..++||||+++++|.+++......+++.+++.++.|++.||+|||++ +++|+||||+||+++.++
T Consensus 57 ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~ 132 (257)
T cd05115 57 IVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQH 132 (257)
T ss_pred eEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCC
Confidence 677777765 4578999999999999999986665789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee--eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++........... ....++..|+|||.+....++.++||||||+++||+++ |..||...... .
T Consensus 133 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~-- 206 (257)
T cd05115 133 YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----E-- 206 (257)
T ss_pred cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----H--
Confidence 999999999986543322111 11223568999999888889999999999999999996 99999643111 0
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.......+.. ...+....+.+.+++.+||+.+|++||++.+|.+.|+..
T Consensus 207 --~~~~~~~~~~-----~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 207 --VMSFIEQGKR-----LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --HHHHHHCCCC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1111111111 112233467888999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=256.28 Aligned_cols=220 Identities=24% Similarity=0.307 Sum_probs=169.6
Q ss_pred ccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 447 DKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
..+.||+|++ ||++.... ..+|+| |++++.++..++..++|||++++
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 82 (260)
T PF00069_consen 3 LVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPG 82 (260)
T ss_dssp EEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETT
T ss_pred EeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccc
Confidence 3467788876 77776655 346665 78888999999999999999999
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
++|.+++.... .+++.++..++.||++||++||++ +|+|+||||+||+++.++.++|+|||.+... .........
T Consensus 83 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~~~ 157 (260)
T PF00069_consen 83 GSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENFNP 157 (260)
T ss_dssp EBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEBSS
T ss_pred ccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccccccc
Confidence 99999998333 689999999999999999999999 9999999999999999999999999999865 222233445
Q ss_pred eeccccccCccccc-CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 574 VRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 574 ~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
..++..|+|||++. +...+.++||||+|+++++|++|..||.............. ............ .....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~--~~~~~ 230 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK-----ILKRPLPSSSQQ--SREKS 230 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH-----HHHTHHHHHTTS--HTTSH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh-----cccccccccccc--cchhH
Confidence 66899999999988 88899999999999999999999999975410011111110 010000000000 00113
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+.+++.+||+.||++||+++++++
T Consensus 231 ~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 231 EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=263.10 Aligned_cols=198 Identities=24% Similarity=0.348 Sum_probs=154.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..+ ..++|+||+++|+|.+++......+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 71 iv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~ 146 (316)
T cd05108 71 VCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQ 146 (316)
T ss_pred CCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCC
Confidence 67777777654 57899999999999999987766788999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+ +..
T Consensus 147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~--~~--~~~ 222 (316)
T cd05108 147 HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SE--ISS 222 (316)
T ss_pred cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--HH--HHH
Confidence 99999999998765433221 122234668999999998899999999999999999998 9999964311 11 111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
....+.. . ..+......+.+++.+||+.+|++||++.+++..|..+..
T Consensus 223 ----~~~~~~~-~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 223 ----ILEKGER-L----PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----HHhCCCC-C----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 1111110 0 1112234568889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=252.88 Aligned_cols=193 Identities=29% Similarity=0.378 Sum_probs=155.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+..++..++||||+++++|.+++..... .+++..+..++.|++.||+|||++ +++|+||||+||+++.+
T Consensus 62 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~ 138 (256)
T cd05039 62 LVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSED 138 (256)
T ss_pred eeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCC
Confidence 77888888889999999999999999999976543 589999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||.+........ ....+..|+|||.+....++.++||||||+++||+++ |..||..... . .+
T Consensus 139 ~~~~l~d~g~~~~~~~~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~--~~-- 208 (256)
T cd05039 139 LVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--K--DV-- 208 (256)
T ss_pred CCEEEcccccccccccccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--H--HH--
Confidence 9999999999986632221 2234567999999988889999999999999999997 9999864311 1 11
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
....... . ....+...++.+.+++.+||+.+|++||+++|++++|+++
T Consensus 209 --~~~~~~~-~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 209 --VPHVEKG-Y----RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred --HHHHhcC-C----CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1111111 0 0111223457889999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=257.60 Aligned_cols=203 Identities=23% Similarity=0.333 Sum_probs=156.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE----------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 540 (702)
|++++.++..++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 7888889999999999999999999999997643 2578999999999999999999999 99999999
Q ss_pred CCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh--CCcCCcCC
Q 038002 541 LRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC--CRSNFEVN 617 (702)
Q Consensus 541 p~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~ 617 (702)
|+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ +..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999986533221 12223456778999999888889999999999999999998 67777533
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
. . ...+ ................ ..+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus 238 ~--~-~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 238 T--D-QQVI-ENAGHFFRDDGRQIYL--PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred C--h-HHHH-HHHHhccccccccccC--CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 1 1 1111 1111111111111111 1122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=252.89 Aligned_cols=195 Identities=27% Similarity=0.424 Sum_probs=153.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++...+.+ ...++||||+++++|.+++... ....++.++..++.|++.||+|||+. +++|+||||+||+++.+
T Consensus 63 i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~ 138 (260)
T cd05073 63 LVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSAS 138 (260)
T ss_pred cceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCC
Confidence 6677777666 7889999999999999999764 33578889999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||.+...............++..|+|||.+....++.++|+||||+++|++++ |+.||...... ....
T Consensus 139 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~ 214 (260)
T cd05073 139 LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----EVIR 214 (260)
T ss_pred CcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH----HHHH
Confidence 999999999998664332222223345678999999988889999999999999999999 89999643111 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
....+.. .......+..+.+++.+||+.+|++||++.+++++|+.
T Consensus 215 ----~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 215 ----ALERGYR-----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----HHhCCCC-----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111110 01122345678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.61 Aligned_cols=201 Identities=21% Similarity=0.222 Sum_probs=147.8
Q ss_pred eeeEEEEEec-----CCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHR-----SSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|++++.++.. ....++||||+++ +|.+++.... ..+++.++..++.|++.||+|||++ +|+|+||||+||
T Consensus 64 i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Ni 139 (288)
T cd07863 64 IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI 139 (288)
T ss_pred eeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 5666655543 4568999999975 8999887643 3489999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+++.++.+||+|||++........ .....++..|+|||.+.+..++.++|||||||++|||++|+.||..........
T Consensus 140 li~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~ 217 (288)
T cd07863 140 LVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG 217 (288)
T ss_pred EECCCCCEEECccCccccccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH
Confidence 999999999999999986543221 233567899999999988889999999999999999999999996442111110
Q ss_pred hhHHHHHHhhhccccccc-------cc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKL-------VE-------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~-------~~-------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...... .......+... .. ....+...+.+.+++.+||+.||++|||++|++.
T Consensus 218 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 218 KIFDLI-GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHh-CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 100000 00000000000 00 0112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.68 Aligned_cols=193 Identities=27% Similarity=0.332 Sum_probs=152.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+.+...+.+++..++||||+++++|.+++.... ..+++.++..++.|++.||.|||+. +|+|+||||+||+++.+
T Consensus 62 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDH 138 (285)
T ss_pred eeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCC
Confidence 6777788888999999999999999999986543 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||++........ .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...............
T Consensus 139 ~~~~l~Dfg~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~ 216 (285)
T cd05630 139 GHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL 216 (285)
T ss_pred CCEEEeeccceeecCCCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh
Confidence 9999999999876533222 22346899999999998889999999999999999999999999754221111111000
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
.. ... ..........+.+++.+||+.||++||| ++|+++
T Consensus 217 -----~~-~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 217 -----VK-EVQ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred -----hh-hhh----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00 000 1112234556889999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=250.82 Aligned_cols=192 Identities=26% Similarity=0.345 Sum_probs=156.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+.+++..++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~ 137 (256)
T cd08529 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAY 137 (256)
T ss_pred eehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCC
Confidence 777888889999999999999999999999775 34688999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||++........ ......+++.|+|||+..+..++.++|+||||++++||++|+.||.... ...
T Consensus 138 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~----- 208 (256)
T cd08529 138 DNVKIGDLGVAKLLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGA----- 208 (256)
T ss_pred CCEEEcccccceeccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHH-----
Confidence 9999999999987643322 2233467889999999988889999999999999999999999996442 111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.......+... .........+.+++.+||+.+|++||++.++++.
T Consensus 209 ~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 209 LILKIIRGVFP-----PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHcCCCC-----CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111111111 1222456678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=257.50 Aligned_cols=207 Identities=23% Similarity=0.290 Sum_probs=154.3
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++.+++.. ....++||||+++++|.+++... .+++.+++.++.|++.||+|||++ +|+|+||||+||+++.
T Consensus 68 i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~ 142 (283)
T cd05080 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDN 142 (283)
T ss_pred EeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcC
Confidence 6777766544 45689999999999999999754 589999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCce--eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 549 SWRAKISDFGLAKLLMPNQTGI--VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
++.+||+|||++.......... .....++..|+|||.+....++.++||||||+++|||++|..|+............
T Consensus 143 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 222 (283)
T cd05080 143 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG 222 (283)
T ss_pred CCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhc
Confidence 9999999999998664322211 11223456799999998888999999999999999999999998643211110000
Q ss_pred HHHHHHhhhccccccc----cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 627 STWVYNCFVAGEFNKL----VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..........+... .....+...+..+.+++.+||+.+|++|||+++|+++|+.+.
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 223 --PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred --ccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000000000000 011123334578999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=252.72 Aligned_cols=196 Identities=26% Similarity=0.322 Sum_probs=154.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++. ++..++||||+++++|.+++.... .+++..+..++.|++.||+|||.. +++|+||||+||+++.++
T Consensus 58 iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~ 132 (257)
T cd05060 58 IVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRH 132 (257)
T ss_pred eeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCC
Confidence 667776655 567899999999999999998765 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee--eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||+++.......... ....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ....
T Consensus 133 ~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~ 208 (257)
T cd05060 133 QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVI 208 (257)
T ss_pred cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHH
Confidence 999999999987643332211 11223467999999988889999999999999999998 9999964311 1111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
... ..... ...+...+..+.+++.+||+.+|++||++.+|++.|++..
T Consensus 209 ~~~----~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 209 AML----ESGER-----LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HHH----HcCCc-----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 111 11110 1122234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=254.20 Aligned_cols=188 Identities=19% Similarity=0.277 Sum_probs=148.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++|+|.+++......+++..++.++.||+.||+|||+. +|+||||||+||+++.++
T Consensus 61 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~ 137 (258)
T cd05078 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREE 137 (258)
T ss_pred hhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEeccc
Confidence 67788888888999999999999999999987665789999999999999999999999 999999999999998776
Q ss_pred c--------EEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCC-cCCcCCCCC
Q 038002 551 R--------AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCR-SNFEVNVST 620 (702)
Q Consensus 551 ~--------~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~-~Pf~~~~~~ 620 (702)
. ++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||++|. .|+.... .
T Consensus 138 ~~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~-~ 211 (258)
T cd05078 138 DRKTGNPPFIKLSDPGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD-S 211 (258)
T ss_pred ccccCCCceEEecccccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc-H
Confidence 5 699999988654321 22457889999998876 45789999999999999999985 5554321 1
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
... .. . .... ...+......+.+++.+||+.||++|||++++++.|+
T Consensus 212 ~~~---~~-~----~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 212 QKK---LQ-F----YEDR------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHH---HH-H----HHcc------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100 00 0 0000 0112223457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=275.18 Aligned_cols=230 Identities=21% Similarity=0.148 Sum_probs=161.4
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEec--------CCeeEEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHR--------SSKKLLVY 488 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~--------~~~~~lV~ 488 (702)
.+...+.||+|+| ||++.... ..||+| |+++..++.. ....++||
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvm 146 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEE
Confidence 4555678888887 88777643 566766 5555554422 23577999
Q ss_pred ecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC-cEEEecccceeecC
Q 038002 489 EFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW-RAKISDFGLAKLLM 564 (702)
Q Consensus 489 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 564 (702)
||+++ +|.+++.. ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.+.
T Consensus 147 E~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~ 222 (440)
T PTZ00036 147 EFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222 (440)
T ss_pred ecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence 99975 77777653 234688999999999999999999999 999999999999998665 69999999998664
Q ss_pred CCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH----Hhh--hcc
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY----NCF--VAG 637 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~----~~~--~~~ 637 (702)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||................. ... ...
T Consensus 223 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~ 300 (440)
T PTZ00036 223 AGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNP 300 (440)
T ss_pred CCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhch
Confidence 3222 223567999999998765 4689999999999999999999999975422111100000000 000 000
Q ss_pred c-----ccccc----ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 638 E-----FNKLV----EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 638 ~-----~~~~~----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. +.... ...++...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 301 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 301 NYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 00000 001122235678999999999999999999999853
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=253.72 Aligned_cols=196 Identities=31% Similarity=0.467 Sum_probs=156.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+..+...++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +++|+||||+||+++++
T Consensus 63 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~ 139 (261)
T cd05034 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGEN 139 (261)
T ss_pred EeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCC
Confidence 7888888888899999999999999999997654 3688999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++................+..|+|||.+.+..++.++|+||||+++|||++ |+.||.... .......
T Consensus 140 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~---~~~~~~~ 216 (261)
T cd05034 140 LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT---NREVLEQ 216 (261)
T ss_pred CCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Confidence 999999999998764322211222334568999999988889999999999999999998 999995431 1111111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
.... . ....+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 217 -----~~~~-~----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 217 -----VERG-Y----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -----HHcC-C----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111 0 111122235678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=255.36 Aligned_cols=191 Identities=21% Similarity=0.245 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.+...+..++..++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+|+||||+||++++++
T Consensus 59 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~ 134 (279)
T cd05633 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHG 134 (279)
T ss_pred EeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCC
Confidence 6677788888999999999999999999987654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc-CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||++....... .....|+..|+|||.+. +..++.++||||+|+++|||++|+.||......... ....
T Consensus 135 ~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~- 209 (279)
T cd05633 135 HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDR- 209 (279)
T ss_pred CEEEccCCcceeccccC---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHH-
Confidence 99999999987553222 12345899999999876 456889999999999999999999999754222111 1110
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
... ......+......+.+++.+||+.||++|| +++|+++.
T Consensus 210 ---~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 210 ---MTL------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ---Hhh------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 000 011123344567889999999999999999 59999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=255.11 Aligned_cols=199 Identities=20% Similarity=0.291 Sum_probs=157.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|++++.++..++..++||||+++++|.+++... ...+++..+..++.||+.||+|||++ +++|+||||+||+++
T Consensus 64 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~ 140 (267)
T cd08229 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFIT 140 (267)
T ss_pred hhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEc
Confidence 677778888899999999999999999998642 33578999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~- 216 (267)
T cd08229 141 ATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY--SL- 216 (267)
T ss_pred CCCCEEECcchhhhccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH--HH-
Confidence 999999999999876543222 22334688899999999888899999999999999999999999964321110 00
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
......... .+.........+.+++.+||+.||++|||+++|++++++.
T Consensus 217 ---~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 217 ---CKKIEQCDY----PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---hhhhhcCCC----CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 011111111 1111223566899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=256.55 Aligned_cols=196 Identities=25% Similarity=0.332 Sum_probs=154.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE--------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIH 536 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH 536 (702)
|++++.++..++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +|+|
T Consensus 69 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H 145 (280)
T cd05092 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVH 145 (280)
T ss_pred CceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence 7788888999999999999999999999997643 2478899999999999999999999 9999
Q ss_pred cCCCCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCC
Q 038002 537 CDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNF 614 (702)
Q Consensus 537 ~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf 614 (702)
+||||+||++++++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 146 ~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 225 (280)
T cd05092 146 RDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW 225 (280)
T ss_pred ccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999997653322111 122335678999999988889999999999999999998 89998
Q ss_pred cCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 615 EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
...... .. ......+.. ...+...+..+.+++.+||+.||++||+++||++.|++
T Consensus 226 ~~~~~~---~~-----~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 226 YQLSNT---EA-----IECITQGRE-----LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred ccCCHH---HH-----HHHHHcCcc-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 543111 11 111111110 01122334678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=255.37 Aligned_cols=188 Identities=22% Similarity=0.312 Sum_probs=148.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.++...++||||+++|+|..++......+++..+..++.||++||+|||++ +|+||||||+||+++..+
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLG 154 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccC
Confidence 88899999999999999999999999999977666789999999999999999999999 999999999999997644
Q ss_pred -------cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhh-hCCcCCcCCCCCc
Q 038002 551 -------RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEII-CCRSNFEVNVSTA 621 (702)
Q Consensus 551 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~ 621 (702)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|..||.......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred cccCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 38999999876442211 2246788999998865 56899999999999999995 6999986442111
Q ss_pred chhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 622 DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
. .... . .... .+......+.+++.+||+.+|++||++++|++.|+
T Consensus 230 ~----~~~~-~--~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 K----ERFY-E--KKHR--------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H----HHHH-H--hccC--------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 0 0100 0 0000 11112346889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=257.79 Aligned_cols=202 Identities=27% Similarity=0.363 Sum_probs=158.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|++++..+...+..++||||+++++|.+++.... ..+++.++..++.||++||+|||++ +|+
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---giv 159 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCI 159 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 6778888889999999999999999999997542 2467888999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
|+||||+||+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 160 H~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 239 (304)
T cd05101 160 HRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239 (304)
T ss_pred ecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999998764332211 122345678999999988889999999999999999998 7888
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCCC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPI 688 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~~ 688 (702)
|.... ..+ .......+... ..+...+..+.+++.+||+.+|++||++.|+++.|+++..+..
T Consensus 240 ~~~~~--~~~------~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 240 YPGIP--VEE------LFKLLKEGHRM-----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred cccCC--HHH------HHHHHHcCCcC-----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 85431 111 11111111110 1122345678899999999999999999999999998776544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=254.28 Aligned_cols=197 Identities=25% Similarity=0.359 Sum_probs=157.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.++.+++..++||||+++++|.+++......+++.++..++.|++.||+|||+. +++|+||||+||+++.++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~ 143 (267)
T cd05066 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNL 143 (267)
T ss_pred cceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCC
Confidence 78888888999999999999999999999987665789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceee--ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVA--GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.++|+|||++............ ...++..|+|||.+.+..++.++|+||||+++||+++ |..||....... ..
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~----~~ 219 (267)
T cd05066 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD----VI 219 (267)
T ss_pred eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH----HH
Confidence 9999999999876443322111 1223567999999988889999999999999999886 999996432110 11
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
. ..... . ........+..+.+++.+||+.+|++||+++++++.|+++
T Consensus 220 ~----~~~~~-~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 220 K----AIEEG-Y----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred H----HHhCC-C----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 11111 0 0111223456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=258.92 Aligned_cols=198 Identities=24% Similarity=0.357 Sum_probs=157.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+...+..++||||+++++|.+++..... .+++.++..++.|++.||+|||++ +|+|+||||+||+++.+
T Consensus 101 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHG 177 (302)
T ss_pred cceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCC
Confidence 77888888999999999999999999999976432 389999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 550 WRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
+.++|+|||++......... ......++..|+|||.+....++.++||||||+++|||++ |..||....... ...
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~~~ 254 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---KFY 254 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---HHH
Confidence 99999999999866433221 1222345678999999988889999999999999999998 999986442111 111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
. ....+ .. ...+.....++.+++.+||+.+|++||++.|+++.|++.
T Consensus 255 ~----~~~~~-~~----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 255 K----LIKEG-YR----MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred H----HHHcC-Cc----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 11111 11 111122356789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-29 Score=268.47 Aligned_cols=204 Identities=22% Similarity=0.275 Sum_probs=149.2
Q ss_pred eeeEEEEEecCC-----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYKHRSS-----KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 545 (702)
|++++..+...+ ..|+||||+. ++|.+.+.... .+++..+..++.||+.||+|||++ +|+||||||+|||
T Consensus 61 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil 135 (372)
T cd07853 61 VLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLL 135 (372)
T ss_pred cCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEE
Confidence 566666666665 8999999996 58888886544 689999999999999999999999 9999999999999
Q ss_pred EeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 546 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
++.++.+||+|||++...............+++.|+|||.+.+. .++.++|||||||++|||++|+.||..........
T Consensus 136 i~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 215 (372)
T cd07853 136 VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215 (372)
T ss_pred ECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 99999999999999987544333333445678999999988764 57899999999999999999999997542111000
Q ss_pred hhHHH---------------HHHhhhcc-cccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 625 LLSTW---------------VYNCFVAG-EFNKLVEE--EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 625 ~~~~~---------------~~~~~~~~-~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+... ........ ........ .......+.+.+++.+||+.||++|||++|+++.
T Consensus 216 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 216 LITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 00000000 00000000 1112235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=255.86 Aligned_cols=196 Identities=26% Similarity=0.361 Sum_probs=154.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE----------------TRPLWRDRVRIALDVARGLLYLHDECEVQI 534 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~i 534 (702)
|+++++++..++..++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +|
T Consensus 69 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i 145 (283)
T cd05090 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FF 145 (283)
T ss_pred eeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ce
Confidence 7888889999999999999999999999985321 2367888899999999999999999 99
Q ss_pred EecCCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCc
Q 038002 535 IHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRS 612 (702)
Q Consensus 535 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~ 612 (702)
+|+||||+||++++++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |..
T Consensus 146 ~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~ 225 (283)
T cd05090 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQ 225 (283)
T ss_pred ehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999999986543321 11223345678999999988889999999999999999998 999
Q ss_pred CCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 613 NFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 613 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
||..... .... +........ ..+......+.+++.+||+.||++||++.+|+++|.+
T Consensus 226 p~~~~~~----~~~~----~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 226 PYYGFSN----QEVI----EMVRKRQLL-----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred CCCCCCH----HHHH----HHHHcCCcC-----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 9864311 1111 111111111 1122335678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=253.46 Aligned_cols=199 Identities=28% Similarity=0.352 Sum_probs=148.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|+++++.+.+....++||||+++|+|.+++.... ...++..+..++.|++.||+|||+. +++|+||||+||++
T Consensus 57 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~ 133 (269)
T cd05087 57 LLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLL 133 (269)
T ss_pred EeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEE
Confidence 7888888999999999999999999999997532 1356778888999999999999999 99999999999999
Q ss_pred eCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCC-------CCCccccccchhHhHHHhhh-CCcCCcCC
Q 038002 547 DDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSG-------LITVKSDVYSFGVVLLEIIC-CRSNFEVN 617 (702)
Q Consensus 547 ~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlGvil~ellt-G~~Pf~~~ 617 (702)
+.++.+||+|||++.......... .....++..|+|||++... .++.++||||||+++|||++ |+.||...
T Consensus 134 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 134 TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999987543322211 1234567889999987532 35789999999999999996 99999643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
... +. . ... ..........+.......+.+.+++..|+ .+|++|||++||++.|+
T Consensus 214 ~~~--~~-~-~~~----~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 214 SDE--QV-L-TYT----VREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChH--HH-H-HHH----hhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 211 11 0 100 11111111122222233456778888898 58999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.26 Aligned_cols=196 Identities=29% Similarity=0.364 Sum_probs=153.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++.+...+..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++
T Consensus 58 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~ 134 (270)
T cd05047 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFI 134 (270)
T ss_pred eeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEe
Confidence 7788888999999999999999999999997532 2367899999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNF 614 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf 614 (702)
|+||||+||++++++.+||+|||++........ ......+..|+|||++....++.++||||||+++|||++ |..||
T Consensus 135 H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf 212 (270)
T cd05047 135 HRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212 (270)
T ss_pred ecccccceEEEcCCCeEEECCCCCccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999863221111 111223567999999988889999999999999999997 99999
Q ss_pred cCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 615 EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...... . .......+.. .+.+......+.+++.+||+.||.+|||++++++.|+++.
T Consensus 213 ~~~~~~---~-----~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 213 CGMTCA---E-----LYEKLPQGYR-----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred cccCHH---H-----HHHHHhCCCC-----CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 643111 0 0111111110 0112223457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=253.76 Aligned_cols=196 Identities=20% Similarity=0.247 Sum_probs=151.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +|+|+||||+||+++.++
T Consensus 68 ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~ 143 (267)
T cd06646 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNG 143 (267)
T ss_pred eeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCC
Confidence 7777888888999999999999999999987554 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++........ ......+++.|+|||.+. ...++.++|+||||+++|||++|+.||..........
T Consensus 144 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--- 219 (267)
T cd06646 144 DVKLADFGVAAKITATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--- 219 (267)
T ss_pred CEEECcCccceeeccccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---
Confidence 999999999986632221 122345788999999874 3457789999999999999999999985331111000
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
.......... ........+..+.+++.+||+.+|++||+++++++.|
T Consensus 220 -----~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 220 -----LMSKSNFQPP-KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -----eeecCCCCCC-CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000000000 0011123456888999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=253.35 Aligned_cols=197 Identities=23% Similarity=0.318 Sum_probs=155.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++...+.++...++||||+++++|.+++......+++.+++.++.|++.||+|||++ +++|+||||+||+++.++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~ 143 (269)
T cd05065 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNL 143 (269)
T ss_pred cceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCC
Confidence 78888889999999999999999999999987666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCce-ee-cee--ccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGI-VA-GVR--GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~-~~-~~~--gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 625 (702)
.+||+|||++.......... .. ... .+..|+|||.+.+..++.++||||||+++||+++ |..||..... ..
T Consensus 144 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~ 219 (269)
T cd05065 144 VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QD 219 (269)
T ss_pred cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HH
Confidence 99999999987654322211 11 111 1357999999988889999999999999999886 9999964311 11
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
...... ... ....+...+..+.+++.+||+.+|++||++++|+.+|+++
T Consensus 220 ~~~~i~-----~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 220 VINAIE-----QDY----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHH-----cCC----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 111 0111223355688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-29 Score=261.02 Aligned_cols=196 Identities=30% Similarity=0.385 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|++++..+..++..++||||+++++|.+++.... ..+++.+++.++.||+.||+|||++ +|+
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~ 146 (303)
T cd05088 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFI 146 (303)
T ss_pred cceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 6788888999999999999999999999997542 2468899999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNF 614 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf 614 (702)
||||||+||+++.++.+||+|||++........ ......+..|+|||.+.+..++.++||||||+++|||++ |..||
T Consensus 147 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 224 (303)
T cd05088 147 HRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 224 (303)
T ss_pred ccccchheEEecCCCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCc
Confidence 999999999999999999999999864211111 111223567999999888889999999999999999998 99999
Q ss_pred cCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 615 EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...... + . ....... .....+......+.+++.+||+.+|++||++++++++|+.+.
T Consensus 225 ~~~~~~--~-~-----~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 225 CGMTCA--E-L-----YEKLPQG-----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred ccCChH--H-H-----HHHHhcC-----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 643111 1 0 1111111 001111223457889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=257.42 Aligned_cols=204 Identities=22% Similarity=0.338 Sum_probs=155.1
Q ss_pred eeeEEEEEecC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRS--SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++.+.+... ...++||||+++++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 68 i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~ 144 (284)
T cd05079 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVES 144 (284)
T ss_pred eeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcC
Confidence 66676666654 678999999999999999976655689999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCc-----
Q 038002 549 SWRAKISDFGLAKLLMPNQTG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA----- 621 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~----- 621 (702)
++.+||+|||++..+...... ......++..|+|||.+.+..++.++||||||+++|||++++.|........
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~ 224 (284)
T cd05079 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIG 224 (284)
T ss_pred CCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcc
Confidence 999999999999876433221 1223456778999999888889999999999999999999877653221100
Q ss_pred ---chhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 622 ---DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 622 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.+..... .......+.. ...+...+..+.+++.+||+.||++||+++++++.|+++
T Consensus 225 ~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 225 PTHGQMTVTR-LVRVLEEGKR-----LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cccccccHHH-HHHHHHcCcc-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000110 0011111110 112233567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=257.95 Aligned_cols=198 Identities=28% Similarity=0.425 Sum_probs=156.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHhhh
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-----------------------TRPLWRDRVRIALDVARGLLYLH 527 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH 527 (702)
|+++++.+..++..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||
T Consensus 65 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 144 (290)
T cd05045 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 144 (290)
T ss_pred EeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH
Confidence 7888888999999999999999999999986421 23678899999999999999999
Q ss_pred hcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHH
Q 038002 528 DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLE 606 (702)
Q Consensus 528 ~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 606 (702)
++ +|+||||||+||++++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||++++|
T Consensus 145 ~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~e 221 (290)
T cd05045 145 EM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 221 (290)
T ss_pred HC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHH
Confidence 99 99999999999999999999999999998653332211 122345678999999888889999999999999999
Q ss_pred hhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 607 IIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 607 llt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
|++ |..||.... .. .+ ....... . ....+......+.+++.+||+.+|++||+++|+++.|+++.
T Consensus 222 l~t~g~~p~~~~~--~~--~~----~~~~~~~-~----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 222 IVTLGGNPYPGIA--PE--RL----FNLLKTG-Y----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred HHhcCCCCCCCCC--HH--HH----HHHHhCC-C----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 998 999996431 11 11 1111111 1 11112234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=249.58 Aligned_cols=196 Identities=25% Similarity=0.342 Sum_probs=155.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.++......++||||+++++|.+++......+++..+..++.|++.+|+|||++ +++||||||+||+++.++
T Consensus 54 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~ 130 (251)
T cd05041 54 IVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENN 130 (251)
T ss_pred eEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCC
Confidence 77888889999999999999999999999977655688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee-eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV-AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||++........... .....+..|+|||.+.+..++.++|+||||+++|||++ |..||...... ....
T Consensus 131 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~ 206 (251)
T cd05041 131 VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRE 206 (251)
T ss_pred cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHH
Confidence 999999999986532221111 11223567999999888889999999999999999999 88888544211 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
..... . ....+...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 207 ----~~~~~-~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 207 ----RIESG-Y----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ----HHhcC-C----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 11110 0 011122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-29 Score=279.18 Aligned_cols=222 Identities=20% Similarity=0.195 Sum_probs=178.9
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV 487 (702)
.+.+...+.||+|+| |++..... ..+|+| |+.+...|+++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 345566789999999 66665544 778888 77788889999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
||||+||+|-.++.+.. ++++..+.-++..|+.||..||+. |+|||||||+|||+|..|++||+|||.+..+..+.
T Consensus 154 MdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 99999999999999888 899999999999999999999999 99999999999999999999999999999887777
Q ss_pred CceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcc-cccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG-EFNK 641 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 641 (702)
.-.....+|||.|++||+++. +.|+..+|.||+||++|||+.|..||.... +.. .+..+... +...
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads-------lve-TY~KIm~hk~~l~ 301 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS-------LVE-TYGKIMNHKESLS 301 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH-------HHH-HHHHHhchhhhcC
Confidence 666667889999999998852 578999999999999999999999997541 111 11112111 1111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPS---MKNVILM 679 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt---~~evl~~ 679 (702)
+. .....++...+||++.+. +|+.|.. ++++...
T Consensus 302 FP---~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 302 FP---DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred CC---cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 11 123367778888887666 7888988 8887664
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.41 Aligned_cols=197 Identities=22% Similarity=0.269 Sum_probs=155.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+ +..++||||+++++|.+++......+++..+..++.|++.||+|||+. +++|+||||+||+++.++
T Consensus 69 i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~ 144 (270)
T cd05056 69 IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPD 144 (270)
T ss_pred hhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCC
Confidence 6777776654 567899999999999999987665689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++...............++..|+|||.+....++.++||||||+++||+++ |..||...... ...
T Consensus 145 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~--- 218 (270)
T cd05056 145 CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVI--- 218 (270)
T ss_pred CeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHH---
Confidence 99999999998764432222222334568999999888889999999999999999986 99999644211 111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.....+... ..+...+..+.+++.+|+..+|++|||+.++++.|+++.
T Consensus 219 --~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 219 --GRIENGERL-----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --HHHHcCCcC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 112234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=256.22 Aligned_cols=203 Identities=22% Similarity=0.306 Sum_probs=153.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-----------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-----------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl 539 (702)
|+++++++..++..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +++|+||
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl 155 (295)
T cd05097 79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDL 155 (295)
T ss_pred cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---Ceecccc
Confidence 7888899999999999999999999999986432 1357888999999999999999999 9999999
Q ss_pred CCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh--CCcCCcC
Q 038002 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC--CRSNFEV 616 (702)
Q Consensus 540 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~ 616 (702)
||+||++++++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ +..||..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999999999765332211 1122345678999999888889999999999999999988 5667754
Q ss_pred CCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 617 NVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
... .+ .... ............ ....+...+..+.+++.+||+.||++||++++|++.|+.
T Consensus 236 ~~~--~~-~~~~-~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 236 LSD--EQ-VIEN-TGEFFRNQGRQI--YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred cCh--HH-HHHH-HHHhhhhccccc--cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 311 11 1111 111011000000 001122345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=252.19 Aligned_cols=188 Identities=21% Similarity=0.315 Sum_probs=149.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..+...++||||+++++|..++......+++..++.++.||++||+|||++ +|+||||||+|||++.++
T Consensus 66 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~ 142 (262)
T cd05077 66 IVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREG 142 (262)
T ss_pred EeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCC
Confidence 88899999999999999999999999999877665789999999999999999999999 999999999999998766
Q ss_pred c-------EEEecccceeecCCCCCceeeceeccccccCccccc-CCCCCccccccchhHhHHHhh-hCCcCCcCCCCCc
Q 038002 551 R-------AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEII-CCRSNFEVNVSTA 621 (702)
Q Consensus 551 ~-------~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~ell-tG~~Pf~~~~~~~ 621 (702)
. ++++|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|..||.......
T Consensus 143 ~~~~~~~~~~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 143 IDGECGPFIKLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred ccCCCCceeEeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 4 899999998754321 2234678899999876 467899999999999999998 5888875431110
Q ss_pred chhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 622 DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
. . ........ ......+.+.+++.+||+.||++||++.+|++.|+
T Consensus 218 -~----~----~~~~~~~~------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 218 -K----E----RFYEGQCM------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -H----H----HHHhcCcc------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 00111110 11112457889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=251.27 Aligned_cols=192 Identities=20% Similarity=0.279 Sum_probs=154.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++...++.++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+|+||||+||+++++
T Consensus 60 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~ 136 (255)
T cd08219 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQN 136 (255)
T ss_pred cceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCC
Confidence 7788888999999999999999999999987543 3478899999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||.+........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...
T Consensus 137 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~--- 208 (255)
T cd08219 137 GKVKLGDFGSARLLTSPGA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNL--- 208 (255)
T ss_pred CcEEEcccCcceeeccccc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HHH---
Confidence 9999999999986643221 22345688899999999888899999999999999999999999964311 000
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......+... ..+......+.+++.+||+.||++||++++++.+
T Consensus 209 -~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 -ILKVCQGSYK-----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -HHHHhcCCCC-----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111111111 1122345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-29 Score=270.28 Aligned_cols=222 Identities=23% Similarity=0.346 Sum_probs=184.4
Q ss_pred cceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 448 KRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
++.||.|-| ||.|.++. ..|||| |++|.+.--..+..+||+|||+
T Consensus 634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME 713 (996)
T KOG0196|consen 634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME 713 (996)
T ss_pred EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence 457899998 99999875 678888 8888888888999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
+|+|+.||+++..++++.+...++++|+.|++||-+. ++|||||...|||++.+...|++|||+++.+..+.....+
T Consensus 714 NGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~yt 790 (996)
T KOG0196|consen 714 NGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT 790 (996)
T ss_pred CCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCcccc
Confidence 9999999999988899999999999999999999999 9999999999999999999999999999987655533333
Q ss_pred ceec--cccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 573 GVRG--SRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 573 ~~~g--t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
..-| ..+|.|||.+..++++.++|||||||++||.++ |++||-.. ...+ .+.. + ...-++ ..+.
T Consensus 791 t~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm-SNQd--VIka-I---e~gyRL------PpPm 857 (996)
T KOG0196|consen 791 TLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-SNQD--VIKA-I---EQGYRL------PPPM 857 (996)
T ss_pred ccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc-chHH--HHHH-H---HhccCC------CCCC
Confidence 3222 458999999999999999999999999999987 99998643 1111 1111 0 011112 2345
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+.+..|.+||+.|||+|-.+||++.+|+.+|+++..
T Consensus 858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 567889999999999999999999999999998543
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=260.15 Aligned_cols=199 Identities=28% Similarity=0.375 Sum_probs=156.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|++++..+..++..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++ +++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~ 162 (307)
T cd05098 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCI 162 (307)
T ss_pred EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 7788888999999999999999999999997542 2478899999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
|+||||+||+++.++.+||+|||.+.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p 242 (307)
T cd05098 163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242 (307)
T ss_pred cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999987653222111 111224568999999988889999999999999999998 8888
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
|.... .++ .......... .+.+......+.+++.+||+.+|++||++.++++.|+.+.+
T Consensus 243 ~~~~~--~~~------~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 243 YPGVP--VEE------LFKLLKEGHR-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred CCcCC--HHH------HHHHHHcCCC-----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 85431 111 1111111111 11222345688899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=266.89 Aligned_cols=203 Identities=20% Similarity=0.235 Sum_probs=153.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++|||++. ++|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 148 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~ 222 (392)
T PHA03207 148 IINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPE 222 (392)
T ss_pred ccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCC
Confidence 7888888999999999999996 6898888443 3789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++......... ......||+.|+|||++....++.++|||||||++|||++|+.||...........+...
T Consensus 223 ~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i 302 (392)
T PHA03207 223 NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSI 302 (392)
T ss_pred CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHH
Confidence 9999999999765433221 223467899999999999889999999999999999999999999754322211111111
Q ss_pred HHHhhhcc--c---------------ccccccc--cc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAG--E---------------FNKLVEE--EV-----DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~--~---------------~~~~~~~--~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. ..... + ......+ .. .......+.+++.+||+.||++||++.|++..
T Consensus 303 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 303 IR-CMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HH-HhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10 00000 0 0000000 00 01124567889999999999999999999975
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=257.49 Aligned_cols=196 Identities=22% Similarity=0.317 Sum_probs=154.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---------------ETRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++.+...+..++++||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+
T Consensus 70 iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~ 146 (283)
T cd05091 70 IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVV 146 (283)
T ss_pred cCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Ccc
Confidence 788888999999999999999999999998532 12367888899999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
||||||+||++++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 226 (283)
T cd05091 147 HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226 (283)
T ss_pred ccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999886533221 11223445778999999988889999999999999999998 8888
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
|..... . . .......+... ..+...+..+.+++.+||+.+|++||++++|+++|++
T Consensus 227 ~~~~~~---~-~----~~~~i~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 227 YCGYSN---Q-D----VIEMIRNRQVL-----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCCCH---H-H----HHHHHHcCCcC-----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 864311 1 1 11112222211 1223356678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=252.20 Aligned_cols=197 Identities=22% Similarity=0.360 Sum_probs=152.3
Q ss_pred eeeEEEEEecCC------eeEEEEecCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCC
Q 038002 471 ISSLLVYKHRSS------KKLLVYEFMSKGSLADLLFNL-----ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539 (702)
Q Consensus 471 i~~l~~~~~~~~------~~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl 539 (702)
|+++++.....+ ..++||||+++++|..++... ...+++..+..++.|++.||+|||++ +|+|+||
T Consensus 63 iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl 139 (273)
T cd05035 63 VMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDL 139 (273)
T ss_pred eeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence 666766554444 489999999999999998543 23578899999999999999999999 9999999
Q ss_pred CCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCC
Q 038002 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVN 617 (702)
Q Consensus 540 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~ 617 (702)
||+||++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 140 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~ 219 (273)
T cd05035 140 AARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219 (273)
T ss_pred chheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998764333211 112234678999999988889999999999999999999 88988643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.. . .. ......+... ..+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 220 ~~--~--~~----~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 220 EN--H--EI----YDYLRHGNRL-----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CH--H--HH----HHHHHcCCCC-----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1 11 1111111111 12234466889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=252.36 Aligned_cols=199 Identities=28% Similarity=0.335 Sum_probs=148.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC----CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET----RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|+++++.+......++||||+++|+|.+++..... ..++..+..++.||+.||+|||++ +|+||||||+||++
T Consensus 57 ii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill 133 (269)
T cd05042 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQL 133 (269)
T ss_pred cceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEe
Confidence 78888899999999999999999999999976532 245778889999999999999999 99999999999999
Q ss_pred eCCCcEEEecccceeecCCCCCc-eeeceeccccccCccccc-------CCCCCccccccchhHhHHHhhh-CCcCCcCC
Q 038002 547 DDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQN-------SGLITVKSDVYSFGVVLLEIIC-CRSNFEVN 617 (702)
Q Consensus 547 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~ 617 (702)
+.++.+||+|||++......... ......++..|+|||++. ...++.++||||||+++|||++ |..||...
T Consensus 134 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 134 TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999999999998754322211 112234567799999764 2456789999999999999999 78888543
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.. ...+. .. ..........+..+......+.+++..|+ .||++||++++|+++|.
T Consensus 214 ~~---~~~~~----~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 214 SD---EQVLK----QV-VREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CH---HHHHH----HH-hhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 11111 11 11111112222233345566777778888 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=253.10 Aligned_cols=199 Identities=25% Similarity=0.457 Sum_probs=155.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 541 (702)
|++++..+...+..++||||+++|+|.+++.... ...++..+..++.|++.||+|||++ +|+||||||
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp 147 (288)
T cd05061 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAA 147 (288)
T ss_pred eeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCCh
Confidence 7888888889999999999999999999997532 2346778889999999999999999 999999999
Q ss_pred CcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCC
Q 038002 542 RNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVS 619 (702)
Q Consensus 542 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 619 (702)
+||++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 148 ~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 148 RNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred heEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999998765332211 1112234678999999988889999999999999999998 7888864311
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
++ . ......+... ..+......+.+++.+||+.||++|||+.++++.|++...
T Consensus 228 --~~--~----~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 228 --EQ--V----LKFVMDGGYL-----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred --HH--H----HHHHHcCCCC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 11 1 1111111111 1112234689999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=252.28 Aligned_cols=198 Identities=25% Similarity=0.433 Sum_probs=151.2
Q ss_pred eeeEEEEE-ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYK-HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+ ..+...++||||+++++|.+++.......++..+..++.|+++||+|||+. +++|+||||+||+++++
T Consensus 58 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~ 134 (262)
T cd05058 58 VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDES 134 (262)
T ss_pred cceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCC
Confidence 66677654 456678999999999999999987655678888899999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCc---eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhC-CcCCcCCCCCcchhh
Q 038002 550 WRAKISDFGLAKLLMPNQTG---IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICC-RSNFEVNVSTADEVL 625 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~ 625 (702)
+.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++| ..||... . ...
T Consensus 135 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~---~~~ 210 (262)
T cd05058 135 FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-D---SFD 210 (262)
T ss_pred CcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-C---HHH
Confidence 99999999999765332211 11223456789999999888899999999999999999995 5555432 1 111
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.... ...+.. ...+...+..+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 211 ~~~~----~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 211 ITVY----LLQGRR-----LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred HHHH----HhcCCC-----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1111 111110 0111223467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=254.62 Aligned_cols=203 Identities=24% Similarity=0.311 Sum_probs=153.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE----------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 540 (702)
|++++.++..++..++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++|+|||
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 7888899999999999999999999999987542 1356788999999999999999999 99999999
Q ss_pred CCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh--CCcCCcCC
Q 038002 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC--CRSNFEVN 617 (702)
Q Consensus 541 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~ 617 (702)
|+||+++.++.++|+|||++..+....... .....++..|++||......++.++||||||+++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999998653322111 122334678999998888889999999999999999998 67888543
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
... +.. ................ ..+...+..+.+++.+||+.||++||++++|++.|+.
T Consensus 238 ~~~--~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 238 SDE--QVI--ENTGEFFRDQGRQVYL--PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ChH--HHH--HHHHHHHhhccccccC--CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111 111 0011101110000001 1122344788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=256.15 Aligned_cols=192 Identities=23% Similarity=0.302 Sum_probs=153.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..+.+.++||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+|+||||+||+++.++
T Consensus 79 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~ 153 (296)
T cd06654 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG 153 (296)
T ss_pred EeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 778888888899999999999999999998643 578899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... .. .
T Consensus 154 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~-----~ 225 (296)
T cd06654 154 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RA-----L 225 (296)
T ss_pred CEEECccccchhcccccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--Hh-----H
Confidence 999999999876533221 122345788999999998888899999999999999999999999643211 10 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
........ ... ..+......+.+++.+||+.||++||+++++++.
T Consensus 226 ~~~~~~~~-~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 226 YLIATNGT-PEL---QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHhcCCC-CCC---CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11111110 000 1123445678899999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=255.20 Aligned_cols=205 Identities=25% Similarity=0.312 Sum_probs=151.9
Q ss_pred eeeEEEEE--ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYK--HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~--~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++.+++ .+....++||||+++++|.+++......+++..+..++.|++.||+|||++ +|+|+||||+||+++.
T Consensus 67 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~ 143 (284)
T cd05081 67 IVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVES 143 (284)
T ss_pred eeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECC
Confidence 66666554 334578999999999999999977655689999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCcee--eceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch---
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE--- 623 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--- 623 (702)
++.+||+|||++........... ....++..|+|||.+.+..++.++||||||+++|||++|..|+.........
T Consensus 144 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd05081 144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMG 223 (284)
T ss_pred CCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcc
Confidence 99999999999987643322111 1122344699999998888999999999999999999988775432110000
Q ss_pred -----hhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 624 -----VLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 624 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
............... ...........+.+++.+||+.+|++|||++||+++|+.+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 224 NDKQGQMIVYHLIELLKNNG-----RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cccccccchHHHHHHHhcCC-----cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000011110 0011223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=248.69 Aligned_cols=205 Identities=22% Similarity=0.247 Sum_probs=166.2
Q ss_pred cceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
...||+|+| |.++..+. +.+||| ++++...|++-+++|+||||+.
T Consensus 354 l~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvn 433 (683)
T KOG0696|consen 354 LMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVN 433 (683)
T ss_pred EEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEec
Confidence 357888888 77776655 677777 3444556777999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
||+|.-.|++.+ ++.+..+.-++.+|+-||-+||++ |||.||||.+||++|.+|++||+|||+++.--- ......
T Consensus 434 GGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~-~~~TTk 508 (683)
T KOG0696|consen 434 GGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF-DGVTTK 508 (683)
T ss_pred CchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccccc-CCccee
Confidence 999999998776 788889999999999999999999 999999999999999999999999999985322 223356
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
+++|||.|+|||++..++|+.++|.||+||+||||+.|+.||+... ++..+.. +.+.. -.++...+
T Consensus 509 TFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~a-----I~ehn------vsyPKslS 574 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQA-----IMEHN------VSYPKSLS 574 (683)
T ss_pred eecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHH-----HHHcc------CcCccccc
Confidence 7899999999999999999999999999999999999999998652 1222211 11111 13456667
Q ss_pred HHHHHHHHHcccCCCCCCC
Q 038002 653 ERMVKTGLLCIQDEPNLRP 671 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RP 671 (702)
.+...+++..|...|.+|.
T Consensus 575 kEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 575 KEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHHHhhcCCcccc
Confidence 7888888889999999993
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=253.77 Aligned_cols=193 Identities=22% Similarity=0.251 Sum_probs=151.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+.+..++..++||||+++++|..++.+....+++..+..++.|++.+|+|||++ +++|+||||+||+++.++
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~ 147 (292)
T cd06644 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDG 147 (292)
T ss_pred EeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCC
Confidence 78888888889999999999999999998876665789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.+||+|||++....... .......+++.|+|||.+. ...++.++|+||||+++|||++|+.||...... . .
T Consensus 148 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~-~ 223 (292)
T cd06644 148 DIKLADFGVSAKNVKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--R-V 223 (292)
T ss_pred CEEEccCccceeccccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--H-H
Confidence 99999999987543221 1223455788999999874 345688999999999999999999999643211 0 0
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ........... ..+......+.+++.+||+.||++||+++++++
T Consensus 224 ~-----~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 224 L-----LKIAKSEPPTL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred H-----HHHhcCCCccC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 11111111111 112234567889999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=250.21 Aligned_cols=197 Identities=23% Similarity=0.304 Sum_probs=150.1
Q ss_pred eeeEEEEEec------CCeeEEEEecCCCCCHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCC
Q 038002 471 ISSLLVYKHR------SSKKLLVYEFMSKGSLADLLFNL-----ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539 (702)
Q Consensus 471 i~~l~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl 539 (702)
|++++.+... ....++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||
T Consensus 62 iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl 138 (272)
T cd05075 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDL 138 (272)
T ss_pred cceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccc
Confidence 6666654321 23579999999999999987432 23478999999999999999999999 9999999
Q ss_pred CCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCC
Q 038002 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVN 617 (702)
Q Consensus 540 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~ 617 (702)
||+||++++++.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 218 (272)
T cd05075 139 AARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218 (272)
T ss_pred chhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999998764332211 112335678999999988899999999999999999999 88898643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.. .. .......+... ..+......+.+++.+||+.||++|||+++|++.|+.+
T Consensus 219 ~~----~~----~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 219 EN----SE----IYDYLRQGNRL-----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CH----HH----HHHHHHcCCCC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11 11 11111222111 11223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=258.34 Aligned_cols=143 Identities=23% Similarity=0.325 Sum_probs=116.5
Q ss_pred eeeEEEEE--ecCCeeEEEEecCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCC
Q 038002 471 ISSLLVYK--HRSSKKLLVYEFMSKGSLADLLFNL--------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~--~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 540 (702)
|++++..+ +.+...++||||+. ++|.+++... ...+++..+..++.||+.||+|||++ +|+|||||
T Consensus 60 iv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlk 135 (317)
T cd07868 60 VISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLK 135 (317)
T ss_pred CcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCC
Confidence 66676665 34667899999996 4888887532 12478889999999999999999999 99999999
Q ss_pred CCcEEE----eCCCcEEEecccceeecCCCCC--ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcC
Q 038002 541 LRNILI----DDSWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSN 613 (702)
Q Consensus 541 p~NIll----~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~P 613 (702)
|+|||+ +.++.+||+|||++........ .......+|+.|+|||++.+ ..++.++||||+||++|||++|+.|
T Consensus 136 p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 136 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred HHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999 4567899999999987643321 12234678999999998876 4689999999999999999999999
Q ss_pred CcCC
Q 038002 614 FEVN 617 (702)
Q Consensus 614 f~~~ 617 (702)
|...
T Consensus 216 f~~~ 219 (317)
T cd07868 216 FHCR 219 (317)
T ss_pred ccCC
Confidence 9654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=250.59 Aligned_cols=195 Identities=22% Similarity=0.347 Sum_probs=156.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll 546 (702)
|++++.++..++..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+ . +++|+||+|+||++
T Consensus 71 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~ 147 (269)
T cd08528 71 IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIML 147 (269)
T ss_pred eeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEE
Confidence 77888889999999999999999999998753 33468899999999999999999996 5 89999999999999
Q ss_pred eCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 547 DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 547 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
+.++.+||+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... ...
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~~~ 221 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LSL 221 (269)
T ss_pred CCCCcEEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----HHH
Confidence 999999999999998764432 23445688899999999888899999999999999999999999964311 111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
. .....+..... ........+.+++.+||+.||++||++.|+.++|+.
T Consensus 222 ~----~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 222 A----TKIVEAVYEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred H----HHHhhccCCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 11111111111 111345678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=249.11 Aligned_cols=187 Identities=22% Similarity=0.328 Sum_probs=148.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.. +..++||||+++|+|.+++......+++..+..++.||+.||+|||++ +|+|+||||+||+++.++
T Consensus 63 i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYG 138 (259)
T ss_pred hhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCc
Confidence 6777777766 778999999999999999987665789999999999999999999999 999999999999999888
Q ss_pred -------cEEEecccceeecCCCCCceeeceeccccccCcccccCC--CCCccccccchhHhHHHhhh-CCcCCcCCCCC
Q 038002 551 -------RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG--LITVKSDVYSFGVVLLEIIC-CRSNFEVNVST 620 (702)
Q Consensus 551 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 620 (702)
.+||+|||++..... .....++..|+|||++... .++.++||||||+++|||++ |..||.... .
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~ 212 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-S 212 (259)
T ss_pred cccCCceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-c
Confidence 799999999986533 1223456789999998766 78999999999999999999 577775442 1
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.... . .+. .... .+......+.+++.+||+.+|.+||++.++++.|+
T Consensus 213 ~~~~--~--~~~---~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 213 SEKE--R--FYQ---DQHR-------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hhHH--H--HHh---cCCC-------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1100 0 000 0000 00111268889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=256.97 Aligned_cols=202 Identities=19% Similarity=0.228 Sum_probs=151.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||++ ++|.+++......+++..+..++.||++||+|||+. +|+|+||||+||+++.++
T Consensus 66 I~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~ 141 (301)
T cd07873 66 IVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERG 141 (301)
T ss_pred cceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCC
Confidence 7888899999999999999997 599999887666788999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... +.......
T Consensus 142 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~ 219 (301)
T cd07873 142 ELKLADFGLARAKSIPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFR 219 (301)
T ss_pred cEEECcCcchhccCCCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHH
Confidence 999999999876432221 1223456889999998765 45788999999999999999999999754211 11100000
Q ss_pred --------HHHhhhcc-cc-----ccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 --------VYNCFVAG-EF-----NKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 --------~~~~~~~~-~~-----~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+...... .. ..... ..........+.+++.+||+.||.+|||++|+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 220 ILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 00 00000 0111234557889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=252.27 Aligned_cols=192 Identities=23% Similarity=0.278 Sum_probs=147.4
Q ss_pred eeeEEEEEec------CCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCc
Q 038002 471 ISSLLVYKHR------SSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543 (702)
Q Consensus 471 i~~l~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 543 (702)
|+++.+.+.. +...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+|+||||+|
T Consensus 65 i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~n 141 (272)
T cd06637 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQN 141 (272)
T ss_pred eeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHH
Confidence 6666665543 357899999999999999998643 3588999999999999999999999 99999999999
Q ss_pred EEEeCCCcEEEecccceeecCCCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 544 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
|++++++.++|+|||++....... .......|+..|+|||++. ...++.++|||||||++|||++|..||....
T Consensus 142 ili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 142 VLLTENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred EEECCCCCEEEccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999999999999999998653322 1233456889999999875 3457889999999999999999999996431
Q ss_pred CCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..... ........... .....+..+.+++.+||+.||.+|||++++++
T Consensus 221 ~~~~~--------~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 221 PMRAL--------FLIPRNPAPRL----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHHHH--------HHHhcCCCCCC----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11000 00011111111 11233457889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=251.09 Aligned_cols=195 Identities=20% Similarity=0.248 Sum_probs=151.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++...+ .+++.++..++.|++.||+|||+. +|+|+||||+||+++.++
T Consensus 68 ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 143 (267)
T cd06645 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNG 143 (267)
T ss_pred eeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence 7788888889999999999999999999987654 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++....... .......|+..|+|||.+. ...++.++|+|||||++|+|++|..||....... . ..
T Consensus 144 ~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-~--~~ 219 (267)
T cd06645 144 HVKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-A--LF 219 (267)
T ss_pred CEEECcceeeeEccCcc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-h--HH
Confidence 99999999987654322 1223456899999999874 4568899999999999999999999985432111 0 00
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. ............. .......+.+++.+||+.+|++||++++|++.
T Consensus 220 ~----~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 220 L----MTKSNFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred h----hhccCCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 0 0000000000000 11234568899999999999999999998853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-28 Score=248.23 Aligned_cols=195 Identities=22% Similarity=0.261 Sum_probs=154.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..+++|||+++++|.+++......+++.++..++.|++.||+|||++ +|+|+||+|+||++++++
T Consensus 62 i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~ 138 (262)
T cd06613 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDG 138 (262)
T ss_pred hhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCC
Confidence 78888889999999999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC---CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG---LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++....... .......++..|+|||.+.+. .++.++|+||||+++|||++|..||....... . ..
T Consensus 139 ~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~-~--~~ 214 (262)
T cd06613 139 DVKLADFGVSAQLTATI-AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR-A--LF 214 (262)
T ss_pred CEEECccccchhhhhhh-hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-H--HH
Confidence 99999999987654322 122335678899999988766 78899999999999999999999996432111 0 00
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ......... ........+..+.+++.+||+.+|.+|||+++|+.
T Consensus 215 ~-----~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 215 L-----ISKSNFPPP-KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred H-----HHhccCCCc-cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 001100000 00123345677999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=253.06 Aligned_cols=194 Identities=25% Similarity=0.291 Sum_probs=152.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+.+...+..++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++++
T Consensus 62 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~ 138 (285)
T cd05632 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDY 138 (285)
T ss_pred ceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCC
Confidence 6677788888999999999999999999886543 3589999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.+||+|||++........ .....|+..|+|||.+.+..++.++|+||||+++|||++|..||........ . ..
T Consensus 139 ~~~kl~Dfg~~~~~~~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~-~~ 212 (285)
T cd05632 139 GHIRISDLGLAVKIPEGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---R-EE 212 (285)
T ss_pred CCEEEecCCcceecCCCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---H-HH
Confidence 9999999999876532221 2344689999999999888899999999999999999999999974421110 0 11
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~~ 679 (702)
......... ..........+.+++.+||+.||++||+ ++++++.
T Consensus 213 ~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 213 VDRRVLETE------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred HHHhhhccc------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 111111111 1122234556788999999999999999 6677663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=263.61 Aligned_cols=200 Identities=23% Similarity=0.220 Sum_probs=145.0
Q ss_pred eeeEEEEEec------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHR------SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|++++..+.. ....++||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||
T Consensus 78 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Ni 150 (355)
T cd07874 78 IISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 150 (355)
T ss_pred hhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHE
Confidence 5566655543 2467999999975 67776643 478888999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++|+.||..........
T Consensus 151 ll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 151 VVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred EECCCCCEEEeeCcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999998653221 2234568999999999998899999999999999999999999996542111000
Q ss_pred hhHHH--------------HHHhhhc--cc-----ccccc-------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 038002 625 LLSTW--------------VYNCFVA--GE-----FNKLV-------EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNV 676 (702)
Q Consensus 625 ~~~~~--------------~~~~~~~--~~-----~~~~~-------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ev 676 (702)
..... ....+.. .. +.... +..........+.+++.+||+.||++|||++|+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~el 308 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEA 308 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHH
Confidence 00000 0000000 00 00000 001122235678899999999999999999999
Q ss_pred HHH
Q 038002 677 ILM 679 (702)
Q Consensus 677 l~~ 679 (702)
++.
T Consensus 309 l~h 311 (355)
T cd07874 309 LQH 311 (355)
T ss_pred hcC
Confidence 985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=266.09 Aligned_cols=199 Identities=25% Similarity=0.359 Sum_probs=155.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----------------------------------------------
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------------------------------------- 504 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------- 504 (702)
|+++++.+..++..++||||+++|+|.+++...+
T Consensus 103 iv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (401)
T cd05107 103 IVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMS 182 (401)
T ss_pred eEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccC
Confidence 7888888999999999999999999999996432
Q ss_pred ---------------------------------------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCC
Q 038002 505 ---------------------------------------------------TRPLWRDRVRIALDVARGLLYLHDECEVQ 533 (702)
Q Consensus 505 ---------------------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ 533 (702)
..+++..+..++.||+.||+|||+. +
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ 259 (401)
T cd05107 183 KDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---N 259 (401)
T ss_pred CccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---C
Confidence 1245677888999999999999999 9
Q ss_pred eEecCCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CC
Q 038002 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CR 611 (702)
Q Consensus 534 ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~ 611 (702)
|+||||||+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |.
T Consensus 260 ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~ 339 (401)
T cd05107 260 CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGG 339 (401)
T ss_pred cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999986533221 11223346788999999988889999999999999999998 88
Q ss_pred cCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 612 SNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 612 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.||...... +. .......+. ....+......+.+++.+||+.+|++||+++||++.|+.+.
T Consensus 340 ~P~~~~~~~--~~-----~~~~~~~~~-----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 340 TPYPELPMN--EQ-----FYNAIKRGY-----RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CCCCCCCch--HH-----HHHHHHcCC-----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 998643111 11 111111111 01112234568899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=257.68 Aligned_cols=198 Identities=27% Similarity=0.376 Sum_probs=155.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++.+..++..++||||+++|+|.+++.... ..+++.++..++.||+.||+|||++ ||+
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~ 156 (314)
T cd05099 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCI 156 (314)
T ss_pred eeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 7788888888999999999999999999996532 2478889999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
|+||||+||+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p 236 (314)
T cd05099 157 HRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236 (314)
T ss_pred eccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999998654322111 111224467999999988889999999999999999999 8889
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
|..... .+ .......+... ..+......+.+++.+||+.+|++||++.++++.|+++.
T Consensus 237 ~~~~~~--~~------~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 237 YPGIPV--EE------LFKLLREGHRM-----DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred CCCCCH--HH------HHHHHHcCCCC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 854311 11 11111111111 112233557889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=251.13 Aligned_cols=197 Identities=23% Similarity=0.309 Sum_probs=155.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC--------CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET--------RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
|++++.++.+.+..++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +|+|+||||+
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~ 146 (275)
T cd05046 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAAR 146 (275)
T ss_pred eeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccc
Confidence 77888899999999999999999999999975441 478999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCc
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTA 621 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~ 621 (702)
||+++.++.++|+|||++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.....
T Consensus 147 Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-- 224 (275)
T cd05046 147 NCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-- 224 (275)
T ss_pred eEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--
Confidence 9999999999999999987543332222333456778999999888888999999999999999998 7888853311
Q ss_pred chhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 622 DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
.. .......+..... .....+..+.+++.+||+.+|++||++.|++++|++
T Consensus 225 -~~-----~~~~~~~~~~~~~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 225 -EE-----VLNRLQAGKLELP----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred -HH-----HHHHHHcCCcCCC----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 11 1111111111111 112345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=248.63 Aligned_cols=196 Identities=26% Similarity=0.358 Sum_probs=153.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++++++...+..++||||+++++|.+++... ...+++.++..++.|++.||+|||+. +++|+||||+||
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~ni 137 (269)
T cd05044 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNC 137 (269)
T ss_pred eeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheE
Confidence 778888888999999999999999999999753 12377899999999999999999999 999999999999
Q ss_pred EEeCCC-----cEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCC
Q 038002 545 LIDDSW-----RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVN 617 (702)
Q Consensus 545 ll~~~~-----~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~ 617 (702)
+++.++ .++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 138 l~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 138 LVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred EEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 999877 8999999999765332211 1122345678999999998899999999999999999998 99999643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
.. ...... ...+.. .......+..+.+++.+||+.+|++||++++|+++|++
T Consensus 218 ~~----~~~~~~----~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 218 NN----QEVLQH----VTAGGR-----LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CH----HHHHHH----HhcCCc-----cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 111111 111110 01223346778899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=262.53 Aligned_cols=228 Identities=21% Similarity=0.219 Sum_probs=160.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecC------Ce
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRS------SK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~------~~ 483 (702)
+.+...+.||+|++ ||++.... ..+|+| |++++..+... ..
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 34455667777776 66665432 445554 66666666433 35
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 101 VYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred eEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 7999999975 66666632 478888999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH-----------HH---
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS-----------TW--- 629 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~-----------~~--- 629 (702)
.... ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............. ..
T Consensus 174 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (359)
T cd07876 174 CTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP 251 (359)
T ss_pred ccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence 3222 2234568999999999998899999999999999999999999997542111000000 00
Q ss_pred HHHhhh--cccc-----ccccc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFV--AGEF-----NKLVE-------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~--~~~~-----~~~~~-------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...... .... ..... ..........+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000000 0000 00000 01112234678899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=252.46 Aligned_cols=195 Identities=21% Similarity=0.226 Sum_probs=152.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++++|..++......+++..+..++.|+++||+|||+. +|+|+||||+||+++.++
T Consensus 64 ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~ 140 (282)
T cd06643 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDG 140 (282)
T ss_pred eeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCC
Confidence 78888888899999999999999999998876555789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.+||+|||++....... .......++..|+|||.+. +..++.++|||||||++|||++|+.||..... ...
T Consensus 141 ~~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~ 216 (282)
T cd06643 141 DIKLADFGVSAKNTRTI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRV 216 (282)
T ss_pred CEEEccccccccccccc-cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHH
Confidence 99999999987653222 1223356889999999873 44577899999999999999999999964311 111
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
... ......... ..+......+.+++.+||+.||++||+++++++.-
T Consensus 217 ~~~-----~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 217 LLK-----IAKSEPPTL---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred HHH-----HhhcCCCCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 111 011110011 11223456789999999999999999999988543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=292.31 Aligned_cols=227 Identities=22% Similarity=0.428 Sum_probs=176.2
Q ss_pred ccceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEecCCeeEEEEecCCCCCHHHH
Q 038002 447 DKRKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHRSSKKLLVYEFMSKGSLADL 499 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~~ 499 (702)
..+.+|+|++ ||+|.... ..|||| |+++++++.+++..++||||+++|+|.++
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~ 773 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV 773 (968)
T ss_pred cccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHH
Confidence 3467899988 99887542 566665 88899999999999999999999999999
Q ss_pred hhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceecccc
Q 038002 500 LFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG 579 (702)
Q Consensus 500 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~ 579 (702)
++ .+++.++..++.|+++||+|||.++..+|+||||||+||+++.++..++. |+.+...... ....+++.
T Consensus 774 l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~ 843 (968)
T PLN00113 774 LR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSA 843 (968)
T ss_pred Hh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcccccc
Confidence 95 47899999999999999999996555599999999999999999888876 5554432211 12357899
Q ss_pred ccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc------ccCHHHHH
Q 038002 580 YMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE------EVDKITLE 653 (702)
Q Consensus 580 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~ 653 (702)
|+|||++.+..++.++|||||||++|||++|+.||+...... ....+|.............+++ ..+.....
T Consensus 844 y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 921 (968)
T PLN00113 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV 921 (968)
T ss_pred ccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence 999999999999999999999999999999999996432211 1222333222222222222222 23456677
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
++.+++.+||+.||++||+|+|++++|+++.+
T Consensus 922 ~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 922 EVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 88999999999999999999999999998754
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=259.01 Aligned_cols=197 Identities=20% Similarity=0.226 Sum_probs=149.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++.++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 61 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~ 137 (327)
T cd08227 61 IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVD 137 (327)
T ss_pred eeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecC
Confidence 888889999999999999999999999999754 33588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCC------ceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCc
Q 038002 550 WRAKISDFGLAKLLMPNQT------GIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA 621 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 621 (702)
+.+++.||+.......... .......++..|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 138 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred CcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 9999999986543321111 01112346778999998865 468899999999999999999999996431111
Q ss_pred chhhhHHHHHHhhhcccccccc----------------------------------------ccccCHHHHHHHHHHHHH
Q 038002 622 DEVLLSTWVYNCFVAGEFNKLV----------------------------------------EEEVDKITLERMVKTGLL 661 (702)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~ 661 (702)
..... . .+...... ...........+.+++.+
T Consensus 218 --~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 289 (327)
T cd08227 218 --MLLEK-L-----NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQ 289 (327)
T ss_pred --HHHHH-h-----cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHH
Confidence 00000 0 00000000 001122345688999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 038002 662 CIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 662 cL~~dP~~RPt~~evl~ 678 (702)
||+.||++|||++|+++
T Consensus 290 ~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 290 CLQRNPDARPSASTLLN 306 (327)
T ss_pred HHhhCchhcCCHHHHhc
Confidence 99999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=248.35 Aligned_cols=195 Identities=25% Similarity=0.326 Sum_probs=154.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+.. ...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++|+||||+||+++.+
T Consensus 58 iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~ 133 (257)
T cd05040 58 LIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASD 133 (257)
T ss_pred ccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecC
Confidence 6777777777 89999999999999999998765 4688999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhh
Q 038002 550 WRAKISDFGLAKLLMPNQTG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLL 626 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 626 (702)
+.+||+|||++..+...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+ .
T Consensus 134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~--~ 209 (257)
T cd05040 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--SQ--I 209 (257)
T ss_pred CEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--HH--H
Confidence 99999999999876442221 1112446778999999988889999999999999999998 9999964311 11 1
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
..... ..... ...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 210 ~~~~~---~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 210 LKKID---KEGER-----LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHH---hcCCc-----CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11010 01100 0112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-28 Score=249.90 Aligned_cols=193 Identities=25% Similarity=0.364 Sum_probs=150.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++
T Consensus 61 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~ 132 (279)
T cd06619 61 IIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRG 132 (279)
T ss_pred eeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCC
Confidence 888889999999999999999999997653 467888899999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............. .
T Consensus 133 ~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~-~ 208 (279)
T cd06619 133 QVKLCDFGVSTQLVNSI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQ-L 208 (279)
T ss_pred CEEEeeCCcceeccccc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHH-H
Confidence 99999999998653322 2335688999999999888899999999999999999999999965322111111001 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
............ .......++.+++.+||+.+|++||+++|+++.
T Consensus 209 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 209 LQCIVDEDPPVL----PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HHHHhccCCCCC----CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111111111111 112234578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=248.29 Aligned_cols=191 Identities=30% Similarity=0.390 Sum_probs=150.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+..+ ..++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.+
T Consensus 61 i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~ 136 (254)
T cd05083 61 LVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSED 136 (254)
T ss_pred cCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCC
Confidence 67777666554 4799999999999999997654 3578999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++....... .....+..|+|||.+.+..++.++|+||||+++|||++ |+.||...... +
T Consensus 137 ~~~kl~Dfg~~~~~~~~~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~----- 205 (254)
T cd05083 137 GVAKVSDFGLARVGSMGV----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK--E----- 205 (254)
T ss_pred CcEEECCCccceeccccC----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH--H-----
Confidence 999999999987643221 12234567999999988889999999999999999998 99998643211 0
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
.......+.. .......+..+.+++.+||+.+|++||+++++++.|++
T Consensus 206 -~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 -VKECVEKGYR-----MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -HHHHHhCCCC-----CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111111111 11122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=262.56 Aligned_cols=200 Identities=28% Similarity=0.381 Sum_probs=149.4
Q ss_pred eeeEEEEE-ecCCeeEEEEecCCCCCHHHHhhcCC---------------------------------------------
Q 038002 471 ISSLLVYK-HRSSKKLLVYEFMSKGSLADLLFNLE--------------------------------------------- 504 (702)
Q Consensus 471 i~~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------- 504 (702)
|+++++.+ ..+...++||||+++|+|.+++....
T Consensus 73 iv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (343)
T cd05103 73 VVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGF 152 (343)
T ss_pred HhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccc
Confidence 44555444 34567899999999999999986431
Q ss_pred ---------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 505 ---------------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 505 ---------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
..+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 153 VEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred cCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 1256778889999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 564 MPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 564 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... . . ......+...
T Consensus 230 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~--~----~~~~~~~~~~- 301 (343)
T cd05103 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-E--F----CRRLKEGTRM- 301 (343)
T ss_pred ccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-H--H----HHHHhccCCC-
Confidence 332211 1122345678999999988889999999999999999997 999986431111 1 1 1111111110
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
..+......+.+++.+||+.||++||++.||++.|+.+.+
T Consensus 302 ----~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 302 ----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1111234568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=263.74 Aligned_cols=189 Identities=20% Similarity=0.219 Sum_probs=139.3
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 467999999975 77777743 478888999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH--------H---H
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST--------W---V 630 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------~---~ 630 (702)
...... ......+++.|+|||++.+..++.++|||||||++|||++|+.||.............. . .
T Consensus 175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 653222 22345689999999999998999999999999999999999999965421110000000 0 0
Q ss_pred H---Hhh--hcccc-----cccc-------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 Y---NCF--VAGEF-----NKLV-------EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~---~~~--~~~~~-----~~~~-------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. ... ..... .... +..........+.+++.+||+.||.+|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000 00000 0000 001112234578899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=255.63 Aligned_cols=201 Identities=24% Similarity=0.326 Sum_probs=152.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+..++..++||||+++++|.+++.... .+++..+..++.|+++||+|||+ . +++|+||||+||+++.+
T Consensus 61 iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~ 136 (308)
T cd06615 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSR 136 (308)
T ss_pred CCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecC
Confidence 7888899999999999999999999999997654 68899999999999999999997 5 89999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.+||+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...............
T Consensus 137 ~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 213 (308)
T cd06615 137 GEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213 (308)
T ss_pred CcEEEccCCCcccccccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc
Confidence 999999999987543221 23356789999999988888999999999999999999999999643211100000000
Q ss_pred HHHhhhcc---------------------cccccc---cccc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAG---------------------EFNKLV---EEEV-DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~---------------------~~~~~~---~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... ...... .+.. .......+.+++.+||+.||++||++++|++.
T Consensus 214 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 214 -VSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred -cccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 000000 0000 01245578999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=250.16 Aligned_cols=205 Identities=25% Similarity=0.351 Sum_probs=156.5
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++.+++.. +...++||||+++++|.+++......+++..+..++.|++.||+|||+. +++|+||||+||+++.
T Consensus 68 i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~ 144 (284)
T cd05038 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVES 144 (284)
T ss_pred hheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcC
Confidence 6667777666 6689999999999999999987766799999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCce--eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh--
Q 038002 549 SWRAKISDFGLAKLLMPNQTGI--VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV-- 624 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~-- 624 (702)
++.++|+|||.+.......... .....++..|+|||.+.+..++.++||||||++++||++|..|+..........
T Consensus 145 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 224 (284)
T cd05038 145 EDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG 224 (284)
T ss_pred CCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc
Confidence 9999999999998765332211 112234567999999988889999999999999999999999986432111000
Q ss_pred -----hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 625 -----LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 625 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.............. ....+......+.+++.+||+.+|++||++.||+++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 225 IAQGQMIVTRLLELLKEGE-----RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccccHHHHHHHHHcCC-----cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000111111110 0111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=249.63 Aligned_cols=199 Identities=22% Similarity=0.302 Sum_probs=148.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|+++++.+......++||||+++|+|.+++.+.. ...++..+..++.||++||+|||+. +++|+||||+||+++
T Consensus 57 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~ 133 (268)
T cd05086 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLT 133 (268)
T ss_pred hhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEc
Confidence 7788888899999999999999999999997642 2356677888999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCC-CceeeceeccccccCcccccC-------CCCCccccccchhHhHHHhhh-CCcCCcCCC
Q 038002 548 DSWRAKISDFGLAKLLMPNQ-TGIVAGVRGSRGYMAPEWQNS-------GLITVKSDVYSFGVVLLEIIC-CRSNFEVNV 618 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~ 618 (702)
.++.+||+|||++....... ........++..|+|||++.. ..++.++||||||+++|||++ |..||....
T Consensus 134 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 134 SDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred CCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999986432211 111223457889999998743 245789999999999999997 466775321
Q ss_pred CCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
..... .....+......++.......+.+.+++..|| .+|++||++++|+++|.
T Consensus 214 ---~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 214 ---DREVL-----NHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---HHHHH-----HHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 11111222222333333335567788888899 57999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=260.67 Aligned_cols=185 Identities=19% Similarity=0.230 Sum_probs=153.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE-eCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI-DDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll-~~~ 549 (702)
|+++...+.++.+.|+|||.+.|+-|.+.+...+ ... .++..|+++|+.|+.|||++ ||+||||||+|||+ +..
T Consensus 378 iv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~ 452 (612)
T KOG0603|consen 378 IVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSA 452 (612)
T ss_pred ceeecceecCCceeeeeehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCC
Confidence 7888899999999999999999999888887654 233 78888999999999999999 99999999999999 589
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
++++|+|||.++..... ....+-|..|.|||++....+++++||||||++||+|++|+.||...... ..
T Consensus 453 g~lrltyFG~a~~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e---- 521 (612)
T KOG0603|consen 453 GHLRLTYFGFWSELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE---- 521 (612)
T ss_pred CcEEEEEechhhhCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH----
Confidence 99999999999876444 33446688999999999999999999999999999999999999765222 11
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+...+..+. .....++...+|+.+||+.||.+||+|.++...
T Consensus 522 i~~~i~~~~--------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 522 IHTRIQMPK--------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHhhcCCc--------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 112222222 225567889999999999999999999998763
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=252.88 Aligned_cols=206 Identities=23% Similarity=0.269 Sum_probs=154.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+ +++|.+++......+++.++..++.||++||+|||++ +|+|+||||+||+++.++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~ 139 (298)
T cd07841 64 IIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDG 139 (298)
T ss_pred ChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCC
Confidence 677778888899999999999 8999999977654689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||....... . +..
T Consensus 140 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~--~~~- 214 (298)
T cd07841 140 VLKLADFGLARSFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-Q--LGK- 214 (298)
T ss_pred CEEEccceeeeeccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-H--HHH-
Confidence 999999999987643321 2223346788999998754 467899999999999999999987776432111 1 100
Q ss_pred HHHhhhcc---------ccccccc---------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCCcC
Q 038002 630 VYNCFVAG---------EFNKLVE---------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGTME 685 (702)
Q Consensus 630 ~~~~~~~~---------~~~~~~~---------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~~~ 685 (702)
........ ....... ..........+.+++.+||+.||++|||++|+++. +++...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~ 290 (298)
T cd07841 215 IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPA 290 (298)
T ss_pred HHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCC
Confidence 00000000 0000000 01123346788999999999999999999999985 444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=247.76 Aligned_cols=193 Identities=22% Similarity=0.268 Sum_probs=155.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..+...++++||+++++|.+++......+++.++..++.|++.||+|||+. +++|+||+|+||+++.++
T Consensus 60 i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~ 136 (256)
T cd06612 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEG 136 (256)
T ss_pred EeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCC
Confidence 78888899999999999999999999999987666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 137 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~------ 209 (256)
T cd06612 137 QAKLADFGVSGQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF------ 209 (256)
T ss_pred cEEEcccccchhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh------
Confidence 999999999987643321 2233457889999999988889999999999999999999999996432111000
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. .... ... ....+......+.+++.+||+.||++|||++|+++
T Consensus 210 -~-~~~~-~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 -M-IPNK-PPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -h-hccC-CCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 0 0000 000 00122334567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=278.67 Aligned_cols=199 Identities=18% Similarity=0.246 Sum_probs=152.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL----------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~----------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 540 (702)
|++++..+.+++..++||||++|++|.+++... ....++..++.++.||++||+|||++ +|+|||||
T Consensus 64 IVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLK 140 (932)
T PRK13184 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLK 140 (932)
T ss_pred cCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCc
Confidence 677888888999999999999999999998642 12345677889999999999999999 99999999
Q ss_pred CCcEEEeCCCcEEEecccceeecCCCCC-----------------ceeeceeccccccCcccccCCCCCccccccchhHh
Q 038002 541 LRNILIDDSWRAKISDFGLAKLLMPNQT-----------------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603 (702)
Q Consensus 541 p~NIll~~~~~~kl~Dfg~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 603 (702)
|+||+++.++.+||+|||++........ .......||+.|+|||.+.+..++.++|||||||+
T Consensus 141 PeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVI 220 (932)
T PRK13184 141 PDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220 (932)
T ss_pred hheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHH
Confidence 9999999999999999999987621110 01123468999999999999999999999999999
Q ss_pred HHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhC
Q 038002 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-SMKNVILMLEG 682 (702)
Q Consensus 604 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~Le~ 682 (702)
+|||++|+.||...... ..... ...... .........+..+.+++.+||+.||++|| +++++++.|+.
T Consensus 221 LyELLTG~~PF~~~~~~--ki~~~----~~i~~P-----~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 221 LYQMLTLSFPYRRKKGR--KISYR----DVILSP-----IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred HHHHHHCCCCCCCcchh--hhhhh----hhccCh-----hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999653111 11000 000000 00001123456788899999999999996 67778887776
Q ss_pred C
Q 038002 683 T 683 (702)
Q Consensus 683 ~ 683 (702)
.
T Consensus 290 ~ 290 (932)
T PRK13184 290 H 290 (932)
T ss_pred H
Confidence 4
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=248.93 Aligned_cols=193 Identities=20% Similarity=0.264 Sum_probs=153.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+++..++..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 139 (265)
T cd06631 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNG 139 (265)
T ss_pred EeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCC
Confidence 7888889999999999999999999999997654 678899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCC-----CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQ-----TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.++|+|||++....... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||........
T Consensus 140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--- 216 (265)
T cd06631 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--- 216 (265)
T ss_pred eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH---
Confidence 99999999987643211 1112235588899999999888899999999999999999999999964311110
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ........ ..+..+......+.+++.+||+.+|++||+++++++
T Consensus 217 ~----~~~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 217 M----FYIGAHRG----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred H----HHhhhccC----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000000 011223345667899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-28 Score=246.12 Aligned_cols=192 Identities=22% Similarity=0.344 Sum_probs=152.1
Q ss_pred eeeEEEEEe-cCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKH-RSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
++++...+. .+...++||||+++++|.+++.... ..+++.++..++.|++.||++||+. +|+|+||||+||+++.
T Consensus 61 i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~ 137 (257)
T cd08223 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTR 137 (257)
T ss_pred eeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEec
Confidence 666666555 4557899999999999999997643 3588999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
++.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||..... . .
T Consensus 138 ~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~---~----~ 209 (257)
T cd08223 138 TNIIKVGDLGIARVLENQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---N----S 209 (257)
T ss_pred CCcEEEecccceEEecccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH---H----H
Confidence 99999999999987643222 22345678999999999888899999999999999999999999964311 1 1
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ...+.. +..+......+.+++.+||+.||++||++.++++.
T Consensus 210 ~~~~-~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 210 LVYR-IIEGKL-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHH-HHhcCC-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111 111111 11233456789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=251.54 Aligned_cols=203 Identities=21% Similarity=0.221 Sum_probs=149.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE--TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++++.+.+++..++||||++ ++|.+++.... ..+++.++..++.||++||+|||++ +|+|+||||+||+++.
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~ 136 (285)
T cd07861 61 IVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDN 136 (285)
T ss_pred EeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcC
Confidence 7888889999999999999997 58988886543 3588999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++....... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.............
T Consensus 137 ~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~ 215 (285)
T cd07861 137 KGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIF 215 (285)
T ss_pred CCcEEECcccceeecCCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 9999999999997653322 11223456889999998765 457899999999999999999999997542111100000
Q ss_pred HHH-------HHhh-----hcccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWV-------YNCF-----VAGEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~-------~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... +... ........... .......+++.+++.+||+.||++|||+++|++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 216 RILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000 0000 00000000000 111224567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.56 Aligned_cols=193 Identities=22% Similarity=0.342 Sum_probs=157.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++++.+++..++||||+++++|.+++... ...+++.++..++.|++.+|+|||+. +++|+||+|+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKA 137 (256)
T ss_pred eeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCC
Confidence 888999999999999999999999999999765 34588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.+||+|||++........ ......+++.|+|||.+.+..++.++|+||||++++||++|+.||...... +
T Consensus 138 ~~~kl~d~~~~~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------~- 208 (256)
T cd08221 138 GLIKLGDFGISKILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-------N- 208 (256)
T ss_pred CCEEECcCcceEEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-------H-
Confidence 9999999999987644332 233456889999999998888899999999999999999999999643111 1
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
.......+.... ........+.+++.+||+.+|++||+++++++.+
T Consensus 209 ~~~~~~~~~~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 209 LVVKIVQGNYTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred HHHHHHcCCCCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111111222111 1233456788999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=247.06 Aligned_cols=194 Identities=25% Similarity=0.315 Sum_probs=151.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRP--LWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~--~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++++++..++..++||||+++++|.+++......+ ++..+..++.||+.||+|||+. +|+|+||||+||+++.
T Consensus 67 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~ 143 (268)
T cd06624 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNT 143 (268)
T ss_pred eeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcC
Confidence 7888889999999999999999999999998654344 7888889999999999999999 9999999999999976
Q ss_pred -CCcEEEecccceeecCCCCCceeeceeccccccCcccccCC--CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 549 -SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG--LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 549 -~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
++.++|+|||++........ ......+++.|+|||++... .++.++|+||||+++|+|++|+.||..........
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~- 221 (268)
T cd06624 144 YSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM- 221 (268)
T ss_pred CCCeEEEecchhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH-
Confidence 67999999999876533221 12234578899999988654 37889999999999999999999996432111100
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... ..+..+....+.+.+++.+||+.+|++|||++|+++.
T Consensus 222 -----~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 222 -----FKVGMFK-----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----hhhhhhc-----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0000000 1112333456778999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=250.47 Aligned_cols=196 Identities=26% Similarity=0.342 Sum_probs=153.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHhhhhc
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------------TRPLWRDRVRIALDVARGLLYLHDE 529 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------------~~~~~~~~~~i~~qi~~aL~~LH~~ 529 (702)
|+++++++..++..++||||+++++|.+++.... ..+++.+++.++.|++.||+|||++
T Consensus 70 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~ 149 (288)
T cd05050 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER 149 (288)
T ss_pred hheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 7788888899999999999999999999997432 1367888899999999999999999
Q ss_pred CCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhh
Q 038002 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608 (702)
Q Consensus 530 ~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 608 (702)
+++||||||+||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++||||||+++|||+
T Consensus 150 ---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 226 (288)
T cd05050 150 ---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 226 (288)
T ss_pred ---CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHH
Confidence 999999999999999999999999999876533221 1112223466799999988888999999999999999999
Q ss_pred h-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 609 C-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 609 t-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
+ |..||..... .+ .......+... ..+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus 227 ~~~~~p~~~~~~--~~------~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 227 SYGMQPYYGMAH--EE------VIYYVRDGNVL-----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred hCCCCCCCCCCH--HH------HHHHHhcCCCC-----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 7 8888853311 11 11111122211 1122345678999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=255.37 Aligned_cols=199 Identities=28% Similarity=0.371 Sum_probs=156.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|++++..+..++..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+
T Consensus 80 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---giv 156 (334)
T cd05100 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCI 156 (334)
T ss_pred eeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Cee
Confidence 7788888888999999999999999999997532 2467888999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
||||||+||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|
T Consensus 157 H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 236 (334)
T cd05100 157 HRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236 (334)
T ss_pred ccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999865432211 1112234567999999988899999999999999999998 8888
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
|..... ++ .......+.. ...+......+.+++.+||+.+|++||++.|+++.|+.+..
T Consensus 237 ~~~~~~--~~------~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 237 YPGIPV--EE------LFKLLKEGHR-----MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CCCCCH--HH------HHHHHHcCCC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 864311 11 1111111111 11122345678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=244.76 Aligned_cols=194 Identities=30% Similarity=0.418 Sum_probs=155.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETR-PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+.+.+..++||||+++++|.+++...... +++.++..++.|++.||++||+. +++|+||||+||+++.+
T Consensus 63 i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~ 139 (258)
T smart00219 63 IVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGEN 139 (258)
T ss_pred hheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccC
Confidence 778888888899999999999999999999876544 89999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+|||++...............+++.|+|||.+....++.++||||+|+++++|++ |+.||.... ....
T Consensus 140 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~----~~~~-- 213 (258)
T smart00219 140 LVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS----NEEV-- 213 (258)
T ss_pred CeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC----HHHH--
Confidence 999999999998765442222212336789999999888889999999999999999998 788886421 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
.......... ......+.++.+++.+||+.||++|||+.|+++.|
T Consensus 214 --~~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 214 --LEYLKKGYRL-----PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --HHHHhcCCCC-----CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111111111 11222466788999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=249.63 Aligned_cols=187 Identities=17% Similarity=0.202 Sum_probs=139.9
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++++|++. .++.+.+.... ..++..+..++.|+++||+|||+. +|+||||||+|||++.++.++|+|||+++.
T Consensus 101 ~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~DFGla~~ 175 (294)
T PHA02882 101 YRFILLEKLV-ENTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASH 175 (294)
T ss_pred EEEEEEehhc-cCHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEEEcCCcee
Confidence 4478888874 36777765543 457888899999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH-HHHhhh
Q 038002 563 LMPNQT------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW-VYNCFV 635 (702)
Q Consensus 563 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-~~~~~~ 635 (702)
+..... .......||+.|+|||...+..++.++|||||||++|||++|..||............... ......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~ 255 (294)
T PHA02882 176 FIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLH 255 (294)
T ss_pred eccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhh
Confidence 643221 1112346999999999999999999999999999999999999999765222211111110 111111
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.+... .......+.+++..|++.+|++||+++++++.|+
T Consensus 256 ~~~~~-------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 256 EGKIK-------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hhhhc-------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11110 1122467888999999999999999999998874
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-28 Score=252.78 Aligned_cols=191 Identities=22% Similarity=0.278 Sum_probs=152.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++++|.+++.+. .+++.++..++.|++.||.|||+. +|+|+||||+||+++.++
T Consensus 78 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~ 152 (297)
T cd06656 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDG 152 (297)
T ss_pred EeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 778888999999999999999999999998653 578899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ..
T Consensus 153 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~---- 225 (297)
T cd06656 153 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY---- 225 (297)
T ss_pred CEEECcCccceEccCCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----
Confidence 999999999886543322 12234578899999999888899999999999999999999999964421110 00
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.....+ ... ...+......+.+++.+||+.+|++||+++++++
T Consensus 226 -~~~~~~-~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 226 -LIATNG-TPE---LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred -eeccCC-CCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 000 0112334566888999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=247.92 Aligned_cols=191 Identities=27% Similarity=0.335 Sum_probs=154.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||++++++
T Consensus 68 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~ 143 (267)
T cd06628 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKG 143 (267)
T ss_pred eeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCC
Confidence 7788889999999999999999999999997654 678889999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC-----ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQT-----GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.++|+|||.++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... . .
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~-~ 220 (267)
T cd06628 144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--Q-A 220 (267)
T ss_pred CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--H-H
Confidence 999999999987642211 1112345788999999998888899999999999999999999999643110 0 0
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. .... ...+..+......+.+++.+||+.||++||++.|+++
T Consensus 221 ----~~-~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 221 ----IF-KIGE-----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----HH-HHhc-----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00 0001 1112233345678889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=243.59 Aligned_cols=227 Identities=17% Similarity=0.169 Sum_probs=172.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~l 486 (702)
.++.....+|+|.| |....... ..||+| ++++..+|.-.++.+|
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCi 168 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICI 168 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEE
Confidence 45566678899988 55554443 677776 7777888999999999
Q ss_pred EEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-----------------
Q 038002 487 VYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD----------------- 548 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~----------------- 548 (702)
|+|.+ |.|+.++|.++.. .++...+..|+.|+++++++||+. +++|.||||||||+.+
T Consensus 169 vfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 169 VFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred EEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceec
Confidence 99999 6799999987643 478899999999999999999999 9999999999999931
Q ss_pred ---CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 549 ---SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 549 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
+..++|+|||.|....... ..+..|..|.|||++.+-.++..+||||+||||.|+.+|...|+.....+ ...
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E-HLa 319 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE-HLA 319 (415)
T ss_pred cCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH-HHH
Confidence 3358999999998754333 44567999999999999999999999999999999999999998664222 111
Q ss_pred hHHHHHHh--------------hhcccc-----------cccccc--------ccCHHHHHHHHHHHHHcccCCCCCCCC
Q 038002 626 LSTWVYNC--------------FVAGEF-----------NKLVEE--------EVDKITLERMVKTGLLCIQDEPNLRPS 672 (702)
Q Consensus 626 ~~~~~~~~--------------~~~~~~-----------~~~~~~--------~~~~~~~~~l~~li~~cL~~dP~~RPt 672 (702)
..+.+... ...+.+ ....+. .....+..++.+|+.+||..||.+|+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT 399 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT 399 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc
Confidence 11111110 000000 000000 123455667999999999999999999
Q ss_pred HHHHHH
Q 038002 673 MKNVIL 678 (702)
Q Consensus 673 ~~evl~ 678 (702)
+.|++.
T Consensus 400 l~EAL~ 405 (415)
T KOG0671|consen 400 LREALS 405 (415)
T ss_pred HHHHhc
Confidence 999985
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=254.28 Aligned_cols=193 Identities=20% Similarity=0.184 Sum_probs=151.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+..++..++||||+.+++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.+
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~ 139 (316)
T cd05574 63 LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHES 139 (316)
T ss_pred chhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCC
Confidence 6777888889999999999999999999997643 4688999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCc----------------------------eeeceeccccccCcccccCCCCCccccccchh
Q 038002 550 WRAKISDFGLAKLLMPNQTG----------------------------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 601 (702)
+.++|+|||++......... ......|+..|+|||.+.+..++.++||||||
T Consensus 140 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG 219 (316)
T cd05574 140 GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLG 219 (316)
T ss_pred CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHH
Confidence 99999999998754322110 01124578899999999888899999999999
Q ss_pred HhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC----HHHHH
Q 038002 602 VVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS----MKNVI 677 (702)
Q Consensus 602 vil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt----~~evl 677 (702)
+++|+|++|..||...... ..... ....... ..........+.+++.+||+.||++||+ ++|++
T Consensus 220 ~ll~~l~~g~~pf~~~~~~---~~~~~-----~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 220 ILLYEMLYGTTPFKGSNRD---ETFSN-----ILKKEVT----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred HHHHHHhhCCCCCCCCchH---HHHHH-----HhcCCcc----CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 9999999999999644211 11111 1111110 0111125678999999999999999999 66666
Q ss_pred H
Q 038002 678 L 678 (702)
Q Consensus 678 ~ 678 (702)
+
T Consensus 288 ~ 288 (316)
T cd05574 288 Q 288 (316)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=9e-28 Score=250.53 Aligned_cols=201 Identities=23% Similarity=0.275 Sum_probs=153.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.++..+...++||||+ +++|.+++......+++.++..++.||++||+|||++ +++|+||||+||+++.++
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~ 136 (286)
T cd07832 61 VVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADG 136 (286)
T ss_pred CcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCC
Confidence 778888889999999999999 9999999977666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||++...............++..|+|||.+.+ ..++.++||||+|++++||++|..||...... ... ..
T Consensus 137 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~-~~ 212 (286)
T cd07832 137 VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQL-AI 212 (286)
T ss_pred cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHH-HH
Confidence 99999999998765433222334568899999998765 45689999999999999999998887543211 111 00
Q ss_pred HHHhhhcc------------ccccccc--------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAG------------EFNKLVE--------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~------------~~~~~~~--------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
........ ....... .+........+.+++.+||+.||++||+++++++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 10000000 0000000 01112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=253.88 Aligned_cols=143 Identities=22% Similarity=0.328 Sum_probs=116.3
Q ss_pred eeeEEEEE--ecCCeeEEEEecCCCCCHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCC
Q 038002 471 ISSLLVYK--HRSSKKLLVYEFMSKGSLADLLFNL--------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~--~~~~~~~lV~e~~~~gsL~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 540 (702)
|++++..+ ..+...++||||+.+ +|.+++... ...+++..+..++.||+.||+|||++ +|+|||||
T Consensus 60 iv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlk 135 (317)
T cd07867 60 VIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLK 135 (317)
T ss_pred eeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCC
Confidence 67777665 456788999999865 788877422 12477888999999999999999999 99999999
Q ss_pred CCcEEE----eCCCcEEEecccceeecCCCCC--ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcC
Q 038002 541 LRNILI----DDSWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSN 613 (702)
Q Consensus 541 p~NIll----~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~P 613 (702)
|+||++ +.++.+||+|||+++....... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|
T Consensus 136 p~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~ 215 (317)
T cd07867 136 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred HHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCC
Confidence 999999 5667899999999987643322 12234568999999998866 4578999999999999999999999
Q ss_pred CcCC
Q 038002 614 FEVN 617 (702)
Q Consensus 614 f~~~ 617 (702)
|...
T Consensus 216 f~~~ 219 (317)
T cd07867 216 FHCR 219 (317)
T ss_pred cccc
Confidence 9654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=253.56 Aligned_cols=203 Identities=17% Similarity=0.151 Sum_probs=149.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.+++..++|+||++ ++|.+++......+++..+..++.||++||+|||++ +|+|+||||+||+++.++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~ 136 (284)
T cd07839 61 IVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNG 136 (284)
T ss_pred eeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCC
Confidence 6777778888999999999997 488888876555789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH-H
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS-T 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~-~ 628 (702)
.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|||++|..|+............. .
T Consensus 137 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 215 (284)
T cd07839 137 ELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 215 (284)
T ss_pred cEEECccchhhccCCCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHH
Confidence 999999999986533221 12234568899999987664 57899999999999999999999875432211111000 0
Q ss_pred -------HHHHhhh---cccccccccc-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 -------WVYNCFV---AGEFNKLVEE-----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 -------~~~~~~~---~~~~~~~~~~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+.... .......... ...+..++.+.+++.+||+.||.+|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 216 LLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 0000000000 112234678889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-28 Score=248.25 Aligned_cols=192 Identities=24% Similarity=0.281 Sum_probs=153.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
+++++..+..++..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++
T Consensus 59 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~ 134 (260)
T cd05611 59 VAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTG 134 (260)
T ss_pred eeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCC
Confidence 7888889999999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++..... .....++..|+|||.+.+..++.++||||||+++|+|++|..||..... ...
T Consensus 135 ~~~l~dfg~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~----- 201 (260)
T cd05611 135 HLKLTDFGLSRNGLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAV----- 201 (260)
T ss_pred cEEEeecccceeccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHH-----
Confidence 999999999876432 1234578899999998887889999999999999999999999964311 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.......... ............+.+++.+||+.+|++||++.++.+.|+
T Consensus 202 ~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 202 FDNILSRRIN--WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHhcccC--CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1111111110 111122234678899999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=249.18 Aligned_cols=203 Identities=22% Similarity=0.253 Sum_probs=151.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.++.+...++||||++++.|..++.... .+++.++..++.|++.||+|||+. +++|+||||+||+++.++
T Consensus 62 i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~ 137 (286)
T cd07847 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQG 137 (286)
T ss_pred EeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCC
Confidence 7888888999999999999999998888876544 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........
T Consensus 138 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (286)
T cd07847 138 QIKLCDFGFARILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKT 216 (286)
T ss_pred cEEECccccceecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999987644321 1223457789999998765 56789999999999999999999999754221111111000
Q ss_pred HHHh-------hhcccc-cc--cccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNC-------FVAGEF-NK--LVEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~-------~~~~~~-~~--~~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... ...... .. .... .........+.+++.+||+.+|++||++.|++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 217 LGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 000000 00 0000 001123567889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=244.66 Aligned_cols=189 Identities=22% Similarity=0.285 Sum_probs=153.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++.... .+++.++..++.|+++||+|||+. +++|+||||+||+++.++
T Consensus 71 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~ 146 (267)
T PHA03390 71 FIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAK 146 (267)
T ss_pred EEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCC
Confidence 7888999999999999999999999999997765 789999999999999999999999 999999999999999998
Q ss_pred -cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 -RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 -~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||++....... ...++..|+|||.+.+..++.++||||||+++|||++|+.||..... +......+
T Consensus 147 ~~~~l~dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~ 219 (267)
T PHA03390 147 DRIYLCDYGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED--EELDLESL 219 (267)
T ss_pred CeEEEecCccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc--chhhHHHH
Confidence 99999999988654322 23578899999999888899999999999999999999999974321 11111111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-MKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~ 678 (702)
... . .. ...........+.+++.+||+.+|.+||+ ++|+++
T Consensus 220 ~~~-~-~~------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 220 LKR-Q-QK------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHh-h-cc------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111 1 10 00122245678899999999999999996 588874
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=247.66 Aligned_cols=190 Identities=22% Similarity=0.278 Sum_probs=155.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+.++...++||||+++++|.+++... .+++.++..++.|++.||+|||+. +++|+||+|+||+++.++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~ 138 (277)
T cd06640 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQG 138 (277)
T ss_pred EeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCC
Confidence 788889999999999999999999999998653 588899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|||++|..||....... ..
T Consensus 139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~--- 210 (277)
T cd06640 139 DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VL--- 210 (277)
T ss_pred CEEEcccccceeccCCcc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----Hh---
Confidence 999999999987643221 2223457889999999988889999999999999999999999996432110 00
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..... ...+.........+.+++.+||+.+|++||+++++++.
T Consensus 211 -~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 211 -FLIPK-----NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -hhhhc-----CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 00000 11123344567789999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=250.31 Aligned_cols=191 Identities=21% Similarity=0.294 Sum_probs=152.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++++|.+++... .+++.++..++.|++.||+|||++ +++|+||||+||+++.++
T Consensus 78 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~ 152 (296)
T cd06655 78 IVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDG 152 (296)
T ss_pred eeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 778888889999999999999999999998653 589999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... . ... .
T Consensus 153 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-~--~~~-~ 227 (296)
T cd06655 153 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-A--LYL-I 227 (296)
T ss_pred CEEEccCccchhcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-H--HHH-H
Confidence 999999999876543322 1223457889999999988889999999999999999999999996542111 0 000 0
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ ..+......+.+++.+||+.||++||++.++++
T Consensus 228 ----~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 228 ----ATNGTPEL---QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----HhcCCccc---CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000 112234557888999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-28 Score=250.95 Aligned_cols=204 Identities=21% Similarity=0.255 Sum_probs=152.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+.+..++..++||||++++.|..++.+. ..+++.++..++.||+.||+|||++ +++|+||+|+||++++++
T Consensus 62 i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~ 137 (288)
T cd07833 62 IVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESG 137 (288)
T ss_pred eeehhheEEECCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCC
Confidence 777788888899999999999987777666543 3689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++...............++..|+|||++.+. .++.++||||||+++|+|++|+.||...............
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 217 (288)
T cd07833 138 VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC 217 (288)
T ss_pred CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999987654433233445678899999998877 8899999999999999999999999644211100000000
Q ss_pred HH-------Hhh-hcc-----cccccccc-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VY-------NCF-VAG-----EFNKLVEE-----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~-------~~~-~~~-----~~~~~~~~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ... ... ........ ..+...+..+.+++.+||+.+|++||+++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 218 LGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000 000 00000000 112233678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=251.29 Aligned_cols=199 Identities=27% Similarity=0.341 Sum_probs=154.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+...+..++||||+++++|.+++...+ .+++..+..++.|++.+|.|||+ + +++|+||||+||+++.+
T Consensus 65 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~ 140 (284)
T cd06620 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSR 140 (284)
T ss_pred cceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCC
Confidence 7788888999999999999999999999987654 68899999999999999999997 5 89999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch----hh
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE----VL 625 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----~~ 625 (702)
+.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......+. ..
T Consensus 141 ~~~~l~d~gl~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~ 217 (284)
T cd06620 141 GQIKLCDFGVSGELINSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG 217 (284)
T ss_pred CcEEEccCCcccchhhhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH
Confidence 999999999987542221 22356899999999988888999999999999999999999999754221110 01
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
....... ........+ ........+.+++.+||+.||++||+++|++++.-
T Consensus 218 ~~~~~~~-~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 218 ILDLLQQ-IVQEPPPRL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHH-HhhccCCCC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 1111111 111111110 01124567889999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=252.10 Aligned_cols=197 Identities=21% Similarity=0.247 Sum_probs=153.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..+++.++||||+++++|.+++...+ .+++..+..++.|++.||+|||++ +++|+||||+||+++.++
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~ 138 (305)
T cd05609 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMG 138 (305)
T ss_pred eeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCC
Confidence 7888888999999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC--------------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcC
Q 038002 551 RAKISDFGLAKLLMPNQT--------------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEV 616 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 616 (702)
.+||+|||+++....... .......++..|+|||.+.+..++.++|+||||+++|||++|..||..
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999998864211100 011124578899999999888899999999999999999999999964
Q ss_pred CCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 617 NVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
... .+ ............ +......+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 219 ~~~--~~------~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 219 DTP--EE------LFGQVISDDIEW---PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCH--HH------HHHHHHhcccCC---CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 311 11 111111111111 11112345678999999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=248.37 Aligned_cols=191 Identities=22% Similarity=0.249 Sum_probs=152.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.+...+..++..++||||+++++|.+++.... .+++.++..++.|+++||+|||+. +|+|+||||+||+++.++
T Consensus 59 i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~ 134 (278)
T cd05606 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHG 134 (278)
T ss_pred EeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCC
Confidence 6777888899999999999999999999987654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++..+.... .....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||...........
T Consensus 135 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---- 207 (278)
T cd05606 135 HVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---- 207 (278)
T ss_pred CEEEccCcCccccCccC---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----
Confidence 99999999987553222 1234689999999988644 688999999999999999999999975422211110
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
...... .....+...+..+.+++.+||+.+|.+|| +++++++.
T Consensus 208 -~~~~~~------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 208 -DRMTLT------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -HHHhhc------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000000 11122333467889999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=218.88 Aligned_cols=104 Identities=36% Similarity=0.558 Sum_probs=76.5
Q ss_pred CCeEEEEecCCCCCCC--CCceEEEccCCcEEEEcCCCCeeeee-ccccCC-cceeEEEecCcCEEEeecCCceEeeecC
Q 038002 73 NITVVWTANRDEQPMP--SNATLALTMDGKLILKTEESKEKPIA-DLVFDE-PASFASMLDSGNFVLYSNRSGIIWESFS 148 (702)
Q Consensus 73 ~~~~vW~An~~~~~~~--~~~~l~~~~~g~L~l~~~~~~~~w~~-~~~~~~-~~~~~~l~d~Gnlvl~~~~~~~~WqSFd 148 (702)
++||||+|||+.|+.. ..++|.|+.||||+|++.+++.+|++ ++.... ...+|+|+|+|||||++..+.+||||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~ 80 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFD 80 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTT
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecC
Confidence 4799999999999865 34899999999999999998899999 443333 5899999999999999999999999999
Q ss_pred CCcccccCCCccCCC------CeEEeeccCCCCc
Q 038002 149 TPTDTILGGQSLENG------EHLLSSVTETNSS 176 (702)
Q Consensus 149 ~PTDTlLpgq~l~~~------~~L~S~~s~~dps 176 (702)
|||||+||||+|+.+ ..++||++.+|||
T Consensus 81 ~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 81 YPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp SSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999862 4599999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=249.13 Aligned_cols=200 Identities=19% Similarity=0.261 Sum_probs=148.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+++.+++..++||||+++ +|.+++......+++..+..++.|+++||+|||+. +|+|+||||+||+++.++
T Consensus 65 i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~ 140 (291)
T cd07844 65 IVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERG 140 (291)
T ss_pred eeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCC
Confidence 77788889999999999999985 99999887665788999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++........ ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||.......+....
T Consensus 141 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~--- 216 (291)
T cd07844 141 ELKLADFGLARAKSVPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK--- 216 (291)
T ss_pred CEEECccccccccCCCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH---
Confidence 999999999875432211 1122346788999998765 56789999999999999999999999654211111110
Q ss_pred HHHhhhc---ccc--------------ccccccc----c-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVA---GEF--------------NKLVEEE----V-DKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~---~~~--------------~~~~~~~----~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....... ..+ ....... . .......+.+++.+||+.+|++||+++|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 000 0000000 0 0111267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=245.80 Aligned_cols=197 Identities=24% Similarity=0.299 Sum_probs=153.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++ +++|+||+|+||+++.++
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~ 145 (272)
T cd06629 70 IVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADG 145 (272)
T ss_pred cceEEEEeccCCceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCC
Confidence 6677788888999999999999999999997764 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCc-eeeceeccccccCcccccCCC--CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGL--ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++|+|||++......... ......++..|+|||.+.... ++.++|+||||+++||+++|..||...... ..
T Consensus 146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~-- 220 (272)
T cd06629 146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AA-- 220 (272)
T ss_pred eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH---HH--
Confidence 9999999999765322111 123345788999999886654 789999999999999999999999532110 00
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ........+...........+.+++.+||+.+|++||+++++++.
T Consensus 221 --~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 221 --MFKL-GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred --HHHh-hccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0110 111111111222333456788999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=249.49 Aligned_cols=198 Identities=24% Similarity=0.339 Sum_probs=153.7
Q ss_pred eeeEEEEE-ecCCeeEEEEecCCCCCHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYK-HRSSKKLLVYEFMSKGSLADLLFNLE-------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
|++++++. ..+...++++||+++++|.+++.... ..+++.++..++.|++.||+|||++ +++|+||||+
T Consensus 70 i~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~ 146 (280)
T cd05043 70 ILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAAR 146 (280)
T ss_pred CCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHh
Confidence 66666654 44688999999999999999987542 3478999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVST 620 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 620 (702)
||++++++.+||+|||+++.+....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||.....
T Consensus 147 nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~- 225 (280)
T cd05043 147 NCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP- 225 (280)
T ss_pred hEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-
Confidence 9999999999999999998654332211 122345678999999988889999999999999999999 9999964311
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...... ...+ .. .......++.+.+++.+||+.||++|||+.++++.|+.+.
T Consensus 226 ---~~~~~~----~~~~-~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 226 ---FEMAAY----LKDG-YR----LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ---HHHHHH----HHcC-CC----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111111 1111 10 0111223567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=247.16 Aligned_cols=194 Identities=21% Similarity=0.225 Sum_probs=147.2
Q ss_pred eeeEEEEE-----ecCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYK-----HRSSKKLLVYEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~-----~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
|++++.++ ++++..++||||+++++|.+++.. ....+++..+..++.|+++||.|||++ +|+||||||+
T Consensus 77 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~ 153 (286)
T cd06638 77 VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGN 153 (286)
T ss_pred eeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHH
Confidence 66676655 356789999999999999998753 233578889999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
||+++.++.+||+|||++........ ......|++.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 154 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 154 NILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred hEEECCCCCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999987643221 2233468899999998753 45788999999999999999999999643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... .... ........... +......+.+++.+||+.||++||+++||++.
T Consensus 233 ~~~~---~~~~-----~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 233 HPMR---ALFK-----IPRNPPPTLHQ---PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred chhH---HHhh-----ccccCCCcccC---CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1111 0000 00010001111 11234578899999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=251.11 Aligned_cols=190 Identities=23% Similarity=0.311 Sum_probs=152.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++++|.+++.. ..+++..+..++.|+++||+|||++ +++|+||+|+||++++++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~ 138 (277)
T cd06642 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQG 138 (277)
T ss_pred cHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCC
Confidence 66777788889999999999999999999864 3588999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|||++|+.|+....... ..
T Consensus 139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~--- 210 (277)
T cd06642 139 DVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR----VL--- 210 (277)
T ss_pred CEEEccccccccccCcch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh----HH---
Confidence 999999999976543221 1223457889999999988889999999999999999999999986431110 00
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... .+.........+.+++.+||+.+|++||++.++++.
T Consensus 211 -~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 211 -FLIPKNS-----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -hhhhcCC-----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0011111 112223445678899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=249.58 Aligned_cols=194 Identities=21% Similarity=0.275 Sum_probs=153.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..+...++||||+++++|.+++.+....+++.++..++.|++.||+|||++ +|+|+||||+||+++.++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~ 140 (280)
T cd06611 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDG 140 (280)
T ss_pred eeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCC
Confidence 88888899999999999999999999999987666789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.++|+|||++....... .......+++.|+|||.+. ...++.++|+||||+++|||++|+.||...... ..
T Consensus 141 ~~~l~d~g~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~---~~ 216 (280)
T cd06611 141 DVKLADFGVSAKNKSTL-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM---RV 216 (280)
T ss_pred CEEEccCccchhhcccc-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH---HH
Confidence 99999999887543222 1223456889999999874 345678999999999999999999999643111 11
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. ........... ..+......+.+++.+||+.+|++||+++++++.
T Consensus 217 ~-----~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 217 L-----LKILKSEPPTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred H-----HHHhcCCCCCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 1 11111111111 1122345678899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=255.07 Aligned_cols=213 Identities=21% Similarity=0.261 Sum_probs=175.0
Q ss_pred cceEEEeEE--EEEeeeeh--hhhH---hh----------------------------eeeEEEEEecCCe--eEEEEec
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFL---IA----------------------------ISSLLVYKHRSSK--KLLVYEF 490 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~a---vk----------------------------i~~l~~~~~~~~~--~~lV~e~ 490 (702)
...||+|+| ||+|.... ..|| || |++++.++.+... +.+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 357899998 99988765 3333 11 9999988876555 8899999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-CCcEEEecccceeecCCCCCc
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-SWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+..|+|..|+++.+ +++.+.+..|++||++||.|||++ .+.|||||||-+||+|+. .|.|||+|+|+|.......
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-- 200 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc--
Confidence 99999999999887 899999999999999999999997 569999999999999965 5789999999999864333
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
...+.|||.|||||... ..|++.+||||||+.++||+|+..||..... ...++.....|.-+..+..--
T Consensus 201 -aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiKP~sl~kV~-- 269 (632)
T KOG0584|consen 201 -AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIKPAALSKVK-- 269 (632)
T ss_pred -cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCCHHHhhccC--
Confidence 34478999999999877 7899999999999999999999999975522 233555666665554444422
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..++.++|.+||.. ..+|||+.|+|+
T Consensus 270 --dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 --DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 34688899999999 999999999997
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=247.44 Aligned_cols=189 Identities=25% Similarity=0.300 Sum_probs=153.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++...+.++...++|+||+++++|.+++... .+++..+..++.|++.||+|||++ +++|+||+|+||++++++
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~ 135 (274)
T cd06609 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEG 135 (274)
T ss_pred eeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCC
Confidence 788888889999999999999999999999764 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... . .
T Consensus 136 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--~--~---- 206 (274)
T cd06609 136 DVKLADFGVSGQLTSTMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--R--V---- 206 (274)
T ss_pred CEEEcccccceeeccccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--H--H----
Confidence 999999999987654321 223456788999999998888999999999999999999999999643211 0 0
Q ss_pred HHhhhccccccccccccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKI-TLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ .+..... ....+.+++.+||+.+|++||+++++++
T Consensus 207 ~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 207 LFLIPKNN-----PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred HHHhhhcC-----CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 01111111 1111111 4567889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=272.67 Aligned_cols=193 Identities=21% Similarity=0.229 Sum_probs=145.3
Q ss_pred eeeEEEEEe--cCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCC----CCeEecCCCC
Q 038002 471 ISSLLVYKH--RSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECE----VQIIHCDIKL 541 (702)
Q Consensus 471 i~~l~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~----~~ivH~dlkp 541 (702)
|++++.++. ....+||||||+++++|.++|... ...+++..++.|+.||+.||+|||+... .+|+|+||||
T Consensus 74 IVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKP 153 (1021)
T PTZ00266 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKP 153 (1021)
T ss_pred cCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcH
Confidence 777777663 456799999999999999999753 2368999999999999999999998510 1599999999
Q ss_pred CcEEEeC-----------------CCcEEEecccceeecCCCCCceeeceeccccccCcccccC--CCCCccccccchhH
Q 038002 542 RNILIDD-----------------SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGV 602 (702)
Q Consensus 542 ~NIll~~-----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGv 602 (702)
+||||+. ...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||
T Consensus 154 eNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ 231 (1021)
T PTZ00266 154 QNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGC 231 (1021)
T ss_pred HHeEeecCccccccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHH
Confidence 9999964 3358999999998653322 1234568999999998854 45889999999999
Q ss_pred hHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 603 il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
|+|||++|..||...... . . ....+.... .+ .....+..+.+||..||+.+|.+||++.|++.
T Consensus 232 ILYELLTGk~PF~~~~~~--~----q-li~~lk~~p--~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 232 IIYELCSGKTPFHKANNF--S----Q-LISELKRGP--DL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHCCCCCCcCCcH--H----H-HHHHHhcCC--CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 999999999999643111 0 1 111111110 00 01123567889999999999999999999984
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=246.98 Aligned_cols=198 Identities=26% Similarity=0.331 Sum_probs=156.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.. ...++||||+++|+|.+++......+++..+..++.||+.||+|||++ +|+|+||||+||+++.++
T Consensus 71 i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~ 146 (279)
T cd05057 71 VVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQ 146 (279)
T ss_pred cceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCC
Confidence 6777777766 789999999999999999988766789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee-eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV-AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||.++.......... ....++..|+|||.+....++.++|+||||+++||+++ |+.||..... .+ .
T Consensus 147 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~--~-- 220 (279)
T cd05057 147 HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--VE--I-- 220 (279)
T ss_pred eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--HH--H--
Confidence 999999999987643322111 11223567999999888889999999999999999998 9999965411 11 1
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
......+.. ...+......+.+++.+||..||++||++.++++.|+.+..
T Consensus 221 --~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 221 --PDLLEKGER-----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred --HHHHhCCCC-----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111111 01112234567889999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=248.05 Aligned_cols=192 Identities=23% Similarity=0.258 Sum_probs=146.6
Q ss_pred eeeEEEEEe------cCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCc
Q 038002 471 ISSLLVYKH------RSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543 (702)
Q Consensus 471 i~~l~~~~~------~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 543 (702)
|+++++++. .++..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+|+||||+|
T Consensus 75 i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~n 151 (282)
T cd06636 75 IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQN 151 (282)
T ss_pred EEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHH
Confidence 666666653 3578899999999999999997643 3478888899999999999999999 99999999999
Q ss_pred EEEeCCCcEEEecccceeecCCCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 544 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
|++++++.++|+|||++........ ......+++.|+|||.+. ...++.++|+||||+++|||++|..||....
T Consensus 152 ili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 152 VLLTENAEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred EEECCCCCEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 9999999999999999876532211 223456889999999875 3467889999999999999999999996432
Q ss_pred CCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... . .. ........ ......+..+.+++.+||+.||.+||++.||++
T Consensus 231 ~~~~-~------~~-~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 231 PMRA-L------FL-IPRNPPPK----LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHhh-h------hh-HhhCCCCC----CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 1110 0 00 00000001 112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=243.21 Aligned_cols=192 Identities=21% Similarity=0.297 Sum_probs=154.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++...++.+++.++||||+++++|.+++.... ..+++.++..++.|++.||+|||++ +++|+||+|+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKD 137 (256)
T ss_pred eeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC
Confidence 7888899999999999999999999999987643 3578899999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||++........ ......+++.|+|||++.+...+.++|+||||+++++|++|..||..... . ..
T Consensus 138 ~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~---~----~~ 209 (256)
T cd08218 138 GTIKLGDFGIARVLNSTVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM---K----NL 209 (256)
T ss_pred CCEEEeeccceeecCcchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH---H----HH
Confidence 9999999999986643221 12234578899999999888899999999999999999999999964311 0 11
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. .....+... ..+......+.+++.+||+.+|++||++++|++.
T Consensus 210 ~-~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 210 V-LKIIRGSYP-----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred H-HHHhcCCCC-----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1 111111111 1223446678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=242.93 Aligned_cols=196 Identities=24% Similarity=0.319 Sum_probs=154.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE--TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|++++..+..++..++|||++++++|.+++.... ..+++..+..++.|++.||+|||++ +|+|+||+|+||++++
T Consensus 61 i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~ 137 (267)
T cd06610 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGE 137 (267)
T ss_pred EEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcC
Confidence 6778888889999999999999999999997642 3588999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCc---eeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 549 SWRAKISDFGLAKLLMPNQTG---IVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
++.++|+|||++......... ......++..|+|||.+... .++.++|+||||++++||++|+.||.......
T Consensus 138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--- 214 (267)
T cd06610 138 DGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--- 214 (267)
T ss_pred CCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---
Confidence 999999999998766443322 12334688899999988766 78999999999999999999999996432111
Q ss_pred hhHHHHHHhhhccccccccccc-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEE-VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... ....... ..... .....++.+.+++.+||+.||++||++++|++
T Consensus 215 ~~~~-----~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 215 VLML-----TLQNDPP-SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hHHH-----HhcCCCC-CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111 1111111 11111 11245678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=242.79 Aligned_cols=190 Identities=26% Similarity=0.348 Sum_probs=152.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+++..++..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~ 139 (258)
T cd06632 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNG 139 (258)
T ss_pred chheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 6778888889999999999999999999997654 588999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCC-CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL-ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++....... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ...
T Consensus 140 ~~kl~d~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~---- 210 (258)
T cd06632 140 VVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAA---- 210 (258)
T ss_pred CEEEccCccceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHH----
Confidence 99999999988754332 223455788999999887666 89999999999999999999999965421 000
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......... +..+......+.+++.+||+.+|++||+++++++
T Consensus 211 ~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 211 VFKIGRSKEL-----PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHHhcccC-----CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1110010111 1122334567888999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=243.42 Aligned_cols=191 Identities=23% Similarity=0.285 Sum_probs=146.7
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|++++..+.+ +...+++|||+++++|.+++.... .+++.....++.|++.||+|||+. +|+|+||||+||+++.
T Consensus 66 i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~ 141 (266)
T cd06651 66 IVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDS 141 (266)
T ss_pred eeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECC
Confidence 6777766654 478899999999999999997654 588899999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCC--CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 549 SWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
++.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~- 217 (266)
T cd06651 142 AGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AA- 217 (266)
T ss_pred CCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HH-
Confidence 9999999999987653211 11122345788999999998888999999999999999999999999643111 00
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ ..+..+....+.+.+++ +||..+|++||+++||++
T Consensus 218 ---~~~~~~~~-----~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 218 ---IFKIATQP-----TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---HHHHhcCC-----CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111111 11222333445566666 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=255.56 Aligned_cols=188 Identities=23% Similarity=0.291 Sum_probs=158.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.+.+.+..+|+||||+.+|.+.+++.+.+ +..+.++..++.|+.+|++|||++ .|+|||||++|||++.+.
T Consensus 117 Ivkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~m 192 (596)
T KOG0586|consen 117 IVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENM 192 (596)
T ss_pred eeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhccccccc
Confidence 8999999999999999999999999999999887 677799999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
++||+|||++..+.. .......+|++.|.|||++.+..| .+.+|+||+|+++|.|+.|..||+...-..-
T Consensus 193 nikIaDfgfS~~~~~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------- 263 (596)
T KOG0586|consen 193 NIKIADFGFSTFFDY--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------- 263 (596)
T ss_pred ceeeeccccceeecc--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------
Confidence 999999999998853 334667899999999999988765 5899999999999999999999986521110
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+....+.+ .++.-.+.++.++|+++|..+|.+|++++++.+
T Consensus 264 -r~rvl~gk~------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 264 -RPRVLRGKY------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -cchheeeee------cccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 011111111 223334567888999999999999999999876
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=243.56 Aligned_cols=192 Identities=23% Similarity=0.317 Sum_probs=153.2
Q ss_pred eeeEEEEEe--cCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhh-----hcCCCCeEecCCC
Q 038002 471 ISSLLVYKH--RSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLH-----DECEVQIIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH-----~~~~~~ivH~dlk 540 (702)
|+++++++. .+...+++|||+++++|.+++... ...+++.+++.++.||+.||+||| +. +++|+|||
T Consensus 61 i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~ 137 (265)
T cd08217 61 IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLK 137 (265)
T ss_pred cceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCC
Confidence 667766553 456789999999999999999754 346889999999999999999999 77 99999999
Q ss_pred CCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCC
Q 038002 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVST 620 (702)
Q Consensus 541 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 620 (702)
|+||+++.++.+||+|||++........ ......+++.|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 138 p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-- 214 (265)
T cd08217 138 PANIFLDANNNVKLGDFGLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-- 214 (265)
T ss_pred HHHEEEecCCCEEEecccccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--
Confidence 9999999999999999999987644332 1233468899999999988889999999999999999999999997542
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ......+.. +..+......+.+++.+||+.+|++||++++|++.
T Consensus 215 --~~~~----~~~~~~~~~-----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 215 --QLQL----ASKIKEGKF-----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --HHHH----HHHHhcCCC-----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 111111111 12334456788999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=246.00 Aligned_cols=202 Identities=19% Similarity=0.233 Sum_probs=147.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+++..++..++||||+. ++|.+++......+.+.++..++.|++.||+|||+. +|+|+||||+||+++.++
T Consensus 65 i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~ 140 (291)
T cd07870 65 IVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLG 140 (291)
T ss_pred EeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCC
Confidence 7788888999999999999996 678777765555678888999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||.......+.. ...+
T Consensus 141 ~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~-~~~~ 218 (291)
T cd07870 141 ELKLADFGLARAKSIPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL-EKIW 218 (291)
T ss_pred cEEEeccccccccCCCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH-HHHH
Confidence 999999999875432221 1223456889999998865 457889999999999999999999997542211110 0000
Q ss_pred HHH---------------hhhcccccccccccc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYN---------------CFVAGEFNKLVEEEV-----DKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~---------------~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... ............... .......+.+++.+|++.||++|||++|++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 219 TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 000000000000000 0012457788999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=247.35 Aligned_cols=193 Identities=26% Similarity=0.379 Sum_probs=150.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL--ETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~ 547 (702)
|+++++.+..++..++||||+++++|..++... ...+++..+..++.|++.||.|||+ . +|+|+||||+||+++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~ 137 (286)
T cd06622 61 IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVN 137 (286)
T ss_pred HHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEEC
Confidence 666777788899999999999999999998764 2368999999999999999999996 5 899999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCC------CCCccccccchhHhHHHhhhCCcCCcCCCCCc
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG------LITVKSDVYSFGVVLLEIICCRSNFEVNVSTA 621 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 621 (702)
.++.+||+|||++....... .....+++.|+|||.+.+. .++.++|+|||||++|+|++|..||.......
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 138 GNGQVKLCDFGVSGNLVASL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred CCCCEEEeecCCcccccCCc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 99999999999987653222 2234578899999987543 35789999999999999999999996431111
Q ss_pred chhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 622 DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. . .......+. ....+......+.+++.+||+.+|++||++++++..
T Consensus 215 ---~~-~-~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 215 ---IF-A-QLSAIVDGD-----PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred ---HH-H-HHHHHhhcC-----CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 00 0 001111111 112334467788999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=242.74 Aligned_cols=194 Identities=25% Similarity=0.335 Sum_probs=151.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.+.+..++|+||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~ 136 (264)
T cd06626 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNG 136 (264)
T ss_pred hhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 6778888889999999999999999999997654 578899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee---eceeccccccCcccccCCC---CCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 551 RAKISDFGLAKLLMPNQTGIV---AGVRGSRGYMAPEWQNSGL---ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
.+||+|||++........... ....++..|+|||.+.... ++.++||||||++++++++|+.||...... .
T Consensus 137 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~---~ 213 (264)
T cd06626 137 VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE---F 213 (264)
T ss_pred CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch---H
Confidence 999999999987644332211 1355788999999987665 889999999999999999999999643211 1
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ... ...... ..+.. .......+.+++.+||+.+|++||++++++.
T Consensus 214 ~~---~~~-~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 214 QI---MFH-VGAGHK-PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HH---HHH-HhcCCC-CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 000 001110 00111 1123567789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-27 Score=241.97 Aligned_cols=191 Identities=21% Similarity=0.241 Sum_probs=148.5
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++++.+.+ +...++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+|+||||+||+++.
T Consensus 66 i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~ 141 (265)
T cd06652 66 IVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDS 141 (265)
T ss_pred eeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecC
Confidence 6677776655 457889999999999999997654 578888999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCC--ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 549 SWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....
T Consensus 142 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~ 218 (265)
T cd06652 142 VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAI 218 (265)
T ss_pred CCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHH
Confidence 99999999999876532111 112234578899999998888889999999999999999999999964311 1111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...... ...+..+......+.+++.+|+. +|++||+++||++
T Consensus 219 ----~~~~~~-----~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 219 ----FKIATQ-----PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----HHHhcC-----CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111111 11122344566778889999985 8999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=233.26 Aligned_cols=194 Identities=22% Similarity=0.331 Sum_probs=154.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++.+++|-.+...++.||.|. .-++.+++.....+++..+-++...++.||.||.+++ +|+|||+||+|||+|+.|
T Consensus 153 IV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~G 229 (391)
T KOG0983|consen 153 IVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERG 229 (391)
T ss_pred eeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCC
Confidence 8999999999999999999994 3677777777667888888899999999999998874 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++||+|||.+-.+..... .+...|-+.|||||.+. ...|+.++||||||+.++||.||+.||......- ..+.
T Consensus 230 niKlCDFGIsGrlvdSkA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF--e~lt 305 (391)
T KOG0983|consen 230 NIKLCDFGISGRLVDSKA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF--EVLT 305 (391)
T ss_pred CEEeecccccceeecccc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH--HHHH
Confidence 999999999987654433 34456889999999874 3478899999999999999999999998652221 1111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. +.. +.+..++.. ...+..+++++..||++|+.+||...++++.
T Consensus 306 k-----vln-~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 306 K-----VLN-EEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred H-----HHh-cCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 111 112222221 2267889999999999999999999998863
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-28 Score=250.42 Aligned_cols=203 Identities=21% Similarity=0.285 Sum_probs=149.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..++..++||||+++++|..+..... .+++.++..++.||+.||+|||+. +|+|+||+|+||++++++
T Consensus 62 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~ 137 (286)
T cd07846 62 LVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSG 137 (286)
T ss_pred hhhHHHhcccCCeEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCC
Confidence 5666777888999999999999999988776543 589999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||...............
T Consensus 138 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~ 216 (286)
T cd07846 138 VVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216 (286)
T ss_pred cEEEEeeeeeeeccCCcc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHH
Confidence 999999999987643332 2233457889999998765 45788999999999999999999999644211100000000
Q ss_pred HH-------Hhhhcccc-cccccc---------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VY-------NCFVAGEF-NKLVEE---------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~-------~~~~~~~~-~~~~~~---------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. .......+ .....+ ...+.....+.+++.+||+.+|++||+++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 217 LGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 00000000 000000 012234677999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=249.77 Aligned_cols=177 Identities=20% Similarity=0.238 Sum_probs=147.4
Q ss_pred cceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
.+.||.|+| |+++.... ..+|+| |++|+..|++.+.+|+||||++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 467899999 77776543 556665 99999999999999999999999
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC--------
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP-------- 565 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~-------- 565 (702)
|++..+|-+.+ -+++..++-++.++..|+++.|+. |+|||||||+|||||.+|++||.|||++.-+.-
T Consensus 714 GDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq 789 (1034)
T KOG0608|consen 714 GDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 789 (1034)
T ss_pred ccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecccccccc
Confidence 99999998765 688888888999999999999999 999999999999999999999999999964310
Q ss_pred CCC---------------------------------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCc
Q 038002 566 NQT---------------------------------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRS 612 (702)
Q Consensus 566 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~ 612 (702)
+.. -......||+.|+|||++....++..+|.||.|||||||+.|+.
T Consensus 790 ~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~ 869 (1034)
T KOG0608|consen 790 EGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQP 869 (1034)
T ss_pred CCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCC
Confidence 000 00012569999999999999999999999999999999999999
Q ss_pred CCcCCCCCcchhhhHH
Q 038002 613 NFEVNVSTADEVLLST 628 (702)
Q Consensus 613 Pf~~~~~~~~~~~~~~ 628 (702)
||-.....+.+..+..
T Consensus 870 pf~~~tp~~tq~kv~n 885 (1034)
T KOG0608|consen 870 PFLADTPGETQYKVIN 885 (1034)
T ss_pred CccCCCCCcceeeeee
Confidence 9976655544444433
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=250.42 Aligned_cols=198 Identities=23% Similarity=0.324 Sum_probs=153.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.. ...++|+||+++|+|.+++......+++..+..++.|++.||+|||++ +|+|+||||+||+++.++
T Consensus 71 iv~~~~~~~~-~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~ 146 (303)
T cd05110 71 LVRLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPN 146 (303)
T ss_pred cccEEEEEcC-CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCC
Confidence 6777777654 457899999999999999987665688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....
T Consensus 147 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~~~~ 222 (303)
T cd05110 147 HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----REIPD 222 (303)
T ss_pred ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH
Confidence 9999999999876433221 1122335678999999988889999999999999999997 8999864311 11111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.. ..+... ..+......+.+++.+||..+|++||+++++++.|+.+.+
T Consensus 223 ~~----~~~~~~-----~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 223 LL----EKGERL-----PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred HH----HCCCCC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 111110 1112234578889999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=245.28 Aligned_cols=195 Identities=28% Similarity=0.392 Sum_probs=153.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+..++..++|+||+++++|.+++......+++..+..++.|++.||+|||+ . +++|+||||+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~ 137 (265)
T cd06605 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSR 137 (265)
T ss_pred hhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCC
Confidence 5666777888899999999999999999998765578899999999999999999999 8 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||.+......... ...++..|+|||.+.+..++.++||||||+++|+|++|..||.......... ...
T Consensus 138 ~~~~l~d~g~~~~~~~~~~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~ 212 (265)
T cd06605 138 GQIKLCDFGVSGQLVNSLAK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI--FEL 212 (265)
T ss_pred CCEEEeecccchhhHHHHhh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH--HHH
Confidence 99999999998765322211 2567889999999988899999999999999999999999996542211111 111
Q ss_pred HHHhhhccccccccccccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKI-TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......... +..... ....+.++|.+||+.||++|||+.+++..
T Consensus 213 -~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 213 -LQYIVNEPP-----PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -HHHHhcCCC-----CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111111 111111 56678999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=242.41 Aligned_cols=195 Identities=26% Similarity=0.373 Sum_probs=154.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+.+++..++||||+++++|.+++.+.. .+++..+..++.|++.||+|||++ +++|+||+|+||+++.++
T Consensus 65 iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~ 140 (268)
T cd06630 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTG 140 (268)
T ss_pred eehhhceeccCCeEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 7788888999999999999999999999997654 688999999999999999999999 999999999999998776
Q ss_pred -cEEEecccceeecCCCCC---ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 551 -RAKISDFGLAKLLMPNQT---GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 551 -~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.+||+|||.+........ .......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.........
T Consensus 141 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--- 217 (268)
T cd06630 141 QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL--- 217 (268)
T ss_pred CEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---
Confidence 599999999987643321 1122345788999999998888899999999999999999999999643211111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ ....+..+......+.+++.+||+.+|++||++.++++
T Consensus 218 -~~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 218 -ALIFKIAS-----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -HHHHHHhc-----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111000 11122344556778999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=241.18 Aligned_cols=191 Identities=23% Similarity=0.354 Sum_probs=151.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+..++..++||||+++++|.+++.... ..+++..+..++.|++.+|+|||++ +++|+||+|+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKH 137 (256)
T ss_pred hhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence 5667778888999999999999999999997653 3478999999999999999999999 99999999999999755
Q ss_pred -CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 -WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 -~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ...
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~-- 210 (256)
T cd08220 138 KMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALV-- 210 (256)
T ss_pred CCEEEEccCCCceecCCCcc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHH--
Confidence 4689999999987643322 22345788999999998888899999999999999999999999654211 111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......... ..+......+.+++.+||+.+|++|||++|+++.
T Consensus 211 ---~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 211 ---LKIMSGTFA-----PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---HHHHhcCCC-----CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111111111 1222346678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-27 Score=245.08 Aligned_cols=201 Identities=21% Similarity=0.215 Sum_probs=148.9
Q ss_pred eeeEEEEEecC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRS--SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++++.+.++ +..++||||++ ++|.+++......+++.++..++.|++.||+|||+. +++|+||+|+||+++.
T Consensus 60 i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~ 135 (282)
T cd07831 60 ILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD 135 (282)
T ss_pred ccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC
Confidence 66777777777 89999999997 588888876555789999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCccccc-CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
+.+||+|||++........ .....++..|+|||.+. +..++.++|||||||++|||++|..||......+......
T Consensus 136 -~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~ 212 (282)
T cd07831 136 -DILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIH 212 (282)
T ss_pred -CCeEEEecccccccccCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHH
Confidence 9999999999986643322 12345788999999764 4567899999999999999999999996542111000000
Q ss_pred HH-------HHHhhhcccccc-----cccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TW-------VYNCFVAGEFNK-----LVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~-------~~~~~~~~~~~~-----~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ............ .... ......+..+.+++.+||+.+|++||+++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 213 DVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00 000000000000 0000 112245688999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=243.48 Aligned_cols=190 Identities=22% Similarity=0.292 Sum_probs=151.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++++++.+..+...++||||+++++|.+++... .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++
T Consensus 64 vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~ 138 (277)
T cd06917 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTG 138 (277)
T ss_pred eeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCC
Confidence 677788888999999999999999999998653 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||++........ ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||........
T Consensus 139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------- 210 (277)
T cd06917 139 NVKLCDFGVAALLNQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------- 210 (277)
T ss_pred CEEEccCCceeecCCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------
Confidence 999999999987644332 2234568889999998765 4578999999999999999999999964321100
Q ss_pred HHHhhhccccccccccccCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDK-ITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. ........ +.... .....+.+++.+||+.||++||++.++++.
T Consensus 211 ~-~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 211 M-MLIPKSKP-----PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred h-hccccCCC-----CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 0 00000001 11111 145678899999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=248.55 Aligned_cols=192 Identities=22% Similarity=0.299 Sum_probs=150.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 81 ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~ 155 (292)
T cd06658 81 VVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDG 155 (292)
T ss_pred HHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCC
Confidence 555666777889999999999999999988543 588999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|||++|..||...... ....
T Consensus 156 ~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~--- 228 (292)
T cd06658 156 RIKLSDFGFCAQVSKEVP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---QAMR--- 228 (292)
T ss_pred CEEEccCcchhhcccccc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHH---
Confidence 999999999876533222 223356889999999998888999999999999999999999999643110 0000
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... .....+. ........+.+++.+||+.||++|||++++++.
T Consensus 229 --~~~~-~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 229 --RIRD-NLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --HHHh-cCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000 1111111 112345578889999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=243.13 Aligned_cols=198 Identities=28% Similarity=0.335 Sum_probs=150.8
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 545 (702)
|+++++++.. .+..++||||+++++|.+++.. ....+++..+..++.||+.||+|||+. +++|+||+|+||+
T Consensus 61 iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil 137 (287)
T cd06621 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNIL 137 (287)
T ss_pred eeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEE
Confidence 7777776643 4578999999999999998753 233578899999999999999999999 9999999999999
Q ss_pred EeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCc-chh
Q 038002 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA-DEV 624 (702)
Q Consensus 546 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-~~~ 624 (702)
++.++.++|+|||++........ ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ...
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (287)
T cd06621 138 LTRKGQVKLCDFGVSGELVNSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI 214 (287)
T ss_pred EecCCeEEEeecccccccccccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH
Confidence 99999999999999875532221 23457889999999988899999999999999999999999997552211 111
Q ss_pred hhHHHHHHhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....+. .......+... .......+.+.+++.+||+.+|++|||+.|+++
T Consensus 215 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 215 ELLSYI----VNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHHHH----hcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111111 11111111111 111234678899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-28 Score=238.04 Aligned_cols=177 Identities=21% Similarity=0.270 Sum_probs=145.5
Q ss_pred EEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEe
Q 038002 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 476 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
-.|+..+++++||||..||.|.-+|.+.+ .+++....-+..+|+.||.|||++ +||.||||.+|.|+|.+|++||+
T Consensus 235 YsFQt~drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 235 YSFQTQDRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred hhhccCceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEee
Confidence 46788999999999999999999987654 688888888999999999999999 99999999999999999999999
Q ss_pred cccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhh
Q 038002 556 DFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFV 635 (702)
Q Consensus 556 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 635 (702)
|||+++.--. .......++|||.|+|||++....|..++|.|.+||++|||++|+.||...... . +.+.+.
T Consensus 311 DFGLCKE~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---k-----LFeLIl 381 (516)
T KOG0690|consen 311 DFGLCKEEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---K-----LFELIL 381 (516)
T ss_pred ecccchhccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---H-----HHHHHH
Confidence 9999985322 223456799999999999999999999999999999999999999999754221 1 111111
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCC
Q 038002 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP 671 (702)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP 671 (702)
..++ ..+...+++...|+...|.+||.+|.
T Consensus 382 ~ed~------kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 MEDL------KFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhhc------cCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1111 23445566778888889999999994
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=245.06 Aligned_cols=191 Identities=20% Similarity=0.267 Sum_probs=152.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..+++.++|+||+++++|.+++.. .++++.++..++.|++.||+|||++ +|+||||+|+||+++.++
T Consensus 78 vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 152 (285)
T cd06648 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDG 152 (285)
T ss_pred hheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCC
Confidence 77888888899999999999999999999976 3688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||.+........ ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....
T Consensus 153 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~--- 224 (285)
T cd06648 153 RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAM--- 224 (285)
T ss_pred cEEEcccccchhhccCCc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHH---
Confidence 999999998875533222 22334588999999999888899999999999999999999999964311 1000
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ .... ........+.+++.+||+.+|++||+++++++
T Consensus 225 -~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 225 -KRIRDNLP-PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred -HHHHhcCC-CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11111110 0110 11224567899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=239.41 Aligned_cols=194 Identities=27% Similarity=0.349 Sum_probs=156.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+..++..++||||+++++|.+++.... .+++..+..++.|+++||+|||+ . +++|+||+|+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~ 136 (264)
T cd06623 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSK 136 (264)
T ss_pred eeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCC
Confidence 7888888999999999999999999999997653 68999999999999999999999 9 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.++|+|||++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........ ....
T Consensus 137 ~~~~l~df~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~-~~~~-- 212 (264)
T cd06623 137 GEVKIADFGISKVLENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF-FELM-- 212 (264)
T ss_pred CCEEEccCccceecccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH-HHHH--
Confidence 99999999999876433322 2245678899999999888899999999999999999999999965422111 1111
Q ss_pred HHHhhhccccccccccccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKI-TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
........ ...+.. .+..+.+++.+||+.+|++||+++++++.
T Consensus 213 --~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 213 --QAICDGPP-----PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred --HHHhcCCC-----CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111111 112222 56789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=252.69 Aligned_cols=220 Identities=23% Similarity=0.256 Sum_probs=183.2
Q ss_pred ccceEEEeEE--EEEeeeeh------hhhHhh----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 447 DKRKLLTVLA--GCLGSITF------LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~------~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
-.+.||+|-| ||.|.... ..|||| |++|++.+.+ ...+||||.
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL 471 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMEL 471 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEec
Confidence 3578999988 99998764 467887 8888888754 567999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
++.|.|.++|+..+..++......++.||+.||+|||+. .++||||...|||+.....+||+|||+++.+..+....
T Consensus 472 ~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 472 APLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred ccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 999999999999888899999999999999999999999 99999999999999999999999999999886665544
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....-...|||||.+.-+.++.++|||-|||.+||++. |..||..-...+- ...+..++ ....++
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV--------I~~iEnGe-----RlP~P~ 615 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV--------IGHIENGE-----RLPCPP 615 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce--------EEEecCCC-----CCCCCC
Confidence 444445678999999999999999999999999999986 9999976522211 11111222 224566
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
..+..+..++.+||.+||.+||++.|+...|+.+
T Consensus 616 nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 616 NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 7788999999999999999999999998887654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=235.12 Aligned_cols=190 Identities=18% Similarity=0.304 Sum_probs=157.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++-|...|++++++++|.||++||+|.-++.+++ +++++.+.-+..+|+.||.|||++ |||.||||.+|+|+|..|
T Consensus 313 lvglhscfqtesrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeg 388 (593)
T KOG0695|consen 313 LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEG 388 (593)
T ss_pred EEehhhhhcccceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCC
Confidence 5666788999999999999999999998887766 788998999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
++||.|+|+++.-.. ......+++|||.|+|||++++..|...+|.|+|||+++||+.|+.||+.......+..-..+.
T Consensus 389 hikltdygmcke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl 467 (593)
T KOG0695|consen 389 HIKLTDYGMCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL 467 (593)
T ss_pred ceeecccchhhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH
Confidence 999999999986432 2334567899999999999999999999999999999999999999998764444444444555
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP 671 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP 671 (702)
.+.+.+..+. ++...+-+...+++.-|.+||.+|.
T Consensus 468 fqvilekqir------iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 468 FQVILEKQIR------IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred HHHHhhhccc------ccceeehhhHHHHHHhhcCCcHHhc
Confidence 5555544432 2233344566777788999999993
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=244.24 Aligned_cols=186 Identities=23% Similarity=0.231 Sum_probs=152.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+.+++..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||+++.++
T Consensus 63 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~ 138 (290)
T cd05580 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDG 138 (290)
T ss_pred ccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCC
Confidence 7888889999999999999999999999997764 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++...... .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||.... ... .
T Consensus 139 ~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~-----~ 206 (290)
T cd05580 139 YIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQ-----I 206 (290)
T ss_pred CEEEeeCCCccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHH-----H
Confidence 9999999999876433 233457899999999888888999999999999999999999996442 110 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
......+.. ..+......+.+++.+||+.||.+|| +++|+++
T Consensus 207 ~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 207 YEKILEGKV------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHhcCCc------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111111111 12223356888999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=243.18 Aligned_cols=193 Identities=25% Similarity=0.288 Sum_probs=148.3
Q ss_pred eeeEEEEEec------CCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCC
Q 038002 471 ISSLLVYKHR------SSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541 (702)
Q Consensus 471 i~~l~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 541 (702)
|+++++.+.. +...++||||+++++|.+++... ...+++..+..++.|++.||+|||++ +++|+||+|
T Consensus 65 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p 141 (275)
T cd06608 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKG 141 (275)
T ss_pred hheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCH
Confidence 6677777654 44589999999999999998653 34688999999999999999999999 999999999
Q ss_pred CcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcC
Q 038002 542 RNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEV 616 (702)
Q Consensus 542 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~ 616 (702)
+||+++.++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||+++|+|++|..||..
T Consensus 142 ~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 142 QNILLTKNAEVKLVDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred HHEEEccCCeEEECCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 99999999999999999987653322 22234568889999998743 3467899999999999999999999963
Q ss_pred CCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 617 NVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... .... .......... .......+.+.+++.+||+.||++|||++++++
T Consensus 221 ~~~~---~~~~-----~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 221 MHPM---RALF-----KIPRNPPPTL---KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cchH---HHHH-----HhhccCCCCC---CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 3111 1111 1111111111 112235678899999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-27 Score=249.20 Aligned_cols=192 Identities=19% Similarity=0.266 Sum_probs=151.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++++|.+++.. ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++
T Consensus 80 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~ 154 (297)
T cd06659 80 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDG 154 (297)
T ss_pred hhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCC
Confidence 56677778889999999999999999998854 3588999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||++..+..... ......++..|+|||++.+..++.++||||||+++|||++|+.||...... + .. .
T Consensus 155 ~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~-~~-~-- 227 (297)
T cd06659 155 RVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--Q-AM-K-- 227 (297)
T ss_pred cEEEeechhHhhcccccc-cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--H-HH-H--
Confidence 999999999875533221 223356889999999998888999999999999999999999999643111 0 00 0
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... .. ..........+.+++.+||+.+|++||+++++++.
T Consensus 228 --~~~~~~~-~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 228 --RLRDSPP-PK--LKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --HHhccCC-CC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0111000 00 01112234568889999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=244.36 Aligned_cols=194 Identities=21% Similarity=0.210 Sum_probs=146.7
Q ss_pred eeeEEEEEecC-----CeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYKHRS-----SKKLLVYEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
+++++.++... +..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+. +|+|+||||+
T Consensus 81 i~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~ 157 (291)
T cd06639 81 VVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGN 157 (291)
T ss_pred eEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHH
Confidence 66666665532 468999999999999998863 234688999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCC-----CCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-----LITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
||+++.++.+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 158 nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 158 NILLTTEGGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred HEEEcCCCCEEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999886533221 12234578899999987543 3688999999999999999999999643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... .... ............ .......+.+++.+||+.+|++||+++|+++.
T Consensus 237 ~~~---~~~~-----~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 237 HPV---KTLF-----KIPRNPPPTLLH---PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred cHH---HHHH-----HHhcCCCCCCCc---ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 1111 011111111111 12344578999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-29 Score=241.66 Aligned_cols=218 Identities=21% Similarity=0.197 Sum_probs=174.2
Q ss_pred ccceEEEeEE--EEEeeeeh--hhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCCCCHH
Q 038002 447 DKRKLLTVLA--GCLGSITF--LCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSKGSLA 497 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~ 497 (702)
...++|+|+. |+++..+. ..+|+| |+++++.+-....+++|||||--|++.
T Consensus 37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiS 116 (502)
T KOG0574|consen 37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSIS 116 (502)
T ss_pred HHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHH
Confidence 3457777776 66555443 445554 888888888889999999999999999
Q ss_pred HHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceecc
Q 038002 498 DLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS 577 (702)
Q Consensus 498 ~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 577 (702)
++++..+..+++.++..+++..++||+|||.. .-||||||..|||++-+|.+||+|||.|-.+..... ....+.||
T Consensus 117 DI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRNTVIGT 192 (502)
T KOG0574|consen 117 DIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRNTVIGT 192 (502)
T ss_pred HHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhCccccC
Confidence 99998887899999999999999999999999 899999999999999999999999999976633221 23457899
Q ss_pred ccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHH
Q 038002 578 RGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVK 657 (702)
Q Consensus 578 ~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 657 (702)
+.|||||++..-.|+.++||||||+...||.-|++||........... ....-+.-+ .-+...+.++-+
T Consensus 193 PFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---------IPT~PPPTF--~KPE~WS~~F~D 261 (502)
T KOG0574|consen 193 PFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---------IPTKPPPTF--KKPEEWSSEFND 261 (502)
T ss_pred cccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---------ccCCCCCCC--CChHhhhhHHHH
Confidence 999999999999999999999999999999999999964322111000 000111111 225567889999
Q ss_pred HHHHcccCCCCCCCCHHHHHHH
Q 038002 658 TGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 658 li~~cL~~dP~~RPt~~evl~~ 679 (702)
++++||-++|++|-|+-++++.
T Consensus 262 Fi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 262 FIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HHHHHhcCCHHHHHHHHHHhhh
Confidence 9999999999999999888763
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=255.60 Aligned_cols=188 Identities=19% Similarity=0.239 Sum_probs=137.5
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
...|+++|++ +++|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccce
Confidence 4579999998 78999888543 589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH-------HHh
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV-------YNC 633 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------~~~ 633 (702)
..... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||................ ...
T Consensus 167 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 167 QADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred ecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 65332 233468999999998866 578899999999999999999999996432111000000000 000
Q ss_pred hhccc-------ccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 634 FVAGE-------FNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 634 ~~~~~-------~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..... +...... .......+.+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000 0000000 0001123457899999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=262.20 Aligned_cols=205 Identities=18% Similarity=0.242 Sum_probs=147.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|++++++++.++..|+|+|++. ++|.+++.... ......++..++.||+.||+|||++ +|+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 8889999999999999999995 57777765432 1244667788999999999999999 99999999999999
Q ss_pred eCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 547 DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 547 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
+.++.+||+|||++..+............||+.|+|||++.+..++.++|||||||++|||++|..++...........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999999876544333333467999999999999889999999999999999999988654322111111111
Q ss_pred HHHHHHh-hhcccccc-------cccc--------cc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 627 STWVYNC-FVAGEFNK-------LVEE--------EV-----DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 627 ~~~~~~~-~~~~~~~~-------~~~~--------~~-----~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... ....++.. .+.. .. .......+.+++.+||+.||++|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111000 00000000 0000 00 00123456778999999999999999999874
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=275.27 Aligned_cols=214 Identities=22% Similarity=0.231 Sum_probs=170.2
Q ss_pred ceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCCCCC
Q 038002 449 RKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMSKGS 495 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~~gs 495 (702)
.++|.|-| ||-+.-.. ...||| ++++++...+.+..+|.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 45777777 88776544 667777 7888888888999999999999999
Q ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC---Cceee
Q 038002 496 LADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ---TGIVA 572 (702)
Q Consensus 496 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~ 572 (702)
|.+++...+ ..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++|||.|..+.... .....
T Consensus 1321 La~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1321 LASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred HHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 999997654 456666667888999999999999 99999999999999999999999999999875543 12334
Q ss_pred ceeccccccCcccccC---CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHH-hhhccccccccccccC
Q 038002 573 GVRGSRGYMAPEWQNS---GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYN-CFVAGEFNKLVEEEVD 648 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 648 (702)
...||+.|||||++.+ +....++|||||||++.||+||++||...+.. |... +...+. .+.++
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--------~aIMy~V~~gh-----~Pq~P 1463 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--------WAIMYHVAAGH-----KPQIP 1463 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--------hHHHhHHhccC-----CCCCc
Confidence 6789999999998854 34567899999999999999999999654221 1111 112222 22445
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...+.+-.+++.+||+.||++|-++.|+++.
T Consensus 1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 5578888999999999999999998888764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=237.58 Aligned_cols=192 Identities=26% Similarity=0.361 Sum_probs=154.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|.++...+..++..++++||+++++|.+++......+++.++..++.|++.||++||+. +++|+||+|+||++++++
T Consensus 59 i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~ 135 (253)
T cd05122 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDG 135 (253)
T ss_pred EeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCC
Confidence 77888888899999999999999999999987655789999999999999999999998 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||.+........ .....++..|+|||.+....++.++|+||||+++|+|++|+.||...... ...
T Consensus 136 ~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----- 206 (253)
T cd05122 136 EVKLIDFGLSAQLSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KAL----- 206 (253)
T ss_pred eEEEeecccccccccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHH-----
Confidence 999999999987654332 33456888999999998888899999999999999999999999643111 000
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ........... .......+.+++.+||+.||++|||++++++
T Consensus 207 ~~-~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 207 FK-IATNGPPGLRN---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HH-HHhcCCCCcCc---ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 01111111111 1112567899999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=242.04 Aligned_cols=190 Identities=23% Similarity=0.318 Sum_probs=153.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++... .+++..+..++.|++.++++||+. +++|+||+|+||+++.++
T Consensus 64 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~ 138 (277)
T cd06641 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHG 138 (277)
T ss_pred EeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCC
Confidence 788888899999999999999999999998643 588999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ....
T Consensus 139 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~--- 210 (277)
T cd06641 139 EVKLADFGVAGQLTDTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVL--- 210 (277)
T ss_pred CEEEeecccceecccchh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHH---
Confidence 999999999876543221 12234578899999999888889999999999999999999999964311 1110
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... .+.........+.+++.+||+.+|++||+++++++.
T Consensus 211 -~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 211 -FLIPKNN-----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -HHHhcCC-----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1111111 111223345678899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-28 Score=254.46 Aligned_cols=214 Identities=24% Similarity=0.260 Sum_probs=174.0
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEec
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+..-+.||-|+| ||-+.... ..|||| ++.+-++|-.+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 344578999988 88887654 788887 66677888999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
|- ||-.|++.-.+.++.+-++..|..+.+.||+|||++ +.||||||..|||+.+.|.|||+|||.|.....
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 95 589999988877899999999999999999999999 999999999999999999999999999987533
Q ss_pred eeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 571 VAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
...++|||.|||||++. .+.|+-++|||||||+..||.-.++|+..... ....+ ++...+-+-+ -
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALY-HIAQNesPtL----q 246 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALY-HIAQNESPTL----Q 246 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHH-HHHhcCCCCC----C
Confidence 34578999999999774 47899999999999999999999999754311 11111 1111111111 1
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..+.++.+++++..||++-|.+|||.+++++.
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 45678889999999999999999999998863
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=244.08 Aligned_cols=203 Identities=21% Similarity=0.222 Sum_probs=150.7
Q ss_pred eeeEEEEEecC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRS--SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
++++++.+... +..++||||+++ +|.+++......+++.++..++.||++||+|||+. +++|+||+|+||++++
T Consensus 60 i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~ 135 (287)
T cd07840 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINN 135 (287)
T ss_pred eeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcC
Confidence 66777777777 899999999975 99999877655789999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~ 215 (287)
T cd07840 136 DGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIF 215 (287)
T ss_pred CCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999998765443222333456788999997654 467899999999999999999999997542211000000
Q ss_pred HHHHHhhhcccc------------------ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEF------------------NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... .......+ ...+........+..+.+++.+||+.+|++||+++++++
T Consensus 216 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 216 ELC-GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHh-CCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000 00000000 000000111112668899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-27 Score=242.40 Aligned_cols=192 Identities=23% Similarity=0.322 Sum_probs=147.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|++++.++..++..++||||++ ++|.+++... ...+++..+..++.||+.||+|||+++ +++||||||+||+++
T Consensus 62 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~ 138 (283)
T cd06617 62 TVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLIN 138 (283)
T ss_pred eeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEEC
Confidence 7888888889999999999996 6888887542 235889999999999999999999852 899999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccC----CCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS----GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
.++.+||+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.......+.
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (283)
T cd06617 139 RNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216 (283)
T ss_pred CCCCEEEeecccccccccccc--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH
Confidence 999999999999886532221 223457889999998754 45688999999999999999999999643111111
Q ss_pred hhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 624 VLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. . .......... ....+..+.+++.+||+.+|++||+++++++
T Consensus 217 --~~----~-~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 --LK----Q-VVEEPSPQLP----AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --HH----H-HHhcCCCCCC----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 0 1111111110 1124567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=242.71 Aligned_cols=193 Identities=26% Similarity=0.310 Sum_probs=152.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++...++..+..|+||||+++++|.+++.... ..+++.++..++.|++.||.|||+. +++|+||+|+||+++.+
T Consensus 55 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~ 131 (277)
T cd05577 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDH 131 (277)
T ss_pred EeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC
Confidence 6778888889999999999999999999997654 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.+||+|||.+....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...........+
T Consensus 132 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--- 206 (277)
T cd05577 132 GNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL--- 206 (277)
T ss_pred CCEEEccCcchhhhccCC--ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---
Confidence 999999999987653321 122345778999999988888999999999999999999999999654221111111
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
...... .....+......+.+++.+||+.||++|| ++.++++
T Consensus 207 -~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 207 -KRRTLE------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -Hhcccc------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 110000 01122334467889999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=244.19 Aligned_cols=198 Identities=22% Similarity=0.264 Sum_probs=153.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++...+..+...++||||+++++|.+++.... .+++.++..++.|++++|+|||+. +++|+||+|+||+++.++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~ 142 (288)
T cd05583 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEG 142 (288)
T ss_pred hhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCC
Confidence 4556677888999999999999999999987653 688899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCC--CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL--ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
.++|+|||++...............++..|+|||.+.+.. .+.++|+||||+++|||++|..||...........+
T Consensus 143 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-- 220 (288)
T cd05583 143 HVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-- 220 (288)
T ss_pred CEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--
Confidence 9999999998876443332233456888999999886654 788999999999999999999999643211111111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
. ...... ....+......+.+++.+||+.||++|||+.++.+.|+-
T Consensus 221 -~-~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 221 -S-RRILKS------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -H-HHHHcc------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1 111111 111223345678899999999999999999888877765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=239.59 Aligned_cols=192 Identities=23% Similarity=0.243 Sum_probs=153.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+.++...++||||+++++|.+++.+.. .+++.++..++.||+.||+|||++ +++|+||+|+||+++.++
T Consensus 55 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~ 130 (262)
T cd05572 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNG 130 (262)
T ss_pred EeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCC
Confidence 7788888899999999999999999999997654 588999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++....... ......++..|+|||.+....++.++|+||||+++|+|++|..||....... .. .
T Consensus 131 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~ 202 (262)
T cd05572 131 YVKLVDFGFAKKLKSGQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--ME----I 202 (262)
T ss_pred CEEEeeCCcccccCccc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HH----H
Confidence 99999999998764432 1223457889999999888888999999999999999999999997552211 11 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
......+.. ....+......+.+++.+||+.+|++||+ ++|+++
T Consensus 203 ~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 203 YNDILKGNG----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHhccCC----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 111111000 11122233678999999999999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=244.72 Aligned_cols=203 Identities=20% Similarity=0.252 Sum_probs=149.7
Q ss_pred eeeEEEEEecC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRS--SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++..++... +..|+||||+++ +|.+++......+++.++..++.||+.||+|||+. +++|+||||+||+++.
T Consensus 66 i~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~ 141 (293)
T cd07843 66 IVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNN 141 (293)
T ss_pred EEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECC
Confidence 67777776666 899999999975 99999877665689999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++........ ......+++.|+|||.+.+. .++.++|+||||+++|||++|..||...........+.
T Consensus 142 ~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~ 220 (293)
T cd07843 142 RGILKICDFGLAREYGSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIF 220 (293)
T ss_pred CCcEEEeecCceeeccCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999999987654322 12234568899999987654 46899999999999999999999997542211100000
Q ss_pred HH-------HHHhh------hccccccc----cccccCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TW-------VYNCF------VAGEFNKL----VEEEVDKI-TLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~-------~~~~~------~~~~~~~~----~~~~~~~~-~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. .+... ........ +....+.. ..+.+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 221 KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00 00000 00000000 00111111 3667889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=244.56 Aligned_cols=202 Identities=18% Similarity=0.182 Sum_probs=144.6
Q ss_pred eeeEEEEEecCCe-----eEEEEecCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCC
Q 038002 471 ISSLLVYKHRSSK-----KLLVYEFMSKGSLADLLFNLE----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541 (702)
Q Consensus 471 i~~l~~~~~~~~~-----~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp 541 (702)
|++++..+...+. .|+||||+++ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||
T Consensus 63 i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~ 138 (295)
T cd07837 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKP 138 (295)
T ss_pred ccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCh
Confidence 5566666665555 8999999986 8988886532 2478999999999999999999999 999999999
Q ss_pred CcEEEeC-CCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCC
Q 038002 542 RNILIDD-SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVS 619 (702)
Q Consensus 542 ~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 619 (702)
+||+++. ++.+||+|||++..+..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.....
T Consensus 139 ~nil~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 139 QNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred HHEEEecCCCeEEEeecccceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999998 88999999999886533221 1122346788999998754 4678999999999999999999999965421
Q ss_pred CcchhhhHHHHHHhhhccc------------cccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 620 TADEVLLSTWVYNCFVAGE------------FNKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~------------~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........... ....... ...... ....+.....+.++|.+||+.||++||+++|++.
T Consensus 218 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 218 LQQLLHIFKLL-GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHHHh-CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 11110000000 0000000 000000 0111235677899999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=250.66 Aligned_cols=200 Identities=22% Similarity=0.210 Sum_probs=145.5
Q ss_pred eeeEEEEEec------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHR------SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|++++..+.. ....|+||||+.+ +|.+.+.. .++..++..++.|++.||+|||++ +|+||||||+||
T Consensus 77 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Ni 149 (353)
T cd07850 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNI 149 (353)
T ss_pred CcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHE
Confidence 5666655543 2467999999964 88888754 378889999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+++.++.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 150 l~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 150 VVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred EECCCCCEEEccCccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999999999999987533221 233457889999999988899999999999999999999999996542111000
Q ss_pred hhHH-----------H---HHHhhhc--c-----cccccccc--------ccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038002 625 LLST-----------W---VYNCFVA--G-----EFNKLVEE--------EVDKITLERMVKTGLLCIQDEPNLRPSMKN 675 (702)
Q Consensus 625 ~~~~-----------~---~~~~~~~--~-----~~~~~~~~--------~~~~~~~~~l~~li~~cL~~dP~~RPt~~e 675 (702)
.+.. . ....... . .+...... .........+.+++.+||+.||++|||++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 307 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDD 307 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHH
Confidence 0000 0 0000000 0 00000000 012234667889999999999999999999
Q ss_pred HHHH
Q 038002 676 VILM 679 (702)
Q Consensus 676 vl~~ 679 (702)
+++.
T Consensus 308 iL~~ 311 (353)
T cd07850 308 ALQH 311 (353)
T ss_pred HhcC
Confidence 9964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=244.48 Aligned_cols=203 Identities=21% Similarity=0.227 Sum_probs=152.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++..+.+++..+++|||+++++|.+++... ...+++..+..++.|++.||+|||++ +|+|+||||+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~ 137 (314)
T cd08216 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGD 137 (314)
T ss_pred hhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecC
Confidence 667778888999999999999999999999764 33588899999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCC------ceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCc
Q 038002 550 WRAKISDFGLAKLLMPNQT------GIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA 621 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 621 (702)
+.+||+||+.+........ .......++..|+|||++.. ..++.++|+||||+++|||++|..||.......
T Consensus 138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~ 217 (314)
T cd08216 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ 217 (314)
T ss_pred CceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999998875532211 11123456778999998865 357899999999999999999999997542111
Q ss_pred chhhhHHHHHHhh-----------hc------------cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 622 DEVLLSTWVYNCF-----------VA------------GEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 622 ~~~~~~~~~~~~~-----------~~------------~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......... .. .................++.+++.+||+.||++|||++++++
T Consensus 218 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 218 ---MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred ---HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000000000 00 000000111223445678899999999999999999999987
Q ss_pred H
Q 038002 679 M 679 (702)
Q Consensus 679 ~ 679 (702)
.
T Consensus 295 ~ 295 (314)
T cd08216 295 H 295 (314)
T ss_pred C
Confidence 4
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=230.11 Aligned_cols=224 Identities=21% Similarity=0.249 Sum_probs=169.8
Q ss_pred ceEEEeEE----EEEeeeehhhhHhh----------------------------eeeEEEEEecCCeeEEEEecCCCCCH
Q 038002 449 RKLLTVLA----GCLGSITFLCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 449 ~~l~~g~~----v~~~~~~~~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL 496 (702)
..+|+|+. .+........+||| |++|+++|+++.+.|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 46788876 23333344778887 78888999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC---cEEEecccceeecCCCC------
Q 038002 497 ADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW---RAKISDFGLAKLLMPNQ------ 567 (702)
Q Consensus 497 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~------ 567 (702)
..+|.+.. .+++.++.++..+|+.||.|||.+ ||.||||||+|||..+-. -+||+||.+..-+....
T Consensus 164 LshI~~~~-~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 164 LSHIQKRK-HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred HHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 99998765 799999999999999999999999 999999999999985543 48999998886543221
Q ss_pred CceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCc-------chhhhHHHHHHhhh
Q 038002 568 TGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA-------DEVLLSTWVYNCFV 635 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~~~~~ 635 (702)
+....+.+|+..|||||+.. ...|+.+.|.||||||+|-|++|..||...-..+ .-..-.+.+.+.+.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22234577999999999652 3468899999999999999999999997653211 11122233344444
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
++... +.++ --...+.+..+++...|..|+.+|-++.+++.
T Consensus 320 EGkYe-FPdk-dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGKYE-FPDK-DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCc-CChh-hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 44331 1122 12345777788888899999999999999887
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=237.72 Aligned_cols=177 Identities=21% Similarity=0.184 Sum_probs=144.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++|+|.+++.+.. .+++..+..++.|+++||+|||+. +|+|+||||+||+++.++
T Consensus 47 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 122 (237)
T cd05576 47 MVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRG 122 (237)
T ss_pred eeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 6777788889999999999999999999987654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++++|||.+...... .....++..|+|||.+....++.++|+||+|+++|||++|+.|+........
T Consensus 123 ~~~l~df~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------- 190 (237)
T cd05576 123 HIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------- 190 (237)
T ss_pred CEEEecccchhccccc----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------
Confidence 9999999987654322 1223456789999998888889999999999999999999988753311100
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
.......+......+.+++.+||+.||++||++
T Consensus 191 ----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 191 ----------THTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ----------cccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 000001223345678899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=245.38 Aligned_cols=204 Identities=24% Similarity=0.265 Sum_probs=147.0
Q ss_pred eeeEEEEEecC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRS--SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|++++..+... +..++||||+.+ +|.+++......+++.++..++.||++||+|||+. +++|+||||+||+++.
T Consensus 68 i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~ 143 (309)
T cd07845 68 IVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTD 143 (309)
T ss_pred CcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 56666666543 678999999975 89999877655789999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............
T Consensus 144 ~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~ 222 (309)
T cd07845 144 KGCLKIADFGLARTYGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII 222 (309)
T ss_pred CCCEEECccceeeecCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999987643321 1222345778999998765 567899999999999999999999997542111100000
Q ss_pred HHH-------HHhhhcccc-ccc-ccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWV-------YNCFVAGEF-NKL-VEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~-------~~~~~~~~~-~~~-~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... +........ ... ... .......+.+.+++.+||+.||++|||++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 223 QLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000000000 000 000 0011235677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=242.70 Aligned_cols=202 Identities=20% Similarity=0.214 Sum_probs=152.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++||||+++ +|.+++......+++.++..++.|++.||+|||++ +|+|+||||+||+++.++
T Consensus 60 i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~ 135 (283)
T cd05118 60 IIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEG 135 (283)
T ss_pred cchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCC
Confidence 66777778888999999999975 89988877655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||.+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...............
T Consensus 136 ~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd05118 136 VLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214 (283)
T ss_pred cEEEeeeeeeEecCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999998765433 122334578889999988766 7899999999999999999999999654221110000000
Q ss_pred HHHhhhccccccccc-----------------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVAGEFNKLVE-----------------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........+..... ..........+.+++.+||+.||.+||++++++.
T Consensus 215 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 215 -LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred -cCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000000000 1122345778999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=244.26 Aligned_cols=196 Identities=25% Similarity=0.266 Sum_probs=153.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++++++++.+++..++||||+++ +|.+++......+++.++..++.|++.||.|||++ +|+|+||+|+||+++.++
T Consensus 87 iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~ 162 (317)
T cd06635 87 SIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPG 162 (317)
T ss_pred EEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCC
Confidence 77888888899999999999975 88888866555789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++...... ....+++.|+|||.+. ...++.++||||||+++|||++|..||...... ....
T Consensus 163 ~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~ 234 (317)
T cd06635 163 QVKLADFGSASIASPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY 234 (317)
T ss_pred CEEEecCCCccccCCc-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHH
Confidence 9999999988754321 2345788999999873 456889999999999999999999998643111 1011
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
......... .........+.+++.+||+.+|.+||+++++++.+......+
T Consensus 235 -----~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 235 -----HIAQNESPT----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -----HHHhccCCC----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 111111111 112234567899999999999999999999998776544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=248.16 Aligned_cols=229 Identities=24% Similarity=0.265 Sum_probs=180.6
Q ss_pred cccceEEEeEE--EEEeeeeh-hhhHhh----------------------------eeeEEEEEecCCeeEEEEecCCCC
Q 038002 446 NDKRKLLTVLA--GCLGSITF-LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFMSKG 494 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~-~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~~~g 494 (702)
.-+++||+|-| |.+.++.. +.|||| |++|++.+-.++.+++|+|||++|
T Consensus 541 ~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnG 620 (807)
T KOG1094|consen 541 RFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENG 620 (807)
T ss_pred ehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcC
Confidence 34678999999 77777776 788887 999999999999999999999999
Q ss_pred CHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce-ee
Q 038002 495 SLADLLFNLETR-PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-VA 572 (702)
Q Consensus 495 sL~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-~~ 572 (702)
+|.+++..+... ..-.....|+.||+.|++||.+- +++||||.+.|+|++.++++||+|||+++.+....... ..
T Consensus 621 DLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqg 697 (807)
T KOG1094|consen 621 DLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQG 697 (807)
T ss_pred cHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeec
Confidence 999999877433 34556677999999999999999 99999999999999999999999999999665544433 33
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhh--CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC--CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
...-..+|||||.+..++++.++|+|+||+++||+++ .+.||..... ++. .+-.......+..... ...+..
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~v--ven~~~~~~~~~~~~~--l~~P~~ 771 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQV--VENAGEFFRDQGRQVV--LSRPPA 771 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHH--HHhhhhhcCCCCccee--ccCCCc
Confidence 4556789999999999999999999999999999864 7788864311 111 1111111111111111 133556
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
....+.++|.+||..|-++||+++++...|...
T Consensus 772 cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 772 CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 677888999999999999999999999988754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=241.67 Aligned_cols=195 Identities=22% Similarity=0.255 Sum_probs=151.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+.++..++.+...++||||+++++|.+++.... .+++.++..++.|+++||+|||+. +++||||+|+||+++.++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~ 142 (290)
T cd05613 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNG 142 (290)
T ss_pred hhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCC
Confidence 6677788888999999999999999999997654 688889999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||++...............|+..|+|||.+.. ..++.++||||||+++|+|++|..||.......... .
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~ 219 (290)
T cd05613 143 HVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA---E 219 (290)
T ss_pred CEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH---H
Confidence 99999999998764433222334568899999998865 346789999999999999999999996432211111 1
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
.... .... ....+......+.+++.+||+.||++|| +++++++.
T Consensus 220 ~~~~-~~~~------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 220 ISRR-ILKS------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred HHHH-hhcc------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1111 1000 1112233456788999999999999997 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=247.88 Aligned_cols=220 Identities=24% Similarity=0.283 Sum_probs=176.8
Q ss_pred ceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCCCCHHH
Q 038002 449 RKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSKGSLAD 498 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~ 498 (702)
.+||-|-. ||.|.... +.|||| +++|++.+-.+-.+|||+|||..|+|.+
T Consensus 273 hKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLd 352 (1157)
T KOG4278|consen 273 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLD 352 (1157)
T ss_pred eccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHH
Confidence 35555544 77777765 666766 7889999999999999999999999999
Q ss_pred HhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceecc
Q 038002 499 LLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS 577 (702)
Q Consensus 499 ~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 577 (702)
+|++... .++.-..+.++.||..|++||..+ ++|||||...|.|+.++..+||+|||+++++..+.........-.
T Consensus 353 YLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFP 429 (1157)
T KOG4278|consen 353 YLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFP 429 (1157)
T ss_pred HHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCc
Confidence 9987653 366677788999999999999999 999999999999999999999999999999866554333344456
Q ss_pred ccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHH
Q 038002 578 RGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMV 656 (702)
Q Consensus 578 ~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 656 (702)
..|.|||-+....++.|+|||+|||+|||+.| |-.||.... . ..++.....+- .-+-+..+++.+.
T Consensus 430 IKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----l----SqVY~LLEkgy-----RM~~PeGCPpkVY 496 (1157)
T KOG4278|consen 430 IKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----L----SQVYGLLEKGY-----RMDGPEGCPPKVY 496 (1157)
T ss_pred ccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----H----HHHHHHHhccc-----cccCCCCCCHHHH
Confidence 78999999999999999999999999999998 888886431 1 11233222221 1123445677899
Q ss_pred HHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 657 KTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 657 ~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
+||+.||++.|.+||++.|+-+.+|.+.
T Consensus 497 eLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 497 ELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 9999999999999999999999998643
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=248.33 Aligned_cols=194 Identities=21% Similarity=0.267 Sum_probs=156.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++|+..|..++.++++.|||.||-.+.++...+..+.+.++..+++|++.||.|||++ +|||||||..|||+.-+|
T Consensus 91 ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldG 167 (1187)
T KOG0579|consen 91 IVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDG 167 (1187)
T ss_pred HHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecC
Confidence 66777777778999999999999999999998888899999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccc-----cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ-----NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
.++|+|||.+..... .......+.|||+|||||+. +..+|+.++||||||++|.||.-+.+|...-.. .
T Consensus 168 dirLADFGVSAKn~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp----M- 241 (1187)
T KOG0579|consen 168 DIRLADFGVSAKNKS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP----M- 241 (1187)
T ss_pred cEeeecccccccchh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch----H-
Confidence 999999998864321 12234568899999999965 467899999999999999999999998743210 0
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+.-.+...+-+.++. +...+..+.+++.+||..||..||++.++++.
T Consensus 242 ---RVllKiaKSePPTLlq---PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 242 ---RVLLKIAKSEPPTLLQ---PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred ---HHHHHHhhcCCCcccC---cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 0111111222222222 34567788999999999999999999998863
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=242.17 Aligned_cols=189 Identities=25% Similarity=0.294 Sum_probs=149.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++.+.+..++..++||||++ |+|.+++......+++.++..++.|++.||.|||+. +|+|+||+|+||++++++
T Consensus 77 iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~ 152 (307)
T cd06607 77 TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPG 152 (307)
T ss_pred EEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCC
Confidence 7888888999999999999997 578887765555789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++|+|||++...... ....+++.|+|||.+. ...++.++||||||+++|||++|..||..... ...
T Consensus 153 ~~kL~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~-- 222 (307)
T cd06607 153 TVKLADFGSASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSA-- 222 (307)
T ss_pred CEEEeecCcceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHH--
Confidence 9999999998765322 2345788999999874 45688999999999999999999999964311 000
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
... ........ .........+.+++.+||+.+|++||++.+|+...
T Consensus 223 --~~~-~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 223 --LYH-IAQNDSPT----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred --HHH-HhcCCCCC----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 010 01111111 11223456789999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=242.34 Aligned_cols=192 Identities=21% Similarity=0.282 Sum_probs=152.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++|+||+++++|.+++.+. .+++.++..++.|++.||+|||++ +++|+||||+||+++.++
T Consensus 78 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~ 152 (293)
T cd06647 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDG 152 (293)
T ss_pred eeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCC
Confidence 667777888899999999999999999998653 478899999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......+++.|+|||.+....++.++|+||||+++|++++|+.||........ ..
T Consensus 153 ~~kL~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~----- 225 (293)
T cd06647 153 SVKLTDFGFCAQITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----- 225 (293)
T ss_pred CEEEccCcceeccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-ee-----
Confidence 999999999876543322 22334678899999998888889999999999999999999999965421111 00
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.....+. .. . .........+.+++.+||+.+|++||++++++.+
T Consensus 226 -~~~~~~~-~~-~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 226 -LIATNGT-PE-L--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred -ehhcCCC-CC-C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00 0 1122345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=240.62 Aligned_cols=194 Identities=24% Similarity=0.313 Sum_probs=154.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++.+..++..++|+||+++++|.+++......+++.++..++.|++.||+|||+. ||+|+||+|+||+++.++
T Consensus 77 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~ 153 (286)
T cd06614 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDG 153 (286)
T ss_pred eeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCC
Confidence 77888889999999999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... . ....
T Consensus 154 ~~~l~d~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~-~~~~-- 227 (286)
T cd06614 154 SVKLADFGFAAQLTKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--R-ALFL-- 227 (286)
T ss_pred CEEECccchhhhhccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--H-HHHH--
Confidence 999999998875533221 122345788999999998888999999999999999999999999643111 0 0000
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......... .........+.+++.+||+.+|.+||+++++++.
T Consensus 228 ---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 228 ---ITTKGIPPL---KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred ---HHhcCCCCC---cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111111111 1112245678899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=237.60 Aligned_cols=199 Identities=23% Similarity=0.243 Sum_probs=150.2
Q ss_pred eeeEEEEEecCCe-----eEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSSK-----KLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~~-----~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++.+.+...+. .+++|||+.+ +|.+++.... ..+++.++..++.|+++||+|||+. +++|+||+|+||
T Consensus 63 i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~ni 138 (287)
T cd07838 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNI 138 (287)
T ss_pred cceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhE
Confidence 6677777777666 9999999975 8999887643 3589999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+++.++.+||+|||++........ .....++..|+|||.+.+..++.++|+||||+++|||++|..||.......
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--- 213 (287)
T cd07838 139 LVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--- 213 (287)
T ss_pred EEccCCCEEEeccCcceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH---
Confidence 999999999999999987643322 223346888999999988889999999999999999999999986542111
Q ss_pred hhHHHHHHhhhc-------------cccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVA-------------GEFNKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~-------------~~~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
............ ........ ..........+.+++.+||+.||++||++++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 214 QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 111111000000 00000000 0112344677889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=240.88 Aligned_cols=193 Identities=23% Similarity=0.340 Sum_probs=147.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++++..+...++||||+. ++|.+++......+++.++..++.|++.||+|||+ . +|+||||+|+||+++++
T Consensus 76 i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~ 151 (296)
T cd06618 76 IVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDAS 151 (296)
T ss_pred hHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCC
Confidence 5667788888999999999985 48888887655578999999999999999999997 5 89999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCC----CCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL----ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
+.+||+|||++..+..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... ...
T Consensus 152 ~~~kL~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~ 227 (296)
T cd06618 152 GNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEV 227 (296)
T ss_pred CCEEECccccchhccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHH
Confidence 9999999999876533222 12234678999999886543 788999999999999999999999643111 001
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+. .......... . ......+.+.+++.+||+.||++||+++++++.
T Consensus 228 ~~-----~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 228 LT-----KILQEEPPSL-P--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HH-----HHhcCCCCCC-C--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 1111111110 0 111245678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=241.29 Aligned_cols=203 Identities=22% Similarity=0.249 Sum_probs=147.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++++++++..++||||+. ++|.+++.... ..+++.++..++.|++.||+|||+. +++|+||+|+||+++.+
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~ 136 (284)
T cd07860 61 IVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 136 (284)
T ss_pred CcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 6777888889999999999996 58999886543 3588999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............
T Consensus 137 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 137 GAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred CCEEEeeccchhhcccCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999876533221 12233467889999987654 468899999999999999999999965421110000000
Q ss_pred HH-------HHhh-----hcccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WV-------YNCF-----VAGEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~-------~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. +... ....+...... .........+.+++.+||+.||++|||++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 216 TLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 0000 00000000000 111223456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=243.36 Aligned_cols=203 Identities=20% Similarity=0.224 Sum_probs=144.2
Q ss_pred eeeEEEEEecC--------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYKHRS--------SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~~~~--------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
|+++++.+... ...++||||+.+ +|.+++......+++.++..++.||+.||+|||++ +++|+||||+
T Consensus 73 iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~ 148 (310)
T cd07865 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAA 148 (310)
T ss_pred ccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHH
Confidence 55666555443 456999999964 89888876655789999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCC---ceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQT---GIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
||+++.++.+||+|||++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||....
T Consensus 149 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 149 NILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred HEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999986643221 112234578889999987654 47889999999999999999999996542
Q ss_pred CCcchhhhHHHHHHhhhcccccc--------------c----ccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 619 STADEVLLSTWVYNCFVAGEFNK--------------L----VEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~--------------~----~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... .................+. . ... .........+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 229 EQH-QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHH-HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 111 1111010000000000000 0 000 000112346778999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=241.95 Aligned_cols=191 Identities=19% Similarity=0.253 Sum_probs=150.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++... ++++..+..++.|++.||+|||+. +++|+||+|+||+++.++
T Consensus 79 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~ 153 (292)
T cd06657 79 VVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDG 153 (292)
T ss_pred hhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCC
Confidence 677778888999999999999999999988543 578999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++........ ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... ......
T Consensus 154 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~~~~~ 228 (292)
T cd06657 154 RVKLSDFGFCAQVSKEVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KAMKMI 228 (292)
T ss_pred CEEEcccccceecccccc-cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Confidence 999999999876543221 223356788999999988888899999999999999999999999643111 100101
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ....... ........+.+++.+||+.+|.+||+++++++
T Consensus 229 ~~-----~~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 229 RD-----NLPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred Hh-----hCCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 00 0111100 11123456788999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=238.45 Aligned_cols=190 Identities=22% Similarity=0.267 Sum_probs=151.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..++||||+++++|.+++... ..+++.++..++.||++||+|||++ +++|+||+|+||++++++
T Consensus 62 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~ 137 (258)
T cd05578 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQG 137 (258)
T ss_pred hHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCC
Confidence 555566778899999999999999999999766 3788999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .
T Consensus 138 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~ 210 (258)
T cd05578 138 HVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ-----I 210 (258)
T ss_pred CEEEeecccccccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH-----H
Confidence 99999999988654332 2234557889999999988889999999999999999999999997553221111 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM--KNVI 677 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~--~evl 677 (702)
...... .....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 211 ~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 211 RAKQET------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHhcc------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111110 1112233345788899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=241.00 Aligned_cols=202 Identities=19% Similarity=0.191 Sum_probs=146.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD- 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~- 548 (702)
|++++.++..++..++||||++ ++|.+++..... ..++..+..++.||+.||+|||++ +++|+||+|+||+++.
T Consensus 63 i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~ 138 (294)
T PLN00009 63 IVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRR 138 (294)
T ss_pred EeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECC
Confidence 7888899999999999999996 588888765432 367888889999999999999999 9999999999999985
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.............
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~ 217 (294)
T PLN00009 139 TNALKLADFGLARAFGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF 217 (294)
T ss_pred CCEEEEcccccccccCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55799999999976533221 1223456889999998765 467899999999999999999999996542111100000
Q ss_pred HHHHHhhhcccc----------------ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEF----------------NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ........+ .........+...+.+.+++.+||+.+|++||+++++++
T Consensus 218 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 218 RI-LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HH-hCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000000 000000112234567889999999999999999999986
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=230.83 Aligned_cols=193 Identities=26% Similarity=0.363 Sum_probs=156.2
Q ss_pred eeeEEEEEecC--CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRS--SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|++++..+... ...++||||+++++|.+++.... .+++.++..++.|++.||+|||+. +++|+||+|+||+++.
T Consensus 61 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~ 136 (260)
T cd06606 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDS 136 (260)
T ss_pred EeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcC
Confidence 77788888877 89999999999999999998765 789999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.++|+|||.+......... ......++..|+|||.+.....+.++||||||+++++|++|..||..... ..
T Consensus 137 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~--- 210 (260)
T cd06606 137 DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PM--- 210 (260)
T ss_pred CCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hH---
Confidence 999999999999877544321 12335678899999999888899999999999999999999999975421 00
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........... ....+......+.+++.+||+.||++||++.++++
T Consensus 211 ~~~~~~~~~~~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 211 AALYKIGSSGE-----PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHHhccccCC-----CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11111110011 11233344678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.6e-27 Score=239.41 Aligned_cols=195 Identities=24% Similarity=0.302 Sum_probs=152.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..|+||||+++++|.+++.... .+++..+..++.||++||+|||+. +++|+||+|+||+++.++
T Consensus 55 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~ 130 (265)
T cd05579 55 VVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNG 130 (265)
T ss_pred hhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCC
Confidence 5566677788999999999999999999998765 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC-------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 551 RAKISDFGLAKLLMPNQT-------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
.++|+|||++........ .......++..|+|||.......+.++|+||||+++|+|++|..||..... .
T Consensus 131 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~ 207 (265)
T cd05579 131 HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---E 207 (265)
T ss_pred CEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---H
Confidence 999999999876533211 122335578899999998888889999999999999999999999964421 1
Q ss_pred hhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 624 VLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
. .......+... ..........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 208 ~-----~~~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 208 E-----IFQNILNGKIE----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred H-----HHHHHhcCCcC----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1 11111111111 0001113678899999999999999999966666665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=240.31 Aligned_cols=203 Identities=23% Similarity=0.227 Sum_probs=148.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
+++++.++.+++..++||||++ ++|.+++.... ..+++..+..++.|+++||+|||++ +++|+||+|+||+++.+
T Consensus 60 iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~ 135 (283)
T cd07835 60 IVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDRE 135 (283)
T ss_pred ccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCC
Confidence 6777788888999999999995 69999987654 3589999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|++|..||..............
T Consensus 136 ~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 136 GALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred CcEEEeecccccccCCCcc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999976533221 12223467889999987654 578999999999999999999999965421111000000
Q ss_pred H-------HHHhh-h----ccccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 W-------VYNCF-V----AGEFNKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~-------~~~~~-~----~~~~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. .+... . ......... ..........+.+++.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 215 TLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00000 0 000000000 0112234467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=241.27 Aligned_cols=196 Identities=26% Similarity=0.354 Sum_probs=146.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhh---c-CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLF---N-LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~---~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|+++++.+..++..+++|||+.. +|.++.. . ....+++..+..++.|++.||+|||+. .+|+||||||+||++
T Consensus 65 iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~ 141 (288)
T cd06616 65 IVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILL 141 (288)
T ss_pred EeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEE
Confidence 77888888889999999999864 6555432 2 234688999999999999999999963 189999999999999
Q ss_pred eCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCC---CCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 547 DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG---LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 547 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
+.++.+||+|||++........ .....++..|+|||.+.+. .++.++||||||+++|||++|+.||.....
T Consensus 142 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---- 215 (288)
T cd06616 142 DRNGNIKLCDFGISGQLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---- 215 (288)
T ss_pred ccCCcEEEeecchhHHhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----
Confidence 9999999999999876533221 1233578899999988765 688999999999999999999999964320
Q ss_pred hhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 624 VLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... ....... .+........+..+.+++.+||+.||++|||+++|++.
T Consensus 216 --~~~~~~~-~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 216 --VFDQLTQ-VVKGDPP-ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --HHHHHhh-hcCCCCC-cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011111 1111111 11112223456789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=235.39 Aligned_cols=197 Identities=24% Similarity=0.352 Sum_probs=148.9
Q ss_pred eeeEEEEEecCC------eeEEEEecCCCCCHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCC
Q 038002 471 ISSLLVYKHRSS------KKLLVYEFMSKGSLADLLFNLE-----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539 (702)
Q Consensus 471 i~~l~~~~~~~~------~~~lV~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl 539 (702)
|+++++++...+ ..++++||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+|+||
T Consensus 63 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~di 139 (273)
T cd05074 63 VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDL 139 (273)
T ss_pred cceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccc
Confidence 666666554322 3478999999999998875321 2468889999999999999999999 9999999
Q ss_pred CCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCC
Q 038002 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVN 617 (702)
Q Consensus 540 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~ 617 (702)
||+||+++.++.+||+|||+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||...
T Consensus 140 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~ 219 (273)
T cd05074 140 AARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219 (273)
T ss_pred chhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence 999999999999999999999865432211 1122334678999999988889999999999999999999 88888643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.. ..... ....... ..........+.+++.+||+.+|++||++.++++.|+++
T Consensus 220 ~~----~~~~~----~~~~~~~-----~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 220 EN----SEIYN----YLIKGNR-----LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CH----HHHHH----HHHcCCc-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 11111 1111111 011123456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=238.33 Aligned_cols=203 Identities=20% Similarity=0.250 Sum_probs=150.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE--TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|++++..+..++..++||||+++ +|.+++.... ..+++.++..++.|++.||+|||+. +++|+||||+||++++
T Consensus 60 i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~ 135 (284)
T cd07836 60 IVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINK 135 (284)
T ss_pred EeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECC
Confidence 78888999999999999999985 8998886544 3588999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.++|+|||++........ ......++..|++||.+.+ ..++.++||||||+++|+|++|+.||.............
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 136 RGELKLADFGLARAFGIPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred CCcEEEeecchhhhhcCCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 99999999999976533221 1223456889999998755 457889999999999999999999997542211111000
Q ss_pred HHH-------HHhhh-c----ccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWV-------YNCFV-A----GEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~-------~~~~~-~----~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... +.... . ......... ...+.....+.+++.+||+.||.+||+++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 215 RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 00000 0 000000000 112234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=233.82 Aligned_cols=192 Identities=23% Similarity=0.342 Sum_probs=155.0
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
++++...+..++..++|+||+++++|.+++.... ..+++.++..++.|++.||++||++ +++|+||+|+||+++
T Consensus 61 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~ 137 (258)
T cd08215 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLT 137 (258)
T ss_pred hhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEc
Confidence 5667777888899999999999999999998753 5789999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++.++|+|||++....... .......+++.|+|||...+..++.++|+||+|+++++|++|..||..... .
T Consensus 138 ~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~----~--- 209 (258)
T cd08215 138 SNGLVKLGDFGISKVLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL----L--- 209 (258)
T ss_pred CCCcEEECCccceeecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH----H---
Confidence 99999999999998764433 223345688899999998888899999999999999999999999964421 0
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. ........... ..+......+.+++.+||..+|++||+++++++.
T Consensus 210 ~-~~~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 210 E-LALKILKGQYP-----PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred H-HHHHHhcCCCC-----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 11111111111 1222445678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=240.58 Aligned_cols=203 Identities=22% Similarity=0.234 Sum_probs=145.9
Q ss_pred eeeEEEEEecCC----------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCC
Q 038002 471 ISSLLVYKHRSS----------KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~~~~~----------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk 540 (702)
|+++++.+.... ..++|+||+++ +|.+++......+++.++..++.||+.||+|||+. +|+|+|||
T Consensus 68 i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~ 143 (302)
T cd07864 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIK 143 (302)
T ss_pred eeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 566666555443 89999999986 78787776655789999999999999999999999 99999999
Q ss_pred CCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCC
Q 038002 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVS 619 (702)
Q Consensus 541 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 619 (702)
|+||++++++.+||+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||.....
T Consensus 144 p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~ 223 (302)
T cd07864 144 CSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE 223 (302)
T ss_pred HHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999998764433222223345778999997754 4578999999999999999999999964321
Q ss_pred CcchhhhHHHHHHhhhcccccccc--------c------c---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLV--------E------E---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~--------~------~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......+.... ........+... + . ......+..+.+++.+||+.||++||+++++++
T Consensus 224 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 224 LAQLELISRLC-GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHHHHHHHh-CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11100010000 000000000000 0 0 001123567899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=236.13 Aligned_cols=192 Identities=23% Similarity=0.330 Sum_probs=151.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+..++..++|+||+++++|.+++.... ..+++..+..++.|+++||+|||+. +++|+||||+||+++++
T Consensus 61 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKN 137 (257)
T ss_pred hhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCC
Confidence 6677788889999999999999999999997643 2478999999999999999999999 99999999999999888
Q ss_pred C-cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 W-RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+ .+||+|||.+....... .......|++.|+|||...+..++.++|+||||++++||++|..||..... ..
T Consensus 138 ~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~ 209 (257)
T cd08225 138 GMVAKLGDFGIARQLNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQ 209 (257)
T ss_pred CCeEEecccccchhccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HH
Confidence 6 46999999988664322 222334588899999998888899999999999999999999999964311 11
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ....... .........+.+++.+||+.+|++|||++|+++.
T Consensus 210 ~~~~-~~~~~~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 210 LVLK-ICQGYFA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHH-HhcccCC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111 1111111 1122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=243.83 Aligned_cols=203 Identities=23% Similarity=0.210 Sum_probs=149.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++.++..++..++||||+.+++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 61 iv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~ 137 (328)
T cd08226 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGD 137 (328)
T ss_pred cceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCC
Confidence 7888999999999999999999999999987653 3588899999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCce------eeceeccccccCcccccCC--CCCccccccchhHhHHHhhhCCcCCcCCCCCc
Q 038002 550 WRAKISDFGLAKLLMPNQTGI------VAGVRGSRGYMAPEWQNSG--LITVKSDVYSFGVVLLEIICCRSNFEVNVSTA 621 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 621 (702)
+.++++||+.+.......... .....++..|+|||++.+. .++.++||||||+++|||++|..||.......
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~ 217 (328)
T cd08226 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217 (328)
T ss_pred CcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH
Confidence 999999998654332211100 0112245679999998763 47899999999999999999999996542111
Q ss_pred chhhhHHHHHHh----------------------h----hccc---------cccccccccCHHHHHHHHHHHHHcccCC
Q 038002 622 DEVLLSTWVYNC----------------------F----VAGE---------FNKLVEEEVDKITLERMVKTGLLCIQDE 666 (702)
Q Consensus 622 ~~~~~~~~~~~~----------------------~----~~~~---------~~~~~~~~~~~~~~~~l~~li~~cL~~d 666 (702)
.. ........ . .+.. ................+.+++.+||+.|
T Consensus 218 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 295 (328)
T cd08226 218 ML--LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQD 295 (328)
T ss_pred HH--HHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCC
Confidence 10 00000000 0 0000 0000011223346778999999999999
Q ss_pred CCCCCCHHHHHH
Q 038002 667 PNLRPSMKNVIL 678 (702)
Q Consensus 667 P~~RPt~~evl~ 678 (702)
|++|||++|+++
T Consensus 296 P~~Rpta~e~l~ 307 (328)
T cd08226 296 PEKRPSASSLLS 307 (328)
T ss_pred cccCCCHHHHhh
Confidence 999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=242.25 Aligned_cols=203 Identities=18% Similarity=0.219 Sum_probs=147.0
Q ss_pred eeeEEEEEecC--CeeEEEEecCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRS--SKKLLVYEFMSKGSLADLLFNLE----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|++++.++... +..++||||+++ +|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||
T Consensus 64 i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Ni 139 (316)
T cd07842 64 VVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANI 139 (316)
T ss_pred ccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHE
Confidence 67788888777 899999999975 7777664321 2578899999999999999999999 999999999999
Q ss_pred EEeC----CCcEEEecccceeecCCCCC--ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 545 LIDD----SWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 545 ll~~----~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
+++. ++.+||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++++|++|+.||...
T Consensus 140 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 140 LVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred EEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999 99999999999987643322 11233567889999997765 46789999999999999999999999755
Q ss_pred CCCcch------hhhHHHHHHhhh------------cccccc--------ccc-cc----cCH--HHHHHHHHHHHHccc
Q 038002 618 VSTADE------VLLSTWVYNCFV------------AGEFNK--------LVE-EE----VDK--ITLERMVKTGLLCIQ 664 (702)
Q Consensus 618 ~~~~~~------~~~~~~~~~~~~------------~~~~~~--------~~~-~~----~~~--~~~~~l~~li~~cL~ 664 (702)
...... ..+... ...+. ..+... ... .. .+. ....++.+++.+||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 298 (316)
T cd07842 220 EAKIKKSNPFQRDQLERI-FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLE 298 (316)
T ss_pred cccccccchhHHHHHHHH-HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhc
Confidence 322100 000000 00000 000000 000 00 001 334578899999999
Q ss_pred CCCCCCCCHHHHHH
Q 038002 665 DEPNLRPSMKNVIL 678 (702)
Q Consensus 665 ~dP~~RPt~~evl~ 678 (702)
.||++|||++|+++
T Consensus 299 ~~P~~Rps~~eil~ 312 (316)
T cd07842 299 YDPTKRITAEEALE 312 (316)
T ss_pred CCcccCcCHHHHhc
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-27 Score=243.28 Aligned_cols=189 Identities=21% Similarity=0.219 Sum_probs=158.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..|++++..|++||-|-||.|...|.+.+ .++...+.-++.-+++|++|||++ +||.|||||+|.+++.+|
T Consensus 482 IvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~G 557 (732)
T KOG0614|consen 482 IVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRG 557 (732)
T ss_pred HHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCC
Confidence 8888989999999999999999999999998776 788888888999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
-+||.|||+|+.+..... .-+++|||.|.|||++.++..+.++|.||||+++|||++|.+||...... . .
T Consensus 558 y~KLVDFGFAKki~~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm----k----t 627 (732)
T KOG0614|consen 558 YLKLVDFGFAKKIGSGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM----K----T 627 (732)
T ss_pred ceEEeehhhHHHhccCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH----H----H
Confidence 999999999998865443 45789999999999999999999999999999999999999999765221 1 1
Q ss_pred HHhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 631 YNCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
+..+..+. +. +.+........+++++....+|.+|.- +.+|-+
T Consensus 628 Yn~ILkGi-----d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 628 YNLILKGI-----DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred HHHHHhhh-----hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 22222221 11 334556677888888899999999965 556554
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=229.97 Aligned_cols=190 Identities=25% Similarity=0.364 Sum_probs=153.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++++..++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.+||+. +|+|+||+|+||+++.++
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~ 136 (254)
T cd06627 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDG 136 (254)
T ss_pred ccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCC
Confidence 6777888888999999999999999999997663 789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||.+......... .....++..|+|||...+..++.++||||+|+++++|++|+.||..... ... .
T Consensus 137 ~~~l~d~~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~---~ 208 (254)
T cd06627 137 VVKLADFGVATKLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAA---L 208 (254)
T ss_pred CEEEeccccceecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHH---H
Confidence 9999999999876543321 2335678899999998877789999999999999999999999964311 000 0
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ...... ...+......+.+++.+||+.+|++||++++++.
T Consensus 209 ~~-~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 209 FR-IVQDDH-----PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HH-HhccCC-----CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 111111 1122334668889999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=238.73 Aligned_cols=237 Identities=25% Similarity=0.300 Sum_probs=176.0
Q ss_pred ceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEEecCC----eeEEEEecCCCCCH
Q 038002 449 RKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYKHRSS----KKLLVYEFMSKGSL 496 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~~~~~----~~~lV~e~~~~gsL 496 (702)
..+++|.| |++|.+..+.|||| |++++...+.+. .++||+||.+.|+|
T Consensus 216 eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL 295 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSL 295 (534)
T ss_pred HHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcH
Confidence 46788887 99999999999999 666666655555 89999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC------CCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-
Q 038002 497 ADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC------EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG- 569 (702)
Q Consensus 497 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 569 (702)
.++|+.+ ..+|.+..+|+..+++||+|||+.. .+.|+|||||.+||||..++...|+|||+|..+......
T Consensus 296 ~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~ 373 (534)
T KOG3653|consen 296 CDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQG 373 (534)
T ss_pred HHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCc
Confidence 9999865 5999999999999999999999863 458999999999999999999999999999988654432
Q ss_pred eeeceeccccccCcccccCCC-CC-----ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH---------HHHHHhh
Q 038002 570 IVAGVRGSRGYMAPEWQNSGL-IT-----VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS---------TWVYNCF 634 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~---------~~~~~~~ 634 (702)
......||.+|||||++.+.. +. .+.||||+|.+||||++.-.-+......+-+..+. +..+...
T Consensus 374 d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~V 453 (534)
T KOG3653|consen 374 DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELV 453 (534)
T ss_pred chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHH
Confidence 223478999999999987642 22 36899999999999998654332110111111111 1111112
Q ss_pred hcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 635 VAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 635 ~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
.....+..+.. -........+.+.+..||..||+.|.|+.=+.+++.++..+.
T Consensus 454 V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 454 VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 22222122221 122355778889999999999999999998888887765544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-26 Score=257.87 Aligned_cols=229 Identities=21% Similarity=0.141 Sum_probs=154.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh------hhhHhheeeEE------------------------E----E-EecCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF------LCFLIAISSLL------------------------V----Y-KHRSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~------~~~avki~~l~------------------------~----~-~~~~~~~~ 485 (702)
+.+...++||+|+| ||++.... ..+|+|.+.-. . . ...+...+
T Consensus 132 ~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (566)
T PLN03225 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYW 211 (566)
T ss_pred CCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceE
Confidence 34556788999998 99987653 45666632210 0 0 14567899
Q ss_pred EEEecCCCCCHHHHhhcCCCC-------------------CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 486 LVYEFMSKGSLADLLFNLETR-------------------PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|||||+.+++|.+++...... .....+..++.||+.||+|||++ +|+||||||+|||+
T Consensus 212 LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~NILl 288 (566)
T PLN03225 212 LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQNIIF 288 (566)
T ss_pred EEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHHEEE
Confidence 999999999999998754311 11234567999999999999999 99999999999999
Q ss_pred eC-CCcEEEecccceeecCCCCCceeeceeccccccCcccccCC----------------------CCCccccccchhHh
Q 038002 547 DD-SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG----------------------LITVKSDVYSFGVV 603 (702)
Q Consensus 547 ~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~DiwSlGvi 603 (702)
+. ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||||+
T Consensus 289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 86 57999999999986644443344556789999999954321 23456799999999
Q ss_pred HHHhhhCCcCCcCCCCCcchhhhHHHHHHh-hhccccccccccc----------cCHHHHHHHHHHHHHcccCCCCCCCC
Q 038002 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNC-FVAGEFNKLVEEE----------VDKITLERMVKTGLLCIQDEPNLRPS 672 (702)
Q Consensus 604 l~elltG~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cL~~dP~~RPt 672 (702)
+|||+++..|+... ...+....... .....+...+... ..........+|+.+||+.||++|||
T Consensus 369 L~el~~~~~~~~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t 443 (566)
T PLN03225 369 FLQMAFPNLRSDSN-----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS 443 (566)
T ss_pred HHHHHhCcCCCchH-----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC
Confidence 99999977665321 00000000000 0000000000010 00111234568999999999999999
Q ss_pred HHHHHHH
Q 038002 673 MKNVILM 679 (702)
Q Consensus 673 ~~evl~~ 679 (702)
++|+++.
T Consensus 444 a~e~L~H 450 (566)
T PLN03225 444 AKAALAH 450 (566)
T ss_pred HHHHhCC
Confidence 9999974
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=236.09 Aligned_cols=203 Identities=20% Similarity=0.269 Sum_probs=148.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++.+..++..++||||+ +++|.+++.... ..+++.++..++.|++.+|.|||++ +++|+||+|+||+++++
T Consensus 60 i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGP 135 (283)
T ss_pred chhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCC
Confidence 444555666789999999999 789999887654 4689999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCccccc-CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+|||++........ .....++..|+|||.+. ...++.++|+||||++++||++|+.||..............
T Consensus 136 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 136 EVVKIADFGLAREIRSRPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred CCEEEeecccceeccCCCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 9999999999986643222 22345788999999774 45678999999999999999999999965422111100000
Q ss_pred ---------HHHHhhhcccccccccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 ---------WVYNCFVAGEFNKLVEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ---------~~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+.............+.. .........+.+++.+||+.||++||+++|++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 214 VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000000000000000 0111124679999999999999999999999853
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-26 Score=247.97 Aligned_cols=228 Identities=21% Similarity=0.264 Sum_probs=170.7
Q ss_pred cceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEec------CCeeEEEEe
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHR------SSKKLLVYE 489 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~------~~~~~lV~e 489 (702)
...+|+|++ ||++.-+. +.|||| |+++++.-++ .....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 467999998 99988544 889998 7777655544 457899999
Q ss_pred cCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe----CCCcEEEecccceeec
Q 038002 490 FMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID----DSWRAKISDFGLAKLL 563 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~----~~~~~kl~Dfg~a~~~ 563 (702)
||.||||+..|.+..+ .+++.+.+.++..+..||.|||++ +|+||||||.||++- .....||+|||.|+.+
T Consensus 98 yC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred ecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 9999999999987643 599999999999999999999999 999999999999982 3335899999999987
Q ss_pred CCCCCceeeceeccccccCccccc-CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc------
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA------ 636 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~------ 636 (702)
..+. ....+.||+.|++||... .+.|+..+|.|||||++|+.+||..||......... .+..+.....
T Consensus 175 ~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~---~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 175 DDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNN---KEIMWHIITKKPSGVA 249 (732)
T ss_pred CCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCcccc---chhhhhhhccCCCcee
Confidence 5444 567889999999999888 488999999999999999999999999765333211 0111111100
Q ss_pred --------c--cccccccc--ccCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhCC
Q 038002 637 --------G--EFNKLVEE--EVDKITLERMVKTGLLCIQDEPNLRP--SMKNVILMLEGT 683 (702)
Q Consensus 637 --------~--~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~RP--t~~evl~~Le~~ 683 (702)
+ ++...++. ........++-+.+..+|..+|++|- ...+.-..+..+
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 0 00011111 23455566777788888999999997 544444444433
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=245.16 Aligned_cols=197 Identities=19% Similarity=0.251 Sum_probs=143.9
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
...++||||+. ++|.+++.... .+++..+..++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 45899999996 68999887654 689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH-------HHh
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV-------YNC 633 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------~~~ 633 (702)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||................ ...
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 654322 22233457889999997754 468899999999999999999999996542110000000000 000
Q ss_pred hhcccccc-------ccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCCc
Q 038002 634 FVAGEFNK-------LVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGTM 684 (702)
Q Consensus 634 ~~~~~~~~-------~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~~ 684 (702)
........ ... .......+..+.+++.+||+.+|++|||++++++. ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 00000000 000 01122346778999999999999999999999986 65543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=232.86 Aligned_cols=191 Identities=21% Similarity=0.238 Sum_probs=148.9
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++++.+.+ +...++||||+++++|.+++.... .+++..+..++.|++.||+|||++ +++|+||||+||+++.
T Consensus 66 i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~ 141 (264)
T cd06653 66 IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDS 141 (264)
T ss_pred cceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcC
Confidence 6677766654 457899999999999999997654 578899999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCC--CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 549 SWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
++.++|+|||+++...... ........++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ..
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~- 217 (264)
T cd06653 142 AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AA- 217 (264)
T ss_pred CCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HH-
Confidence 9999999999998653211 11122355788999999998888899999999999999999999999643111 00
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......+ ..+..+....+.+.+++.+||+ +|.+||++.+++.
T Consensus 218 ---~~~~~~~~-----~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 218 ---IFKIATQP-----TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HHHHHcCC-----CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111111 1123344566789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=233.12 Aligned_cols=190 Identities=27% Similarity=0.341 Sum_probs=153.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|+++...+..+...++||||+++++|.+++.+. ...+++..+..++.|++.||+|||+. +++|+||+|+||+++
T Consensus 61 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~ 137 (256)
T cd08530 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLV 137 (256)
T ss_pred chhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEe
Confidence 666667778889999999999999999998662 23578899999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
+++.+||+|||++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+.
T Consensus 138 ~~~~~kl~d~g~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~ 210 (256)
T cd08530 138 ANDLVKIGDLGISKVLKKNM---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLR 210 (256)
T ss_pred cCCcEEEeeccchhhhccCC---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence 99999999999998764431 2234578899999999888899999999999999999999999964421 1111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
........ +........++.+++.+||+.+|++||++.++++.
T Consensus 211 ----~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 211 ----YKVQRGKY-----PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred ----HHHhcCCC-----CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11111111 12233566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=243.67 Aligned_cols=195 Identities=21% Similarity=0.274 Sum_probs=142.8
Q ss_pred cCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
.....++||||+. ++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 3567899999995 58999987654 589999999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCC---ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH------
Q 038002 560 AKLLMPNQT---GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW------ 629 (702)
Q Consensus 560 a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------ 629 (702)
+........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~ 233 (334)
T cd07855 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE 233 (334)
T ss_pred ceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChh
Confidence 986543222 11223568889999998755 46889999999999999999999999654211100000000
Q ss_pred -HHHhhhccccccc---cc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 -VYNCFVAGEFNKL---VE-------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 -~~~~~~~~~~~~~---~~-------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.........+... .. .......+..+.+++.+||+.+|++||++++++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 00 01122346789999999999999999999998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=240.22 Aligned_cols=203 Identities=22% Similarity=0.261 Sum_probs=147.1
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++++++.. +...++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+|+||||+||+++.
T Consensus 69 i~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~ 142 (337)
T cd07852 69 IVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNS 142 (337)
T ss_pred ccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcC
Confidence 6677766643 457899999997 5999988654 678889999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCC----ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 549 SWRAKISDFGLAKLLMPNQT----GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
++.+||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........
T Consensus 143 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~ 222 (337)
T cd07852 143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222 (337)
T ss_pred CCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999986643322 12234568899999997754 56789999999999999999999999643211110
Q ss_pred hhhHHHH-------HHhhh---ccccccccc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 624 VLLSTWV-------YNCFV---AGEFNKLVE-------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 624 ~~~~~~~-------~~~~~---~~~~~~~~~-------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....... ..... ...+...+. ..........+.+++.+||+.||++|||+.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 223 EKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00000 000000000 01112246788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=238.29 Aligned_cols=188 Identities=25% Similarity=0.312 Sum_probs=147.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++++...+.+++..++||||+. ++|.+++......+++.++..++.||+.||+|||+. +++|+||+|+||+++.++
T Consensus 83 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~ 158 (313)
T cd06633 83 TIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPG 158 (313)
T ss_pred CccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCC
Confidence 7778888899999999999996 588888876655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++..... .....++..|+|||.+. ...++.++||||||+++|||++|..||....... .
T Consensus 159 ~~kL~dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~- 228 (313)
T cd06633 159 QVKLADFGSASKSSP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----A- 228 (313)
T ss_pred CEEEeecCCCcccCC-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----H-
Confidence 999999998864321 12346788999999874 4568889999999999999999999986431111 0
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... ......... ........+.+++.+||+.+|++||++++++..
T Consensus 229 --~~~-~~~~~~~~~----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 229 --LYH-IAQNDSPTL----QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --HHH-HHhcCCCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011111111 112234568889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=237.59 Aligned_cols=191 Identities=24% Similarity=0.258 Sum_probs=149.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++++.+++..++..++||||+. |+|.+++......+++.++..++.|++.||.|||++ +++|+||+|+||+++.++
T Consensus 77 i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~ 152 (308)
T cd06634 77 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPG 152 (308)
T ss_pred cccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCC
Confidence 6777788888999999999996 588888766555688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++|+|||++...... ....+++.|+|||.+. ...++.++||||||+++|+|++|..||...... . .
T Consensus 153 ~~kl~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~-~-- 222 (308)
T cd06634 153 LVKLGDFGSASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--S-A-- 222 (308)
T ss_pred cEEECCcccceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--H-H--
Confidence 9999999998765322 2345788999999864 356788999999999999999999998543111 0 0
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
. .......... .........+.+++.+||+.+|++||+++++++...-
T Consensus 223 --~-~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 223 --L-YHIAQNESPA----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred --H-HHHhhcCCCC----cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 0 0111111111 1122345678899999999999999999999976443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=241.84 Aligned_cols=209 Identities=22% Similarity=0.278 Sum_probs=152.2
Q ss_pred eeeEEEEEecCC-----eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYKHRSS-----KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 545 (702)
|+++.+.+...+ ..|+||||++ ++|.+++.... .+++..+..++.||+.||+|||++ +|+|+||||+||+
T Consensus 61 i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nil 135 (330)
T cd07834 61 IIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNIL 135 (330)
T ss_pred hhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 444455555443 8899999997 48999987655 789999999999999999999999 9999999999999
Q ss_pred EeCCCcEEEecccceeecCCCCC--ceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcc
Q 038002 546 IDDSWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD 622 (702)
Q Consensus 546 l~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 622 (702)
++.++.++|+|||++........ .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||........
T Consensus 136 i~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~ 215 (330)
T cd07834 136 VNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215 (330)
T ss_pred EcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence 99999999999999987654331 122344578899999998877 889999999999999999999999965421110
Q ss_pred hhhhHHHHHHh--------hhccccccccc----------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhC
Q 038002 623 EVLLSTWVYNC--------FVAGEFNKLVE----------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEG 682 (702)
Q Consensus 623 ~~~~~~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~ 682 (702)
...... .... .........+. ..........+.+++.+||+.+|++||+++++++. +++
T Consensus 216 ~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 294 (330)
T cd07834 216 LNLIVE-VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ 294 (330)
T ss_pred HHHHHH-hcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence 000000 0000 00000000000 01122346678999999999999999999999984 555
Q ss_pred CcC
Q 038002 683 TME 685 (702)
Q Consensus 683 ~~~ 685 (702)
...
T Consensus 295 ~~~ 297 (330)
T cd07834 295 LHD 297 (330)
T ss_pred hcc
Confidence 443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=242.22 Aligned_cols=197 Identities=22% Similarity=0.288 Sum_probs=141.2
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
....++||||+.+ +|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 80 FNDVYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred cceEEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 3468999999965 888887543 589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc--eeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH-------
Q 038002 561 KLLMPNQTG--IVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV------- 630 (702)
Q Consensus 561 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~------- 630 (702)
......... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 865432211 1223567899999997654 568899999999999999999999996432110000000000
Q ss_pred HHhhhccccc---cccc--c-----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCC
Q 038002 631 YNCFVAGEFN---KLVE--E-----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGT 683 (702)
Q Consensus 631 ~~~~~~~~~~---~~~~--~-----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~ 683 (702)
.......... .... . ...+.....+.+++.+||+.||++|||+.|+++. ++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000000 0000 0 0112235678999999999999999999999986 5554
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-26 Score=237.52 Aligned_cols=190 Identities=23% Similarity=0.296 Sum_probs=151.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++|||++++++|.+++.+.+ .+++.++..++.|++.||++||+. +++|+||+|+||+++.++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~ 139 (280)
T cd05581 64 IIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDM 139 (280)
T ss_pred chhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCC
Confidence 3444556677899999999999999999998765 799999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC-------------------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCC
Q 038002 551 RAKISDFGLAKLLMPNQT-------------------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCR 611 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~ 611 (702)
.++|+|||++........ .......++..|+|||......++.++|+||||++++++++|+
T Consensus 140 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 140 HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 999999999986643321 1122345788999999988888999999999999999999999
Q ss_pred cCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 038002 612 SNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM----KNVIL 678 (702)
Q Consensus 612 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~----~evl~ 678 (702)
.||.... ..... ..... .....+....+.+.+++.+||+.+|++||++ +++++
T Consensus 220 ~p~~~~~---~~~~~-----~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 220 PPFRGSN---EYLTF-----QKILK------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred CCCCCcc---HHHHH-----HHHHh------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 9997542 11111 11111 0112233346778999999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-26 Score=235.67 Aligned_cols=203 Identities=24% Similarity=0.227 Sum_probs=150.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++++.+++...+..++||||++ ++|.+++......+++.++..++.|++.||+|||++ +|+|+||+|+||++++++
T Consensus 60 i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~ 135 (282)
T cd07829 60 IVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDG 135 (282)
T ss_pred HHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCC
Confidence 5566677778899999999998 599999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.++|+|||.+........ ......++..|+|||.+.+. .++.++||||||++++||++|+.||...............
T Consensus 136 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 214 (282)
T cd07829 136 VLKLADFGLARAFGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQI 214 (282)
T ss_pred CEEEecCCcccccCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHH
Confidence 999999999987643322 12233457789999988766 7899999999999999999999999654211100000000
Q ss_pred -------HHHhh-----hcccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 -------VYNCF-----VAGEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 -------~~~~~-----~~~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+... ........... ...+.....+.+++.+||+.||++||++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 215 LGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000 00001000000 111123567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=239.05 Aligned_cols=212 Identities=19% Similarity=0.196 Sum_probs=170.7
Q ss_pred ceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCCCCC
Q 038002 449 RKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMSKGS 495 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~~gs 495 (702)
+.+|.|-| ||-|..+. +.|||| |+.+...+++.++.++|||-+.|-=
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 46888877 88777665 888988 8888889999999999999997655
Q ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC---CcEEEecccceeecCCCCCceee
Q 038002 496 LADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS---WRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 496 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|+-+|.....+++++...-++.||+.||.|||.+ +|+|+||||+|||+... -++||+|||+|+++.... ...
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--FRr 724 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--FRR 724 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh--hhh
Confidence 5555666666899998888999999999999999 99999999999999554 469999999999985543 345
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
.+.|||.|+|||+++++.|...-|+||.|||+|--++|..||.......+++.... -+..+..-.+.+
T Consensus 725 sVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAa------------FMyPp~PW~eis 792 (888)
T KOG4236|consen 725 SVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAA------------FMYPPNPWSEIS 792 (888)
T ss_pred hhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccc------------cccCCCchhhcC
Confidence 67899999999999999999999999999999999999999975533322222111 122223344567
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHH
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVI 677 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl 677 (702)
...+++|...||..-++|-+.++.+
T Consensus 793 ~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 793 PEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred HHHHHHHHHHHHHHHHHhcchHhhc
Confidence 7788889999999999998877643
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.4e-25 Score=197.11 Aligned_cols=112 Identities=33% Similarity=0.470 Sum_probs=98.9
Q ss_pred ccccCCCCeeEcCCCeEEEEEEeCCC-c-eEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcCCCCeee
Q 038002 35 SLSPSGQHSWNSSSGLFQFGFYKQGS-G-YSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKP 112 (702)
Q Consensus 35 ~l~~~~~~~~~s~~g~f~lgF~~~~~-~-~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~~~~~~w 112 (702)
.|..+ ++|+|++|.|++|||.... . .+++|||.+++ +++||.||++.| ....+.|.|+.||+|+|+|.+|.++|
T Consensus 3 ~l~~~--~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~~dGnLvl~~~~g~~vW 78 (116)
T cd00028 3 PLSSG--QTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQSDGNLVIYDGSGTVVW 78 (116)
T ss_pred CcCCC--CEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEecCCCeEEEcCCCcEEE
Confidence 45544 7899999999999999654 3 89999999877 889999999987 36778999999999999999999999
Q ss_pred eeccccCCcceeEEEecCcCEEEeecCCceEeeecCCC
Q 038002 113 IADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTP 150 (702)
Q Consensus 113 ~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~P 150 (702)
+|++.......+|+|+|||||||++..+.+||||||||
T Consensus 79 ~S~~~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~P 116 (116)
T cd00028 79 SSNTTRVNGNYVLVLLDDGNLVLYDSDGNFLWQSFDYP 116 (116)
T ss_pred EecccCCCCceEEEEeCCCCEEEECCCCCEEEcCCCCC
Confidence 99985435678999999999999999999999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=237.72 Aligned_cols=193 Identities=21% Similarity=0.214 Sum_probs=138.7
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
....++||||+.+ +|...+......+++.++..++.|+++||+|||++ +|+|+||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccc
Confidence 4467999999965 78887766555799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCc----------eeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 561 KLLMPNQTG----------IVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 561 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~- 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK- 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-
Confidence 865432211 1123456888999997754 4578999999999999999999999964422111110000
Q ss_pred HHHhhhcc------cccc----ccccc-------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVAG------EFNK----LVEEE-------VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~------~~~~----~~~~~-------~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ .+.. ..... ........+.+++.+||+.||++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 0000 00000 01122367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-25 Score=238.98 Aligned_cols=201 Identities=19% Similarity=0.173 Sum_probs=150.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..++..++||||++ ++|.+++.... .+++.....++.|++.||+|||+. +|+|+||+|+||+++.++
T Consensus 82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKG 156 (335)
T ss_pred eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCC
Confidence 7778888999999999999997 59999987544 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCC-------------CceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcC
Q 038002 551 RAKISDFGLAKLLMPNQ-------------TGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEV 616 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~ 616 (702)
.++|+|||++....... ........++..|+|||.+.+. .++.++|+||||+++|||++|..||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998664111 1112233467889999988654 468999999999999999999999975
Q ss_pred CCCCcchhhhHHHHHHhhhcc---cccc------------cccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 617 NVSTADEVLLSTWVYNCFVAG---EFNK------------LVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~---~~~~------------~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..... .+ ..+....... .+.. .... .........+.+++.+||+.+|++||+++|++.
T Consensus 237 ~~~~~---~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 237 ENEID---QL-GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCHHH---HH-HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 42211 11 1111100000 0000 0000 111223567889999999999999999999997
Q ss_pred HH
Q 038002 679 ML 680 (702)
Q Consensus 679 ~L 680 (702)
.-
T Consensus 313 ~~ 314 (335)
T PTZ00024 313 HE 314 (335)
T ss_pred Cc
Confidence 43
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=231.06 Aligned_cols=219 Identities=22% Similarity=0.207 Sum_probs=169.9
Q ss_pred eEEEeEE--EEEeeeeh--hhhHhh----------------------------------eeeEEEEEe-cCCeeEEEEec
Q 038002 450 KLLTVLA--GCLGSITF--LCFLIA----------------------------------ISSLLVYKH-RSSKKLLVYEF 490 (702)
Q Consensus 450 ~l~~g~~--v~~~~~~~--~~~avk----------------------------------i~~l~~~~~-~~~~~~lV~e~ 490 (702)
.+|+|+| ||++-... +.|||| |++++++|. +.+.++-|+||
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEY 549 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEY 549 (775)
T ss_pred HhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeee
Confidence 4899999 88876544 778887 899998774 67788999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe---CCCcEEEecccceeecCCCC
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID---DSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|+|.+|+-+|+..+ .+++.++..|+.||+.||.||.+. ...|||-||||.|||+. .-|.+||.|||+++++..+.
T Consensus 550 ceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddS 627 (775)
T KOG1151|consen 550 CEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDS 627 (775)
T ss_pred cCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCc
Confidence 99999999998776 799999999999999999999986 55899999999999994 45789999999999986554
Q ss_pred Cc------eeeceeccccccCccccc----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcc
Q 038002 568 TG------IVAGVRGSRGYMAPEWQN----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG 637 (702)
Q Consensus 568 ~~------~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 637 (702)
.. ......||..|++||.+. ...++.|+||||+|||+|..+.|+.||.......+...... .+...
T Consensus 628 y~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT----IlkAt 703 (775)
T KOG1151|consen 628 YNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT----ILKAT 703 (775)
T ss_pred cCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc----hhcce
Confidence 32 234577999999999653 23678999999999999999999999986532221111100 01111
Q ss_pred ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 638 EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 638 ~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
++.. ...+..+.+...+|++||++.-++|....++..
T Consensus 704 EVqF----P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 704 EVQF----PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred eccC----CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1111 122345667888999999999999988887754
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-25 Score=229.89 Aligned_cols=190 Identities=23% Similarity=0.333 Sum_probs=149.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
|++++.++.+++..++||||+++++|.+++.. ....+++.++..++.|++.||+|||+. +++|+||+|+||+++
T Consensus 64 i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~ 140 (260)
T cd08222 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLK 140 (260)
T ss_pred HHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEee
Confidence 44555666778889999999999999998864 234689999999999999999999999 999999999999997
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
. +.++|+|||++........ ......+++.|+|||...+..++.++|+||||+++|+|++|..||.... ....
T Consensus 141 ~-~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~- 213 (260)
T cd08222 141 N-NLLKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSV- 213 (260)
T ss_pred c-CCEeecccCceeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHH-
Confidence 5 5699999999987643322 2233557889999999888888999999999999999999999995331 1110
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......+. .+..+......+.+++.+||+.+|++||+++|+++
T Consensus 214 ---~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 214 ---VLRIVEGP-----TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---HHHHHcCC-----CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 01111111 11223455678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-26 Score=242.86 Aligned_cols=218 Identities=22% Similarity=0.275 Sum_probs=173.3
Q ss_pred cccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.+.-++||+|.| |..|.... ..|||| +++|++.-.+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 3344568999998 67777664 678888 7777776666 8889999
Q ss_pred ecCCCCCHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 489 EFMSKGSLADLLFN-LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 489 e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|.++.|||.+.|.+ ....+.......++.||+.|++||..+ ++|||||-..|+|+...-.+||+|||+.+.+....
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 99999999999988 333577888899999999999999999 99999999999999999899999999999886554
Q ss_pred Cc-eee-ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 568 TG-IVA-GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 568 ~~-~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.. ... ...-...|.|||.++...++.++|+|+|||++|||++ |+.||.... ... +.+.+..++. +
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~----g~q----IL~~iD~~er---L- 334 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR----GIQ----ILKNIDAGER---L- 334 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC----HHH----HHHhcccccc---C-
Confidence 42 222 2334567999999999999999999999999999998 889996541 111 1111111111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+...++++.++++.||..+|++|||+..|.+
T Consensus 335 -pRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 -PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -CCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 235567899999999999999999999999974
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=244.98 Aligned_cols=213 Identities=25% Similarity=0.298 Sum_probs=165.2
Q ss_pred cceEEEeE---EEEEeeeehhhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCCCCHHHH
Q 038002 448 KRKLLTVL---AGCLGSITFLCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSKGSLADL 499 (702)
Q Consensus 448 ~~~l~~g~---~v~~~~~~~~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~~ 499 (702)
++.+|.|. +||+|....+.|||| |++++...++++..||..|.|.. +|.++
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dl 592 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDL 592 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHH
Confidence 34455554 499999999999999 99999999999999999999965 99999
Q ss_pred hhcCCCC---CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC---C--CcEEEecccceeecCCCCCce-
Q 038002 500 LFNLETR---PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD---S--WRAKISDFGLAKLLMPNQTGI- 570 (702)
Q Consensus 500 l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~--~~~kl~Dfg~a~~~~~~~~~~- 570 (702)
+...... ......+.++.|+++||++||+- +||||||||.||||+. + .+++|+|||+++.+..++...
T Consensus 593 ie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~ 669 (903)
T KOG1027|consen 593 IESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS 669 (903)
T ss_pred HhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence 9874111 11145577899999999999998 9999999999999965 3 469999999999887665432
Q ss_pred -eeceeccccccCcccccCCCCCccccccchhHhHHHhhhC-CcCCcCCCCCcchhhhHHHHHHhhhccccc-ccccccc
Q 038002 571 -VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICC-RSNFEVNVSTADEVLLSTWVYNCFVAGEFN-KLVEEEV 647 (702)
Q Consensus 571 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 647 (702)
.....||-+|+|||.+....-+.++||||+||++|..++| .+||...-.. +.+ +..++.. ..+.+
T Consensus 670 r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~N--------Il~~~~~L~~L~~-- 737 (903)
T KOG1027|consen 670 RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QAN--------ILTGNYTLVHLEP-- 737 (903)
T ss_pred cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh--hhh--------hhcCccceeeecc--
Confidence 3457799999999999988888899999999999999996 8999644111 111 1111110 01111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+ .+..+||.+|+..+|..||++.+|+.
T Consensus 738 ~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 738 LPD--CEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred Cch--HHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 17889999999999999999999874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-25 Score=237.67 Aligned_cols=203 Identities=19% Similarity=0.225 Sum_probs=144.8
Q ss_pred eeeEEEEEecC------CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRS------SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++++++... ...++|+||+.. +|.+++. ..+++.++..++.|++.||+|||++ +|+||||||+||
T Consensus 76 iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NI 148 (342)
T cd07879 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNL 148 (342)
T ss_pred ccchhheecccccCCCCceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence 55555555433 456999999964 7777652 2588999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .
T Consensus 149 ll~~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~ 223 (342)
T cd07879 149 AVNEDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-Q 223 (342)
T ss_pred EECCCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 9999999999999998754221 223457889999998765 468899999999999999999999997542110 0
Q ss_pred hhhHHHHH----------Hhhhccc-------cccccccc---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hh
Q 038002 624 VLLSTWVY----------NCFVAGE-------FNKLVEEE---VDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LE 681 (702)
Q Consensus 624 ~~~~~~~~----------~~~~~~~-------~~~~~~~~---~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le 681 (702)
...... ....... ........ ..+.....+.+++.+||+.||++||++++++.. ++
T Consensus 224 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~ 301 (342)
T cd07879 224 --LTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFD 301 (342)
T ss_pred --HHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchh
Confidence 000000 0000000 00000000 011234568899999999999999999999954 77
Q ss_pred CCcCCC
Q 038002 682 GTMEIP 687 (702)
Q Consensus 682 ~~~~~~ 687 (702)
...+.+
T Consensus 302 ~~~~~~ 307 (342)
T cd07879 302 SFRDAD 307 (342)
T ss_pred hccccc
Confidence 765543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=219.94 Aligned_cols=219 Identities=20% Similarity=0.226 Sum_probs=151.7
Q ss_pred eeeEEEEEec-CCeeEEEEecCCCCCHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYKHR-SSKKLLVYEFMSKGSLADLLFNLE----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 545 (702)
|+.|...|-+ +...+|++||.+. +|.++|+..+ ..++...+..|+.||+.|+.|||++ -|+||||||.|||
T Consensus 89 vi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIl 164 (438)
T KOG0666|consen 89 VISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANIL 164 (438)
T ss_pred chhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEE
Confidence 4455433433 8999999999977 9999997543 2478889999999999999999999 9999999999999
Q ss_pred EeCC----CcEEEecccceeecCCCCCc--eeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 546 IDDS----WRAKISDFGLAKLLMPNQTG--IVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 546 l~~~----~~~kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
+..+ |++||+|+|+++++...-.. ....+.-|..|+|||.+.+ ..|+.+.|||++|||+.||++-++.|....
T Consensus 165 vmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 165 VMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred EeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9776 89999999999988543322 2345678999999998765 578999999999999999999998886542
Q ss_pred CCcch-----hhhHHHHHHhh---hcccccccc---------cc----ccC-----------HHHHHHHHHHHHHcccCC
Q 038002 619 STADE-----VLLSTWVYNCF---VAGEFNKLV---------EE----EVD-----------KITLERMVKTGLLCIQDE 666 (702)
Q Consensus 619 ~~~~~-----~~~~~~~~~~~---~~~~~~~~~---------~~----~~~-----------~~~~~~l~~li~~cL~~d 666 (702)
...+. ......+.+.. ....++.+. .. -.+ ....+...+|+.++|+.|
T Consensus 245 ~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yD 324 (438)
T KOG0666|consen 245 EKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYD 324 (438)
T ss_pred hhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccC
Confidence 21111 11111111110 000111000 00 000 001223678889999999
Q ss_pred CCCCCCHHHHHHHHhCCcCCCCCCCCCC
Q 038002 667 PNLRPSMKNVILMLEGTMEIPILAFPPL 694 (702)
Q Consensus 667 P~~RPt~~evl~~Le~~~~~~~p~~P~~ 694 (702)
|.+|.|+++.++..=- .+.+.||.|..
T Consensus 325 P~kRIta~qAleh~yF-~~d~lpp~pt~ 351 (438)
T KOG0666|consen 325 PIKRITAEQALEHPYF-TEDPLPPLPTS 351 (438)
T ss_pred chhhccHHHHhccccc-ccCCCCCCccc
Confidence 9999999988764321 23445555543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=252.02 Aligned_cols=183 Identities=25% Similarity=0.372 Sum_probs=142.4
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
...+||-||||+.-.|.+++..+...-.....+++++||++||+|+|++ |||||||||.||+++++..|||+|||+|
T Consensus 668 ~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLA 744 (1351)
T KOG1035|consen 668 PLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLA 744 (1351)
T ss_pred ceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccc
Confidence 4568999999999999999877653335778899999999999999999 9999999999999999999999999999
Q ss_pred eecC-----------------CCCCceeeceeccccccCcccccCC---CCCccccccchhHhHHHhhhCCcCCcCCCCC
Q 038002 561 KLLM-----------------PNQTGIVAGVRGSRGYMAPEWQNSG---LITVKSDVYSFGVVLLEIICCRSNFEVNVST 620 (702)
Q Consensus 561 ~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 620 (702)
.... .......+...||.-|+|||++.+. .|+.|+|+||||||++||+ .||...+
T Consensus 745 t~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsM-- 819 (1351)
T KOG1035|consen 745 TDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSM-- 819 (1351)
T ss_pred hhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchH--
Confidence 8721 0111234567899999999988654 5999999999999999998 5675431
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....+....+.+.++.. +.........-.++|.+|++.||.+|||+.|+|.
T Consensus 820 -----ERa~iL~~LR~g~iP~~--~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 -----ERASILTNLRKGSIPEP--ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred -----HHHHHHHhcccCCCCCC--cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 12223334445555444 2223334555678899999999999999999984
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-25 Score=227.45 Aligned_cols=186 Identities=25% Similarity=0.259 Sum_probs=149.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..++||||+++++|.+++.... .+++.++..++.|++.||.|||+. +++|+||+|+||+++.++
T Consensus 55 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~ 130 (250)
T cd05123 55 IVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADG 130 (250)
T ss_pred HHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCC
Confidence 4555677788999999999999999999997664 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.++|+|||++....... .......++..|+|||...+...+.++|+||||+++|++++|..||..... ...
T Consensus 131 ~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~----- 201 (250)
T cd05123 131 HIKLTDFGLAKELSSEG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEI----- 201 (250)
T ss_pred cEEEeecCcceecccCC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHH-----
Confidence 99999999998764332 123345678899999999888889999999999999999999999964311 111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKN 675 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e 675 (702)
........ ...+......+.+++.+||..||++||++.+
T Consensus 202 ~~~~~~~~------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 202 YEKILKDP------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHhcCC------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11111111 1222333677889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.6e-25 Score=235.72 Aligned_cols=193 Identities=21% Similarity=0.216 Sum_probs=139.0
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
....++++||+. ++|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 456789999986 68999986544 689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH-------H
Q 038002 561 KLLMPNQT---GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST-------W 629 (702)
Q Consensus 561 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------~ 629 (702)
........ .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||.............. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86543221 11233568899999997755 5688999999999999999999999965421100000000 0
Q ss_pred HHHhhhcc----------ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVAG----------EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ .................+.+++.+||+.||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 00000000111123567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=235.28 Aligned_cols=205 Identities=20% Similarity=0.225 Sum_probs=146.0
Q ss_pred eeeEEEEEecCC------eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSS------KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~------~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++.+.+..+. ..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||
T Consensus 76 iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Ni 149 (343)
T cd07880 76 VIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNL 149 (343)
T ss_pred ccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 556666555443 469999999 7799998864 3688999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
+++.++.+||+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.........
T Consensus 150 ll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 150 AVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EEcCCCCEEEeecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999998765322 223456889999998765 45789999999999999999999999744211100
Q ss_pred hhhHHH-------HHHhhhccc-------ccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhCCc
Q 038002 624 VLLSTW-------VYNCFVAGE-------FNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL--MLEGTM 684 (702)
Q Consensus 624 ~~~~~~-------~~~~~~~~~-------~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~--~Le~~~ 684 (702)
...... ......... +...... .........+.+++.+||+.||++|||+.++++ .++...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 000000 000000000 0000000 111233556889999999999999999999994 445443
Q ss_pred C
Q 038002 685 E 685 (702)
Q Consensus 685 ~ 685 (702)
+
T Consensus 306 ~ 306 (343)
T cd07880 306 D 306 (343)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=253.29 Aligned_cols=87 Identities=33% Similarity=0.419 Sum_probs=80.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++..++.||||||+++++|.+++.... .+++..++.++.||+.||+|||.+ +|+||||||+|||++.++
T Consensus 66 Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g 141 (669)
T cd05610 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEG 141 (669)
T ss_pred cCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCC
Confidence 6677788888999999999999999999997654 678899999999999999999999 999999999999999999
Q ss_pred cEEEeccccee
Q 038002 551 RAKISDFGLAK 561 (702)
Q Consensus 551 ~~kl~Dfg~a~ 561 (702)
.+||+|||+++
T Consensus 142 ~vkL~DFGls~ 152 (669)
T cd05610 142 HIKLTDFGLSK 152 (669)
T ss_pred CEEEEeCCCCc
Confidence 99999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=237.02 Aligned_cols=191 Identities=20% Similarity=0.243 Sum_probs=134.9
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe-CCCcEEEecccce
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID-DSWRAKISDFGLA 560 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a 560 (702)
...++||||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++ +++.+||+|||.+
T Consensus 89 ~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~ 162 (342)
T cd07854 89 NSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLA 162 (342)
T ss_pred ceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccc
Confidence 46899999997 5999888643 588999999999999999999999 999999999999997 4567899999999
Q ss_pred eecCCCCC--ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH-------H
Q 038002 561 KLLMPNQT--GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW-------V 630 (702)
Q Consensus 561 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-------~ 630 (702)
........ .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||............... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07854 163 RIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREED 242 (342)
T ss_pred eecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 86532211 11122357889999997644 56788999999999999999999999644211110000000 0
Q ss_pred HH--------hhh-ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YN--------CFV-AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~--------~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ... ...................+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 243 RNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 000 0000000000111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-25 Score=249.71 Aligned_cols=198 Identities=25% Similarity=0.364 Sum_probs=160.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+.+++....++..++|+||++.|+|.++|++.+ ..+...+.+.++.||+.|++||++. +++
T Consensus 364 iv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~v 440 (609)
T KOG0200|consen 364 IVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCV 440 (609)
T ss_pred hhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Ccc
Confidence 7888888878999999999999999999998776 3378889999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceec--cccccCcccccCCCCCccccccchhHhHHHhhh-CCc
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRG--SRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRS 612 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~ 612 (702)
||||-..|||+.++..+||+|||+++............-.+ ...|||||.+....|+.++|||||||+||||++ |..
T Consensus 441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 99999999999999999999999999765544443332222 345999999999999999999999999999998 888
Q ss_pred CCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 613 NFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 613 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
|+... ....+ ..+....+.. .+.+....+++.++|+.||+.+|++||++.++++.++..
T Consensus 521 PYp~~-~~~~~------l~~~l~~G~r-----~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 521 PYPGI-PPTEE------LLEFLKEGNR-----MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCC-CcHHH------HHHHHhcCCC-----CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 88642 10111 1222222221 123444577888999999999999999999999999883
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=237.54 Aligned_cols=186 Identities=20% Similarity=0.256 Sum_probs=137.4
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++|+||+ +++|.+++... .+++.++..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++..
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred cEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 489999999 67999998753 689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH-------HHHhh
Q 038002 563 LMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW-------VYNCF 634 (702)
Q Consensus 563 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-------~~~~~ 634 (702)
.... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... ....+
T Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 5332 223457888999998755 46789999999999999999999999644211100000000 00000
Q ss_pred hccccccccc-------c---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 635 VAGEFNKLVE-------E---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 635 ~~~~~~~~~~-------~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........+. . ......+..+.+++.+||+.||++|||+++|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000000 0 011123678999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=232.35 Aligned_cols=199 Identities=24% Similarity=0.272 Sum_probs=144.7
Q ss_pred eeeEEEEEec-CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHR-SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++...+.. +...++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+|+||+|+||+++++
T Consensus 71 iv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~ 144 (328)
T cd07856 71 IISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINEN 144 (328)
T ss_pred eeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCC
Confidence 6777777654 67899999998 56999888643 477888889999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+|||.+...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.+
T Consensus 145 ~~~~l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 145 CDLKICDFGLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred CCEEeCccccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999998754221 123456888999998765 5789999999999999999999999965421110000000
Q ss_pred HH-------HHhhhcccccccc----c------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WV-------YNCFVAGEFNKLV----E------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~-------~~~~~~~~~~~~~----~------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. ............. . .+..+.....+.+++.+||+.+|++||++++++..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0000000000000 0 01111235788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=207.93 Aligned_cols=167 Identities=22% Similarity=0.216 Sum_probs=127.8
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
|+|.+++...+..+++.+++.++.||++||+|||++ + ||+||+++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999987665799999999999999999999998 5 999999999999999 99998754322
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
..|++.|+|||++.+..++.++|||||||++|||++|+.||........ .... ......... ............
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~-~~~~~~~~~---~~~~~~~~~~~~ 137 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEI-LLNGMPADD---PRDRSNLESVSA 137 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHH-HHHHhccCC---ccccccHHHHHh
Confidence 2578999999999999999999999999999999999999964321111 1111 111111100 000011222333
Q ss_pred --HHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 654 --RMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 654 --~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.+.+++.+||+.||++||++.|+++.+...
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 689999999999999999999999988653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=229.97 Aligned_cols=199 Identities=20% Similarity=0.228 Sum_probs=141.3
Q ss_pred eeeEEEEEec------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHR------SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++...+.. ....+++++++ +++|.+++... .+++..+..++.|+++||+|||++ +|+|+||||+||
T Consensus 78 iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NI 151 (345)
T cd07877 78 VIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNL 151 (345)
T ss_pred ccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHE
Confidence 5555554432 34578888887 78999888643 588999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
+++.++.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........
T Consensus 152 ll~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 152 AVNEDCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred EEcCCCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 9999999999999998764321 223457889999998765 56889999999999999999999999643211100
Q ss_pred hhhHHH-------HHHhhhccc-------ccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 624 VLLSTW-------VYNCFVAGE-------FNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 624 ~~~~~~-------~~~~~~~~~-------~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...... ......... +...... .........+.+++.+||+.||.+||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000 000000000 0000000 0001134568899999999999999999998874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=222.94 Aligned_cols=101 Identities=27% Similarity=0.261 Sum_probs=86.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------------eeeEEEEEe----c
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------------ISSLLVYKH----R 480 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------------i~~l~~~~~----~ 480 (702)
..|...++||-|-| |+++.... +.||+| |++|+.+|. +
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 55667788888888 88887665 677776 888887765 5
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
+.++++|+|++ |-+|..+|.... ..++...+.+|++||+.||.|||.+| ||||.||||+|||+
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 88999999999 778988887654 35999999999999999999999997 99999999999999
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-25 Score=242.77 Aligned_cols=222 Identities=25% Similarity=0.308 Sum_probs=177.8
Q ss_pred ccceEEEeEE--EEEeeeeh------hhhHhh----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 447 DKRKLLTVLA--GCLGSITF------LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~------~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
..++||.|+| ||+|...- .+||+| +++|++...... ..||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 3468999988 99888642 577776 555555555444 8999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
++.|.|.++++.++..+-....+.|..||++||.|||++ +++||||-..||||..-..+||.|||+++....+....
T Consensus 779 mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred cccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 999999999999888899999999999999999999999 99999999999999999999999999999886655432
Q ss_pred e-eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 571 V-AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 571 ~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
. ....-.+.|||-|.+....++.++|||||||++||++| |..|++..... + +...+..++. + +.+
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~--e------I~dlle~geR--L---sqP 922 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE--E------IPDLLEKGER--L---SQP 922 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH--H------hhHHHhcccc--C---CCC
Confidence 2 22334567999999999999999999999999999998 99999755111 1 1111111211 1 335
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+....++..++.+||..|++.||+++++...+.....
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 5667788899999999999999999999998876543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-26 Score=220.53 Aligned_cols=196 Identities=25% Similarity=0.279 Sum_probs=154.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFN----LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|+++++..-.++..++.||.|+- ||+.+.+. ...++++...-+|..-.+.||.||.+. ..|||||+||+|||+
T Consensus 125 IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILl 201 (361)
T KOG1006|consen 125 IVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILL 201 (361)
T ss_pred HHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEE
Confidence 88888888889999999999954 77766532 234688888889999999999999887 489999999999999
Q ss_pred eCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 547 DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 547 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+..|.+||+|||.+-.+...- ..+.-.|-.+|||||.+.. ..|+.++|+||||++|||+.||..|+....+.-+
T Consensus 202 dr~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe-- 277 (361)
T KOG1006|consen 202 DRHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE-- 277 (361)
T ss_pred ecCCCEeeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH--
Confidence 999999999999987653322 2334467889999997743 3589999999999999999999999975422111
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......++.+.+....-..+.+..+.+++.-||.+|-.+||...++.+
T Consensus 278 -----ql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 278 -----QLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred -----HHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1122344555555555445567888999999999999999999998875
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=188.81 Aligned_cols=111 Identities=30% Similarity=0.457 Sum_probs=97.1
Q ss_pred ccccCCCCeeEcCCCeEEEEEEeCCC-ceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcCCCCeeee
Q 038002 35 SLSPSGQHSWNSSSGLFQFGFYKQGS-GYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPI 113 (702)
Q Consensus 35 ~l~~~~~~~~~s~~g~f~lgF~~~~~-~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~~~~~~w~ 113 (702)
.|..+ +.|+|+++.|++|||.... ..+++|||++.+ +++||.||++.|+.. .+.|.|+.||+|+|++.+|.++|+
T Consensus 3 ~l~~~--~~l~s~~~~f~~G~~~~~~q~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 3 TLSSG--QTLVSGNSLFELGFFTLIMQNDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred ccCCC--CEEecCCCcEeeeccccCCCCCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEE
Confidence 45444 7899999999999999554 488999999887 889999999988743 489999999999999999999999
Q ss_pred eccccCCcceeEEEecCcCEEEeecCCceEeeecCC
Q 038002 114 ADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149 (702)
Q Consensus 114 ~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~ 149 (702)
|++....+..+|+|+|+|||||++..+.+|||||||
T Consensus 79 S~t~~~~~~~~~~L~ddGnlvl~~~~~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTTGANGNYVLVLLDDGNLVIYDSDGNFLWQSFDY 114 (114)
T ss_pred ecccCCCCceEEEEeCCCCEEEECCCCCEEeCCCCC
Confidence 988534567889999999999999999999999997
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=214.49 Aligned_cols=194 Identities=19% Similarity=0.256 Sum_probs=144.8
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
...+|+||++|+. +|..+|.+...+++..++.+++.++..||.|+|.. .|+|||+||+|+||+.++.+||+|||++
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 5568999999976 99999988877899999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC---ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc
Q 038002 561 KLLMPNQT---GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA 636 (702)
Q Consensus 561 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 636 (702)
+.+..... ...+....|..|++||.+.+ +.|+++.|||..|||+.||+++.+.+...... .+..+.......+..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-qql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-QQLHLISQLCGSITK 250 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-HHHHHHHHHhccCCc
Confidence 76643322 22344566999999997654 68999999999999999999999998765221 122111111111111
Q ss_pred cccccc--------c-----cc---ccCHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 637 GEFNKL--------V-----EE---EVDKIT------LERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 637 ~~~~~~--------~-----~~---~~~~~~------~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..++.. + .+ ..-.+. .++..+++.++|..||.+||++++++..
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111100 0 00 000111 2367788999999999999999988754
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=255.98 Aligned_cols=180 Identities=18% Similarity=0.162 Sum_probs=130.5
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC------------
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD------------ 548 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~------------ 548 (702)
...+++++|++ +++|.++|......+++.+++.++.||++||+|||++ ||+||||||+||||+.
T Consensus 52 ~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~ 127 (793)
T PLN00181 52 DDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASC 127 (793)
T ss_pred cchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeecccc
Confidence 45678888987 5699999987655689999999999999999999999 9999999999999954
Q ss_pred -------CCcEEEecccceeecCCCCC---------------ceeeceeccccccCcccccCCCCCccccccchhHhHHH
Q 038002 549 -------SWRAKISDFGLAKLLMPNQT---------------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLE 606 (702)
Q Consensus 549 -------~~~~kl~Dfg~a~~~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 606 (702)
++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||+|||
T Consensus 128 ~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~E 207 (793)
T PLN00181 128 SDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFE 207 (793)
T ss_pred CcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHH
Confidence 44556666666653211000 00011357888999999998899999999999999999
Q ss_pred hhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 607 IICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 607 lltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
|++|..|+.... ...... ..... .+. ..........++.+||+.||.+||++.|+++.
T Consensus 208 Ll~~~~~~~~~~-----~~~~~~-----~~~~~----~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 208 LFCPVSSREEKS-----RTMSSL-----RHRVL----PPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HhhCCCchhhHH-----HHHHHH-----HHhhc----Chh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 999988874220 011110 00000 110 01123345678889999999999999999863
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-24 Score=195.33 Aligned_cols=202 Identities=20% Similarity=0.218 Sum_probs=152.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..-+.++..-||+|||.. +|..+.......++.+.+..++.|+++||.|+|++ +++||||||.|.|++.+|
T Consensus 63 ivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ng 138 (292)
T KOG0662|consen 63 IVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNG 138 (292)
T ss_pred eeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCC
Confidence 88898888899999999999965 89999988877899999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
.+|++|||+++.++-.-. ......-|..|.+|.++.+ +.|+...|+||-|||+.|+.. |++.|... ...++....-
T Consensus 139 elkladfglarafgipvr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~-dvddqlkrif 216 (292)
T KOG0662|consen 139 ELKLADFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-DVDDQLKRIF 216 (292)
T ss_pred cEEecccchhhhcCCceE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC-cHHHHHHHHH
Confidence 999999999998754332 2233456889999998866 478999999999999999987 55555443 3333332222
Q ss_pred HHHHhhhcccccccc---cc-------------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WVYNCFVAGEFNKLV---EE-------------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~---~~-------------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+......+..++.+- +- .+-+.....=++++.+.|.-+|.+|.++++.++
T Consensus 217 ~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 217 RLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 222222222222111 10 111222334467777888999999999998875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=232.24 Aligned_cols=192 Identities=20% Similarity=0.113 Sum_probs=132.5
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEec
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLE-----------------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHC 537 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~ 537 (702)
++..+|||||+++++|.++++... ...++..+..++.|++.+|+|||+. +|+||
T Consensus 257 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHr 333 (507)
T PLN03224 257 KGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHR 333 (507)
T ss_pred CCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecC
Confidence 356899999999999999986421 1235677888999999999999999 99999
Q ss_pred CCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCC--------------------C--Cccc
Q 038002 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL--------------------I--TVKS 595 (702)
Q Consensus 538 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--------------------~--~~~~ 595 (702)
||||+||+++.++.+||+|||++...............+++.|+|||.+.... + ..+.
T Consensus 334 DLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~ 413 (507)
T PLN03224 334 DIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413 (507)
T ss_pred CCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCcc
Confidence 99999999999999999999999765332221112223478999999775322 1 1347
Q ss_pred cccchhHhHHHhhhCCc-CCcCCCCCcchhhhHH---HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCC---C
Q 038002 596 DVYSFGVVLLEIICCRS-NFEVNVSTADEVLLST---WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEP---N 668 (702)
Q Consensus 596 DiwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP---~ 668 (702)
||||+||++|+|+++.. |+........+..... ..+........ +-.......+...+++.+||..+| .
T Consensus 414 DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~----~~~~~d~~s~~~~dLi~~LL~~~~~~~~ 489 (507)
T PLN03224 414 DSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY----DFSLLDRNKEAGWDLACKLITKRDQANR 489 (507)
T ss_pred chhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC----CcccccccChHHHHHHHHHhccCCCCcc
Confidence 99999999999999875 6643211111100000 01111111111 111223346778889999999766 6
Q ss_pred CCCCHHHHHHH
Q 038002 669 LRPSMKNVILM 679 (702)
Q Consensus 669 ~RPt~~evl~~ 679 (702)
+|+|++|+++.
T Consensus 490 ~RlSa~eaL~H 500 (507)
T PLN03224 490 GRLSVGQALSH 500 (507)
T ss_pred cCCCHHHHhCC
Confidence 89999999863
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=216.47 Aligned_cols=234 Identities=22% Similarity=0.225 Sum_probs=173.1
Q ss_pred cceEEEeEE--EEEeeeehhhhHhhee--------------------------eEEEEEec----CCeeEEEEecCCCCC
Q 038002 448 KRKLLTVLA--GCLGSITFLCFLIAIS--------------------------SLLVYKHR----SSKKLLVYEFMSKGS 495 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~~~~avki~--------------------------~l~~~~~~----~~~~~lV~e~~~~gs 495 (702)
.+.+|+|-| |.+|..+...|||||- .++..-.. -.+++||++|.+.||
T Consensus 216 ~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GS 295 (513)
T KOG2052|consen 216 QEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGS 295 (513)
T ss_pred EEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCc
Confidence 467899988 9999999999999932 22211111 347899999999999
Q ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhc-----CCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-
Q 038002 496 LADLLFNLETRPLWRDRVRIALDVARGLLYLHDE-----CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG- 569 (702)
Q Consensus 496 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-----~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~- 569 (702)
|.|+|... .++.+..++++..++.||++||.. ..+.|.|||||..|||+..++...|+|+|+|.........
T Consensus 296 L~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~i 373 (513)
T KOG2052|consen 296 LYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTI 373 (513)
T ss_pred HHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcc
Confidence 99999763 689999999999999999999975 3568999999999999999999999999999887554322
Q ss_pred --eeeceeccccccCcccccCCC----C--CccccccchhHhHHHhhhC----------CcCCcCCCCCcchhhhHHHHH
Q 038002 570 --IVAGVRGSRGYMAPEWQNSGL----I--TVKSDVYSFGVVLLEIICC----------RSNFEVNVSTADEVLLSTWVY 631 (702)
Q Consensus 570 --~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwSlGvil~elltG----------~~Pf~~~~~~~~~~~~~~~~~ 631 (702)
.....+||.+|||||++.... + -..+||||||.++||++.. +.||......+... +...
T Consensus 374 di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~---eeMr 450 (513)
T KOG2052|consen 374 DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF---EEMR 450 (513)
T ss_pred cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH---HHHh
Confidence 123567999999999885431 1 1468999999999999742 36665432221110 0011
Q ss_pred Hhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 632 NCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 632 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
...-...+...++. -...+....+.++|+.||..+|.-|-|+-.+-+.|.++.+.
T Consensus 451 kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 451 KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 11112222222222 23456788999999999999999999999999999887643
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=226.90 Aligned_cols=193 Identities=24% Similarity=0.284 Sum_probs=152.3
Q ss_pred eeeEEEEEe-----cCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKH-----RSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~-----~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
++.++++|. .++.++||||||.+||..|+++.. +.++.|..+..|++.++.|+.+||.+ .++|||||-.||
T Consensus 78 v~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~Ni 154 (953)
T KOG0587|consen 78 VATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNV 154 (953)
T ss_pred cceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceE
Confidence 555554443 388999999999999999999865 34688999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcCCCC
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEVNVS 619 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 619 (702)
|++.++.+||+|||.+..+.... .......||+.|||||++.- ..|+.++|+||||++..||.-|.+|+.....
T Consensus 155 LLT~e~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 155 LLTENAEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred EEeccCcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 99999999999999998764322 23445779999999998742 3577899999999999999999999964422
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. +.-.+.+..-+.+ .-+..-++++.++|..||..|.++||++.++++
T Consensus 234 mr--------aLF~IpRNPPPkL---krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 234 MR--------ALFLIPRNPPPKL---KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred hh--------hhccCCCCCCccc---cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11 0000111111111 125567889999999999999999999998875
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=209.65 Aligned_cols=191 Identities=26% Similarity=0.303 Sum_probs=150.2
Q ss_pred eeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc
Q 038002 472 SSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR 551 (702)
Q Consensus 472 ~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 551 (702)
+++.+.+......+++|||+++++|.+++.... .+++..+..++.++++++.+||+. +++|+||+|+||+++.++.
T Consensus 50 ~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~ 125 (244)
T smart00220 50 VRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGH 125 (244)
T ss_pred HHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCc
Confidence 445556667789999999999999999997654 388999999999999999999999 9999999999999999999
Q ss_pred EEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH
Q 038002 552 AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY 631 (702)
Q Consensus 552 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~ 631 (702)
++|+|||.+....... ......++..|++||.+....++.++||||||+++++|++|..||...... ... .
T Consensus 126 ~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~----~ 196 (244)
T smart00220 126 VKLADFGLARQLDPGG--LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LEL----F 196 (244)
T ss_pred EEEccccceeeecccc--ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHH----H
Confidence 9999999998764432 233455788999999998888899999999999999999999999653111 111 1
Q ss_pred HhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 632 NCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........... .........+.+++.+||..+|++||++.++++
T Consensus 197 ~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 197 KKIGKPKPPFP---PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHhccCCCCc---cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 11111111100 000014568889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-24 Score=196.22 Aligned_cols=142 Identities=30% Similarity=0.386 Sum_probs=120.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
++.+++...++...++.||.|.. ||+.+-.+ .+...++...-+|+..+++||.|||++ ..+||||+||+|||++
T Consensus 107 ~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn 183 (282)
T KOG0984|consen 107 TVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILIN 183 (282)
T ss_pred EEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEc
Confidence 67888888889999999999965 88776543 344688899999999999999999998 6999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCccccc----CCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN----SGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
.+|++|++|||.+-.+...-. .+--.|-..|+|||.+. ...|+-++||||||+.+.||.+++.||+..
T Consensus 184 ~~GqVKiCDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 184 YDGQVKICDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cCCcEEEcccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 999999999999987643322 12234778999999764 347899999999999999999999999765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-23 Score=217.57 Aligned_cols=228 Identities=18% Similarity=0.126 Sum_probs=168.9
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~lV 487 (702)
.|......|+|.| |+.+.... ..|||| +++|+-.|...+++|||
T Consensus 433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClV 512 (752)
T KOG0670|consen 433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLV 512 (752)
T ss_pred eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEE
Confidence 3444556788888 77776554 678887 44555667779999999
Q ss_pred EecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-CcEEEecccceeecC
Q 038002 488 YEFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS-WRAKISDFGLAKLLM 564 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~ 564 (702)
+|-+ ..+|.+.|++.+. .+....+..++.|+..||..|... ||+|.||||+|||+++. ..+||||||.|....
T Consensus 513 FE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ 588 (752)
T KOG0670|consen 513 FEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFAS 588 (752)
T ss_pred ehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccc
Confidence 9999 4599999988764 377889999999999999999998 99999999999999765 468999999998764
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh--------------HHHH
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL--------------STWV 630 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~--------------~~~~ 630 (702)
.+. .+....+..|.|||++.+.+|+...|+||+||.||||.||+..|.+.....--... ..+.
T Consensus 589 ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~ 665 (752)
T KOG0670|consen 589 ENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK 665 (752)
T ss_pred ccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence 433 34455677899999999999999999999999999999999999765221100000 0000
Q ss_pred HHhh--------------hccc---ccccccc---------------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 631 YNCF--------------VAGE---FNKLVEE---------------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 631 ~~~~--------------~~~~---~~~~~~~---------------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+++ ...+ +...+.+ .-.......+.+|+..||..||++|.|..+.|+
T Consensus 666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0000 0000 0000000 123456778999999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-23 Score=203.10 Aligned_cols=191 Identities=23% Similarity=0.219 Sum_probs=144.5
Q ss_pred cCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
+....|+|||+|. .+|.+.+. ..++-+.+..++.|++.|++|||+. ||+||||||+||++..+..+||.|||+
T Consensus 92 ~~~e~y~v~e~m~-~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 92 EFQEVYLVMELMD-ANLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHhHHHHHHhhh-hHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 3567899999995 48998886 2577788899999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH----------
Q 038002 560 AKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW---------- 629 (702)
Q Consensus 560 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~---------- 629 (702)
|+.-... ...+....+..|.|||++.+-.+.+.+||||+||++.||++|..-|.+....+.-....+.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 9864332 3566778899999999998888999999999999999999999998754221110000000
Q ss_pred ---------HH--Hhhhcccccccccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 630 ---------VY--NCFVAGEFNKLVEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 630 ---------~~--~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. +....-.+...+.. +.++.....+.+++.+||..||++|.+++++|+.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 00 00000111111111 2233446678899999999999999999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-24 Score=203.82 Aligned_cols=193 Identities=20% Similarity=0.244 Sum_probs=142.4
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.++|+|+|.|. .+|..+|-... .++...+.-+++||++||+|||+. +|+||||||.|.|++.+-.+||+|||+++
T Consensus 130 qEiYV~TELmQ-SDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHHHHHH-hhhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 35678888884 47877776543 678888888999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH-----------
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW----------- 629 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----------- 629 (702)
....+.....+...-|..|.|||++.+ +.|+.+.||||.|||+.||+-.+..|...... ++..+...
T Consensus 205 vee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi-qQL~lItdLLGTPs~EaMr 283 (449)
T KOG0664|consen 205 TWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI-EQLQMIIDLLGTPSQEAMK 283 (449)
T ss_pred ccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH-HHHHHHHHHhCCCcHHHHH
Confidence 877666666677778999999998876 57999999999999999999888888654222 22111110
Q ss_pred -----HHHhhhcc-----ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 630 -----VYNCFVAG-----EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 630 -----~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
....+.++ .+..+..-.-+.....+...+...++..||++|.+.++.+..+
T Consensus 284 ~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 284 YACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 01111111 1111111111223344566777789999999999999988765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-22 Score=211.39 Aligned_cols=138 Identities=25% Similarity=0.291 Sum_probs=125.4
Q ss_pred eeeEEEEEecCCeeEEEEecC-CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFM-SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~-~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|++++.+|++++.+||+||-. ++.+|.++|.... ++++.++..|+.|++.|+++||++ ||||||||-+|+.++.+
T Consensus 631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~ 706 (772)
T KOG1152|consen 631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSN 706 (772)
T ss_pred hhhhhheeecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecC
Confidence 899999999999999999987 6779999997665 899999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCc
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFE 615 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~ 615 (702)
|.+||+|||.+......+ ...++||..|.|||++.+..| ...-|||++|++||.++..+.||.
T Consensus 707 g~~klidfgsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 707 GFVKLIDFGSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CeEEEeeccchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999998764333 456789999999999998876 466799999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=197.45 Aligned_cols=191 Identities=22% Similarity=0.276 Sum_probs=150.3
Q ss_pred EEEecCCeeEEEEecCCCCCHHHHhhc-----CC--CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 476 VYKHRSSKKLLVYEFMSKGSLADLLFN-----LE--TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 476 ~~~~~~~~~~lV~e~~~~gsL~~~l~~-----~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
..-++...++++|.++.-|+|..+|.. .. ..++..+...++.|++.|++|||++ +|||.||...|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 455678899999999999999999982 21 2356677888999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceee-ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhh
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVA-GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 626 (702)
.-++||+|-.+++.+......... ....+..||+||.+.+..|+.++|+|||||++|||+| |+.|+...+..+
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----- 506 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----- 506 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH-----
Confidence 999999999999866544332222 2234568999999999999999999999999999998 889985431111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
.....+.+. .-..+.+.++++..++.-||...|++||+++|++.-|.+
T Consensus 507 ---m~~ylkdGy-----RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 507 ---MEHYLKDGY-----RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred ---HHHHHhccc-----eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 111111111 112345567889999999999999999999999998864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=189.24 Aligned_cols=161 Identities=36% Similarity=0.542 Sum_probs=140.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-C
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-S 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~ 549 (702)
|.+++.++......+++||++++++|.+++......+++..+..++.++++++++||+. +++|+||+|.||+++. +
T Consensus 53 i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~ 129 (215)
T cd00180 53 IVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDN 129 (215)
T ss_pred eeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCC
Confidence 77888888888999999999999999999987644688999999999999999999999 9999999999999999 8
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+.++|+||+.+........ ......+...|++||..... ..+.+.|+|++|+++++|
T Consensus 130 ~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------- 187 (215)
T cd00180 130 GKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------- 187 (215)
T ss_pred CcEEEecCCceEEccCCcc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------
Confidence 9999999999987644321 12234578899999988776 888999999999999998
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
..+.+++.+|++.||++||+++++++.|
T Consensus 188 ------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5678888999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-22 Score=189.47 Aligned_cols=199 Identities=20% Similarity=0.285 Sum_probs=149.5
Q ss_pred eeeEEE--EEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLV--YKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~--~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|++|+. .-.....+-||+||+++.+...+.. .++..++..++.|++.||.|+|+. ||.|||+||.|+++|.
T Consensus 95 Ii~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh 167 (338)
T KOG0668|consen 95 IIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDH 167 (338)
T ss_pred eeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeech
Confidence 667763 3455788899999999988877763 567788899999999999999999 9999999999999987
Q ss_pred CC-cEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 549 SW-RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~-~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.. .++|+|+|+|.++........ ...+..|--||.+-. ..|+..-|+|||||++..|+..+.||-...+..++...
T Consensus 168 ~~rkLrlIDWGLAEFYHp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk 245 (338)
T KOG0668|consen 168 ELRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK 245 (338)
T ss_pred hhceeeeeecchHhhcCCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence 54 599999999998866554332 345778899997754 57889999999999999999999999776555544322
Q ss_pred HHHH------------HHhhhcc------------ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWV------------YNCFVAG------------EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~------------~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...+ ++....+ .+..++..+-.....++.++++.+.|..|-.+|||+.|.+.
T Consensus 246 IakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 246 IAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111 0011111 22222222223334578899999999999999999999875
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=171.90 Aligned_cols=110 Identities=29% Similarity=0.522 Sum_probs=85.2
Q ss_pred ecCCccccCcCcceeeeeecCCccEEEeecCccceEEeeeeeeeeccCcceEEEEEEccCCcEEEEEecccCCCCcceEE
Q 038002 206 WANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLYSHHFKNDGNSTVGI 285 (702)
Q Consensus 206 w~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~dG~lr~y~~~~~~~~~~~w~~ 285 (702)
||+|+|+|..+++.|.+.....-.+.+..+..+.+ +.+...+.+.++|++||.+|++++|.|....+. |.+
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~------~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~---W~~ 71 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVY------YTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQS---WSV 71 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEE------EEEecCCCceEEEEEEeeeeEEEEEEEecCCCc---EEE
Confidence 89999999988887765522222222232233322 444566888999999999999999999755554 999
Q ss_pred EEeecccccccccCCCCCccccCCCCCCCCCccCCCCCccccC
Q 038002 286 EWSALEKQCVVKGFCGLNSYCSTSTNISTKGDCHCFRGFNFIN 328 (702)
Q Consensus 286 ~w~~p~~~Cd~~g~CG~~g~C~~~~~~~~~~~C~C~~GF~~~~ 328 (702)
.|++|.++||+|+.||+||+|+. +..+.|.||+||+|++
T Consensus 72 ~~~~p~d~Cd~y~~CG~~g~C~~----~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 72 FWSAPKDQCDVYGFCGPNGICNS----NNSPKCSCLPGFEPKN 110 (110)
T ss_pred EEEecccCCCCccccCCccEeCC----CCCCceECCCCcCCCc
Confidence 99999999999999999999965 3578899999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=191.40 Aligned_cols=188 Identities=19% Similarity=0.290 Sum_probs=136.6
Q ss_pred EEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE--eCCCcEE
Q 038002 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI--DDSWRAK 553 (702)
Q Consensus 476 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll--~~~~~~k 553 (702)
..|+..+.+++++||++.|+|..-+... .+-+....+++.|+++||.|||++ ++||||||.+|||| .+..++|
T Consensus 89 vaFqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvK 163 (378)
T KOG1345|consen 89 VAFQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVK 163 (378)
T ss_pred HHhhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEE
Confidence 5577799999999999999999988653 477788889999999999999999 99999999999999 3345899
Q ss_pred EecccceeecCCCCCceeeceeccccccCcccccC---C--CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 554 ISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS---G--LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 554 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
|+|||.....+ ........+..|.+||.... + ...+.+|||.||+++|.++||..||+.. ...+. .-
T Consensus 164 lcDFG~t~k~g----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~---~Y 235 (378)
T KOG1345|consen 164 LCDFGLTRKVG----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDK---PY 235 (378)
T ss_pred eeecccccccC----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCc---hH
Confidence 99999987532 22233445678999996532 2 3457899999999999999999999743 22222 22
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+.+..+..+......+ .-...++.+.++.++-|..+|++|--..++.+
T Consensus 236 ~~~~~w~~rk~~~~P~--~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 236 WEWEQWLKRKNPALPK--KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred HHHHHHhcccCccCch--hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 3333443333322111 12234667778888899999999944444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.5e-21 Score=196.67 Aligned_cols=229 Identities=20% Similarity=0.213 Sum_probs=164.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh-----hhhHhh--------------------------eeeEEEEEecCCeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-----LCFLIA--------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-----~~~avk--------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
..++...++|+|.| |+++.+.. +.||+| |+.+...+++++...+|||
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 34455678889988 77766533 567776 8888899999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-CCcEEEecccceeecCCCC-
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-SWRAKISDFGLAKLLMPNQ- 567 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~- 567 (702)
|++.-+..++.. .++..++..+++.++.||+++|.+ |||||||||.|+|.+. .++-.|+|||+|.......
T Consensus 116 ~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 116 YFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred ccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 999999999885 466889999999999999999999 9999999999999964 4678999999998211000
Q ss_pred ------------------------------------------CceeeceeccccccCcccccC-CCCCccccccchhHhH
Q 038002 568 ------------------------------------------TGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVL 604 (702)
Q Consensus 568 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil 604 (702)
........||++|.|||++.. ...+++.||||.|||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 000113459999999998754 5678999999999999
Q ss_pred HHhhhCCcCCcCCCCCcchhhhHHHHHH-------hhhccc------------------cccc-----cc-------c-c
Q 038002 605 LEIICCRSNFEVNVSTADEVLLSTWVYN-------CFVAGE------------------FNKL-----VE-------E-E 646 (702)
Q Consensus 605 ~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~~~~~------------------~~~~-----~~-------~-~ 646 (702)
+.+++++.||-......+.......+.. ....+. +..+ .. . .
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 9999999999654222211111000000 000000 0000 00 0 0
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........+.+++.+||+.||.+|.|+++.|+
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 11122337889999999999999999999886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-20 Score=198.75 Aligned_cols=193 Identities=20% Similarity=0.237 Sum_probs=144.9
Q ss_pred eeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc
Q 038002 472 SSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR 551 (702)
Q Consensus 472 ~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~ 551 (702)
+.+++.+...+..++.||||.+|+|.+.-+-.+ .+++.++....++.++||+|||+. +-+|||||-.||++.+.|.
T Consensus 75 vay~gsylr~dklwicMEycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gD 150 (829)
T KOG0576|consen 75 VAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGD 150 (829)
T ss_pred HHHHhhhhhhcCcEEEEEecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCc
Confidence 333444555889999999999999999876544 789999999999999999999999 9999999999999999999
Q ss_pred EEEecccceeecCCCCCceeeceeccccccCcccc---cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 552 AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ---NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 552 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+|++|||.+..+...- .....+.||+.|||||+. +.+.|...+|||++|+...|+---+.|...... ..
T Consensus 151 vklaDfgvsaqitati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp------mr- 222 (829)
T KOG0576|consen 151 VKLADFGVSAQITATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP------MR- 222 (829)
T ss_pred eeecccCchhhhhhhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch------HH-
Confidence 9999999987653221 123457899999999965 466889999999999999999877776532211 00
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+...+..... +.....-...-.+.+.++++.+|..+|.+||+++.++.
T Consensus 223 -~l~LmTkS~~-qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 223 -ALFLMTKSGF-QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -HHHHhhccCC-CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1111111111 11111123345677888888999999999999987654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-19 Score=177.07 Aligned_cols=143 Identities=27% Similarity=0.367 Sum_probs=124.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
+++++..+......++++|++++++|.+++......+++..+..++.+++.++.+||+. +++|+||+|+||+++.++
T Consensus 59 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 59 IVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDG 135 (225)
T ss_pred hhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 66677778888999999999999999999987653388999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccc-cCCCCCccccccchhHhHHHhhhCCcCCcC
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ-NSGLITVKSDVYSFGVVLLEIICCRSNFEV 616 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 616 (702)
.++|+|||.+...............++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 136 LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999999999988754431123345678889999988 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.2e-19 Score=201.45 Aligned_cols=183 Identities=21% Similarity=0.260 Sum_probs=145.4
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
+-+||||++ +|..++.... ++...++..++.|++.|++|||+. ||.||||||+|+++..+|.+||+|||.+..+.
T Consensus 397 ~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeec
Confidence 334999999 9999997763 788899999999999999999999 99999999999999999999999999998775
Q ss_pred CCCC---ceeeceeccccccCcccccCCCCCc-cccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc
Q 038002 565 PNQT---GIVAGVRGSRGYMAPEWQNSGLITV-KSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640 (702)
Q Consensus 565 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (702)
.... ......+|+.+|+|||.+.+..|.+ ..||||.|+++..|++|+.||......+... ..........
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~ 545 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRN 545 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccc
Confidence 4333 3445688999999999998888875 5799999999999999999998663332221 0000111111
Q ss_pred ccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 641 KLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 641 ~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....+ .+......+...+|.+||+.||.+|.|+++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11111 345566778899999999999999999999986
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=176.98 Aligned_cols=200 Identities=20% Similarity=0.160 Sum_probs=145.9
Q ss_pred eeeEEEEE-ecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYK-HRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
+..+...+ ..+...|+||+.+ |.+|.++..... .+++...++.++.|++.+|++||+. |++||||||+|+++..
T Consensus 82 ~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~ 157 (322)
T KOG1164|consen 82 FPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQ 157 (322)
T ss_pred CCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecC
Confidence 34445555 4777899999999 889999986655 6799999999999999999999999 9999999999999975
Q ss_pred C-----CcEEEeccccee--ecCCCCC-------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCC
Q 038002 549 S-----WRAKISDFGLAK--LLMPNQT-------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614 (702)
Q Consensus 549 ~-----~~~kl~Dfg~a~--~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 614 (702)
. ..+.|.|||+++ .+..... ......+||..|.++....+...+.+.|+||++.++.|++.|..||
T Consensus 158 ~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW 237 (322)
T KOG1164|consen 158 SSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPW 237 (322)
T ss_pred CCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCC
Confidence 4 469999999998 3322211 1123466999999999999999999999999999999999999999
Q ss_pred cCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 615 EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
....................... ..... ...+.++..-+-..+..++|....+...|+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 238 EALEMTDLKSKFEKDPRKLLTDR------FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred ccccccchHHHHHHHhhhhcccc------ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 65432222111111111110000 11112 23344444444557999999999999988664
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-18 Score=169.18 Aligned_cols=170 Identities=21% Similarity=0.205 Sum_probs=147.5
Q ss_pred cccccceEEEeEE--EEEeeee--hhhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 444 KVNDKRKLLTVLA--GCLGSIT--FLCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~--~~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
.++.-++||+|.| .+.|.-. +++|||| |...+-+.+++.+-.||+|.+ |
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-G 107 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-G 107 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-C
Confidence 4566789999999 4445432 3899998 888888889999999999999 8
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-----CCcEEEecccceeecCCCCC
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-----SWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~~~~ 568 (702)
.||+|++.-.+.+++...++.++.|++.-++++|++ .+|.|||||+|+||.. ...+.|+|||+|+.+....+
T Consensus 108 PSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 108 PSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred cCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 999999998888999999999999999999999999 9999999999999943 33589999999998754433
Q ss_pred c------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 569 G------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 569 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
. ......||..||+-....++..+.+.|+-|||-++...|-|..||..-
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 2 234567999999999999999999999999999999999999999865
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.6e-18 Score=161.97 Aligned_cols=172 Identities=23% Similarity=0.187 Sum_probs=147.4
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
..+++..++||.|+| .|+|.... +.||+| |..+..++.++.+-.+|||.+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 456778899999999 77776543 888888 777778899999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe---CCCcEEEecccceeecCCCCC
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID---DSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
|.||++++.-...+++..+++-++-|++.-++|+|.+ ++|||||||+|+|.. ...++.++|||+++.+....+
T Consensus 94 -GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 94 -GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred -CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 8999999987777899999999999999999999999 999999999999994 345699999999997754332
Q ss_pred c------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 569 G------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 569 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
. ......||..|.+-....+...+.+.|+-|+|.+|..+.-|..||+..
T Consensus 170 ~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 170 RQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred cccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 1 223567999999988888788899999999999999999999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=172.90 Aligned_cols=207 Identities=24% Similarity=0.397 Sum_probs=156.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCe-EecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQI-IHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~i-vH~dlkp~NIll~~~ 549 (702)
+.++++..-++...++|.+||..|+|.|.+.....++++.-...++++|+.||+|||.. .| .|+.++..|-++|..
T Consensus 9 ~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s~nClvd~~ 85 (484)
T KOG1023|consen 9 LNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKSSNCLVDSR 85 (484)
T ss_pred hhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeeccccceeeee
Confidence 35666777778999999999999999999998777899999999999999999999998 55 999999999999999
Q ss_pred CcEEEecccceeecCCCC-CceeeceeccccccCcccccCC-------CCCccccccchhHhHHHhhhCCcCCcCCCCCc
Q 038002 550 WRAKISDFGLAKLLMPNQ-TGIVAGVRGSRGYMAPEWQNSG-------LITVKSDVYSFGVVLLEIICCRSNFEVNVSTA 621 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~ 621 (702)
..+||+|||+........ ........-..-|.|||.++.. ..+.++||||||++++|+++.+.||.......
T Consensus 86 w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~ 165 (484)
T KOG1023|consen 86 WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVE 165 (484)
T ss_pred EEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccC
Confidence 999999999998764311 1111122245579999988653 14678999999999999999999998753333
Q ss_pred chhhhHHHHHHhhhccccccccccccC--HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 622 DEVLLSTWVYNCFVAGEFNKLVEEEVD--KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+.. +.+.. ... .....+.+.+. .+..+.+..++..||..+|++||+++++-..++.+..
T Consensus 166 ~~~---eii~~-~~~-~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 166 DPD---EIILR-VKK-GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ChH---HHHHH-HHh-cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 221 11111 111 11112222111 1444579999999999999999999999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.1e-15 Score=156.43 Aligned_cols=205 Identities=26% Similarity=0.328 Sum_probs=151.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+.+...+......++++|++.+++|.+++..... .+.......++.|++.+++|+|+. +++|||+||+||+++.
T Consensus 60 i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~ 136 (384)
T COG0515 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDR 136 (384)
T ss_pred eeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecC
Confidence 56677777777778999999999999977766542 688899999999999999999999 9999999999999999
Q ss_pred CC-cEEEecccceeecCCCCCc-----eeeceeccccccCcccccC---CCCCccccccchhHhHHHhhhCCcCCcCCCC
Q 038002 549 SW-RAKISDFGLAKLLMPNQTG-----IVAGVRGSRGYMAPEWQNS---GLITVKSDVYSFGVVLLEIICCRSNFEVNVS 619 (702)
Q Consensus 549 ~~-~~kl~Dfg~a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 619 (702)
.+ .++++|||.+......... ......|+..|++||.+.. .......|+||+|++++++++|..||.....
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 88 7999999999865443321 2356779999999998877 5788999999999999999999999765422
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
................. .................+.+++..++..+|..|.++.+....
T Consensus 217 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 217 SSATSQTLKIILELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccHHHHHHHHHhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 10011111111111100 000011111112234577888888999999999998887764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.2e-17 Score=171.37 Aligned_cols=173 Identities=22% Similarity=0.267 Sum_probs=131.1
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccc
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLE--TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFG 558 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 558 (702)
....|+.|++|...+|.++|...+ ...++...+.++.|++.|++| + +.+|+|+||.||++..+..+||.|||
T Consensus 328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 346899999999999999996543 357788999999999999999 6 99999999999999999999999999
Q ss_pred ceeecCCCC-----CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHH
Q 038002 559 LAKLLMPNQ-----TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYN 632 (702)
Q Consensus 559 ~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 632 (702)
+........ ....+...||..||+||.+.+..|+.++||||||+||+|++. -..+++- .....
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-----------~~t~~ 470 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-----------IATLT 470 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-----------HHhhh
Confidence 998775544 223445679999999999999999999999999999999986 3333321 11122
Q ss_pred hhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038002 633 CFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKN 675 (702)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e 675 (702)
.+..+.+++..-.+ .+.-..++.+++...|.+||++.+
T Consensus 471 d~r~g~ip~~~~~d-----~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQD-----YPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hhhcCCCChHHhhc-----CcHHHHHHHHhcCCCcccCchHHH
Confidence 22333333111111 123346778899999999994433
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-16 Score=152.06 Aligned_cols=194 Identities=22% Similarity=0.284 Sum_probs=144.6
Q ss_pred eeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 472 SSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETR-PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 472 ~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
..+++.+....++.+|..||+.|+|...|++.... .+..++.+++.++++|++|||+.. +-|.---|....+++|++.
T Consensus 250 lpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedl 328 (448)
T KOG0195|consen 250 LPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDL 328 (448)
T ss_pred hhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchh
Confidence 34456777889999999999999999999877543 678899999999999999999972 2344456889999999998
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCC---ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT---VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
+.+|.- +-+++. .......-.|.|++||.++.++-+ .++|+|||.+++|||.|.+.||..-...+-...+
T Consensus 329 tarism-ad~kfs-----fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki- 401 (448)
T KOG0195|consen 329 TARISM-ADTKFS-----FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI- 401 (448)
T ss_pred hhheec-ccceee-----eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-
Confidence 877752 111111 111122347889999988765433 6789999999999999999999754222111111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..+-+...+++..+..+.+++.-|+..||.+||.++.|+-.||+..
T Consensus 402 -----------aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 -----------ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----------hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1122233566677888999999999999999999999999999754
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-17 Score=183.55 Aligned_cols=187 Identities=25% Similarity=0.287 Sum_probs=133.5
Q ss_pred ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccc
Q 038002 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFG 558 (702)
Q Consensus 479 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 558 (702)
..++..|||-+|+.. +|.|.|.... .+..-+..-|+.|++.||..+|+. ||+|||||.||||+..-.-+.|+||.
T Consensus 91 ~t~kAAylvRqyvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 91 VTDKAAYLVRQYVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred HhhHHHHHHHHHHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 457778899999965 9999986654 677888888999999999999999 99999999999999999999999998
Q ss_pred ceeecC--CCCCc----eeeceeccccccCcccccC----------CC-CCccccccchhHhHHHhhh-CCcCCcCCCCC
Q 038002 559 LAKLLM--PNQTG----IVAGVRGSRGYMAPEWQNS----------GL-ITVKSDVYSFGVVLLEIIC-CRSNFEVNVST 620 (702)
Q Consensus 559 ~a~~~~--~~~~~----~~~~~~gt~~y~aPE~~~~----------~~-~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 620 (702)
.-+... .+... ...+...-.-|+|||.+-. .. .+++.||||+||++.||++ |++||...
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--- 242 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--- 242 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence 765331 11111 1112222335999996532 12 5688999999999999998 68888643
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.+.. ++.+. ........+..+...+++++..|++.||++|.++++.++--.++
T Consensus 243 ----QL~a-----Yr~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 243 ----QLLA-----YRSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ----HHHh-----HhccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 1111 11111 00000111112233788899999999999999999999886654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.4e-15 Score=150.39 Aligned_cols=185 Identities=21% Similarity=0.230 Sum_probs=131.7
Q ss_pred ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE--eCCC--cEEE
Q 038002 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI--DDSW--RAKI 554 (702)
Q Consensus 479 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll--~~~~--~~kl 554 (702)
-++...||||..++. +|.+++.... .+.....-++.|+++|+.|||++ ||.|||+|.+|||+ |+++ .+.|
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVv 386 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVV 386 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEE
Confidence 457889999999966 9999997653 67777888999999999999999 99999999999999 4444 4789
Q ss_pred ecccceeecCCCC-----CceeeceeccccccCcccccCCC------CCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 555 SDFGLAKLLMPNQ-----TGIVAGVRGSRGYMAPEWQNSGL------ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 555 ~Dfg~a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
+|||.+-.-.... .......-|....||||+....+ .-.|+|.|+.|.+.||++....||.... +
T Consensus 387 aDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG----e 462 (598)
T KOG4158|consen 387 ADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG----E 462 (598)
T ss_pred cccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc----h
Confidence 9999886432211 11112344677789999875422 2268999999999999999999997531 1
Q ss_pred hhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 624 VLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
..+.... +.+.+++. .+......+.+++...|+.||.+|++..-....|.
T Consensus 463 m~L~~r~---Yqe~qLPa-----lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 463 MLLDTRT---YQESQLPA-----LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred heechhh---hhhhhCCC-----CcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 1111111 12222222 22334456667777789999999999766555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.1e-16 Score=168.28 Aligned_cols=182 Identities=23% Similarity=0.205 Sum_probs=144.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
++++...++.+...++++++..+|.|...+.+.. ...+.....+...++-+++++|+. +|+|+|+|++||+++.+|
T Consensus 59 ~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~G 134 (612)
T KOG0603|consen 59 LVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEG 134 (612)
T ss_pred eeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccC
Confidence 5778889999999999999999999999887665 566677777888999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
++++.|||+++..-..+.. +||..|||||++. ....++|.||||++.+||++|..||... ..
T Consensus 135 hi~~tdfglske~v~~~~~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-----~~------ 196 (612)
T KOG0603|consen 135 HIKLTDFGLSKEAVKEKIA-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-----TM------ 196 (612)
T ss_pred ccccCCchhhhHhHhhhhc-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-----HH------
Confidence 9999999999876443332 7899999999988 5678999999999999999999999641 00
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCH--HHHHHHHh
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSM--KNVILMLE 681 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~--~evl~~Le 681 (702)
..+.. .....+......+.+++..++..+|..|--. ..+.+.++
T Consensus 197 -~~Il~------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 197 -KRILK------AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred -HHHhh------hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 00000 0113455666777778888888899888654 34444443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.4e-15 Score=153.14 Aligned_cols=161 Identities=21% Similarity=0.285 Sum_probs=105.4
Q ss_pred eEEEEecCCCCCHHHHhhc---CCCC---CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecc
Q 038002 484 KLLVYEFMSKGSLADLLFN---LETR---PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDF 557 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~---~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 557 (702)
.+++|+-+ .++|.+++.. .... .....++.+..|+++.+++||.. |++|+||||+|++++.+|.++|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcCh
Confidence 46788888 4588887642 1111 22344456778999999999999 9999999999999999999999999
Q ss_pred cceeecCCCCCceeeceeccccccCcccccC--------CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 558 GLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS--------GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 558 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
+.....+... .. ...+..|.+||.... -.++.+.|.|+||+++|.|++++.||...........
T Consensus 190 ~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~---- 261 (288)
T PF14531_consen 190 SSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW---- 261 (288)
T ss_dssp GGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred HHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence 8877543211 11 234577999996532 2578899999999999999999999976522211110
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCC
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLR 670 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~R 670 (702)
.+ .... +.++.+..||..+|+.||++|
T Consensus 262 --------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred --------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 01 1223 678889999999999999988
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=8.9e-15 Score=155.45 Aligned_cols=97 Identities=22% Similarity=0.134 Sum_probs=77.1
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCC-CCCcEEEeCCCcEEEecccc
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI-KLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl-kp~NIll~~~~~~kl~Dfg~ 559 (702)
.+..||||||++|++|... ... . ...++.|++++|+|||++ ||+|||| ||+|||++.++.+||+|||+
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~~----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RPH----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Ccc----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 3568999999999999732 111 1 146788999999999999 9999999 99999999999999999999
Q ss_pred eeecCCCCCc-------eeeceeccccccCcccccC
Q 038002 560 AKLLMPNQTG-------IVAGVRGSRGYMAPEWQNS 588 (702)
Q Consensus 560 a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 588 (702)
++.+...... ......+++.|.|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9977543321 1235668889999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.1e-15 Score=170.03 Aligned_cols=169 Identities=18% Similarity=0.106 Sum_probs=139.1
Q ss_pred CcccccccceEEEeEE--EEEeeeeh-hhhHhh---------------------------eeeEEEEEecCCeeEEEEec
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF-LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~-~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+.+++...+.+|+|++ ||.|.... ..||+| |..+...+.-.+.-+||+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 5566777789999998 99998766 788888 22222333447777999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe-------CCCcEEEecccceeec
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID-------DSWRAKISDFGLAKLL 563 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~-------~~~~~kl~Dfg~a~~~ 563 (702)
.+.|+|.+++...+ .+++..++.++.|+++-+++||.. +||||||||+|+||. ++.-++|+|||.+..+
T Consensus 776 ~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 776 SPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred cccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 99999999998443 799999999999999999999999 999999999999993 3445999999998755
Q ss_pred CCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcC
Q 038002 564 MPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSN 613 (702)
Q Consensus 564 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~P 613 (702)
..-.. .......+|-.+-.+|...+++++..+|.|.|+.+++-||.|+..
T Consensus 852 ~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 852 KLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred eEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 33222 245567789999999999999999999999999999999999854
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-13 Score=134.12 Aligned_cols=75 Identities=20% Similarity=0.199 Sum_probs=64.7
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhh-hhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYL-HDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.+|||||+++++|...+... ..++..++..++.|++.+|++| |+. ||+||||||+||+++ ++.++|+|||++..
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 38999999998876654333 3688899999999999999999 688 999999999999998 47899999999975
Q ss_pred c
Q 038002 563 L 563 (702)
Q Consensus 563 ~ 563 (702)
.
T Consensus 167 ~ 167 (190)
T cd05147 167 H 167 (190)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.3e-14 Score=137.77 Aligned_cols=102 Identities=13% Similarity=0.168 Sum_probs=78.8
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
....+|||||++|.+|.++.. .++ ....+++.+|..+|+. |++|||+||+||+++.++ ++|+|||..
T Consensus 115 ~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~ 181 (232)
T PRK10359 115 AHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGK 181 (232)
T ss_pred cCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCc
Confidence 356899999999999988742 222 2456999999999999 999999999999999988 999999987
Q ss_pred eecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhh
Q 038002 561 KLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608 (702)
Q Consensus 561 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 608 (702)
......... ..+.....+..++|+|+||+.+..+.
T Consensus 182 ~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 182 RCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred ccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 654221110 01344455668999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.6e-13 Score=155.39 Aligned_cols=199 Identities=22% Similarity=0.214 Sum_probs=131.1
Q ss_pred ccccceEEEeEE--EEEeeee--hhhhHhheeeEEE----EEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHH
Q 038002 445 VNDKRKLLTVLA--GCLGSIT--FLCFLIAISSLLV----YKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIA 516 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~--~~~~avki~~l~~----~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~ 516 (702)
+...|.+..|+. ||..... ...+|+||.+=-. ....-+..+.| |+=...++..+ .++.
T Consensus 85 f~~IklisngAygavylvrh~~trqrfa~kiNkq~lilRnilt~a~npfvv------gDc~tllk~~g-~lPv------- 150 (1205)
T KOG0606|consen 85 FNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLILRNILTFAGNPFVV------GDCATLLKNIG-PLPV------- 150 (1205)
T ss_pred cceeEeeccCCCCceeeeeccccccchhhcccccchhhhccccccCCccee------chhhhhcccCC-CCcc-------
Confidence 334455555544 7777554 3677777432111 11112233333 44455555433 2222
Q ss_pred HHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC--------------ceeeceeccccccC
Q 038002 517 LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT--------------GIVAGVRGSRGYMA 582 (702)
Q Consensus 517 ~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~gt~~y~a 582 (702)
+++.+++|||.. +|+|||+||+|.+|..-|++|+.|||+.+....... .....++||+.|+|
T Consensus 151 -dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyia 226 (1205)
T KOG0606|consen 151 -DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIA 226 (1205)
T ss_pred -hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccC
Confidence 237899999999 999999999999999999999999999975422110 11234789999999
Q ss_pred cccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHc
Q 038002 583 PEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLC 662 (702)
Q Consensus 583 PE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 662 (702)
||++..+.|...+|+|++|+|+||.+.|..||..+..++ .+...+...+ .+. +-+.....+..+++.++
T Consensus 227 PeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd~i---~wp-----E~dea~p~Ea~dli~~L 295 (1205)
T KOG0606|consen 227 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISDDI---EWP-----EEDEALPPEAQDLIEQL 295 (1205)
T ss_pred hhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhhhc---ccc-----ccCcCCCHHHHHHHHHH
Confidence 999999999999999999999999999999998663221 1221111111 111 11233445677778888
Q ss_pred ccCCCCCCCC
Q 038002 663 IQDEPNLRPS 672 (702)
Q Consensus 663 L~~dP~~RPt 672 (702)
|+.+|.+|--
T Consensus 296 L~qnp~~Rlg 305 (1205)
T KOG0606|consen 296 LRQNPLCRLG 305 (1205)
T ss_pred HHhChHhhcc
Confidence 9999999953
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.5e-13 Score=131.03 Aligned_cols=76 Identities=20% Similarity=0.159 Sum_probs=64.9
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.+|||||++|+++....... ..++..+...++.|++.++.+||+ . ||+||||||+||+++ ++.++|+|||++..
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~ 166 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVE 166 (190)
T ss_pred CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEccccee
Confidence 48999999988654432222 357788999999999999999999 8 999999999999999 78999999999987
Q ss_pred cC
Q 038002 563 LM 564 (702)
Q Consensus 563 ~~ 564 (702)
..
T Consensus 167 ~~ 168 (190)
T cd05145 167 LD 168 (190)
T ss_pred cC
Confidence 54
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.1e-13 Score=128.90 Aligned_cols=132 Identities=15% Similarity=0.112 Sum_probs=97.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCC-CCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI-KLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dl-kp~NIll~~~ 549 (702)
|.+++.+ +..+++|||+.|.+|.+.+.. ....++.|++++|+++|++ ||+|||| ||+|||++.+
T Consensus 64 vP~ll~~----~~~~lvmeyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~ 128 (218)
T PRK12274 64 TPRLLHW----DGRHLDRSYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQED 128 (218)
T ss_pred CCEEEEE----cCEEEEEeeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCC
Confidence 4455544 456999999999999764321 1235778999999999999 9999999 7999999999
Q ss_pred CcEEEecccceeecCCCCCc----e--------eeceeccccccCcccccC-CCCC-ccccccchhHhHHHhhhCCcCCc
Q 038002 550 WRAKISDFGLAKLLMPNQTG----I--------VAGVRGSRGYMAPEWQNS-GLIT-VKSDVYSFGVVLLEIICCRSNFE 615 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~----~--------~~~~~gt~~y~aPE~~~~-~~~~-~~~DiwSlGvil~elltG~~Pf~ 615 (702)
+.++|+|||++......... . ..-...++.|+.|+...- ...+ ...+.++-|..+|.++|++.++-
T Consensus 129 g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 129 GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 99999999999865433310 0 001225777888874322 1233 56788899999999999999886
Q ss_pred CC
Q 038002 616 VN 617 (702)
Q Consensus 616 ~~ 617 (702)
.+
T Consensus 209 ~~ 210 (218)
T PRK12274 209 ED 210 (218)
T ss_pred cc
Confidence 54
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.4e-12 Score=147.84 Aligned_cols=197 Identities=23% Similarity=0.282 Sum_probs=149.5
Q ss_pred heeeEEEEEecCCeeEEEEecCCCCCHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHhhh-hcCCCCeEecCCCCCcEEEe
Q 038002 470 AISSLLVYKHRSSKKLLVYEFMSKGSLADLLF-NLETRPLWRDRVRIALDVARGLLYLH-DECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 470 ki~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~-~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~dlkp~NIll~ 547 (702)
+++.+++...+.+..++++||..++++.+.+. ......+...+..++.|+..++.|+| .. ++.|+||||+|.+++
T Consensus 82 n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~ 158 (601)
T KOG0590|consen 82 NTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLD 158 (601)
T ss_pred cccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhc
Confidence 35666777788999999999999999999994 33335777788889999999999999 87 999999999999999
Q ss_pred CCC-cEEEecccceeecCC-CC-Cceeeceec-cccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcc
Q 038002 548 DSW-RAKISDFGLAKLLMP-NQ-TGIVAGVRG-SRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD 622 (702)
Q Consensus 548 ~~~-~~kl~Dfg~a~~~~~-~~-~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~ 622 (702)
..+ .++++|||+|..+.. .. .......+| ++.|.|||...+. ...+..|+||.|+++..+++|..|+........
T Consensus 159 ~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~ 238 (601)
T KOG0590|consen 159 ESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG 238 (601)
T ss_pred cCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc
Confidence 999 999999999998866 33 333445678 9999999988774 556889999999999999999999976533221
Q ss_pred hhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 623 EVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ...| .... ................+++.+++..+|..|.+.+++..
T Consensus 239 ~--~~~~-----~~~~--~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 239 R--YSSW-----KSNK--GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--ceee-----cccc--cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1 1111 1110 00001112233556677778889899999999887653
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-11 Score=124.56 Aligned_cols=76 Identities=22% Similarity=0.287 Sum_probs=64.9
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC-eEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ-IIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
..++||||+++.+|...+.... .....++..++.||+.+|++||++ + |+|+||||+||+++ ++.++|+|||.+.
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~ 196 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSV 196 (237)
T ss_pred CceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhh
Confidence 4589999999988877653332 455667788999999999999999 9 99999999999999 8899999999987
Q ss_pred ec
Q 038002 562 LL 563 (702)
Q Consensus 562 ~~ 563 (702)
..
T Consensus 197 ~~ 198 (237)
T smart00090 197 EL 198 (237)
T ss_pred cc
Confidence 54
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.9e-11 Score=122.23 Aligned_cols=194 Identities=21% Similarity=0.282 Sum_probs=130.9
Q ss_pred HhheeeEE--EEEecCCeeEEEEecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 468 LIAISSLL--VYKHRSSKKLLVYEFMSKGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 468 avki~~l~--~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
.||..++. ..+++..+..++.|||..|+|..+|++.. ..+....-.+|+.||+.||.|||+ |.+.|+|+++.-+
T Consensus 129 lvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~ 207 (458)
T KOG1266|consen 129 LVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCD 207 (458)
T ss_pred HHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchh
Confidence 44444444 23346778899999999999999998643 246677778899999999999999 5779999999999
Q ss_pred cEEEeCCCcEEEecccceeecC--C-CCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLM--P-NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVS 619 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~--~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 619 (702)
.|++..++-+||.--.-..... . ..........+-++|.+||.-.....+.++|||+||+..+||..+..--....+
T Consensus 208 tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS 287 (458)
T KOG1266|consen 208 TIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSES 287 (458)
T ss_pred heeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcc
Confidence 9999999999886322111100 0 001111234467899999987777788899999999999999888764322211
Q ss_pred Cc-chhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 620 TA-DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 620 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. .+......+ .. +.. ..=..++.+|++..|..||+|.+++..
T Consensus 288 ~~~~ee~ia~~i-~~-----len-----------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 288 KVEVEENIANVI-IG-----LEN-----------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred eeehhhhhhhhe-ee-----ccC-----------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 11 111111000 00 000 111245566999999999999988753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.2e-11 Score=119.06 Aligned_cols=78 Identities=26% Similarity=0.448 Sum_probs=68.4
Q ss_pred EEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEe
Q 038002 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 476 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
.++...+..++||||++|++|.+++.... . ++..++.+++.+|++||+. +++|+|++|.||+++ ++.++|+
T Consensus 66 ~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~li 136 (211)
T PRK14879 66 VYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLI 136 (211)
T ss_pred EEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEE
Confidence 44556678899999999999999986533 1 7888999999999999999 999999999999999 7899999
Q ss_pred cccceee
Q 038002 556 DFGLAKL 562 (702)
Q Consensus 556 Dfg~a~~ 562 (702)
|||.+..
T Consensus 137 Df~~a~~ 143 (211)
T PRK14879 137 DFGLAEF 143 (211)
T ss_pred ECCcccC
Confidence 9998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.9e-11 Score=133.80 Aligned_cols=75 Identities=27% Similarity=0.445 Sum_probs=65.7
Q ss_pred EEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEE
Q 038002 475 LVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKI 554 (702)
Q Consensus 475 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 554 (702)
..+...+...++||||+++++|.+++. ....++.|++++|++||+. +|+||||||+||++ +++.++|
T Consensus 402 ~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~l 468 (535)
T PRK09605 402 VIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYL 468 (535)
T ss_pred EEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEE
Confidence 344555667899999999999999885 3567899999999999999 99999999999999 5779999
Q ss_pred ecccceee
Q 038002 555 SDFGLAKL 562 (702)
Q Consensus 555 ~Dfg~a~~ 562 (702)
+|||+++.
T Consensus 469 iDFGla~~ 476 (535)
T PRK09605 469 IDFGLGKY 476 (535)
T ss_pred EeCccccc
Confidence 99999875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.4e-11 Score=116.19 Aligned_cols=74 Identities=26% Similarity=0.429 Sum_probs=64.1
Q ss_pred EEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 477 YKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 477 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
++...+..++||||++|++|.+++..... .++.+++.+|++||+. +++|+|++|+||+++ ++.++++|
T Consensus 65 ~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liD 132 (199)
T TIGR03724 65 YDVDPDNKTIVMEYIEGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLID 132 (199)
T ss_pred EEEECCCCEEEEEEECCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEE
Confidence 33456677999999999999998754321 7899999999999999 999999999999999 78999999
Q ss_pred ccceee
Q 038002 557 FGLAKL 562 (702)
Q Consensus 557 fg~a~~ 562 (702)
||++..
T Consensus 133 fg~a~~ 138 (199)
T TIGR03724 133 FGLGKY 138 (199)
T ss_pred CCCCcC
Confidence 998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-10 Score=114.02 Aligned_cols=73 Identities=21% Similarity=0.230 Sum_probs=62.9
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
...++||||++|++|.++... .....++.+++.++.++|+. +|+|+||||+||++++++.++|+|||++.
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~ 173 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMV 173 (198)
T ss_pred CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCccc
Confidence 456999999999999876431 33567889999999999999 99999999999999999999999999997
Q ss_pred ecC
Q 038002 562 LLM 564 (702)
Q Consensus 562 ~~~ 564 (702)
...
T Consensus 174 ~~~ 176 (198)
T cd05144 174 STD 176 (198)
T ss_pred cCC
Confidence 553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.4e-10 Score=110.87 Aligned_cols=83 Identities=18% Similarity=0.141 Sum_probs=65.3
Q ss_pred eeeEEEEEecCC---eeE-EEEec--CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HhhhhcCCCCeEecCCCCCc
Q 038002 471 ISSLLVYKHRSS---KKL-LVYEF--MSKGSLADLLFNLETRPLWRDRVRIALDVARGL-LYLHDECEVQIIHCDIKLRN 543 (702)
Q Consensus 471 i~~l~~~~~~~~---~~~-lV~e~--~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL-~~LH~~~~~~ivH~dlkp~N 543 (702)
|++++++++++. ..+ +|+|| +++++|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|
T Consensus 63 Ivr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~N 135 (210)
T PRK10345 63 IPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQN 135 (210)
T ss_pred cceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHH
Confidence 788888888763 434 78999 6679999999663 35444 35678888777 999999 99999999999
Q ss_pred EEEeC----CCcEEEecccce
Q 038002 544 ILIDD----SWRAKISDFGLA 560 (702)
Q Consensus 544 Ill~~----~~~~kl~Dfg~a 560 (702)
||++. +..++|+|++.+
T Consensus 136 ILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEeccCCCCCcEEEEECCCC
Confidence 99974 347999995433
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-10 Score=90.71 Aligned_cols=55 Identities=31% Similarity=0.372 Sum_probs=44.6
Q ss_pred eeeEEeeeccCCCCcccc--ccCCHHhhhhhccCCceeeEEEec----CCceeeccccccc
Q 038002 355 YNITSLKITWLGGLPYAK--LSVSKKDCSKSCLNDCYFGAAFYS----DGACSKHKFPLMF 409 (702)
Q Consensus 355 ~~~~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~----~~~C~~~~~~l~~ 409 (702)
++|.+++.+++|+..... ...++++|+++||+||||+||+|. +++|+.|.+.|.+
T Consensus 5 d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 5 DGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 467777788888875443 235999999999999999999995 3789999988765
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.4e-10 Score=94.13 Aligned_cols=72 Identities=19% Similarity=0.269 Sum_probs=57.3
Q ss_pred eeeeEEeeeccCCCCccccccCCHHhhhhhccCCceeeEEEec--CCceeecccccccccccCCccceEEEeec
Q 038002 354 FYNITSLKITWLGGLPYAKLSVSKKDCSKSCLNDCYFGAAFYS--DGACSKHKFPLMFATKDQYASAILFIKWS 425 (702)
Q Consensus 354 ~~~~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~~l~~~~~~~~~~~~~~lKv~ 425 (702)
...|..+..+++++..+.....++++|++.||+||+|.||+|. +++|++|..++.+.......+..+|||++
T Consensus 11 ~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 3467788888888776544334999999999999999999995 58999999888886655444678999974
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.8e-10 Score=108.59 Aligned_cols=74 Identities=22% Similarity=0.268 Sum_probs=59.2
Q ss_pred eeEEEEecCCCCCHHHH-hhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 483 KKLLVYEFMSKGSLADL-LFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~-l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
..++||||++++++... +.... . ..++..++.+++.++.++|. . +|+|+||||+||+++ ++.++|+|||.+
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg~a 161 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVPQA 161 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECccc
Confidence 46899999999543321 11111 1 15678899999999999999 8 999999999999999 889999999999
Q ss_pred eec
Q 038002 561 KLL 563 (702)
Q Consensus 561 ~~~ 563 (702)
...
T Consensus 162 ~~~ 164 (187)
T cd05119 162 VEI 164 (187)
T ss_pred ccc
Confidence 754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.9e-09 Score=98.13 Aligned_cols=85 Identities=24% Similarity=0.280 Sum_probs=71.8
Q ss_pred heeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 470 AISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 470 ki~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
.+.+++.+...++..+++|||++++.+..+ +......++.+++++|++||.....+++|+|++|+||++++.
T Consensus 54 ~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 54 PVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred CCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 366777777778899999999998877654 456667788999999999999644479999999999999998
Q ss_pred CcEEEecccceee
Q 038002 550 WRAKISDFGLAKL 562 (702)
Q Consensus 550 ~~~kl~Dfg~a~~ 562 (702)
+.++++||+.+..
T Consensus 126 ~~~~l~Df~~~~~ 138 (155)
T cd05120 126 KILGIIDWEYAGY 138 (155)
T ss_pred cEEEEEecccccC
Confidence 9999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.89 E-value=7.3e-09 Score=92.10 Aligned_cols=88 Identities=26% Similarity=0.445 Sum_probs=67.1
Q ss_pred eEEEccCCcEEEEcCC-CCeeeeeccccC-CcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEee
Q 038002 92 TLALTMDGKLILKTEE-SKEKPIADLVFD-EPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSS 169 (702)
Q Consensus 92 ~l~~~~~g~L~l~~~~-~~~~w~~~~~~~-~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S~ 169 (702)
++.++.||+||+++.. +.++|++++... .....+.|+++|||||++.++.++|+| .++
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S--~t~------------------ 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSS--NTT------------------ 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEe--ccc------------------
Confidence 5667889999999765 478999987432 234789999999999999988999998 110
Q ss_pred ccCCCCcccceEeeeccCCceeeeeccccccccceeecCC
Q 038002 170 VTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANG 209 (702)
Q Consensus 170 ~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g 209 (702)
...|.+.+.|+.+|++++|.. ...+.|++.
T Consensus 83 -----~~~~~~~~~L~ddGnlvl~~~-----~~~~~W~Sf 112 (114)
T smart00108 83 -----GANGNYVLVLLDDGNLVIYDS-----DGNFLWQSF 112 (114)
T ss_pred -----CCCCceEEEEeCCCCEEEECC-----CCCEEeCCC
Confidence 135678999999999999832 224678764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.7e-09 Score=105.64 Aligned_cols=71 Identities=21% Similarity=0.228 Sum_probs=60.3
Q ss_pred eEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 484 KLLVYEFMSK-GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 484 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.++|||+++| .+|.+++... .++.. .+.||+.+|++||++ ||+|+||||+|||++.++.++|+|||.+..
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 121 ADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 3599999997 6999998653 34433 357899999999999 999999999999999989999999998875
Q ss_pred c
Q 038002 563 L 563 (702)
Q Consensus 563 ~ 563 (702)
.
T Consensus 192 ~ 192 (239)
T PRK01723 192 R 192 (239)
T ss_pred C
Confidence 3
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.2e-08 Score=90.94 Aligned_cols=89 Identities=25% Similarity=0.428 Sum_probs=67.9
Q ss_pred eEEEcc-CCcEEEEcCC-CCeeeeecccc-CCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 92 TLALTM-DGKLILKTEE-SKEKPIADLVF-DEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 92 ~l~~~~-~g~L~l~~~~-~~~~w~~~~~~-~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
++.++. ||+||+++.. +.++|++++.. ......+.|+++|||||++.++.++|+|=- .
T Consensus 23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~--~----------------- 83 (116)
T cd00028 23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNT--T----------------- 83 (116)
T ss_pred cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecc--c-----------------
Confidence 455676 9999999765 47899998753 245678999999999999998999999811 0
Q ss_pred eccCCCCcccceEeeeccCCceeeeeccccccccceeecCCc
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGT 210 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~ 210 (702)
. +.+.+.+.|+.+|++++|... ..+.|++..
T Consensus 84 -----~-~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~ 114 (116)
T cd00028 84 -----R-VNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFD 114 (116)
T ss_pred -----C-CCCceEEEEeCCCCEEEECCC-----CCEEEcCCC
Confidence 0 257789999999999998432 356788653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.1e-08 Score=111.39 Aligned_cols=186 Identities=22% Similarity=0.197 Sum_probs=138.0
Q ss_pred EEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR----GLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 474 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~----aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
....++.++..++-+|.+. .+|.++.......++....+..+.+..+ ||.++|.. +++|-|+||.||+...+
T Consensus 183 ~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~ 258 (524)
T KOG0601|consen 183 DSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSD 258 (524)
T ss_pred cCcccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccc
Confidence 4456678899999999995 6888888776655788888888888888 99999999 99999999999999988
Q ss_pred -CcEEEecccceeecCCCCCc----eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 550 -WRAKISDFGLAKLLMPNQTG----IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 550 -~~~kl~Dfg~a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
...+++|||+...+...... ......|...|++||..+ ..++.+.|||++|.++.+..++..+....-..
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---- 333 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS---- 333 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC----
Confidence 88999999999987654421 122345778899999765 46789999999999999999988776433100
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl 677 (702)
.|....... +..++......++...+..|++.+|..|++.+.+.
T Consensus 334 -----~W~~~r~~~----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 334 -----SWSQLRQGY----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred -----Ccccccccc----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 111111111 11122222344455588889999999999877665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.1e-09 Score=120.24 Aligned_cols=181 Identities=20% Similarity=0.190 Sum_probs=134.7
Q ss_pred ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccc
Q 038002 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFG 558 (702)
Q Consensus 479 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 558 (702)
.-....+||++|+.+++|...|+..+ ..+.+.+......+.+++++||.. .+.|+|++|.|++...++..++.||+
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence 34778899999999999999998766 455555666777889999999998 79999999999999999999999998
Q ss_pred ceeecCC---------------------CC---------CceeeceeccccccCcccccCCCCCccccccchhHhHHHhh
Q 038002 559 LAKLLMP---------------------NQ---------TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608 (702)
Q Consensus 559 ~a~~~~~---------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 608 (702)
....... .. ........+|+.|.+||...+......+|+|++|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 4332110 00 01112356899999999999999999999999999999999
Q ss_pred hCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038002 609 CCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMK 674 (702)
Q Consensus 609 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ 674 (702)
+|..||....... +.+.+..+.+.-. ..+.+...+..+++.+.+..+|.+|-.+.
T Consensus 1030 ~g~pp~na~tpq~--------~f~ni~~~~~~~p---~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQ--------IFENILNRDIPWP---EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCCCCCcchhh--------hhhccccCCCCCC---CCccccChhhhhhhhhhhccCchhccCcc
Confidence 9999997542111 1122222222111 23444556677777778899999997766
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-08 Score=83.33 Aligned_cols=63 Identities=11% Similarity=0.065 Sum_probs=48.2
Q ss_pred eEEeeeccCCCCccccccCCHHhhhhhccC---CceeeEEEec--CCceeeccccc-ccccccCCccceEEEe
Q 038002 357 ITSLKITWLGGLPYAKLSVSKKDCSKSCLN---DCYFGAAFYS--DGACSKHKFPL-MFATKDQYASAILFIK 423 (702)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~l-~~~~~~~~~~~~~~lK 423 (702)
|.++..++.|+... .+++||+++|++ ||+|.||+|. +++|..|..++ .+.+.....+..+|+|
T Consensus 11 fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 11 TLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred EEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 34444455554432 489999999999 9999999994 45899999999 7776666567788887
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-07 Score=98.80 Aligned_cols=193 Identities=13% Similarity=0.148 Sum_probs=125.1
Q ss_pred eEEEEecCCCCC-HHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecc
Q 038002 484 KLLVYEFMSKGS-LADLLFNLE-----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDF 557 (702)
Q Consensus 484 ~~lV~e~~~~gs-L~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 557 (702)
.-++|+.+++.. ...++.-.. ....|.-.++.++.++.+.+.||.+ |.+-||+.++|+|+.+++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 667777776642 222221111 1267899999999999999999999 9999999999999999999999986
Q ss_pred cceeecCCCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhC-CcCCcCCCCCc-----chhhh
Q 038002 558 GLAKLLMPNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICC-RSNFEVNVSTA-----DEVLL 626 (702)
Q Consensus 558 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~-----~~~~~ 626 (702)
..-... ..........|...|.+||.-. +-.-+...|.|.||+++++++.| ++||....... .+..+
T Consensus 162 Dsfqi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I 239 (637)
T COG4248 162 DSFQIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI 239 (637)
T ss_pred cceeec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence 554443 1222234466889999999543 33456789999999999999987 99997642211 11111
Q ss_pred HH--HHHHhh-hccccccccccccC-HHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHhCC
Q 038002 627 ST--WVYNCF-VAGEFNKLVEEEVD-KITLERMVKTGLLCIQD--EPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 627 ~~--~~~~~~-~~~~~~~~~~~~~~-~~~~~~l~~li~~cL~~--dP~~RPt~~evl~~Le~~ 683 (702)
.. +.+... ..+..... .+.+ ......+..+..+|+.. ++.-|||++..+..|..+
T Consensus 240 a~g~f~ya~~~~~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hcceeeechhccCCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 11 111110 01111110 0111 12344556666677754 467899999998888654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.3e-08 Score=108.90 Aligned_cols=78 Identities=26% Similarity=0.317 Sum_probs=61.9
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR-GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~-aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
.+..+|||||++|++|.++........ ....++.+++. .+..+|.. |++|+|+||.||+++.++.++++|||+
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~ 303 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGI 303 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCC
Confidence 445689999999999998875332122 23456666665 46788998 999999999999999999999999999
Q ss_pred eeecC
Q 038002 560 AKLLM 564 (702)
Q Consensus 560 a~~~~ 564 (702)
+..+.
T Consensus 304 ~~~l~ 308 (437)
T TIGR01982 304 VGRLS 308 (437)
T ss_pred eeECC
Confidence 98764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=5.6e-08 Score=107.27 Aligned_cols=154 Identities=18% Similarity=0.197 Sum_probs=102.7
Q ss_pred HHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee--------eceeccccccCcc
Q 038002 513 VRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV--------AGVRGSRGYMAPE 584 (702)
Q Consensus 513 ~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~--------~~~~gt~~y~aPE 584 (702)
..=+.+++.|+.|+|.. .++||++|.|++|.++.++..||+.|+++........... .-..-...|.|||
T Consensus 102 f~nl~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE 179 (700)
T KOG2137|consen 102 FANLGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPE 179 (700)
T ss_pred hhhhhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccch
Confidence 33345666999999998 5999999999999999999999999998876543111100 1122456799999
Q ss_pred cccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcc
Q 038002 585 WQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCI 663 (702)
Q Consensus 585 ~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL 663 (702)
++.+...+.++|+||+|+++|.+.. |+.-+....... ...... ...+.. ..-+..+.+.++.+=+.+++
T Consensus 180 ~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~------~~~~~~---~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 180 YLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSR------NLLNAG---AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred hhccccccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhh------cccccc---cccccccCcHHHHHHHHHHh
Confidence 9998888999999999999999994 544443321111 000000 000000 01122344556666666789
Q ss_pred cCCCCCCCCHHHHHH
Q 038002 664 QDEPNLRPSMKNVIL 678 (702)
Q Consensus 664 ~~dP~~RPt~~evl~ 678 (702)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999997776543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.9e-07 Score=89.34 Aligned_cols=84 Identities=17% Similarity=0.181 Sum_probs=63.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHhh-hhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLAD-LLFNLETRPLWRDRVRIALDVARGLLYL-HDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~~~~~ivH~dlkp~NIll~~ 548 (702)
+.+.+.. ...+|||||+.+..+.. .+++. .++..+...+..+++.+|..| |+. +|+||||++.||++++
T Consensus 90 vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~NIL~~~ 160 (197)
T cd05146 90 CPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYNMLWHD 160 (197)
T ss_pred CCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEC
Confidence 4555543 56789999997654422 22221 344556677889999999998 888 9999999999999974
Q ss_pred CCcEEEecccceeecC
Q 038002 549 SWRAKISDFGLAKLLM 564 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~ 564 (702)
+.+.|+|||.+....
T Consensus 161 -~~v~iIDF~qav~~~ 175 (197)
T cd05146 161 -GKVWFIDVSQSVEPT 175 (197)
T ss_pred -CcEEEEECCCceeCC
Confidence 689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.8e-07 Score=89.38 Aligned_cols=71 Identities=23% Similarity=0.220 Sum_probs=54.7
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC--CCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC--EVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
+..++||||++|.++.+.- .....++.+++++|+.||... ..+++|+|++|.||+++ ++.++++||+.
T Consensus 64 ~~~~lv~e~i~G~~l~~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~ 133 (170)
T cd05151 64 ETGVLITEFIEGSELLTED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEY 133 (170)
T ss_pred CCCeEEEEecCCCcccccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccc
Confidence 3468999999998876530 111345678999999999982 12359999999999999 66899999998
Q ss_pred eee
Q 038002 560 AKL 562 (702)
Q Consensus 560 a~~ 562 (702)
+..
T Consensus 134 a~~ 136 (170)
T cd05151 134 AGM 136 (170)
T ss_pred ccC
Confidence 763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=5e-07 Score=84.89 Aligned_cols=75 Identities=29% Similarity=0.447 Sum_probs=64.2
Q ss_pred EEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEe
Q 038002 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 476 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
.++-+.+...|+|||++|..|.+.+... ...++..+-.-+.-||.. ||+|+||.++||++.... +.++
T Consensus 66 v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 66 VYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred EEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEE
Confidence 3455677888999999999999998654 256777888889999999 999999999999998764 9999
Q ss_pred cccceee
Q 038002 556 DFGLAKL 562 (702)
Q Consensus 556 Dfg~a~~ 562 (702)
|||++..
T Consensus 134 DfGLg~~ 140 (204)
T COG3642 134 DFGLGEF 140 (204)
T ss_pred ECCcccc
Confidence 9999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.4e-06 Score=96.08 Aligned_cols=129 Identities=17% Similarity=0.227 Sum_probs=97.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|.+++...+.++..|||+|-+. .|..++++.. .......+.||+.||.|||..| +++|++|.-..|+|+..|
T Consensus 71 Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~G 142 (690)
T KOG1243|consen 71 ILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESG 142 (690)
T ss_pred hhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCC
Confidence 7788888899999999999994 5777776543 5666677899999999998764 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhC
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICC 610 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG 610 (702)
.-||++|..+........ ......---.|..|+.+.... -..|.|-||++++|++.|
T Consensus 143 eWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 143 EWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 999999988764322111 011111222466666443221 456999999999999998
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=1.4e-06 Score=89.28 Aligned_cols=78 Identities=19% Similarity=0.193 Sum_probs=65.9
Q ss_pred CeeEEEEecCCCC-CHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-------CCcE
Q 038002 482 SKKLLVYEFMSKG-SLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-------SWRA 552 (702)
Q Consensus 482 ~~~~lV~e~~~~g-sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-------~~~~ 552 (702)
...+||||++++. +|.+++... ....+......++.+++..++-||.. ||+|+|+++.|||++. +..+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence 4678999999986 899998642 22456677788999999999999999 9999999999999975 4679
Q ss_pred EEecccceee
Q 038002 553 KISDFGLAKL 562 (702)
Q Consensus 553 kl~Dfg~a~~ 562 (702)
.|+||+.+..
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.2e-07 Score=101.31 Aligned_cols=183 Identities=21% Similarity=0.162 Sum_probs=126.3
Q ss_pred EEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-CcEEE
Q 038002 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS-WRAKI 554 (702)
Q Consensus 476 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl 554 (702)
..+......|+=-||++++++...+.- ...+++..++.+..|++.++.++|+. .++|+|+||+||++..+ +.-++
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~ 408 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKL 408 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhc
Confidence 334445566799999999998887732 22477888899999999999999998 99999999999999876 78899
Q ss_pred ecccceeecCCCCCceeeceeccccc-cCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHh
Q 038002 555 SDFGLAKLLMPNQTGIVAGVRGSRGY-MAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 555 ~Dfg~a~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
.||+.+..+.-.. ......+..| .+++......+..++|++|||.-+.|.+++..--.... .+..
T Consensus 409 ~~~~~~t~~~~~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----------~~~~ 474 (524)
T KOG0601|consen 409 GDFGCWTRLAFSS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----------QSLT 474 (524)
T ss_pred cccccccccceec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----------ccee
Confidence 9999886432111 1111223334 35555566788899999999999999998875432210 0001
Q ss_pred hhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 634 FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
+..+... ..+ ...+.+..+.+.++..++..||.+.++..+.+-
T Consensus 475 i~~~~~p-----~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 475 IRSGDTP-----NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eeccccc-----CCC-chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 1111111 111 122556666667999999999999888776654
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=1.7e-06 Score=80.88 Aligned_cols=84 Identities=21% Similarity=0.324 Sum_probs=67.6
Q ss_pred EEEecCCeeEEEEecCCC-CCHHHHhhcCCCCCCHHHH-HHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc--
Q 038002 476 VYKHRSSKKLLVYEFMSK-GSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR-- 551 (702)
Q Consensus 476 ~~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~-~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-- 551 (702)
.+|-+...-.|+|||++| .++.+++..........+. ..++..|-+.+.-||.+ +|+||||..+||++..++.
T Consensus 77 l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~ 153 (229)
T KOG3087|consen 77 LIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQI 153 (229)
T ss_pred EEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcC
Confidence 455666677899999987 5888888766544444444 78899999999999999 9999999999999966553
Q ss_pred -EEEecccceee
Q 038002 552 -AKISDFGLAKL 562 (702)
Q Consensus 552 -~kl~Dfg~a~~ 562 (702)
+.++|||++..
T Consensus 154 ~~~lIdfgls~~ 165 (229)
T KOG3087|consen 154 TPILIDFGLSSV 165 (229)
T ss_pred ceEEEeecchhc
Confidence 58999999864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.29 E-value=7.9e-06 Score=72.38 Aligned_cols=100 Identities=23% Similarity=0.255 Sum_probs=70.2
Q ss_pred CeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEe-cCCCCCCCCCceEEEccCCcEEEEcCCCCeeeeeccccCC
Q 038002 42 HSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTA-NRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDE 120 (702)
Q Consensus 42 ~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~A-n~~~~~~~~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~ 120 (702)
+.+.+.+|.+.|-|..+|+. -| |. ...+++|.. +..... ...+.++|+.||||||+|..+.++|.|.. ..
T Consensus 12 ~p~~~~s~~~~L~l~~dGnL---vl-~~--~~~~~iWss~~t~~~~-~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~--~p 82 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGNL---VL-YD--SNGSVIWSSNNTSGRG-NSGCYLVLQDDGNLVLYDSSGNVLWQSFD--YP 82 (114)
T ss_dssp EEEEECETTEEEEEETTSEE---EE-EE--TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTT--SS
T ss_pred cccccccccccceECCCCeE---EE-Ec--CCCCEEEEecccCCcc-ccCeEEEEeCCCCEEEEeecceEEEeecC--CC
Confidence 45656558899999988863 22 22 235779999 433321 15789999999999999998999999843 45
Q ss_pred cceeEEEec--CcCEEEeecCCceEeeecCCCc
Q 038002 121 PASFASMLD--SGNFVLYSNRSGIIWESFSTPT 151 (702)
Q Consensus 121 ~~~~~~l~d--~Gnlvl~~~~~~~~WqSFd~PT 151 (702)
..+.+..++ +||++ +.....+.|.|=+.|+
T Consensus 83 tdt~L~~q~l~~~~~~-~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 83 TDTLLPGQKLGDGNVT-GKNDSLTSWSSNTDPS 114 (114)
T ss_dssp S-EEEEEET--TSEEE-EESTSSEEEESS----
T ss_pred ccEEEeccCcccCCCc-cccceEEeECCCCCCC
Confidence 677888888 99999 8777889999866653
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.4e-06 Score=84.52 Aligned_cols=78 Identities=28% Similarity=0.315 Sum_probs=67.5
Q ss_pred CeeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC---cEEEecc
Q 038002 482 SKKLLVYEFMSKG-SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW---RAKISDF 557 (702)
Q Consensus 482 ~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Df 557 (702)
...+||+|++++. +|.+++.... ..+......++.++++.++-||++ ||+|+|+++.|||++.+. .+.++||
T Consensus 90 ~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDl 165 (206)
T PF06293_consen 90 YRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDL 165 (206)
T ss_pred eeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcc
Confidence 3568999999984 8999997644 266677888999999999999999 999999999999998887 8999999
Q ss_pred cceeec
Q 038002 558 GLAKLL 563 (702)
Q Consensus 558 g~a~~~ 563 (702)
+.++..
T Consensus 166 d~~~~~ 171 (206)
T PF06293_consen 166 DRMRFR 171 (206)
T ss_pred hhceeC
Confidence 987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.02 E-value=7.6e-06 Score=79.17 Aligned_cols=83 Identities=24% Similarity=0.324 Sum_probs=53.9
Q ss_pred eeeEEEEEecCCeeEEEEecCC--CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHh-hhhcCCCCeEecCCCCCcEEEe
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMS--KGSLADLLFNLETRPLWRDRVRIALDVARGLLY-LHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~-LH~~~~~~ivH~dlkp~NIll~ 547 (702)
+.+.+.+. ..+|||||++ |..+..+.... ++..+...++.+++..+.. +|.. ||+||||.+.||+++
T Consensus 72 vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~ 141 (188)
T PF01163_consen 72 VPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVD 141 (188)
T ss_dssp S--EEEEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEE
T ss_pred CCcEEEEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEee
Confidence 45554332 4579999998 65555443221 1134556677888885555 5788 999999999999999
Q ss_pred CCCcEEEecccceeecC
Q 038002 548 DSWRAKISDFGLAKLLM 564 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~ 564 (702)
++ .+.|+|||.+....
T Consensus 142 ~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TT-CEEE--GTTEEETT
T ss_pred cc-eEEEEecCcceecC
Confidence 88 99999999887653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=97.96 E-value=1.7e-05 Score=79.13 Aligned_cols=90 Identities=23% Similarity=0.283 Sum_probs=68.0
Q ss_pred eeeEEEEEecC---CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----------------
Q 038002 471 ISSLLVYKHRS---SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC----------------- 530 (702)
Q Consensus 471 i~~l~~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----------------- 530 (702)
+.+++.+.... +..++||||++|.+|.+.+.. ..++..+...++.++++.|+.||+..
T Consensus 59 vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~ 136 (223)
T cd05154 59 VPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLE 136 (223)
T ss_pred CCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHH
Confidence 34455555443 367999999999988876542 24677777788888888888888521
Q ss_pred ------------------------------------CCCeEecCCCCCcEEEeC--CCcEEEecccceee
Q 038002 531 ------------------------------------EVQIIHCDIKLRNILIDD--SWRAKISDFGLAKL 562 (702)
Q Consensus 531 ------------------------------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~ 562 (702)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 137 RQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999988 56789999987764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=97.94 E-value=2e-05 Score=88.16 Aligned_cols=75 Identities=23% Similarity=0.188 Sum_probs=54.4
Q ss_pred CCeeEEEEecCCCCCHHHHh--hcCCC---CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC----c
Q 038002 481 SSKKLLVYEFMSKGSLADLL--FNLET---RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW----R 551 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l--~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~ 551 (702)
....+|||||++|+.|.++- ...+. .+....+..++.|+ +.. |++|+|+||.||+++.++ +
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~---GffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRD---GFFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhC---CeeeCCCChHHeEEecCCCCCCe
Confidence 56778999999999998753 22211 12222333344444 346 999999999999999888 9
Q ss_pred EEEecccceeecCC
Q 038002 552 AKISDFGLAKLLMP 565 (702)
Q Consensus 552 ~kl~Dfg~a~~~~~ 565 (702)
++++|||+...+..
T Consensus 303 i~llDFGivg~l~~ 316 (537)
T PRK04750 303 YIALDFGIVGSLNK 316 (537)
T ss_pred EEEEecceEEECCH
Confidence 99999999987643
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.86 E-value=3.2e-05 Score=63.20 Aligned_cols=67 Identities=22% Similarity=0.254 Sum_probs=44.6
Q ss_pred eeEEeeeccCCCCcccc-ccCCHHhhhhhccC-CceeeEEEec--CCceeecc-cccccccccCCccceEEE
Q 038002 356 NITSLKITWLGGLPYAK-LSVSKKDCSKSCLN-DCYFGAAFYS--DGACSKHK-FPLMFATKDQYASAILFI 422 (702)
Q Consensus 356 ~~~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~~~~~~~~~~~~~l 422 (702)
.|..++++.+++..... ...++++|++.|++ +|+|.||.|. ++.|.+|. .++.+.......+..+|.
T Consensus 5 ~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~~~~~~~~~~y~ 76 (78)
T smart00473 5 CFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDARLFPSGGVDLYE 76 (78)
T ss_pred eeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccceecccCCceeEE
Confidence 45566666666443322 22399999999999 9999999995 67999998 555554433333334443
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.74 E-value=4.2e-05 Score=74.85 Aligned_cols=68 Identities=21% Similarity=0.216 Sum_probs=53.9
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
....+|||||++|..|.+... +++ .+...+.+++.-||+. |++|+|.+|.|+++++++ ++++||+..
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k 181 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGK 181 (229)
T ss_pred eeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccc
Confidence 456679999999988876542 222 2445677889999999 999999999999998654 999999865
Q ss_pred e
Q 038002 561 K 561 (702)
Q Consensus 561 ~ 561 (702)
+
T Consensus 182 ~ 182 (229)
T PF06176_consen 182 R 182 (229)
T ss_pred c
Confidence 4
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00034 Score=75.34 Aligned_cols=113 Identities=21% Similarity=0.316 Sum_probs=89.4
Q ss_pred cCCeeEEEEecCCC-CCHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 480 RSSKKLLVYEFMSK-GSLADLLFNLE--------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 480 ~~~~~~lV~e~~~~-gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
.+..++|||+|+++ ++|.++.+... .+.++...+.++.|+..||.++|+. |+.-+-|.|.+|
T Consensus 348 ~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kI 424 (655)
T KOG3741|consen 348 GDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKI 424 (655)
T ss_pred CcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHe
Confidence 46788999999986 68888765321 2356889999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcC
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSN 613 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~P 613 (702)
+++.+.+++|+..|....+..+.. |-+. --.+-|.=.||.+++.|.||...
T Consensus 425 lv~G~~RIriS~C~i~Dvl~~d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 425 LVTGKMRIRISGCGIMDVLQEDPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred EeeCcceEEEecccceeeecCCCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 999999999998888776644431 1111 12456888899999999999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.59 E-value=7.4e-05 Score=74.67 Aligned_cols=73 Identities=18% Similarity=0.131 Sum_probs=53.2
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
-++..+|||+++|-.|...- ++.+..-.++..|++-+.-+-.. ||+|||+++-||+++++|.+.++||--+
T Consensus 179 ~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 179 WNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred cccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCEEEEeCccc
Confidence 56778999999996665432 22333444555555555544455 9999999999999999999999999765
Q ss_pred ee
Q 038002 561 KL 562 (702)
Q Consensus 561 ~~ 562 (702)
..
T Consensus 250 v~ 251 (304)
T COG0478 250 VP 251 (304)
T ss_pred cc
Confidence 53
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00032 Score=68.53 Aligned_cols=79 Identities=22% Similarity=0.119 Sum_probs=66.0
Q ss_pred CCeeEEEEecCCC-CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc--EEEec
Q 038002 481 SSKKLLVYEFMSK-GSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR--AKISD 556 (702)
Q Consensus 481 ~~~~~lV~e~~~~-gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~D 556 (702)
.-+.+||+|-+++ -+|.+++.+.. .+.+..+...++.++++.++-||+. |+.|+|+-+.||+++.++. ++++|
T Consensus 97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEE
Confidence 3457899998864 59999886543 2567778889999999999999999 9999999999999986677 99999
Q ss_pred ccceee
Q 038002 557 FGLAKL 562 (702)
Q Consensus 557 fg~a~~ 562 (702)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 986653
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.00098 Score=53.85 Aligned_cols=30 Identities=23% Similarity=0.320 Sum_probs=26.5
Q ss_pred CHHhhhhhccCCceeeEEEec--CCceeeccc
Q 038002 376 SKKDCSKSCLNDCYFGAAFYS--DGACSKHKF 405 (702)
Q Consensus 376 s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 405 (702)
+.++|++.|+.||+|.||.|. .+.|+.+..
T Consensus 26 s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 26 SAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 899999999999999999994 468988754
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0035 Score=60.89 Aligned_cols=87 Identities=25% Similarity=0.317 Sum_probs=66.9
Q ss_pred eeEEEEEecCCeeEEEEecCCCCCHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 472 SSLLVYKHRSSKKLLVYEFMSKGSLADL---LFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 472 ~~l~~~~~~~~~~~lV~e~~~~gsL~~~---l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
.++++.+ ..++|.||...+++... +.+. ...+|..+.+|+.++++.+.+|+......+.-.|++|+|+-+++
T Consensus 23 pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~ 97 (188)
T PF12260_consen 23 PKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVND 97 (188)
T ss_pred CCeeeEC----CCEEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeC
Confidence 4555555 23678999987765432 1111 14789999999999999999999854447999999999999999
Q ss_pred CCcEEEecccceeec
Q 038002 549 SWRAKISDFGLAKLL 563 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~ 563 (702)
++++|++|...+...
T Consensus 98 ~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 98 DGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEEechhcchh
Confidence 999999999877644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0031 Score=70.46 Aligned_cols=84 Identities=20% Similarity=0.292 Sum_probs=59.5
Q ss_pred EEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 477 YKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 477 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
+.+-.+..+|+|||++|-.+.++........+.........++. +..+-.. |++|.|.+|.||+++.++++.+.|
T Consensus 234 ~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 234 YWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD---GFFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred ehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc---CccccCCCccceEEecCCcEEEEc
Confidence 34447888999999999999998543333455333332222211 2222224 999999999999999999999999
Q ss_pred ccceeecCC
Q 038002 557 FGLAKLLMP 565 (702)
Q Consensus 557 fg~a~~~~~ 565 (702)
||+...+..
T Consensus 309 fGi~g~l~~ 317 (517)
T COG0661 309 FGIVGRLDP 317 (517)
T ss_pred CcceecCCH
Confidence 999887643
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.004 Score=69.31 Aligned_cols=84 Identities=19% Similarity=0.198 Sum_probs=59.4
Q ss_pred EEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC----CCcE
Q 038002 477 YKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD----SWRA 552 (702)
Q Consensus 477 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~----~~~~ 552 (702)
+..-....+|+||||+|..+.|.-.-....++...+..-+.+...-+-+ .. |++|+|-+|.||++.. ++.+
T Consensus 270 y~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf--~~---GffHaDPHPGNilv~~~~~~~~~i 344 (538)
T KOG1235|consen 270 YWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIF--KT---GFFHADPHPGNILVRPNPEGDEEI 344 (538)
T ss_pred hhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHH--hc---CCccCCCCCCcEEEecCCCCCccE
Confidence 3444678899999999998887654444456666544433333222222 22 8999999999999984 6789
Q ss_pred EEecccceeecCC
Q 038002 553 KISDFGLAKLLMP 565 (702)
Q Consensus 553 kl~Dfg~a~~~~~ 565 (702)
.+.|||+...+..
T Consensus 345 vllDhGl~~~is~ 357 (538)
T KOG1235|consen 345 VLLDHGLYAVISH 357 (538)
T ss_pred EEEcccccccccH
Confidence 9999999887643
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.01 Score=60.30 Aligned_cols=30 Identities=27% Similarity=0.339 Sum_probs=26.6
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
..++|+|+.|.||+++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 369999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0063 Score=60.50 Aligned_cols=77 Identities=22% Similarity=0.220 Sum_probs=56.3
Q ss_pred CeeEEEEecCCCCC-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 482 SKKLLVYEFMSKGS-LADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 482 ~~~~lV~e~~~~gs-L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
.+-.|||||+.... -.-.|+.. .+...+...+..++++.+.-|-. . ++||+||+.=|||+. ++.+.|+|++-
T Consensus 139 ~~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~Q 212 (268)
T COG1718 139 RNNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQ 212 (268)
T ss_pred cCCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE-CCeEEEEECcc
Confidence 34579999995431 11112111 23334677788899999988877 5 999999999999999 78999999998
Q ss_pred eeecC
Q 038002 560 AKLLM 564 (702)
Q Consensus 560 a~~~~ 564 (702)
|....
T Consensus 213 aV~~~ 217 (268)
T COG1718 213 AVTID 217 (268)
T ss_pred ccccC
Confidence 87653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.023 Score=57.02 Aligned_cols=29 Identities=17% Similarity=0.232 Sum_probs=25.8
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
..++|+|+.|.||++++++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 3678999999999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.026 Score=56.26 Aligned_cols=31 Identities=39% Similarity=0.446 Sum_probs=21.8
Q ss_pred CCeEecCCCCCcEEEe-CCCcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILID-DSWRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~ 562 (702)
..++|+|+.|.||+++ +++.+.|+||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 4899999999999999 666678999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.004 Score=69.02 Aligned_cols=135 Identities=20% Similarity=0.080 Sum_probs=99.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKG-SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
.+..++-++.++...++++++.++ +-...+......+...+...+.+.-.+++++||+. .=+|+| ||+..+
T Consensus 296 ~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~- 367 (829)
T KOG0576|consen 296 VVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE- 367 (829)
T ss_pred cccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-
Confidence 455556677788999999999887 33222222222344455556777778899999997 568888 777655
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCc
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 615 (702)
+..|..||+....+.+.. ......+++.++|||+.....+..+.|.|++|+-..++.-|.+|-.
T Consensus 368 ~~~~~~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 368 EEVKLLDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccccccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 678999999887664433 3445678999999999999999999999999998888877777654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.021 Score=67.75 Aligned_cols=166 Identities=19% Similarity=0.169 Sum_probs=111.8
Q ss_pred EEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC---cEEEeCCCcEEEe--cccce
Q 038002 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR---NILIDDSWRAKIS--DFGLA 560 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~---NIll~~~~~~kl~--Dfg~a 560 (702)
+..|++..-++...+.... ..+....+.+..++.+||+++|+. ...|.-+..+ +...+..+.+.+. ||+..
T Consensus 263 v~~~~~s~~~~~~~~q~v~-~i~~~~~r~~~~~~~~GL~~~h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss 338 (1351)
T KOG1035|consen 263 VLQEICSKVELRSLLQSVG-SIPLETLRILHQKLLEGLAYLHSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSS 338 (1351)
T ss_pred HHHhhcCccchHHHHhhcc-ccCHHHHHHHHHHHhhhHHHHHHh---ccceeEEecccccccccCccceeecchhhhccc
Confidence 3457788888888887665 688888999999999999999998 5555555444 4444556666666 88877
Q ss_pred eecCCCCCceeeceeccccccCcccccCCCCC--ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccc
Q 038002 561 KLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT--VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGE 638 (702)
Q Consensus 561 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 638 (702)
........... ...+..+.+||........ ...|+|.+|..+..+..|..+-.....
T Consensus 339 ~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~------------------- 397 (1351)
T KOG1035|consen 339 KPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAV------------------- 397 (1351)
T ss_pred ccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccc-------------------
Confidence 76543332221 2234567788876655444 447999999999999988765432210
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 639 FNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 639 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
...+++... ...+.+...+|+..++++|+++.+++...
T Consensus 398 ~~~~l~~~~----~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 398 PVSLLDVLS----TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcccc----chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 001111111 11455667779999999999999999765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.039 Score=55.69 Aligned_cols=31 Identities=26% Similarity=0.409 Sum_probs=26.3
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++|+|+.|.||+++++...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3699999999999998776667999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.026 Score=58.12 Aligned_cols=74 Identities=18% Similarity=0.152 Sum_probs=53.1
Q ss_pred cCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
+.++.++|||++.|-.|...-+-. +.. .+...+..-+--|..+ |+||+|..-=||++++++.++++||--
T Consensus 179 D~~RH~Vvmelv~g~Pl~~v~~v~----d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 179 DHNRHCVVMELVDGYPLRQVRHVE----DPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred cccceeeHHHhhcccceeeeeecC----ChH---HHHHHHHHHHHHHHHc---CceecccchheeEEecCCCEEEeechH
Confidence 356789999999997776543221 222 2333344445556677 999999999999999999999999965
Q ss_pred eeec
Q 038002 560 AKLL 563 (702)
Q Consensus 560 a~~~ 563 (702)
....
T Consensus 249 mvS~ 252 (465)
T KOG2268|consen 249 MVST 252 (465)
T ss_pred hhcc
Confidence 5443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.0034 Score=75.66 Aligned_cols=133 Identities=13% Similarity=0.008 Sum_probs=98.2
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCC---CCHHHHHHHHHHHHHHHHhhhhcCC--CCeEecCCCCCcEEEeCCCcEEEe
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETR---PLWRDRVRIALDVARGLLYLHDECE--VQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~~--~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
....+.+++++.+|.+.+.|-+...+ ++...+.....+.+.+..-.|.... --.+|+++|+-|.++..+..+|+.
T Consensus 1303 s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~g 1382 (2724)
T KOG1826|consen 1303 STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLG 1382 (2724)
T ss_pred ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccc
Confidence 56678899999999999998765433 2222222223333555555554421 146899999999999999999999
Q ss_pred cccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCC
Q 038002 556 DFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614 (702)
Q Consensus 556 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 614 (702)
++|+.+.. .......+...+++.|+.|++...-.++.++|+|..|+.+|+.-.|..+|
T Consensus 1383 k~gLdKIk-np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1383 KGGLDKIK-NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred cccccccc-CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999843 22333345566788999999888888888999999999999998888777
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=93.44 E-value=0.26 Score=59.30 Aligned_cols=30 Identities=30% Similarity=0.532 Sum_probs=24.6
Q ss_pred CeEecCCCCCcEEEeCC-Cc-EEEecccceee
Q 038002 533 QIIHCDIKLRNILIDDS-WR-AKISDFGLAKL 562 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~-~~-~kl~Dfg~a~~ 562 (702)
.++|+|+++.||+++.+ .. .-|.||.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 59999999999999753 33 57999988765
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.40 E-value=0.16 Score=53.38 Aligned_cols=75 Identities=19% Similarity=0.203 Sum_probs=58.1
Q ss_pred cCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
+....|++|++- |++|.-. ....++++..++.+.+.-+.-+... ...-|||+.-.||||+ +|++.|+||-+
T Consensus 297 e~~y~yl~~kdh-gt~is~i-----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISII-----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecC-Cceeeee-----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 345566777775 4444321 1345788999999988888888776 5889999999999999 99999999999
Q ss_pred eeec
Q 038002 560 AKLL 563 (702)
Q Consensus 560 a~~~ 563 (702)
++.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9853
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=92.96 E-value=0.15 Score=48.19 Aligned_cols=101 Identities=16% Similarity=0.133 Sum_probs=63.1
Q ss_pred ccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCCCCHHH
Q 038002 447 DKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSKGSLAD 498 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~ 498 (702)
..+.|++|.+ ||++......+|+| -.+++.| +..++.|||+.|..|.+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~~L~~ 101 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCcchhh
Confidence 3455666654 88877776666666 1222222 23345599999988877
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCC-CCcEEEeCCCcEEEecccceee
Q 038002 499 LLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK-LRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 499 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlk-p~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.-... + .+-...+++.---|... ||-|+.|+ |..+++-.+..+.|+||..|..
T Consensus 102 ~~~~~----~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG----D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc----c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 65422 1 12233455554445555 99999986 5555555555999999998874
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.72 E-value=0.47 Score=49.69 Aligned_cols=28 Identities=21% Similarity=0.364 Sum_probs=21.6
Q ss_pred CCCeEecCCCCCcEEEeCC-Cc-EEEeccc
Q 038002 531 EVQIIHCDIKLRNILIDDS-WR-AKISDFG 558 (702)
Q Consensus 531 ~~~ivH~dlkp~NIll~~~-~~-~kl~Dfg 558 (702)
...++|||+.+.||+++.+ +. +.|+|..
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence 4589999999999999865 33 5677654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=91.96 E-value=0.82 Score=44.71 Aligned_cols=80 Identities=21% Similarity=0.217 Sum_probs=56.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCC------CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSK------GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~------gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|.+++++-+++.-.-+|+|.+.. .+|.+++++.. ++. + +...+-+-.++|-++ .|+.+|++|.||
T Consensus 79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~--~~~-~---~~~~L~~f~~~l~~~---~Iv~~dl~~~NI 149 (199)
T PF10707_consen 79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG--LTE-E---LRQALDEFKRYLLDH---HIVIRDLNPHNI 149 (199)
T ss_pred cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC--ccH-H---HHHHHHHHHHHHHHc---CCeecCCCcccE
Confidence 67888999999999999998743 47888885543 443 2 333334445677777 999999999999
Q ss_pred EEeCCC----cEEEec-ccc
Q 038002 545 LIDDSW----RAKISD-FGL 559 (702)
Q Consensus 545 ll~~~~----~~kl~D-fg~ 559 (702)
++.... .+.|+| ||.
T Consensus 150 v~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 150 VVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEEecCCCceEEEEEeCCCC
Confidence 994332 467776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.21 E-value=0.44 Score=50.02 Aligned_cols=32 Identities=28% Similarity=0.412 Sum_probs=28.9
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
..++|||+++.||+++....+-|+||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 47999999999999999988999999998753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.90 E-value=0.54 Score=47.17 Aligned_cols=30 Identities=23% Similarity=0.356 Sum_probs=26.6
Q ss_pred CCeEecCCCCCcEEEeC-CCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDD-SWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~ 561 (702)
..++|+|+.+.||++++ ++.+.|+||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 37999999999999998 5789999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=89.46 E-value=0.65 Score=48.63 Aligned_cols=31 Identities=29% Similarity=0.373 Sum_probs=27.3
Q ss_pred CCCeEecCCCCCcEEEeCC----CcEEEeccccee
Q 038002 531 EVQIIHCDIKLRNILIDDS----WRAKISDFGLAK 561 (702)
Q Consensus 531 ~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~ 561 (702)
...++|+|+.|.||+++++ +.++++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4589999999999999875 789999998775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.24 E-value=1 Score=44.33 Aligned_cols=101 Identities=18% Similarity=0.071 Sum_probs=62.4
Q ss_pred cCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
++...-+|.|+|-.. +.. -..++..-+.+|.-.|+.. .+.+|||..|+||+-|..|.+||.|-+.
T Consensus 125 n~~~yGvIlE~Cy~~-----------~i~---~~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 125 NNYKYGVILERCYKI-----------KIN---FSNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred CCceeEEEEeeccCc-----------ccc---hhHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 556667899998431 111 1122233356788888542 4899999999999999999999999653
Q ss_pred eeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCC
Q 038002 560 AKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCR 611 (702)
Q Consensus 560 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~ 611 (702)
-.. .+..|.--| ....+.++.+-+|=.-+++++...
T Consensus 190 Ll~-------------~~V~~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 190 LLE-------------NQVNMVNIE---YESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred hhh-------------heeeEEeee---ccccChHHHHHHHHHHHHHHHHHH
Confidence 321 011122211 123456677777766777776544
|
The function of this family is unknown. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=89.21 E-value=0.49 Score=49.76 Aligned_cols=30 Identities=30% Similarity=0.370 Sum_probs=27.0
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.+++|+|+++.||+++.++...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 499999999999999998877899998765
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.97 E-value=0.71 Score=48.79 Aligned_cols=30 Identities=27% Similarity=0.359 Sum_probs=26.2
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999977666899999775
|
|
| >smart00223 APPLE APPLE domain | Back alignment and domain information |
|---|
Probab=88.59 E-value=0.47 Score=38.78 Aligned_cols=43 Identities=16% Similarity=0.188 Sum_probs=31.6
Q ss_pred eccCCCCccccccC-CHHhhhhhccCCceeeEEEe--cCC---ceeecc
Q 038002 362 ITWLGGLPYAKLSV-SKKDCSKSCLNDCYFGAAFY--SDG---ACSKHK 404 (702)
Q Consensus 362 ~~~~~~~~~~~~~~-s~~~C~~~Cl~nCsC~a~~~--~~~---~C~~~~ 404 (702)
++++.+.+...... +.++|++.|..+=.|.+|.| .+. .|+.+.
T Consensus 8 ~~df~G~Dl~~~~~~~~~~Cq~~Ct~~~~C~~FTf~~~~~~~~~C~LK~ 56 (79)
T smart00223 8 NVDFRGSDINTVYVPSAQVCQKRCTSHPRCLFFTFSTNEPPEEKCLLKD 56 (79)
T ss_pred CccccCceeeeeecCCHHHHHHhhcCCCCccEEEeeCCCCCCCEeEeCc
Confidence 45555555444333 99999999999999999999 344 687764
|
Four-fold repeat in plasma kallikrein and coagulation factor XI. Factor XI apple 3 mediates binding to platelets. Factor XI apple 1 binds high-molecular-mass kininogen. Apple 4 in factor XI mediates dimer formation and binds to factor XIIa. Mutations in apple 4 cause factor XI deficiency, an inherited bleeding disorder. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=88.06 E-value=0.92 Score=47.65 Aligned_cols=29 Identities=28% Similarity=0.381 Sum_probs=25.5
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999988 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=86.92 E-value=0.74 Score=48.01 Aligned_cols=30 Identities=30% Similarity=0.375 Sum_probs=26.8
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.+++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999998778899998765
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=86.74 E-value=1.9 Score=45.74 Aligned_cols=76 Identities=20% Similarity=0.249 Sum_probs=55.6
Q ss_pred eeEEEEecCCCCCH-HHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 483 KKLLVYEFMSKGSL-ADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 483 ~~~lV~e~~~~gsL-~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
..+|||+|+-.-.. .-.|+. ..++...+..+-.|++.-+.-|-+.| ++||.||+--|+|+. +|.+.|+|.+-+.
T Consensus 238 ~hVLVM~FlGrdgw~aPkLKd--~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 238 NHVLVMEFLGRDGWAAPKLKD--ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred cceEeeeeccCCCCcCccccc--ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-CCEEEEEEccccc
Confidence 34799999943211 111221 13666778888889999999888876 899999999999875 5689999988766
Q ss_pred ec
Q 038002 562 LL 563 (702)
Q Consensus 562 ~~ 563 (702)
..
T Consensus 313 E~ 314 (520)
T KOG2270|consen 313 EH 314 (520)
T ss_pred cC
Confidence 43
|
|
| >PF14295 PAN_4: PAN domain; PDB: 2YIL_E 2YIP_C 2YIO_A | Back alignment and domain information |
|---|
Probab=85.41 E-value=0.51 Score=34.57 Aligned_cols=22 Identities=23% Similarity=0.409 Sum_probs=17.5
Q ss_pred CHHhhhhhccCCceeeEEEecC
Q 038002 376 SKKDCSKSCLNDCYFGAAFYSD 397 (702)
Q Consensus 376 s~~~C~~~Cl~nCsC~a~~~~~ 397 (702)
+.++|.+.|..+=.|.+|.|..
T Consensus 17 s~~~C~~~C~~~~~C~~~~~~~ 38 (51)
T PF14295_consen 17 SPEECQAACAADPGCQAFTFNP 38 (51)
T ss_dssp -HHHHHHHHHTSTT--EEEEET
T ss_pred CHHHHHHHccCCCCCCEEEEEC
Confidence 8999999999999999999943
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=84.99 E-value=1.7 Score=46.04 Aligned_cols=28 Identities=39% Similarity=0.522 Sum_probs=25.6
Q ss_pred eEecCCCCCcEEEeCCCc-EEEeccccee
Q 038002 534 IIHCDIKLRNILIDDSWR-AKISDFGLAK 561 (702)
Q Consensus 534 ivH~dlkp~NIll~~~~~-~kl~Dfg~a~ 561 (702)
+||+|+.|.||+++.+.. ..++||+.+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998885 8999999775
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.99 E-value=0.79 Score=44.18 Aligned_cols=29 Identities=21% Similarity=0.268 Sum_probs=25.6
Q ss_pred CeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..+|+|+.|.||++.+++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 679999999999998877 89999998753
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=84.24 E-value=1.1 Score=46.97 Aligned_cols=37 Identities=32% Similarity=0.388 Sum_probs=23.5
Q ss_pred HHHHHHHHHHHHHhhhhc-CCCCeEecCCCCCcEEEeC
Q 038002 512 RVRIALDVARGLLYLHDE-CEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 512 ~~~i~~qi~~aL~~LH~~-~~~~ivH~dlkp~NIll~~ 548 (702)
+..++.||+.-.--.-+. |....+|-||||+|||+-+
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence 344666775543212222 2348999999999999943
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF00024 PAN_1: PAN domain This Prosite entry concerns apple domains, a subset of PAN domains; InterPro: IPR003014 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=82.98 E-value=0.84 Score=36.79 Aligned_cols=30 Identities=23% Similarity=0.443 Sum_probs=25.8
Q ss_pred CHHhhhhhccCCce-eeEEEec--CCceeeccc
Q 038002 376 SKKDCSKSCLNDCY-FGAAFYS--DGACSKHKF 405 (702)
Q Consensus 376 s~~~C~~~Cl~nCs-C~a~~~~--~~~C~~~~~ 405 (702)
++++|...|+.+-. |.+|.|. ...|.+...
T Consensus 24 s~~~C~~~C~~~~~~C~s~~y~~~~~~C~L~~~ 56 (79)
T PF00024_consen 24 SLEECAQLCLNEPRRCKSFNYDPSSKTCYLSSS 56 (79)
T ss_dssp SHHHHHHHHHHSTT-ESEEEEETTTTEEEEECS
T ss_pred CHHHHHhhcCcCcccCCeEEEECCCCEEEEcCC
Confidence 99999999999999 9999994 458887643
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs It has been shown that, the N-terminal N domains of members of the plasminogen/hepatocyte growth factor family, the apple domains of the plasma prekallikrein/coagulation factor XI family, and domains of various nematode proteins belong to the same module superfamily, the PAN module []. PAN contains a conserved core of three disulphide bridges. In some members of the family there is an additional fourth disulphide bridge that links the N and C termini of the domain.; PDB: 1GP9_C 2QJ2_B 1GMO_H 1NK1_B 3MKP_B 1BHT_B 3HN4_A 1GMN_A 3HMS_A 3HMT_B .... |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=82.59 E-value=1 Score=45.99 Aligned_cols=30 Identities=20% Similarity=0.316 Sum_probs=25.9
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++|+|+.|.||++++++ +.|+||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3699999999999999877 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 702 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-27 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 7e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-14 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-14 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-14 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-14 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-14 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-14 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-14 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-14 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-14 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 9e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-13 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 5e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-09 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-09 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-09 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-09 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-09 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-09 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-09 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-09 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-09 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 5e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 7e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-09 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 6e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-07 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-07 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 9e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-06 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-06 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 8e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 9e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-05 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-05 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-05 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-05 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-05 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-05 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 4e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-05 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-05 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-05 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 7e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-04 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-04 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 702 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-80 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-71 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-68 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 3e-51 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 9e-44 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-41 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-41 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-41 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 5e-41 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 3e-39 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 3e-38 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-37 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-37 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-36 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-36 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 3e-36 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-36 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-35 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-25 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-25 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-25 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-25 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 1e-24 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 3e-24 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 8e-24 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 2e-23 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-23 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 7e-23 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 8e-23 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 9e-23 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-22 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-22 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-22 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-22 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-22 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 2e-22 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 2e-22 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 3e-22 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-22 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-22 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-22 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 4e-22 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 5e-22 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 5e-22 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 7e-22 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 7e-22 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-21 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-21 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 1e-21 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-21 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-21 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 2e-21 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-21 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-21 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 2e-21 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 4e-21 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 6e-21 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 7e-21 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 8e-21 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-20 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-20 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-20 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 3e-20 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-20 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-20 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 3e-20 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-20 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-20 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 4e-20 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 5e-20 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 6e-20 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 9e-20 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-19 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 1e-19 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-19 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-19 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 2e-19 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-19 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-19 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-19 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-19 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 3e-19 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-19 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 8e-19 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 9e-19 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-18 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-18 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-18 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-18 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-18 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-18 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 4e-18 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 5e-18 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 5e-18 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 5e-18 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-17 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-17 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-17 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 3e-17 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 5e-17 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-17 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 9e-17 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-16 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 3e-16 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 7e-16 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-15 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 2e-15 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 3e-15 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 5e-15 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-15 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 8e-15 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-15 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-14 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 1e-14 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-14 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-14 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 4e-14 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 2e-05 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 5e-14 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 6e-14 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-13 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 1e-13 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 2e-13 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 2e-06 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 2e-05 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 4e-13 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 5e-13 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 8e-13 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 2e-07 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 5e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-13 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 1e-12 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-12 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 2e-12 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 3e-12 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-12 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-12 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-12 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 5e-12 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 5e-12 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 9e-07 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 4e-05 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 8e-12 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 8e-12 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 1e-11 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 1e-04 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 2e-11 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-11 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 2e-11 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-11 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-11 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-11 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 2e-11 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 3e-11 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 5e-08 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 3e-11 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 3e-08 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 3e-11 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-11 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 3e-11 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-11 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 3e-11 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 5e-08 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-11 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 4e-11 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 4e-11 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-11 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 4e-11 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-11 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 4e-11 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 5e-11 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 2e-05 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-11 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-11 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 5e-11 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 6e-11 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 7e-11 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 7e-11 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 7e-11 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-11 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 8e-11 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 8e-11 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 9e-11 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 9e-11 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-10 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-10 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 1e-10 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 2e-10 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 2e-10 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 5e-09 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 2e-10 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 2e-10 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 2e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 2e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 2e-10 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 2e-10 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 9e-08 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-10 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-10 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-10 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-10 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 5e-10 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 6e-10 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 6e-10 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 8e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 8e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-06 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 9e-10 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-09 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 2e-09 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 2e-09 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-09 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 2e-09 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 5e-09 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-09 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 2e-09 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-09 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 3e-09 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 3e-09 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 3e-09 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-09 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 4e-09 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 4e-09 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 4e-09 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-09 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 6e-09 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 6e-09 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 8e-09 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 9e-09 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-09 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 1e-08 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-08 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-08 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-08 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-08 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 2e-08 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 3e-08 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-08 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 6e-08 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 8e-08 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-07 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-07 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 2e-07 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 2e-07 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 2e-07 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-07 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 5e-07 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 7e-07 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 8e-07 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-06 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-06 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 3e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-05 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 4e-05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 1e-80
Identities = 81/210 (38%), Positives = 121/210 (57%), Gaps = 8/210 (3%)
Query: 481 SSKKLLVYEFMSKGSLADLLFNLETRPL---WRDRVRIALDVARGLLYLHDECEVQIIHC 537
+++LLVY +M+ GS+A L W R RIAL ARGL YLHD C+ +IIH
Sbjct: 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDV 597
D+K NIL+D+ + A + DFGLAKL+ T + VRG+ G++APE+ ++G + K+DV
Sbjct: 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDV 218
Query: 598 YSFGVVLLEIICCRSNFEVNVSTADE-VLLSTWVYNCFVAGEFNKLV----EEEVDKITL 652
+ +GV+LLE+I + F++ D+ V+L WV + LV + +
Sbjct: 219 FGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278
Query: 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682
E++++ LLC Q P RP M V+ MLEG
Sbjct: 279 EQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 5e-71
Identities = 75/222 (33%), Positives = 124/222 (55%), Gaps = 12/222 (5%)
Query: 473 SLLVYKHRSSKKLLVYEFMSKGSLADLLF--NLETRPL-WRDRVRIALDVARGLLYLHDE 529
SL+ + ++ +L+Y++M G+L L+ +L T + W R+ I + ARGL YLH
Sbjct: 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL-LMPNQTGIVAGVRGSRGYMAPEWQNS 588
IIH D+K NIL+D+++ KI+DFG++K +QT + V+G+ GY+ PE+
Sbjct: 159 A---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV----E 644
G +T KSDVYSFGVVL E++C RS ++ + V L+ W G+ ++V
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVESHNNGQLEQIVDPNLA 274
Query: 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686
+++ +L + T + C+ RPSM +V+ LE + +
Sbjct: 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-68
Identities = 74/206 (35%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 484 KLLVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHCDIKL 541
LVY +M GSL D L L+ P W R +IA A G+ +LH+ IH DIK
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKS 161
Query: 542 RNILIDDSWRAKISDFGLAKLL-MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSF 600
NIL+D+++ AKISDFGLA+ QT + + + G+ YMAPE G IT KSD+YSF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSF 220
Query: 601 GVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFV-AGEFNKLVE---EEVDKITLERMV 656
GVVLLEII + + LL ++ + D ++E M
Sbjct: 221 GVVLLEIITGLPAVD---EHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMY 277
Query: 657 KTGLLCIQDEPNLRPSMKNVILMLEG 682
C+ ++ N RP +K V +L+
Sbjct: 278 SVASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-51
Identities = 54/227 (23%), Positives = 89/227 (39%), Gaps = 28/227 (12%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQ---- 533
L+ F KGSL+D L + W + IA +ARGL YLH++
Sbjct: 92 SVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGH 148
Query: 534 ---IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA-GVRGSRGYMAPE----- 584
I H DIK +N+L+ ++ A I+DFGLA ++ G G+R YMAPE
Sbjct: 149 KPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208
Query: 585 WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV- 643
++ D+Y+ G+VL E+ + + V + + + ++V
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-EYMLPFEEEIGQHPSLEDMQEVVV 267
Query: 644 --------EEEVDK-ITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
+ K + + +T C + R S V +
Sbjct: 268 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-44
Identities = 58/254 (22%), Positives = 89/254 (35%), Gaps = 34/254 (13%)
Query: 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDE------CEVQI 534
+ LLV E+ GSL L W R+A V RGL YLH E + I
Sbjct: 84 RMEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAI 141
Query: 535 IHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA-------GVRGSRGYMAPE--- 584
H D+ RN+L+ + ISDFGL+ L N+ G+ YMAPE
Sbjct: 142 SHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLE 201
Query: 585 ----WQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639
++ + D+Y+ G++ EI C F ++ T V N +
Sbjct: 202 GAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDM 261
Query: 640 NKLVEEE-----------VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPI 688
LV E + + + + +T C + R + + + M I
Sbjct: 262 QVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321
Query: 689 LAFPPLSHVNSLSH 702
+ H
Sbjct: 322 RNKSVSPTAHHHHH 335
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-41
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V ++ SL L ET+ + + IA ARG+ YLH + IIH D+K NI
Sbjct: 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIF 152
Query: 546 IDDSWRAKISDFGLAKLL-MPNQTGIVAGVRGSRGYMAPE---WQNSGLITVKSDVYSFG 601
+ + KI DFGLA + + + GS +MAPE Q+S + +SDVY+FG
Sbjct: 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFG 212
Query: 602 VVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLL 661
+VL E++ + + N++ D+++ + V +V +RM +
Sbjct: 213 IVLYELMTGQLPYS-NINNRDQII---EM----VGRGSLSPDLSKVRSNCPKRMKRLMAE 264
Query: 662 CIQDEPNLRPSMKNVILMLE 681
C++ + + RPS ++ +E
Sbjct: 265 CLKKKRDERPSFPRILAEIE 284
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
+V E++S+GSL LL R R R+ +A DVA+G+ YLH I+H ++K N
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPN 169
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
+L+D + K+ DFGL++ L + G+ +MAPE KSDVYSFGV+
Sbjct: 170 LLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKL---VEEEVDKITLERMVKTGL 660
L E+ + + N++ A V V F + ++ +
Sbjct: 229 LWELATLQQPWG-NLNPAQVVAA--------VG--FKCKRLEIPRNLNPQVAAIIEG--- 274
Query: 661 LCIQDEPNLRPSMKNVILMLEGTMEIPILAFPPLSHVN 698
C +EP RPS ++ +L + A PP + +
Sbjct: 275 -CWTNEPWKRPSFATIMDLLR---PLIKSAVPPPNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 26/224 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
LV E+ GSL ++L E P + L ++G+ YLH +IH D+K N
Sbjct: 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135
Query: 544 ILIDDSWR-AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+L+ KI DFG A + + T GS +MAPE + K DV+S+G+
Sbjct: 136 LLLVAGGTVLKICDFGTACDIQTHMTNNK----GSAAWMAPEVFEGSNYSEKCDVFSWGI 191
Query: 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG----EFNKLVEEEVDKITLERMVKT 658
+L E+I R F+ E+ + V K + + ++ + + R
Sbjct: 192 ILWEVITRRKPFD-------EIGGPAFRIMWAVHNGTRPPLIKNLPKPIESL-MTR---- 239
Query: 659 GLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPPLSHVNSLSH 702
C +P+ RPSM+ ++ ++ M A PL + S
Sbjct: 240 ---CWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSL 280
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 48/206 (23%), Positives = 86/206 (41%), Gaps = 35/206 (16%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L+ +M GSL ++L + V+ ALD+ARG+ +LH E I + R++
Sbjct: 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSV 144
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---WQNSGLITVKSDVYSFG 601
+ID+ A+IS + G + ++APE + +D++SF
Sbjct: 145 MIDEDMTARISMADVKFSFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFA 198
Query: 602 VVLLEIICCR------SNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERM 655
V+L E++ SN E+ + A E L T + +KL++
Sbjct: 199 VLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI--SPHVSKLMKI---------- 246
Query: 656 VKTGLLCIQDEPNLRPSMKNVILMLE 681
C+ ++P RP ++ +LE
Sbjct: 247 ------CMNEDPAKRPKFDMIVPILE 266
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 57/230 (24%), Positives = 94/230 (40%), Gaps = 27/230 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+ E++ G+L ++ +++++ W RV A D+A G+ YLH IIH D+ N L
Sbjct: 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCL 140
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAG-------------VRGSRGYMAPEWQNSGLIT 592
+ ++ ++DFGLA+L++ +T V G+ +MAPE N
Sbjct: 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652
K DV+SFG+VL EII + + + L+ V G ++
Sbjct: 201 EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------VRGFLDRYCPPNCPPSFF 253
Query: 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPPLSHVNSLSH 702
V+ C +P RPS + LE P + L
Sbjct: 254 PITVR----CCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQLDR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 46/203 (22%), Positives = 86/203 (42%), Gaps = 22/203 (10%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V EF+ G L L + W ++R+ LD+A G+ Y+ + I+H D++ NI
Sbjct: 98 MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIF 156
Query: 546 IDDSWR-----AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE--WQNSGLITVKSDVY 598
+ AK++DFGL++ + + +G++ G+ +MAPE T K+D Y
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQSVHSVSGLL----GNFQWMAPETIGAEEESYTEKADTY 212
Query: 599 SFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKT 658
SF ++L I+ F+ S + + + + + + +E
Sbjct: 213 SFAMILYTILTGEGPFD-EYSYGK-IKFINMIREEGLRPTIPEDCPPRLRNV-IEL---- 265
Query: 659 GLLCIQDEPNLRPSMKNVILMLE 681
C +P RP ++ L
Sbjct: 266 ---CWSGDPKKRPHFSYIVKELS 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 40/211 (18%), Positives = 85/211 (40%), Gaps = 33/211 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
++ +L ++ + + +IA ++ +G+ YLH + I+H D+K +N+
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVF 162
Query: 546 IDDSWRAKISDFGLAKL----LMPNQTGIVAGVRGSRGYMAPE---------WQNSGLIT 592
D+ + I+DFGL + + + G ++APE ++ +
Sbjct: 163 YDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK--LVEEEVDKI 650
SDV++ G + E+ F+ A+ ++ + G K L + + K
Sbjct: 222 KHSDVFALGTIWYELHAREWPFKTQ--PAEAII--------WQMGTGMKPNLSQIGMGKE 271
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
+ ++ C E RP+ ++ MLE
Sbjct: 272 ISDILLF----CWAFEQEERPTFTKLMDMLE 298
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 63/211 (29%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV EF G L +L + + V A+ +ARG+ YLHDE V IIH D+K NI
Sbjct: 83 LVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNI 139
Query: 545 LIDDS--------WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSD 596
LI KI+DFGLA+ ++T ++ G+ +MAPE + + + SD
Sbjct: 140 LILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMAPEVIRASMFSKGSD 196
Query: 597 VYSFGVVLLEIICCR------SNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
V+S+GV+L E++ V A L C F KL+E+
Sbjct: 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTC--PEPFAKLMED----- 249
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
C +P+ RPS N++ L
Sbjct: 250 -----------CWNPDPHSRPSFTNILDQLT 269
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 51/221 (23%), Positives = 84/221 (38%), Gaps = 30/221 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQ-----IIHCDI 539
L+ + GSL D L + L +RI L +A GL +LH E I H D+
Sbjct: 83 LITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDL 139
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA---GVRGSRGYMAPE------WQNSGL 590
K +NIL+ + + I+D GLA + + + G++ YMAPE +
Sbjct: 140 KSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFD 199
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV------- 643
+ D+++FG+VL E+ + + + V N + K+V
Sbjct: 200 SYKRVDIWAFGLVLWEVARRMVSNGIVEDY--KPPFYDVVPNDPSFEDMRKVVCVDQQRP 257
Query: 644 ---EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
TL + K C P+ R + + L
Sbjct: 258 NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 48/222 (21%), Positives = 86/222 (38%), Gaps = 30/222 (13%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDE-----CEVQIIHCD 538
L+ ++ GSL D L ++ L + +++A GL +LH E + I H D
Sbjct: 111 YLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA---GVRGSRGYMAPE------WQNSG 589
+K +NIL+ + I+D GLA + + + G++ YM PE +N
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 590 LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV------ 643
+ +D+YSFG++L E+ + + ++ V + + ++V
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEY--QLPYHDLVPSDPSYEDMREIVCIKKLR 285
Query: 644 ----EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
L +M K C P R + V L
Sbjct: 286 PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 52/221 (23%), Positives = 81/221 (36%), Gaps = 30/221 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQ-----IIHCDI 539
LV ++ GSL D L + +++AL A GL +LH E I H D+
Sbjct: 117 LVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDL 173
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA---GVRGSRGYMAPE-WQNSGLITV-- 593
K +NIL+ + I+D GLA I G++ YMAPE +S +
Sbjct: 174 KSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 233
Query: 594 ---KSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV------- 643
++D+Y+ G+V EI S ++ ++ V + E K+V
Sbjct: 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDY--QLPYYDLVPSDPSVEEMRKVVCEQKLRP 291
Query: 644 ---EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
L M K C R + + L
Sbjct: 292 NIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 49/215 (22%), Positives = 78/215 (36%), Gaps = 38/215 (17%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E + G L R + +++ D A G+ YL IH D+ RN
Sbjct: 188 YIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNC 244
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNSGLITVKSDVYS 599
L+ + KISDFG+++ G V+ + APE N G + +SDV+S
Sbjct: 245 LVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK----WTAPEALNYGRYSSESDVWS 300
Query: 600 FGVVLLEII-------CCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652
FG++L E SN + L +L + V ++
Sbjct: 301 FGILLWETFSLGASPYPNLSNQQTREFVEKGGRL-----------PCPELCPDAVFRLME 349
Query: 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687
+ C EP RPS + L+ +
Sbjct: 350 Q--------CWAYEPGQRPSFSTIYQELQSIRKRH 376
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-25
Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 4/125 (3%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
+V E+MSKGSL D L + L V +A +A G+ Y+ + +H D++ N
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAAN 310
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+ ++ K++DFGLA+L+ N+ G + + APE G T+KSDV+SFG++
Sbjct: 311 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 370
Query: 604 LLEII 608
L E+
Sbjct: 371 LTELT 375
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 30/131 (22%), Positives = 56/131 (42%), Gaps = 15/131 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E++ SL + L + + L++ L YLH + +++ D+K NI
Sbjct: 161 IVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENI 213
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
++ + + K+ D G + N G + G+ G+ APE TV +D+Y+ G L
Sbjct: 214 MLTEE-QLKLIDLGAVSRI--NSFGYLY---GTPGFQAPE-IVRTGPTVATDIYTVGRTL 266
Query: 605 LEIICCRSNFE 615
+
Sbjct: 267 AALTLDLPTRN 277
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 4/125 (3%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
+V E+MSKGSL D L + L V +A +A G+ Y+ + +H D++ N
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAAN 393
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+ ++ K++DFGLA+L+ N+ G + + APE G T+KSDV+SFG++
Sbjct: 394 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 453
Query: 604 LLEII 608
L E+
Sbjct: 454 LTELT 458
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 36/125 (28%), Positives = 66/125 (52%), Gaps = 4/125 (3%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++ EFM+ G+L D L + + + +A ++ + YL + IH ++ RN
Sbjct: 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARN 348
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
L+ ++ K++DFGL++L+ + AG + + APE ++KSDV++FGV+
Sbjct: 349 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 408
Query: 604 LLEII 608
L EI
Sbjct: 409 LWEIA 413
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 44/125 (35%), Positives = 71/125 (56%), Gaps = 4/125 (3%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++ EFM+KGSL D L + E + + +A G+ ++ + IH D++ N
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAAN 314
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+ S KI+DFGLA+++ N+ G + + APE N G T+KSDV+SFG++
Sbjct: 315 ILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374
Query: 604 LLEII 608
L+EI+
Sbjct: 375 LMEIV 379
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L+ EF+ GSL + L + + + +++ A+ + +G+ YL Q +H D+ RN+
Sbjct: 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNV 157
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
L++ + KI DFGL K + ++ + APE + SDV+SFG
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF-WYAPECLMQSKFYIASDVWSFG 216
Query: 602 VVLLEII-CCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE------------EVD 648
V L E++ C S+ A + + + ++E EV
Sbjct: 217 VTLHELLTYCDSDSS---PMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY 273
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
++ M C + +P+ R S +N+I E
Sbjct: 274 QL----M----RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 41/127 (32%), Positives = 70/127 (55%), Gaps = 6/127 (4%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ +M G L + + + P +D + L VARG+ YL E + +H D+ RN
Sbjct: 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNC 155
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQNSGLITVKSDVYSFG 601
++D+S+ K++DFGLA+ ++ + V R +R + A E + T KSDV+SFG
Sbjct: 156 MLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFG 215
Query: 602 VVLLEII 608
V+L E++
Sbjct: 216 VLLWELL 222
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 43/124 (34%), Positives = 63/124 (50%), Gaps = 8/124 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+M+KGSL D L + L ++ +LDV + YL +H D+ RN+
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNV 320
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ + AK+SDFGL K Q V+ + APE + KSDV+SFG++L
Sbjct: 321 LVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSDVWSFGILL 376
Query: 605 LEII 608
EI
Sbjct: 377 WEIY 380
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 7e-23
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ E++ GSL D L + R ++ + +G+ YL + IH D+ RNIL
Sbjct: 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 146
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFGV 602
+++ R KI DFGL K+L ++ G + APE +V SDV+SFGV
Sbjct: 147 VENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-WYAPESLTESKFSVASDVWSFGV 205
Query: 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE------------EVDKI 650
VL E+ + ++ + +L++ E+ I
Sbjct: 206 VLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMI 264
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
M C + N RPS +++ L ++
Sbjct: 265 ----M----TECWNNNVNQRPSFRDLALRVD 287
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 8e-23
Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ E++ GSL D L + R ++ + +G+ YL + IH D+ RNIL
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNIL 177
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFGV 602
+++ R KI DFGL K+L ++ G + APE +V SDV+SFGV
Sbjct: 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-WYAPESLTESKFSVASDVWSFGV 236
Query: 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE------------EVDKI 650
VL E+ + ++ + +L++ E+ I
Sbjct: 237 VLYELF-TYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMI 295
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
M + C + N RPS +++ L ++
Sbjct: 296 ----MTE----CWNNNVNQRPSFRDLALRVD 318
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 38/143 (26%), Positives = 68/143 (47%), Gaps = 18/143 (12%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E+M+ G L + L + R + + + DV + YL + Q +H D+ RN
Sbjct: 95 FIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNC 151
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG----VRGSRGYMAPEWQNSGLITVKSDVYSF 600
L++D K+SDFGL++ ++ ++ G VR + PE + KSD+++F
Sbjct: 152 LVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSKFSSKSDIWAF 207
Query: 601 GVVLLEIICC-------RSNFEV 616
GV++ EI +N E
Sbjct: 208 GVLMWEIYSLGKMPYERFTNSET 230
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 55/234 (23%), Positives = 87/234 (37%), Gaps = 37/234 (15%)
Query: 464 FLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGL 523
+ ++ LV E++ GSL D L + A + G+
Sbjct: 94 HIIKYKGC----CEDAGAASLQLVMEYVPLGSLRDYL--PRHSIGLAQLLLFAQQICEGM 147
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGY 580
YLH IH D+ RN+L+D+ KI DFGLAK + G +
Sbjct: 148 AYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-W 203
Query: 581 MAPEWQNSGLITVKSDVYSFGVVLLEII-CCRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639
APE SDV+SFGV L E++ C S+ + + ++
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTVLRL 260
Query: 640 NKLVEE------------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
+L+E EV + M C + E + RP+ +N+I +L+
Sbjct: 261 TELLERGERLPRPDKCPAEVYHL----M----KNCWETEASFRPTFENLIPILK 306
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 52/197 (26%), Positives = 82/197 (41%), Gaps = 35/197 (17%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV E++ +L++ + PL + + G+ + H +++I+H DIK +NI
Sbjct: 88 LVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNI 142
Query: 545 LIDDSWRAKISDFGLAKLLMPN---QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
LID + KI DFG+AK L QT V G+ Y +PE +D+YS G
Sbjct: 143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVL---GTVQYFSPEQAKGEATDECTDIYSIG 199
Query: 602 VVLLEIICCRSNF--EVNVSTA-----DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLER 654
+VL E++ F E VS A D V V + K + + + + L
Sbjct: 200 IVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN--------VTTDVRKDIPQSLSNVILRA 251
Query: 655 MVKTGLLCIQDEPNLRP 671
K + R
Sbjct: 252 TEK--------DKANRY 260
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 44/129 (34%), Positives = 70/129 (54%), Gaps = 12/129 (9%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++ E+M GSL D L L + +A +A G+ ++ + IH D++ N
Sbjct: 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAAN 139
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAG----VRGSRGYMAPEWQNSGLITVKSDVYS 599
IL+ D+ KI+DFGLA+L+ N+ G ++ + APE N G T+KSDV+S
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK----WTAPEAINYGTFTIKSDVWS 195
Query: 600 FGVVLLEII 608
FG++L EI+
Sbjct: 196 FGILLTEIV 204
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 40/200 (20%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E++ +L D++ P+ + + + D + L + H + IIH D+K NI
Sbjct: 93 IVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANI 147
Query: 545 LIDDSWRAKISDFGLAKLLMPN-----QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
+I + K+ DFG+A+ + + QT V G+ Y++PE + +SDVYS
Sbjct: 148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVI---GTAQYLSPEQARGDSVDARSDVYS 204
Query: 600 FGVVLLEIICCRSNF--EVNVSTA------DEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651
G VL E++ F + VS A D + S ++ + ++D +
Sbjct: 205 LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS----------ARHEGLSADLDAVV 254
Query: 652 LERMVKTGLLCIQDEPNLRP 671
L+ + K P R
Sbjct: 255 LKALAK--------NPENRY 266
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 39/127 (30%), Positives = 64/127 (50%), Gaps = 7/127 (5%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++V E+M GSL L + + V + V G+ YL ++ +H D+ RN+
Sbjct: 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNV 182
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
L+D + K+SDFGL+++L + G R + APE + SDV+SFG
Sbjct: 183 LVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR-WTAPEAIAFRTFSSASDVWSFG 241
Query: 602 VVLLEII 608
VV+ E++
Sbjct: 242 VVMWEVL 248
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 41/127 (32%), Positives = 69/127 (54%), Gaps = 6/127 (4%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L+V +M G L + + N P +D + L VA+G+ YL + +H D+ RN
Sbjct: 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNC 159
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQNSGLITVKSDVYSFG 601
++D+ + K++DFGLA+ + + V G++ +MA E + T KSDV+SFG
Sbjct: 160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 219
Query: 602 VVLLEII 608
V+L E++
Sbjct: 220 VLLWELM 226
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 33/213 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E++ G L D L R + + + +G+ YL + +H D+ RNIL
Sbjct: 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNIL 159
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFGV 602
++ KI+DFGLAKLL ++ V G + APE + + + +SDV+SFGV
Sbjct: 160 VESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-WYAPESLSDNIFSRQSDVWSFGV 218
Query: 603 VLLEII--CCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE------------EVD 648
VL E+ C +S +L+EE EV
Sbjct: 219 VLYELFTYCDKSCSPSAEFLRMMGCERDVPALS----RLLELLEEGQRLPAPPACPAEVH 274
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
++ M LC P RPS + L+
Sbjct: 275 EL----M----KLCWAPSPQDRPSFSALGPQLD 299
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 18/143 (12%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV EFM G L+D L + + LDV G+ YL + +IH D+ RN
Sbjct: 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNC 135
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG----VRGSRGYMAPEWQNSGLITVKSDVYSF 600
L+ ++ K+SDFG+ + ++ +Q G V+ + +PE + + KSDV+SF
Sbjct: 136 LVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WASPEVFSFSRYSSKSDVWSF 191
Query: 601 GVVLLEIICC-------RSNFEV 616
GV++ E+ RSN EV
Sbjct: 192 GVLMWEVFSEGKIPYENRSNSEV 214
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 47/192 (24%), Positives = 73/192 (38%), Gaps = 32/192 (16%)
Query: 489 EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
E M+ G+L L F + + R + +GL +LH IIH D+K NI I
Sbjct: 109 ELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFI 164
Query: 547 D-DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+ KI D GLA L + V G+ +MAPE DVY+FG+ +L
Sbjct: 165 TGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCML 220
Query: 606 EIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGL----- 660
E+ + C A + + V V + +++ +
Sbjct: 221 EMATSEYPY----------------SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIE 264
Query: 661 LCIQDEPNLRPS 672
CI+ + R S
Sbjct: 265 GCIRQNKDERYS 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 39/127 (30%), Positives = 60/127 (47%), Gaps = 7/127 (5%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+LV E G L L + + V+ G+ YL E +H D+ RN+
Sbjct: 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRDLAARNV 141
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
L+ + AKISDFGL+K L + + A G + + APE N + +SDV+S+G
Sbjct: 142 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK-WYAPECINFRKFSSRSDVWSYG 200
Query: 602 VVLLEII 608
V + E +
Sbjct: 201 VTMWEAL 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 11/128 (8%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E++S G L + L + + + DV G+ +L Q IH D+ RN
Sbjct: 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNC 135
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG----VRGSRGYMAPEWQNSGLITVKSDVYSF 600
L+D K+SDFG+ + ++ +Q G V+ + APE + + KSDV++F
Sbjct: 136 LVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK----WSAPEVFHYFKYSSKSDVWAF 191
Query: 601 GVVLLEII 608
G+++ E+
Sbjct: 192 GILMWEVF 199
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 40/127 (31%), Positives = 69/127 (54%), Gaps = 6/127 (4%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L+V +M G L + + N P +D + L VA+G+ +L + +H D+ RN
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNC 223
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQNSGLITVKSDVYSFG 601
++D+ + K++DFGLA+ + + V G++ +MA E + T KSDV+SFG
Sbjct: 224 MLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 283
Query: 602 VVLLEII 608
V+L E++
Sbjct: 284 VLLWELM 290
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-22
Identities = 33/129 (25%), Positives = 54/129 (41%), Gaps = 13/129 (10%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E G L L + V +L + + + YL + +H DI +RNI
Sbjct: 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNI 144
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNSGLITVKSDVYS 599
L+ K+ DFGL++ + + S +M+PE N T SDV+
Sbjct: 145 LVASPECVKLGDFGLSRYIEDEDY-----YKASVTRLPIKWMSPESINFRRFTTASDVWM 199
Query: 600 FGVVLLEII 608
F V + EI+
Sbjct: 200 FAVCMWEIL 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 36/130 (27%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+++ E+M G+L L + V + +A G+ YL + +H D+ RNI
Sbjct: 122 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNI 178
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG------YMAPEWQNSGLITVKSDVY 598
L++ + K+SDFGL+++L + + G + APE + T SDV+
Sbjct: 179 LVNSNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRWTAPEAISYRKFTSASDVW 234
Query: 599 SFGVVLLEII 608
SFG+V+ E++
Sbjct: 235 SFGIVMWEVM 244
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 7e-22
Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 14/129 (10%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ + M G L D + + + + + +A+G+ YL + +++H D+ RN+L
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVL 149
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG------YMAPEWQNSGLITVKSDVYS 599
+ KI+DFGLAKLL + + G +MA E + T +SDV+S
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 204
Query: 600 FGVVLLEII 608
+GV + E++
Sbjct: 205 YGVTVWELM 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 7e-22
Identities = 40/126 (31%), Positives = 55/126 (43%), Gaps = 7/126 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E GSL D L + L R A+ VA G+ YL + IH D+ RN+L
Sbjct: 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLL 153
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQNSGLITVKSDVYSFGV 602
+ KI DFGL + L N V + + APE + + SD + FGV
Sbjct: 154 LATRDLVKIGDFGLMRALPQNDDHYVMQ-EHRKVPFAWCAPESLKTRTFSHASDTWMFGV 212
Query: 603 VLLEII 608
L E+
Sbjct: 213 TLWEMF 218
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 34/127 (26%), Positives = 68/127 (53%), Gaps = 8/127 (6%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV +++ GSL D + + + + +A+G+ YL E ++H ++ RN+
Sbjct: 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNV 146
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR---GYMAPEWQNSGLITVKSDVYSFG 601
L+ + +++DFG+A LL P+ ++ ++ +MA E + G T +SDV+S+G
Sbjct: 147 LLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIHFGKYTHQSDVWSYG 204
Query: 602 VVLLEII 608
V + E++
Sbjct: 205 VTVWELM 211
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 43/168 (25%), Positives = 69/168 (41%), Gaps = 28/168 (16%)
Query: 468 LIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDR-------VRIALDVA 520
L+ +S K R +++ FM G L L L +R VR +D+A
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL--LASRIGENPFNLPLQTLVRFMVDIA 147
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VR 575
G+ YL IH D+ RN ++ + ++DFGL++ + V+
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 576 GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII-------CCRSNFEV 616
++A E L TV SDV++FGV + EI+ N E+
Sbjct: 205 ----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 13/129 (10%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E + G L L + + A ++ L YL + +H DI RN+
Sbjct: 91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNV 147
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNSGLITVKSDVYS 599
L+ + K+ DFGL++ + + + S+G +MAPE N T SDV+
Sbjct: 148 LVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFTSASDVWM 202
Query: 600 FGVVLLEII 608
FGV + EI+
Sbjct: 203 FGVCMWEIL 211
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 12/129 (9%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++ EFM+ G+L D L + + + +A ++ + YL + IH D+ RN
Sbjct: 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARN 141
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAG----VRGSRGYMAPEWQNSGLITVKSDVYS 599
L+ ++ K++DFGL++L+ + AG ++ + APE ++KSDV++
Sbjct: 142 CLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAPESLAYNKFSIKSDVWA 197
Query: 600 FGVVLLEII 608
FGV+L EI
Sbjct: 198 FGVLLWEIA 206
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 43/124 (34%), Positives = 63/124 (50%), Gaps = 8/124 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+M+KGSL D L + L ++ +LDV + YL +H D+ RN+
Sbjct: 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNV 148
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ + AK+SDFGL K Q V+ + APE + KSDV+SFG++L
Sbjct: 149 LVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSDVWSFGILL 204
Query: 605 LEII 608
EI
Sbjct: 205 WEIY 208
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 42/127 (33%), Positives = 62/127 (48%), Gaps = 8/127 (6%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+LV E G L L ++ + + V+ G+ YL E E +H D+ RN+
Sbjct: 93 MLVMEMAELGPLNKYLQQNRHVKD-KNIIELVHQVSMGMKYL--E-ESNFVHRDLAARNV 148
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
L+ AKISDFGL+K L ++ A G + + APE N + KSDV+SFG
Sbjct: 149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK-WYAPECINYYKFSSKSDVWSFG 207
Query: 602 VVLLEII 608
V++ E
Sbjct: 208 VLMWEAF 214
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 35/125 (28%), Positives = 50/125 (40%), Gaps = 12/125 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDR-VRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+ ++ LA +L PL R V I + L H H D+K NI
Sbjct: 111 VDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENI 165
Query: 545 LIDDSWRAKISDFGLAKLLMPN---QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
L+ A + DFG+A Q G G+ YMAPE + T ++D+Y+
Sbjct: 166 LVSADDFAYLVDFGIASATTDEKLTQLGNTV---GTLYYMAPERFSESHATYRADIYALT 222
Query: 602 VVLLE 606
VL E
Sbjct: 223 CVLYE 227
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 44/217 (20%), Positives = 82/217 (37%), Gaps = 34/217 (15%)
Query: 477 YKHRSSKKLLVY---EFMSKGSLADLL--FNLETRPLWRDRVRIALDVARGLLYLHDECE 531
SS K+ +Y + K +L D + + I + +A + +LH +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLL-----------MPNQTGIVAGVRGSRGY 580
++H D+K NI K+ DFGL + G G++ Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 581 MAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640
M+PE + + K D++S G++L E++ + ST E + + +F
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLY-------SFSTQMERVR---IITDVRNLKFP 292
Query: 641 KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
L ++ + MV+ + P RP ++I
Sbjct: 293 LLFTQKYPQ--EHMMVQ---DMLSPSPTERPEATDII 324
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 7/127 (5%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++V E+M GSL L + + V + +A G+ YL D +H D+ RNI
Sbjct: 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNI 178
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
LI+ + K+SDFGL ++L + G R + +PE T SDV+S+G
Sbjct: 179 LINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR-WTSPEAIAYRKFTSASDVWSYG 237
Query: 602 VVLLEII 608
+VL E++
Sbjct: 238 IVLWEVM 244
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 4e-21
Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 7/127 (5%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+LV E G L L + + V+ G+ YL E +H ++ RN+
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNV 467
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---RGYMAPEWQNSGLITVKSDVYSFG 601
L+ + AKISDFGL+K L + + A G + + APE N + +SDV+S+G
Sbjct: 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK-WYAPECINFRKFSSRSDVWSYG 526
Query: 602 VVLLEII 608
V + E +
Sbjct: 527 VTMWEAL 533
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 6e-21
Identities = 35/149 (23%), Positives = 60/149 (40%), Gaps = 24/149 (16%)
Query: 485 LLVYEFMSKGSLADLL-----FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+++ FM G L L + ++ +D+A G+ YL +H D+
Sbjct: 117 MVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL---SNRNFLHRDL 173
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNSGLITVK 594
RN ++ D ++DFGL+K + V+ ++A E + T K
Sbjct: 174 AARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WIAIESLADRVYTSK 229
Query: 595 SDVYSFGVVLLEII-------CCRSNFEV 616
SDV++FGV + EI N E+
Sbjct: 230 SDVWAFGVTMWEIATRGMTPYPGVQNHEM 258
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 7e-21
Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 14/129 (10%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ + M G L D + + + + + +A+G+ YL + +++H D+ RN+L
Sbjct: 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVL 149
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG------YMAPEWQNSGLITVKSDVYS 599
+ KI+DFGLAKLL + + G +MA E + T +SDV+S
Sbjct: 150 VKTPQHVKITDFGLAKLLGAEE-----KEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 204
Query: 600 FGVVLLEII 608
+GV + E++
Sbjct: 205 YGVTVWELM 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 45/142 (31%), Positives = 70/142 (49%), Gaps = 25/142 (17%)
Query: 485 LLVYEFMSKGSLADLL------------FNLETRPL-WRDRVRIALDVARGLLYLHDECE 531
L++ E+ G L + L F + RD + + VA+G+ +L
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---S 182
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQ 586
IH D+ RN+L+ + AKI DFGLA+ +M + IV G V+ +MAPE
Sbjct: 183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK----WMAPESI 238
Query: 587 NSGLITVKSDVYSFGVVLLEII 608
+ TV+SDV+S+G++L EI
Sbjct: 239 FDCVYTVQSDVWSYGILLWEIF 260
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 33/131 (25%), Positives = 61/131 (46%), Gaps = 8/131 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+ EF KG+L + L + + + +G+ Y+H + ++I+ D+K NI
Sbjct: 97 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNI 153
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKSDVYSFGVV 603
+ D+ + KI DFGL L G +G+ YM+PE + + D+Y+ G++
Sbjct: 154 FLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLI 210
Query: 604 LLEIICCRSNF 614
L E++
Sbjct: 211 LAELLHVCDTA 221
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-20
Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 14/134 (10%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+ E + +L + + + L + + + GL +LH + I+H D+K NIL
Sbjct: 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNIL 150
Query: 546 I-----DDSWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPE---WQNSGLITVKS 595
I +A ISDFGL K L + +GV G+ G++APE T
Sbjct: 151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210
Query: 596 DVYSFGVVLLEIIC 609
D++S G V +I
Sbjct: 211 DIFSAGCVFYYVIS 224
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 41/144 (28%), Positives = 68/144 (47%), Gaps = 27/144 (18%)
Query: 485 LLVYEFMSKGSLADLL--------------FNLETRPL-WRDRVRIALDVARGLLYLHDE 529
++ E+ SKG+L + L + + ++D V +ARG+ YL
Sbjct: 117 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-- 174
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPE 584
+ IH D+ RN+L+ ++ KI+DFGLA+ + V+ +MAPE
Sbjct: 175 -SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK----WMAPE 229
Query: 585 WQNSGLITVKSDVYSFGVVLLEII 608
+ T +SDV+SFGV++ EI
Sbjct: 230 ALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 46/144 (31%), Positives = 68/144 (47%), Gaps = 27/144 (18%)
Query: 485 LLVYEFMSKGSLADLL-----------FNLETRPLW----RDRVRIALDVARGLLYLHDE 529
++ E+ SKG+L + L +N P +D V A VARG+ YL
Sbjct: 151 YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA-- 208
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPE 584
+ IH D+ RN+L+ + KI+DFGLA+ + V+ +MAPE
Sbjct: 209 -SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK----WMAPE 263
Query: 585 WQNSGLITVKSDVYSFGVVLLEII 608
+ T +SDV+SFGV+L EI
Sbjct: 264 ALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 50/231 (21%), Positives = 89/231 (38%), Gaps = 59/231 (25%)
Query: 485 LLVYEFMSKGSLADLL--------------FNLETRPL-WRDRVRIALDVARGLLYLHDE 529
++ E+ SKG+L + L + + ++D V +ARG+ YL
Sbjct: 163 YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA-- 220
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPE 584
+ IH D+ RN+L+ ++ KI+DFGLA+ + V+ +MAPE
Sbjct: 221 -SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVK----WMAPE 275
Query: 585 WQNSGLITVKSDVYSFGVVLLEII-------CCRSNFEVNVSTADEVLLSTWVYNCFVAG 637
+ T +SDV+SFGV++ EI E ++ G
Sbjct: 276 ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------------LFKLLKEG 321
Query: 638 ---EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
+ E+ + + C P+ RP+ K ++ L+ +
Sbjct: 322 HRMDKPANCTNELYMMMRD--------CWHAVPSQRPTFKQLVEDLDRILT 364
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 37/118 (31%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 494 GSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRA 552
SL L +V D L +LH + ++H D+K NI + R
Sbjct: 141 PSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRC 196
Query: 553 KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKSDVYSFGVVLLEIIC 609
K+ DFGL L G V G YMAPE Q S +DV+S G+ +LE+ C
Sbjct: 197 KLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQGS--YGTAADVFSLGLTILEVAC 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 31/146 (21%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLW-----------------RDRVRIALDVARGLLYLH 527
+++ EF G+L+ L R + + + VA+G+ +L
Sbjct: 108 MVIVEFCKFGNLSTYL--RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA 165
Query: 528 DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMA 582
+ IH D+ RNIL+ + KI DFGLA+ + + + G ++ +MA
Sbjct: 166 ---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMA 218
Query: 583 PEWQNSGLITVKSDVYSFGVVLLEII 608
PE + T++SDV+SFGV+L EI
Sbjct: 219 PETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 31/148 (20%), Positives = 60/148 (40%), Gaps = 24/148 (16%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+LV EF+ GSL L + ++ +A +A + +L + +IH ++ +NI
Sbjct: 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNI 144
Query: 545 LIDDSWR--------AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKS 595
L+ K+SD G++ ++P + ++ PE +N + + +
Sbjct: 145 LLIREEDRKTGNPPFIKLSDPGISITVLPKDIL-QERIP----WVPPECIENPKNLNLAT 199
Query: 596 DVYSFGVVLLEIICC-------RSNFEV 616
D +SFG L EI +
Sbjct: 200 DKWSFGTTLWEICSGGDKPLSALDSQRK 227
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 43/199 (21%), Positives = 82/199 (41%), Gaps = 33/199 (16%)
Query: 489 EFMSKGSLADLL--FNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
E G L+ ++ F + R + V + + + L ++H +++H DIK N+
Sbjct: 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVF 168
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKSDVYSFGVVL 604
I + K+ D GL + ++T + G+ YM+PE +G KSD++S G +L
Sbjct: 169 ITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLL 226
Query: 605 LEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI-------TLERMVK 657
E+ +S F + + K+ + + + L ++V
Sbjct: 227 YEMAALQSPFYGDKMNLYSL--------------CKKIEQCDYPPLPSDHYSEELRQLVN 272
Query: 658 TGLLCIQDEPNLRPSMKNV 676
+CI +P RP + V
Sbjct: 273 ---MCINPDPEKRPDVTYV 288
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-20
Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 28/153 (18%)
Query: 485 LLVYEFMSKGSLADLL---------FNLETRPLWRDRVRIALDVARGLLYLHDECEVQII 535
L++ E M++G L L + P +++A ++A G+ YL+ + +
Sbjct: 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFV 160
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNSGL 590
H D+ RN ++ + + KI DFG+ + + G VR +M+PE G+
Sbjct: 161 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR----WMSPESLKDGV 216
Query: 591 ITVKSDVYSFGVVLLEII-------CCRSNFEV 616
T SDV+SFGVVL EI SN +V
Sbjct: 217 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 29/146 (19%)
Query: 485 LLVYEFMSKGSLADLL-----------------FNLETRPLWRDRVRIALDVARGLLYLH 527
L++ E+ G L + L + E D + + VA+G+ +L
Sbjct: 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA 162
Query: 528 DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMA 582
IH D+ RNIL+ KI DFGLA+ + + +V G V+ +MA
Sbjct: 163 ---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK----WMA 215
Query: 583 PEWQNSGLITVKSDVYSFGVVLLEII 608
PE + + T +SDV+S+G+ L E+
Sbjct: 216 PESIFNCVYTFESDVWSYGIFLWELF 241
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 35/129 (27%), Positives = 58/129 (44%), Gaps = 13/129 (10%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E + G L L + + A ++ L YL + +H DI RN+
Sbjct: 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNV 522
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG-----YMAPEWQNSGLITVKSDVYS 599
L+ + K+ DFGL++ + + + S+G +MAPE N T SDV+
Sbjct: 523 LVSSNDCVKLGDFGLSRYMEDSTY-----YKASKGKLPIKWMAPESINFRRFTSASDVWM 577
Query: 600 FGVVLLEII 608
FGV + EI+
Sbjct: 578 FGVCMWEIL 586
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 48/216 (22%), Positives = 80/216 (37%), Gaps = 36/216 (16%)
Query: 479 HRSSKKLLVY---EFMSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLHDECEVQ 533
SS K+ +Y + K +L D + T V I L +A + +LH +
Sbjct: 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---G 138
Query: 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLL-----------MPNQTGIVAGVRGSRGYMA 582
++H D+K NI K+ DFGL + G G++ YM+
Sbjct: 139 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198
Query: 583 PE-WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641
PE + + K D++S G++L E++ F T E + +F
Sbjct: 199 PEQIHGNS-YSHKVDIFSLGLILFELLY---PFS----TQMERVR---TLTDVRNLKFPP 247
Query: 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
L ++ MV+ + P RP N+I
Sbjct: 248 LFTQKYPC--EYVMVQ---DMLSPSPMERPEAINII 278
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 24/148 (16%)
Query: 480 RSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIA---LDVARGLLYLHDECEVQII 535
+ L + E+ G+L DL+ + L + R + L Y+H + II
Sbjct: 85 KKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFRQILEALSYIHSQ---GII 138
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-------------GSRGYMA 582
H D+K NI ID+S KI DFGLAK + + + + G+ Y+A
Sbjct: 139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVA 198
Query: 583 PE-WQNSGLITVKSDVYSFGVVLLEIIC 609
E +G K D+YS G++ E+I
Sbjct: 199 TEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 1e-19
Identities = 27/141 (19%), Positives = 54/141 (38%), Gaps = 24/141 (17%)
Query: 485 LLVYEFM--SKGSLADLLFNLETR---PLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+Y M + + ++L + + + R+++ L V R L LH ++H +
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 232
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW-----------QNS 588
+ +I++D ++ F + G SRG+ PE
Sbjct: 233 RPVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRR 287
Query: 589 GLITVKSDVYSFGVVLLEIIC 609
L+T D ++ G+V+ I C
Sbjct: 288 TLMTFSFDAWALGLVIYWIWC 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 20/147 (13%), Positives = 41/147 (27%), Gaps = 16/147 (10%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWR------DRVRIALDVARGLLYLHDECEVQIIHCD 538
LL+ S L L L+ ++R + + R L + ++H
Sbjct: 164 LLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGH 219
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW--QNSGLITVKSD 596
N+ I R + D + Y E+ ++ T +
Sbjct: 220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS----VPVTYAPREFLNASTATFTHALN 275
Query: 597 VYSFGVVLLEIICCRSNFEVNVSTADE 623
+ G+ + + C F +
Sbjct: 276 AWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 2e-19
Identities = 22/136 (16%), Positives = 46/136 (33%), Gaps = 15/136 (11%)
Query: 485 LLVYEFMSKGSLADLLFNLETR------PLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
+Y M +L L + + R+++ L V R L LH ++H
Sbjct: 181 FFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTY 236
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW-----QNSGLITV 593
++ +I++D ++ F + + A + L+T
Sbjct: 237 LRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296
Query: 594 KSDVYSFGVVLLEIIC 609
D ++ G+ + I C
Sbjct: 297 AFDTWTLGLAIYWIWC 312
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 38/125 (30%), Positives = 53/125 (42%), Gaps = 13/125 (10%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNILID 547
E + GSL L+ + L DR GL YLH +I+H D+K N+L+
Sbjct: 130 ELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLS 184
Query: 548 -DSWRAKISDFGLAKLLMPNQTGIVAGVRGS-RG---YMAPE-WQNSGLITVKSDVYSFG 601
D RA + DFG A L P+ G G +MAPE K D++S
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSC 243
Query: 602 VVLLE 606
++L
Sbjct: 244 CMMLH 248
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 45/235 (19%), Positives = 86/235 (36%), Gaps = 43/235 (18%)
Query: 485 LLVYEFMSKGSLADLLFNLETR--PLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKL 541
L+ F +G+L + + L+ + L D++ + L + RGL +H + H D+K
Sbjct: 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKP 162
Query: 542 RNILIDDSWRAKISDFGLAKLLMP--------NQTGIVAGVRGSRGYMAPE-WQNSG--L 590
NIL+ D + + D G A R + Y APE + +
Sbjct: 163 TNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL-----STWVYNCFVAGEFNKLVEE 645
I ++DV+S G VL ++ +++ D V L + + + +L+
Sbjct: 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNS 282
Query: 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFPPLSHVNSL 700
+ +P+ RP + ++ LE + P H +
Sbjct: 283 ----------------MMTVDPHQRPHIPLLLSQLEA-----LQPPAPGQHTTQI 316
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 34/159 (21%)
Query: 485 LLVYEFMSKGSLADLL---------------FNLETRPLWRDRVRIALDVARGLLYLHDE 529
+++ + S G L + L +++ D V + +A G+ YL
Sbjct: 88 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS-- 145
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPE 584
++H D+ RN+L+ D KISD GL + + + G +R +MAPE
Sbjct: 146 -SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIR----WMAPE 200
Query: 585 WQNSGLITVKSDVYSFGVVLLEII-------CCRSNFEV 616
G ++ SD++S+GVVL E+ C SN +V
Sbjct: 201 AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 44/159 (27%), Positives = 65/159 (40%), Gaps = 34/159 (21%)
Query: 485 LLVYEFMSKGSLADLL--------------FNLETRPL-WRDRVRIALDVARGLLYLHDE 529
++V+E+M G L L L + IA +A G++YL
Sbjct: 93 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA-- 150
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPE 584
+H D+ RN L+ + KI DFG+++ + V G +R +M PE
Sbjct: 151 -SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR----WMPPE 205
Query: 585 WQNSGLITVKSDVYSFGVVLLEII-------CCRSNFEV 616
T +SDV+SFGV+L EI SN EV
Sbjct: 206 SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 244
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-19
Identities = 40/123 (32%), Positives = 57/123 (46%), Gaps = 9/123 (7%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546
E + GSL+ LL + ++ + GL YLHD QI+H DIK N+LI
Sbjct: 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLI 155
Query: 547 D-DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE--WQNSGLITVKSDVYSFGVV 603
+ S KISDFG +K L G+ YMAPE + +D++S G
Sbjct: 156 NTYSGVLKISDFGTSKRLAGINP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCT 214
Query: 604 LLE 606
++E
Sbjct: 215 IIE 217
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 47/140 (33%), Positives = 63/140 (45%), Gaps = 25/140 (17%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLW--------RDRVRIALDVARGLLYLHDECEVQIIH 536
++ E M+ G L L ETRP D + +A D+A G YL E IH
Sbjct: 109 FILMELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIH 163
Query: 537 CDIKLRNILIDDSWR---AKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNS 588
DI RN L+ AKI DFG+A+ + G V+ +M PE
Sbjct: 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK----WMPPEAFME 219
Query: 589 GLITVKSDVYSFGVVLLEII 608
G+ T K+D +SFGV+L EI
Sbjct: 220 GIFTSKTDTWSFGVLLWEIF 239
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 39/154 (25%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLW-------------------------RDRVRIALDV 519
LL+ E+ GSL L E+R + D + A +
Sbjct: 102 LLIVEYAKYGSLRGFL--RESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159
Query: 520 ARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRG 579
++G+ YL E++++H D+ RNIL+ + + KISDFGL++ + + V+ S+G
Sbjct: 160 SQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS----YVKRSQG 212
Query: 580 -----YMAPEWQNSGLITVKSDVYSFGVVLLEII 608
+MA E + T +SDV+SFGV+L EI+
Sbjct: 213 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 46/158 (29%), Positives = 67/158 (42%), Gaps = 33/158 (20%)
Query: 485 LLVYEFMSKGSLADLL-------------FNLETRPL-WRDRVRIALDVARGLLYLHDEC 530
L+V+E+M G L L ++ PL + +A VA G++YL
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA--- 175
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEW 585
+ +H D+ RN L+ KI DFG+++ + V G +R +M PE
Sbjct: 176 GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR----WMPPES 231
Query: 586 QNSGLITVKSDVYSFGVVLLEII-------CCRSNFEV 616
T +SDV+SFGVVL EI SN E
Sbjct: 232 ILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 9e-19
Identities = 36/120 (30%), Positives = 66/120 (55%), Gaps = 8/120 (6%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547
E M GSL +L + + + ++++ V +GL YL ++ +I+H D+K NIL++
Sbjct: 111 EHMDGGSLDQVL--KKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVN 166
Query: 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607
K+ DFG++ L+ + G+R YM+PE +V+SD++S G+ L+E+
Sbjct: 167 SRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 37/152 (24%), Positives = 64/152 (42%), Gaps = 19/152 (12%)
Query: 481 SSKKLLVYEFMSKGSLADLLFNLETR-PLWRDRV-RIALDVARGLLYLHDECEVQIIHCD 538
+ L+ + KG L + L +E+R PL D V +I R + ++H + IIH D
Sbjct: 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRD 163
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----------VRGSRGYMAPE--- 584
+K+ N+L+ + K+ DFG A + + + Y PE
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 585 -WQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
+ N I K D+++ G +L + + FE
Sbjct: 224 LYSNFP-IGEKQDIWALGCILYLLCFRQHPFE 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 47/140 (33%), Positives = 63/140 (45%), Gaps = 25/140 (17%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLW--------RDRVRIALDVARGLLYLHDECEVQIIH 536
++ E M+ G L L ETRP D + +A D+A G YL E IH
Sbjct: 150 FILLELMAGGDLKSFL--RETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIH 204
Query: 537 CDIKLRNILIDDSWR---AKISDFGLAKLLMPNQTGIVAG-----VRGSRGYMAPEWQNS 588
DI RN L+ AKI DFG+A+ + G V+ +M PE
Sbjct: 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK----WMPPEAFME 260
Query: 589 GLITVKSDVYSFGVVLLEII 608
G+ T K+D +SFGV+L EI
Sbjct: 261 GIFTSKTDTWSFGVLLWEIF 280
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 18/138 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E L L ++ W + ++ + +H I+H D+K N L
Sbjct: 105 MVMEC-GNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFL 159
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPE-----------WQNSGLITV 593
I D K+ DFG+A + P+ T +V G+ YM PE ++ I+
Sbjct: 160 IVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 218
Query: 594 KSDVYSFGVVLLEIICCR 611
KSDV+S G +L + +
Sbjct: 219 KSDVWSLGCILYYMTYGK 236
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 44/196 (22%), Positives = 79/196 (40%), Gaps = 34/196 (17%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V ++ G L + + D++ + + L ++HD +I+H DIK +NI
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNI 156
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPE-WQNSGLITVKSDVYSFGV 602
+ ++ DFG+A++L N T +A G+ Y++PE +N KSD+++ G
Sbjct: 157 FLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGC 213
Query: 603 VLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI------TLERMV 656
VL E+ + FE L K++ + L +V
Sbjct: 214 VLYELCTLKHAFE----AGSMKNL------------VLKIISGSFPPVSLHYSYDLRSLV 257
Query: 657 KTGLLCIQDEPNLRPS 672
+ P RPS
Sbjct: 258 S---QLFKRNPRDRPS 270
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 18/138 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E L L ++ W + ++ + +H I+H D+K N L
Sbjct: 86 MVMEC-GNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFL 140
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPE-----------WQNSGLITV 593
I D K+ DFG+A + P+ T +V G+ YM PE ++ I+
Sbjct: 141 IVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP 199
Query: 594 KSDVYSFGVVLLEIICCR 611
KSDV+S G +L + +
Sbjct: 200 KSDVWSLGCILYYMTYGK 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 48/151 (31%), Positives = 66/151 (43%), Gaps = 44/151 (29%)
Query: 485 LLVYEFMSKGSLADLL--------------FNLETRPL-WRDRVRIALDVARGLLYLHDE 529
L E+ G+L D L N L + + A DVARG+ YL
Sbjct: 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL--- 158
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGY--------- 580
+ Q IH D+ RNIL+ +++ AKI+DFGL+ RG Y
Sbjct: 159 SQKQFIHRDLAARNILVGENYVAKIADFGLS--------------RGQEVYVKKTMGRLP 204
Query: 581 ---MAPEWQNSGLITVKSDVYSFGVVLLEII 608
MA E N + T SDV+S+GV+L EI+
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 4e-18
Identities = 35/138 (25%), Positives = 58/138 (42%), Gaps = 18/138 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E L L ++ W + ++ + +H I+H D+K N L
Sbjct: 133 MVMEC-GNIDLNSWLKKKKSIDPWERK-SYWKNMLEAVHTIHQH---GIVHSDLKPANFL 187
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPE-----------WQNSGLITV 593
I D K+ DFG+A + P+ T +V G+ YM PE ++ I+
Sbjct: 188 IVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP 246
Query: 594 KSDVYSFGVVLLEIICCR 611
KSDV+S G +L + +
Sbjct: 247 KSDVWSLGCILYYMTYGK 264
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 34/151 (22%)
Query: 485 LLVYEFMSKGSLADLL---------------------FNLETRPL-WRDRVRIALDVARG 522
L++E+ G L + L + L + D + A VA+G
Sbjct: 125 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKG 184
Query: 523 LLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-----VRGS 577
+ +L +H D+ RN+L+ KI DFGLA+ +M + +V G V+
Sbjct: 185 MEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVK-- 239
Query: 578 RGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608
+MAPE G+ T+KSDV+S+G++L EI
Sbjct: 240 --WMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 5e-18
Identities = 52/217 (23%), Positives = 90/217 (41%), Gaps = 26/217 (11%)
Query: 398 GACSKHKFPLMFATKDQYASAILFIKWSSGQANLSTHRIAPPIGNDKVNDKRKLLTVLAG 457
GAC+K PLM + F K+ + L + R K R+ +
Sbjct: 93 GACTKPGGPLMVIVE--------FCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGA 144
Query: 458 CLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIA 516
+ + S+ + +S + + +S + +L L + +
Sbjct: 145 IPVDLK-----RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199
Query: 517 LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG--- 573
VA+G+ +L + IH D+ RNIL+ + KI DFGLA+ + + + G
Sbjct: 200 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 574 --VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEII 608
++ +MAPE + T++SDV+SFGV+L EI
Sbjct: 257 LPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 38/213 (17%), Positives = 71/213 (33%), Gaps = 59/213 (27%)
Query: 489 EFMSKGSLADLL--FNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
E+ + GSLAD + ++ + L V RGL Y+H ++H DIK NI
Sbjct: 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIF 147
Query: 546 ID-------------------DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-W 585
I + KI D G + Q G ++A E
Sbjct: 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVL 202
Query: 586 QNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645
Q + K+D+++ + ++ +++++ +
Sbjct: 203 QENYTHLPKADIFALALTVVCAAGAEPLP-------------------RNGDQWHEIRQG 243
Query: 646 EVDKIT------LERMVKTGLLCIQDEPNLRPS 672
+ +I ++K + I +P RPS
Sbjct: 244 RLPRIPQVLSQEFTELLK---VMIHPDPERRPS 273
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 42/167 (25%), Positives = 68/167 (40%), Gaps = 42/167 (25%)
Query: 485 LLVYEFMSKGSLADLL----------------------FNLETRPL-WRDRVRIALDVAR 521
L++E+M+ G L + L + PL +++ IA VA
Sbjct: 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGY- 580
G+ YL E + +H D+ RN L+ ++ KI+DFGL++ +
Sbjct: 186 GMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY----YKADGNDAI 238
Query: 581 ----MAPEWQNSGLITVKSDVYSFGVVLLEII-------CCRSNFEV 616
M PE T +SDV+++GVVL EI ++ EV
Sbjct: 239 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 35/132 (26%), Positives = 62/132 (46%), Gaps = 24/132 (18%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRV------RIALDVARGLLYLHDECEVQIIHCDIKLR 542
E M SL + + + +IA+ + + L +LH + + +IH D+K
Sbjct: 86 ELMD-TSLDKFYKQVIDKG---QTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPS 139
Query: 543 NILIDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPE----WQNSGLITVKS 595
N+LI+ + K+ DFG++ L + G + YMAPE N +VKS
Sbjct: 140 NVLINALGQVKMCDFGISGYLVDDVAKDIDA-----GCKPYMAPERINPELNQKGYSVKS 194
Query: 596 DVYSFGVVLLEI 607
D++S G+ ++E+
Sbjct: 195 DIWSLGITMIEL 206
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 43/221 (19%)
Query: 486 LVYEFMSKGSLADLL------FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+ E + +L DL+ + + + +A G+ +LH ++IIH D+
Sbjct: 86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDL 141
Query: 540 KLRNILID-------------DSWRAKISDFGLAKLLMPNQTGIVAGVR---GSRGYMAP 583
K +NIL+ ++ R ISDFGL K L Q+ + G+ G+ AP
Sbjct: 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAP 201
Query: 584 E-------WQNSGLITVKSDVYSFGVVLLEIICCRSN-FEVNVSTADEVLLSTWVYNCFV 635
E Q +T D++S G V I+ + F S ++ + +
Sbjct: 202 ELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMK 261
Query: 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNV 676
L+ E D I +M I +P RP+ V
Sbjct: 262 CLHDRSLIAEATDLI--SQM-------IDHDPLKRPTAMKV 293
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 26/162 (16%), Positives = 58/162 (35%), Gaps = 28/162 (17%)
Query: 467 FLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRD-----RVRIALDVAR 521
+ S ++++ S +LV E S G+L + + NL + + A+ +
Sbjct: 128 MFMKFYSAHLFQNGS---VLVGELYSYGTLLNAI-NLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRA-----------KISDFGLA---KLLMPNQ 567
+ +H + +IIH DIK N ++ + + + D G + KL
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC 609
+ G+ E ++ + D + + ++
Sbjct: 241 I--FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 48/210 (22%), Positives = 82/210 (39%), Gaps = 36/210 (17%)
Query: 477 YKHRSSKKL-LVYEFMSKGSLADLL--FNLETRPLWRDRV-RIALDVARGLLYLHDECEV 532
R++ L +V E+ G LA ++ E + L + V R+ + L H +
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 533 --QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPE-WQNS 588
++H D+K N+ +D K+ DFGLA++L N A G+ YM+PE
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
KSD++S G +L E+ F + E+ K+ E +
Sbjct: 192 SY-NEKSDIWSLGCLLYELCALMPPFTAF--SQKEL--------------AGKIREGKFR 234
Query: 649 KI------TLERMVKTGLLCIQDEPNLRPS 672
+I L ++ + + RPS
Sbjct: 235 RIPYRYSDELNEIIT---RMLNLKDYHRPS 261
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 9e-17
Identities = 32/134 (23%), Positives = 54/134 (40%), Gaps = 16/134 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
+V FM+ GS DL+ + + + IA V + L Y+H +H +K
Sbjct: 103 VVTSFMAYGSAKDLICTHFMDGM--NELAIAYILQGVLKALDYIHHM---GYVHRSVKAS 157
Query: 543 NILIDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRG---YMAPE--WQNSGLITVK 594
+ILI + +S + Q + + S +++PE QN K
Sbjct: 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK 217
Query: 595 SDVYSFGVVLLEII 608
SD+YS G+ E+
Sbjct: 218 SDIYSVGITACELA 231
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 83.2 bits (205), Expect = 1e-16
Identities = 39/136 (28%), Positives = 58/136 (42%), Gaps = 10/136 (7%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLHDECEVQIIH 536
+ LL E+ G L L E ++ + D++ L YLH+ +IIH
Sbjct: 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIH 144
Query: 537 CDIKLRNILIDDSWRA---KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITV 593
D+K NI++ + KI D G AK L + + G+ Y+APE TV
Sbjct: 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTV 202
Query: 594 KSDVYSFGVVLLEIIC 609
D +SFG + E I
Sbjct: 203 TVDYWSFGTLAFECIT 218
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 19/130 (14%)
Query: 489 EFMSKGSLADLL---FNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
E MS S +++ + + + +I L + L +L + ++IIH DIK NI
Sbjct: 101 ELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNI 157
Query: 545 LIDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPE----WQNSGLITVKSDV 597
L+D S K+ DFG++ L + G R YMAPE + V+SDV
Sbjct: 158 LLDRSGNIKLCDFGISGQLVDSIAKTRDA-----GCRPYMAPERIDPSASRQGYDVRSDV 212
Query: 598 YSFGVVLLEI 607
+S G+ L E+
Sbjct: 213 WSLGITLYEL 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 7e-16
Identities = 31/149 (20%), Positives = 58/149 (38%), Gaps = 20/149 (13%)
Query: 476 VYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLHDECEV 532
+ + +++ L+ EF GSL +L + + DV G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 533 QIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---- 584
I+H +IK NI+ D K++DFG A+ L ++ + G+ Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYER 189
Query: 585 ----WQNSGLITVKSDVYSFGVVLLEIIC 609
+ D++S GV
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 13/144 (9%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWR-DRVRI-ALDVARGLLYLHDECE 531
+ Y + KL + + M+ G DL ++L ++ +R A ++ GL ++H+
Sbjct: 257 MSYAFHTPDKLSFILDLMNGG---DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR-- 311
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI 591
+++ D+K NIL+D+ +ISD GLA + G+ GYMAPE G+
Sbjct: 312 -FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPEVLQKGVA 367
Query: 592 TVKS-DVYSFGVVLLEIICCRSNF 614
S D +S G +L +++ S F
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPF 391
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 32/128 (25%), Positives = 58/128 (45%), Gaps = 18/128 (14%)
Query: 489 EFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547
E M + + L P+ + ++ + + + L YL ++ +IH D+K NIL+D
Sbjct: 104 ELMGTCA--EKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLD 159
Query: 548 DSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPE-----WQNSGLITVKSDVYS 599
+ + K+ DFG++ L G YMAPE +++DV+S
Sbjct: 160 ERGQIKLCDFGISGRLVDDKAKDRSA-----GCAAYMAPERIDPPDPTKPDYDIRADVWS 214
Query: 600 FGVVLLEI 607
G+ L+E+
Sbjct: 215 LGISLVEL 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 36/140 (25%), Positives = 61/140 (43%), Gaps = 17/140 (12%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECE 531
+ ++ ++YE+M S+ I + V + Y+H+E
Sbjct: 114 NYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK- 171
Query: 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE--WQNSG 589
I H D+K NIL+D + R K+SDFG ++ M + + G RG+ +M PE S
Sbjct: 172 -NICHRDVKPSNILMDKNGRVKLSDFGESE-YMVD--KKIKGSRGTYEFMPPEFFSNESS 227
Query: 590 LITVKSDVYSFGVVLLEIIC 609
K D++S G+ L +
Sbjct: 228 YNGAKVDIWSLGICLYVMFY 247
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 31/149 (20%), Positives = 58/149 (38%), Gaps = 20/149 (13%)
Query: 476 VYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRV--RIALDVARGLLYLHDECEV 532
+ + +++ L+ EF GSL +L + + DV G+ +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN--- 131
Query: 533 QIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---- 584
I+H +IK NI+ D K++DFG A+ L ++ + G+ Y+ P+
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ--FVSLYGTEEYLHPDMYER 189
Query: 585 ----WQNSGLITVKSDVYSFGVVLLEIIC 609
+ D++S GV
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-15
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 39/168 (23%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
+V E + SL +L + R + AR G YLH ++IH
Sbjct: 92 VVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 139
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLIT 592
D+KL N+ +++ KI DFGLA + + G R G+ Y+APE + +
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYD------GERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640
+ DV+S G ++ ++ + FE L T Y E++
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE------TSCLKET--YLRIKKNEYS 233
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 42/135 (31%), Positives = 65/135 (48%), Gaps = 22/135 (16%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
LV EF GS+ DL+ N + L IA ++ RGL +LH ++IH DIK +
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTL--KEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ 158
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQ----TGIVAGVRGSRGYMAPE-----WQNSGLITV 593
N+L+ ++ K+ DFG++ L T I G+ +MAPE
Sbjct: 159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVIACDENPDATYDF 213
Query: 594 KSDVYSFGVVLLEII 608
KSD++S G+ +E+
Sbjct: 214 KSDLWSLGITAIEMA 228
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-15
Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 17/136 (12%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV----RIAL---DVARGLLYLHDECEVQIIHCD 538
LV + +S GS+ D++ ++ + + V IA +V GL YLH IH D
Sbjct: 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRD 146
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR----GSRGYMAPE--WQNSGLIT 592
+K NIL+ + +I+DFG++ L VR G+ +MAPE Q G
Sbjct: 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-D 205
Query: 593 VKSDVYSFGVVLLEII 608
K+D++SFG+ +E+
Sbjct: 206 FKADIWSFGITAIELA 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 47/143 (32%), Positives = 72/143 (50%), Gaps = 7/143 (4%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEV 532
L Y + + L LV M+ G L ++++ R A ++ GL LH E
Sbjct: 249 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE--- 305
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
+I++ D+K NIL+DD +ISD GLA + QT + G G+ GYMAPE + T
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYT 363
Query: 593 VKSDVYSFGVVLLEIICCRSNFE 615
D ++ G +L E+I +S F+
Sbjct: 364 FSPDWWALGCLLYEMIAGQSPFQ 386
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 42/168 (25%), Positives = 69/168 (41%), Gaps = 39/168 (23%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
+V E + SL +L + R + AR G YLH ++IH
Sbjct: 118 VVLELCRRRSLLELH---------KRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHR 165
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLIT 592
D+KL N+ +++ KI DFGLA + + G R G+ Y+APE + +
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYD------GERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640
+ DV+S G ++ ++ + FE L T Y E++
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE------TSCLKET--YLRIKKNEYS 259
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 44/148 (29%), Positives = 62/148 (41%), Gaps = 14/148 (9%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWR-----DRVRI-ALDVARGLLYLH 527
L Y + L LV M+ G D+ +++ R + GL +LH
Sbjct: 250 LAYAFETKTDLCLVMTIMNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 528 DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN 587
II+ D+K N+L+DD +ISD GLA L QT G+ G+MAPE
Sbjct: 307 QR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
Query: 588 SGLITVKSDVYSFGVVLLEIICCRSNFE 615
D ++ GV L E+I R F
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFR 390
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 19/209 (9%), Positives = 51/209 (24%), Gaps = 43/209 (20%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E++ GSL ++ +T P +R +A H + +
Sbjct: 108 VVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVR 161
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+ ++ M + D+ G L
Sbjct: 162 VSIDGDVVLAYP---------------------ATMPDA-------NPQDDIRGIGASLY 193
Query: 606 EIICCRSNFEVNVSTADEVLLSTWVYNCFVA-GEFNKLVEEEVDKITLERMVKTGLLCIQ 664
++ R + + + ++ + ++ + +
Sbjct: 194 ALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQG------- 246
Query: 665 DEPNLRPSMKNVILMLEGTMEIPILAFPP 693
+ +R + + LM + T
Sbjct: 247 -DGGIRSASTLLNLMQQATAVADRTEVLG 274
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.4 bits (176), Expect = 4e-14
Identities = 40/254 (15%), Positives = 67/254 (26%), Gaps = 35/254 (13%)
Query: 28 STISLGSSLSPSGQHSWNSSSGLFQFGFYKQGS----GYSLGIWLVTSPNITVVWTANRD 83
S + +LS S + F+ G+ +W+ R+
Sbjct: 15 SVLPAYQTLSAG--QYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFSSTIPLRN 72
Query: 84 EQPMPSNATLALTMDGKLILKTEESKEKPIA-----DLVFDEPASFASMLDSGNFVLYSN 138
A LA + L + + + + D GN VL +
Sbjct: 73 -----KKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVDS 127
Query: 139 RSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNML 198
+ + L G L+ V G L Q DGN+V Y N
Sbjct: 128 LALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV---YGAGASKLVFQGDGNLVAYGPNG- 183
Query: 199 NKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIY 258
A W GT + N V+ +L+ S +
Sbjct: 184 ----AATWNAGTQGKG--AVRAVFQGDGNLVVYGAGNA----VLWHSHTGGHA-----SA 228
Query: 259 RTTLDSDGILRLYS 272
L ++G + +
Sbjct: 229 VLRLQANGSIAILD 242
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.2 bits (108), Expect = 2e-05
Identities = 26/173 (15%), Positives = 48/173 (27%), Gaps = 12/173 (6%)
Query: 140 SGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLN 199
T + Q+L G++LLS RF L +Q DGN+V+
Sbjct: 3 GRTRIPFNGVGTSVLPAYQTLSAGQYLLSP-------NQRFKLLLQGDGNLVIQDNGATV 55
Query: 200 KALEAYW-ANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIY 258
+ T + + L S + + + S ++
Sbjct: 56 WVANEQQPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVW---LTDNSTFTSNDQWNRT 112
Query: 259 RTTLDSDGILRLYSHHFKNDGNSTVGIEWSALEKQCVVKGFCGLNSYCSTSTN 311
L DG + L +G + + A++ + L
Sbjct: 113 HLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAP-GSELVQGVVYGAG 164
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 46/188 (24%), Positives = 75/188 (39%), Gaps = 37/188 (19%)
Query: 469 IAISSLLVYKHR----------SSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVR-IA 516
+ I L KH S + LV E G + L N +P + R
Sbjct: 62 VKIHCQL--KHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFM 118
Query: 517 LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR- 575
+ G+LYLH I+H D+ L N+L+ + KI+DFGLA L +
Sbjct: 119 HQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP------HEKH 169
Query: 576 ----GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY 631
G+ Y++PE ++SDV+S G + ++ R F+ + + +T
Sbjct: 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD------TDTVKNT--L 221
Query: 632 NCFVAGEF 639
N V ++
Sbjct: 222 NKVVLADY 229
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 43/130 (33%), Positives = 67/130 (51%), Gaps = 20/130 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
++ E++ GS DLL E PL D +IA ++ +GL YLH E + IH DIK
Sbjct: 97 IIMEYLGGGSALDLL---EPGPL--DETQIATILREILKGLDYLHSE---KKIHRDIKAA 148
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQ----TGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
N+L+ + K++DFG+A L Q T + G+ +MAPE K+D++
Sbjct: 149 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-----GTPFWMAPEVIKQSAYDSKADIW 203
Query: 599 SFGVVLLEII 608
S G+ +E+
Sbjct: 204 SLGITAIELA 213
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 34/127 (26%), Positives = 63/127 (49%), Gaps = 14/127 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+++ GSL D++ + ++ + + + L +LH Q+IH DIK NI
Sbjct: 94 VVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNI 147
Query: 545 LIDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
L+ K++DFG + ++ +V G+ +MAPE K D++S G
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 602 VVLLEII 608
++ +E+I
Sbjct: 204 IMAIEMI 210
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 36/127 (28%), Positives = 68/127 (53%), Gaps = 14/127 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRV-RIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ EF+ G+L D++ L +++ + V + L YLH + +IH DIK +I
Sbjct: 119 VLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSI 172
Query: 545 LIDDSWRAKISDFGLAKLL---MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
L+ R K+SDFG + +P + +V G+ +MAPE + L + D++S G
Sbjct: 173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISRSLYATEVDIWSLG 228
Query: 602 VVLLEII 608
++++E++
Sbjct: 229 IMVIEMV 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 69.6 bits (169), Expect = 2e-13
Identities = 38/245 (15%), Positives = 72/245 (29%), Gaps = 54/245 (22%)
Query: 66 IWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFA 125
I S + T + + S+ + D L+L +S + A A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLF--DSDVRVWASNTAGATGCRA 60
Query: 126 SMLDSGNFVLYSNRSGIIWESFST------------------------------------ 149
+ G V+ + ++ I W S +
Sbjct: 61 VLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGPGLWDSGTSNKGSVVV 120
Query: 150 -PTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWAN 208
+ + N H + + + L+M+ D N+VL+ R+ + W+
Sbjct: 121 ANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRD------DRVWST 174
Query: 209 GTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGIL 268
T + L PNG + +L+ ++ S S + Y L D L
Sbjct: 175 NTAGKGTGCR---AVLQPNGRMDVLTNQN--IAVWTSGNSRSAGR----YVFVLQPDRNL 225
Query: 269 RLYSH 273
+Y
Sbjct: 226 AIYGG 230
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 2e-06
Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 25/139 (17%)
Query: 149 TPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWAN 208
+ Q+L + L F MQ D N+VL+ + WA+
Sbjct: 6 GLSHEGSHPQTLHAAQSL---------ELSSFRFTMQSDCNLVLFDSD------VRVWAS 50
Query: 209 GTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGIL 268
T + + L +G+L +L+ I + S N Y L D +
Sbjct: 51 NTAGAT----GCRAVLQSDGLLVILTAQ--NTIRWSSGTKGSIGN----YVLVLQPDRTV 100
Query: 269 RLYSHHFKNDGNSTVGIEW 287
+Y + G S G
Sbjct: 101 TIYGPGLWDSGTSNKGSVV 119
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 2e-05
Identities = 24/144 (16%), Positives = 43/144 (29%), Gaps = 34/144 (23%)
Query: 66 IWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFA 125
I T N T + + S L++ D L+L + + A
Sbjct: 127 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL-FDRDDRVWSTNTAGKGTGCRA 185
Query: 126 SMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQ 185
+ +G + +N++ +W S + S GR+ +Q
Sbjct: 186 VLQPNGRMDVLTNQNIAVWTS-------------------------GNSRSAGRYVFVLQ 220
Query: 186 EDGNIVLYPRNMLNKALEAYWANG 209
D N+ +Y A W G
Sbjct: 221 PDRNLAIYGG--------ALWTTG 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 18/130 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
+V E+ GS++D++ + L IA +GL YLH + IH DIK
Sbjct: 101 IVMEYCGAGSVSDIIRLRN-KTL--TEDEIATILQSTLKGLEYLHFM---RKIHRDIKAG 154
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQ----TGIVAGVRGSRGYMAPEWQNSGLITVKSDVY 598
NIL++ AK++DFG+A L T I G+ +MAPE +D++
Sbjct: 155 NILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMAPEVIQEIGYNCVADIW 209
Query: 599 SFGVVLLEII 608
S G+ +E+
Sbjct: 210 SLGITAIEMA 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 18/129 (13%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL---DVARGLLYLHDECEVQIIHCDIKLR 542
LV E+ GS +DLL + +PL V IA +GL YLH +IH D+K
Sbjct: 131 LVMEYCL-GSASDLL-EVHKKPL--QEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAG 183
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---WQNSGLITVKSDVYS 599
NIL+ + K+ DFG A ++ P + + G+ +MAPE + G K DV+S
Sbjct: 184 NILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWS 238
Query: 600 FGVVLLEII 608
G+ +E+
Sbjct: 239 LGITCIELA 247
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 8e-13
Identities = 27/124 (21%), Positives = 50/124 (40%), Gaps = 25/124 (20%)
Query: 151 TDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGT 210
+D + G L+ G L + G + +Q D N+VLY N A WA+GT
Sbjct: 1 SDRLNSGHQLDTGGSL---------AEGGYLFIIQNDCNLVLYDNN------RAVWASGT 45
Query: 211 DIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRL 270
+ ++ L + +G L + SG++ ++ + + Y L D + +
Sbjct: 46 NGKASGCV---LKMQNDGNLVIYSGSRA-------IWASNTNRQNGNYYLILQRDRNVVI 95
Query: 271 YSHH 274
Y +
Sbjct: 96 YDNS 99
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-07
Identities = 22/120 (18%), Positives = 40/120 (33%), Gaps = 14/120 (11%)
Query: 29 TISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMP 88
++ G L G + G + F + LV N VW +
Sbjct: 3 RLNSGHQLDTGGS----LAEGGYLFIIQNDCN-------LVLYDNNRAVWASGT--NGKA 49
Query: 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFS 148
S L + DG L++ S+ ++ + + N V+Y N + IW + +
Sbjct: 50 SGCVLKMQNDGNLVIY-SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHT 108
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 5e-05
Identities = 26/123 (21%), Positives = 42/123 (34%), Gaps = 32/123 (26%)
Query: 90 NATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149
+ D L+L + ++ + M + GN V+YS S IW S
Sbjct: 20 GYLFIIQNDCNLVL-YDNNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-SRAIWASN-- 75
Query: 150 PTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANG 209
TN G + L +Q D N+V+Y + + A WA
Sbjct: 76 -----------------------TNRQNGNYYLILQRDRNVVIY-----DNSNNAIWATH 107
Query: 210 TDI 212
T++
Sbjct: 108 TNV 110
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 26/143 (18%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V+E + + +L L+ E R + V+ I+ + GL Y+H C IIH DIK N+
Sbjct: 107 MVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENV 163
Query: 545 LIDDSWRA------KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE------WQNSGLIT 592
L++ KI+D G A + T + +R Y +PE W
Sbjct: 164 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ----TREYRSPEVLLGAPW------G 213
Query: 593 VKSDVYSFGVVLLEIICCRSNFE 615
+D++S ++ E+I FE
Sbjct: 214 CGADIWSTACLIFELITGDFLFE 236
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 36/163 (22%)
Query: 469 IAISSLL----------VYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL 517
IAI L V + L +V+E +++G + + T ++
Sbjct: 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK------PLSE 136
Query: 518 DVAR--------GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569
D AR G+ YLH + +IIH DIK N+L+ + KI+DFG++ +
Sbjct: 137 DQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD-A 192
Query: 570 IVAGVRGSRGYMAPE---WQNSGLITVKSDVYSFGVVLLEIIC 609
+++ G+ +MAPE DV++ GV L +
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 38/146 (26%), Positives = 65/146 (44%), Gaps = 25/146 (17%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
+V + + G DL ++L + V + + L YL ++ +IIH
Sbjct: 92 MVVDLLLGG---DLRYHL------QQNVHFKEETVKLFICELVMALDYLQNQ---RIIHR 139
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE--WQNSGLITVKS 595
D+K NIL+D+ I+DF +A +L + + G++ YMAPE G +
Sbjct: 140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFA 197
Query: 596 -DVYSFGVVLLEIICCRSNFEVNVST 620
D +S GV E++ R + + ST
Sbjct: 198 VDWWSLGVTAYELLRGRRPYHIRSST 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 32/130 (24%), Positives = 59/130 (45%), Gaps = 8/130 (6%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
+ ++ L+ E+ G++ L L R ++A L Y H + ++IH DI
Sbjct: 80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-TYITELANALSYCHSK---RVIHRDI 135
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
K N+L+ + KI+DFG + ++ + G+ Y+ PE + K D++S
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHDEKVDLWS 192
Query: 600 FGVVLLEIIC 609
GV+ E +
Sbjct: 193 LGVLCYEFLV 202
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 34/135 (25%), Positives = 54/135 (40%), Gaps = 18/135 (13%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
K++ L+ EF +G L L R ++A L Y H+ ++IH DI
Sbjct: 85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-TFMEELADALHYCHER---KVIHRDI 140
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVK 594
K N+L+ KI+DFG + +R G+ Y+ PE K
Sbjct: 141 KPENLLMGYKGELKIADFGWSVH--------APSLRRRTMCGTLDYLPPEMIEGKTHDEK 192
Query: 595 SDVYSFGVVLLEIIC 609
D++ GV+ E +
Sbjct: 193 VDLWCAGVLCYEFLV 207
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 49/157 (31%), Positives = 72/157 (45%), Gaps = 23/157 (14%)
Query: 467 FLIAISSLLVYKHRSSKKL-LVYEFMSKGSLADLLFNLET-RPLWRDRVRI-ALDVARGL 523
FL A L Y ++ +L V E+ + G +L F+L R DR R ++ L
Sbjct: 209 FLTA----LKYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSAL 261
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSR 578
YLH E +++ D+KL N+++D KI+DFGL K GI G G+
Sbjct: 262 DYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKE------GIKDGATMKTFCGTP 313
Query: 579 GYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
Y+APE D + GVV+ E++C R F
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 33/133 (24%), Positives = 63/133 (47%), Gaps = 19/133 (14%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ EF G++ ++ L+ R L +++ + + L +LH + +IIH D+K N+
Sbjct: 93 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNV 148
Query: 545 LIDDSWRAKISDFG----LAKLLMPNQTGIVAGVRGSRGYMAPE-----WQNSGLITVKS 595
L+ +++DFG K L + I G+ +MAPE K+
Sbjct: 149 LMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 596 DVYSFGVVLLEII 608
D++S G+ L+E+
Sbjct: 204 DIWSLGITLIEMA 216
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 4e-12
Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-- 567
++ +I + + LH I+H D+K NIL+DD K++DFG + L P +
Sbjct: 124 KETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL 180
Query: 568 TGIVAGVRGSRGYMAPE------WQNSGLITVKSDVYSFGVVL 604
+ G+ Y+APE N + D++S GV++
Sbjct: 181 REVC----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 5e-12
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 34/162 (20%)
Query: 467 FLIAISSLLVYKHRSSKKL-LVYEFMSKGSLADLLFNLET-RPLWRDRVRI-ALDVARGL 523
FL A L Y ++ +L V E+ + G +L F+L R +R R ++ L
Sbjct: 66 FLTA----LKYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSAL 118
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSR 578
YLH +++ DIKL N+++D KI+DFGL K GI G G+
Sbjct: 119 EYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE------GISDGATMKTFCGTP 169
Query: 579 GYMAPEWQNSGLITVKS-----DVYSFGVVLLEIICCRSNFE 615
Y+APE ++ D + GVV+ E++C R F
Sbjct: 170 EYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 5e-12
Identities = 25/122 (20%), Positives = 40/122 (32%), Gaps = 24/122 (19%)
Query: 152 DTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211
+ +L GQ+L L + G + L +Q N+V Y WA+ TD
Sbjct: 3 NVLLSGQTLHADHSLQA---------GAYTLTIQNKCNLVKYQNG------RQIWASNTD 47
Query: 212 IQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLY 271
+ +L L +G L + N + + Y L DG +Y
Sbjct: 48 RRGS---GCRLTLLSDGNLVIYDHN------NNDVWGSACWGDNGKYALVLQKDGRFVIY 98
Query: 272 SH 273
Sbjct: 99 GP 100
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 9e-07
Identities = 22/121 (18%), Positives = 40/121 (33%), Gaps = 16/121 (13%)
Query: 26 LKSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQ 85
+ + + G +L +G + Q LV N +W +N D +
Sbjct: 1 MDNVLLSGQTLHADHS----LQAGAYTLTI--QNKCN-----LVKYQNGRQIWASNTDRR 49
Query: 86 PMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWE 145
S L L DG L++ + + + D + G FV+Y ++W
Sbjct: 50 G--SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWS 104
Query: 146 S 146
Sbjct: 105 L 105
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 4e-05
Identities = 19/122 (15%), Positives = 39/122 (31%), Gaps = 34/122 (27%)
Query: 90 NATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149
TL + L+ + ++ ++ ++L GN V+Y + + +W S
Sbjct: 21 AYTLTIQNKCNLVK-YQNGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGS--- 76
Query: 150 PTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANG 209
G++ L +Q+DG V+Y W+ G
Sbjct: 77 ----------------------ACWGDNGKYALVLQKDGRFVIYGP--------VLWSLG 106
Query: 210 TD 211
+
Sbjct: 107 PN 108
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV M ADL ++ + L D V+ + + RGL Y+H IIH D+K N+
Sbjct: 111 LVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNL 163
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ-NSGLITVKSDVYSFGVV 603
+++ KI DFGLA+ TG VA +R Y APE N D++S G +
Sbjct: 164 AVNEDCELKILDFGLARHTADEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCI 219
Query: 604 LLEIICCRSNF 614
+ E++ R+ F
Sbjct: 220 MAELLTGRTLF 230
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 25/149 (16%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLY 525
L Y + L LV ++ G DLL L + R+ ++AR +
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGG---DLLTLLS-----KFEDRLPEEMARFYLAEMVIAIDS 190
Query: 526 LHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE- 584
+H ++ +H DIK NIL+D + +++DFG LM + T + G+ Y++PE
Sbjct: 191 VH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 585 ----WQNSGLITVKSDVYSFGVVLLEIIC 609
G + D +S GV + E++
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEMLY 276
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-11
Identities = 24/121 (19%), Positives = 36/121 (29%), Gaps = 22/121 (18%)
Query: 153 TILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTDI 212
+L G + L S MQ D N+VLY + + T
Sbjct: 4 VLLTGDVIHTDNQL---------SYESAAFVMQGDCNLVLYNEA-------GGFQSNTHG 47
Query: 213 QSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLYS 272
+ L L+ G L++ S N + Y Y TL D + +Y
Sbjct: 48 RGVDCT---LRLNNRGQLEIHSANSNTPV---WVYPRSVNTVRGNYAATLGPDQHVTIYG 101
Query: 273 H 273
Sbjct: 102 P 102
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 10/88 (11%), Positives = 23/88 (26%), Gaps = 32/88 (36%)
Query: 124 FASMLDSGNFVLYSNRSG-IIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCL 182
+ + G ++S S +W N+ G +
Sbjct: 53 TLRLNNRGQLEIHSANSNTPVW-----------------------VYPRSVNTVRGNYAA 89
Query: 183 NMQEDGNIVLYPRNMLNKALEAYWANGT 210
+ D ++ +Y A+ W+
Sbjct: 90 TLGPDQHVTIY-----GPAI---WSTPA 109
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 19/97 (19%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQTGI--VAGVRGS 577
R + LH V + H DIK N+L++ K+ DFG AK L P++ + + S
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC----S 194
Query: 578 RGYMAPEWQNSGLI------TVKSDVYSFGVVLLEII 608
R Y APE LI T D++S G + E++
Sbjct: 195 RYYRAPE-----LIFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 35/121 (28%), Positives = 58/121 (47%), Gaps = 7/121 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
++YEFMS G L + + + + + V V +GL ++H+ +H D+K NI+
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIM 287
Query: 546 I--DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
S K+ DFGL L P Q+ V G+ + APE + +D++S GV+
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 345
Query: 604 L 604
Sbjct: 346 S 346
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 19/134 (14%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV FM DL ++ L DR++ + + +GL Y+H IIH D+K N+
Sbjct: 107 LVMPFMG----TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNL 159
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE----WQNSGLITVKSDVYSF 600
+++ KI DFGLA+ TG V +R Y APE W T D++S
Sbjct: 160 AVNEDCELKILDFGLARQADSEMTGYVV----TRWYRAPEVILNWMR---YTQTVDIWSV 212
Query: 601 GVVLLEIICCRSNF 614
G ++ E+I ++ F
Sbjct: 213 GCIMAEMITGKTLF 226
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 32/150 (21%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLY 525
L + + +KL + G +LL + R R L Y
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNG---ELLKYI------RKIGSFDETCTRFYTAEIVSALEY 145
Query: 526 LHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPE 584
LH + IIH D+K NIL+++ +I+DFG AK+L P A G+ Y++PE
Sbjct: 146 LHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 585 WQNSGLITVK-----SDVYSFGVVLLEIIC 609
L+T K SD+++ G ++ +++
Sbjct: 203 -----LLTEKSACKSSDLWALGCIIYQLVA 227
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 29/150 (19%)
Query: 486 LVYEFMSKGSLADLLFNLET-RPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRN 543
V E+++ G DL+F+++ R L + R + +++ L YLH+ II+ D+KL N
Sbjct: 130 FVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDN 183
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKS--- 595
+L+D K++D+G+ K G+ G G+ Y+APE ++ +
Sbjct: 184 VLLDSEGHIKLTDYGMCKE------GLRPGDTTSTFCGTPNYIAPE-----ILRGEDYGF 232
Query: 596 --DVYSFGVVLLEIICCRSNFEVNVSTADE 623
D ++ GV++ E++ RS F++ S+ +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP 262
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 40/150 (26%), Positives = 77/150 (51%), Gaps = 29/150 (19%)
Query: 486 LVYEFMSKGSLADLLFNLET-RPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRN 543
V E+++ G DL+F+++ R L + R + +++ L YLH+ II+ D+KL N
Sbjct: 87 FVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDN 140
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKS--- 595
+L+D K++D+G+ K G+ G G+ Y+APE ++ +
Sbjct: 141 VLLDSEGHIKLTDYGMCKE------GLRPGDTTSTFCGTPNYIAPE-----ILRGEDYGF 189
Query: 596 --DVYSFGVVLLEIICCRSNFEVNVSTADE 623
D ++ GV++ E++ RS F++ S+ +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNP 219
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 45/142 (31%), Positives = 74/142 (52%), Gaps = 29/142 (20%)
Query: 486 LVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRN 543
V EF++ G DL+F+++ +R R R A ++ L++LHD+ II+ D+KL N
Sbjct: 101 FVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDN 154
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKS--- 595
+L+D K++DFG+ K GI GV G+ Y+APE ++
Sbjct: 155 VLLDHEGHCKLADFGMCKE------GICNGVTTATFCGTPDYIAPE-----ILQEMLYGP 203
Query: 596 --DVYSFGVVLLEIICCRSNFE 615
D ++ GV+L E++C + FE
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFE 225
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-11
Identities = 20/124 (16%), Positives = 45/124 (36%), Gaps = 22/124 (17%)
Query: 150 PTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANG 209
+ + Q + + L +T + L M++D N+VL + N W +G
Sbjct: 5 VRNVLFSSQVMYDNAQL---------ATRDYSLVMRDDCNLVLTKGSKTN----IVWESG 51
Query: 210 TDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILR 269
T + ++ + + L +G L + + + ++ + Y L +G
Sbjct: 52 TSGRGQHCF---MRLGHSGELDITDDR------LNTVFVSNTVGQEGDYVLILQINGQAV 102
Query: 270 LYSH 273
+Y
Sbjct: 103 VYGP 106
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 5e-08
Identities = 21/123 (17%), Positives = 39/123 (31%), Gaps = 36/123 (29%)
Query: 90 NATLALTMDGKLILKTEESKEKPIADLVFDEPAS--FASMLDSGNFVLYSNRSGIIWESF 147
+ +L + D L+L T+ SK + + F + SG + +R ++ S
Sbjct: 25 DYSLVMRDDCNLVL-TKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVS- 82
Query: 148 STPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWA 207
T G + L +Q +G V+Y A+ W+
Sbjct: 83 ------------------------NTVGQEGDYVLILQINGQAVVY-----GPAV---WS 110
Query: 208 NGT 210
Sbjct: 111 TAA 113
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-11
Identities = 27/128 (21%), Positives = 45/128 (35%), Gaps = 25/128 (19%)
Query: 146 SFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAY 205
+ + + GQ L L + L MQ D N+VLY
Sbjct: 1 NIPFTNNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLYGGK-------YG 44
Query: 206 WANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSD 265
W + T E+ + L L+ G L + + F++ +S +S ++ Y L D
Sbjct: 45 WQSNTHGNGEHCF---LRLNHKGELIIKDDD------FKTIWSSRSSSKQGEYVLILQDD 95
Query: 266 GILRLYSH 273
G +Y
Sbjct: 96 GFGVIYGP 103
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 3e-08
Identities = 21/132 (15%), Positives = 39/132 (29%), Gaps = 39/132 (29%)
Query: 81 NRDEQPMPSNATLALTMDGKLILKTEESKEKPI--ADLVFDEPASFASMLDSGNFVLYSN 138
D + N L + D L+L K ++ + F + G ++ +
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVL----YGGKYGWQSNTHGNGEHCFLRLNHKGELIIKDD 71
Query: 139 RSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNML 198
IW S ++S G + L +Q+DG V+Y
Sbjct: 72 DFKTIWSS-------------------------RSSSKQGEYVLILQDDGFGVIYGP--- 103
Query: 199 NKALEAYWANGT 210
A + +
Sbjct: 104 -----AIFETSS 110
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 25/99 (25%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMP 565
+ + G+ YLH + +I H D+K NI++ K+ DFGLA +
Sbjct: 115 EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ G+ ++APE N + +++D++S GV+
Sbjct: 172 GV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 42/142 (29%), Positives = 74/142 (52%), Gaps = 15/142 (10%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLET-RPLWRDRVRI-ALDVARGLLYLHDECEVQIIHC 537
+ KL L+ ++++ G +L +L V+I ++ L +LH ++ II+
Sbjct: 130 TETKLHLILDYINGG---ELFTHLSQRERFTEHEVQIYVGEIVLALEHLH---KLGIIYR 183
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE---WQNSGLITVK 594
DIKL NIL+D + ++DFGL+K + ++T G+ YMAP+ +SG K
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG--HDK 241
Query: 595 S-DVYSFGVVLLEIICCRSNFE 615
+ D +S GV++ E++ S F
Sbjct: 242 AVDWWSLGVLMYELLTGASPFT 263
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 31/107 (28%), Positives = 48/107 (44%), Gaps = 10/107 (9%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI--DDSWRAKISDFGLAKLLMPNQ 567
+ I + L YLH++ I H DIK N L + S+ K+ DFGL+K
Sbjct: 168 KLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224
Query: 568 TGIVAGVR---GSRGYMAPE--WQNSGLITVKSDVYSFGVVLLEIIC 609
G G+ G+ ++APE + K D +S GV+L ++
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 29/142 (20%)
Query: 486 LVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRN 543
V E+++ G DL+++++ A ++A GL +L + II+ D+KL N
Sbjct: 419 FVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDN 472
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKS--- 595
+++D KI+DFG+ K I GV G+ Y+APE +I +
Sbjct: 473 VMLDSEGHIKIADFGMCKE------NIWDGVTTKTFCGTPDYIAPE-----IIAYQPYGK 521
Query: 596 --DVYSFGVVLLEIICCRSNFE 615
D ++FGV+L E++ ++ FE
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFE 543
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-11
Identities = 25/122 (20%), Positives = 42/122 (34%), Gaps = 23/122 (18%)
Query: 152 DTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211
+ + G+ L G+ L + MQED N+VLY + + WA+ T
Sbjct: 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYDHS------TSVWASNTG 46
Query: 212 IQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLY 271
I + K L +G + ++ S+ Y L DG + +Y
Sbjct: 47 ILGKKGC--KAVLQSDGNFVVYDAEGRSL------WASHSVRGNGNYVLVLQEDGNVVIY 98
Query: 272 SH 273
Sbjct: 99 GS 100
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 5e-08
Identities = 23/122 (18%), Positives = 37/122 (30%), Gaps = 33/122 (27%)
Query: 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFS 148
+ D L+L + + + A + GNFV+Y +W S
Sbjct: 19 EPYHFIMQEDCNLVLYDHSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWAS-- 76
Query: 149 TPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWAN 208
+ G + L +QEDGN+V+Y W+
Sbjct: 77 -----------------------HSVRGNGNYVLVLQEDGNVVIYGS--------DIWST 105
Query: 209 GT 210
GT
Sbjct: 106 GT 107
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 9/103 (8%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D RI V G+ Y+H +I+H D+K N+L+ +I DFGL+ +
Sbjct: 126 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC 609
+ + G+ Y+APE + G K DV+S GV+L ++
Sbjct: 183 KK--MKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLS 222
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 34/144 (23%), Positives = 58/144 (40%), Gaps = 13/144 (9%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEV 532
L + + L LV E+ G L LL R + + R ++ + +H +
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSVH---RL 181
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-------W 585
+H DIK NIL+D +++DFG L + T G+ Y++PE
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 586 QNSGLITVKSDVYSFGVVLLEIIC 609
+G + D ++ GV E+
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFY 265
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 31/97 (31%), Positives = 48/97 (49%), Gaps = 21/97 (21%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQ--TGIVAGVRGS 577
R + ++H + I H DIK +N+L++ K+ DFG AK L+P++ + S
Sbjct: 152 RAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYIC----S 204
Query: 578 RGYMAPEWQNSGLI------TVKSDVYSFGVVLLEII 608
R Y APE L+ T D++S G V E+I
Sbjct: 205 RFYRAPE-----LMLGATEYTPSIDLWSIGCVFGELI 236
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 32/105 (30%), Positives = 47/105 (44%), Gaps = 13/105 (12%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D I + G+ YLH I+H DIK NIL+ + KI DFGL+ +
Sbjct: 146 CDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 567 Q--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC 609
+ G+ Y+APE K DV+S GV++ ++C
Sbjct: 203 YKLRDRL----GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLC 242
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 28/99 (28%), Positives = 46/99 (46%), Gaps = 11/99 (11%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMP 565
+D + V + YLH+ I+H D+K N+L ++S + I+DFGL+K+
Sbjct: 106 KDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQN 161
Query: 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
G+ GY+APE + D +S GV+
Sbjct: 162 GIMSTAC---GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 40/142 (28%), Positives = 70/142 (49%), Gaps = 29/142 (20%)
Query: 486 LVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRN 543
V E+++ G DL+++++ A ++A GL +L + II+ D+KL N
Sbjct: 98 FVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDN 151
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKS--- 595
+++D KI+DFG+ K I GV G+ Y+APE +I +
Sbjct: 152 VMLDSEGHIKIADFGMCKE------NIWDGVTTKTFCGTPDYIAPE-----IIAYQPYGK 200
Query: 596 --DVYSFGVVLLEIICCRSNFE 615
D ++FGV+L E++ ++ FE
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFE 222
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 31/141 (21%)
Query: 486 LVYEFMSKGSLADL-----LFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDI 539
LV +++ + + ++ + L V++ + + R L Y+H I H DI
Sbjct: 130 LVLDYVPE----TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDI 182
Query: 540 KLRNILID-DSWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPEWQNSGLI----- 591
K +N+L+D D+ K+ DFG AK L+ + + SR Y APE LI
Sbjct: 183 KPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC----SRYYRAPE-----LIFGATD 233
Query: 592 -TVKSDVYSFGVVLLEIICCR 611
T DV+S G VL E++ +
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQ 254
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 5e-11
Identities = 30/123 (24%), Positives = 49/123 (39%), Gaps = 27/123 (21%)
Query: 151 TDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGT 210
T+ +L GQ+L+ HL G F L MQ+D N+VLY W + T
Sbjct: 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLY---------NGNWQSNT 44
Query: 211 DIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRL 270
KL L+ G L + +G+ +++S + + Y + DG L +
Sbjct: 45 ANNG---RDCKLTLTDYGELVIKNGDG--STVWKS----GAQSVKGNYAAVVHPDGRLVV 95
Query: 271 YSH 273
+
Sbjct: 96 FGP 98
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-05
Identities = 10/90 (11%), Positives = 25/90 (27%), Gaps = 33/90 (36%)
Query: 124 FASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLN 183
++ D G V+ + +W+S S G +
Sbjct: 52 KLTLTDYGELVIKNGDGSTVWKS-------------------------GAQSVKGNYAAV 86
Query: 184 MQEDGNIVLYPRNMLNKALEAYWANGTDIQ 213
+ DG +V++ + + ++
Sbjct: 87 VHPDGRLVVFG--------PSVFKIDPWVR 108
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 34/121 (28%), Positives = 58/121 (47%), Gaps = 7/121 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ EF+S G L D + + + + + GL ++H+ I+H DIK NI+
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIM 181
Query: 546 I--DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
+ KI DFGLA L P++ IV + + APE + + +D+++ GV+
Sbjct: 182 CETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
Query: 604 L 604
Sbjct: 240 G 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 15/103 (14%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-- 567
++ I + + +LH I+H D+K NIL+DD+ + ++SDFG + L P +
Sbjct: 200 KETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL 256
Query: 568 TGIVAGVRGSRGYMAPE------WQNSGLITVKSDVYSFGVVL 604
+ G+ GY+APE + + D+++ GV+L
Sbjct: 257 RELC----GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-11
Identities = 37/141 (26%), Positives = 66/141 (46%), Gaps = 31/141 (21%)
Query: 486 LVYEFMSKGSLADL-----LFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDI 539
LV E++ + + + + + +++ + + R L Y+H + I H DI
Sbjct: 115 LVLEYVPE----TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDI 167
Query: 540 KLRNILID-DSWRAKISDFGLAKLLMPNQTGI--VAGVRGSRGYMAPEWQNSGLI----- 591
K +N+L+D S K+ DFG AK+L+ + + + SR Y APE LI
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC----SRYYRAPE-----LIFGATN 218
Query: 592 -TVKSDVYSFGVVLLEIICCR 611
T D++S G V+ E++ +
Sbjct: 219 YTTNIDIWSTGCVMAELMQGQ 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 38/132 (28%), Positives = 57/132 (43%), Gaps = 15/132 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E M A+L + L +R+ L + G+ +LH IIH D+K NI
Sbjct: 107 IVMELMD----ANL-CQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 158
Query: 545 LIDDSWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
++ KI DFGLA+ + T V +R Y APE D++S G
Sbjct: 159 VVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYYRAPEVILGMGYKENVDIWSVGC 214
Query: 603 VLLEIICCRSNF 614
++ E+I F
Sbjct: 215 IMGEMIKGGVLF 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 7e-11
Identities = 31/103 (30%), Positives = 47/103 (45%), Gaps = 9/103 (8%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D I V G+ YLH I+H D+K N+L+ + KI DFGL+ +
Sbjct: 136 VDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC 609
+ + G+ Y+APE K DV+S GV+L ++
Sbjct: 193 KK--MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 7e-11
Identities = 25/99 (25%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMP 565
+ + + G+ YLH + +I H D+K NI++ + R K+ DFG+A +
Sbjct: 108 DEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
Query: 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ G+ ++APE N + +++D++S GV+
Sbjct: 165 GN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 7e-11
Identities = 30/121 (24%), Positives = 53/121 (43%), Gaps = 7/121 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+++EF+S + + + R+ V V L +LH I H DI+ NI+
Sbjct: 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENII 134
Query: 546 I--DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
S KI +FG A+ L P + + Y APE +++ +D++S G +
Sbjct: 135 YQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTL 192
Query: 604 L 604
+
Sbjct: 193 V 193
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 12/141 (8%)
Query: 475 LVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRI-ALDVARGLLYLHDECEV 532
L Y + + L +V E+M G DL+ + + R +V L +H +
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIH---SM 187
Query: 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLI 591
IH D+K N+L+D S K++DFG + G+ Y++PE ++ G
Sbjct: 188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 592 TV--KS-DVYSFGVVLLEIIC 609
+ D +S GV L E++
Sbjct: 248 GYYGRECDWWSVGVFLYEMLV 268
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 25/99 (25%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMP 565
+ + G+ YLH + +I H D+K NI++ K+ DFGLA +
Sbjct: 115 EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
Query: 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ G+ ++APE N + +++D++S GV+
Sbjct: 172 GVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 34/131 (25%), Positives = 61/131 (46%), Gaps = 14/131 (10%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV FM DL + ++++ + + +GL Y+H ++H D+K N+
Sbjct: 106 LVMPFMQ----TDL-QKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNL 157
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ-NSGLITVKSDVYSFGVV 603
+++ KI DFGLA+ TG V +R Y APE + D++S G +
Sbjct: 158 AVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEVILSWMHYNQTVDIWSVGCI 213
Query: 604 LLEIICCRSNF 614
+ E++ ++ F
Sbjct: 214 MAEMLTGKTLF 224
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 9e-11
Identities = 36/139 (25%), Positives = 57/139 (41%), Gaps = 23/139 (16%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
L+ E+ S G + D L R+ AR + Y H + I+H
Sbjct: 91 LIMEYASGGEVFDYLVA---------HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHR 138
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLITVKSD 596
D+K N+L+D KI+DFG + + G+ Y APE +Q + D
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVD 196
Query: 597 VYSFGVVLLEIICCRSNFE 615
V+S GV+L ++ F+
Sbjct: 197 VWSLGVILYTLVSGSLPFD 215
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 9e-11
Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 29/142 (20%)
Query: 486 LVYEFMSKGSLADLLFNLET-RPLWRDRVRI-ALDVARGLLYLHDECEVQIIHCDIKLRN 543
V E+++ G DL++++++ R A ++ GL +LH + I++ D+KL N
Sbjct: 95 FVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDN 148
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLITVKS--- 595
IL+D KI+DFG+ K ++ + G+ Y+APE ++ +
Sbjct: 149 ILLDKDGHIKIADFGMCKE------NMLGDAKTNTFCGTPDYIAPE-----ILLGQKYNH 197
Query: 596 --DVYSFGVVLLEIICCRSNFE 615
D +SFGV+L E++ +S F
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFH 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 32/123 (26%), Positives = 59/123 (47%), Gaps = 9/123 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLW-RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L+ E+ + G + L + D +R+ + G+ YLH I+H D+K +NI
Sbjct: 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNI 162
Query: 545 LI---DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFG 601
L+ KI DFG+++ + + + G+ Y+APE N IT +D+++ G
Sbjct: 163 LLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIG 220
Query: 602 VVL 604
++
Sbjct: 221 IIA 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 10/99 (10%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMP 565
RD + + YLH+ I+H D+K N+L D+ KI+DFGL+K++
Sbjct: 148 RDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEH 203
Query: 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
++ V G+ GY APE + D++S G++
Sbjct: 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 28/93 (30%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 519 VARGLLYLHDECEVQIIHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQTGIVAGVRGS 577
V + + H+ ++H DIK NILID + K+ DFG LL + + G+
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGT 211
Query: 578 RGYMAPEW-QNSGLITVKSDVYSFGVVLLEIIC 609
R Y PEW + + V+S G++L +++C
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 244
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 28/99 (28%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMP 565
+ + G+ YLH QI H D+K NI++ R KI DFGLA +
Sbjct: 114 EEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ G+ ++APE N + +++D++S GV+
Sbjct: 171 GNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 2e-10
Identities = 27/141 (19%), Positives = 46/141 (32%), Gaps = 32/141 (22%)
Query: 132 NFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIV 191
N +++S + + +SLE T + MQ D N+V
Sbjct: 1 NNIIFSK------QPDDNHPQILHATESLE-----------ILFGTHVYRFIMQTDCNLV 43
Query: 192 LYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKS 251
LY N WA T L P+GVL +++ +++S +
Sbjct: 44 LYDNN------NPIWATNTGGLGNGCR---AVLQPDGVLVVITNEN--VTVWQSPVA--- 89
Query: 252 MNETVIYRTTLDSDGILRLYS 272
+ Y L D + +Y
Sbjct: 90 -GKAGHYVLVLQPDRNVVIYG 109
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 5e-09
Identities = 21/143 (14%), Positives = 41/143 (28%), Gaps = 35/143 (24%)
Query: 70 TSPNITVVWTANRDEQPMPSNA-TLALTMDGKLILKTEESKEKPIADLVFDEPASFASML 128
+ ++ E ++ + D L+L + + + A +
Sbjct: 10 DDNHPQILHATESLEILFGTHVYRFIMQTDCNLVL-YDNNNPIWATNTGGLGNGCRAVLQ 68
Query: 129 DSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDG 188
G V+ +N + +W+S G + L +Q D
Sbjct: 69 PDGVLVVITNENVTVWQS-------------------------PVAGKAGHYVLVLQPDR 103
Query: 189 NIVLYPRNMLNKALEAYWANGTD 211
N+V+Y A WA T
Sbjct: 104 NVVIYGD--------ALWATQTV 118
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 29/93 (31%), Positives = 43/93 (46%), Gaps = 8/93 (8%)
Query: 519 VARGLLYLHDECEVQIIHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQTGIVAGVRGS 577
V + + H ++H DIK NILID AK+ DFG LL G+
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL---HDEPYTDFDGT 201
Query: 578 RGYMAPEW-QNSGLITVKSDVYSFGVVLLEIIC 609
R Y PEW + + V+S G++L +++C
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVC 234
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 41/148 (27%), Positives = 71/148 (47%), Gaps = 30/148 (20%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLETRPLWR-DRVRI-ALDVARGLLYLHDECEVQIIHC 537
+ KL L+ +F+ G DL L ++ + V+ ++A L +LH + II+
Sbjct: 97 TEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALDHLH---SLGIIYR 150
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLIT 592
D+K NIL+D+ K++DFGL+K I + G+ YMAPE ++
Sbjct: 151 DLKPENILLDEEGHIKLTDFGLSKE------SIDHEKKAYSFCGTVEYMAPE-----VVN 199
Query: 593 VKS-----DVYSFGVVLLEIICCRSNFE 615
+ D +SFGV++ E++ F+
Sbjct: 200 RRGHTQSADWWSFGVLMFEMLTGTLPFQ 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 24/145 (16%)
Query: 477 YKHRSSKKL--LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYL 526
Y HR + L E+ S G L D + + + A+ G++YL
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFFHQLMAGVVYL 121
Query: 527 HDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-GSRGYMAPE- 584
H I H DIK N+L+D+ KISDFGLA + N + G+ Y+APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 585 WQNSGLITVKSDVYSFGVVLLEIIC 609
+ DV+S G+VL ++
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 30/148 (20%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLETRPLWR-DRVRI-ALDVARGLLYLHDECEVQIIHC 537
+ KL L+ E++S G +L LE ++ D +++ L +LH + II+
Sbjct: 92 TGGKLYLILEYLSGG---ELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYR 145
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLIT 592
D+K NI+++ K++DFGL K I G G+ YMAPE ++
Sbjct: 146 DLKPENIMLNHQGHVKLTDFGLCKE------SIHDGTVTHTFCGTIEYMAPE-----ILM 194
Query: 593 VKS-----DVYSFGVVLLEIICCRSNFE 615
D +S G ++ +++ F
Sbjct: 195 RSGHNRAVDWWSLGALMYDMLTGAPPFT 222
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 30/148 (20%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLE-TRPLWRDRVRI-ALDVARGLLYLHDECEVQIIHC 537
++ KL V ++++ G +L ++L+ R R R A ++A L YLH + I++
Sbjct: 110 TADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLH---SLNIVYR 163
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-----GSRGYMAPEWQNSGLIT 592
D+K NIL+D ++DFGL K I G+ Y+APE ++
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCKE------NIEHNSTTSTFCGTPEYLAPE-----VLH 212
Query: 593 VKS-----DVYSFGVVLLEIICCRSNFE 615
+ D + G VL E++ F
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFY 240
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 2e-10
Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 24/121 (19%)
Query: 152 DTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211
+ + G++L GE L + GR+ MQED N+VLY + + WA T
Sbjct: 2 NILYSGETLSPGEFL---------NNGRYVFIMQEDCNLVLYDVD------KPIWATNTG 46
Query: 212 IQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLY 271
+ L++ +G L + S ++ + E Y L D + +Y
Sbjct: 47 GLDRRCH---LSMQSDGNLVVYSPR------NNPIWASNTGGENGNYVCVLQKDRNVVIY 97
Query: 272 S 272
Sbjct: 98 G 98
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 9e-08
Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 16/93 (17%)
Query: 127 MLDSGNFVLYSNRSGIIWESFSTPTDTIL-------GGQSLENGEHLLSSVTETNSSTGR 179
M + N VLY + IW + + D G + + + + T G
Sbjct: 25 MQEDCNLVLY-DVDKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGN 83
Query: 180 FCLNMQEDGNIVLYPRNMLNKALEAYWANGTDI 212
+ +Q+D N+V+Y A WA GT+I
Sbjct: 84 YVCVLQKDRNVVIYGT--------ARWATGTNI 108
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 32/125 (25%), Positives = 49/125 (39%), Gaps = 10/125 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLW---RDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
+V+EFM L + + L Y HD IIH D+K
Sbjct: 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPH 159
Query: 543 NILI---DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
+L+ ++S K+ FG+A L + + G G+ +MAPE DV+
Sbjct: 160 CVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWG 218
Query: 600 FGVVL 604
GV+L
Sbjct: 219 CGVIL 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 34/105 (32%), Positives = 48/105 (45%), Gaps = 13/105 (12%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D RI V G+ Y+H I+H D+K NIL+ + KI DFGL+ N
Sbjct: 121 HDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 567 Q--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC 609
+ G+ Y+APE G K DV+S GV+L ++
Sbjct: 178 TKMKDRI----GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLS 217
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 42/145 (28%), Positives = 62/145 (42%), Gaps = 24/145 (16%)
Query: 477 YKHRSSKKL--LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYL 526
Y HR + L E+ S G L D + + + A+ G++YL
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRIEP---------DIGMPEPDAQRFFHQLMAGVVYL 121
Query: 527 HDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR-GSRGYMAPE- 584
H I H DIK N+L+D+ KISDFGLA + N + G+ Y+APE
Sbjct: 122 HGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178
Query: 585 WQNSGLITVKSDVYSFGVVLLEIIC 609
+ DV+S G+VL ++
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLA 203
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 35/131 (26%), Positives = 58/131 (44%), Gaps = 23/131 (17%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+ +E +S +L +L+ + + VR A + + L LH +IIHCD+K NI
Sbjct: 176 MTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENI 231
Query: 545 LIDDSWRA--KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE------WQNSGLITVKSD 596
L+ R+ K+ DFG + + SR Y APE + + D
Sbjct: 232 LLKQQGRSGIKVIDFGSSCYEHQRVYTYIQ----SRFYRAPEVILGARY------GMPID 281
Query: 597 VYSFGVVLLEI 607
++S G +L E+
Sbjct: 282 MWSLGCILAEL 292
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 34/121 (28%), Positives = 59/121 (48%), Gaps = 7/121 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E++ G L D + + D + + G+ ++H I+H D+K NIL
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENIL 219
Query: 546 I--DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
D+ + KI DFGLA+ P + + G+ ++APE N ++ +D++S GV+
Sbjct: 220 CVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
Query: 604 L 604
Sbjct: 278 A 278
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 15/132 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIAL-DVARGLLYLHDECEVQIIHCDIKLRNI 544
LV E M A+L + L +R+ L + G+ +LH IIH D+K NI
Sbjct: 144 LVMELMD----ANL-CQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 195
Query: 545 LIDDSWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
++ KI DFGLA+ + T V +R Y APE D++S G
Sbjct: 196 VVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYYRAPEVILGMGYKENVDIWSVGC 251
Query: 603 VLLEIICCRSNF 614
++ E++ + F
Sbjct: 252 IMGEMVRHKILF 263
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 27/101 (26%), Positives = 46/101 (45%), Gaps = 11/101 (10%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
+ + YLH+ IIH D+K N+L+ ++ KI+DFG +K+L
Sbjct: 239 ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
Query: 567 QTGIVAGVRGSRGYMAPE---WQNSGLITVKSDVYSFGVVL 604
++ + G+ Y+APE + D +S GV+L
Sbjct: 296 S--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 8e-10
Identities = 39/154 (25%), Positives = 57/154 (37%), Gaps = 39/154 (25%)
Query: 476 VYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRV---RIALDVAR--------GL 523
V + +K+ +V E+ G + D V R + A GL
Sbjct: 74 VLYNEEKQKMYMVMEYCVCGMQE--ML---------DSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMA 582
YLH + I+H DIK N+L+ KIS G+A+ L P +GS +
Sbjct: 123 EYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 583 PEWQNSGLIT-------VKSDVYSFGVVLLEIIC 609
PE + K D++S GV L I
Sbjct: 180 PE-----IANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.4 bits (148), Expect = 8e-10
Identities = 92/576 (15%), Positives = 155/576 (26%), Gaps = 160/576 (27%)
Query: 57 KQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLA-------LTMDGKLILKTEESK 109
KQ + V N + + + EQ PS T L D ++ K S+
Sbjct: 74 KQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSR 133
Query: 110 EKPIAD----LVFDEPASFAS---MLDSGNFVLYSN--RS---------GIIWESFS--- 148
+P L+ PA +L SG + + S I W +
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCN 193
Query: 149 TPTDTILGGQSL---------ENGEHLLSSVTETNSSTGR----FCLNMQEDGNIVLYPR 195
+P + Q L +H + +S E+ +VL
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL--L 251
Query: 196 NMLN-KALEAYWANGTDIQSEYPYSVK-LNLSPN-GVLQLLSGNKTQKILFRSSYSLKSM 252
N+ N KA A+ ++ K L + V LS T I SL
Sbjct: 252 NVQNAKAWNAF-----NLSC------KILLTTRFKQVTDFLSAATTTHI------SLDHH 294
Query: 253 NETVIYRTTLDSDGILRLYSHHFKNDGNSTVGIEWSALEKQCVVKGF------CG--LNS 304
+ T+ T + +L Y + L ++ V+ +
Sbjct: 295 SMTL---TPDEVKSLLLKY-----------LDCRPQDLPRE-VLTTNPRRLSIIAESIRD 339
Query: 305 YCSTSTNISTKGDCHCFRGFNFINPKMKFLGCYRNFSDEEGCKRKMPAEFY------NIT 358
+T N ++ N E RKM +I
Sbjct: 340 GLATWDN---------WKHVNCDKLTTIIESSLNVLEPAE--YRKMFDRLSVFPPSAHIP 388
Query: 359 S--LKITWLGGLPYAKLSVSKKDCSKSCLN-----------DCYFGAAFYSDGACSKHKF 405
+ L + W + + V K S + Y + + H+
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448
Query: 406 PLMFATKDQYASAILFIKWSSGQANLS----THRIAPPIG--------NDKVNDKRKLL- 452
+ D Y F L +H IG +++ R +
Sbjct: 449 IV-----DHYNIPKTFDSDDLIPPYLDQYFYSH-----IGHHLKNIEHPERMTLFRMVFL 498
Query: 453 ------------TVLAGCLGSITFLCFLIAISSLLVYKHRSSKKLLVYEFMSKGSLADLL 500
+ GSI + L YK YE + ++ D L
Sbjct: 499 DFRFLEQKIRHDSTAWNASGSILNT-----LQQLKFYKPYICDNDPKYERLVN-AILDFL 552
Query: 501 FNLET---RPLWRDRVRIALDVARGLLYLHDECEVQ 533
+E + D +RIAL ++ +VQ
Sbjct: 553 PKIEENLICSKYTDLLRIALMAEDEAIFEEAHKQVQ 588
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 2e-06
Identities = 53/336 (15%), Positives = 98/336 (29%), Gaps = 109/336 (32%)
Query: 13 TVSEIIRAAQN--HQLKSTISLGSSLSPSGQHSWNSS----SGLFQFGFYKQGSGYSL-- 64
+ ++ Q +Q+ + S S + + +S L + Y+ L
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYEN----CLLV 249
Query: 65 --GIW--------------LVTSPNITVVWTANRDEQPMPSNATLALTMDGKLI-LKTEE 107
+ L+T+ V + + T +++D + L +E
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQVT-------DFLSAATTTHISLDHHSMTLTPDE 302
Query: 108 SKE---KPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGE 164
K K + D P +L + L II ES T +N +
Sbjct: 303 VKSLLLKYLDCRPQDLPRE---VLTTNPRRL-----SIIAESIRDGLATW------DNWK 348
Query: 165 HL-LSSVTETNSSTGRFCLNMQEDG-------NIVLYPRNML--NKALEAYWANGTDIQS 214
H+ +T S LN+ E + ++P + L W +
Sbjct: 349 HVNCDKLTTIIES----SLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 215 EYPYSVKLNLSPNGVLQLLSGNKT--QKILFRSSYSL---------KSMNETVIYRTTLD 263
V+ L + +K S+ S+ K NE ++R+ +D
Sbjct: 405 MV------------VVNKLH-KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVD 451
Query: 264 SDGILR---------------LYSH---HFKNDGNS 281
I + YSH H KN +
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP 487
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 9e-10
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 12/100 (12%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D + + Y H I+H ++K N+L+ K++DFGLA + +
Sbjct: 105 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 567 Q--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ G G+ GY++PE + D+++ GV+L
Sbjct: 162 EAWHGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 32/150 (21%)
Query: 481 SSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECE 531
+ L ++ E+ S G L + + N R + D AR G+ Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERICN---------AGRFSEDEARFFFQQLLSGVSYCHSM-- 135
Query: 532 VQIIHCDIKLRNILIDDSW--RAKISDFGLAKLLMPN---QTGIVAGVRGSRGYMAPE-W 585
QI H D+KL N L+D S R KI DFG +K + + ++ + G+ Y+APE
Sbjct: 136 -QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-----GTPAYIAPEVL 189
Query: 586 QNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
+DV+S GV L ++ FE
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 42/130 (32%), Positives = 63/130 (48%), Gaps = 21/130 (16%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV+E +S +L DLL N R + + R A + LL+L E+ IIHCD+K NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENI 190
Query: 545 LIDDSWRA--KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE------WQNSGLITVKSD 596
L+ + R+ KI DFG + L + SR Y +PE + + D
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQLGQRIYQYIQ----SRFYRSPEVLLGMPY------DLAID 240
Query: 597 VYSFGVVLLE 606
++S G +L+E
Sbjct: 241 MWSLGCILVE 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 12/100 (12%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D + + Y H I+H ++K N+L+ K++DFGLA + +
Sbjct: 128 ADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 567 Q--TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ G G+ GY++PE + D+++ GV+L
Sbjct: 185 EAWHGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 28/102 (27%), Positives = 41/102 (40%), Gaps = 17/102 (16%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D RI DV + Y H + H D+K N L K+ DFGLA P
Sbjct: 106 SDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162
Query: 567 Q--TGIVAGVRGSRGYMAPE--WQNSGLITVKSDVYSFGVVL 604
+ V G+ Y++P+ G + D +S GV++
Sbjct: 163 KMMRTKV----GTPYYVSPQVLEGLYGP---ECDEWSAGVMM 197
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 2e-09
Identities = 24/121 (19%), Positives = 44/121 (36%), Gaps = 23/121 (19%)
Query: 152 DTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211
+++ SL G L + L MQ D N VLY + WA+ T
Sbjct: 2 NSLSSPNSLFTGHSL--------EVGPSYRLIMQGDCNFVLYDSG------KPVWASNTG 47
Query: 212 IQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLY 271
L NG L + +++ ++++++ K+ + Y L D + +Y
Sbjct: 48 GLGSGCRLT---LHNNGNLVIY--DQSNRVIWQT----KTNGKEDHYVLVLQQDRNVVIY 98
Query: 272 S 272
Sbjct: 99 G 99
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 5e-09
Identities = 21/121 (17%), Positives = 43/121 (35%), Gaps = 34/121 (28%)
Query: 90 NATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149
+ L + D +L + K ++ ++ ++GN V+Y + +IW++
Sbjct: 21 SYRLIMQGDCNFVL-YDSGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQT--- 76
Query: 150 PTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANG 209
+TN + L +Q+D N+V+Y WA G
Sbjct: 77 ----------------------KTNGKEDHYVLVLQQDRNVVIYGP--------VVWATG 106
Query: 210 T 210
+
Sbjct: 107 S 107
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 32/131 (24%), Positives = 51/131 (38%), Gaps = 12/131 (9%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLW-RDRVRIALDVARGLLYLHDECEVQIIHC 537
H L++ E M G L + + R+ I D+ + +LH I H
Sbjct: 96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHR 152
Query: 538 DIKLRNILI---DDSWRAKISDFGLAKLLMPNQ-TGIVAGVRGSRGYMAPEWQNSGLITV 593
D+K N+L + K++DFG AK N + Y+APE
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC----YTPYYVAPEVLGPEKYDK 208
Query: 594 KSDVYSFGVVL 604
D++S GV++
Sbjct: 209 SCDMWSLGVIM 219
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 33/102 (32%), Positives = 45/102 (44%), Gaps = 17/102 (16%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D RI V G+ Y+H I+H D+K NIL+ + KI DFGL+ N
Sbjct: 121 HDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 567 Q--TGIVAGVRGSRGYMAPE--WQNSGLITVKSDVYSFGVVL 604
+ G+ Y+APE K DV+S GV+L
Sbjct: 178 TKMKDRI----GTAYYIAPEVLRGTYDE---KCDVWSAGVIL 212
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 42/140 (30%), Positives = 66/140 (47%), Gaps = 25/140 (17%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V + M DL L+T+ L D + + RGL Y+H ++H D+K N+
Sbjct: 107 IVQDLME----TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNL 159
Query: 545 LIDDSWRAKISDFGLAKLLMPNQ------TGIVAGVRGSRGYMAPE----WQNSGLITVK 594
L++ + KI DFGLA++ P+ T VA +R Y APE + T
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA----TRWYRAPEIMLNSKG---YTKS 212
Query: 595 SDVYSFGVVLLEIICCRSNF 614
D++S G +L E++ R F
Sbjct: 213 IDIWSVGCILAEMLSNRPIF 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 37/136 (27%), Positives = 59/136 (43%), Gaps = 29/136 (21%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
+V E++S G L D + R+ AR + Y H ++H
Sbjct: 88 MVMEYVSGGELFDYICK---------HGRVEEMEARRLFQQILSAVDYCHRHM---VVHR 135
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPN---QTGIVAGVRGSRGYMAPE-WQNSGLITV 593
D+K N+L+D AKI+DFGL+ ++ +T GS Y APE
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPEVISGRLYAGP 190
Query: 594 KSDVYSFGVVLLEIIC 609
+ D++S GV+L ++C
Sbjct: 191 EVDIWSCGVILYALLC 206
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 26/99 (26%), Positives = 45/99 (45%), Gaps = 8/99 (8%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLLMP 565
R+ + + + + YLH + ++H D+K NIL + +I DFG AK L
Sbjct: 116 REASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
G++ + ++APE D++S GV+L
Sbjct: 173 EN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 27/103 (26%), Positives = 44/103 (42%), Gaps = 15/103 (14%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
+ + YLH+ IIH D+K N+L+ ++ KI+DFG +K+L
Sbjct: 114 ATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 567 Q--TGIVAGVRGSRGYMAPE---WQNSGLITVKSDVYSFGVVL 604
+ G+ Y+APE + D +S GV+L
Sbjct: 171 SLMRTLC----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 34/132 (25%), Positives = 55/132 (41%), Gaps = 23/132 (17%)
Query: 486 LVYEFMSKGSLADL--LFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLR 542
LV E M DL + + + + ++ + GL LH+ ++H D+
Sbjct: 111 LVTELMR----TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPG 163
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPE----WQNSGLITVKSD 596
NIL+ D+ I DF LA+ + T V R Y APE ++ T D
Sbjct: 164 NILLADNNDITICDFNLAREDTADANKTHYVT----HRWYRAPELVMQFKG---FTKLVD 216
Query: 597 VYSFGVVLLEII 608
++S G V+ E+
Sbjct: 217 MWSAGCVMAEMF 228
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 26/141 (18%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V E+M DL LE PL + R + RGL Y+H ++H D+K N+
Sbjct: 99 IVQEYME----TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANL 151
Query: 545 LIDDSW-RAKISDFGLAKLLMPNQ------TGIVAGVRGSRGYMAPE----WQNSGLITV 593
I+ KI DFGLA+++ P+ + + ++ Y +P N T
Sbjct: 152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV----TKWYRSPRLLLSPNN---YTK 204
Query: 594 KSDVYSFGVVLLEIICCRSNF 614
D+++ G + E++ ++ F
Sbjct: 205 AIDMWAAGCIFAEMLTGKTLF 225
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 27/104 (25%), Positives = 40/104 (38%), Gaps = 21/104 (20%)
Query: 471 ISSLLVYKH----------RSSKKL-LVYEFMSKGSLADLLFNLETRP--LWRDRVR-IA 516
I L KH R ++L LV+E+ +L L+ + V+ I
Sbjct: 53 IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSIT 108
Query: 517 LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560
+ + + H IH D+K NILI K+ DFG A
Sbjct: 109 WQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 40/138 (28%), Positives = 55/138 (39%), Gaps = 28/138 (20%)
Query: 486 LVYEFMSKGSLADLL-----FNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540
LV+E M GS+ + FN E + + DVA L +LH++ I H D+K
Sbjct: 88 LVFEKMRGGSILSHIHKRRHFN-E-----LEASVVVQDVASALDFLHNK---GIAHRDLK 138
Query: 541 LRNILI---DDSWRAKISDFGLAKLLMPNQTGIVAGVR------GSRGYMAPEWQNSGLI 591
NIL + KI DF L + N GS YMAPE +
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 592 TVKS-----DVYSFGVVL 604
D++S GV+L
Sbjct: 199 EASIYDKRCDLWSLGVIL 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
+ I + + ++HD ++H D+K N+L +D+ KI DFG A+L P+
Sbjct: 106 TEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162
Query: 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
+ + Y APE N D++S GV+L
Sbjct: 163 N-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 6e-09
Identities = 35/129 (27%), Positives = 55/129 (42%), Gaps = 20/129 (15%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLW---RDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
+V E G L + + + + R + + L Y H + ++H D+K
Sbjct: 97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPE 153
Query: 543 NILI---DDSWRAKISDFGLAKLLMPNQ--TGIVAGVRGSRGYMAPE--WQNSGLITVKS 595
NIL KI DFGLA+L ++ T G+ YMAPE ++ K
Sbjct: 154 NILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA----GTALYMAPEVFKRDVTF---KC 206
Query: 596 DVYSFGVVL 604
D++S GVV+
Sbjct: 207 DIWSAGVVM 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 42/149 (28%), Positives = 58/149 (38%), Gaps = 34/149 (22%)
Query: 471 ISSLLVYKH----------RSSKKL-LVYEFMSKGSLADLLFNLETRP--LWRDRVR-IA 516
I L +H + K+ LV+EF+ +L +LE P L V+
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYL 130
Query: 517 LDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL---MPNQTGIVAG 573
+ G+ + H IIH DIK NIL+ S K+ DFG A+ L VA
Sbjct: 131 FQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA- 186
Query: 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGV 602
+R Y APE + V Y V
Sbjct: 187 ---TRWYRAPE------LLVGDVKYGKAV 206
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 25/101 (24%), Positives = 43/101 (42%), Gaps = 14/101 (13%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
R+ I + + YLH I H D+K N+L + K++DFG AK +
Sbjct: 161 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 567 QTGIVAGVRGSRGYMAPE---WQNSGLITVKSDVYSFGVVL 604
+ + + Y+APE + D++S GV++
Sbjct: 218 NS--LTTPCYTPYYVAPEVLGPEKYDK---SCDMWSLGVIM 253
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 26/92 (28%), Positives = 42/92 (45%), Gaps = 6/92 (6%)
Query: 519 VARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSR 578
+ + YL + IIH DIK NI+I + + K+ DFG A L + G+
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTI 193
Query: 579 GYMAPE-WQNSGLITVKSDVYSFGVVLLEIIC 609
Y APE + + +++S GV L ++
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 24/98 (24%), Positives = 43/98 (43%), Gaps = 7/98 (7%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPN 566
D + +L+ H ++H ++K N+L+ K++DFGLA +
Sbjct: 110 ADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
Q G G+ GY++PE D+++ GV+L
Sbjct: 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 12/98 (12%)
Query: 522 GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ---TGIVAGVRGSR 578
+ Y H I+H D+K N+L+DD+ KI+DFGL+ ++ T GS
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC-----GSP 171
Query: 579 GYMAPE-WQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
Y APE + DV+S G+VL ++ R F+
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 7/86 (8%)
Query: 479 HRSSKKLLVYEFMS---KGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQI 534
H +K LV+EFM K + R L + V+ + +GL + H+ +I
Sbjct: 73 HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KI 129
Query: 535 IHCDIKLRNILIDDSWRAKISDFGLA 560
+H D+K +N+LI+ + K+ DFGLA
Sbjct: 130 LHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 38/142 (26%), Positives = 62/142 (43%), Gaps = 29/142 (20%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR--------GLLYLHDECEVQIIHC 537
+V E++S G L D + R+ +R G+ Y H ++H
Sbjct: 93 MVMEYVSGGELFDYICK---------NGRLDEKESRRLFQQILSGVDYCHRHM---VVHR 140
Query: 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQ---TGIVAGVRGSRGYMAPE-WQNSGLITV 593
D+K N+L+D AKI+DFGL+ ++ + T GS Y APE
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC-----GSPNYAAPEVISGRLYAGP 195
Query: 594 KSDVYSFGVVLLEIICCRSNFE 615
+ D++S GV+L ++C F+
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 2e-08
Identities = 22/84 (26%), Positives = 43/84 (51%), Gaps = 5/84 (5%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHC 537
H +K LV+EF+ + L + + ++ + +GL + H +++H
Sbjct: 72 HTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHR 127
Query: 538 DIKLRNILIDDSWRAKISDFGLAK 561
D+K +N+LI+ K++DFGLA+
Sbjct: 128 DLKPQNLLINTEGAIKLADFGLAR 151
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 24/77 (31%), Positives = 38/77 (49%), Gaps = 5/77 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV+E + + L L L + ++ + RGL +LH I+H D+K NI
Sbjct: 96 LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI 151
Query: 545 LIDDSWRAKISDFGLAK 561
L+ K++DFGLA+
Sbjct: 152 LVTSGGTVKLADFGLAR 168
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 36/180 (20%), Positives = 59/180 (32%), Gaps = 57/180 (31%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V+E + L + + L V+ I V +GL YLH +C +IIH DIK NI
Sbjct: 122 MVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENI 178
Query: 545 LI-------------------------------------------------DDSWRAKIS 555
L+ + + KI+
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 556 DFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615
D G A + + T + +R Y + E +D++S + E+ FE
Sbjct: 239 DLGNACWVHKHFTEDI----QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 29/95 (30%), Positives = 45/95 (47%), Gaps = 17/95 (17%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRA-KISDFGLAKLLMPNQ--TGIVAGVRGS 577
+ L Y H + I+H D+K N++ID R ++ D+GLA+ P Q VA S
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA----S 193
Query: 578 RGYMAPE----WQNSGLITVKSDVYSFGVVLLEII 608
R + PE +Q D++S G +L +I
Sbjct: 194 RYFKGPELLVDYQM---YDYSLDMWSLGCMLASMI 225
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 3e-08
Identities = 23/77 (29%), Positives = 43/77 (55%), Gaps = 5/77 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV+E + + L L + + + ++ + + RGL +LH ++H D+K +NI
Sbjct: 96 LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNI 151
Query: 545 LIDDSWRAKISDFGLAK 561
L+ S + K++DFGLA+
Sbjct: 152 LVTSSGQIKLADFGLAR 168
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 36/143 (25%), Positives = 57/143 (39%), Gaps = 24/143 (16%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E M DL + T+ L D ++ R + LH +IH D+K N+
Sbjct: 91 IIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNL 143
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS---------RGYMAPE----WQNSGLI 591
LI+ + K+ DFGLA+++ + R Y APE
Sbjct: 144 LINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK---Y 200
Query: 592 TVKSDVYSFGVVLLEIICCRSNF 614
+ DV+S G +L E+ R F
Sbjct: 201 SRAMDVWSCGCILAELFLRRPIF 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 39/157 (24%)
Query: 467 FLIAISSLLVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR---- 521
FL+ L + + + L +V E+++ G + L R R + AR
Sbjct: 102 FLVK----LEFSFKDNSNLYMVMEYVAGGEMFSHL---------RRIGRFSEPHARFYAA 148
Query: 522 ----GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS 577
YLH +I+ D+K N+LID +++DFG AK + +T + G+
Sbjct: 149 QIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWTLC---GT 201
Query: 578 RGYMAPEWQNSGLITVKS-----DVYSFGVVLLEIIC 609
+APE +I K D ++ GV++ E+
Sbjct: 202 PEALAPE-----IILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 21/108 (19%), Positives = 44/108 (40%), Gaps = 8/108 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
LV+++M DL + L + + + + + YLH ++H D+K NI
Sbjct: 88 LVFDYME----TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNI 140
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLIT 592
L++ K++DFGL++ + + + ++T
Sbjct: 141 LLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT 188
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 39/157 (24%)
Query: 467 FLIAISSLLVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVAR---- 521
F+I + + ++++ ++ +++ G +L L R R VA+
Sbjct: 67 FIIR----MWGTFQDAQQIFMIMDYIEGG---ELFSLL------RKSQRFPNPVAKFYAA 113
Query: 522 ----GLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGS 577
L YLH + II+ D+K NIL+D + KI+DFG AK + P+ T + G+
Sbjct: 114 EVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYTLC---GT 166
Query: 578 RGYMAPEWQNSGLITVKS-----DVYSFGVVLLEIIC 609
Y+APE +++ K D +SFG+++ E++
Sbjct: 167 PDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 2e-07
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 10/86 (11%)
Query: 479 HRSSKKLLVYEFMSKGSLADL--LFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQII 535
H + +LV+E + + DL L ++ L + L + G+ Y HD +++
Sbjct: 70 HTKKRLVLVFEHLDQ----DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVL 122
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAK 561
H D+K +N+LI+ KI+DFGLA+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 2e-07
Identities = 25/86 (29%), Positives = 44/86 (51%), Gaps = 10/86 (11%)
Query: 479 HRSSKKLLVYEFMSKGSLADL--LFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQII 535
H K LV+EF + DL F+ L + V+ + +GL + H ++
Sbjct: 71 HSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVL 123
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAK 561
H D+K +N+LI+ + K+++FGLA+
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 26/86 (30%), Positives = 44/86 (51%), Gaps = 10/86 (11%)
Query: 479 HRSSKKLLVYEFMSKGSLADL--LFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQII 535
H LV+EFM K DL + + L +++ + RG+ + H +I+
Sbjct: 89 HSERCLTLVFEFMEK----DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RIL 141
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAK 561
H D+K +N+LI+ K++DFGLA+
Sbjct: 142 HRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 37/147 (25%), Positives = 57/147 (38%), Gaps = 40/147 (27%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+ +E + K + + L +P VR +A + L +LH+ Q+ H D+K NI
Sbjct: 99 IAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENI 154
Query: 545 LIDDSWRA-------------------KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE- 584
L +S +++DFG A + T IVA +R Y PE
Sbjct: 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVA----TRHYRPPEV 210
Query: 585 -----WQNSGLITVKSDVYSFGVVLLE 606
W DV+S G +L E
Sbjct: 211 ILELGW------AQPCDVWSIGCILFE 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 469 IAISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD 528
I + Y LV++F LA LL N+ + + R+ + GL Y+H
Sbjct: 84 ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 142
Query: 529 ECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560
+I+H D+K N+LI K++DFGLA
Sbjct: 143 N---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 23/103 (22%), Positives = 43/103 (41%), Gaps = 23/103 (22%)
Query: 476 VYKHRSSKKL-LVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVA----------RGL 523
V+ + +K+ L++++ DL ++ R ++ + L G+
Sbjct: 86 VFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRA----KISDFGLAKL 562
YLH ++H D+K NIL+ KI+D G A+L
Sbjct: 142 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 25/86 (29%), Positives = 44/86 (51%), Gaps = 10/86 (11%)
Query: 479 HRSSKKLLVYEFMSKGSLADL--LFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQII 535
H LV+E++ K DL + + V+ + RGL Y H + +++
Sbjct: 70 HTEKSLTLVFEYLDK----DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVL 122
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAK 561
H D+K +N+LI++ K++DFGLA+
Sbjct: 123 HRDLKPQNLLINERGELKLADFGLAR 148
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 20/90 (22%), Positives = 41/90 (45%), Gaps = 14/90 (15%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLET-RPLWRDRVR-IALDVARGLLYLHDECEVQIIH 536
H + + L++E+ DL ++ + ++ + G+ + H + +H
Sbjct: 103 HHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLH 155
Query: 537 CDIKLRNILIDDSWRA-----KISDFGLAK 561
D+K +N+L+ S + KI DFGLA+
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 35/147 (23%), Positives = 58/147 (39%), Gaps = 40/147 (27%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V+E + S D + P D +R +A + + + +LH ++ H D+K NI
Sbjct: 94 IVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENI 149
Query: 545 LIDDSWRA-------------------KISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE- 584
L S K+ DFG A + + +V+ +R Y APE
Sbjct: 150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVS----TRHYRAPEV 205
Query: 585 -----WQNSGLITVKSDVYSFGVVLLE 606
W + DV+S G +L+E
Sbjct: 206 ILALGW------SQPCDVWSIGCILIE 226
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 28/86 (32%), Positives = 43/86 (50%), Gaps = 10/86 (11%)
Query: 479 HRSSKKLLVYEFMSKGSLADL--LFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQII 535
S LV++FM DL + + L ++ L +GL YLH I+
Sbjct: 82 GHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 134
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAK 561
H D+K N+L+D++ K++DFGLAK
Sbjct: 135 HRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 36/153 (23%), Positives = 59/153 (38%), Gaps = 46/153 (30%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVR-IALDVARGLLYLHDECEVQIIHCDIKLRNI 544
L++E + SL +++ + ++ +++ + L YL + + H D+K NI
Sbjct: 113 LIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENI 168
Query: 545 LIDDSWRA-------------------------KISDFGLAKLLMPNQTGIVAGVRGSRG 579
L+DD + K+ DFG A I+ +R
Sbjct: 169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIIN----TRQ 224
Query: 580 YMAPE------WQNSGLITVKSDVYSFGVVLLE 606
Y APE W V SD++SFG VL E
Sbjct: 225 YRAPEVILNLGW------DVSSDMWSFGCVLAE 251
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 20/73 (27%), Positives = 32/73 (43%), Gaps = 4/73 (5%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-TGIVAGVRGSRG 579
G ++H E IIH D+K N L++ K+ DFGLA+ + + T IV + +
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 580 YMAPEWQNSGLIT 592
+T
Sbjct: 197 PGPHNKNLKKQLT 209
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 15/40 (37%), Positives = 22/40 (55%), Gaps = 3/40 (7%)
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560
G+ Y+H I+H D+K N L++ K+ DFGLA
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.3 bits (106), Expect = 4e-05
Identities = 15/90 (16%), Positives = 25/90 (27%), Gaps = 4/90 (4%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V EF G DL I + L + H D+ N+L
Sbjct: 139 IVLEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVR 575
+ + K+ K G+ +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 7e-04
Identities = 17/55 (30%), Positives = 25/55 (45%), Gaps = 6/55 (10%)
Query: 510 RDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAK 561
R+ I + + YLH I H D+K N+L + K++DFG AK
Sbjct: 117 REASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 702 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.98 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.98 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.98 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.98 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.98 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.98 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.98 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.98 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.98 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.98 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.98 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.98 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.98 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.98 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.98 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.98 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.98 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.98 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.98 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.98 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.98 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.97 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.97 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.97 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.96 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.96 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.96 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.96 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.96 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.96 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.95 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.89 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.84 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.84 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.84 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.81 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.8 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.75 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.73 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.69 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.68 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.66 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.64 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.62 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.56 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.54 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.47 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.44 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.36 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.35 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.31 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.27 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.22 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.2 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.19 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.09 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.02 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.24 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.22 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.13 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.89 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.74 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 96.34 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 93.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 92.47 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 92.21 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 91.58 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 90.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 86.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 86.45 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 84.77 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 83.66 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 81.45 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 80.11 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=357.42 Aligned_cols=229 Identities=20% Similarity=0.199 Sum_probs=182.8
Q ss_pred ccccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCC----CceEEEccCCc
Q 038002 25 QLKSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPS----NATLALTMDGK 100 (702)
Q Consensus 25 ~~~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~----~~~l~~~~~g~ 100 (702)
.+.++|.+|++|+++ ++|+|++|+|+||||.++ .+|+ |+ +.+ +||+|||+.|+.++ +++|+|+.||+
T Consensus 12 ~~~~~l~~g~~l~~~--~~l~S~~g~F~lgf~~~~-~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 12 VGTSVLPAYQTLSAG--QYLLSPNQRFKLLLQGDG-NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp TTSSEECTTEEBCTT--CEEECTTSSEEEEECTTS-CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred ccCCEecCCCEecCC--CEEEcCCCcEEEEEECCC-CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 445999999999976 899999999999999655 4566 76 777 99999999999764 78999999999
Q ss_pred EEE--EcCCCCeeeeeccccC-----CcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCc----cCCCCeEEee
Q 038002 101 LIL--KTEESKEKPIADLVFD-----EPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQS----LENGEHLLSS 169 (702)
Q Consensus 101 L~l--~~~~~~~~w~~~~~~~-----~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~----l~~~~~L~S~ 169 (702)
|+| .|+++++||++++... .++++|+|+|+|||||++ +.+|||| ||||||||||+ |..++.|
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~~~lWqS--~ptdtlLpg~~~~~~l~~g~~L--- 155 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--SLALWNG--TPAIPLVPGAIDSLLLAPGSEL--- 155 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--EEEEEES--CTTSCCCCSCTTCEEECSSEEE---
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--CceeeCc--ccccccccccccccccccCccc---
Confidence 999 7778899999987431 346799999999999998 7899999 99999999999 7778888
Q ss_pred ccCCCCcccceEeeeccCCceeeeeccccccccceeecCCccccCcCcceeeeeecCCccEEEeecCccceEEeeeeeee
Q 038002 170 VTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSL 249 (702)
Q Consensus 170 ~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (702)
++.+||++|.|+++|+++|++++|. +...+||+++++.... ..+.++.+|.+.+++.++..... ++.
T Consensus 156 ~S~~dps~G~fsl~l~~dGnlvLy~-----~~~~~yW~Sgt~~~~~----~~l~l~~dGnLvl~d~~~~~vWs---S~t- 222 (276)
T 3m7h_A 156 VQGVVYGAGASKLVFQGDGNLVAYG-----PNGAATWNAGTQGKGA----VRAVFQGDGNLVVYGAGNAVLWH---SHT- 222 (276)
T ss_dssp CTTCEEEETTEEEEECTTSCEEEEC-----TTSSEEEECCCTTTTC----CEEEECTTSCEEEECTTSCEEEE---CSC-
T ss_pred ccCCCCCCceEEEeecCCceEEEEe-----CCCeEEEECCCCCCcc----EEEEEcCCCeEEEEeCCCcEEEE---ecC-
Confidence 5688999999999999999988762 2347899999985432 24788889998887765532221 121
Q ss_pred eccCcceEEEEEEccCCcEEEEEecccCCCCcceEEEEeecc
Q 038002 250 KSMNETVIYRTTLDSDGILRLYSHHFKNDGNSTVGIEWSALE 291 (702)
Q Consensus 250 ~~~~~~~~~rl~Ld~dG~lr~y~~~~~~~~~~~w~~~w~~p~ 291 (702)
... ..+|++|+.||||++|.| ...|...|.+|.
T Consensus 223 -~~~--~~~rl~Ld~dGnLvly~~------~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 223 -GGH--ASAVLRLQANGSIAILDE------KPVWARFGFQPT 255 (276)
T ss_dssp -TTC--TTCEEEECTTSCEEEEEE------EEEEESSSCCTT
T ss_pred -CCC--CCEEEEEcCCccEEEEcC------CCeEEccCccCC
Confidence 111 237999999999999987 123655555553
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=362.64 Aligned_cols=224 Identities=18% Similarity=0.153 Sum_probs=181.6
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh----------------------eeeEEEEEecCCeeEEEEecCCCCCHHH
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------ISSLLVYKHRSSKKLLVYEFMSKGSLAD 498 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~ 498 (702)
+...++||+|+| ||++.... ..|||| |+++++++++++..|||||||+||+|.+
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~ 139 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQ 139 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHH
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHH
Confidence 344578999998 99988664 788888 8999999999999999999999999999
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC-cEEEecccceeecCCCCCc----eeec
Q 038002 499 LLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW-RAKISDFGLAKLLMPNQTG----IVAG 573 (702)
Q Consensus 499 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~----~~~~ 573 (702)
+|.+.+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.++ ++||+|||+|+.+...... ....
T Consensus 140 ~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~ 215 (336)
T 4g3f_A 140 LIKQMG-CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215 (336)
T ss_dssp HHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CC
T ss_pred HHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCc
Confidence 998765 799999999999999999999999 999999999999999987 6999999999987543221 1234
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +...... ...++...++
T Consensus 216 ~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~-----i~~~~~~---~~~~~~~~s~ 284 (336)
T 4g3f_A 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLK-----IASEPPP---IREIPPSCAP 284 (336)
T ss_dssp CCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHH-----HHHSCCG---GGGSCTTSCH
T ss_pred cccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH-----HHcCCCC---chhcCccCCH
Confidence 6799999999999999999999999999999999999999975422211 111 1111110 0123445567
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.+.+++.+||+.||++|||++||++.|+..
T Consensus 285 ~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 285 LTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 889999999999999999999999988653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=359.84 Aligned_cols=226 Identities=23% Similarity=0.245 Sum_probs=174.7
Q ss_pred cccceEEEeEE--EEEeeeehhhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCCCC
Q 038002 446 NDKRKLLTVLA--GCLGSITFLCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMSKG 494 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~~g 494 (702)
...++||+|+| ||+|.... .|||| |+++++++. ++..+||||||++|
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gG 116 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGS 116 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSC
T ss_pred EEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCC
Confidence 34568999998 89887543 45665 888998775 46789999999999
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC-Cceeec
Q 038002 495 SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-TGIVAG 573 (702)
Q Consensus 495 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~~~~~ 573 (702)
+|.++|......+++.++..|+.||++||+|||++ +||||||||+|||+++++.+||+|||+|+...... ......
T Consensus 117 sL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~ 193 (307)
T 3omv_A 117 SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQ 193 (307)
T ss_dssp BHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------
T ss_pred CHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecc
Confidence 99999987777899999999999999999999999 99999999999999999999999999998764332 223455
Q ss_pred eeccccccCcccccC---CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 574 VRGSRGYMAPEWQNS---GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
..||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ..+.. ....+.... .....+..
T Consensus 194 ~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~---~~~~~----~~~~~~~~p-~~~~~~~~ 265 (307)
T 3omv_A 194 PTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR---DQIIF----MVGRGYASP-DLSKLYKN 265 (307)
T ss_dssp CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHH----HHHTTCCCC-CSTTSCTT
T ss_pred cccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH---HHHHH----HHhcCCCCC-Cccccccc
Confidence 789999999998853 46899999999999999999999999643211 11111 111111111 01123344
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.++.+.+++.+||+.||++|||++||+++|+.+.
T Consensus 266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 5678899999999999999999999999998764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=358.40 Aligned_cols=225 Identities=24% Similarity=0.290 Sum_probs=176.9
Q ss_pred cccceEEEeEE--EEEeeee-------hhhhHhh---------------------------eeeEEEEEecCCeeEEEEe
Q 038002 446 NDKRKLLTVLA--GCLGSIT-------FLCFLIA---------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~-------~~~~avk---------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
...++||+|+| ||+|... ...|||| |+++++++.+++..|||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34578999998 9998753 2567887 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEe
Q 038002 490 FMSKGSLADLLFNLE--------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
||++|+|.++|.... ..+++.+++.|+.||++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 999999999997642 2488999999999999999999999 99999999999999999999999
Q ss_pred cccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHh
Q 038002 556 DFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 556 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... . .. ....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--~--~~----~~~~ 272 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--N--TE----AIDC 272 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--H--HH----HHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--H--HH----HHHH
Confidence 9999987644332 22345679999999999999999999999999999999999 899996431 1 11 1111
Q ss_pred hhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 634 FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
+..+. ..+.+...++++.+++.+||+.||++|||++||+++|+.+.+.
T Consensus 273 i~~g~-----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQGR-----ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHTC-----CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcCC-----CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 12221 1122334466789999999999999999999999999997654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=353.73 Aligned_cols=219 Identities=18% Similarity=0.224 Sum_probs=180.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.++..++||+|+| ||++.... ..|||| |+++++++++++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 44566678999998 99988764 778887 899999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
+||+|.+++.+. ++++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..... ..
T Consensus 154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 999999999763 699999999999999999999999 999999999999999999999999999997644332 34
Q ss_pred eceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 572 AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..... ..+........ ......
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~----~~i~~~~~~~~---~~~~~~ 296 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAM----KMIRDNLPPRL---KNLHKV 296 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH----HHHHHSSCCCC---SCGGGS
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHH----HHHHcCCCCCC---CccccC
Confidence 56789999999999999999999999999999999999999996431 11111 11111110000 112334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
++.+.+||.+||+.||++|||++|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 678899999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=358.28 Aligned_cols=219 Identities=20% Similarity=0.254 Sum_probs=176.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
++|+..++||+|+| ||++.... +.|||| |+++++++++++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 45677889999999 99998654 778887 8999999999999999999
Q ss_pred cCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 490 FMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+||+|.++|...+ ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999997654 3478999999999999999999999 99999999999999999999999999998753211
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ... ....+..+... ..+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~-----~~~~i~~~~~~-----~~~ 246 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS---MKN-----LVLKIISGSFP-----PVS 246 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHH-----HHHHHHHTCCC-----CCC
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHH-----HHHHHHcCCCC-----CCC
Confidence 12345679999999999999999999999999999999999999996541 111 11112222221 123
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...+..+.+||.+||+.||++|||++|+++
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345678899999999999999999999986
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.26 Aligned_cols=226 Identities=24% Similarity=0.331 Sum_probs=182.8
Q ss_pred cccccceEEEeEE--EEEeeee-------hhhhHhh---------------------------eeeEEEEEecCCeeEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSIT-------FLCFLIA---------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~-------~~~~avk---------------------------i~~l~~~~~~~~~~~lV 487 (702)
.+...++||+|+| ||+|... ...|||| |+++++++.+++..|||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3445678999999 9998753 2467877 99999999999999999
Q ss_pred EecCCCCCHHHHhhcCC------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEe
Q 038002 488 YEFMSKGSLADLLFNLE------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
||||++|+|.++|...+ ..+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence 99999999999997532 3689999999999999999999999 99999999999999999999999
Q ss_pred cccceeecCCCCCce-eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHh
Q 038002 556 DFGLAKLLMPNQTGI-VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 556 Dfg~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
|||+|+......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.... ..+ +...
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~~~------~~~~ 242 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNE------VIEC 242 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHH------HHHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHH------HHHH
Confidence 999998764433322 234679999999999999999999999999999999998 899996531 111 1112
Q ss_pred hhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 634 FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+..+... ..+...++++.+++.+||+.||++|||++||++.|+++.+
T Consensus 243 i~~~~~~-----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRVL-----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCC-----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222211 2233456688999999999999999999999999998653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.78 Aligned_cols=217 Identities=17% Similarity=0.239 Sum_probs=181.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..+.||+|+| ||++.... ..||+| |++++..+++++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 44666789999998 99888654 678887 899999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||++||+|.++|.+.+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 9999999999998755 799999999999999999999999 999999999999999999999999999998754432
Q ss_pred -ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 569 -GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 569 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ... ....+..... ..
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~-----~~~~i~~~~~------~~ 253 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EGL-----IFAKIIKLEY------DF 253 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHHTCC------CC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHH-----HHHHHHcCCC------CC
Confidence 33456789999999999999999999999999999999999999996431 111 1111222221 12
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVI 677 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl 677 (702)
+...++++.+|+.+||+.||++|||++|++
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 233456789999999999999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=351.96 Aligned_cols=224 Identities=21% Similarity=0.256 Sum_probs=183.0
Q ss_pred ccceEEEeEE--EEEeeeeh-------hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 447 DKRKLLTVLA--GCLGSITF-------LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~-------~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
-.++||+|+| ||+|.... ..|||| |+++++++.+++..+||||
T Consensus 30 ~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~E 109 (308)
T 4gt4_A 30 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFS 109 (308)
T ss_dssp EEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred EeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEE
Confidence 3568999999 99998632 568887 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEE
Q 038002 490 FMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKI 554 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 554 (702)
||++|+|.++|.... ..+++.+++.|+.||++||+|||++ +||||||||+|||+++++.+||
T Consensus 110 y~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki 186 (308)
T 4gt4_A 110 YCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKI 186 (308)
T ss_dssp CCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred cCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEE
Confidence 999999999996532 2488999999999999999999999 9999999999999999999999
Q ss_pred ecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHH
Q 038002 555 SDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYN 632 (702)
Q Consensus 555 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 632 (702)
+|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.... . .. +..
T Consensus 187 ~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~--~~----~~~ 258 (308)
T 4gt4_A 187 SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--N--QD----VVE 258 (308)
T ss_dssp CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--H--HH----HHH
T ss_pred CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--H--HH----HHH
Confidence 99999987643322 22345679999999999999999999999999999999998 899996541 1 11 111
Q ss_pred hhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 633 CFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
.+..+... +.+...+..+.+++.+||+.||++|||++||+++|+....+
T Consensus 259 ~i~~~~~~-----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl 307 (308)
T 4gt4_A 259 MIRNRQVL-----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL 307 (308)
T ss_dssp HHHTTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred HHHcCCCC-----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence 22222211 22334567789999999999999999999999999986543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=355.72 Aligned_cols=219 Identities=18% Similarity=0.224 Sum_probs=181.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
++++..++||+|+| ||++.... ..|||| |+++++++++++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 45667789999998 99988764 778887 899999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
+||+|.+++... ++++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... ..
T Consensus 231 ~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 304 (423)
T 4fie_A 231 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 304 (423)
T ss_dssp TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CB
T ss_pred CCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cc
Confidence 999999999754 599999999999999999999999 999999999999999999999999999997644332 34
Q ss_pred eceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 572 AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
...+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... ..... ..+.......+ ......
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~----~~~~~----~~i~~~~~~~~---~~~~~~ 373 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP----PLKAM----KMIRDNLPPRL---KNLHKV 373 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH----HHHHHSCCCCC---SCTTSS
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC----HHHHH----HHHHcCCCCCC---cccccC
Confidence 56789999999999999999999999999999999999999996431 11111 11111111000 112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+..+.+||.+||+.||++|||++|+++
T Consensus 374 s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 668899999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=340.58 Aligned_cols=214 Identities=23% Similarity=0.287 Sum_probs=170.3
Q ss_pred cccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEec----CCeeEEEE
Q 038002 446 NDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHR----SSKKLLVY 488 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~----~~~~~lV~ 488 (702)
+..++||+|+| ||++.... ..||+| |+++++++++ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999998 99988764 667776 8999988764 46789999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC--eEecCCCCCcEEEeC-CCcEEEecccceeecCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ--IIHCDIKLRNILIDD-SWRAKISDFGLAKLLMP 565 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~ 565 (702)
|||+||+|.+++.+.. .+++.++..++.||+.||+|||++ + |+||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998754 799999999999999999999998 7 999999999999974 78999999999986432
Q ss_pred CCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 566 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
. .....+||+.|+|||++.+ .++.++|||||||++|||+||+.||...... .. .......+..+...+
T Consensus 185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~---~~----~~~~i~~~~~~~~~~- 252 (290)
T 3fpq_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQ----IYRRVTSGVKPASFD- 252 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HH----HHHHHTTTCCCGGGG-
T ss_pred C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH---HH----HHHHHHcCCCCCCCC-
Confidence 2 2345689999999998865 6999999999999999999999999643111 11 112222222211122
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...++++.+++.+||+.||++|||++|+++
T Consensus 253 ---~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 ---KVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223456889999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=344.75 Aligned_cols=236 Identities=20% Similarity=0.170 Sum_probs=179.4
Q ss_pred ccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEEecCC----eeEEEEecCCCC
Q 038002 447 DKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYKHRSS----KKLLVYEFMSKG 494 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~~~~~----~~~lV~e~~~~g 494 (702)
-.++||+|+| ||+|......|||| |+++++++.+++ ..|||||||++|
T Consensus 7 L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g 86 (303)
T 3hmm_A 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence 4578999999 99999888889998 888888776543 689999999999
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----CCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 495 SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-----EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 495 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+|.++|+.. .+++.++.+++.|+++||+|||+++ ..+|+||||||+|||++.++.+||+|||+++........
T Consensus 87 sL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 164 (303)
T 3hmm_A 87 SLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164 (303)
T ss_dssp BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred cHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCc
Confidence 999999764 5899999999999999999999752 348999999999999999999999999999877544322
Q ss_pred ---eeeceeccccccCcccccCC------CCCccccccchhHhHHHhhhCCcCCcCCCCCcc---h----hhhHHHHHHh
Q 038002 570 ---IVAGVRGSRGYMAPEWQNSG------LITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD---E----VLLSTWVYNC 633 (702)
Q Consensus 570 ---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~----~~~~~~~~~~ 633 (702)
......||+.|+|||++.+. .++.++|||||||++|||+||..||........ . ..........
T Consensus 165 ~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 244 (303)
T 3hmm_A 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244 (303)
T ss_dssp ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHH
Confidence 12346799999999988654 467899999999999999999888754321110 0 0001111111
Q ss_pred hhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 634 FVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 634 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.........+.. ....+..+.+.+++.+||+.||++||||.||+++|+.+.
T Consensus 245 ~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 222222221221 223456788999999999999999999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=337.64 Aligned_cols=214 Identities=22% Similarity=0.296 Sum_probs=164.5
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.++..+.||+|+| ||++.... ..||+| |+++++++++++..|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4566778999988 88887643 677777 8999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+ +|+|.+++.+.+ ++++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-- 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-- 166 (275)
T ss_dssp CC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred CC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--
Confidence 99 679999998765 799999999999999999999999 99999999999999999999999999998754322
Q ss_pred eeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ... ....+..+.. ..+
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~---~~~-----~~~~i~~~~~------~~p 232 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES---IPV-----LFKNISNGVY------TLP 232 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHHTCC------CCC
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC---HHH-----HHHHHHcCCC------CCC
Confidence 2345789999999999988776 589999999999999999999996431 111 1111122211 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...++.+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 334567889999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=351.99 Aligned_cols=228 Identities=24% Similarity=0.292 Sum_probs=181.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh-------hhhHhh-----------------------------eeeEEEEEec-CCe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-------LCFLIA-----------------------------ISSLLVYKHR-SSK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk-----------------------------i~~l~~~~~~-~~~ 483 (702)
+.++..++||+|+| ||+|.... ..|||| |+++++++.+ ++.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 34555678999998 88886543 346665 8889987754 567
Q ss_pred eEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 484 KLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
.+||||||++|+|.++|+... ..+++.+++.++.||++||+|||++ +||||||||+|||+++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCC
Confidence 999999999999999997532 2478999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhh
Q 038002 549 SWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 626 (702)
++.+||+|||+|+.+...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... .
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~--~-- 296 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E-- 296 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--H--
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--H--
Confidence 999999999999977554433 3345789999999999999999999999999999999998 999997542211 1
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.......+.. ...+...++++.+++.+||+.||++|||++||+++|+.+.+
T Consensus 297 ---~~~~i~~g~~-----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 297 ---FCRRLKEGTR-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ---HHHHHHHTCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCC-----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 1111112111 12233345678899999999999999999999999987643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=343.77 Aligned_cols=216 Identities=21% Similarity=0.195 Sum_probs=174.4
Q ss_pred cccccceEEEeEE--EEEeeee-----hhhhHhh-----------------------------eeeEEEEEecCCeeEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSIT-----FLCFLIA-----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~-----~~~~avk-----------------------------i~~l~~~~~~~~~~~lV 487 (702)
.++..+.||+|+| ||++... .+.||+| |+++++.+++++..|||
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4566788999988 8887642 2467777 88999999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
||||+||+|.++|.+.+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 105 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 180 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 180 (304)
T ss_dssp ECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence 99999999999998765 799999999999999999999999 99999999999999999999999999998653322
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ...+..... ..
T Consensus 181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~---~~~~-----~~~i~~~~~------~~ 245 (304)
T 3ubd_A 181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD---RKET-----MTMILKAKL------GM 245 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH-----HHHHHHCCC------CC
T ss_pred -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC---HHHH-----HHHHHcCCC------CC
Confidence 22345789999999999999999999999999999999999999996431 1111 111111111 12
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSM-----KNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~ 678 (702)
+...++++.+++.+||+.||++|||+ +|+++
T Consensus 246 p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 23346678999999999999999984 67764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=328.91 Aligned_cols=217 Identities=19% Similarity=0.207 Sum_probs=160.3
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCC---------
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSS--------- 482 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~--------- 482 (702)
.++..+.||+|+| ||++.... ..|||| |+++++.+.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 3455678999998 89887653 678887 888887776543
Q ss_pred ---eeEEEEecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecc
Q 038002 483 ---KKLLVYEFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDF 557 (702)
Q Consensus 483 ---~~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 557 (702)
..|+|||||++|+|.+++..... ..++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999986542 245667889999999999999999 9999999999999999999999999
Q ss_pred cceeecCCCCCc-----------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 558 GLAKLLMPNQTG-----------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 558 g~a~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
|+|+.+...... .....+||+.|+|||++.+..|+.++|||||||++|||++ ||... .+...
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~---~~~~~- 235 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ---MERVR- 235 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHH-
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc---cHHHH-
Confidence 999876543221 1234579999999999999999999999999999999996 77421 11110
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..........+ .......+.+.+++.+||+.||++|||++|+++
T Consensus 236 ---~~~~~~~~~~p-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 ---TLTDVRNLKFP-----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHHTTCCC-----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHhcCCCC-----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111122211 112233456678999999999999999999987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=329.97 Aligned_cols=169 Identities=20% Similarity=0.255 Sum_probs=143.7
Q ss_pred cccccccceEEEeEE--EEEeeee-----hhhhHhh--------------------------eeeEEEEEecCCeeEEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSIT-----FLCFLIA--------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~-----~~~~avk--------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
.+.++..++||+|+| ||++... ...||+| |++++..++++++.|+||
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 456777889999998 8988653 2567776 888899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-CcEEEecccceeecCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS-WRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 567 (702)
||+++|+|.+++. .+++.++..++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 100 E~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 100 PYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp ECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred eCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence 9999999999993 589999999999999999999999 99999999999999877 799999999998654321
Q ss_pred C---------------------------ceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 568 T---------------------------GIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 568 ~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
. ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1 112345799999999988765 5899999999999999999999999654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=343.93 Aligned_cols=218 Identities=20% Similarity=0.168 Sum_probs=178.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------------eeeEEEEEecCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------------ISSLLVYKHRSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------------i~~l~~~~~~~~~~~ 485 (702)
+.+...+.||+|+| ||++.... ..||+| |++++..|++++.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 45666789999999 88887654 667776 788999999999999
Q ss_pred EEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
|||||++||+|.++|.+.+ .+++.++..++.||+.||+|||++ |||||||||+|||++.+|++||+|||+|+.+..
T Consensus 269 lVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 9999999999999998765 799999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 566 NQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 566 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.. ....+||+.|+|||++.. ..|+.++|||||||++|||++|+.||......... . .........
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~-~----i~~~i~~~~------ 410 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-E----IDRMTLTMA------ 410 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH-H----HHHHHHHCC------
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-H----HHHhhcCCC------
Confidence 33 345689999999999864 57999999999999999999999999654222111 1 111111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
...+...+.++.+||.+||+.||++|++ ++||++
T Consensus 411 ~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 411 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1223345678899999999999999998 677765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=326.42 Aligned_cols=228 Identities=19% Similarity=0.192 Sum_probs=173.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEe------cCCe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKH------RSSK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~------~~~~ 483 (702)
+.++..+.||+|+| ||++.... ..|||| |++++++++ +.++
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 45667789999998 99988654 778887 778887754 4578
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.|||||||+ |+|.+++...+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 999999996 68999997655 799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC---CceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccc-
Q 038002 564 MPNQ---TGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGE- 638 (702)
Q Consensus 564 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~- 638 (702)
.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .+.. +........
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~---~l~~-I~~~~g~p~~ 284 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH---QLQL-IMMVLGTPSP 284 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHH-HHHHHCCCCG
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH---HHHH-HHHhcCCCCh
Confidence 4322 2234467899999999988764 57999999999999999999999997542111 1111 111000000
Q ss_pred ----------cccc---ccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 639 ----------FNKL---VEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 639 ----------~~~~---~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... +.. ...+..++++.+|+.+||+.||++|||++|+++.
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 000 1112235678899999999999999999999873
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=295.08 Aligned_cols=212 Identities=19% Similarity=0.244 Sum_probs=161.3
Q ss_pred cccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEc
Q 038002 26 LKSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKT 105 (702)
Q Consensus 26 ~~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~ 105 (702)
+.++|.+|++|.++ ++| ++|.|+|||+.+++. .+ |.. +++||+|||+.| ..+.|+|+.||||||+|
T Consensus 7 ~~~~i~~g~~L~~g--~~l--~~g~f~l~f~~~gnl---~l-y~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 7 LSHEGSHPQTLHAA--QSL--ELSSFRFTMQSDCNL---VL-FDS---DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp SSSSSCSCSCCCTT--CEE--CSTTEEEEECTTSCE---EE-EES---SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred ccceeCCCCEECCC--CEE--EcCCEEEEECCCCcE---EE-EEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 34999999999987 677 599999999987764 23 432 799999999976 67899999999999999
Q ss_pred CCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCccc----------ccCCCccCCC-CeEEeeccCCC
Q 038002 106 EESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDT----------ILGGQSLENG-EHLLSSVTETN 174 (702)
Q Consensus 106 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDT----------lLpgq~l~~~-~~L~S~~s~~d 174 (702)
.+|.++|+|++.......+|+|+|+|||||++. ++|||||||||| |+|||+++.+ ++|+| .+|
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~---~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s---~~d 146 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP---GLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA---TQS 146 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS---EEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS---SCC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC---CEEECCCCCCcccccCCccceEEecCCcCCCccceEEc---CcE
Confidence 999999999875334456899999999999954 899999999855 5888877653 57774 789
Q ss_pred CcccceEeeeccCCceeeeeccccccccceeecCCccccCcCcceeeeeecCCccEEEeecCccceEEeeeeeeeeccCc
Q 038002 175 SSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNE 254 (702)
Q Consensus 175 ps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (702)
|++|.|+|.|+++|+++++. +..+||+++++.. .+... +.+..+|.+.++..++..... ++ ...+.
T Consensus 147 ~s~G~~~l~l~~dG~LvL~~------~~~~~W~s~~~~~-~~~~~--~~L~~~Gnl~ly~~~~~~vw~---s~--~~~~~ 212 (236)
T 1dlp_A 147 LQLSPYRLSMETDCNLVLFD------RDDRVWSTNTAGK-GTGCR--AVLQPNGRMDVLTNQNIAVWT---SG--NSRSA 212 (236)
T ss_dssp CBCSSCEEEEETTTEEEEEB------TTBCCSCCCCCSS-CSSCE--EEEETTTEEEEEETTTEEEEE---CC--CCCSS
T ss_pred eecCcEEEEECCCCcEEEEc------CCEeEEeCCCcCC-CCceE--EEECCCCcEEEEeCCCcEEEE---eC--CCCCC
Confidence 99999999999999887762 2257999999843 33323 566778876666544332211 22 22222
Q ss_pred ceEEEEEEccCCcEEEEE
Q 038002 255 TVIYRTTLDSDGILRLYS 272 (702)
Q Consensus 255 ~~~~rl~Ld~dG~lr~y~ 272 (702)
..+|++||+||++++|.
T Consensus 213 -~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 213 -GRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp -SCCEEEECSSSCEEEEC
T ss_pred -CCEEEEEcCCCcEEEeC
Confidence 35789999999999994
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=340.06 Aligned_cols=221 Identities=21% Similarity=0.241 Sum_probs=179.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.+...+.||+|+| ||++.... ..||+| |+++++.+++++..|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 34556678999988 88887654 567766 889999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC--CcEEEecccceeecCCCCCc
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS--WRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~--~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+||+|.++|......+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-- 311 (573)
T 3uto_A 237 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311 (573)
T ss_dssp CCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--
T ss_pred CCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--
Confidence 99999999987666799999999999999999999999 99999999999999754 899999999999875433
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... ... ...+...... +......
T Consensus 312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~---~~~-----~~~i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DET-----LRNVKSCDWN--MDDSAFS 381 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHH-----HHHHHTTCCC--CCSGGGT
T ss_pred ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH---HHH-----HHHHHhCCCC--CCccccc
Confidence 34556899999999999999999999999999999999999999964411 111 1111111111 1111222
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..++.+.+||.+||+.||++|||++|+++
T Consensus 382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34567889999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.61 Aligned_cols=243 Identities=35% Similarity=0.584 Sum_probs=195.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh----------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.+...+.||+|++ ||++.... ..||+| |+++++++.+++..++||||+
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 109 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYM 109 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECC
T ss_pred hccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEec
Confidence 44556678888887 88876543 556666 788889999999999999999
Q ss_pred CCCCHHHHhhcCCC---CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 492 SKGSLADLLFNLET---RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 492 ~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
++|+|.+++..... .+++..+..++.|++.||+|||+++..+|+||||||+||+++.++.+||+|||++........
T Consensus 110 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 189 (326)
T 3uim_A 110 ANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT 189 (326)
T ss_dssp TTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS
T ss_pred cCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc
Confidence 99999999987542 388999999999999999999998666999999999999999999999999999998765555
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCC-CCcchhhhHHHHHHhhhcccccccccc--
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNV-STADEVLLSTWVYNCFVAGEFNKLVEE-- 645 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 645 (702)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..........+..............+.
T Consensus 190 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 3uim_A 190 HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269 (326)
T ss_dssp CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTC
T ss_pred cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhh
Confidence 55556679999999999988889999999999999999999999996321 111122233333333333333333332
Q ss_pred --ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 646 --EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 646 --~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.......+.+.+++.+||+.||++|||++||+++|++...
T Consensus 270 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 270 QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 4567888999999999999999999999999999998543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=308.28 Aligned_cols=235 Identities=25% Similarity=0.290 Sum_probs=175.2
Q ss_pred cccccccceEEEeEE--EEEeeeehhhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITFLCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
...++..+.||+|++ ||++......||+| |+++++++.+++..++||||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 345566788999987 88887666667766 78889999999999999999
Q ss_pred CCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCC--eEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 491 MSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQ--IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
+++|+|.+++..... .+++.+++.++.||+.||+|||++ + |+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999987542 289999999999999999999999 8 999999999999999999999999999864332
Q ss_pred CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... .. ....
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~----~~~~~~~~~---~~-----~~~~ 259 (309)
T 3p86_A 193 F-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP----AQVVAAVGF---KC-----KRLE 259 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHH---SC-----CCCC
T ss_pred c-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHh---cC-----CCCC
Confidence 2 123346789999999999999999999999999999999999999964311 111110100 00 0112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCCCCCCC
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFP 692 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~~p~~P 692 (702)
.+......+.+++.+||+.||++|||+++++++|+.+.+-..|+.+
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 2334456789999999999999999999999999997765554433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.37 Aligned_cols=241 Identities=31% Similarity=0.543 Sum_probs=191.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh---------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
..++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||||++
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 118 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCT
T ss_pred hccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCC
Confidence 34455667788877 77776543 555655 8889999999999999999999
Q ss_pred CCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC-C
Q 038002 493 KGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-T 568 (702)
Q Consensus 493 ~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~ 568 (702)
+|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....... .
T Consensus 119 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp TCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred CCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999997653 2488999999999999999999999 99999999999999999999999999998754322 2
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc---
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE--- 645 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 645 (702)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ......+.......+.+...+++
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHHHhcChhhc
Confidence 22344568999999999988899999999999999999999999997653222 22222333333333333333332
Q ss_pred -ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 646 -EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 646 -~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
.........+.+++.+||+.||++|||++|+++.|+.+.++.
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 456788999999999999999999999999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=299.08 Aligned_cols=235 Identities=23% Similarity=0.225 Sum_probs=179.8
Q ss_pred cccccccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEE----ecCCeeEEEEe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYK----HRSSKKLLVYE 489 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~----~~~~~~~lV~e 489 (702)
.+.+...+.||+|++ ||++......|||| |+++++++ +.....++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 86 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITH 86 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEEC
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehh
Confidence 456667789999988 88888766777777 66666553 33567899999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhh--------hcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLH--------DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
|+++|+|.+++... .+++..+..++.||+.||+||| ++ +|+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 87 YHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp CCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred hccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 99999999999543 6899999999999999999999 87 99999999999999999999999999998
Q ss_pred ecCCCCCce---eeceeccccccCcccccCC------CCCccccccchhHhHHHhhhC----------CcCCcCCCCCcc
Q 038002 562 LLMPNQTGI---VAGVRGSRGYMAPEWQNSG------LITVKSDVYSFGVVLLEIICC----------RSNFEVNVSTAD 622 (702)
Q Consensus 562 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltG----------~~Pf~~~~~~~~ 622 (702)
......... .....||+.|+|||.+.+. .++.++||||||+++|||++| ..||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 765443322 2234799999999988776 455799999999999999999 788765422221
Q ss_pred hhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 623 EVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
... ...........................+.+++.+||+.||++|||++||+++|+++
T Consensus 242 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 SFE--DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CHH--HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred chh--hhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 111 11111111111111111123445788999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=297.37 Aligned_cols=236 Identities=22% Similarity=0.253 Sum_probs=181.3
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEE
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~l 486 (702)
..++++..+.||+|++ ||++.... ..+|+| |+++++++++++..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 3556777788999987 88876543 456655 7888999999999999
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 89 v~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 999999999999997654 689999999999999999999999 9999999999999999999999999999876444
Q ss_pred CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
.........||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ... .... ....... ....
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~-----~~~~-~~~~~~~-~~~~ 235 (294)
T 4eqm_A 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--VSI-----AIKH-IQDSVPN-VTTD 235 (294)
T ss_dssp ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--HHH-----HHHH-HSSCCCC-HHHH
T ss_pred cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHH-----HHHH-hhccCCC-cchh
Confidence 33334456799999999999999999999999999999999999999965411 000 1111 1111111 1112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhCCcCCCCC
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRP-SMKNVILMLEGTMEIPIL 689 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~Le~~~~~~~p 689 (702)
.....++.+.+++.+||+.||++|| +++++.+.|+.+..-...
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 2334567889999999999999998 999999999987654433
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.66 Aligned_cols=229 Identities=23% Similarity=0.320 Sum_probs=180.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.+...+.||+|++ ||++.... ..+|+| |+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 34455677888877 77776543 455555 888999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce-
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI- 570 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~- 570 (702)
++++|.+++......+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 166 (310)
T 3s95_A 90 KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166 (310)
T ss_dssp TTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccccc
Confidence 99999999998766899999999999999999999999 99999999999999999999999999998764332211
Q ss_pred ------------eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccc
Q 038002 571 ------------VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGE 638 (702)
Q Consensus 571 ------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 638 (702)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+.............
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~----------- 235 (310)
T 3s95_A 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN----------- 235 (310)
T ss_dssp -------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-----------
T ss_pred ccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-----------
Confidence 114579999999999999999999999999999999999999987543222111100
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 639 FNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 639 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.........+...+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp HHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00001111122334578899999999999999999999999998643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=292.57 Aligned_cols=232 Identities=15% Similarity=0.104 Sum_probs=181.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
..++..+.||+|++ ||++.... ..||+| +++++.++.++...++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 88 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 88 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-
Confidence 44556677888876 77776432 566666 777888899999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc-----EEEecccceeecCCCC
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR-----AKISDFGLAKLLMPNQ 567 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~~~~~ 567 (702)
+++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++.......
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 89 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 9999999988766799999999999999999999999 9999999999999987776 9999999998775433
Q ss_pred Cc------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 568 TG------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 568 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||............... .........
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~-- 242 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-GEKKQSTPL-- 242 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH-HHHHHHSCH--
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHH-HhhccCccH--
Confidence 21 234567999999999999989999999999999999999999999765322222111111 111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.......++.+.+++.+||+.||++||++++|++.|+++.
T Consensus 243 ---~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 243 ---RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp ---HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred ---HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1112234568899999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=292.29 Aligned_cols=221 Identities=21% Similarity=0.218 Sum_probs=177.8
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEec
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
..++...++||+|++ ||++.... ..||+| |+++++++..++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 456677789999987 88886533 566666 88899999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++++|.+++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 172 (297)
T 3fxz_A 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (297)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred CCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-c
Confidence 9999999999764 589999999999999999999999 999999999999999999999999999987644332 2
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ..... ...... .... ..+..
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~----~~~~~~-~~~~---~~~~~ 241 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALY----LIATNG-TPEL---QNPEK 241 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHH----HHHHHC-SCCC---SCGGG
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHH----HHHhCC-CCCC---CCccc
Confidence 3446799999999999999999999999999999999999999964311 11110 000111 0000 11233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+..+.+++.+||+.||++|||++|+++.
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 45678899999999999999999999873
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=292.25 Aligned_cols=227 Identities=20% Similarity=0.305 Sum_probs=183.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 45566678888887 88776554 456666 88899999999999999999999
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.............
T Consensus 88 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 164 (268)
T 3sxs_A 88 GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164 (268)
T ss_dssp CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCS
T ss_pred CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccC
Confidence 999999987665699999999999999999999999 99999999999999999999999999998775544433344
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... . . ......+. ....+...+
T Consensus 165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~-~-----~~~~~~~~-----~~~~~~~~~ 231 (268)
T 3sxs_A 165 TKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS--E-V-----VLKVSQGH-----RLYRPHLAS 231 (268)
T ss_dssp CCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH--H-H-----HHHHHTTC-----CCCCCTTSC
T ss_pred CCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH--H-H-----HHHHHcCC-----CCCCCCcCh
Confidence 556778999999988889999999999999999999 99999644111 1 1 01111111 011122234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
+.+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 232 DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 578899999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=290.26 Aligned_cols=233 Identities=17% Similarity=0.133 Sum_probs=180.1
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
.+.++..+.||+|++ ||++.... ..||+| |..+..++..++..++||||+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc
Confidence 345666788898887 88887433 567776 444556667899999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE---eCCCcEEEecccceeecCCCCC
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
+++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||++........
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 9999999987666799999999999999999999999 99999999999999 7899999999999987654332
Q ss_pred ------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccc
Q 038002 569 ------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKL 642 (702)
Q Consensus 569 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (702)
.......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................... ...
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~--- 239 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI--- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCH---
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-chh---
Confidence 1223467899999999999999999999999999999999999999765332222221111111110 000
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 643 VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 643 ~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.......++.+.+++.+||+.||++|||+++|+++|+++.
T Consensus 240 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 240 --EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp --HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred --hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 0111223568899999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-33 Score=306.15 Aligned_cols=225 Identities=18% Similarity=0.167 Sum_probs=179.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..++||+|++ ||++.... ..+|+| |++++..+++++..||||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 44566788999988 88887654 556666 788889999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 99999999999988666899999999999999999999999 999999999999999999999999999987755544
Q ss_pred ceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...... +........++
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~---~~~~~~-i~~~~~~~~~p--- 303 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL---VETYGK-IMNHKERFQFP--- 303 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH-HHTHHHHCCCC---
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh---hHHHHh-hhhccccccCC---
Confidence 4445578999999999886 56789999999999999999999999975411 111111 11000000111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNL--RPSMKNVILM 679 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 679 (702)
......++.+.++|.+||+.+|++ ||+++|+++.
T Consensus 304 --~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 304 --TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp --SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred --cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111224567889999999998888 9999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=300.65 Aligned_cols=229 Identities=23% Similarity=0.329 Sum_probs=180.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~lV 487 (702)
..++..+.||+|++ ||++.... ..|||| |+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 44555678899887 88877642 336666 88899999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 999999999999987766899999999999999999999999 99999999999999999999999999999775433
Q ss_pred Cc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 568 TG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 568 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ......+ ..
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~----~~~----~~~~~~~-----~~ 272 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN----RDV----ISSVEEG-----YR 272 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH----HHH----HHHHHTT-----CC
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH----HHH----HHHHHcC-----CC
Confidence 22 2223446778999999988899999999999999999999 9999964311 111 1111111 11
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
...+...+..+.+++.+||+.||++|||+++|+++|+.+...+
T Consensus 273 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 1223344568899999999999999999999999999876443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.80 Aligned_cols=241 Identities=23% Similarity=0.250 Sum_probs=181.9
Q ss_pred ccccccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEEecCC----eeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYKHRSS----KKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~~~~~----~~~lV~e~ 490 (702)
..++..+.||+|++ ||++......|||| |+++++++..+. ..++||||
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~ 103 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred hhchhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEec
Confidence 34556678999988 88887777777777 788887777643 47999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC-------CCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-------EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
+++|+|.+++... .+++.++..++.||+.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~ 181 (322)
T 3soc_A 104 HEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181 (322)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred CCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence 9999999999764 4899999999999999999999851 228999999999999999999999999999876
Q ss_pred CCCCCc-eeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh--------HHH
Q 038002 564 MPNQTG-IVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL--------STW 629 (702)
Q Consensus 564 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~--------~~~ 629 (702)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||............ ...
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (322)
T 3soc_A 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261 (322)
T ss_dssp CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHH
T ss_pred ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhh
Confidence 544322 2334678999999998876 35567899999999999999999999764322111000 000
Q ss_pred HHHhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 630 VYNCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.............+.. .........+.+++.+||+.||++|||++||+++|+.+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111111111111 1233566789999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=293.67 Aligned_cols=226 Identities=22% Similarity=0.311 Sum_probs=181.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||||+++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 34555678888887 88776643 456665 88899999999999999999999
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.............
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 166 (269)
T 4hcu_A 90 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 166 (269)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence 999999987776799999999999999999999999 99999999999999999999999999998664333222334
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
..+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... . .. ......+ .....+...+
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~-~~----~~~~~~~-----~~~~~~~~~~ 233 (269)
T 4hcu_A 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---S-EV----VEDISTG-----FRLYKPRLAS 233 (269)
T ss_dssp TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H-HH----HHHHHTT-----CCCCCCTTSC
T ss_pred cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---H-HH----HHHHhcC-----ccCCCCCcCC
Confidence 456788999999988899999999999999999999 9999964311 1 11 1111111 0111222335
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..+.+++.+||+.||++||+++|++++|+++.
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 67889999999999999999999999998764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-33 Score=288.36 Aligned_cols=232 Identities=17% Similarity=0.132 Sum_probs=180.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
+.++..+.||+|++ ||++.... ..||+| +..+..+...++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 45566778888876 88887432 667776 344456667889999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE---eCCCcEEEecccceeecCCCCCc
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||++.........
T Consensus 88 ~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (296)
T 3uzp_A 88 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164 (296)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence 9999999986666799999999999999999999999 99999999999999 58889999999999876544321
Q ss_pred ------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 570 ------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 570 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||..................... ...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~---- 239 (296)
T 3uzp_A 165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TPI---- 239 (296)
T ss_dssp CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-SCH----
T ss_pred cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC-Cch----
Confidence 123467999999999999989999999999999999999999999764322222221111111110 000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
+......++.+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 240 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 240 -EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp -HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred -HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0112234567899999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-33 Score=302.49 Aligned_cols=220 Identities=18% Similarity=0.257 Sum_probs=172.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.++..+.||+|++ ||++.... ..+|+| |++++.++++++..|+|
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 34556678888887 77776543 445555 78889999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 132 ~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~- 206 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP- 206 (396)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-
T ss_pred EEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccC-
Confidence 99999999999998754 799999999999999999999999 9999999999999999999999999999853222
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch-hhhHHHHHHhhhccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE-VLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........+..... .
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 280 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 280 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------C
T ss_pred CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------C
Confidence 22344578999999999999999999999999999999999999999654221111 1111112222222211 2
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
.+...+..+.+++.+||+.||++||++
T Consensus 281 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 233456678999999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.09 Aligned_cols=217 Identities=23% Similarity=0.304 Sum_probs=171.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.++..+.||+|++ ||++.... ..||+| |++++.++++++..|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 44566788999988 88876543 456665 88889999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999999997754 799999999999999999999999 99999999999999999999999999998543222
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. ....+..... ..
T Consensus 179 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~---~~-----~~~~i~~~~~------~~ 243 (353)
T 3txo_A 179 -VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE---DD-----LFEAILNDEV------VY 243 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH-----HHHHHHHCCC------CC
T ss_pred -ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH---HH-----HHHHHHcCCC------CC
Confidence 233456799999999999888899999999999999999999999965411 11 1111111111 12
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSM------KNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~------~evl~ 678 (702)
+......+.+++.+||+.||++||++ +|+++
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 22345678899999999999999998 67765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-33 Score=295.48 Aligned_cols=217 Identities=18% Similarity=0.222 Sum_probs=175.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
..++..+.||+|++ |+++.... ..||+| |+++++++.+++..|+|||
T Consensus 15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 94 (328)
T 3fe3_A 15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME 94 (328)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence 34566778899987 88777533 566666 8889999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-- 168 (328)
T 3fe3_A 95 YASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-- 168 (328)
T ss_dssp CCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--
Confidence 999999999997654 799999999999999999999999 99999999999999999999999999998664332
Q ss_pred eeeceeccccccCcccccCCCCC-ccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLIT-VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||..... .. .......+.. ..+
T Consensus 169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~----~~~~i~~~~~------~~p 234 (328)
T 3fe3_A 169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL----KE----LRERVLRGKY------RIP 234 (328)
T ss_dssp GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH----HH----HHHHHHHCCC------CCC
T ss_pred ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH----HH----HHHHHHhCCC------CCC
Confidence 23456799999999999877764 899999999999999999999965411 11 1111111111 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...+..+.+++.+||+.||.+|||++|+++.
T Consensus 235 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2345678899999999999999999999874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.81 Aligned_cols=222 Identities=19% Similarity=0.209 Sum_probs=176.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
+.+...+.||+|++ ||++.... ..+|+| |+++++.+++.+..++||||++
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 45566678888887 78776543 445544 8899999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC--CCcEEEecccceeecCCCCCce
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD--SWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++....... .
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~ 159 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence 9999999987666799999999999999999999999 9999999999999987 7899999999998764433 3
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..... ..+...... ........
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~-----~~i~~~~~~--~~~~~~~~ 229 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQII-----ENIMNAEYT--FDEEAFKE 229 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH-----HHHHHTCCC--CCHHHHTT
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHH-----HHHHcCCCC--CChhhhcc
Confidence 445679999999999998889999999999999999999999996531 11111 111111110 01111123
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 35678999999999999999999999983
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=302.84 Aligned_cols=206 Identities=15% Similarity=0.170 Sum_probs=158.5
Q ss_pred eeeEEEEEecC----CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHRS----SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|+++++++... ...+|||||+ +++|.+++......+++.+++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 55566655543 5689999999 9999999988766899999999999999999999999 99999999999999
Q ss_pred e--CCCcEEEecccceeecCCCCCc------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 547 D--DSWRAKISDFGLAKLLMPNQTG------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 547 ~--~~~~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
+ .++.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876432211 1133559999999999999899999999999999999999999997542
Q ss_pred CCcchhhhHHHHHHhhhcccccccccccc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEEEV-DKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.......... .. ....+...++... ....+..+.+++.+||+.||++||++++|+++|+.+.
T Consensus 266 ~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 266 KDPKYVRDSK---IR-YRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp TCHHHHHHHH---HH-HHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHH---HH-hhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 2221111111 11 1111222221110 1223567889999999999999999999999998643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-32 Score=292.72 Aligned_cols=229 Identities=16% Similarity=0.121 Sum_probs=176.1
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
.++..+.||+|++ ||++.... ..||+| |++++.++..++..++||||+ +
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-C
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-C
Confidence 3455566777776 77666432 455555 778889999999999999999 9
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc-----EEEecccceeecCCCCC
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR-----AKISDFGLAKLLMPNQT 568 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-----~kl~Dfg~a~~~~~~~~ 568 (702)
++|.+++......+++.+++.++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+++.+.....
T Consensus 89 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~ 165 (330)
T 2izr_A 89 PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165 (330)
T ss_dssp CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence 999999987666899999999999999999999999 9999999999999998887 99999999997644332
Q ss_pred c------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccc
Q 038002 569 G------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKL 642 (702)
Q Consensus 569 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (702)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.................. .....
T Consensus 166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-----~~~~~ 240 (330)
T 2izr_A 166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT-----KRATP 240 (330)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH-----HHHSC
T ss_pred CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh-----hccCC
Confidence 1 124567999999999999999999999999999999999999999765322211111111100 00000
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 643 VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 643 ~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
. .......+ .+.+++.+||+.||.+||++++|++.|+.+
T Consensus 241 ~-~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 241 I-EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp H-HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred H-HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 0 00111123 899999999999999999999999999753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-33 Score=293.81 Aligned_cols=217 Identities=20% Similarity=0.239 Sum_probs=174.0
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.++..+.||+|++ ||++.... ..+|+| |++++..+++.+..|+|||
T Consensus 6 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 4455678888877 77766542 455555 7888899999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 86 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 160 (337)
T 1o6l_A 86 YANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp CCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCC-C
Confidence 999999999997654 789999999999999999999999 99999999999999999999999999998643222 2
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..... ..+.
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~-----~~~~i~~~~~------~~p~ 226 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HER-----LFELILMEEI------RFPR 226 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHHCCC------CCCT
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHH-----HHHHHHcCCC------CCCC
Confidence 2345679999999999999999999999999999999999999996431 111 1111111111 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRP-----SMKNVILM 679 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~ 679 (702)
..+..+.+++.+||+.||++|| +++|+++.
T Consensus 227 ~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 3456789999999999999999 89998763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=288.93 Aligned_cols=239 Identities=18% Similarity=0.159 Sum_probs=183.2
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCC--eeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSS--KKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~--~~~lV 487 (702)
...+...+.||+|++ ||++.... ..||+| |+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 456667788999987 88887653 566666 677777776654 88999
Q ss_pred EecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE----eCCCcEEEeccccee
Q 038002 488 YEFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAK 561 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 561 (702)
|||+++++|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987543 389999999999999999999999 99999999999999 777889999999998
Q ss_pred ecCCCCCceeeceeccccccCccccc--------CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHh
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQN--------SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||...................
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 7654332 33456899999999875 5788999999999999999999999997543322211111111111
Q ss_pred hhccccc---------------cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 634 FVAGEFN---------------KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 634 ~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.....+. ..............+.+++.+||+.||++|||++|+++.......
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1100000 001114457788899999999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.06 Aligned_cols=199 Identities=27% Similarity=0.373 Sum_probs=162.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++++.+++..|+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+
T Consensus 149 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iv 225 (370)
T 2psq_A 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCI 225 (370)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 7889999999999999999999999999998653 2478999999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
||||||+|||++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.|
T Consensus 226 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 226 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp CSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999999876443321 2233456789999999999999999999999999999999 9999
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
|..... .+ . ......+. ....+......+.+++.+||+.||++||+++|+++.|+.+..
T Consensus 306 ~~~~~~--~~--~----~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 306 YPGIPV--EE--L----FKLLKEGH-----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp STTCCG--GG--H----HHHHHTTC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCH--HH--H----HHHHhcCC-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 965411 11 1 11111111 112233445678999999999999999999999999998643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-33 Score=303.00 Aligned_cols=226 Identities=23% Similarity=0.312 Sum_probs=169.7
Q ss_pred ccccccceEEEeEE--EEEeeee-----hhhhHhh----------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSIT-----FLCFLIA----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~-----~~~~avk----------------------------i~~l~~~~~~~~~~~lV 487 (702)
..+...+.||+|++ ||++... ...||+| |+++++++.+++..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 44556788999988 8888754 2456666 88899999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++......+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 125 ~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 201 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201 (373)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence 999999999999988776799999999999999999999999 99999999999999999999999999998765433
Q ss_pred Cce--eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 568 TGI--VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 568 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..... .....+. .
T Consensus 202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~----~~~~~----~~i~~~~-----~ 268 (373)
T 2qol_A 202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS----NQDVI----KAVDEGY-----R 268 (373)
T ss_dssp ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC----HHHHH----HHHHTTE-----E
T ss_pred ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC----HHHHH----HHHHcCC-----C
Confidence 211 122335778999999998899999999999999999998 999996431 11111 1111111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...+...+..+.+++.+||+.||++||++++|+++|+.+.
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 308 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI 308 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence 1122334567899999999999999999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-33 Score=292.10 Aligned_cols=226 Identities=21% Similarity=0.304 Sum_probs=177.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..+.||+|++ ||++.... ..||+| |++++.++.+++..++||||+++
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 103 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 103 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTT
T ss_pred HHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCC
Confidence 45556678888887 77776554 456665 88899999999999999999999
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.............
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 180 (283)
T 3gen_A 104 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180 (283)
T ss_dssp CBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence 999999987666799999999999999999999999 99999999999999999999999999998664332222233
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .... .....+ . ....+....
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~----~~~~----~~~~~~-~----~~~~~~~~~ 247 (283)
T 3gen_A 181 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN----SETA----EHIAQG-L----RLYRPHLAS 247 (283)
T ss_dssp TTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH----HHHH----HHHHTT-C----CCCCCTTCC
T ss_pred CccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh----hHHH----HHHhcc-c----CCCCCCcCC
Confidence 456788999999988889999999999999999998 9999964411 1111 111111 0 111122234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
+.+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 248 EKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 67889999999999999999999999998753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.1e-33 Score=297.53 Aligned_cols=221 Identities=22% Similarity=0.244 Sum_probs=173.2
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------------eeeEEEEEecCCee
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------------ISSLLVYKHRSSKK 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------------i~~l~~~~~~~~~~ 484 (702)
.+.+...+.||+|++ ||++.... ..+|+| |+++++++++++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 344556677888876 77665442 344444 78888999999999
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC----cEEEecccce
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW----RAKISDFGLA 560 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a 560 (702)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 99999999999999997654 799999999999999999999999 999999999999998777 7999999999
Q ss_pred eecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc
Q 038002 561 KLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640 (702)
Q Consensus 561 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (702)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..... ..+......
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~-----~~i~~~~~~ 236 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETL-----ANITAVSYD 236 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHH-----HHHHTTCCC
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHH-----HHHHhcCCC
Confidence 8764432 2345679999999999998899999999999999999999999996531 11111 111111110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 641 KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 641 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+.......++.+.++|.+||+.||++|||++|+++
T Consensus 237 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 --FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011111223567889999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-32 Score=289.13 Aligned_cols=231 Identities=20% Similarity=0.170 Sum_probs=175.3
Q ss_pred cccccccceEEEeEE--EEEeeeeh-hhhHhh-----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF-LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~-~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+.++..++||+|++ ||++.... ..||+| |+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 456667788999987 88877643 556665 8888999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++ +|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9985 89998887776799999999999999999999999 999999999999999999999999999987643322
Q ss_pred eeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc-------
Q 038002 570 IVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK------- 641 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 641 (702)
......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... .......+..
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~ 253 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL-GTPNPREWPQVQELPLW 253 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH-CCCCTTTSGGGTTSHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH-CCCChHHhhhhhccchh
Confidence 2334568999999998865 568999999999999999999999997653222111111100 0000000000
Q ss_pred ------cccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 642 ------LVEE----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 642 ------~~~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... .......+++.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 112234567889999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=299.75 Aligned_cols=222 Identities=18% Similarity=0.144 Sum_probs=176.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.+...+.||+|++ ||++.... ..+|+| |++++.++++++..|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 44556788999988 88877654 556665 788899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||++||+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp CCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred eCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999999999764 589999999999999999999999 999999999999999999999999999987755443
Q ss_pred ceeeceeccccccCcccccCCC----CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGL----ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .... ..+.........
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~---~~~~-----~~i~~~~~~~~~- 294 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGTY-----SKIMNHKNSLTF- 294 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH-----HHHHTHHHHCCC-
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh---hhHH-----HHHHhccccccC-
Confidence 3344678999999999987654 78999999999999999999999974411 1111 111111000000
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNL--RPSMKNVILM 679 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~--RPt~~evl~~ 679 (702)
......+..+.++|.+||+.+|.+ ||+++||++.
T Consensus 295 -p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 -PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp -CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred -CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 011124567889999999999988 9999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=3.7e-33 Score=293.87 Aligned_cols=214 Identities=19% Similarity=0.168 Sum_probs=171.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..++||+|++ ||++.... ..|||| |+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 45666788999988 89887753 667776 778899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+ +++|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 6799999987766799999999999999999999999 99999999999999999999999999998764332
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......||+.|+|||++.+ .++.++||||||+++|||++|..|+... . .......+... ....
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~-------~~~~~~~~~~~----~~~~ 274 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----E-------GWQQLRQGYLP----PEFT 274 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----H-------HHHHHTTTCCC----HHHH
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----c-------HHHHHhccCCC----cccc
Confidence 2334568999999998875 7899999999999999999997766422 0 01111111111 1122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....+.+.+++.+||+.||++|||++|+++
T Consensus 275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 275 AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 234567899999999999999999999986
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.9e-33 Score=293.45 Aligned_cols=223 Identities=21% Similarity=0.224 Sum_probs=175.7
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 456677788888877 88776543 556665 7888899999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC-
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT- 568 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 568 (702)
|+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 999999999997654 699999999999999999999999 999999999999999999999999999987643222
Q ss_pred ceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
.......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....+ ....... ..
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~-----~~~~~~~----~~ 230 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDW-----KEKKTYL----NP 230 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHH-----HTTCTTS----TT
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHH-----hcccccC----Cc
Confidence 22345679999999999877665 7899999999999999999999975422211 11111 1111000 01
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 12335677899999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.4e-32 Score=303.90 Aligned_cols=232 Identities=17% Similarity=0.147 Sum_probs=182.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
.+.++..++||+|++ ||++.... ..|||| |..+..++..++..+|||||+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 345667788999988 88887543 677777 445567778899999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE---eCCCcEEEecccceeecCCCCC
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
+++|.+++......+++.+++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999999987666899999999999999999999999 99999999999999 6889999999999987754432
Q ss_pred c------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccc
Q 038002 569 G------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKL 642 (702)
Q Consensus 569 ~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (702)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+...... .....+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~~-- 238 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-KVATSIE-- 238 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH-HHHSCHH--
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc-cccccHH--
Confidence 1 122567999999999999999999999999999999999999999765332222222111111 1111111
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 643 VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 643 ~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
......+.++.+++.+||+.||++||++++|+++|+.+
T Consensus 239 ---~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 239 ---ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp ---HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred ---HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11112356789999999999999999999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.98 E-value=5.7e-33 Score=285.94 Aligned_cols=221 Identities=27% Similarity=0.306 Sum_probs=166.8
Q ss_pred ccccccceEEEeEE--EEEeeeehhhhHhh-------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITFLCFLIA-------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~~~~avk-------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
..++..+.||+|++ ||++......+|+| |+++++++.+++..++|||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 34555678888877 78776555555554 7788899999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC---eEecCCCCCcEEEeC--------CCcEEEeccc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ---IIHCDIKLRNILIDD--------SWRAKISDFG 558 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~---ivH~dlkp~NIll~~--------~~~~kl~Dfg 558 (702)
|+++++|.+++.. ..+++.++..++.|++.||+|||++ + |+||||||+||+++. ++.+||+|||
T Consensus 87 ~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 87 FARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp CCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred cCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999964 3689999999999999999999999 7 999999999999986 7789999999
Q ss_pred ceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccc
Q 038002 559 LAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGE 638 (702)
Q Consensus 559 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 638 (702)
++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .... ... .....
T Consensus 162 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~---~~~-~~~~~ 230 (271)
T 3dtc_A 162 LAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----GLAV---AYG-VAMNK 230 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC----HHHH---HHH-HHTSC
T ss_pred cccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHH---HHh-hhcCC
Confidence 9986543322 24568999999999988899999999999999999999999996431 1111 111 11111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 639 FNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 639 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
. ....+...++.+.+++.+||+.||++|||++|++++|+.+
T Consensus 231 ~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 231 L----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred C----CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1 1122334456789999999999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=6.1e-33 Score=300.92 Aligned_cols=229 Identities=25% Similarity=0.289 Sum_probs=181.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh---------hhhHhh-----------------------------eeeEEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF---------LCFLIA-----------------------------ISSLLVYKHRSS 482 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~---------~~~avk-----------------------------i~~l~~~~~~~~ 482 (702)
+.+...++||+|++ ||++.... ..||+| |+++++++.+++
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 148 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 148 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence 44555678999987 88776421 235554 888999999999
Q ss_pred eeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 483 KKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++
T Consensus 149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 225 (382)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEc
Confidence 9999999999999999997653 3489999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhh
Q 038002 548 DSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVL 625 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 625 (702)
.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.... ...
T Consensus 226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~----~~~ 301 (382)
T 3tt0_A 226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VEE 301 (382)
T ss_dssp TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----HHH
T ss_pred CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----HHH
Confidence 999999999999987644322 22334567889999999999999999999999999999999 999996431 111
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
.......+.. ...+......+.+++.+||+.||++|||++||++.|+.+....
T Consensus 302 ----~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 ----LFKLLKEGHR-----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ----HHHHHHTTCC-----CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ----HHHHHHcCCC-----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1111111111 1122234567899999999999999999999999999875433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=294.19 Aligned_cols=205 Identities=17% Similarity=0.198 Sum_probs=158.7
Q ss_pred eeeEEEEEec----CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 471 ISSLLVYKHR----SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 471 i~~l~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
|+++++++.. +...++||||+ +++|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+||++
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 184 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLL 184 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEE
Confidence 5566766666 78999999999 999999998765 799999999999999999999999 99999999999999
Q ss_pred eCCC--cEEEecccceeecCCCCC------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 547 DDSW--RAKISDFGLAKLLMPNQT------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 547 ~~~~--~~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
+.++ .+||+|||+++.+..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9887 999999999987643221 11134578999999999998899999999999999999999999996432
Q ss_pred CCcchhhhHHHHHHhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
........ ..... ...+...+.. ......++.+.+++.+||+.||++||++++|+++|+...
T Consensus 265 ~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDPVAVQT---AKTNL-LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCHHHHHH---HHHHH-HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccHHHHH---HHHhh-cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 22111111 11110 0111111111 001134568999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=303.16 Aligned_cols=224 Identities=19% Similarity=0.165 Sum_probs=175.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..+.||+|++ ||++.... ..||+| |++++..+++++..||||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 34556678899987 78777643 556665 788889999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++.+.+..+++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.......
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 99999999999987655799999999999999999999999 999999999999999999999999999988755444
Q ss_pred ceeeceeccccccCccccc-------CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQN-------SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...... +..... .
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~-----i~~~~~-~ 288 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST---AETYGK-----IVHYKE-H 288 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHHHHH-----HHTHHH-H
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH---HHHHHH-----HHhccc-C
Confidence 3334568999999999886 45789999999999999999999999965411 111111 111000 0
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLR---PSMKNVILM 679 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~R---Pt~~evl~~ 679 (702)
...+......+..+.++|.+||+ +|++| |+++|+++.
T Consensus 289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 00011122345688999999999 99998 589998863
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.1e-33 Score=302.59 Aligned_cols=226 Identities=21% Similarity=0.231 Sum_probs=178.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+.+...+.||+|++ ||++.... ..|||| |+++++++..++..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34455678888877 88887652 566666 88899999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++|+|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999999999987665799999999999999999999999 99999999999999999999999999998653322111
Q ss_pred e-eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 571 V-AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 571 ~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
. ....+++.|+|||.+....++.++||||||+++|||++ |..||..... ..... ....+.. ...+
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~----~~~~~----~~~~~~~-----~~~~ 337 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN----QQTRE----FVEKGGR-----LPCP 337 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH----HHHHH----HHHTTCC-----CCCC
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHH----HHHcCCC-----CCCC
Confidence 1 12345778999999988889999999999999999998 9999964311 11111 1111110 1122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...++.+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 234567889999999999999999999999998753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.4e-32 Score=286.23 Aligned_cols=230 Identities=24% Similarity=0.313 Sum_probs=166.7
Q ss_pred cccccccceEEEeEE--EEEeeeehhhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITFLCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
...++..++||+|++ ||++.... .+|+| |++++++ ......++||||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~~~~~lv~e~ 100 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQW 100 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECSSSCEEEEEC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccCCccEEEEEe
Confidence 455666788999988 88776432 24444 6666664 466778999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC-Cc
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ-TG 569 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~-~~ 569 (702)
+++++|.+++......+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (289)
T 3og7_A 101 CEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177 (289)
T ss_dssp CCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------
T ss_pred cCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccc
Confidence 999999999987776799999999999999999999999 99999999999999999999999999998654322 22
Q ss_pred eeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 570 IVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||...... ...... ...+...... ..
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~----~~~~~~~~~~-~~ 249 (289)
T 3og7_A 178 QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEM----VGRGSLSPDL-SK 249 (289)
T ss_dssp ------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHH----HHHTSCCCCT-TS
T ss_pred cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHH----hcccccCcch-hh
Confidence 234467899999999886 567889999999999999999999999754211 111111 1111111111 11
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.....+..+.+++.+||+.||++|||+++++++|+.+.
T Consensus 250 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 22344678999999999999999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=2.6e-32 Score=290.17 Aligned_cols=238 Identities=21% Similarity=0.255 Sum_probs=179.1
Q ss_pred ccccccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEEecC----CeeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYKHRS----SKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~~~~----~~~~lV~e~ 490 (702)
+.++..+.||+|++ ||++......||+| |+++++++... ...++||||
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 116 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECC
T ss_pred cceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEec
Confidence 45666789999987 89888777777777 77778777766 789999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----CCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-----EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
+++|+|.+++... .+++.+++.++.|++.||+|||+++ ..+|+||||||+||+++.++.+||+|||++..+..
T Consensus 117 ~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~ 194 (337)
T 3mdy_A 117 HENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194 (337)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence 9999999999764 5899999999999999999999751 23899999999999999999999999999987644
Q ss_pred CCCce---eeceeccccccCcccccCCCCCcc------ccccchhHhHHHhhhC----------CcCCcCCCCCcchhhh
Q 038002 566 NQTGI---VAGVRGSRGYMAPEWQNSGLITVK------SDVYSFGVVLLEIICC----------RSNFEVNVSTADEVLL 626 (702)
Q Consensus 566 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlGvil~elltG----------~~Pf~~~~~~~~~~~~ 626 (702)
..... .....||+.|+|||.+.+.....+ +||||||+++|||++| +.||...........
T Consensus 195 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~- 273 (337)
T 3mdy_A 195 DTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE- 273 (337)
T ss_dssp --------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHH-
T ss_pred ccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchh-
Confidence 33221 124579999999999887666554 9999999999999999 556543322111111
Q ss_pred HHHHHHhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 627 STWVYNCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
. ................ .......+.+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 274 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 274 -D-MREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp -H-HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -h-hHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 0 1111111111111111 1233678889999999999999999999999999998654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-32 Score=284.50 Aligned_cols=231 Identities=31% Similarity=0.439 Sum_probs=180.6
Q ss_pred cceEEEeEE--EEEeeeehhhhHhh-------------------------------eeeEEEEEecCCeeEEEEecCCCC
Q 038002 448 KRKLLTVLA--GCLGSITFLCFLIA-------------------------------ISSLLVYKHRSSKKLLVYEFMSKG 494 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~~~~avk-------------------------------i~~l~~~~~~~~~~~lV~e~~~~g 494 (702)
.+.||+|++ ||++......+|+| |+++++++.+++..++||||++++
T Consensus 36 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 115 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNG 115 (307)
T ss_dssp CCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred CCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCC
Confidence 467888877 77776554555554 888899999999999999999999
Q ss_pred CHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-ee
Q 038002 495 SLADLLFNL--ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IV 571 (702)
Q Consensus 495 sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~ 571 (702)
+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......... ..
T Consensus 116 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 116 SLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp BHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred cHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 999999753 23589999999999999999999999 9999999999999999999999999999876543322 23
Q ss_pred eceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc---ccC
Q 038002 572 AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE---EVD 648 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 648 (702)
....|++.|+|||.+.+ .++.++||||||+++|+|++|..||................. .....+...++. ..+
T Consensus 193 ~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 269 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE--DEEKTIEDYIDKKMNDAD 269 (307)
T ss_dssp SSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHH--TTSCCHHHHSCSSCSCCC
T ss_pred cccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhh--hhhhhhhhhccccccccc
Confidence 34578999999998765 478999999999999999999999976533221111111110 011112222222 345
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
....+.+.+++.+||+.||++|||+++|+++|+++.
T Consensus 270 ~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 270 STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 677889999999999999999999999999998764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.4e-33 Score=287.99 Aligned_cols=226 Identities=21% Similarity=0.246 Sum_probs=166.7
Q ss_pred cccccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~l 486 (702)
.+.++..+.||+|++ ||++.... ..+|+| |+++++++ .++..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 455666778899887 88776532 234444 78888777 4567899
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
||||+++++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 169 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcc
Confidence 9999999999999987766799999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
.........+++.|+|||.+....++.++||||||+++|||++ |..||...... + .. .....+.. .
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~--~-~~-----~~i~~~~~-----~ 236 (281)
T 1mp8_A 170 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--D-VI-----GRIENGER-----L 236 (281)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G-HH-----HHHHTTCC-----C
T ss_pred cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH--H-HH-----HHHHcCCC-----C
Confidence 3323334456789999999988899999999999999999997 99999754211 1 11 11111111 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 237 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 122344567889999999999999999999999998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=3.9e-33 Score=299.49 Aligned_cols=228 Identities=24% Similarity=0.300 Sum_probs=177.0
Q ss_pred cccccccceEEEeEE--EEEeeeeh-------hhhHhh-----------------------------eeeEEEEEecC-C
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF-------LCFLIA-----------------------------ISSLLVYKHRS-S 482 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk-----------------------------i~~l~~~~~~~-~ 482 (702)
.+.++..+.||+|++ ||++.... ..|||| |+++++++.+. .
T Consensus 21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 345566778899887 88875321 445555 78888877764 4
Q ss_pred eeEEEEecCCCCCHHHHhhcCCC---------------------------------------------------------
Q 038002 483 KKLLVYEFMSKGSLADLLFNLET--------------------------------------------------------- 505 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 505 (702)
..++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 59999999999999999986542
Q ss_pred --------CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC-ceeeceec
Q 038002 506 --------RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRG 576 (702)
Q Consensus 506 --------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~g 576 (702)
.+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........ .......|
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~ 257 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEE
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCC
Confidence 178899999999999999999999 999999999999999999999999999987644333 23345678
Q ss_pred cccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHH
Q 038002 577 SRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERM 655 (702)
Q Consensus 577 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 655 (702)
|+.|+|||++.+..++.++||||||+++|||++ |+.||....... . . ......+. ....+......+
T Consensus 258 t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~-~----~~~~~~~~-----~~~~~~~~~~~l 325 (359)
T 3vhe_A 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E-F----CRRLKEGT-----RMRAPDYTTPEM 325 (359)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--H-H----HHHHHHTC-----CCCCCTTCCHHH
T ss_pred CceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--H-H----HHHHHcCC-----CCCCCCCCCHHH
Confidence 999999999988999999999999999999998 999997542221 1 1 11111111 111222345678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 656 VKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 656 ~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+++.+||+.||++|||++||+++|+.+.
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 89999999999999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-32 Score=292.92 Aligned_cols=220 Identities=18% Similarity=0.258 Sum_probs=170.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.++..+.||+|++ ||++.... ..+|+| |++++.++++++..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 34455677888876 77666442 344444 88889999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999997654 799999999999999999999999 99999999999999999999999999998643222
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch-hhhHHHHHHhhhccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE-VLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..........+..... .
T Consensus 165 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~ 237 (345)
T 3a8x_A 165 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R 237 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------C
T ss_pred -CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------C
Confidence 2234567999999999999999999999999999999999999999653221110 0111112222222211 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
.+...+..+.+++.+||+.||++||++
T Consensus 238 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 223445678899999999999999996
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=295.00 Aligned_cols=217 Identities=21% Similarity=0.247 Sum_probs=173.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV 487 (702)
..++..+.||+|++ ||++.... ..||+| |++++..+++.+..|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 34555678999987 78776543 455555 77888999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||++||+|.+++...+ .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999998654 699999999999999999999999 99999999999999999999999999998643222
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..... ..
T Consensus 176 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~-----~~~~i~~~~~------~~ 240 (353)
T 2i0e_A 176 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDE-----LFQSIMEHNV------AY 240 (353)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHHCCC------CC
T ss_pred -cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC---HHH-----HHHHHHhCCC------CC
Confidence 22345679999999999999999999999999999999999999996431 111 1111111111 12
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
+...+..+.+++.+||+.||++||+ +++|++
T Consensus 241 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 241 PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 2344668899999999999999995 467665
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.3e-33 Score=293.53 Aligned_cols=224 Identities=21% Similarity=0.211 Sum_probs=155.4
Q ss_pred cceEEEeEE--EEEeeeeh--hhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCCCCHHH
Q 038002 448 KRKLLTVLA--GCLGSITF--LCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSKGSLAD 498 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~--~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL~~ 498 (702)
.+.||+|++ ||++.... ..||+| |+++++++++++..|+||||+++|+|.+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFE 95 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHH
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHH
Confidence 367888877 77776643 556666 8889999999999999999999999999
Q ss_pred HhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC---cEEEecccceeecCCCCCceeecee
Q 038002 499 LLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW---RAKISDFGLAKLLMPNQTGIVAGVR 575 (702)
Q Consensus 499 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~ 575 (702)
++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++....... .......
T Consensus 96 ~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~ 170 (325)
T 3kn6_A 96 RIKKKK-HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QPLKTPC 170 (325)
T ss_dssp HHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------
T ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-CcccccC
Confidence 998764 799999999999999999999999 999999999999997766 89999999998754332 2234556
Q ss_pred ccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHH
Q 038002 576 GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERM 655 (702)
Q Consensus 576 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 655 (702)
||+.|+|||.+.+..++.++||||||+++|||++|+.||............. .....+..+... ...+.....++.+
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-~~~~~i~~~~~~--~~~~~~~~~s~~~ 247 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV-EIMKKIKKGDFS--FEGEAWKNVSQEA 247 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH-HHHHHHTTTCCC--CCSHHHHTSCHHH
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH-HHHHHHHcCCCC--CCcccccCCCHHH
Confidence 8999999999999999999999999999999999999997542211111111 112222222211 1111112346788
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHH
Q 038002 656 VKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 656 ~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+++.+||+.||++|||++|+++.
T Consensus 248 ~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 248 KDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HHHHHHHCCCChhHCCCHHHHhcC
Confidence 999999999999999999999853
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-33 Score=298.04 Aligned_cols=187 Identities=21% Similarity=0.247 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+++++..|+||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 101 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g 176 (373)
T 2r5t_A 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQG 176 (373)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred CCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCC
Confidence 7788899999999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... .
T Consensus 177 ~ikL~DFG~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~-----~ 247 (373)
T 2r5t_A 177 HIVLTDFGLCKENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAE-----M 247 (373)
T ss_dssp CEEECCCCBCGGGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB---HHH-----H
T ss_pred CEEEeeCccccccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHH-----H
Confidence 99999999998643222 22345679999999999999999999999999999999999999996431 111 1
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNV 676 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ev 676 (702)
...+..... ..+......+.+++.+||+.||++||++.+.
T Consensus 248 ~~~i~~~~~------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 248 YDNILNKPL------QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp HHHHHHSCC------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred HHHHHhccc------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 111111111 1122345678899999999999999998543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=302.13 Aligned_cols=224 Identities=17% Similarity=0.166 Sum_probs=175.5
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEE
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.+.++..+.||+|++ ||++.... ..+|+| |+++++++.+++..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3456667788999988 88775432 445544 88999999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe---CCCcEEEecccceeecC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID---DSWRAKISDFGLAKLLM 564 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~ 564 (702)
|||+++|+|.+.+.... .+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 99999999999998765 699999999999999999999999 999999999999998 46789999999998764
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ... ....+..+.... .
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~----~~~----~~~~i~~~~~~~--~ 233 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED----QHR----LYQQIKAGAYDF--P 233 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHH----HHHHHHHTCCCC--C
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc----HHH----HHHHHHhCCCCC--C
Confidence 3322 2345679999999999998899999999999999999999999996431 111 111112221111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.......++.+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11112345678899999999999999999999873
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-32 Score=292.37 Aligned_cols=200 Identities=27% Similarity=0.370 Sum_probs=162.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHhhhh
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET----------------------RPLWRDRVRIALDVARGLLYLHD 528 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~ 528 (702)
|+++++++..++..++||||+++|+|.+++..... .+++.+++.++.||+.||+|||+
T Consensus 111 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 190 (344)
T 1rjb_A 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190 (344)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh
Confidence 78888999999999999999999999999987542 27889999999999999999999
Q ss_pred cCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHh
Q 038002 529 ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEI 607 (702)
Q Consensus 529 ~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 607 (702)
+ +|+||||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||
T Consensus 191 ~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el 267 (344)
T 1rjb_A 191 K---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267 (344)
T ss_dssp T---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred C---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHH
Confidence 9 9999999999999999999999999999876443332 23456678899999999888999999999999999999
Q ss_pred hh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 608 IC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 608 lt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
++ |..||....... ..... ...+ . ....+...++.+.+++.+||+.||++|||+++|++.|+.+..
T Consensus 268 ~t~g~~p~~~~~~~~---~~~~~----~~~~-~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 268 FSLGVNPYPGIPVDA---NFYKL----IQNG-F----KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp TTTSCCSSTTCCCSH---HHHHH----HHTT-C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HcCCCCCcccCCcHH---HHHHH----HhcC-C----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 98 999997542211 11111 1111 1 111223345678999999999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-33 Score=296.53 Aligned_cols=216 Identities=21% Similarity=0.272 Sum_probs=173.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.+...+.||+|++ ||++.... ..||+| |++++..+++++..|+|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 34556678999987 88877543 445555 78889999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 97 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 172 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172 (345)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence 99999999999998654 689999999999999999999999 99999999999999999999999999998643222
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+.... ...
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~-----~~~~i~~~~------~~~ 237 (345)
T 1xjd_A 173 -AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEE-----LFHSIRMDN------PFY 237 (345)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHHCC------CCC
T ss_pred -CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHH-----HHHHHHhCC------CCC
Confidence 22345679999999999999999999999999999999999999996431 111 111111111 112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMK-NVI 677 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~-evl 677 (702)
+...+..+.+++.+||+.||++||++. +|+
T Consensus 238 p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 223456788999999999999999997 665
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=294.38 Aligned_cols=219 Identities=21% Similarity=0.265 Sum_probs=174.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.+...+.||+|++ ||++.... ..+|+| |++++.++++++..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 44556678888887 77776543 445555 888999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++.......
T Consensus 95 e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~- 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET- 169 (384)
T ss_dssp CCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC-
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC-
Confidence 9999999999998754 799999999999999999999999 99999999999999999999999999998764332
Q ss_pred ceeeceeccccccCcccccC---CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQNS---GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||............. ...... .
T Consensus 170 -~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~-----~~~~~~------~ 237 (384)
T 4fr4_A 170 -QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH-----TFETTV------V 237 (384)
T ss_dssp -CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH-----HHHHCC------C
T ss_pred -ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH-----HHhhcc------c
Confidence 2445679999999998863 458999999999999999999999997543222111111 111111 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPS-MKNVIL 678 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~ 678 (702)
..+...+..+.+++.+||+.||++||+ +++|++
T Consensus 238 ~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 123334678899999999999999998 777764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=296.62 Aligned_cols=220 Identities=20% Similarity=0.184 Sum_probs=162.8
Q ss_pred ceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEec----CCeeEEEEecCCCCCHH
Q 038002 449 RKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHR----SSKKLLVYEFMSKGSLA 497 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~----~~~~~lV~e~~~~gsL~ 497 (702)
+.||+|++ ||++.... ..||+| |++++++++. ++..||||||+++|+|.
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~ 147 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHH
Confidence 46777776 77666543 455655 6777776654 77899999999999999
Q ss_pred HHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC---CCcEEEecccceeecCCCCCceeec
Q 038002 498 DLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD---SWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 498 ~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++...... ....
T Consensus 148 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~--~~~~ 222 (400)
T 1nxk_A 148 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN--SLTT 222 (400)
T ss_dssp HHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---------
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC--cccc
Confidence 9998754 3589999999999999999999999 9999999999999987 7899999999998754322 2345
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .+..+.... ........+.
T Consensus 223 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~~--~~~~~~~~s~ 296 (400)
T 1nxk_A 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYEF--PNPEWSEVSE 296 (400)
T ss_dssp ----CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCCC--CTTTTTTSCH
T ss_pred CCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCcccC--CCcccccCCH
Confidence 6789999999999999999999999999999999999999975532211110111 111111110 0011123456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+.++|.+||+.||++|||++|+++.
T Consensus 297 ~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 297 EVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 78999999999999999999999984
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=282.92 Aligned_cols=223 Identities=23% Similarity=0.372 Sum_probs=172.9
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------------eeeEEEEEecCCe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------------ISSLLVYKHRSSK 483 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------------i~~l~~~~~~~~~ 483 (702)
.+.++..+.||+|++ ||++.... ..||+| |+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 345556677888877 77776542 455555 667777776555
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC--eEecCCCCCcEEEeCCCc-----EEEec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ--IIHCDIKLRNILIDDSWR-----AKISD 556 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~-----~kl~D 556 (702)
++||||+++++|.+++......+++..+..++.|++.||+|||++ + |+||||||+||+++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999999988777899999999999999999999999 8 999999999999988776 99999
Q ss_pred ccceeecCCCCCceeeceeccccccCcccc--cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh
Q 038002 557 FGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ--NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF 634 (702)
Q Consensus 557 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 634 (702)
||++..... ......||+.|+|||.+ ....++.++||||||+++|||++|+.||....... ...... .
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~----~ 242 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--IKFINM----I 242 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--HHHHHH----H
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--HHHHHH----H
Confidence 999975422 23446789999999988 44567899999999999999999999997542221 111111 1
Q ss_pred hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 635 VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
..... ....+...++.+.+++.+||+.||++|||++|+++.|+++
T Consensus 243 ~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REEGL----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHSCC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hccCC----CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 1122334456889999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=284.77 Aligned_cols=227 Identities=16% Similarity=0.133 Sum_probs=170.4
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+++..++||+|++ ||++.... ..||+| |+++++++.+++..++||||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 3455677888877 77776543 456655 78889999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++ +|.+.+......+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 83 ~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 157 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC 157 (292)
T ss_dssp CSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-SC
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-cc
Confidence 976 66666666556799999999999999999999999 99999999999999999999999999998764322 22
Q ss_pred eeceeccccccCcccccCCC-CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhh---cccccccc---
Q 038002 571 VAGVRGSRGYMAPEWQNSGL-ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFV---AGEFNKLV--- 643 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--- 643 (702)
.....||+.|+|||.+.+.. ++.++||||||+++|||++|..||.......+ .+.. ...... ...+....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKR-IFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHH-HHHHHCCCCTTTCTTGGGST
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHH-HHHHhCCCChhhhhhhcccc
Confidence 34456899999999887655 79999999999999999999988754322111 1111 111100 00000000
Q ss_pred -------------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 644 -------------EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 644 -------------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00122345678889999999999999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-32 Score=288.12 Aligned_cols=213 Identities=23% Similarity=0.239 Sum_probs=172.5
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.++..+.||+|++ ||++.... ..+|+| |++++..+++++..|+|||
T Consensus 7 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 4455677888877 77766542 445554 8888999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp CCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 999999999998755 789999999999999999999999 9999999999999999999999999999875332
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..... ..+.
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~-----~~~~i~~~~~------~~p~ 224 (318)
T 1fot_A 160 -TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMK-----TYEKILNAEL------RFPP 224 (318)
T ss_dssp -BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHH-----HHHHHHHCCC------CCCT
T ss_pred -cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHH-----HHHHHHhCCC------CCCC
Confidence 234579999999999999999999999999999999999999996431 111 1111111111 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
.....+.+++.+||+.||++|| +++|+++
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 3456788999999999999999 8899885
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=281.26 Aligned_cols=221 Identities=20% Similarity=0.258 Sum_probs=175.3
Q ss_pred ccccccceEEEeEE--EEEeeeehhhhHhh-----------------------------eeeEEEEEecC--CeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITFLCFLIA-----------------------------ISSLLVYKHRS--SKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~~~~avk-----------------------------i~~l~~~~~~~--~~~~lV~e 489 (702)
+.++..+.||+|++ ||++......+|+| |+++++++.+. +..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 44556678999987 88887766666666 78888888876 88999999
Q ss_pred cCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCC--eEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 490 FMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQ--IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
|+++|+|.+++..... .+++.++..++.||+.||+|||++ + |+||||||+||+++.++.++|.|||++.....
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp CCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 9999999999987654 489999999999999999999998 8 99999999999999999999999988764322
Q ss_pred CCceeeceeccccccCcccccCCCCCc---cccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITV---KSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... . .. ....... ..
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~-~~---~~~~~~~-~~---- 228 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---M-EI---GMKVALE-GL---- 228 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---H-HH---HHHHHHS-CC----
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---H-HH---HHHHHhc-CC----
Confidence 2345799999999987655444 89999999999999999999964311 1 10 1111111 11
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
....+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11223344567899999999999999999999999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-32 Score=288.83 Aligned_cols=214 Identities=20% Similarity=0.184 Sum_probs=174.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..+.||+|++ ||++.... ..||+| |++++..+++++..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 44556678899887 88776542 455555 788889999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 9999999999998754 689999999999999999999999 9999999999999999999999999999876432
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..+.. ..+
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~-----~~~~i~~~~~------~~p 258 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ---PIQ-----IYEKIVSGKV------RFP 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHHCCC------CCC
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---HHH-----HHHHHHcCCC------CCC
Confidence 234579999999999999999999999999999999999999996431 111 1111222211 122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
...+..+.+++.+||+.||++||+ ++||++
T Consensus 259 ~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 334567899999999999999998 888875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-32 Score=290.90 Aligned_cols=192 Identities=24% Similarity=0.326 Sum_probs=155.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 76 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~ 151 (326)
T 2y0a_A 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRN 151 (326)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred CCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCC
Confidence 7888899999999999999999999999997654 789999999999999999999999 999999999999998877
Q ss_pred ----cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 551 ----RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 551 ----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... ....
T Consensus 152 ~~~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~ 226 (326)
T 2y0a_A 152 VPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETL 226 (326)
T ss_dssp SSSCCEEECCCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH
T ss_pred CCCCCEEEEECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH---HHHH
Confidence 899999999987643322 3345799999999999988999999999999999999999999964311 1111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ...... ..........+..+.+++.+||+.||++|||++|+++
T Consensus 227 ~~-----~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 227 AN-----VSAVNY--EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HH-----HHHTCC--CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HH-----HHhcCC--CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 111100 0011111223567889999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=295.64 Aligned_cols=222 Identities=21% Similarity=0.217 Sum_probs=176.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.+...+.||+|++ ||++.... ..+|+| |+++++++.+++..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 44566678899877 88776543 445554 888999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC--CCcEEEecccceeecCCCCCc
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD--SWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
++|+|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||++........
T Consensus 131 ~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 206 (387)
T 1kob_A 131 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 206 (387)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcc-
Confidence 99999999987766799999999999999999999999 9999999999999974 57799999999987654332
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... ....+. ....... ........
T Consensus 207 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~-----~i~~~~~--~~~~~~~~ 275 (387)
T 1kob_A 207 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQ-----NVKRCDW--EFDEDAFS 275 (387)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH-----HHHHCCC--CCCSSTTT
T ss_pred -eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHH-----HHHhCCC--CCCccccc
Confidence 334579999999999999899999999999999999999999996431 111111 1111111 01112223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..+..+.+++.+||+.||++|||++|+++.
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 346688999999999999999999999874
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=287.96 Aligned_cols=235 Identities=21% Similarity=0.242 Sum_probs=174.6
Q ss_pred cccccccceEEEeEE--EEEeee------ehhhhHhh---------------------------eeeEEEEEec--CCee
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSI------TFLCFLIA---------------------------ISSLLVYKHR--SSKK 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~------~~~~~avk---------------------------i~~l~~~~~~--~~~~ 484 (702)
.+.++..++||+|++ ||++.. ....||+| |+++++++.. ....
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 345566788899887 777763 12556666 7778777644 4668
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
++||||+++++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 999999999999999988766799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCC--------cchhhhHHHHHHhh
Q 038002 565 PNQTG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVST--------ADEVLLSTWVYNCF 634 (702)
Q Consensus 565 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~--------~~~~~~~~~~~~~~ 634 (702)
..... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ..............
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43321 122344677899999999889999999999999999999999998542100 00000000111111
Q ss_pred hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 635 VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.... ....+...++.+.+++.+||+.||++|||++|++++|+.+.
T Consensus 246 ~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 246 KNNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HTTC-----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccC-----cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1111 11223345678999999999999999999999999998753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=293.75 Aligned_cols=226 Identities=19% Similarity=0.216 Sum_probs=177.5
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
+.+.+...+.||+|++ ||++.... ..+|+| |+++++++++++..|+||||++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 99 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMK 99 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCC
Confidence 3455666788999987 88877653 567776 8889999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC----CcEEEecccceeecCCCCC
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS----WRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~~~~~~~ 568 (702)
+|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+.++ +.+||+|||++........
T Consensus 100 gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 100 GGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp SCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 999999997764 699999999999999999999999 99999999999998443 3599999999987644332
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......||+.|+|||++.+..++.++||||||+++|||++|..||.......... ....+..+... ......
T Consensus 176 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-----~~~~i~~~~~~--~~~~~~ 247 (342)
T 2qr7_A 176 -LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE-----ILARIGSGKFS--LSGGYW 247 (342)
T ss_dssp -CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH-----HHHHHHHCCCC--CCSTTT
T ss_pred -ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH-----HHHHHccCCcc--cCcccc
Confidence 2344678999999999988888999999999999999999999997542221111 11112222211 111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...++.+.+++.+||+.||++||+++|+++
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 345678899999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=291.67 Aligned_cols=225 Identities=23% Similarity=0.289 Sum_probs=175.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hh----hHhh----------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LC----FLIA----------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~----~avk----------------------------i~~l~~~~~~~~~~~l 486 (702)
..++..+.||+|++ ||++.... .. ||+| |+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 45566788999987 88876532 22 3443 788888887654 789
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
|+||+++|+|.+++......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 9999999999999988777899999999999999999999999 9999999999999999999999999999877544
Q ss_pred CCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 567 QTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 567 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... . .... ...+. .
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~--~~~~----~~~~~-----~ 237 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E--ISSI----LEKGE-----R 237 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G--HHHH----HHTTC-----C
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH--H--HHHH----HHcCC-----C
Confidence 322 2233456889999999999999999999999999999999 99999754211 1 1111 11111 0
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...+......+.+++.+||+.||++||+++|++++|+.+.
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1122334567889999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=294.23 Aligned_cols=227 Identities=22% Similarity=0.273 Sum_probs=179.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh-------hhhHhh----------------------------eeeEEEEEecCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-------LCFLIA----------------------------ISSLLVYKHRSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk----------------------------i~~l~~~~~~~~~~~ 485 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 34555678888887 88877642 445655 888999999999999
Q ss_pred EEEecCCCCCHHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 486 LVYEFMSKGSLADLLFNLE-----------------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
+||||+++++|.+++.... ..+++.+++.++.||++||+|||++ +|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcc
Confidence 9999999999999997642 4688999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVST 620 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 620 (702)
||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-- 281 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA-- 281 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC--
Confidence 99999999999999999986543221 12234567899999999988889999999999999999999 999996431
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.. . .......+... ..+...+..+.+++.+||+.||++||++++++++|+++.+
T Consensus 282 ~~--~----~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 282 HE--E----VIYYVRDGNIL-----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp HH--H----HHHHHHTTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hH--H----HHHHHhCCCcC-----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 11 1 11111222211 1223345678999999999999999999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=291.90 Aligned_cols=216 Identities=21% Similarity=0.221 Sum_probs=173.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45666788999987 88887633 556665 788999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+ +|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 89 EYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp CCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred ECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 999 789999887654 799999999999999999999999 99999999999999999999999999998654332
Q ss_pred ceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.......... ..... ....
T Consensus 163 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~--------~i~~~------~~~~ 227 (336)
T 3h4j_B 163 -FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK--------KVNSC------VYVM 227 (336)
T ss_dssp -TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------CCCSS------CCCC
T ss_pred -ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------HHHcC------CCCC
Confidence 2344579999999999987765 789999999999999999999997542211000 00000 0112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 228 p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 228 PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 33345678899999999999999999999874
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=291.98 Aligned_cols=242 Identities=23% Similarity=0.266 Sum_probs=176.8
Q ss_pred cccccccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEE-----ecCCeeEEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYK-----HRSSKKLLVY 488 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~-----~~~~~~~lV~ 488 (702)
.+.++..+.||+|++ ||++......||+| |++++..+ ......++||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 91 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVM 91 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEE
T ss_pred hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEE
Confidence 345667789999988 99887766777777 55555422 2344679999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC------CCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC------EVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
||+++|+|.+++.... .++..+..++.||++||+|||+++ ..+|+||||||+|||++.++.+||+|||++..
T Consensus 92 e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 92 EYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp CCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence 9999999999997654 588999999999999999999862 22899999999999999999999999999987
Q ss_pred cCCCCC-------ceeeceeccccccCcccccC-------CCCCccccccchhHhHHHhhhCCcCCcCCCCCcch-hhhH
Q 038002 563 LMPNQT-------GIVAGVRGSRGYMAPEWQNS-------GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE-VLLS 627 (702)
Q Consensus 563 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~-~~~~ 627 (702)
+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||......... ....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 643221 11224568999999998876 45668999999999999999998877544222111 1000
Q ss_pred ---------HHHHHhhhcccccccccc--ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 628 ---------TWVYNCFVAGEFNKLVEE--EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 628 ---------~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...............+.. ......++.+.+++.+||+.||++|||++|++++|+++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 000001111111111111 1234567789999999999999999999999999998653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=291.66 Aligned_cols=225 Identities=21% Similarity=0.275 Sum_probs=173.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hh----hHhh----------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LC----FLIA----------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~----~avk----------------------------i~~l~~~~~~~~~~~l 486 (702)
..++..+.||+|++ ||++.... .. +++| |+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 45566678888877 78776532 22 3433 778888775 567899
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
||||+++|+|.+++......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 168 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168 (325)
T ss_dssp EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence 9999999999999987766789999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 567 QTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 567 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....+..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~~~----~~~~~~~----- 235 (325)
T 3kex_A 169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPD----LLEKGER----- 235 (325)
T ss_dssp TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----HHH----HHHTTCB-----
T ss_pred cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----HHH----HHHcCCC-----
Confidence 322 2344567889999999998899999999999999999999 999997542211 111 1111110
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...+......+.+++.+||+.||++||+++|+++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111223446788999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-33 Score=284.78 Aligned_cols=225 Identities=22% Similarity=0.295 Sum_probs=177.7
Q ss_pred cccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCCC
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSKG 494 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~g 494 (702)
.++..+.||+|++ ||++.... ..+|+| |+++++++.+++..++||||++++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 88 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCC
Confidence 4455667787776 77766533 445555 888899999999999999999999
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeece
Q 038002 495 SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGV 574 (702)
Q Consensus 495 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 574 (702)
+|.+++......+++.++..++.|++.||+|||++ +|+|+||||+||+++.++.+||+|||++..............
T Consensus 89 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 165 (267)
T 3t9t_A 89 CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT 165 (267)
T ss_dssp BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred cHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence 99999988766789999999999999999999999 999999999999999999999999999986543222222334
Q ss_pred eccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 575 RGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 575 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
.+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... . .. ......+. ....+...+.
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~-~~----~~~i~~~~-----~~~~~~~~~~ 232 (267)
T 3t9t_A 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---S-EV----VEDISTGF-----RLYKPRLAST 232 (267)
T ss_dssp TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H-HH----HHHHHTTC-----CCCCCTTSCH
T ss_pred cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH---H-HH----HHHHhcCC-----cCCCCccCcH
Confidence 56788999999988889999999999999999999 8999964311 1 11 11111110 1111223456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+.+++.+||+.||++||++++++++|+++.
T Consensus 233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 233 HVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7889999999999999999999999998764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=309.14 Aligned_cols=199 Identities=25% Similarity=0.338 Sum_probs=162.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++++..++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 278 iv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~ 354 (495)
T 1opk_A 278 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGEN 354 (495)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCC
Confidence 8899999999999999999999999999998643 3589999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||+++..............+++.|+|||.+....++.++||||||+++|||++ |..||...... + ..
T Consensus 355 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--~--~~- 429 (495)
T 1opk_A 355 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--Q--VY- 429 (495)
T ss_dssp GCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G--HH-
T ss_pred CcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--H--HH-
Confidence 999999999998765433222334456788999999988899999999999999999999 99999654211 1 11
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.....+ . ....+...++.+.++|.+||+.||++|||+++|+++|+.+.+
T Consensus 430 ---~~~~~~-~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 430 ---ELLEKD-Y----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---HHHHTT-C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---HHHHcC-C----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 111111 1 112233445678899999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.02 Aligned_cols=217 Identities=19% Similarity=0.261 Sum_probs=173.0
Q ss_pred cccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecCCCC
Q 038002 446 NDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFMSKG 494 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~~~g 494 (702)
...++||+|++ ||++.... ..|||| |+++++++..++..++||||++++
T Consensus 48 ~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~ 127 (321)
T 2c30_A 48 DSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGG 127 (321)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSC
T ss_pred hccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCC
Confidence 33457888877 88887652 667776 778889999999999999999999
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeece
Q 038002 495 SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGV 574 (702)
Q Consensus 495 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 574 (702)
+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........ .....
T Consensus 128 ~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 201 (321)
T 2c30_A 128 ALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 201 (321)
T ss_dssp BHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCCC
T ss_pred CHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-ccccc
Confidence 999998653 689999999999999999999999 999999999999999999999999999987644322 23456
Q ss_pred eccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHH
Q 038002 575 RGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLER 654 (702)
Q Consensus 575 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (702)
.||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..... ........... ......+..
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~----~~~~~----~~~~~~~~~~~---~~~~~~~~~ 270 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS----PVQAM----KRLRDSPPPKL---KNSHKVSPV 270 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHH----HHHHHSSCCCC---TTGGGSCHH
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHH----HHHhcCCCCCc---CccccCCHH
Confidence 79999999999998899999999999999999999999996431 11111 11111111111 111233567
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 655 MVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 655 l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+.+++.+||+.||++|||++|+++.
T Consensus 271 l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 271 LRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHccCChhhCcCHHHHhcC
Confidence 8899999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=292.95 Aligned_cols=222 Identities=19% Similarity=0.169 Sum_probs=173.3
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKL 485 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~ 485 (702)
.+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 455667788999987 88776542 445554 788899999999999
Q ss_pred EEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc---EEEecccc
Q 038002 486 LVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR---AKISDFGL 559 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~ 559 (702)
+||||+++++|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 999999999999887643 23489999999999999999999999 9999999999999976654 99999999
Q ss_pred eeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccc
Q 038002 560 AKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639 (702)
Q Consensus 560 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (702)
+........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||... ... .......+..
T Consensus 180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~-----~~~~i~~~~~ 249 (351)
T 3c0i_A 180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KER-----LFEGIIKGKY 249 (351)
T ss_dssp CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHH-----HHHHHHHTCC
T ss_pred eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHH-----HHHHHHcCCC
Confidence 987654322 234457999999999999889999999999999999999999999643 111 1111111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 640 NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 640 ~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.. ........+..+.+++.+||+.||++|||++|+++
T Consensus 250 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM--NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 10 00011123567889999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-33 Score=290.02 Aligned_cols=232 Identities=22% Similarity=0.286 Sum_probs=178.2
Q ss_pred cccccceEEEeEE--EEEeee------ehhhhHhh----------------------------eeeEEEEEecC--CeeE
Q 038002 444 KVNDKRKLLTVLA--GCLGSI------TFLCFLIA----------------------------ISSLLVYKHRS--SKKL 485 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~------~~~~~avk----------------------------i~~l~~~~~~~--~~~~ 485 (702)
.++..+.||+|++ ||++.. ....||+| |+++++++..+ +..+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 3456678999987 887762 22556666 77777777765 7789
Q ss_pred EEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
+||||+++++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 99999999999999977666799999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCC--------CcchhhhHHHHHHhhh
Q 038002 566 NQTG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVS--------TADEVLLSTWVYNCFV 635 (702)
Q Consensus 566 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~ 635 (702)
.... ......+|..|+|||.+.+..++.++||||||+++|||++|..|+..... ....... ........
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV-TRLVNTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH-HHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH-HHHHHHHh
Confidence 4331 22345678889999999888899999999999999999999998743210 0000000 00111111
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+. ....+...++.+.+++.+||+.||++|||+++++++|+.+.
T Consensus 258 ~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGK-----RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTC-----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccC-----CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111 11223345678999999999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=288.99 Aligned_cols=234 Identities=21% Similarity=0.210 Sum_probs=179.8
Q ss_pred ccccccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEEecCC----eeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYKHRSS----KKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~~~~~----~~~lV~e~ 490 (702)
+.+...+.||+|++ ||++......||+| |+++++++...+ ..++||||
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~ 121 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 121 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECC
T ss_pred ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEee
Confidence 34555678899877 88887766667776 777888877765 89999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhh--------hcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLH--------DECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+||+++.++.+||+|||++..
T Consensus 122 ~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 196 (342)
T 1b6c_B 122 HEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVR 196 (342)
T ss_dssp CTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCcee
Confidence 9999999999764 5899999999999999999999 77 999999999999999999999999999987
Q ss_pred cCCCCCc---eeeceeccccccCcccccCC------CCCccccccchhHhHHHhhhC----------CcCCcCCCCCcch
Q 038002 563 LMPNQTG---IVAGVRGSRGYMAPEWQNSG------LITVKSDVYSFGVVLLEIICC----------RSNFEVNVSTADE 623 (702)
Q Consensus 563 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltG----------~~Pf~~~~~~~~~ 623 (702)
....... ......||+.|+|||.+.+. .++.++||||||+++|||++| +.||.........
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~ 276 (342)
T 1b6c_B 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 276 (342)
T ss_dssp EETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCccc
Confidence 6544322 12345789999999988765 234789999999999999999 7787654222111
Q ss_pred hhhHHHHHHhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 624 VLLSTWVYNCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
. .. .............+.. .......+.+.+++.+||+.||++|||++||+++|+.+.
T Consensus 277 ~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 277 V--EE-MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp H--HH-HHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--HH-HHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 1 11 1111112111111111 123467789999999999999999999999999998764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-32 Score=292.68 Aligned_cols=196 Identities=23% Similarity=0.264 Sum_probs=156.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..+..++..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 121 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 196 (355)
T 1vzo_A 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNG 196 (355)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred eeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 7777888888999999999999999999998654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||+++.+............||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........+..
T Consensus 197 ~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 276 (355)
T 1vzo_A 197 HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR 276 (355)
T ss_dssp CEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH
T ss_pred cEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH
Confidence 99999999998765444333445679999999999875 3578999999999999999999999975432222111111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVILML 680 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~~L 680 (702)
. .... ....+......+.+++.+||+.||++|| +++|+++..
T Consensus 277 ~----~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 277 R----ILKS------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp H----HHHC------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred H----Hhcc------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1 1111 1122334456788999999999999999 999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-32 Score=289.90 Aligned_cols=222 Identities=20% Similarity=0.217 Sum_probs=165.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||||+++
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 132 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTG 132 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCC
Confidence 34555677888876 77776653 456666 78888999999999999999999
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC---CCcEEEecccceeecCCCCCce
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD---SWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++....... .
T Consensus 133 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 206 (349)
T 2w4o_A 133 GELFDRIVEKG-YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--L 206 (349)
T ss_dssp CBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--c
Confidence 99999997654 689999999999999999999999 9999999999999975 8899999999998654322 2
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ...+...... ........
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~-----~~~i~~~~~~--~~~~~~~~ 277 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFM-----FRRILNCEYY--FISPWWDE 277 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHH-----HHHHHTTCCC--CCTTTTTT
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHH-----HHHHHhCCCc--cCCchhhh
Confidence 33467899999999999889999999999999999999999999644211 111 1111111111 01111233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+..+.+++.+||+.||++|||++|+++.
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 45678999999999999999999999873
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=295.72 Aligned_cols=235 Identities=16% Similarity=0.104 Sum_probs=174.4
Q ss_pred cccccccceEEEe--EE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEE
Q 038002 442 NDKVNDKRKLLTV--LA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 442 ~~~~~~~~~l~~g--~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~l 486 (702)
...++..+.||+| ++ ||++.... ..||+| |+++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3556677899999 65 88887653 566766 8889999999999999
Q ss_pred EEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 487 VYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
||||+++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999997652 3689999999999999999999999 999999999999999999999999999875422
Q ss_pred CCC------ceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc-
Q 038002 566 NQT------GIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA- 636 (702)
Q Consensus 566 ~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 636 (702)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 260 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT 260 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence 211 11223468999999999877 678999999999999999999999997542221111000000000000
Q ss_pred -----c--------------------------ccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 637 -----G--------------------------EFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 637 -----~--------------------------~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. .................+.+++.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 000000001233345679999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-33 Score=306.37 Aligned_cols=226 Identities=24% Similarity=0.361 Sum_probs=176.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..++||+|+| ||++.... ..|||| |+++++++. ++..++||||+++
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~ 266 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAK 266 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTT
T ss_pred HHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCC
Confidence 34455677888877 78777653 456666 777887775 6789999999999
Q ss_pred CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 494 GSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 494 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 267 g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~ 343 (454)
T 1qcf_A 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343 (454)
T ss_dssp CBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTC
T ss_pred CcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccC
Confidence 99999997543 2588899999999999999999999 9999999999999999999999999999876432222222
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
...+++.|+|||.+....++.++||||||+++|||++ |+.||.... . .... .....+. ....+...
T Consensus 344 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--~--~~~~----~~i~~~~-----~~~~~~~~ 410 (454)
T 1qcf_A 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--N--PEVI----RALERGY-----RMPRPENC 410 (454)
T ss_dssp SSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--H--HHHH----HHHHHTC-----CCCCCTTS
T ss_pred CCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--H--HHHH----HHHHcCC-----CCCCCCCC
Confidence 3446788999999988899999999999999999999 999996431 1 1111 1111111 11122334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
++.+.++|.+||+.||++|||+++|+++|+.+..
T Consensus 411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 5678999999999999999999999999999754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=293.95 Aligned_cols=222 Identities=19% Similarity=0.221 Sum_probs=174.8
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
.+.+...+.||+|++ ||++.... ..+|+| |+++++++.+++..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345666788999987 88776543 455655 888899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC---cEEEecccceeecCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW---RAKISDFGLAKLLMP 565 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---~~kl~Dfg~a~~~~~ 565 (702)
||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++.....
T Consensus 108 e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 9999999999997654 689999999999999999999999 999999999999997654 599999999987643
Q ss_pred CCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 566 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ... ....+..+.... ..
T Consensus 184 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~----~~~----~~~~i~~~~~~~--~~ 251 (362)
T 2bdw_A 184 SE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHR----LYAQIKAGAYDY--PS 251 (362)
T ss_dssp CC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH----HHHHHHHTCCCC--CT
T ss_pred Cc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC----HHH----HHHHHHhCCCCC--Cc
Confidence 32 2334679999999999998899999999999999999999999996431 111 111111111110 01
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......+..+.+++.+||+.||++||+++|+++.
T Consensus 252 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1112345678899999999999999999998864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=286.35 Aligned_cols=224 Identities=25% Similarity=0.312 Sum_probs=167.0
Q ss_pred cccccceEEEeEE--EEEeeeehhhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCCCCH
Q 038002 444 KVNDKRKLLTVLA--GCLGSITFLCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL 496 (702)
.++..+.||+|++ ||++......||+| |+++++++. +..++||||+++++|
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L 86 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSL 86 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBH
T ss_pred HeeeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCH
Confidence 4455677888887 88877666666666 777777665 458999999999999
Q ss_pred HHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc-EEEecccceeecCCCCCceeec
Q 038002 497 ADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR-AKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 497 ~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~-~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
.+++..... .+++.+++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++...... ...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~----~~~ 162 (307)
T 2eva_A 87 YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTN 162 (307)
T ss_dssp HHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------------
T ss_pred HHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc----ccc
Confidence 999986543 3688999999999999999999922129999999999999998887 799999999765322 223
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||......... . ... ...+.. .......+.
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~---~~~-~~~~~~-----~~~~~~~~~ 231 (307)
T 2eva_A 163 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--I---MWA-VHNGTR-----PPLIKNLPK 231 (307)
T ss_dssp --CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--H---HHH-HHTTCC-----CCCBTTCCH
T ss_pred CCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--H---HHH-HhcCCC-----CCcccccCH
Confidence 46899999999999889999999999999999999999999754222111 1 011 111111 111223356
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+.+++.+||+.||++|||+++++++|+.+.
T Consensus 232 ~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 232 PIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 7889999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-32 Score=303.34 Aligned_cols=228 Identities=27% Similarity=0.342 Sum_probs=172.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..++||+|+| ||++.... ..|||| |+++++++.+ +..++||||+++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 34455667888877 77776654 446666 7888887765 778999999999
Q ss_pred CCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 494 GSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 494 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 263 gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 339 (452)
T 1fmk_A 263 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339 (452)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceeccc
Confidence 9999999753 23589999999999999999999999 9999999999999999999999999999876443322233
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
...++..|+|||.+....++.++||||||+++|||++ |+.||..... .+ .......+. ....+...
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--~~------~~~~i~~~~-----~~~~~~~~ 406 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE------VLDQVERGY-----RMPCPPEC 406 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HH------HHHHHHTTC-----CCCCCTTS
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--HH------HHHHHHcCC-----CCCCCCCC
Confidence 4457789999999988899999999999999999999 9999964311 11 111111111 11123344
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
++.+.+++.+||+.||++|||+++|+++|+.+..-.
T Consensus 407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 668899999999999999999999999999976443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=290.85 Aligned_cols=221 Identities=15% Similarity=0.054 Sum_probs=175.6
Q ss_pred ccccccceEEEeEE--EEEee-----e--ehhhhHhh---------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGS-----I--TFLCFLIA---------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~-----~--~~~~~avk---------------------------i~~l~~~~~~~~~~~l 486 (702)
+.+...+.||+|++ ||++. . ....||+| |++++..+..++..++
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~l 144 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEE
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEE
Confidence 44556678999987 88883 1 22566666 7788899999999999
Q ss_pred EEecCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-----------CCc
Q 038002 487 VYEFMSKGSLADLLFN----LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-----------SWR 551 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-----------~~~ 551 (702)
||||+++|+|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+|||++. ++.
T Consensus 145 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp EECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999974 334699999999999999999999999 9999999999999988 899
Q ss_pred EEEecccceeecCCC-CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 552 AKISDFGLAKLLMPN-QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 552 ~kl~Dfg~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 222 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------- 294 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK------- 294 (365)
T ss_dssp EEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-------
T ss_pred EEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-------
Confidence 999999999865422 223345567999999999999999999999999999999999999999643221100
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhCCc
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLR-PSMKNVILMLEGTM 684 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~R-Pt~~evl~~Le~~~ 684 (702)
....+... ...+.+.+++..||+.+|.+| |+++++.+.|+...
T Consensus 295 --------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 295 --------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp --------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred --------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00111111 124567778888999999999 67888888887643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=287.58 Aligned_cols=199 Identities=25% Similarity=0.371 Sum_probs=162.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC-----------------CCCHHHHHHHHHHHHHHHHhhhhcCCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET-----------------RPLWRDRVRIALDVARGLLYLHDECEVQ 533 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ 533 (702)
|+++++++..++..++||||+++|+|.+++..... .+++.+++.++.||+.||+|||++ +
T Consensus 89 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ 165 (313)
T 1t46_A 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---N 165 (313)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred eeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence 88889999999999999999999999999986542 388999999999999999999999 9
Q ss_pred eEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CC
Q 038002 534 IIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CR 611 (702)
Q Consensus 534 ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~ 611 (702)
|+||||||+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+
T Consensus 166 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 245 (313)
T 1t46_A 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245 (313)
T ss_dssp CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999876544332 2234567889999999988899999999999999999999 99
Q ss_pred cCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 612 SNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 612 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.||....... ........ . . ....+...+..+.+++.+||+.||++|||++|++++|+++.
T Consensus 246 ~p~~~~~~~~---~~~~~~~~----~-~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 246 SPYPGMPVDS---KFYKMIKE----G-F----RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp CSSTTCCSSH---HHHHHHHH----T-C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccchh---HHHHHhcc----C-C----CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 9997542211 11111111 1 1 11112234567899999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=282.87 Aligned_cols=225 Identities=20% Similarity=0.222 Sum_probs=166.3
Q ss_pred ccccceEEEeEE--EEEeeeeh-hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 445 VNDKRKLLTVLA--GCLGSITF-LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~-~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
++..+.||+|++ ||++.... ..+|+| |+++++++.+++..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 445567777766 77665532 445554 8889999999999999999998
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
+ +|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (288)
T 1ob3_A 84 Q-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYT 158 (288)
T ss_dssp E-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred C-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-ccc
Confidence 6 99999987766799999999999999999999999 999999999999999999999999999987643221 223
Q ss_pred ceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc---cccccc-----c
Q 038002 573 GVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA---GEFNKL-----V 643 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~ 643 (702)
...+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ..+.. ....... ..+... .
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMR-IFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH-HHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH-HHHHHCCCChhhchhhhccccc
Confidence 4568999999998865 46899999999999999999999999754211 11111 1110000 000000 0
Q ss_pred c-----------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 644 E-----------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 644 ~-----------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+ ........+.+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 0111234567889999999999999999999986
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=289.35 Aligned_cols=229 Identities=20% Similarity=0.221 Sum_probs=167.0
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCC----
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSS---- 482 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~---- 482 (702)
..+.++..+.||+|++ ||++.... ..||+| |+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4566777889999987 88887533 566666 677777666544
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..|+||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred ccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 3499999999999999997654 689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc
Q 038002 563 LMPNQT--GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640 (702)
Q Consensus 563 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (702)
...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... .. ............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~-----~~~~~~~~~~~~ 238 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VS-----VAYQHVREDPIP 238 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH-----HHHHHHHCCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HH-----HHHHHhcCCCCC
Confidence 644322 122345689999999999998999999999999999999999999964411 11 111111111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHHhCC
Q 038002 641 KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKN-VILMLEGT 683 (702)
Q Consensus 641 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e-vl~~Le~~ 683 (702)
........+..+.+++.+||+.||++||++.+ +...|...
T Consensus 239 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 239 ---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp ---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 01112234567889999999999999996555 44555554
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=286.26 Aligned_cols=226 Identities=25% Similarity=0.323 Sum_probs=178.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh-------hhhHhh----------------------------eeeEEEEEecCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-------LCFLIA----------------------------ISSLLVYKHRSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk----------------------------i~~l~~~~~~~~~~~ 485 (702)
..+...+.||+|++ ||++.... ..||+| |+++++++.+++..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 44555678888887 88776421 345554 888899999999999
Q ss_pred EEEecCCCCCHHHHhhcCCC-----------------------CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 486 LVYEFMSKGSLADLLFNLET-----------------------RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
+||||+++++|.+++..... .+++.+++.++.||++||+|||++ +|+||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchh
Confidence 99999999999999986532 378999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVST 620 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~ 620 (702)
||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543322 1233457788999999988889999999999999999999 99999654211
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
. . ......+. ....+...++.+.+++.+||+.||++||+++|+++.|+++.
T Consensus 260 --~--~----~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 260 --R--L----FNLLKTGH-----RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp --G--H----HHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --H--H----HHHhhcCC-----cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 1 11111111 11222344567899999999999999999999999998753
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-33 Score=292.24 Aligned_cols=235 Identities=23% Similarity=0.239 Sum_probs=177.9
Q ss_pred Ccccc-cccceEEEeEE--EEEeeee------hhhhHhh----------------------------eeeEEEEEec--C
Q 038002 441 GNDKV-NDKRKLLTVLA--GCLGSIT------FLCFLIA----------------------------ISSLLVYKHR--S 481 (702)
Q Consensus 441 ~~~~~-~~~~~l~~g~~--v~~~~~~------~~~~avk----------------------------i~~l~~~~~~--~ 481 (702)
+..++ +..++||+|++ ||++... ...||+| |+++++++.+ .
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 34444 66788999988 7665431 2456665 7788877776 5
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
...++||||+++++|.+++... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccc
Confidence 7889999999999999999765 489999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCCc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCc-------chhhhHHHHHH
Q 038002 562 LLMPNQTG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA-------DEVLLSTWVYN 632 (702)
Q Consensus 562 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~~ 632 (702)
........ ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 87544321 2234557888999999988889999999999999999999999996431000 00000000011
Q ss_pred hhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 633 CFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
..... .....+...+..+.+++.+||+.||++|||++|++++|+.+.+
T Consensus 263 ~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 263 LLERG-----ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcc-----cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111 1112234456789999999999999999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-32 Score=285.21 Aligned_cols=230 Identities=15% Similarity=0.114 Sum_probs=169.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..++..+.||+|++ ||++.... ..||+| |+++++++..++..++||
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM 113 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence 34556678888877 88776542 445554 888899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++........
T Consensus 114 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 189 (309)
T 2h34_A 114 RLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189 (309)
T ss_dssp ECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC---------
T ss_pred EecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccc
Confidence 9999999999998654 689999999999999999999999 999999999999999999999999999987654433
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .... ..... ..... .....
T Consensus 190 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~~~----~~~~~-~~~~~--~~~~~ 258 (309)
T 2h34_A 190 TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ----LSVM----GAHIN-QAIPR--PSTVR 258 (309)
T ss_dssp -------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH----HHHH----HHHHH-SCCCC--GGGTS
T ss_pred ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch----HHHH----HHHhc-cCCCC--ccccC
Confidence 33445678999999999998899999999999999999999999996431 1111 11111 11110 11223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhCCcCCC
Q 038002 649 KITLERMVKTGLLCIQDEPNLRP-SMKNVILMLEGTMEIP 687 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~Le~~~~~~ 687 (702)
...+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 34456788999999999999999 9999999999865443
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=286.28 Aligned_cols=225 Identities=19% Similarity=0.208 Sum_probs=172.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh---------hhhHhh---------------------------eeeEEEEEecCCee
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF---------LCFLIA---------------------------ISSLLVYKHRSSKK 484 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~---------~~~avk---------------------------i~~l~~~~~~~~~~ 484 (702)
+.+...+.||+|++ ||++.... ..+|+| |+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 44556678888877 77765443 124444 88899999999999
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc--------EEEec
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR--------AKISD 556 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--------~kl~D 556 (702)
++||||+++++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999988765699999999999999999999999 9999999999999998887 99999
Q ss_pred ccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhh
Q 038002 557 FGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFV 635 (702)
Q Consensus 557 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 635 (702)
||++..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+....... .... ... .
T Consensus 165 fg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~~-~~~--~ 233 (289)
T 4fvq_A 165 PGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ---RKLQ-FYE--D 233 (289)
T ss_dssp CCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHH-HHH--T
T ss_pred CcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH---HHHH-Hhh--c
Confidence 999865422 123457899999998877 778999999999999999999655543321111 1100 000 1
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCCCC
Q 038002 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPIL 689 (702)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~~p 689 (702)
.... +......+.+++.+||+.||++|||++|+++.|+.+.....+
T Consensus 234 ~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 234 RHQL--------PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp TCCC--------CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred cCCC--------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 1111 111244688899999999999999999999999998764433
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=281.65 Aligned_cols=225 Identities=21% Similarity=0.245 Sum_probs=172.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.+...+.||+|++ ||++.... ..||+| |+++++++++ +..++|
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 90 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWII 90 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEE
Confidence 44556678888877 77776432 125554 7888887765 457999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 167 (281)
T 3cc6_A 91 MELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167 (281)
T ss_dssp EECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred EecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence 999999999999987666799999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
........+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ... ....+.. ..
T Consensus 168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~~~----~~~~~~~-----~~ 234 (281)
T 3cc6_A 168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIG----VLEKGDR-----LP 234 (281)
T ss_dssp -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----HHH----HHHHTCC-----CC
T ss_pred ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----HHH----HHhcCCC-----CC
Confidence 333344557889999999988899999999999999999998 999996432111 111 1111110 11
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+...++.+.+++.+||+.||++||+++|+++.|+.+.
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 12234567889999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=299.95 Aligned_cols=222 Identities=24% Similarity=0.244 Sum_probs=176.0
Q ss_pred ccccccceEEEeEE--EEEeeeehhhhHhh-------------------------eeeEEEEEecC-CeeEEEEecCCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITFLCFLIA-------------------------ISSLLVYKHRS-SKKLLVYEFMSKG 494 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~~~~avk-------------------------i~~l~~~~~~~-~~~~lV~e~~~~g 494 (702)
+.++..++||+|+| ||++......|||| |+++++++.+. +..++||||+++|
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g 272 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTC
T ss_pred HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCC
Confidence 34455678899987 88887766777777 77888776544 4899999999999
Q ss_pred CHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 495 SLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 495 sL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
+|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 273 ~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~----~~ 345 (450)
T 1k9a_A 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 345 (450)
T ss_dssp BHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---------
T ss_pred cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----cC
Confidence 99999987543 368999999999999999999999 99999999999999999999999999998643221 22
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... . ......+. ....+...+
T Consensus 346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~------~~~i~~~~-----~~~~p~~~~ 412 (450)
T 1k9a_A 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V------VPRVEKGY-----KMDAPDGCP 412 (450)
T ss_dssp -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--H------HHHHHTTC-----CCCCCTTCC
T ss_pred CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H------HHHHHcCC-----CCCCCCcCC
Confidence 356889999999999999999999999999999998 999997542211 1 11111111 112233446
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..+.++|.+||+.||++|||+++|++.|+.+.
T Consensus 413 ~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 413 PAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 78899999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-32 Score=285.35 Aligned_cols=197 Identities=25% Similarity=0.323 Sum_probs=163.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++++.+++..++||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +|+|+||||+||+++.+
T Consensus 71 i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~ 147 (288)
T 3kfa_A 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 147 (288)
T ss_dssp BCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGG
T ss_pred EeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCC
Confidence 8889999999999999999999999999998753 3589999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... ....
T Consensus 148 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~~~~ 223 (288)
T 3kfa_A 148 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----QVYE 223 (288)
T ss_dssp GCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----GHHH
T ss_pred CCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 999999999998775554444455677889999999988899999999999999999999 99999654211 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
. .... .....+...++.+.+++.+||+.||++|||+++++++|+.+
T Consensus 224 ~----~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 224 L----LEKD-----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp H----HHTT-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----Hhcc-----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 1 1111 11122233456789999999999999999999999999864
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=288.25 Aligned_cols=227 Identities=20% Similarity=0.239 Sum_probs=161.3
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
.++..++||+|++ ||++.... ..||+| |+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 3455567777776 77765442 455555 888899999999999999999
Q ss_pred CCCCHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 492 SKGSLADLLFNLE-----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 492 ~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
+ ++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 59999986532 3588999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc---------
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA--------- 636 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------- 636 (702)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+.. .......
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~-i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKL-IFDIMGTPNESLWPSV 236 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH-HHHHHCSCCTTTCGGG
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHH-HHHHhCCCChhHhhhh
Confidence 22 2334568999999998876 46899999999999999999999999754211 11111 1110000
Q ss_pred ---------------cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 637 ---------------GEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 637 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..+...+.+.........+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 0000001111112345678999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=287.93 Aligned_cols=226 Identities=22% Similarity=0.288 Sum_probs=173.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh------hhhHhh----------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF------LCFLIA----------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~------~~~avk----------------------------i~~l~~~~~~~~~~~l 486 (702)
..+...+.||+|++ ||++.... ..||+| |+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 34455678999987 88876542 135655 7888999999999999
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
||||+++++|.+++......+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 200 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 200 (333)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence 9999999999999987766799999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 567 QTG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 567 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. .......+.
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~----~~----~~~~~~~~~----- 267 (333)
T 1mqb_A 201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----HE----VMKAINDGF----- 267 (333)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HH----HHHHHHTTC-----
T ss_pred cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH----HH----HHHHHHCCC-----
Confidence 221 1222345788999999998899999999999999999999 9999964311 11 111111111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
....+...+..+.+++.+||+.||++||++.+++++|+.+.
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 308 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 308 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112234567899999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-32 Score=293.75 Aligned_cols=193 Identities=24% Similarity=0.311 Sum_probs=156.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE--eC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI--DD 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll--~~ 548 (702)
|+++++++.+++..+|||||+++++|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||+ +.
T Consensus 148 Iv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 224 (373)
T 2x4f_A 148 LIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRD 224 (373)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETT
T ss_pred CCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCC
Confidence 88899999999999999999999999999987665799999999999999999999999 99999999999999 56
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||.... ....+..
T Consensus 225 ~~~~kl~DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~ 299 (373)
T 2x4f_A 225 AKQIKIIDFGLARRYKPREK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNN 299 (373)
T ss_dssp TTEEEECCCSSCEECCTTCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHH
T ss_pred CCcEEEEeCCCceecCCccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH
Confidence 77899999999987644332 234568999999999998899999999999999999999999996541 1111111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+...... ..........+.+.+++.+||+.||++|||++|+++
T Consensus 300 -----i~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 300 -----ILACRWD--LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -----HHHTCCC--SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----HHhccCC--CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111110 011111234568899999999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=289.86 Aligned_cols=224 Identities=21% Similarity=0.184 Sum_probs=165.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
.++++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 98 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYA 98 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeC
Confidence 355667788888887 78777653 566766 888999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc--EEEecccceeecCCCCCc
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR--AKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~ 569 (702)
++|+|.+++.... ++++.++..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||+++......
T Consensus 99 ~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-- 172 (361)
T 3uc3_A 99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-- 172 (361)
T ss_dssp CSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------
T ss_pred CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--
Confidence 9999999997654 699999999999999999999999 9999999999999987765 9999999997532222
Q ss_pred eeeceeccccccCcccccCCCCCcc-ccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVK-SDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||............. .......... ...
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~----~~~ 244 (361)
T 3uc3_A 173 QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI----QRILSVKYSI----PDD 244 (361)
T ss_dssp --------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH----HHHHTTCCCC----CTT
T ss_pred CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH----HHHhcCCCCC----CCc
Confidence 2334569999999999887777655 899999999999999999997543222211111 1111111100 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...+..+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 1235678899999999999999999999974
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=286.74 Aligned_cols=230 Identities=17% Similarity=0.191 Sum_probs=168.4
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
++..++||+|++ ||++.... ..||+| |+++++++.+++..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 445567777776 77776543 456665 7788899999999999999997
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~~ 158 (324)
T 3mtl_A 84 -KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYD 158 (324)
T ss_dssp -EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred -cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-cccc
Confidence 599999988776799999999999999999999999 99999999999999999999999999998653222 2233
Q ss_pred ceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh---hcccccccccc---
Q 038002 573 GVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF---VAGEFNKLVEE--- 645 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~--- 645 (702)
...||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... + .. ....... ....+......
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~--~~-~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-E--QL-HFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-H--HH-HHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-H--HH-HHHHHHhCCCChHhchhhhcchhh
Confidence 4568999999998876 57899999999999999999999999754211 1 11 1111100 00001100000
Q ss_pred --------------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhCC
Q 038002 646 --------------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL--MLEGT 683 (702)
Q Consensus 646 --------------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~--~Le~~ 683 (702)
.........+.+++.+||+.||++|||++|+++ .+.++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 112234567889999999999999999999988 34443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=302.64 Aligned_cols=221 Identities=24% Similarity=0.260 Sum_probs=178.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..++..+.||+|++ ||++.... ..||+| |++++..+++++..|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 45566788999988 88887643 556665 888899999999999999
Q ss_pred ecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 489 EFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
||++||+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 99999999999987542 489999999999999999999999 99999999999999999999999999998764433
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.. ..... ....
T Consensus 341 --~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----~i~~~------~~~~ 408 (576)
T 2acx_A 341 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----LVKEV------PEEY 408 (576)
T ss_dssp --CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH----HHHHC------CCCC
T ss_pred --cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH----Hhhcc------cccC
Confidence 23445799999999999988999999999999999999999999976432211111111 11111 1122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
+...+..+.+++.+||+.||++|| +++||++
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 334467889999999999999999 7888875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-32 Score=300.55 Aligned_cols=217 Identities=20% Similarity=0.236 Sum_probs=173.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..++..+.||+|++ ||++.... ..||+| |++++.++.+++..++||
T Consensus 148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 227 (446)
T 4ejn_A 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM 227 (446)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence 34556788999988 88776543 566666 677888899999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
||+++|+|.+++.... .+++..+..++.||+.||+|||+ + +|+||||||+|||++.++.+||+|||+++......
T Consensus 228 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 228 EYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999997654 78999999999999999999998 8 99999999999999999999999999998543222
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||..... . .. ...+..... ..
T Consensus 304 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~-~~----~~~i~~~~~------~~ 368 (446)
T 4ejn_A 304 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---E-KL----FELILMEEI------RF 368 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---H-HH----HHHHHHCCC------CC
T ss_pred -cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---H-HH----HHHHHhCCC------CC
Confidence 223456799999999999999999999999999999999999999964311 1 11 111111111 12
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
+......+.+++.+||+.||++|| +++|+++
T Consensus 369 p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 369 PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 223456788999999999999999 9999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=283.98 Aligned_cols=198 Identities=22% Similarity=0.243 Sum_probs=152.0
Q ss_pred eeeEEEEEecCC-----eeEEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSS-----KKLLVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++++++.... ..++||||+. ++|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+||
T Consensus 76 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Ni 151 (308)
T 3g33_A 76 VVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI 151 (308)
T ss_dssp BCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTE
T ss_pred eEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence 667777776554 5899999997 599999987653 389999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+++.++.+||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .
T Consensus 152 l~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~ 226 (308)
T 3g33_A 152 LVTSGGTVKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---D 226 (308)
T ss_dssp EECTTSCEEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---H
T ss_pred EEcCCCCEEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---H
Confidence 99999999999999998654322 234567899999999998889999999999999999999999999654211 1
Q ss_pred hhHHHHHHhh---hccccccc-------cc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCF---VAGEFNKL-------VE-------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~---~~~~~~~~-------~~-------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... ..... ....+... .. ........+.+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 227 QLGK-IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHH-HHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHH-HHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 1111 11110 00000000 00 0112234578899999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-32 Score=278.01 Aligned_cols=217 Identities=24% Similarity=0.280 Sum_probs=152.2
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.++..+.||+|++ ||++.... ..||+| |++++.++.+++..++|||
T Consensus 12 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 3445567777776 77766432 445554 7888899999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++++|.+++......+++.++..++.|+++||+|||++ +|+|+||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 167 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE- 167 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC-
Confidence 9999999999988766799999999999999999999999 999999999999999999999999999987643222
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . ....... ...+.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-----~~~~~~~------~~~~~ 233 (278)
T 3cok_A 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L-----NKVVLAD------YEMPS 233 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCSSC------CCCCT
T ss_pred cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H-----HHHhhcc------cCCcc
Confidence 22345689999999999888899999999999999999999999975422110 0 0000000 11223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+..+.+++.+||+.||++|||++++++
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 34567889999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-32 Score=282.66 Aligned_cols=225 Identities=25% Similarity=0.360 Sum_probs=175.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..+.||+|++ ||++.... ..+|+| |+++++++. ++..++||||+++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 91 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCC
Confidence 44556678888876 77776544 456665 777777765 5568999999999
Q ss_pred CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 494 GSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 494 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++............
T Consensus 92 ~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 168 (279)
T 1qpc_A 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (279)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccccc
Confidence 99999997543 2589999999999999999999999 9999999999999999999999999999877544333333
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... . .. ......+. ....+...
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~-~~----~~~~~~~~-----~~~~~~~~ 235 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---P-EV----IQNLERGY-----RMVRPDNC 235 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---H-HH----HHHHHTTC-----CCCCCTTC
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---H-HH----HHHHhccc-----CCCCcccc
Confidence 4557789999999988889999999999999999999 9999964311 1 11 11111110 11122334
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
++.+.+++.+||+.||++|||+++++++|+.+.
T Consensus 236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 568899999999999999999999999999853
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=296.76 Aligned_cols=198 Identities=25% Similarity=0.325 Sum_probs=158.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++++++.+++..++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 136 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NI 212 (367)
T 3l9p_A 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 212 (367)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhE
Confidence 8889999999999999999999999999997643 3588999999999999999999999 999999999999
Q ss_pred EEeCCC---cEEEecccceeecCCCC-CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCC
Q 038002 545 LIDDSW---RAKISDFGLAKLLMPNQ-TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVS 619 (702)
Q Consensus 545 ll~~~~---~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 619 (702)
|++.++ .+||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus 213 ll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~- 291 (367)
T 3l9p_A 213 LLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS- 291 (367)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred EEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC-
Confidence 998555 59999999997543221 112234567899999999988899999999999999999998 999996541
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.... ......+.. ...+...+..+.+++.+||+.||++||++++|++.|+.+.
T Consensus 292 ---~~~~----~~~i~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 292 ---NQEV----LEFVTSGGR-----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp ---HHHH----HHHHHTTCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHH----HHHHHcCCC-----CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1111 111111111 1112234567889999999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=290.34 Aligned_cols=234 Identities=14% Similarity=0.127 Sum_probs=176.0
Q ss_pred ccccccceEEEeEE--EEEeeee----------hhhhHhhee-------------------------------------e
Q 038002 443 DKVNDKRKLLTVLA--GCLGSIT----------FLCFLIAIS-------------------------------------S 473 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~----------~~~~avki~-------------------------------------~ 473 (702)
+.+...+.||+|++ ||++... ...||+|+. +
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~ 121 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPT 121 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccc
Confidence 45566778899887 8888764 356777622 1
Q ss_pred EEEEEec-CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC-
Q 038002 474 LLVYKHR-SSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW- 550 (702)
Q Consensus 474 l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~- 550 (702)
++.++.. ++..++||||+ +++|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 122 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~ 197 (352)
T 2jii_A 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQ 197 (352)
T ss_dssp CCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEE
T ss_pred hhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCC
Confidence 3445544 78999999999 99999999875 34699999999999999999999999 999999999999999998
Q ss_pred -cEEEecccceeecCCCCCc------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch
Q 038002 551 -RAKISDFGLAKLLMPNQTG------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE 623 (702)
Q Consensus 551 -~~kl~Dfg~a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~ 623 (702)
.+||+|||+++.+...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........
T Consensus 198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 277 (352)
T 2jii_A 198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED 277 (352)
T ss_dssp EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence 8999999999876432211 123457899999999999989999999999999999999999999765322211
Q ss_pred hhhHHHHHHhhhcccccccccc-ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 624 VLLSTWVYNCFVAGEFNKLVEE-EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.. ... ... ......+... ......+..+.+++.+||+.||++||++++|+++|+++.
T Consensus 278 ~~--~~~-~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 278 IM--KQK-QKF-VDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp HH--HHH-HHH-HHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred HH--HHH-Hhc-cCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 11 111 111 1111111111 001123567889999999999999999999999998864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=294.33 Aligned_cols=239 Identities=18% Similarity=0.154 Sum_probs=182.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCC--eeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSS--KKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~--~~~lV 487 (702)
...+...+.||+|++ ||++.... ..||+| |+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 456667788999987 88887653 566766 777887777654 78999
Q ss_pred EecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE----eCCCcEEEeccccee
Q 038002 488 YEFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAK 561 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~ 561 (702)
|||+++|+|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999976532 389999999999999999999999 99999999999999 777789999999998
Q ss_pred ecCCCCCceeeceeccccccCcccccC--------CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHh
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQNS--------GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...................
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 764432 2334568999999998764 567889999999999999999999997543222211111111111
Q ss_pred hhcccc-------------ccc--cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 634 FVAGEF-------------NKL--VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 634 ~~~~~~-------------~~~--~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.....+ ... ............+.+++.+||+.||++||+++|+++.|+.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 000000 000 0113457788899999999999999999999999999987654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-32 Score=287.50 Aligned_cols=226 Identities=23% Similarity=0.278 Sum_probs=170.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hh----hHhh----------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LC----FLIA----------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~----~avk----------------------------i~~l~~~~~~~~~~~l 486 (702)
..++..+.||+|++ ||++.... .. +++| |+++++++..+. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 45566788899887 88876532 22 2333 777777777654 889
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
|+||+++|+|.+++......+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 94 v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~ 170 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence 9999999999999988776899999999999999999999999 9999999999999999999999999999876433
Q ss_pred CC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 567 QT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 567 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.. .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... + .... ...+. .
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--~--~~~~----~~~~~-----~ 237 (327)
T 3lzb_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--E--ISSI----LEKGE-----R 237 (327)
T ss_dssp ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G--HHHH----HHTTC-----C
T ss_pred cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH--H--HHHH----HHcCC-----C
Confidence 32 12233456788999999999999999999999999999999 99999754211 1 1111 11111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...+......+.+++.+||+.||++||+++|+++.|+.+..
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11222345578899999999999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=296.66 Aligned_cols=222 Identities=23% Similarity=0.246 Sum_probs=176.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.+...+.||+|++ ||++.... ..||+| |++++..+++.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 44556678999988 88887643 566665 788889999999999999
Q ss_pred ecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 489 EFMSKGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
||++||+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997643 3589999999999999999999999 999999999999999999999999999987644
Q ss_pred CCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 566 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ .........
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~----~~~i~~~~~------ 410 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL----KQRVLEQAV------ 410 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHH----HHHHHHCCC------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHH----HHHHhhccc------
Confidence 332 233457999999999999999999999999999999999999999765322111111 111111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPSM-----KNVIL 678 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~ 678 (702)
..+...+..+.+++.+||+.||++||++ ++|++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1233446788899999999999999975 56654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-32 Score=289.89 Aligned_cols=234 Identities=23% Similarity=0.234 Sum_probs=178.9
Q ss_pred ccccccceEEEeEE--EEEeee------ehhhhHhh---------------------------eeeEEEEEe--cCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSI------TFLCFLIA---------------------------ISSLLVYKH--RSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~------~~~~~avk---------------------------i~~l~~~~~--~~~~~~ 485 (702)
+.++..+.||+|++ ||++.. ....||+| |+++++++. +++..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 45566788999987 887763 12556666 777776664 567799
Q ss_pred EEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
+||||+++++|.+++......+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 99999999999999987655799999999999999999999999 999999999999999999999999999997754
Q ss_pred CCCc--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCc-------chhhhHHHHHHhhhc
Q 038002 566 NQTG--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA-------DEVLLSTWVYNCFVA 636 (702)
Q Consensus 566 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~-------~~~~~~~~~~~~~~~ 636 (702)
.... ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ...............
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 4332 1233557888999999988889999999999999999999999986431100 000000001111111
Q ss_pred cccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 637 GEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
+ .....+...++.+.+++.+||+.||++|||++|++++|+.+.
T Consensus 260 ~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 302 (327)
T 3lxl_A 260 G-----QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW 302 (327)
T ss_dssp T-----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred c-----cCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 111223445678899999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=274.41 Aligned_cols=222 Identities=20% Similarity=0.218 Sum_probs=175.0
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEE
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.+.++..+.||+|++ ||++.... ..+|+| |+++++++.+++..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3556677788898877 88776543 455555 78889999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc---EEEecccceeecC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR---AKISDFGLAKLLM 564 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~a~~~~ 564 (702)
|||+++++|.+.+.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++....
T Consensus 84 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 99999999999887654 689999999999999999999999 9999999999999976655 9999999998764
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .... ......+.....
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~~----~~~~~~~~~~~~-- 227 (284)
T 3kk8_A 160 DSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED----QHRL----YAQIKAGAYDYP-- 227 (284)
T ss_dssp SSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH----HHHHHHTCCCCC--
T ss_pred cCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc----hhHH----HHHHHhccccCC--
Confidence 3322 334578999999999999999999999999999999999999996431 1111 111111111110
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......++.+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111234567889999999999999999999988
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-32 Score=286.26 Aligned_cols=203 Identities=21% Similarity=0.248 Sum_probs=150.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 73 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~ 148 (316)
T 2ac3_A 73 VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPN 148 (316)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSS
T ss_pred eeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCC
Confidence 8888999999999999999999999999997754 689999999999999999999999 999999999999998877
Q ss_pred c---EEEecccceeecCCCCC------ceeeceeccccccCcccccC-----CCCCccccccchhHhHHHhhhCCcCCcC
Q 038002 551 R---AKISDFGLAKLLMPNQT------GIVAGVRGSRGYMAPEWQNS-----GLITVKSDVYSFGVVLLEIICCRSNFEV 616 (702)
Q Consensus 551 ~---~kl~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlGvil~elltG~~Pf~~ 616 (702)
. +||+|||++........ .......||+.|+|||++.. ..++.++||||||+++|||++|+.||..
T Consensus 149 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 149 QVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp SSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 6 99999999986532211 11223568999999998864 5678999999999999999999999976
Q ss_pred CCCCcchhh-------hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 617 NVSTADEVL-------LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 617 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......... ...........+.... ........+..+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEF--PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCSCSCC----CCHHHHHHHHHHHHHCCCCC--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccccccchhHHHHHHHHHhccCccc--CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 532210000 0011111111111100 000001235678999999999999999999999984
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=286.46 Aligned_cols=168 Identities=25% Similarity=0.240 Sum_probs=145.1
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~l 486 (702)
...++..++||+|++ ||++.... ..||+| |+++++++...+..++
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~l 113 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCL 113 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEE
Confidence 455667788999987 88877643 556666 7788899999999999
Q ss_pred EEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-----------------
Q 038002 487 VYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD----------------- 548 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~----------------- 548 (702)
||||+ +++|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.
T Consensus 114 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred EEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccc
Confidence 99999 999999998764 3589999999999999999999999 9999999999999975
Q ss_pred --------CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 549 --------SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 549 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999865332 23456899999999999999999999999999999999999999754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=313.59 Aligned_cols=216 Identities=21% Similarity=0.250 Sum_probs=174.1
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
.+...+.||+|+| ||++.... ..|||| |++++.++++.+..||||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 3445567888877 77776543 445655 677888999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 422 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~- 496 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG- 496 (674)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT-
T ss_pred eCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCC-
Confidence 9999999999998765 799999999999999999999999 99999999999999999999999999998643322
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
.......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ... ....+..... ..+
T Consensus 497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~---~~~-----~~~~i~~~~~------~~p 562 (674)
T 3pfq_A 497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDE-----LFQSIMEHNV------AYP 562 (674)
T ss_dssp CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHSSCC------CCC
T ss_pred cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC---HHH-----HHHHHHhCCC------CCC
Confidence 23445789999999999999999999999999999999999999997531 111 1112222211 223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSM-----KNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~-----~evl~ 678 (702)
...+.++.+||.+||+.||++||++ +||++
T Consensus 563 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 3456788999999999999999997 66664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.31 Aligned_cols=178 Identities=20% Similarity=0.274 Sum_probs=140.0
Q ss_pred eeEEEEecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 483 KKLLVYEFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
..++||||+++++|.+++..... ..++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 211 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLV 211 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcc
Confidence 38999999999999999987543 255667899999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCC-----------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 561 KLLMPNQT-----------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 561 ~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
........ .......||+.|+|||.+.+..++.++||||||+++|||++|..|+... ..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------~~---- 281 (332)
T 3qd2_B 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------VR---- 281 (332)
T ss_dssp EECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------HH----
T ss_pred cccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------HH----
Confidence 98754421 1123456999999999999889999999999999999999987765311 00
Q ss_pred HHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 VYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......... +.........+.+++.+||+.||++|||++|+++
T Consensus 282 ~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 282 IITDVRNLKF-----PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHTTCC-----CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHhhccCC-----CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 1111111111 1122334567789999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=280.82 Aligned_cols=225 Identities=23% Similarity=0.356 Sum_probs=171.7
Q ss_pred cccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEE-EecCCeeEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVY-KHRSSKKLLV 487 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~-~~~~~~~~lV 487 (702)
.++..+.||+|++ ||++.... ..+|+| |++++++ +..++..++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 105 (298)
T 3f66_A 26 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 105 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred ehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEE
Confidence 3445678888877 88776432 124444 7777776 5667889999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 106 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 999999999999988776789999999999999999999999 99999999999999999999999999998664332
Q ss_pred C---ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 568 T---GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 568 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||....... . ... ...+..
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-~---~~~----~~~~~~---- 250 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-I---TVY----LLQGRR---- 250 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-H---HHH----HHTTCC----
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-H---HHH----HhcCCC----
Confidence 1 12234567889999999988899999999999999999999 555554331111 1 110 111110
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...+...+..+.+++.+||+.||++|||++|++++|+++.
T Consensus 251 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 290 (298)
T 3f66_A 251 -LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 290 (298)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112223457889999999999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-32 Score=287.58 Aligned_cols=199 Identities=27% Similarity=0.359 Sum_probs=161.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCC---------------CCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLET---------------RPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++++.+++..++||||+++++|.+++..... .+++.+++.++.||+.||+|||++ +|+
T Consensus 103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iv 179 (334)
T 2pvf_A 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCI 179 (334)
T ss_dssp BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 78889999999999999999999999999986542 378999999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSN 613 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~P 613 (702)
||||||+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.|
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999999876543321 1233456788999999988889999999999999999999 9999
Q ss_pred CcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 614 FEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 614 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
|.... .. .. ......+.. ...+......+.+++.+||+.||++|||++|+++.|+++..
T Consensus 260 ~~~~~--~~--~~----~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 260 YPGIP--VE--EL----FKLLKEGHR-----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp STTCC--HH--HH----HHHHHHTCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcCC--HH--HH----HHHHhcCCC-----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 96431 11 11 111111111 11223345678899999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-32 Score=285.34 Aligned_cols=194 Identities=21% Similarity=0.303 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD- 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~- 548 (702)
|++++.++++++..++||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+||+++.
T Consensus 91 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~ 167 (327)
T 3lm5_A 91 VINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSI 167 (327)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCB
T ss_pred EEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecC
Confidence 788889999999999999999999999998654 34689999999999999999999999 9999999999999987
Q ss_pred --CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 549 --SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 549 --~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
++.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ....
T Consensus 168 ~~~~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~ 242 (327)
T 3lm5_A 168 YPLGDIKIVDFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETY 242 (327)
T ss_dssp TTBCCEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred CCCCcEEEeeCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHH
Confidence 78999999999987643322 3345789999999999999999999999999999999999999965411 1111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. ...... .............+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~-----i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 243 LN-----ISQVNV--DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HH-----HHHTCC--CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HH-----HHhccc--ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 10 011000 01111223345678899999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=277.70 Aligned_cols=216 Identities=22% Similarity=0.301 Sum_probs=170.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..+.||+|++ ||++.... ..+|+| |+++++++.+++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 88 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 88 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence 34555678888877 77776543 345554 788899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 89 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred ecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 9999999999997654 689999999999999999999999 99999999999999999999999999986543222
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ........ ...+
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~-----~~~~~~~~------~~~~ 227 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY---QET-----YKRISRVE------FTFP 227 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH-----HHHHHHTC------CCCC
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH---HHH-----HHHHHhCC------CCCC
Confidence 2345689999999999988999999999999999999999999964311 111 11111111 1122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....+.+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2345678899999999999999999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=279.14 Aligned_cols=190 Identities=20% Similarity=0.276 Sum_probs=149.5
Q ss_pred eeeEEEEEec--CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 471 ISSLLVYKHR--SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 471 i~~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
|+++++++.+ ++..++||||+++++|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~ 172 (298)
T 2zv2_A 98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGE 172 (298)
T ss_dssp BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECC
Confidence 6677777765 6789999999999999987643 3689999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCC---CCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL---ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
++.+||+|||++....... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.... ...
T Consensus 173 ~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~----~~~ 247 (298)
T 2zv2_A 173 DGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER----IMC 247 (298)
T ss_dssp TSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS----HHH
T ss_pred CCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc----HHH
Confidence 9999999999998764332 2234567999999999987654 4788999999999999999999996431 111
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ........... ......++.+.+++.+||+.||++|||++|+++
T Consensus 248 ~----~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 L----HSKIKSQALEF----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp H----HHHHHHCCCCC----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred H----HHHHhcccCCC----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 1 11111111111 111234567899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=294.90 Aligned_cols=216 Identities=23% Similarity=0.320 Sum_probs=173.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..+...+.||+|++ ||++.... ..||+| |+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 34455677888887 77776542 555655 888899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~- 170 (476)
T 2y94_A 96 EYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE- 170 (476)
T ss_dssp ECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-
T ss_pred eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc-
Confidence 9999999999997654 799999999999999999999999 99999999999999999999999999998764432
Q ss_pred ceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... . ....+..+.. ..
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~-----~~~~i~~~~~------~~ 235 (476)
T 2y94_A 171 -FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---T-----LFKKICDGIF------YT 235 (476)
T ss_dssp -CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---H-----HHHHHHTTCC------CC
T ss_pred -cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---H-----HHHHHhcCCc------CC
Confidence 2345679999999999987765 78999999999999999999999754211 1 1111122111 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+......+.+++.+||+.||++|||++|+++
T Consensus 236 p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 2223457889999999999999999999997
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=283.41 Aligned_cols=192 Identities=23% Similarity=0.300 Sum_probs=155.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 77 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~ 152 (321)
T 2a2a_A 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKN 152 (321)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTT
T ss_pred cceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCC
Confidence 7788899999999999999999999999997654 689999999999999999999999 999999999999999888
Q ss_pred ----cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 551 ----RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 551 ----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ....
T Consensus 153 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~ 227 (321)
T 2a2a_A 153 IPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETL 227 (321)
T ss_dssp SSSCCEEECCCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHH
T ss_pred CCcCCEEEccCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH---HHHH
Confidence 799999999987644322 3345689999999999988999999999999999999999999964311 1111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ ..........+..+.+++.+||+.||++|||++|+++
T Consensus 228 -----~~i~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 228 -----ANITSVSY--DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp -----HHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred -----HHHHhccc--ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11111110 0111111223567889999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=285.25 Aligned_cols=199 Identities=27% Similarity=0.368 Sum_probs=159.3
Q ss_pred eeeEEEEEecC-CeeEEEEecCCCCCHHHHhhcCCCC---------------CCHHHHHHHHHHHHHHHHhhhhcCCCCe
Q 038002 471 ISSLLVYKHRS-SKKLLVYEFMSKGSLADLLFNLETR---------------PLWRDRVRIALDVARGLLYLHDECEVQI 534 (702)
Q Consensus 471 i~~l~~~~~~~-~~~~lV~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~i~~qi~~aL~~LH~~~~~~i 534 (702)
|+++++++... ...++||||+++++|.+++...... +++.++..++.||+.||+|||++ +|
T Consensus 93 iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i 169 (316)
T 2xir_A 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 169 (316)
T ss_dssp BCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 77788776654 5699999999999999999876432 78999999999999999999999 99
Q ss_pred EecCCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCc
Q 038002 535 IHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRS 612 (702)
Q Consensus 535 vH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~ 612 (702)
+||||||+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~ 249 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999876544332 2345678899999999988899999999999999999998 999
Q ss_pred CCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 613 NFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 613 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
||....... . . ......+.. ...+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 250 p~~~~~~~~--~-~----~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 250 PYPGVKIDE--E-F----CRRLKEGTR-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp SSTTCCCSH--H-H----HHHHHHTCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccchhH--H-H----HHHhccCcc-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 997542211 1 1 111111111 1112234567889999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.15 Aligned_cols=224 Identities=22% Similarity=0.350 Sum_probs=173.1
Q ss_pred cccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCee-EEEEe
Q 038002 446 NDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKK-LLVYE 489 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~-~lV~e 489 (702)
+..+.||+|++ ||++.... ..+|+| |+++++++.+.+.. ++|||
T Consensus 24 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 103 (298)
T 3pls_A 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLP 103 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEC
T ss_pred ccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEe
Confidence 34578899887 88776422 235554 77888888766555 99999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC-
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT- 568 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 568 (702)
|+.+++|.+++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 104 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 104 YMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred cccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999988766789999999999999999999999 999999999999999999999999999986543221
Q ss_pred --ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 569 --GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 569 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..|+.......+ ..... .... ...
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~---~~~~~----~~~~-----~~~ 248 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---LTHFL----AQGR-----RLP 248 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG---HHHHH----HTTC-----CCC
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH---HHHHh----hcCC-----CCC
Confidence 122345678899999999999999999999999999999996666543322111 11111 1111 011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+...++.+.+++.+||+.||++|||+++++++|+.+.
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 286 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV 286 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 12234567889999999999999999999999998853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=288.32 Aligned_cols=192 Identities=22% Similarity=0.323 Sum_probs=146.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||| +.+++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++ ++
T Consensus 71 iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~ 144 (343)
T 3dbq_A 71 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DG 144 (343)
T ss_dssp BCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TT
T ss_pred eEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CC
Confidence 7888999999999999999 56889999998764 789999999999999999999999 999999999999997 57
Q ss_pred cEEEecccceeecCCCCCc-eeeceeccccccCcccccC-----------CCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 551 RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNS-----------GLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
.+||+|||++......... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 224 (343)
T 3dbq_A 145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 224 (343)
T ss_dssp EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence 8999999999876443322 2335679999999998854 678899999999999999999999996431
Q ss_pred CCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. .... .......... ...+......+.+++.+||+.||++|||++|+++.
T Consensus 225 ~---~~~~----~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 225 N---QISK----LHAIIDPNHE----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp S---HHHH----HHHHHCTTSC----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred h---HHHH----HHHHhcCCcc----cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1 1110 0111111111 11122224578899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=282.65 Aligned_cols=228 Identities=25% Similarity=0.368 Sum_probs=178.3
Q ss_pred cccccccceEEEeEE--EEEeeee-------hhhhHhh----------------------------eeeEEEEEecCCee
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSIT-------FLCFLIA----------------------------ISSLLVYKHRSSKK 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~-------~~~~avk----------------------------i~~l~~~~~~~~~~ 484 (702)
.+.+...+.||+|++ ||++... ...||+| |+++++++.+++..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345566778898887 8876543 1345554 88889999999999
Q ss_pred EEEEecCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEe
Q 038002 485 LLVYEFMSKGSLADLLFNLE---------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
++||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEEC
Confidence 99999999999999997532 3468999999999999999999999 99999999999999999999999
Q ss_pred cccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHh
Q 038002 556 DFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 556 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ... ....
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~----~~~~ 252 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS----NEQ----VLRF 252 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----HHH----HHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC----HHH----HHHH
Confidence 99999865332221 1223457889999999988899999999999999999999 899996431 111 1111
Q ss_pred hhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 634 FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...+... ..+...+..+.+++.+||+.||++|||++|+++.|++...
T Consensus 253 ~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 253 VMEGGLL-----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHTTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHcCCcC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111 1123345678899999999999999999999999998644
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=285.16 Aligned_cols=228 Identities=22% Similarity=0.329 Sum_probs=165.9
Q ss_pred cccccccceEEEeEE--EEEeeeehh-----hhHhh-----------------------------eeeEEEEEecCCee-
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITFL-----CFLIA-----------------------------ISSLLVYKHRSSKK- 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~~-----~~avk-----------------------------i~~l~~~~~~~~~~- 484 (702)
.+.++..+.||+|++ ||++..... .||+| |+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 345666788999987 888875541 46666 67777777766655
Q ss_pred -----EEEEecCCCCCHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEE
Q 038002 485 -----LLVYEFMSKGSLADLLFNLE-----TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKI 554 (702)
Q Consensus 485 -----~lV~e~~~~gsL~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 554 (702)
++||||+++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 99999999999999996432 2488999999999999999999999 9999999999999999999999
Q ss_pred ecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHH
Q 038002 555 SDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYN 632 (702)
Q Consensus 555 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 632 (702)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~~----~~ 250 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA----EI----YN 250 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----GH----HH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH----HH----HH
Confidence 99999987643332 12233456788999999998899999999999999999999 99999754211 11 11
Q ss_pred hhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 633 CFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
....+.. ...+...++.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 251 ~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 251 YLIGGNR-----LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHHTTCC-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcCCC-----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 11223345678999999999999999999999999998643
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=285.21 Aligned_cols=183 Identities=22% Similarity=0.219 Sum_probs=153.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCC-CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKG-SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS 549 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~ 549 (702)
|+++++++.+++..++||||+.+| +|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.+
T Consensus 91 Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 91 IIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED 166 (335)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred EeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence 788899999999999999999777 9999998765 699999999999999999999999 99999999999999999
Q ss_pred CcEEEecccceeecCCCCCceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 550 WRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 550 ~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
+.+||+|||++........ .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~---- 236 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----T---- 236 (335)
T ss_dssp SCEEECCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----G----
T ss_pred CcEEEeecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----H----
Confidence 9999999999987644332 334678999999999887776 8899999999999999999999963210 0
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... . ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus 237 ------~~~~----~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ------VEAA----I--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ------TTTC----C--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ------Hhhc----c--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0 0111235678899999999999999999999985
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=276.41 Aligned_cols=223 Identities=18% Similarity=0.209 Sum_probs=172.5
Q ss_pred ccccccceEEEeEE--EEEeeee--hhhhHhh-----------------------eeeEEEEEec---------------
Q 038002 443 DKVNDKRKLLTVLA--GCLGSIT--FLCFLIA-----------------------ISSLLVYKHR--------------- 480 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~--~~~~avk-----------------------i~~l~~~~~~--------------- 480 (702)
..++..+.||+|++ ||++... ...||+| |+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~ 90 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccccc
Confidence 34445566777766 7776654 2555655 6666666543
Q ss_pred -CCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccc
Q 038002 481 -SSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFG 558 (702)
Q Consensus 481 -~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 558 (702)
....++||||+++++|.+++... ...+++..+..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 167 (284)
T 2a19_B 91 KTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFG 167 (284)
T ss_dssp EEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred CcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcch
Confidence 56689999999999999999754 24689999999999999999999999 99999999999999999999999999
Q ss_pred ceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccc
Q 038002 559 LAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGE 638 (702)
Q Consensus 559 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 638 (702)
++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+... . ..........
T Consensus 168 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------~----~~~~~~~~~~ 235 (284)
T 2a19_B 168 LVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------S----KFFTDLRDGI 235 (284)
T ss_dssp TCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH------H----HHHHHHHTTC
T ss_pred hheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH------H----HHHHHhhccc
Confidence 9987654332 23456899999999999889999999999999999999999887421 0 0111111111
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCCC
Q 038002 639 FNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPI 688 (702)
Q Consensus 639 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~~ 688 (702)
+ +......+.+++.+||+.||++|||+.|+++.|+.+..-+.
T Consensus 236 ~--------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 236 I--------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp C--------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred c--------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1 12234567889999999999999999999999998765443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-32 Score=290.20 Aligned_cols=224 Identities=22% Similarity=0.366 Sum_probs=164.6
Q ss_pred ccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEE-ecCCeeEEEE
Q 038002 445 VNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYK-HRSSKKLLVY 488 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~-~~~~~~~lV~ 488 (702)
++..+.||+|++ ||++.... ..+|+| |+++++++ ..++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 344567888887 88776532 234554 77777764 5567899999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++......+++.++..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 171 e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred ECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 99999999999988776789999999999999999999999 999999999999999999999999999986643321
Q ss_pred c---eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 569 G---IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 569 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
. ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... . ... ...+..
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~--~--~~~----~~~~~~----- 314 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I--TVY----LLQGRR----- 314 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC--H--HHH----HHTTCC-----
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH--H--HHH----HHcCCC-----
Confidence 1 1233457789999999998999999999999999999999 677775432211 1 111 111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...+...+..+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 315 ~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0112233567889999999999999999999999998854
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.19 Aligned_cols=189 Identities=19% Similarity=0.214 Sum_probs=150.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++..++.++..|+||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 83 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~ 158 (327)
T 3a62_A 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQG 158 (327)
T ss_dssp BCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTS
T ss_pred ccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCC
Confidence 7788889999999999999999999999997654 688999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~ 630 (702)
.+||+|||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..... ....
T Consensus 159 ~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~---- 230 (327)
T 3a62_A 159 HVKLTDFGLCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR---KKTI---- 230 (327)
T ss_dssp CEEECCCSCC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHH----
T ss_pred cEEEEeCCcccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH---HHHH----
Confidence 99999999997543222 123345789999999999988999999999999999999999999964311 1111
Q ss_pred HHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
..+..... ..+......+.+++.+||+.||++|| +++|+++
T Consensus 231 -~~i~~~~~------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 231 -DKILKCKL------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -HHHHHTCC------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -HHHHhCCC------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11111111 12233456788999999999999999 7778876
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=279.14 Aligned_cols=197 Identities=22% Similarity=0.279 Sum_probs=160.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++ ..+..++||||+++++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 72 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~ 147 (287)
T 1u59_A 72 IVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRH 147 (287)
T ss_dssp BCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETT
T ss_pred EeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCC
Confidence 78888887 45679999999999999999987766799999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCce--eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGI--VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... ...
T Consensus 148 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~ 223 (287)
T 1u59_A 148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP----EVM 223 (287)
T ss_dssp EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH----HHH
T ss_pred CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH----HHH
Confidence 99999999998775443321 223446889999999988889999999999999999998 99999654211 111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.....+.. ...+...+..+.+++.+||+.||++||+++++++.|+.+.
T Consensus 224 ----~~i~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 224 ----AFIEQGKR-----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp ----HHHHTTCC-----CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHhcCCc-----CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111 1223345678899999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=281.60 Aligned_cols=231 Identities=19% Similarity=0.160 Sum_probs=166.6
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
.++..++||+|++ ||++.... ..||+| |+++++++.+++..++||||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3455667788776 77766542 445555 88899999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 84 ~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 158 (311)
T 4agu_A 84 CDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-Y 158 (311)
T ss_dssp CSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-c
Confidence 99999999887654 689999999999999999999999 999999999999999999999999999987643322 2
Q ss_pred eeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH-------Hhhhccccc--
Q 038002 571 VAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY-------NCFVAGEFN-- 640 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~-- 640 (702)
.....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||................. .........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 334568999999998865 6789999999999999999999999975421111111100000 000000000
Q ss_pred -ccccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 641 -KLVEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 641 -~~~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...+. ......+..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0112345678899999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.6e-32 Score=287.39 Aligned_cols=198 Identities=26% Similarity=0.403 Sum_probs=159.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEec
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNL-------------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHC 537 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~ 537 (702)
|+++++++.+++..++||||+++|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~ 188 (333)
T 2i1m_A 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHR 188 (333)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccC
Confidence 888999999999999999999999999999753 23578999999999999999999999 99999
Q ss_pred CCCCCcEEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCc
Q 038002 538 DIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFE 615 (702)
Q Consensus 538 dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~ 615 (702)
||||+||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 189 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 268 (333)
T 2i1m_A 189 DVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP 268 (333)
T ss_dssp CCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCc
Confidence 99999999999999999999999876443322 2334567889999999988899999999999999999998 999997
Q ss_pred CCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 616 VNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
...... ........ . . ....+...+..+.+++.+||+.||++|||++||+++|+.+
T Consensus 269 ~~~~~~---~~~~~~~~----~-~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 269 GILVNS---KFYKLVKD----G-Y----QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp TCCSSH---HHHHHHHH----T-C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchhH---HHHHHHhc----C-C----CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 542221 11111111 1 0 1111222356788999999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.9e-32 Score=283.34 Aligned_cols=229 Identities=20% Similarity=0.199 Sum_probs=170.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEe----cCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKH----RSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~----~~~~~~lV 487 (702)
..++..+.||+|++ ||++.... ..||+| |+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 34556678888887 77776532 566666 667776665 45688999
Q ss_pred EecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 488 YEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
|||+++++|.+++.. ....+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999976 344689999999999999999999999 99999999999999999999999999987653
Q ss_pred CCCCc--------eeeceeccccccCcccccCCC---CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHh
Q 038002 565 PNQTG--------IVAGVRGSRGYMAPEWQNSGL---ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 565 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
..... ......||+.|+|||.+.... ++.++||||||+++|||++|+.||........... . .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~--~-~--- 259 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA--L-A--- 259 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH--H-H---
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh--H-H---
Confidence 21110 012245699999999887543 68899999999999999999999964211111110 0 0
Q ss_pred hhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 634 FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
... .. ........+..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 260 ~~~-~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQN-QL----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHC-C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhc-cC----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00 011122345678999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=275.30 Aligned_cols=219 Identities=19% Similarity=0.170 Sum_probs=170.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.+...+.||+|++ ||++.... ..+|+| |++++.++.+++..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 44555677888876 77776543 344444 888999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE---eCCCcEEEecccceeecCCCCC
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~- 163 (277)
T 3f3z_A 89 TGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK- 163 (277)
T ss_dssp CSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-
T ss_pred CCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-
Confidence 9999999987654 689999999999999999999999 99999999999999 788999999999998764433
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||.... .... ......+.... .....
T Consensus 164 -~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~-----~~~~~~~~~~~--~~~~~ 231 (277)
T 3f3z_A 164 -MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEV-----MLKIREGTFTF--PEKDW 231 (277)
T ss_dssp -CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHH-----HHHHHHCCCCC--CHHHH
T ss_pred -chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHH-----HHHHHhCCCCC--Cchhh
Confidence 23445689999999988654 8999999999999999999999996531 1111 11111111110 00000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...++.+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 232 LNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 123567889999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=290.62 Aligned_cols=192 Identities=23% Similarity=0.319 Sum_probs=147.7
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..++..|+||| +.+++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++ ++
T Consensus 118 iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~ 191 (390)
T 2zmd_A 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DG 191 (390)
T ss_dssp BCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SS
T ss_pred EEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CC
Confidence 7888899999999999999 56889999998765 788999999999999999999999 999999999999995 58
Q ss_pred cEEEecccceeecCCCCCc-eeeceeccccccCcccccC-----------CCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 551 RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNS-----------GLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
.+||+|||++..+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 271 (390)
T 2zmd_A 192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 271 (390)
T ss_dssp CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence 9999999999876443322 2335679999999998864 468899999999999999999999996431
Q ss_pred CCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.. ...+ .......... ..+......+.+++.+||+.||++|||++|+++.
T Consensus 272 ~~--~~~~-----~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 272 NQ--ISKL-----HAIIDPNHEI----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp CH--HHHH-----HHHHCTTSCC----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HH--HHHH-----HHHhCccccC----CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11 0111 1111111111 1111224578899999999999999999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=280.48 Aligned_cols=230 Identities=18% Similarity=0.243 Sum_probs=167.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..++..+.||+|++ ||++.... ..||+| |++++.++..++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 34555677888877 77776432 445554 788888999999999999
Q ss_pred ecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 489 EFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 489 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
||+++++|.+++.. ....+++.+++.++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999864 344689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 566 NQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 566 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... .............
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~~~~~~~~~~~~-- 259 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL--YSL----CKKIEQCDYPPLP-- 259 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH--HHH----HHHHHTTCSCCCC--
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH--HHH----HHHhhcccCCCCc--
Confidence 222 2234568999999999998899999999999999999999999996542111 111 1111111111111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
.......+.+++.+||+.||++|||+++|++.|+.+...
T Consensus 260 --~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~ 298 (310)
T 2wqm_A 260 --SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC 298 (310)
T ss_dssp --TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 123456788999999999999999999999999987543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=277.45 Aligned_cols=196 Identities=25% Similarity=0.299 Sum_probs=157.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++ ..+..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 80 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~ 154 (291)
T 1xbb_A 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQH 154 (291)
T ss_dssp BCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred EEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCC
Confidence 77788777 5677899999999999999998754 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCcee--eceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++........... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ...
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~- 229 (291)
T 1xbb_A 155 YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEV- 229 (291)
T ss_dssp EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HHH-
T ss_pred cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH----HHH-
Confidence 999999999987754433221 22346788999999988889999999999999999999 9999965311 111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
......+.. ...+...+..+.+++.+||+.||++||++++++++|+++.
T Consensus 230 ---~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 230 ---TAMLEKGER-----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ---HHHHHTTCC-----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---HHHHHcCCC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111111111 1223345668999999999999999999999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=288.45 Aligned_cols=226 Identities=20% Similarity=0.224 Sum_probs=160.7
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecC--CeeEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRS--SKKLLV 487 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~--~~~~lV 487 (702)
.++..+.||+|++ ||++.... ..||+| |++++.++..+ ...|+|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 4555677888877 77776543 556655 77888877643 478999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||++ ++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 90 ~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 90 FDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred ecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 99997 5999999763 689999999999999999999999 99999999999999999999999999998753211
Q ss_pred --------------------CceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 568 --------------------TGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 568 --------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... . +
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~--~ 240 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN-Q--L 240 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-H--H
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH-H--H
Confidence 112334679999999998876 678999999999999999999999997542111 1 1
Q ss_pred HHHHHHhhhcc-----------------------------cccccccc--------ccCHHHHHHHHHHHHHcccCCCCC
Q 038002 627 STWVYNCFVAG-----------------------------EFNKLVEE--------EVDKITLERMVKTGLLCIQDEPNL 669 (702)
Q Consensus 627 ~~~~~~~~~~~-----------------------------~~~~~~~~--------~~~~~~~~~l~~li~~cL~~dP~~ 669 (702)
.. +....... .....+.. .......+.+.+++.+||+.||++
T Consensus 241 ~~-i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~ 319 (388)
T 3oz6_A 241 ER-IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNK 319 (388)
T ss_dssp HH-HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGG
T ss_pred HH-HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCccc
Confidence 00 10000000 00000000 000123567899999999999999
Q ss_pred CCCHHHHHHH
Q 038002 670 RPSMKNVILM 679 (702)
Q Consensus 670 RPt~~evl~~ 679 (702)
|||++|+++.
T Consensus 320 R~t~~e~l~H 329 (388)
T 3oz6_A 320 RISANDALKH 329 (388)
T ss_dssp SCCHHHHTTS
T ss_pred CCCHHHHhCC
Confidence 9999999876
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-32 Score=306.01 Aligned_cols=228 Identities=27% Similarity=0.342 Sum_probs=178.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..++||+|.| ||++.... ..|||| |+++++++.+ +..+|||||+++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 44555678999988 88887655 456766 7888887765 779999999999
Q ss_pred CCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 494 GSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 494 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 346 gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 422 (535)
T 2h8h_A 346 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422 (535)
T ss_dssp EEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTC
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceeccc
Confidence 9999999753 23589999999999999999999999 9999999999999999999999999999865432211122
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
...++..|+|||.+....++.++||||||+++|||++ |+.||..... .+ ....+..+. ....+...
T Consensus 423 ~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--~~------~~~~i~~~~-----~~~~~~~~ 489 (535)
T 2h8h_A 423 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--RE------VLDQVERGY-----RMPCPPEC 489 (535)
T ss_dssp STTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--HH------HHHHHHTTC-----CCCCCTTC
T ss_pred CCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HH------HHHHHHcCC-----CCCCCCCC
Confidence 3446788999999988899999999999999999999 9999964311 11 111111111 11122344
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCC
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~ 687 (702)
.+.+.++|.+||+.||++|||+++|+++|+.+..-.
T Consensus 490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 567889999999999999999999999999976533
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.22 Aligned_cols=196 Identities=29% Similarity=0.366 Sum_probs=157.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQII 535 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~iv 535 (702)
|+++++++.+++..++||||+++++|.+++.... ..+++.+++.++.||+.||+|||++ +|+
T Consensus 88 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~iv 164 (327)
T 1fvr_A 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFI 164 (327)
T ss_dssp BCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred hhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 7888899999999999999999999999997653 3689999999999999999999999 999
Q ss_pred ecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCC
Q 038002 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNF 614 (702)
Q Consensus 536 H~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf 614 (702)
||||||+||+++.++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 165 H~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 242 (327)
T 1fvr_A 165 HRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242 (327)
T ss_dssp CSCCSGGGEEECGGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCCccceEEEcCCCeEEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999997432111 1223456889999999988889999999999999999998 99999
Q ss_pred cCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 615 EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..... .. .......+ .....+......+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 243 ~~~~~----~~----~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 243 CGMTC----AE----LYEKLPQG-----YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp TTCCH----HH----HHHHGGGT-----CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcH----HH----HHHHhhcC-----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 65411 11 11111111 111122334567899999999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=274.52 Aligned_cols=215 Identities=21% Similarity=0.221 Sum_probs=172.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..+.||+|++ ||++.... ..+|+| |+++++++.+++..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 44556678888876 77776543 344444 788899999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~- 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR- 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC-
T ss_pred EeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc-
Confidence 9999999999997654 689999999999999999999999 99999999999999999999999999997654322
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ........ ...+
T Consensus 169 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~-----~~~~~~~~------~~~~ 232 (284)
T 2vgo_A 169 --RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TET-----HRRIVNVD------LKFP 232 (284)
T ss_dssp --BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHH-----HHHHHTTC------CCCC
T ss_pred --cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHH-----HHHHhccc------cCCC
Confidence 2345689999999999988999999999999999999999999964311 111 11111111 1122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
...+..+.+++.+||+.||++||+++|+++
T Consensus 233 ~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 334567889999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=278.56 Aligned_cols=227 Identities=19% Similarity=0.218 Sum_probs=171.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------eeeEEEEEec--CCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------ISSLLVYKHR--SSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------i~~l~~~~~~--~~~~~lV~e~~ 491 (702)
+.++..+.||+|++ ||++.... ..||+| |++++.++.+ ....++||||+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~ 115 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 115 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECC
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEecc
Confidence 45566678888887 88776533 566666 7778888877 77899999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC-cEEEecccceeecCCCCCce
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW-RAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~ 570 (702)
++++|.+++. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||++........
T Consensus 116 ~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-- 186 (330)
T 3nsz_A 116 NNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-- 186 (330)
T ss_dssp CCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC--
T ss_pred CchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc--
Confidence 9999999985 478999999999999999999999 999999999999999777 899999999987644332
Q ss_pred eeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH------HHHhh---------
Q 038002 571 VAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW------VYNCF--------- 634 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~------~~~~~--------- 634 (702)
.....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.......+....... .....
T Consensus 187 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (330)
T 3nsz_A 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266 (330)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence 334568999999998876 67899999999999999999999999654222111110000 00000
Q ss_pred ---------hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 635 ---------VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 635 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....+............+..+.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred chhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00011111111222234678999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=284.90 Aligned_cols=228 Identities=18% Similarity=0.139 Sum_probs=166.1
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
.+.++..++||+|++ ||++.... ..||+| |++++.++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 355667788999987 88876443 556666 788889999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe-----CCCcEEEecccceeec
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID-----DSWRAKISDFGLAKLL 563 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~-----~~~~~kl~Dfg~a~~~ 563 (702)
||+++ +|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++...
T Consensus 113 e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99985 9999998765 689999999999999999999999 999999999999994 4556999999999876
Q ss_pred CCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh--hcc---
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF--VAG--- 637 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~--- 637 (702)
..... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||...... ..+........ ...
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTST
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCchhhhh
Confidence 43322 23345689999999988764 5899999999999999999999999654211 11111110000 000
Q ss_pred ----------cccccccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 638 ----------EFNKLVEE----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 638 ----------~~~~~~~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ .......+.+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 111224567889999999999999999999986
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=303.99 Aligned_cols=218 Identities=22% Similarity=0.243 Sum_probs=170.7
Q ss_pred ceEEEeEE--EEEeeeeh----hhhHhh----------------------------eeeEEEEEecCCeeEEEEecCCCC
Q 038002 449 RKLLTVLA--GCLGSITF----LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFMSKG 494 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~----~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~~~g 494 (702)
.+||+|+| ||++.... ..|||| |+++++++.. +..++||||+++|
T Consensus 342 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g 420 (613)
T 2ozo_A 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGG 420 (613)
T ss_dssp EEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTC
T ss_pred cEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCC
Confidence 36899988 88876542 446666 8888888876 5699999999999
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce--ee
Q 038002 495 SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI--VA 572 (702)
Q Consensus 495 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~ 572 (702)
+|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......... ..
T Consensus 421 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 497 (613)
T 2ozo_A 421 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497 (613)
T ss_dssp BHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred cHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence 99999987766799999999999999999999999 99999999999999999999999999998764332211 12
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT 651 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 651 (702)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||...... + . ...+..+.. ...+...
T Consensus 498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--~--~----~~~i~~~~~-----~~~p~~~ 564 (613)
T 2ozo_A 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--E--V----MAFIEQGKR-----MECPPEC 564 (613)
T ss_dssp ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--H--H----HHHHHTTCC-----CCCCTTC
T ss_pred CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--H--H----HHHHHcCCC-----CCCCCcC
Confidence 2345688999999998899999999999999999998 99999754211 1 1 111111111 1223345
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 652 LERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 652 ~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
+..+.++|.+||+.||++||++++|+++|+..
T Consensus 565 ~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 565 PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 67889999999999999999999999999874
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=272.53 Aligned_cols=193 Identities=23% Similarity=0.299 Sum_probs=154.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+|+||||+||+++.++
T Consensus 67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 142 (276)
T 2yex_A 67 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERD 142 (276)
T ss_dssp BCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred ceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCC
Confidence 7888899999999999999999999999997543 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH
Q 038002 551 RAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST 628 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 628 (702)
.+||+|||++........ .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....
T Consensus 143 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~ 220 (276)
T 2yex_A 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSD 220 (276)
T ss_dssp CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHH
T ss_pred CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHH
Confidence 999999999986543221 22334668999999999887665 7899999999999999999999975422211 1111
Q ss_pred HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+ ...... . .........+.+++.+||+.||++|||++|+++
T Consensus 221 ~-----~~~~~~--~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 221 W-----KEKKTY--L--NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp H-----HTTCTT--S--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h-----hhcccc--c--CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 1 111000 0 011233567889999999999999999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=283.54 Aligned_cols=223 Identities=20% Similarity=0.130 Sum_probs=165.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~l 486 (702)
..++..+.||+|++ ||++.... ..+|+| |+++++++.+++..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 44556678888887 77775432 344444 7889999999999999
Q ss_pred EEecCCCCCHHHHhhcC---------------------------------------CCCCCHHHHHHHHHHHHHHHHhhh
Q 038002 487 VYEFMSKGSLADLLFNL---------------------------------------ETRPLWRDRVRIALDVARGLLYLH 527 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~aL~~LH 527 (702)
||||+++|+|.+++... ...+++..+..++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998521 001356778889999999999999
Q ss_pred hcCCCCeEecCCCCCcEEEeCCC--cEEEecccceeecCCCCC---ceeeceeccccccCcccccC--CCCCccccccch
Q 038002 528 DECEVQIIHCDIKLRNILIDDSW--RAKISDFGLAKLLMPNQT---GIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSF 600 (702)
Q Consensus 528 ~~~~~~ivH~dlkp~NIll~~~~--~~kl~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSl 600 (702)
++ +|+||||||+||+++.++ .+||+|||++..+..... .......||+.|+|||.+.+ ..++.++|||||
T Consensus 186 ~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diwsl 262 (345)
T 3hko_A 186 NQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSA 262 (345)
T ss_dssp HT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHH
T ss_pred HC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHH
Confidence 99 999999999999998776 899999999987643221 12345679999999998865 678899999999
Q ss_pred hHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 601 GVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 601 Gvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
|+++|||++|+.||..... ...... ....... ............+.+++.+||+.||++||++.|+++
T Consensus 263 G~il~el~~g~~pf~~~~~---~~~~~~-----~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 263 GVLLHLLLMGAVPFPGVND---ADTISQ-----VLNKKLC--FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHSSCSSCCSSH---HHHHHH-----HHHCCCC--TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCh---HHHHHH-----HHhcccc--cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999964411 111111 1111110 011111224567889999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=277.12 Aligned_cols=229 Identities=17% Similarity=0.153 Sum_probs=173.0
Q ss_pred cccccccceEEEeEE--EEEeeee---hhhhHhh--------------------------------eeeEEEEEecCCee
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSIT---FLCFLIA--------------------------------ISSLLVYKHRSSKK 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~---~~~~avk--------------------------------i~~l~~~~~~~~~~ 484 (702)
.+.++..+.||+|++ ||++... ...||+| +++++.+++.++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 455667788899887 8877652 2556665 56778889999999
Q ss_pred EEEEecCCCCCHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC---------------
Q 038002 485 LLVYEFMSKGSLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD--------------- 548 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~--------------- 548 (702)
++||||+ +++|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 9999999 8899999987643 588999999999999999999999 9999999999999987
Q ss_pred ----CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 549 ----SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 549 ----~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
++.+||+|||++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||..........
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999875332 234568999999999998899999999999999999999999997542111000
Q ss_pred hhHHHH-------HHhhhccc----------------------cccccc-cccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038002 625 LLSTWV-------YNCFVAGE----------------------FNKLVE-EEVDKITLERMVKTGLLCIQDEPNLRPSMK 674 (702)
Q Consensus 625 ~~~~~~-------~~~~~~~~----------------------~~~~~~-~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ 674 (702)
...... ........ ...... ........+.+.+++.+||+.||++|||++
T Consensus 245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 324 (339)
T 1z57_A 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324 (339)
T ss_dssp HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence 000000 00000000 000000 012345678899999999999999999999
Q ss_pred HHHH
Q 038002 675 NVIL 678 (702)
Q Consensus 675 evl~ 678 (702)
|+++
T Consensus 325 ell~ 328 (339)
T 1z57_A 325 EALK 328 (339)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=285.25 Aligned_cols=214 Identities=24% Similarity=0.257 Sum_probs=167.9
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEec
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+...+.||+|++ ||++.... ..||+| |+++++++.+++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 445567888877 77776432 455555 78888999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+. |+|.+++......+++.++..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||++......
T Consensus 136 ~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---- 207 (348)
T 1u5q_A 136 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 207 (348)
T ss_dssp CS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC----
Confidence 97 688888876555799999999999999999999999 9999999999999999999999999999865322
Q ss_pred eeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 571 VAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
....||+.|+|||++. ...++.++||||||+++|||++|+.||..... ... ... ..........
T Consensus 208 -~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~----~~~-~~~~~~~~~~---- 274 (348)
T 1u5q_A 208 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSA----LYH-IAQNESPALQ---- 274 (348)
T ss_dssp -CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH----HHH-HHHSCCCCCC----
T ss_pred -CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHH----HHH-HHhcCCCCCC----
Confidence 2356899999999874 56789999999999999999999999964311 111 111 1111111111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....++.+.+++.+||+.||++|||++++++.
T Consensus 275 ~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22335678899999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=280.93 Aligned_cols=200 Identities=20% Similarity=0.233 Sum_probs=153.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++ ++
T Consensus 91 iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~ 166 (319)
T 2y4i_B 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NG 166 (319)
T ss_dssp BCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---
T ss_pred EeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CC
Confidence 78888899999999999999999999999988766799999999999999999999999 999999999999998 67
Q ss_pred cEEEecccceeecCCCC----CceeeceeccccccCcccccC---------CCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 551 RAKISDFGLAKLLMPNQ----TGIVAGVRGSRGYMAPEWQNS---------GLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
.+||+|||++....... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||...
T Consensus 167 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 246 (319)
T 2y4i_B 167 KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246 (319)
T ss_dssp CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred CEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999987653211 112233558999999998764 45789999999999999999999999643
Q ss_pred CCCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 618 VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
.. ... ......+...... ....+..+.+++.+||+.||++|||+++++++|+.+.+.
T Consensus 247 ~~---~~~-----~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 247 PA---EAI-----IWQMGTGMKPNLS----QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CH---HHH-----HHHHHTTCCCCCC----CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CH---HHH-----HHHhccCCCCCCC----cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11 111 1111111111111 112345688999999999999999999999999997654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=281.49 Aligned_cols=169 Identities=26% Similarity=0.235 Sum_probs=141.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~l 486 (702)
+.++..+.||+|++ ||++.... ..|||| |+++..++..++..++
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 133 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCL 133 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEE
Confidence 45566778999987 88886543 456665 6677788889999999
Q ss_pred EEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe--CCCcEEEecccceeec
Q 038002 487 VYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID--DSWRAKISDFGLAKLL 563 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~ 563 (702)
||||++ ++|.+++.... ..+++..+..++.||+.||+|||.+ ..+|+||||||+|||++ .++.+||+|||++...
T Consensus 134 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~ 211 (382)
T 2vx3_A 134 VFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211 (382)
T ss_dssp EEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceec
Confidence 999996 49999998764 3589999999999999999999942 12999999999999994 5778999999999876
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 212 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 212 GQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp TCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 432 23456899999999999989999999999999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=287.47 Aligned_cols=167 Identities=21% Similarity=0.179 Sum_probs=144.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~l 486 (702)
..++..+.||+|+| ||++.... ..|||| |++++..+...+..++
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 34666789999988 88886554 566666 6777888999999999
Q ss_pred EEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCc--EEEecccceeec
Q 038002 487 VYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWR--AKISDFGLAKLL 563 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~~ 563 (702)
||||+. ++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++...
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 59999988764 3489999999999999999999999 9999999999999999887 999999999765
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCC
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVN 617 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 617 (702)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 322 23456899999999999989999999999999999999999999754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-31 Score=273.18 Aligned_cols=219 Identities=24% Similarity=0.256 Sum_probs=164.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+.+...++||+|++ ||++.... ..+|+| |+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45556678888877 77766543 444544 88899999999999999999
Q ss_pred CCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE---eCCCcEEEecccceeecC
Q 038002 491 MSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 491 ~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 564 (702)
+++++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998643 34689999999999999999999999 99999999999999 456789999999998654
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
... ......|++.|+|||.+. ..++.++||||||+++|||++|+.||..... .+ ..... ........ .
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~--~~--~~~~~--~~~~~~~~--~- 246 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL--EE--VQQKA--TYKEPNYA--V- 246 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--HH--HHHHH--HHCCCCCC--C-
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH--HH--HHhhh--ccCCcccc--c-
Confidence 332 234456899999999876 5688999999999999999999999965311 11 10000 00011100 0
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......+.+.+++.+||+.||++|||++|+++
T Consensus 247 --~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01113467889999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=277.84 Aligned_cols=229 Identities=22% Similarity=0.253 Sum_probs=162.9
Q ss_pred ccccccceEEEeEE--EEEeeee--hhhhHhh----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSIT--FLCFLIA----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~--~~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+.++..+.||+|++ ||++... ...||+| |+++++++..++..++||||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 94 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKL 94 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEEC
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehh
Confidence 44455566777766 6666543 2445554 77888889999999999999
Q ss_pred CCCCCHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 491 MSKGSLADLLFN-------LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 491 ~~~gsL~~~l~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
+++++|.+++.. ....+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 95 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 171 (303)
T 2vwi_A 95 LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFL 171 (303)
T ss_dssp CTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred ccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence 999999999974 233589999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCC----ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccc
Q 038002 564 MPNQT----GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGE 638 (702)
Q Consensus 564 ~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 638 (702)
..... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... . .. ..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~-~~-~~~~~~~~~~ 247 (303)
T 2vwi_A 172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK--V-LM-LTLQNDPPSL 247 (303)
T ss_dssp C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--H-HH-HHHTSSCCCT
T ss_pred ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh--H-HH-HHhccCCCcc
Confidence 43221 11234568999999998865 568999999999999999999999997542111 1 00 0000000000
Q ss_pred cccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 639 FNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 639 ~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
................+.+++.+||+.||++||+++|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0001111222234567889999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=277.27 Aligned_cols=199 Identities=23% Similarity=0.247 Sum_probs=157.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..++ .++||||+++++|.+++......+++.++..++.||+.||+|||++ +|+|+||||+||+++.++
T Consensus 83 i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 83 LIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRD 158 (291)
T ss_dssp BCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETT
T ss_pred cccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCC
Confidence 778888877655 8999999999999999987655789999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCce--eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGI--VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||..... ...
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~-- 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQI-- 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH--
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHH--
Confidence 99999999998775443221 223457788999999988889999999999999999999 9999964411 111
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.......... ...+...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus 234 ---~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 234 ---LHKIDKEGER----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---HHHHHTSCCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---HHHHHccCCC----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 1111111111 11223345678999999999999999999999999988653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=277.30 Aligned_cols=222 Identities=24% Similarity=0.254 Sum_probs=169.0
Q ss_pred ccccccceEEEeEE--EEEeeeehhhhHhh-------------------------eeeEEEEEe-cCCeeEEEEecCCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITFLCFLIA-------------------------ISSLLVYKH-RSSKKLLVYEFMSKG 494 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~~~~avk-------------------------i~~l~~~~~-~~~~~~lV~e~~~~g 494 (702)
+.++..+.||+|++ ||++......+|+| |+++++++. .++..++||||++++
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~ 100 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTE
T ss_pred hhceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCC
Confidence 44556678888887 88877666667776 777777654 456899999999999
Q ss_pred CHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 495 SLADLLFNLET-RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 495 sL~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
+|.+++..... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ..
T Consensus 101 ~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~ 173 (278)
T 1byg_A 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DT 173 (278)
T ss_dssp EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------------
T ss_pred CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc----cC
Confidence 99999976532 278999999999999999999999 99999999999999999999999999987653322 23
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
..+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... + . ......+. ....+...+
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~-~-----~~~~~~~~-----~~~~~~~~~ 240 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D-V-----VPRVEKGY-----KMDAPDGCP 240 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG--G-H-----HHHHTTTC-----CCCCCTTCC
T ss_pred CCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH--H-H-----HHHHhcCC-----CCCCcccCC
Confidence 357889999999988899999999999999999998 99999654111 1 1 11111111 112233445
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..+.+++.+||+.||++||+++|+++.|+.+.
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 68899999999999999999999999998764
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=283.86 Aligned_cols=230 Identities=20% Similarity=0.171 Sum_probs=170.8
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------------eeeEEEEEe----
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------------ISSLLVYKH---- 479 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------------i~~l~~~~~---- 479 (702)
..+++..++||+|++ ||++.... ..||+| |++++..+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 455667788999987 88886543 456665 556677666
Q ss_pred cCCeeEEEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC--------
Q 038002 480 RSSKKLLVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW-------- 550 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-------- 550 (702)
++...++||||+ +++|.+.+... ...+++.+++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhh
Confidence 677999999999 55666655543 356999999999999999999999953 899999999999998775
Q ss_pred -----------------------------------------cEEEecccceeecCCCCCceeeceeccccccCcccccCC
Q 038002 551 -----------------------------------------RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG 589 (702)
Q Consensus 551 -----------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 589 (702)
.+||+|||++...... .....||+.|+|||++.+.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHHTS
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhcCC
Confidence 7999999999876432 2345689999999999988
Q ss_pred CCCccccccchhHhHHHhhhCCcCCcCCCCCcch--hhhHHHHHHhhh--------ccc-----------ccc-------
Q 038002 590 LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE--VLLSTWVYNCFV--------AGE-----------FNK------- 641 (702)
Q Consensus 590 ~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~--~~~~~~~~~~~~--------~~~-----------~~~------- 641 (702)
.++.++|||||||++|||++|+.||......... ............ .+. +..
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 9999999999999999999999999765322211 000000100000 000 000
Q ss_pred ----ccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 642 ----LVE--EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 642 ----~~~--~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+. ...+......+.+|+.+||+.||++|||++|+++
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 0235677889999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-31 Score=275.33 Aligned_cols=213 Identities=19% Similarity=0.238 Sum_probs=167.8
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV 487 (702)
...++..+.||+|++ ||++.... ..||+| |+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 445556678888876 77776642 556655 78888999999999999
Q ss_pred EecCCCCCHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC----------------
Q 038002 488 YEFMSKGSLADLLFNLE---TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD---------------- 548 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~---------------- 548 (702)
|||+++++|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997642 3689999999999999999999999 9999999999999984
Q ss_pred ---CCcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 549 ---SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 549 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
...+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|||++|..|+... .
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~-- 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG----D-- 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS----H--
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch----h--
Confidence 4479999999998764332 23489999999988765 6678999999999999999999876432 1
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ......+... ..+...+..+.+++.+||+.||++|||++|+++
T Consensus 236 ~-----~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 Q-----WHEIRQGRLP-----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H-----HHHHHTTCCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-----HHHHHcCCCC-----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 0 1111122111 122234567889999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=279.56 Aligned_cols=234 Identities=21% Similarity=0.240 Sum_probs=175.3
Q ss_pred ccccccceEEEeEE--EEEeee------ehhhhHhh---------------------------eeeEEEEEecC--CeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSI------TFLCFLIA---------------------------ISSLLVYKHRS--SKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~------~~~~~avk---------------------------i~~l~~~~~~~--~~~~ 485 (702)
..++..+.||+|++ ||++.. ....||+| |+++++++... ...+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 34455678888876 777752 12455555 77777766554 4789
Q ss_pred EEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
+||||+++++|.+++......+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 121 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~ 197 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred EEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence 99999999999999988766799999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCce--eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCC--------CcchhhhHHHHHHhhh
Q 038002 566 NQTGI--VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVS--------TADEVLLSTWVYNCFV 635 (702)
Q Consensus 566 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~ 635 (702)
..... .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... ................
T Consensus 198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (326)
T 2w1i_A 198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277 (326)
T ss_dssp SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence 43221 1234567789999999888899999999999999999999999863200 0000000000111111
Q ss_pred ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+. ....+...+..+.+++.+||+.||++|||++||+++|+.+.
T Consensus 278 ~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 278 NNG-----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp TTC-----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC-----CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 11123344578899999999999999999999999998753
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=279.76 Aligned_cols=192 Identities=24% Similarity=0.364 Sum_probs=152.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.+++..+..++||||+++++|.+++.... .+++..+..++.||+.||+|||+. ||+|+||||+||+++.++
T Consensus 162 iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~ 237 (365)
T 2y7j_A 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNM 237 (365)
T ss_dssp BCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred EeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 6777888999999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccC------CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS------GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ..
T Consensus 238 ~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~----~~ 311 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR----QI 311 (365)
T ss_dssp CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS----HH
T ss_pred CEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC----HH
Confidence 999999999987654332 345679999999998753 357899999999999999999999996431 11
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... .....+..... .+ .....+..+.+++.+||+.||++|||++|+++
T Consensus 312 ~~~----~~i~~~~~~~~-~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 312 LML----RMIMEGQYQFS-SP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHH----HHHHHTCCCCC-HH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHH----HHHHhCCCCCC-Cc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11111111100 00 00123456889999999999999999999986
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=274.78 Aligned_cols=192 Identities=24% Similarity=0.322 Sum_probs=151.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+|+||||+||+++.++
T Consensus 70 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 145 (283)
T 3bhy_A 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKN 145 (283)
T ss_dssp BCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSS
T ss_pred eeehhheecCCCeEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCC
Confidence 7888899999999999999999999999997644 689999999999999999999999 999999999999998877
Q ss_pred ----cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 551 ----RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 551 ----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .....
T Consensus 146 ~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~ 220 (283)
T 3bhy_A 146 VPNPRIKLIDFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL 220 (283)
T ss_dssp SSSCCEEECCCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH
T ss_pred CCCCceEEEecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHH
Confidence 899999999987643322 234568999999999998899999999999999999999999996531 11111
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ ..........+..+.+++.+||+.||++||+++|+++
T Consensus 221 -----~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 221 -----TNISAVNY--DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp -----HHHHTTCC--CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----HHhHhccc--CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 11111110 0011111223567889999999999999999999997
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-31 Score=282.47 Aligned_cols=204 Identities=19% Similarity=0.242 Sum_probs=150.5
Q ss_pred eeeEEEEEec--------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYKHR--------SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
|+++++++.. ++..++||||+++ +|.+.+......+++.++..++.||+.||+|||++ +|+||||||+
T Consensus 78 iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~ 153 (351)
T 3mi9_A 78 VVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAA 153 (351)
T ss_dssp BCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred cccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHH
Confidence 7777777765 5678999999975 88888877766799999999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCC---CceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQ---TGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
||+++.++.+||+|||++..+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 154 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 233 (351)
T 3mi9_A 154 NVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 233 (351)
T ss_dssp GEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999998764322 122344678999999998865 568999999999999999999999997542
Q ss_pred CCcchhhhHHHHHHhhhccccccc-----------ccc---ccC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKL-----------VEE---EVD-----KITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~---~~~-----~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... ................+... ... ... ......+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 234 EQH-QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHH-HHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHH-HHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 111 11000000000000000000 000 000 0113568899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-31 Score=281.60 Aligned_cols=217 Identities=20% Similarity=0.239 Sum_probs=172.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
..+...+.||+|++ ||++.... ..+|+| |+++++++.+++..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 44556678888877 77765432 333333 888999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++........
T Consensus 121 e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 196 (335)
T 2owb_A 121 ELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196 (335)
T ss_dssp CCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred ecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence 9999999999987654 789999999999999999999999 999999999999999999999999999987643322
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ... ......... ..+
T Consensus 197 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~-----~~~~~~~~~------~~~ 261 (335)
T 2owb_A 197 -RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KET-----YLRIKKNEY------SIP 261 (335)
T ss_dssp -CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH-----HHHHHHTCC------CCC
T ss_pred -cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHH-----HHHHhcCCC------CCC
Confidence 23345689999999999888899999999999999999999999964311 111 111111111 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......+.+++.+||+.||++||+++|+++
T Consensus 262 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 233457888999999999999999999997
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=305.24 Aligned_cols=218 Identities=24% Similarity=0.264 Sum_probs=169.7
Q ss_pred cceEEEeEE--EEEeeeeh----hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 448 KRKLLTVLA--GCLGSITF----LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~----~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
.++||+|+| ||++.... ..|||| |++++++++. +..++||||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence 357999988 88885431 456655 7888888864 56899999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC--ce
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT--GI 570 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~ 570 (702)
+|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..... ..
T Consensus 453 ~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 453 LGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp TEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 999999997654 789999999999999999999999 999999999999999999999999999987654332 12
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .. ....+..+.. ...+.
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~----~~----~~~~i~~~~~-----~~~p~ 595 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SE----VTAMLEKGER-----MGCPA 595 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HH----HHHHHHTTCC-----CCCCT
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH----HH----HHHHHHcCCC-----CCCCC
Confidence 233456788999999998899999999999999999998 9999965411 11 1111111111 12233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
..+..+.++|.+||+.||++||++++|+++|+..
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 4457889999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=292.32 Aligned_cols=228 Identities=21% Similarity=0.204 Sum_probs=162.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecC------Ce
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRS------SK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~------~~ 483 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++... .+
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 34556678888887 77776543 556666 77777777544 46
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.|+||||+++ +|.+.+.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 142 ~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred EEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 7999999976 56666643 488999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH-------------
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV------------- 630 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~------------- 630 (702)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 215 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~ 292 (464)
T 3ttj_A 215 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292 (464)
T ss_dssp --CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred CCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence 4322 2345679999999999999999999999999999999999999997542111000000000
Q ss_pred -HHhhhcc-------cccccccc-------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 631 -YNCFVAG-------EFNKLVEE-------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 631 -~~~~~~~-------~~~~~~~~-------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...+... .+...... .........+.+|+.+||+.||++|||++|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 00000000 1122336789999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=275.22 Aligned_cols=219 Identities=20% Similarity=0.233 Sum_probs=173.8
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV 487 (702)
...+...+.||+|++ ||++.... ..+|+| |+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 345566778888877 77766542 333433 88889999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 99999999999987654 689999999999999999999999 99999999999999999999999999998764332
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
. ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ......... ..
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~-----~~~~~~~~~------~~ 234 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KET-----YLRIKKNEY------SI 234 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH-----HHHHHTTCC------CC
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH-----HHHHhhccC------CC
Confidence 2 23345689999999999888899999999999999999999999965311 111 111111111 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 235 PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 22334678899999999999999999999973
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=269.56 Aligned_cols=216 Identities=24% Similarity=0.282 Sum_probs=165.9
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEec----CCeeEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHR----SSKKLL 486 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~----~~~~~l 486 (702)
.++..+.||+|++ ||++.... ..||+| |+++++++.. +...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 3455567888887 88776543 344443 7777776654 567999
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC--eEecCCCCCcEEEe-CCCcEEEecccceeec
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ--IIHCDIKLRNILID-DSWRAKISDFGLAKLL 563 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~ 563 (702)
||||+++++|.+++.... .+++..+..++.||+.||+|||++ + |+|+||||+||+++ .++.+||+|||++...
T Consensus 107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 999999999999997654 689999999999999999999999 8 99999999999997 7899999999999754
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
.... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||....... . .......+.....
T Consensus 183 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~----~~~~~~~~~~~~~- 250 (290)
T 1t4h_A 183 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA---Q----IYRRVTSGVKPAS- 250 (290)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH---H----HHHHHTTTCCCGG-
T ss_pred cccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH---H----HHHHHhccCCccc-
Confidence 3322 234568999999998764 58999999999999999999999996532111 1 1111111111111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+......+.+++.+||+.||++|||++|+++
T Consensus 251 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 251 ---FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---cCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 12222357889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=288.74 Aligned_cols=192 Identities=23% Similarity=0.300 Sum_probs=142.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++. .+..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 202 iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 202 IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp BCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred EeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 666777765 456899999999999999987654 799999999999999999999999 999999999999996544
Q ss_pred ---cEEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 551 ---RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 551 ---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
.+||+|||+++..... .......||+.|+|||++. ...++.++||||||+++|+|++|+.||........
T Consensus 277 ~~~~~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-- 352 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-- 352 (419)
T ss_dssp SSCCEEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--
T ss_pred CcceEEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--
Confidence 5999999999876432 2234567999999999875 36788999999999999999999999975422211
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... ....+.... .+......++.+.+++.+||+.||++|||++|+++
T Consensus 353 -~~~----~i~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 353 -LKD----QITSGKYNF--IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp -HHH----HHHTTCCCC--CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HHH----HHhcCCCCC--CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 111 111111110 01111223567899999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=279.92 Aligned_cols=230 Identities=20% Similarity=0.199 Sum_probs=153.9
Q ss_pred ccccc-cceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEec----CCeeEEEEec
Q 038002 443 DKVND-KRKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHR----SSKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~-~~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~----~~~~~lV~e~ 490 (702)
+.+.. ++.||+|++ ||++.... ..||+| |++++.++.. +...++||||
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~ 107 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMEC 107 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEec
Confidence 44444 346899987 88887763 677877 6777776665 5668999999
Q ss_pred CCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC---CCcEEEecccceeecCCC
Q 038002 491 MSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD---SWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 491 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~ 566 (702)
+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++......
T Consensus 108 ~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~ 184 (336)
T 3fhr_A 108 MEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184 (336)
T ss_dssp CTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc
Confidence 99999999998764 3589999999999999999999999 9999999999999976 455999999999865432
Q ss_pred CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
. .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............ ......... .....
T Consensus 185 ~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~~--~~~~~ 255 (336)
T 3fhr_A 185 A---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM----KRRIRLGQY--GFPNP 255 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------CCCTT
T ss_pred c---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH----HHhhhcccc--ccCch
Confidence 2 23456899999999998888999999999999999999999999654221110000 000000000 00111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhCCc
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL--MLEGTM 684 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~--~Le~~~ 684 (702)
.....+..+.+++.+||+.||++|||++|+++ .+....
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 11234667889999999999999999999998 444433
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-31 Score=285.52 Aligned_cols=226 Identities=22% Similarity=0.286 Sum_probs=171.3
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+.+...+.||+|++ ||++.... ..+|+| |+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 345566678888887 88776652 455555 7888999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
|+++++|.+++.... .+++..+..++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 999999999997754 68999999999999999999998 5 8999999999999999999999999998754221
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHH--------------------
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLST-------------------- 628 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-------------------- 628 (702)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..............
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 12345689999999999999999999999999999999999999975421110000000
Q ss_pred --------------HHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 629 --------------WVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 629 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
............ .......+..+.+++.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPP----KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCC----CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccCCCCcccchhhhhHHhccCCC----CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000000 0111223567899999999999999999999987
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=271.63 Aligned_cols=217 Identities=25% Similarity=0.256 Sum_probs=166.4
Q ss_pred ccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecCCCCC
Q 038002 447 DKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFMSKGS 495 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~~~gs 495 (702)
....||+|++ ||++.... ..||+| |+++++++...+..++||||+++++
T Consensus 26 ~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 105 (295)
T 2clq_A 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS 105 (295)
T ss_dssp SBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEE
T ss_pred CcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCC
Confidence 3456777776 77776533 445555 8888999999999999999999999
Q ss_pred HHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-CCcEEEecccceeecCCCCCceee
Q 038002 496 LADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-SWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 496 L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|.+++..... ..++..+..++.||+.||+|||++ +|+|+||||+||+++. ++.+||+|||++....... ....
T Consensus 106 L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 181 (295)
T 2clq_A 106 LSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTE 181 (295)
T ss_dssp HHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------C
T ss_pred HHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-Cccc
Confidence 9999987533 356888899999999999999999 9999999999999988 8999999999998764322 1223
Q ss_pred ceeccccccCcccccCC--CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 573 GVRGSRGYMAPEWQNSG--LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
...|++.|+|||.+.+. .++.++||||||+++|+|++|+.||....... .... ..... ......+..
T Consensus 182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~----~~~~~-----~~~~~~~~~ 250 (295)
T 2clq_A 182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--AAMF----KVGMF-----KVHPEIPES 250 (295)
T ss_dssp CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--HHHH----HHHHH-----CCCCCCCTT
T ss_pred ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--HHHH----hhccc-----ccccccccc
Confidence 45689999999988654 37899999999999999999999996431111 1000 00000 011122334
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+..+.+++.+||+.||++||+++|+++
T Consensus 251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 251 MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 5668889999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-30 Score=272.92 Aligned_cols=221 Identities=19% Similarity=0.214 Sum_probs=171.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.+...+.||+|++ ||++.... ..||+| |+++++.+.+++..++||||+++
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence 44555677888887 88876653 556666 78888999999999999999999
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
++|.+++......+++.++..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++........ ....
T Consensus 109 ~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~ 184 (314)
T 3com_A 109 GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-KRNT 184 (314)
T ss_dssp EEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-CBCC
T ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-ccCc
Confidence 999999975555799999999999999999999999 999999999999999999999999999987643322 2234
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
..|++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ... ... ......... ..+...+.
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~---~~~-~~~~~~~~~---~~~~~~~~ 253 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRA---IFM-IPTNPPPTF---RKPELWSD 253 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHH---HHH-HHHSCCCCC---SSGGGSCH
T ss_pred cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHH---HHH-HhcCCCccc---CCcccCCH
Confidence 5689999999999988999999999999999999999999964311 100 000 011110000 11222356
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+.+++.+||+.||++|||++++++
T Consensus 254 ~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 254 NFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHHHHHccCChhhCcCHHHHHh
Confidence 7889999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=280.90 Aligned_cols=229 Identities=20% Similarity=0.185 Sum_probs=170.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~l 486 (702)
..+...+.||+|++ ||++.... ..||+| |+++++++.+++..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 34555667777766 77665532 444444 7788888999999999
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
||||+++ +|.+++......+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 90 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165 (346)
T ss_dssp EEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred EEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence 9999986 89999987766789999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc---cccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA---GEFNKL 642 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 642 (702)
. .......+|+.|+|||.+.+ ..++.++||||||+++|||++|..||..... ...+.. ....... ..+...
T Consensus 166 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~-i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 166 N-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTR-IFETLGTPTEEQWPDM 240 (346)
T ss_dssp C-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHH-HHHHHCCCCTTTSSST
T ss_pred c-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHH-HHHHcCCCChhhhhhh
Confidence 2 22344568999999998865 4589999999999999999999999965421 111111 1111000 000000
Q ss_pred ------cc---------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038002 643 ------VE---------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILML 680 (702)
Q Consensus 643 ------~~---------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~L 680 (702)
+. ..........+.+++.+||+.||++|||++|+++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 00 011123457899999999999999999999999854
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=274.67 Aligned_cols=218 Identities=22% Similarity=0.263 Sum_probs=173.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+.+...+.||+|++ ||++.... ..||+| |+++++.+.+++..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 34555678888887 88876542 556665 78888899999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++++|.+++.. ..+++.++..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 102 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 175 (303)
T 3a7i_A 102 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K 175 (303)
T ss_dssp CTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-C
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-c
Confidence 999999999965 3689999999999999999999999 999999999999999999999999999987644322 2
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... ...... ...... .......
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~----~~~~~~-----~~~~~~~ 242 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH----PMKVLF----LIPKNN-----PPTLEGN 242 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHH----HHHHSC-----CCCCCSS
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC----HHHHHH----HhhcCC-----CCCCccc
Confidence 234568999999999998899999999999999999999999996431 111111 111111 1112223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+..+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 45678899999999999999999999874
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=275.63 Aligned_cols=226 Identities=22% Similarity=0.279 Sum_probs=165.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh-----hhhHhh-----------------------------eeeEEEEEecCC----
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-----LCFLIA-----------------------------ISSLLVYKHRSS---- 482 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-----~~~avk-----------------------------i~~l~~~~~~~~---- 482 (702)
..+...+.||+|++ ||++.... ..||+| |+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 34455677888887 77765432 245555 666777766544
Q ss_pred -eeEEEEecCCCCCHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 483 -KKLLVYEFMSKGSLADLLFN-----LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 483 -~~~lV~e~~~~gsL~~~l~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
..++||||+++++|.+++.. ....+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence 45999999999999999853 234689999999999999999999999 999999999999999999999999
Q ss_pred ccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhh
Q 038002 557 FGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCF 634 (702)
Q Consensus 557 fg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 634 (702)
||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . .. ...
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~--~~----~~~ 262 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH--E--MY----DYL 262 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--G--HH----HHH
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH--H--HH----HHH
Confidence 999987643322 12233457889999999999999999999999999999999 88999654211 1 11 111
Q ss_pred hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 635 VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
..+.. ...+...+..+.+++.+||+.||++|||+++++++|+.+.
T Consensus 263 ~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 263 LHGHR-----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp HTTCC-----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCC-----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 1112234567899999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=277.02 Aligned_cols=197 Identities=21% Similarity=0.256 Sum_probs=154.3
Q ss_pred eeeEEEEE--ecCCeeEEEEecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcCCCC-----eEecCCC
Q 038002 471 ISSLLVYK--HRSSKKLLVYEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDECEVQ-----IIHCDIK 540 (702)
Q Consensus 471 i~~l~~~~--~~~~~~~lV~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~-----ivH~dlk 540 (702)
|+++++++ +.++..++||||+++++|.+++... ...+++.+++.++.|++.||+|||++ + |+|+|||
T Consensus 67 i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLK 143 (279)
T ss_dssp BCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCS
T ss_pred CCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccc
Confidence 77787765 5578999999999999999999753 23489999999999999999999999 8 9999999
Q ss_pred CCcEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCC
Q 038002 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVST 620 (702)
Q Consensus 541 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~ 620 (702)
|+||+++.++.+||+|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 144 p~NIl~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-- 220 (279)
T 2w5a_A 144 PANVFLDGKQNVKLGDFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-- 220 (279)
T ss_dssp GGGEEECSSSCEEECCCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred hhhEEEcCCCCEEEecCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--
Confidence 9999999999999999999987543221 1233568999999999988889999999999999999999999996541
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.... ......+... ..+...+..+.+++.+||+.||++||+++||++.+....
T Consensus 221 --~~~~----~~~i~~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 221 --QKEL----AGKIREGKFR-----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp --HHHH----HHHHHHTCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred --HHHH----HHHHhhcccc-----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 1111 1111222111 122334567899999999999999999999998776544
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=275.37 Aligned_cols=229 Identities=15% Similarity=0.146 Sum_probs=170.1
Q ss_pred cccccccceEEEeEE--EEEeeeeh---hhhHhh--------------------------------eeeEEEEEecCCee
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF---LCFLIA--------------------------------ISSLLVYKHRSSKK 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~---~~~avk--------------------------------i~~l~~~~~~~~~~ 484 (702)
.+.++..+.||+|++ ||++.... ..||+| ++.+..++...+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 456667788999987 88776532 356665 55666888889999
Q ss_pred EEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE-----------------
Q 038002 485 LLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----------------- 546 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll----------------- 546 (702)
++||||+ +++|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 567777666543 4689999999999999999999999 99999999999999
Q ss_pred --eCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 547 --DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 547 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 67889999999999875332 234568999999999998899999999999999999999999997542111000
Q ss_pred hhHHHH-------HHhhhccc----------------------cccccc-cccCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038002 625 LLSTWV-------YNCFVAGE----------------------FNKLVE-EEVDKITLERMVKTGLLCIQDEPNLRPSMK 674 (702)
Q Consensus 625 ~~~~~~-------~~~~~~~~----------------------~~~~~~-~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ 674 (702)
...... ........ ...... ..........+.+++.+||+.||++|||++
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 000000 00000000 000000 012334567899999999999999999999
Q ss_pred HHHH
Q 038002 675 NVIL 678 (702)
Q Consensus 675 evl~ 678 (702)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=293.22 Aligned_cols=219 Identities=23% Similarity=0.234 Sum_probs=170.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
+.++..++||+|++ ||++.... ..+|+| |+++++++++++..++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45666788999988 88777643 455655 8889999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC---CcEEEecccceeecCCC
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS---WRAKISDFGLAKLLMPN 566 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 566 (702)
|+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.. +.+||+|||++......
T Consensus 117 ~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 117 CYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999887654 689999999999999999999999 99999999999999764 45999999999876543
Q ss_pred CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
. ......||+.|+|||++. ..++.++|||||||++|+|++|..||..... ... ...+..+.... ...
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~-----~~~i~~~~~~~--~~~ 259 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEI-----LRKVEKGKYTF--DSP 259 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHH-----HHHHHHTCCCC--CSG
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH---HHH-----HHHHHhCCCCC--Cch
Confidence 3 234467999999999876 4689999999999999999999999965411 111 11111111110 111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 11234567889999999999999999999885
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=290.70 Aligned_cols=222 Identities=23% Similarity=0.228 Sum_probs=173.3
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEE
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.+.++..+.||+|++ ||++.... ..||+| |++++.++.+.+..++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3455666788999988 88877643 556666 88899999999999999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe---CCCcEEEecccceeecC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID---DSWRAKISDFGLAKLLM 564 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~ 564 (702)
|||+++++|.+.+.... .+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 99999999999987654 799999999999999999999999 999999999999995 45679999999998654
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.... ....+ ..+..+.....
T Consensus 176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~-----~~i~~~~~~~~-- 242 (486)
T 3mwu_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL-----KRVETGKYAFD-- 242 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH-----HHHHHTCCCSC--
T ss_pred CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHH-----HHHHhCCCCCC--
Confidence 332 2344579999999998875 58999999999999999999999996431 11111 11111111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.......++.+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 243 LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11112345678899999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-31 Score=292.69 Aligned_cols=221 Identities=23% Similarity=0.238 Sum_probs=176.2
Q ss_pred CcccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEE
Q 038002 441 GNDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 441 ~~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~l 486 (702)
+.+.++..+.||+|++ ||++.... ..|||| |++++.++++.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4566777889999987 88777653 566666 7888999999999999
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE---eCCCcEEEecccceeec
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLL 563 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~a~~~ 563 (702)
||||+.+|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||++..+
T Consensus 104 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999999999997655 799999999999999999999999 99999999999999 56789999999999876
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
..... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||.... .... ...+..+.....
T Consensus 180 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~-----~~~i~~~~~~~~- 247 (484)
T 3nyv_A 180 EASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDI-----LKKVEKGKYTFE- 247 (484)
T ss_dssp CCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHH-----HHHHHHCCCCCC-
T ss_pred ccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHH-----HHHHHcCCCCCC-
Confidence 44332 334569999999998865 68999999999999999999999996541 1111 111111111111
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.......++.+.+++.+||+.||++|||++|+++
T Consensus 248 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 -LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0111234567889999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=273.47 Aligned_cols=221 Identities=21% Similarity=0.248 Sum_probs=161.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEE
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
.+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 345566788898887 77777632 566666 788899999999999999
Q ss_pred ecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 489 EFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 489 e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
||+++ +|.+++.. ....+++.++..++.||+.||+|||++ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99975 88887754 344799999999999999999999984 2899999999999999999999999999987643
Q ss_pred CCCceeeceeccccccCcccc----cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 566 NQTGIVAGVRGSRGYMAPEWQ----NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 566 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||........ ... . ........
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~-~~~~~~~~ 233 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ--QLK----Q-VVEEPSPQ 233 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH--HHH----H-HHHSCCCC
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH--HHH----H-HhccCCCC
Confidence 322 2334689999999985 566789999999999999999999999964321111 111 1 11111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. .....+..+.+++.+||+.||++|||++|+++
T Consensus 234 ~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 L----PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp C----CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred c----ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1 11234567899999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=281.13 Aligned_cols=222 Identities=19% Similarity=0.209 Sum_probs=154.5
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEE--------ecCCe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYK--------HRSSK 483 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~--------~~~~~ 483 (702)
.++..+.||+|++ ||++.... ..||+| |++++.++ .....
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 4455677888877 77776532 556665 77777776 45566
Q ss_pred eEEEEecCCCCCHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC--eEecCCCCCcEEEeCCCcEEEecccc
Q 038002 484 KLLVYEFMSKGSLADLLFN--LETRPLWRDRVRIALDVARGLLYLHDECEVQ--IIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
.++||||+. |+|.+++.. ....+++.+++.++.||+.||+|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred EEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 899999996 699998865 334699999999999999999999999 8 99999999999999999999999999
Q ss_pred eeecCCCCCce-----------eeceeccccccCcccc---cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 560 AKLLMPNQTGI-----------VAGVRGSRGYMAPEWQ---NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 560 a~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
+.......... .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||.......
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---- 260 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---- 260 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence 98764432211 1134589999999988 56678999999999999999999999996431110
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
........ .........+.+++.+||+.||++|||++|+++.|+.+..
T Consensus 261 --------~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 261 --------IVNGKYSI----PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------CCC----CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------hhcCcccC----CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00001100 0111123457889999999999999999999999988643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=289.64 Aligned_cols=232 Identities=18% Similarity=0.178 Sum_probs=159.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEE-----ecCCee
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYK-----HRSSKK 484 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~-----~~~~~~ 484 (702)
+.++..+.||+|++ ||++.... ..|||| |+++++++ +..+..
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 45667788999988 88886543 566766 77888777 344689
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred EEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 9999998 569999997654 799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC--------------------------ceeeceeccccccCcccc-cCCCCCccccccchhHhHHHhhh--------
Q 038002 565 PNQT--------------------------GIVAGVRGSRGYMAPEWQ-NSGLITVKSDVYSFGVVLLEIIC-------- 609 (702)
Q Consensus 565 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~ellt-------- 609 (702)
.... .......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2221 123446789999999975 56679999999999999999999
Q ss_pred ---CCcCCcCCCCCc----------------chhhhHHHHHHhhhccc-----------cc---ccc-------ccccCH
Q 038002 610 ---CRSNFEVNVSTA----------------DEVLLSTWVYNCFVAGE-----------FN---KLV-------EEEVDK 649 (702)
Q Consensus 610 ---G~~Pf~~~~~~~----------------~~~~~~~~~~~~~~~~~-----------~~---~~~-------~~~~~~ 649 (702)
|+.+|....... ........+........ .. ..+ .....+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 555554321100 00000000000000000 00 000 001122
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.....+.+|+.+||+.||++|||++|+++.
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 336778999999999999999999999984
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=286.43 Aligned_cols=169 Identities=21% Similarity=0.186 Sum_probs=137.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecC-----Ce
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRS-----SK 483 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~-----~~ 483 (702)
.+.+...+.||+|++ ||++.... ..|||| |++++.++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 456667789999987 88887654 567776 77788777665 67
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 999999986 59999997654 699999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCC---------------------ceeeceeccccccCcccc-cCCCCCccccccchhHhHHHhhhCCcCCc
Q 038002 564 MPNQT---------------------GIVAGVRGSRGYMAPEWQ-NSGLITVKSDVYSFGVVLLEIICCRSNFE 615 (702)
Q Consensus 564 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlGvil~elltG~~Pf~ 615 (702)
..... .......||+.|+|||++ ....++.++|||||||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 43321 123556789999999975 56679999999999999999998655543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=274.66 Aligned_cols=197 Identities=23% Similarity=0.355 Sum_probs=157.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE---e
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI---D 547 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll---~ 547 (702)
|+++++++.+++..++||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+|+||||+||++ +
T Consensus 68 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~ 143 (304)
T 2jam_A 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPE 143 (304)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSS
T ss_pred eeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCC
Confidence 7888899999999999999999999999997654 689999999999999999999999 99999999999999 7
Q ss_pred CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 548 DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.++.+||+|||++...... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... .. ..
T Consensus 144 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~-~~- 215 (304)
T 2jam_A 144 ENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ES-KL- 215 (304)
T ss_dssp TTCCEEBCSCSTTCCCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HH-HH-
T ss_pred CCCCEEEccCCcceecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HH-HH-
Confidence 8899999999998754322 1233568999999999999899999999999999999999999996431 11 11
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhCCc
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL--MLEGTM 684 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~--~Le~~~ 684 (702)
...+..+... .........+..+.+++.+||+.||++|||++|+++ .+++..
T Consensus 216 ---~~~i~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 216 ---FEKIKEGYYE--FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ---HHHHHHCCCC--CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ---HHHHHcCCCC--CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1111111110 111122334567899999999999999999999997 445443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=286.04 Aligned_cols=184 Identities=12% Similarity=0.042 Sum_probs=139.0
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEe
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDR------VRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKIS 555 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~------~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~ 555 (702)
...|+||||++ |+|.+++......+.+..+ ..++.||+.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 161 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~ 236 (371)
T 3q60_A 161 ANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLG 236 (371)
T ss_dssp EEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEEC
T ss_pred eeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEE
Confidence 44899999998 8999999875434555555 67889999999999999 99999999999999999999999
Q ss_pred cccceeecCCCCCceeeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHh
Q 038002 556 DFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 556 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
|||+++.... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||........... .......
T Consensus 237 DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~-~~~~~~~ 311 (371)
T 3q60_A 237 DVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW-KRPSLRV 311 (371)
T ss_dssp CGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCC-CBCCTTS
T ss_pred ecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccch-hhhhhhh
Confidence 9999987532 1224456799999999987 6899999999999999999999999976532211100 0000000
Q ss_pred hhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 634 FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..... .........++.+.+++.+||+.||++|||++|+++
T Consensus 312 ~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 312 PGTDS----LAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCCCS----CCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccc----cchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 000111234678899999999999999999999875
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-31 Score=281.42 Aligned_cols=203 Identities=22% Similarity=0.310 Sum_probs=150.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||||+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 86 iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~ 161 (331)
T 4aaa_A 86 LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSG 161 (331)
T ss_dssp BCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred EeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCC
Confidence 8889999999999999999999999998876554 799999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW 629 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~ 629 (702)
.+||+|||++........ ......|++.|+|||.+.+. .++.++||||||+++|||++|+.||...............
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 240 (331)
T 4aaa_A 162 VVKLCDFGFARTLAAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240 (331)
T ss_dssp CEEECCCTTC-------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred cEEEEeCCCceeecCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Confidence 999999999986543222 23345689999999988765 7899999999999999999999999754211110000000
Q ss_pred H-------HHhhh-----c-ccccccccc----ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 630 V-------YNCFV-----A-GEFNKLVEE----EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 630 ~-------~~~~~-----~-~~~~~~~~~----~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ...+. . ......... ...+..++.+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000 0 000000000 112234678999999999999999999999886
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=269.58 Aligned_cols=216 Identities=22% Similarity=0.309 Sum_probs=162.3
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+...+.||+|++ ||.+.... ..||+| |++++.++.+++..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4455567777776 77766542 445554 7888899999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++++|.+++.... .+++.++..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-- 165 (276)
T 2h6d_A 92 YVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-- 165 (276)
T ss_dssp CCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred ccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--
Confidence 999999999997654 689999999999999999999999 99999999999999999999999999998764332
Q ss_pred eeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... ... .......+.. ..+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~-----~~~~~~~~~~------~~~ 231 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPT-----LFKKIRGGVF------YIP 231 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHHCCC------CCC
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHH-----HHHHhhcCcc------cCc
Confidence 2234568999999999887765 689999999999999999999996431 111 1111111111 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2234678899999999999999999999984
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-31 Score=287.29 Aligned_cols=168 Identities=17% Similarity=0.191 Sum_probs=133.1
Q ss_pred eEEEEecCCCCCHHHHhhcCCCC------CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecc
Q 038002 484 KLLVYEFMSKGSLADLLFNLETR------PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDF 557 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Df 557 (702)
.|+||||+ +|+|.+++...... +++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 175 ~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DF 250 (377)
T 3byv_A 175 RFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 250 (377)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCG
T ss_pred EEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEec
Confidence 89999999 67999999764311 22578888999999999999999 9999999999999999999999999
Q ss_pred cceeecCCCCCceeeceeccccccCcccccCC-----------CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 558 GLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-----------LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 558 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
|+++.... ......| +.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus 251 G~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~-- 323 (377)
T 3byv_A 251 EHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSE-- 323 (377)
T ss_dssp GGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSG--
T ss_pred hhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchh--
Confidence 99986322 3345567 999999998877 89999999999999999999999996542111100
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... .....++.+.+++.+||+.||++|||++|+++
T Consensus 324 --------------~~~~--~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 324 --------------WIFR--SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp --------------GGGS--SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred --------------hhhh--hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 0000 01123467889999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=270.32 Aligned_cols=192 Identities=22% Similarity=0.297 Sum_probs=154.1
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..++..++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+|+||||+||+++.++
T Consensus 86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~ 161 (298)
T 1phk_A 86 IIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 161 (298)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred EeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCC
Confidence 7778889999999999999999999999997654 689999999999999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCccccc------CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN------SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
.+||+|||++........ .....+++.|+|||.+. ...++.++||||||+++|||++|+.||.... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~ 236 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QML 236 (298)
T ss_dssp CEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH
T ss_pred cEEEecccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHH
Confidence 999999999987644322 33456899999999874 4568899999999999999999999996431 111
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. ......+.... ........+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~-----~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 237 M-----LRMIMSGNYQF--GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H-----HHHHHHTCCCC--CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H-----HHHHhcCCccc--CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 1 11111111110 01111234567899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-31 Score=278.13 Aligned_cols=199 Identities=25% Similarity=0.332 Sum_probs=157.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLE------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++++++.+++..++||||+++++|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||
T Consensus 95 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NI 171 (327)
T 2yfx_A 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNC 171 (327)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred CCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHE
Confidence 8889999999999999999999999999998654 3488999999999999999999999 999999999999
Q ss_pred EEeC---CCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCC
Q 038002 545 LIDD---SWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVS 619 (702)
Q Consensus 545 ll~~---~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~ 619 (702)
+++. +..+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 172 li~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~- 250 (327)
T 2yfx_A 172 LLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS- 250 (327)
T ss_dssp EESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-
T ss_pred EEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC-
Confidence 9984 44699999999976533222 12234557889999999988899999999999999999998 999996431
Q ss_pred CcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 620 TADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
.... ......+.. ...+......+.+++.+||+.||++||++++|++.|+.+..
T Consensus 251 ---~~~~----~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 251 ---NQEV----LEFVTSGGR-----MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp ---HHHH----HHHHHTTCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHH----HHHHhcCCC-----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1111 111111111 11122345678899999999999999999999999987543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-30 Score=279.25 Aligned_cols=228 Identities=22% Similarity=0.209 Sum_probs=168.0
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEE----------------
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYK---------------- 478 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~---------------- 478 (702)
...++..+.||+|++ ||++.... ..||+| |+++++++
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~ 85 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD 85 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence 345677788999988 88887643 677777 77787776
Q ss_pred ----------------------ecCCeeEEEEecCCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC
Q 038002 479 ----------------------HRSSKKLLVYEFMSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQ 533 (702)
Q Consensus 479 ----------------------~~~~~~~lV~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ 533 (702)
..+...++||||+++ +|.+.+.. ....+++..+..++.||++||+|||++ +
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---g 161 (383)
T 3eb0_A 86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---G 161 (383)
T ss_dssp ------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---T
T ss_pred cccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence 334558999999984 88777753 344799999999999999999999999 9
Q ss_pred eEecCCCCCcEEEe-CCCcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCC
Q 038002 534 IIHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCR 611 (702)
Q Consensus 534 ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~ 611 (702)
|+||||||+||+++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||+++|||++|+
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 239 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCC
Confidence 99999999999998 688999999999987644332 3345689999999988764 5899999999999999999999
Q ss_pred cCCcCCCCCcchhhhHHHHHHh--------------hhccccccccc----cccCHHHHHHHHHHHHHcccCCCCCCCCH
Q 038002 612 SNFEVNVSTADEVLLSTWVYNC--------------FVAGEFNKLVE----EEVDKITLERMVKTGLLCIQDEPNLRPSM 673 (702)
Q Consensus 612 ~Pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~ 673 (702)
.||....... .+....... .....+..... ...+...+..+.+++.+||+.||++|||+
T Consensus 240 ~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 316 (383)
T 3eb0_A 240 PLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINP 316 (383)
T ss_dssp CSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 9997542111 111111000 00000000000 01233345678999999999999999999
Q ss_pred HHHHH
Q 038002 674 KNVIL 678 (702)
Q Consensus 674 ~evl~ 678 (702)
+|+++
T Consensus 317 ~e~l~ 321 (383)
T 3eb0_A 317 YEAMA 321 (383)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=278.14 Aligned_cols=232 Identities=20% Similarity=0.175 Sum_probs=167.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecC------Ce
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRS------SK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~------~~ 483 (702)
..++..+.||+|++ ||++.... ..||+| |++++.++..+ ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 44566778899988 88887543 566666 67777777665 35
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.|+||||+ +++|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 69999999 88999999763 689999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH-------HHhhh
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV-------YNCFV 635 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------~~~~~ 635 (702)
... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... ...+.
T Consensus 179 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 179 DSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp CSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred ccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 432 234568999999998876 689999999999999999999999997542111000000000 00000
Q ss_pred ccc-------ccccc---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCCc
Q 038002 636 AGE-------FNKLV---EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGTM 684 (702)
Q Consensus 636 ~~~-------~~~~~---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~~ 684 (702)
... +.... -..........+.+++.+||+.||++|||++|+++. ++...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 000 00000 001223346778999999999999999999999983 55543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=301.55 Aligned_cols=225 Identities=20% Similarity=0.230 Sum_probs=172.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.+...+.||+|++ ||++.... ..+|+| |+++++++. ++..++|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv 468 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 468 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEE
Confidence 34455678899888 88876532 234444 788888774 5678999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++......+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 469 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~ 545 (656)
T 2j0j_A 469 MELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545 (656)
T ss_dssp EECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred EEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence 999999999999987766789999999999999999999999 99999999999999999999999999998765443
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
........+++.|+|||.+.+..++.++||||||+++|||++ |..||..... . .. ...+..+.. ..
T Consensus 546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~-~~----~~~i~~~~~-----~~ 612 (656)
T 2j0j_A 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---N-DV----IGRIENGER-----LP 612 (656)
T ss_dssp --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---H-HH----HHHHHHTCC-----CC
T ss_pred ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---H-HH----HHHHHcCCC-----CC
Confidence 333334557789999999988899999999999999999997 9999964311 1 11 111111111 11
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+...+..+.+++.+||+.||++|||+++|+++|+.+.
T Consensus 613 ~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 613 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 22334568889999999999999999999999998753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-30 Score=275.51 Aligned_cols=236 Identities=21% Similarity=0.225 Sum_probs=170.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------------eeeEEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------------ISSLLVYKHRS 481 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------------i~~l~~~~~~~ 481 (702)
..+...+.||+|++ ||++.... ..||+| |++++.++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 45566778888887 88776532 455655 44556666543
Q ss_pred C----eeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC------CC
Q 038002 482 S----KKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD------SW 550 (702)
Q Consensus 482 ~----~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~------~~ 550 (702)
+ ..++|||++ +++|.+++.... ..+++.++..++.||+.||+|||+++ +|+||||||+|||++. .+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcc
Confidence 3 899999999 899999998753 35899999999999999999999942 8999999999999953 34
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCc---chhhhH
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTA---DEVLLS 627 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~~~ 627 (702)
.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.
T Consensus 176 ~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 176 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 7999999999876432 234468999999999998899999999999999999999999997542211 011111
Q ss_pred HHHHHhhhc--------c-----------cc-----------ccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038002 628 TWVYNCFVA--------G-----------EF-----------NKLVE--EEVDKITLERMVKTGLLCIQDEPNLRPSMKN 675 (702)
Q Consensus 628 ~~~~~~~~~--------~-----------~~-----------~~~~~--~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e 675 (702)
. ....... . .. ..... ...+......+.+++.+||+.||++|||++|
T Consensus 252 ~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 252 Q-IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp H-HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred H-HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 1 0000000 0 00 00000 0245677889999999999999999999999
Q ss_pred HHH--HHhCCcCC
Q 038002 676 VIL--MLEGTMEI 686 (702)
Q Consensus 676 vl~--~Le~~~~~ 686 (702)
+++ .+.+....
T Consensus 331 ll~hp~f~~~~~~ 343 (373)
T 1q8y_A 331 LVNHPWLKDTLGM 343 (373)
T ss_dssp HHTCGGGTTCTTC
T ss_pred HhhChhhhcccCc
Confidence 998 44554433
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=287.02 Aligned_cols=191 Identities=25% Similarity=0.306 Sum_probs=153.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++++++..++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++
T Consensus 108 iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 108 IIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN 183 (504)
T ss_dssp BCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTT
T ss_pred CCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCC
Confidence 7788899999999999999999999999997654 799999999999999999999999 999999999999998776
Q ss_pred ---cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 551 ---RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 551 ---~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||..... ..
T Consensus 184 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~--- 254 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND---QD--- 254 (504)
T ss_dssp CCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HH---
T ss_pred CCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH---HH---
Confidence 69999999998765433 234457999999999887 4689999999999999999999999975411 11
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....+..+.... ........+..+.+++.+||+.||.+|||++|+++
T Consensus 255 --~~~~i~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 255 --IIKKVEKGKYYF--DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp --HHHHHHHCCCCC--CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHHHcCCCCC--CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111111111110 00011123567899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=274.86 Aligned_cols=220 Identities=21% Similarity=0.210 Sum_probs=163.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEec------CCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHR------SSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~------~~~~~ 485 (702)
..++..+.||+|++ ||++.... ..||+| |+++++++.. .+..+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~ 103 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 103 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEE
Confidence 45566778888877 88877632 556666 6777777765 57899
Q ss_pred EEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 486 LVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||++....
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 9999999999999998653 3688999999999999999999999 99999999999999999999999999988654
Q ss_pred CCCCceeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccc
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 639 (702)
.... ......|++.|+|||.+. +..++.++||||||+++|+|++|+.||.... .... .. .......
T Consensus 181 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~---~~-~~~~~~~ 251 (326)
T 2x7f_A 181 RTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRA---LF-LIPRNPA 251 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC----HHHH---HH-HHHHSCC
T ss_pred cCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc----HHHH---HH-HhhcCcc
Confidence 3221 223456899999999886 5678899999999999999999999996431 1110 00 1111111
Q ss_pred ccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 640 NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 640 ~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... ....+..+.+++.+||+.||++||+++++++
T Consensus 252 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 PRLK----SKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCCS----CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCC----ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 1223567889999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-30 Score=273.35 Aligned_cols=192 Identities=23% Similarity=0.311 Sum_probs=148.6
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++..++ .++||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 77 i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 151 (322)
T 2ycf_A 77 IIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 151 (322)
T ss_dssp BCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSS
T ss_pred CceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCC
Confidence 667777776655 899999999999999997654 789999999999999999999999 999999999999998766
Q ss_pred c---EEEecccceeecCCCCCceeeceeccccccCccccc---CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 551 R---AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 551 ~---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
. +||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||........
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 227 (322)
T 2ycf_A 152 EDCLIKITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-- 227 (322)
T ss_dssp SSCCEEECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--
T ss_pred CCCeEEEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--
Confidence 4 9999999998764322 223456899999999863 56788999999999999999999999975422211
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+.... ..+... ..+......+..+.+++.+||+.||++||+++|+++
T Consensus 228 -~~~~~----~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 -LKDQI----TSGKYN--FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHHHH----HHTCCC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHH----HhCccc--cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 11111 111110 001111223567889999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-30 Score=275.64 Aligned_cols=225 Identities=20% Similarity=0.198 Sum_probs=159.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCC------e
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSS------K 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~------~ 483 (702)
..++..+.||+|++ ||++.... ..||+| |+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 34556678888877 77775432 455655 777888776654 7
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.++||||+++ +|.+++.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred eEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 8999999975 78888853 588999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHH-----------
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYN----------- 632 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~----------- 632 (702)
.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ........
T Consensus 178 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 178 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID---QWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHC-CCCCCHHHHTT
T ss_pred cccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHH
Confidence 4322 2334678999999999998899999999999999999999999997542110 00000000
Q ss_pred ------hhh--cc-----ccccccc-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 633 ------CFV--AG-----EFNKLVE-------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 633 ------~~~--~~-----~~~~~~~-------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... .. .+..... ..........+.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000 00 0000000 01122346789999999999999999999999973
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=272.70 Aligned_cols=221 Identities=18% Similarity=0.176 Sum_probs=166.2
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.++..+.||+|++ ||++.... ..+|+| |+++++++..++..++||||+
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECC
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeC
Confidence 44555667777766 77666542 445544 788889999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
++++|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 99 ~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 174 (302)
T 2j7t_A 99 PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKR 174 (302)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC-
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-ccc
Confidence 99999999987666799999999999999999999999 99999999999999999999999999875431111 112
Q ss_pred eceeccccccCcccc-----cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 572 AGVRGSRGYMAPEWQ-----NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
....|++.|+|||.+ ....++.++||||||+++|+|++|..||..... .... ........... .
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~-----~~~~~~~~~~~---~ 243 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVL-----LKIAKSDPPTL---L 243 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHH-----HHHHHSCCCCC---S
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHH-----HHHhccCCccc---C
Confidence 335689999999987 466789999999999999999999999964311 1111 11111111111 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+...+..+.+++.+||+.||++|||++++++
T Consensus 244 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 12233567889999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=265.23 Aligned_cols=223 Identities=22% Similarity=0.179 Sum_probs=166.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEE--ecCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYK--HRSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~--~~~~~~~ 485 (702)
..++..+.||+|++ ||++.... ..+|+| |+++++++ .+.+..+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 34566678888877 77765532 334443 77888776 5567899
Q ss_pred EEEecCCCCCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 486 LVYEFMSKGSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
+||||++++ |.+++... ...+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 999999886 77777653 34689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCC-CceeeceeccccccCcccccCCC--CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 565 PNQ-TGIVAGVRGSRGYMAPEWQNSGL--ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 565 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
... ........|++.|+|||.+.+.. ++.++||||||+++|||++|+.||.... ... .......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~----~~~~i~~~~~-- 230 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----IYK----LFENIGKGSY-- 230 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS----HHH----HHHHHHHCCC--
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch----HHH----HHHHHhcCCC--
Confidence 322 22334566899999999887643 4789999999999999999999997431 111 1111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCC
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGT 683 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~ 683 (702)
..+......+.+++.+||+.||++|||++|+++. +.+.
T Consensus 231 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1122345678899999999999999999999974 4443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-30 Score=282.47 Aligned_cols=233 Identities=19% Similarity=0.154 Sum_probs=167.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh-hhhHhh-----------------------eeeEEEEEecC------CeeEEEEe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF-LCFLIA-----------------------ISSLLVYKHRS------SKKLLVYE 489 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~-~~~avk-----------------------i~~l~~~~~~~------~~~~lV~e 489 (702)
...+...+.||+|++ ||++.... ..+|+| |++++.++... ...++|||
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e 118 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEee
Confidence 345667789999988 88887644 346655 77888777433 34889999
Q ss_pred cCCCCCHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe-CCCcEEEecccceeecCCC
Q 038002 490 FMSKGSLADLLF--NLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID-DSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 490 ~~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~ 566 (702)
|++++.+..... .....+++..+..++.||++||+|||++ +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 119 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 119 YVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp CCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 998754443332 2344689999999999999999999999 999999999999999 7999999999999876443
Q ss_pred CCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH-----------HHhh
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV-----------YNCF 634 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-----------~~~~ 634 (702)
.. .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.... ....
T Consensus 196 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~ 273 (394)
T 4e7w_A 196 EP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY 273 (394)
T ss_dssp CC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGG
T ss_pred CC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 32 2345689999999988654 68999999999999999999999997542111100000000 0000
Q ss_pred hccccccccc----cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 635 VAGEFNKLVE----EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 635 ~~~~~~~~~~----~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....+..... .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp SSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0011110000 01222345689999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=280.80 Aligned_cols=226 Identities=19% Similarity=0.142 Sum_probs=165.1
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEec------CCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHR------SSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~------~~~~~lV~e~ 490 (702)
.+...+.||+|++ ||++.... ..|||| |++++.++.. ....++||||
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 134 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 134 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEEC
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhc
Confidence 4556678999987 88887753 667777 6777766532 2346799999
Q ss_pred CCCCCHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-CcEEEecccceeecCCC
Q 038002 491 MSKGSLADLLFN---LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS-WRAKISDFGLAKLLMPN 566 (702)
Q Consensus 491 ~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~~~~~~ 566 (702)
+++ +|.+.+.. ....+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+++.....
T Consensus 135 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~ 210 (420)
T 1j1b_A 135 VPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210 (420)
T ss_dssp CCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred ccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence 986 66666542 344789999999999999999999999 99999999999999965 56899999999876443
Q ss_pred CCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHH-------hh--hc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYN-------CF--VA 636 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-------~~--~~ 636 (702)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...... .+ ..
T Consensus 211 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~~~lg~p~~~~~~~~~ 285 (420)
T 1j1b_A 211 EP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQIREMN 285 (420)
T ss_dssp CC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSCCHHHHHHHC
T ss_pred CC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHHHhhC
Confidence 32 2345689999999988664 7899999999999999999999999754211 111111110 00 00
Q ss_pred ccccccccc---------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 637 GEFNKLVEE---------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 637 ~~~~~~~~~---------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........+ .........+.+|+.+||+.||++|||++|+++
T Consensus 286 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 286 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000000000 112234578999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-30 Score=269.16 Aligned_cols=221 Identities=23% Similarity=0.317 Sum_probs=159.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEec------------
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHR------------ 480 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~------------ 480 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 34455567777766 77766432 455555 6666665533
Q ss_pred -CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 481 -SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 481 -~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
.+..++||||+++++|.+++......+++.+++.++.||+.||+|||++ +|+|+||||+||+++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 5788999999999999999987665688899999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCC-------------CceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhh
Q 038002 560 AKLLMPNQ-------------TGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVL 625 (702)
Q Consensus 560 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~ 625 (702)
+....... ........|++.|+|||.+.+. .++.++||||||+++|||++ ||... .....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---~~~~~ 236 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---MERVN 236 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---HHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---hhHHH
Confidence 98654321 1122345689999999988754 78999999999999999998 55321 11111
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......... ....+.........+.+++.+||+.||++|||++++++
T Consensus 237 ----~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 ----ILKKLRSVS--IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ----HHHHHHSTT--CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----HHHhccccc--cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111111 11122334445667889999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=279.33 Aligned_cols=222 Identities=24% Similarity=0.287 Sum_probs=159.3
Q ss_pred cccccceEEEeEE--EEE-eeeehhhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCCCC
Q 038002 444 KVNDKRKLLTVLA--GCL-GSITFLCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSKGS 495 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~-~~~~~~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~gs 495 (702)
.+...+.||+|++ |+. +......|||| |++++..+.+++..++||||+. |+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gs 94 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LN 94 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EE
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CC
Confidence 3444567888887 543 33333566666 8889999999999999999996 69
Q ss_pred HHHHhhcCCCC------CCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-------------CcEEEec
Q 038002 496 LADLLFNLETR------PLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS-------------WRAKISD 556 (702)
Q Consensus 496 L~~~l~~~~~~------~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-------------~~~kl~D 556 (702)
|.+++...... ..+..++.++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~D 171 (434)
T 2rio_A 95 LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171 (434)
T ss_dssp HHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECC
T ss_pred HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcc
Confidence 99999865421 12334578999999999999999 99999999999999754 4899999
Q ss_pred ccceeecCCCCCc---eeeceeccccccCcccccC-------CCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhh
Q 038002 557 FGLAKLLMPNQTG---IVAGVRGSRGYMAPEWQNS-------GLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVL 625 (702)
Q Consensus 557 fg~a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 625 (702)
||++......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||...... .
T Consensus 172 FG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~--~-- 247 (434)
T 2rio_A 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR--E-- 247 (434)
T ss_dssp CTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH--H--
T ss_pred cccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh--H--
Confidence 9999987543321 1234679999999998865 678999999999999999999 99999643211 1
Q ss_pred hHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 626 LSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......... .. ..........+..+.+++.+||+.||++|||+.||++
T Consensus 248 -~~i~~~~~~---~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -SNIIRGIFS---LD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -HHHHHTCCC---CC-CCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHhcCCCC---cc-cccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 111111000 00 1111224567789999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-30 Score=274.09 Aligned_cols=230 Identities=19% Similarity=0.218 Sum_probs=169.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecC-----CeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRS-----SKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~-----~~~~ 485 (702)
..+...+.||+|++ ||++.... ..||+| |++++.++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 45667788999987 88886543 556666 66777776544 4789
Q ss_pred EEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
+||||+. ++|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 107 iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 107 IVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 9999997 5999999764 589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc--eeeceeccccccCccccc-CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc--
Q 038002 566 NQTG--IVAGVRGSRGYMAPEWQN-SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN-- 640 (702)
Q Consensus 566 ~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 640 (702)
.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...........+.... .......+.
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL-GSPSQEDLNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHH-CSCCHHHHHTC
T ss_pred CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHh-CCCCHHHHHHh
Confidence 3221 123457999999999765 4568999999999999999999999997542211111110000 000000000
Q ss_pred ----------cccc------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 641 ----------KLVE------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 641 ----------~~~~------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ..........+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 01122345678999999999999999999999973
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=274.83 Aligned_cols=227 Identities=21% Similarity=0.167 Sum_probs=157.6
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCC-------eeEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSS-------KKLL 486 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~-------~~~l 486 (702)
.++..+.||+|++ ||++.... ..|||| |+++++++...+ ..++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 3455678888887 88777643 566666 777877775433 2899
Q ss_pred EEecCCCCCHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHhhh--hcCCCCeEecCCCCCcEEEeC-CCcEEEecccce
Q 038002 487 VYEFMSKGSLADLLF---NLETRPLWRDRVRIALDVARGLLYLH--DECEVQIIHCDIKLRNILIDD-SWRAKISDFGLA 560 (702)
Q Consensus 487 V~e~~~~gsL~~~l~---~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~~~ivH~dlkp~NIll~~-~~~~kl~Dfg~a 560 (702)
||||+++ +|.+.+. .....+++..+..++.|++.||+||| ++ +|+||||||+|||++. ++.+||+|||++
T Consensus 104 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred Eeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 9999987 5554443 23446889999999999999999999 88 9999999999999997 899999999999
Q ss_pred eecCCCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHH-------
Q 038002 561 KLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYN------- 632 (702)
Q Consensus 561 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~------- 632 (702)
........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... .........
T Consensus 180 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 180 KKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHEIVRVLGCPSRE 254 (360)
T ss_dssp BCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCHH
T ss_pred eecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHHHHHHcCCCCHH
Confidence 87644332 2345689999999988654 5899999999999999999999999754211 111111100
Q ss_pred ---hhhcc--ccccc---------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 633 ---CFVAG--EFNKL---------VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 633 ---~~~~~--~~~~~---------~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..... ..... .........+..+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000 00000 0001122246789999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-30 Score=280.33 Aligned_cols=226 Identities=17% Similarity=0.194 Sum_probs=153.1
Q ss_pred ceEEEeEE--EEEeeee----hhhhHhh-------------------------eeeEEEEE--ecCCeeEEEEecCCCCC
Q 038002 449 RKLLTVLA--GCLGSIT----FLCFLIA-------------------------ISSLLVYK--HRSSKKLLVYEFMSKGS 495 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~----~~~~avk-------------------------i~~l~~~~--~~~~~~~lV~e~~~~gs 495 (702)
++||+|++ ||++... ...||+| |++++.++ +.+...++||||+.+ +
T Consensus 27 ~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~ 105 (405)
T 3rgf_A 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-D 105 (405)
T ss_dssp CCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-E
T ss_pred cEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-C
Confidence 46888888 8888744 2566666 77788777 558899999999975 8
Q ss_pred HHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE----eCCCcEEEecccceeec
Q 038002 496 LADLLFNL--------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI----DDSWRAKISDFGLAKLL 563 (702)
Q Consensus 496 L~~~l~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll----~~~~~~kl~Dfg~a~~~ 563 (702)
|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 182 (405)
T 3rgf_A 106 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182 (405)
T ss_dssp HHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred HHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence 88887532 12488999999999999999999999 99999999999999 67789999999999876
Q ss_pred CCCCC--ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcc------hhhhHHHHHHhh
Q 038002 564 MPNQT--GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD------EVLLSTWVYNCF 634 (702)
Q Consensus 564 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~~~~~~~~~~ 634 (702)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ...+.. +....
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~-i~~~~ 261 (405)
T 3rgf_A 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR-IFNVM 261 (405)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH-HHHHH
T ss_pred CCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH-HHHhh
Confidence 43221 22345678999999998876 4589999999999999999999999975422100 000100 00000
Q ss_pred h---cccccccc-------------cc------------ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 635 V---AGEFNKLV-------------EE------------EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 635 ~---~~~~~~~~-------------~~------------~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
. ...+.... .. .........+.+|+.+||+.||++|||++|+++.
T Consensus 262 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp CCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 00000000 00 0000114578899999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=266.92 Aligned_cols=198 Identities=22% Similarity=0.268 Sum_probs=152.2
Q ss_pred eeeEEEEEe-----cCCeeEEEEecCCCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcE
Q 038002 471 ISSLLVYKH-----RSSKKLLVYEFMSKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544 (702)
Q Consensus 471 i~~l~~~~~-----~~~~~~lV~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NI 544 (702)
|+++++++. .+...++||||++ |+|.+++.... ..+++.++..++.||+.||+|||++ ||+||||||+||
T Consensus 76 i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Ni 151 (326)
T 1blx_A 76 VVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNI 151 (326)
T ss_dssp BCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred eEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHe
Confidence 667777665 6788999999998 59999998754 3489999999999999999999999 999999999999
Q ss_pred EEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 545 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
+++.++.+||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ..
T Consensus 152 li~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~ 226 (326)
T 1blx_A 152 LVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VD 226 (326)
T ss_dssp EECTTCCEEECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HH
T ss_pred EEcCCCCEEEecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH---HH
Confidence 99999999999999998653222 23345689999999999888999999999999999999999999975421 11
Q ss_pred hhHHHHHHhhhc---cccccc--------------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 625 LLSTWVYNCFVA---GEFNKL--------------VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 625 ~~~~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.... ....... ..+... ............+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 227 QLGK-ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHH-HHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHH-HHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111 1110000 000000 000122334667889999999999999999999995
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-30 Score=275.12 Aligned_cols=203 Identities=20% Similarity=0.167 Sum_probs=143.1
Q ss_pred eeeEEEEE-----ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEE
Q 038002 471 ISSLLVYK-----HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545 (702)
Q Consensus 471 i~~l~~~~-----~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIl 545 (702)
|++++.++ ......++||||++ |+|.+++......+++.++..++.||+.||+|||++ +|+||||||+||+
T Consensus 91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 56666666 33457899999997 689999887766799999999999999999999999 9999999999999
Q ss_pred EeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchh
Q 038002 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEV 624 (702)
Q Consensus 546 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~ 624 (702)
++.++.+||+|||++....... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||..........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp ECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999997543322 2334568999999998876 678999999999999999999999997542111000
Q ss_pred hhHHHH---------------HHhhhccccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 625 LLSTWV---------------YNCFVAGEFNKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 625 ~~~~~~---------------~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...... .............. ..........+.+++.+||+.||++|||++|+++.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000 00000000000000 01222345678999999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-30 Score=269.45 Aligned_cols=192 Identities=23% Similarity=0.331 Sum_probs=145.3
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++++++.+++..++||| +.+++|.+++.... .+++.++..++.||++||+|||++ +|+||||||+||++++ +
T Consensus 90 iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~ 163 (313)
T 3cek_A 90 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-G 163 (313)
T ss_dssp BCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-T
T ss_pred eEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-C
Confidence 7788899999999999999 66889999998765 789999999999999999999999 9999999999999975 8
Q ss_pred cEEEecccceeecCCCCCc-eeeceeccccccCcccccC-----------CCCCccccccchhHhHHHhhhCCcCCcCCC
Q 038002 551 RAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNS-----------GLITVKSDVYSFGVVLLEIICCRSNFEVNV 618 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 618 (702)
.+||+|||++......... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (313)
T 3cek_A 164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII 243 (313)
T ss_dssp EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence 9999999999876443321 2234568999999998865 468889999999999999999999996432
Q ss_pred CCcchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 619 STADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
... ... .......... ..+......+.+++.+||+.||++||+++|+++.
T Consensus 244 ~~~--~~~-----~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 244 NQI--SKL-----HAIIDPNHEI----EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp SHH--HHH-----HHHHCTTSCC----CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHH--HHH-----HHHHhccccc----CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111 111 1111111111 1112224678899999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=273.16 Aligned_cols=182 Identities=24% Similarity=0.344 Sum_probs=150.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe-C
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSK-GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID-D 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~-~ 548 (702)
|+++++++.+++..++|||++.+ ++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++ .
T Consensus 110 i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 185 (320)
T 3a99_A 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLN 185 (320)
T ss_dssp BCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETT
T ss_pred ceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCC
Confidence 67788999999999999999986 89999997654 789999999999999999999999 999999999999999 7
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||... ...
T Consensus 186 ~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~--- 255 (320)
T 3a99_A 186 RGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEI--- 255 (320)
T ss_dssp TTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH---
T ss_pred CCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hhh---
Confidence 8899999999998764322 234568999999998876655 68899999999999999999999532 100
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..... ..+...++.+.+++.+||+.||++|||++||++.
T Consensus 256 -------~~~~~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 -------IRGQV------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -------HHCCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------hcccc------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0112234678899999999999999999999873
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.1e-30 Score=280.43 Aligned_cols=219 Identities=23% Similarity=0.257 Sum_probs=159.7
Q ss_pred ccccceEEEeEE---EEEeeeehhhhHhh-------------------------eeeEEEEEecCCeeEEEEecCCCCCH
Q 038002 445 VNDKRKLLTVLA---GCLGSITFLCFLIA-------------------------ISSLLVYKHRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 445 ~~~~~~l~~g~~---v~~~~~~~~~~avk-------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL 496 (702)
+...+.||+|++ ++.+......|||| |++++..+++++..|+||||+. |+|
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 344567777776 33333334666666 8889999999999999999996 599
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-----CCcEEEecccceeecCCCCC--c
Q 038002 497 ADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-----SWRAKISDFGLAKLLMPNQT--G 569 (702)
Q Consensus 497 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~~~~--~ 569 (702)
.+++........+.++..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++....... .
T Consensus 105 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~ 181 (432)
T 3p23_A 105 QEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181 (432)
T ss_dssp HHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred HHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCccee
Confidence 999987765566667789999999999999999 9999999999999943 33688999999987653322 2
Q ss_pred eeeceeccccccCccccc---CCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 570 IVAGVRGSRGYMAPEWQN---SGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
......||+.|+|||++. ...++.++|||||||++|||++ |..||...... .. . ........ ...
T Consensus 182 ~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--~~---~---~~~~~~~~-~~~-- 250 (432)
T 3p23_A 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--QA---N---ILLGACSL-DCL-- 250 (432)
T ss_dssp ----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--HH---H---HHTTCCCC-TTS--
T ss_pred eccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--HH---H---HHhccCCc-ccc--
Confidence 234467999999999887 4567889999999999999999 99999643111 00 0 00011111 111
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.........+.+++.+||+.||++|||++||++
T Consensus 251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 112345667889999999999999999999984
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=271.20 Aligned_cols=195 Identities=21% Similarity=0.324 Sum_probs=153.5
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHH------hhcC-CCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADL------LFNL-ETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~ 542 (702)
|+++++++.+++..++||||+++++|.++ +... ...+++.++..++.||+.||+|||+ + +|+|+||||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 67777888999999999999999999998 6543 3468999999999999999999999 8 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCCceeeceeccccccCcccccCC-CCCc-cccccchhHhHHHhhhCCcCCcCCCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG-LITV-KSDVYSFGVVLLEIICCRSNFEVNVST 620 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlGvil~elltG~~Pf~~~~~~ 620 (702)
||+++.++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred hEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 999999999999999999876433 33456789999999998876 6666 999999999999999999999754221
Q ss_pred cchhhhHHHHHHhhhccccccccc-------------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVE-------------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+ .......+....... .......+..+.+++.+||+.||++|||++|+++
T Consensus 259 ~~-------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 VE-------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HH-------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HH-------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11 111111111110000 0011334668899999999999999999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=278.25 Aligned_cols=227 Identities=19% Similarity=0.210 Sum_probs=150.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecC------Ce
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRS------SK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~------~~ 483 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 34556678888887 88876433 556665 66777777543 67
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.|+|||++ +++|.+++.. ..+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 109 ~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 89999999 7899999865 3699999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHH-------HHhhh
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV-------YNCFV 635 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~-------~~~~~ 635 (702)
... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... .....
T Consensus 183 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 183 ADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred ccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 322 334578999999998876 678999999999999999999999997542111000000000 00000
Q ss_pred cccccccc---c-------cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 636 AGEFNKLV---E-------EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 636 ~~~~~~~~---~-------~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.......+ . ..........+.+|+.+||+.||++|||++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 0 01111235678999999999999999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=262.06 Aligned_cols=219 Identities=23% Similarity=0.247 Sum_probs=167.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++.+++..++|||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 34555667777766 77766532 445554 7888899999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC---CcEEEecccceeecCCC
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS---WRAKISDFGLAKLLMPN 566 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~---~~~kl~Dfg~a~~~~~~ 566 (702)
|+++++|.+++.... .+++.++..++.||+.||+|||++ +|+|+||||+||+++.+ +.+||+|||++......
T Consensus 102 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 102 LYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 999999999987654 689999999999999999999999 99999999999999654 46999999999866433
Q ss_pred CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
.. .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.... .... ......+...... .
T Consensus 178 ~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~----~~~~~~~~~~~~~--~ 244 (287)
T 2wei_A 178 TK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN----EYDI----LKRVETGKYAFDL--P 244 (287)
T ss_dssp SS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHHH----HHHHHHCCCCCCS--G
T ss_pred Cc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC----HHHH----HHHHHcCCCCCCc--h
Confidence 22 233458999999998875 48899999999999999999999996531 1111 1111111111111 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11223567889999999999999999999987
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=265.72 Aligned_cols=219 Identities=18% Similarity=0.229 Sum_probs=154.1
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
.++..+.||+|++ ||++.... ..||+| |+++++++.+++..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp GEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred cccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 3444567777777 77776542 455555 88899999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+ ++.+..++......+++..+..++.||++||+|||+ + +|+|+||||+||+++.++.+||+|||++........
T Consensus 106 ~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA- 180 (318)
T ss_dssp C-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred c-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc-
Confidence 9 566776666545578999999999999999999998 6 899999999999999999999999999976543222
Q ss_pred eeeceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 570 IVAGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.....+++.|+|||.+. ...++.++||||||+++|||++|+.||...... .... ........... .
T Consensus 181 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~-----~~~~~~~~~~~-~ 251 (318)
T 2dyl_A 181 -KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVL-----TKVLQEEPPLL-P 251 (318)
T ss_dssp -------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHH-----HHHHHSCCCCC-C
T ss_pred -ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHH-----HHHhccCCCCC-C
Confidence 23456899999999884 456889999999999999999999999753111 1111 11111111111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.....+..+.+++.+||+.||++||+++|+++
T Consensus 252 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 252 --GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01123567889999999999999999999886
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=272.34 Aligned_cols=223 Identities=18% Similarity=0.164 Sum_probs=164.0
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCee-----
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKK----- 484 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~----- 484 (702)
..+...+.||+|++ ||++.... ..||+| |+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 34455678999987 88886543 566766 67777888777665
Q ss_pred -EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 485 -LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 485 -~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
++||||+. ++|.+++.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 122 ~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999997 589888743 589999999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh-hccc---
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF-VAGE--- 638 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~--- 638 (702)
... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... .+........ ....
T Consensus 195 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~ 267 (371)
T 4exu_A 195 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQ 267 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHHHT
T ss_pred ccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCcHHHHH
Confidence 322 234568999999998876 688999999999999999999999997542111 1111000000 0000
Q ss_pred -------------cccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 639 -------------FNKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 639 -------------~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
+..... ..........+.+++.+||+.||++|||++|+++.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000 01122346788999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=269.43 Aligned_cols=232 Identities=19% Similarity=0.182 Sum_probs=169.3
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecC-----Cee
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRS-----SKK 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~-----~~~ 484 (702)
.+.+...+.||+|++ ||++.... ..||+| |+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 345666788999987 88877652 556666 66777665543 789
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
++||||+. ++|.+++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999997 5999998763 689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc---------eeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh
Q 038002 565 PNQTG---------IVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF 634 (702)
Q Consensus 565 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 634 (702)
..... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||....... .+.. .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~-~~~~~ 239 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLL-IFGII 239 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHH
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHH-HHHHh
Confidence 32211 1223568999999997654 678999999999999999999999997542110 0000 00000
Q ss_pred hcc-------------------cccccc---ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhCC
Q 038002 635 VAG-------------------EFNKLV---EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL--MLEGT 683 (702)
Q Consensus 635 ~~~-------------------~~~~~~---~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~--~Le~~ 683 (702)
... .+.... ........+..+.+++.+||+.||++|||++|+++ .++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000 000000 00112234567889999999999999999999997 34443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=266.77 Aligned_cols=182 Identities=25% Similarity=0.375 Sum_probs=145.9
Q ss_pred eeeEEEEEecCCeeEEEEec-CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe-C
Q 038002 471 ISSLLVYKHRSSKKLLVYEF-MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID-D 548 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~-~ 548 (702)
|+++++++..++..++|||+ +.+++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++ .
T Consensus 100 i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLR 175 (312)
T ss_dssp BCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETT
T ss_pred eeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCC
Confidence 66777888889999999999 78999999998754 689999999999999999999999 999999999999999 8
Q ss_pred CCcEEEecccceeecCCCCCceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhH
Q 038002 549 SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 627 (702)
++.+||+|||++....... .....|++.|+|||++.+..+ +.++||||||+++|||++|+.||... ...
T Consensus 176 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~--- 245 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QEI--- 245 (312)
T ss_dssp TTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHH---
T ss_pred CCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HHH---
Confidence 8999999999998764432 234568999999998876655 45899999999999999999999532 100
Q ss_pred HHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..... ..+......+.+++.+||+.||++|||++|+++.
T Consensus 246 -------~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 -------LEAEL------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -------HHTCC------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -------hhhcc------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 1122345678899999999999999999999983
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=267.50 Aligned_cols=223 Identities=24% Similarity=0.281 Sum_probs=151.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
+.++..+.||+|++ ||++.... ..||+| |+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 44556678899887 88777652 566666 8888999999999999999
Q ss_pred cCCCCCHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCC
Q 038002 490 FMSKGSLADLLFN----LETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMP 565 (702)
Q Consensus 490 ~~~~gsL~~~l~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 565 (702)
|+++ +|.+++.. ....+++..+..++.|++.||+|||++ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9985 88887763 234689999999999999999999994 2899999999999999999999999999986643
Q ss_pred CCCceeeceeccccccCcccc----cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 566 NQTGIVAGVRGSRGYMAPEWQ----NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 566 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
... .....|++.|+|||.+ .+..++.++||||||+++|||++|+.||.......+. ......+....
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~~~~~~ 249 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-------LTQVVKGDPPQ 249 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------CCCCCSCCCC
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-------HHHHhcCCCCC
Confidence 322 2334689999999988 4567899999999999999999999999753211110 00111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+...........+.+++.+||+.||++||+++|+++
T Consensus 250 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 250 -LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp -CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111112234567899999999999999999999865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=266.32 Aligned_cols=227 Identities=18% Similarity=0.200 Sum_probs=160.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEE-------------
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYK------------- 478 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~------------- 478 (702)
..++..+.||+|++ ||++.... ..||+| |+++++++
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 44556677788877 77776543 455655 66777665
Q ss_pred -ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe-CCCcEEEec
Q 038002 479 -HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID-DSWRAKISD 556 (702)
Q Consensus 479 -~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~-~~~~~kl~D 556 (702)
.+.+..++||||++ |+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||+++ +++.+||+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEcc
Confidence 34578999999998 599999965 3688999999999999999999999 999999999999997 567999999
Q ss_pred ccceeecCCCCC--ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHh
Q 038002 557 FGLAKLLMPNQT--GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 557 fg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
||++........ .......+++.|+|||.+.. ..++.++||||||+++|||++|+.||...... ..........
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~~~~~~ 241 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQLILESI 241 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHS
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhc
Confidence 999987643221 12233457899999998755 67899999999999999999999999754211 1111100000
Q ss_pred ----------hhc-------cccccccc--cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 634 ----------FVA-------GEFNKLVE--EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 634 ----------~~~-------~~~~~~~~--~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
... ........ .......+..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 000 00000000 0112234678999999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.5e-29 Score=265.69 Aligned_cols=222 Identities=18% Similarity=0.165 Sum_probs=162.4
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCe------e
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSK------K 484 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~------~ 484 (702)
.+...+.||+|++ ||++.... ..||+| |+++++++...+. .
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3455678888887 88776543 556665 6777777776654 4
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
++||||+. ++|.+++.. .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 105 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp EEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred EEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 99999997 588888743 589999999999999999999999 99999999999999999999999999997653
Q ss_pred CCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHH----------h
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYN----------C 633 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~----------~ 633 (702)
.. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+...... .
T Consensus 178 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 250 (353)
T 3coi_A 178 AE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTEFVQK 250 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHHHHTT
T ss_pred CC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHHHH
Confidence 22 234568999999998876 678999999999999999999999997542110 11100000 0
Q ss_pred hhcc-------ccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 634 FVAG-------EFNKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 634 ~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... .+..... ..........+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 0000000 01223456789999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.7e-29 Score=273.91 Aligned_cols=168 Identities=16% Similarity=0.187 Sum_probs=131.0
Q ss_pred eeEEEEecCCCCCHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 483 KKLLVYEFMSKGSLADLLF------NLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
..+++|+++ +++|.+++. .....+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEe
Confidence 457777766 679999984 2233477888999999999999999999 999999999999999999999999
Q ss_pred ccceeecCCCCCceeeceeccccccCcccc----------cCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 557 FGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ----------NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 557 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
||+++..... .....| +.|+|||++ ....++.++|||||||++|||++|+.||........
T Consensus 255 FG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~---- 325 (413)
T 3dzo_A 255 FEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG---- 325 (413)
T ss_dssp GGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC----
T ss_pred ccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh----
Confidence 9998865322 344567 999999988 556688999999999999999999999965421110
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl 677 (702)
....+.. ....++.+.+++.+||+.||++||++.+++
T Consensus 326 ------------~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 326 ------------SEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp ------------SGGGGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred ------------HHHHHhh--cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 0000110 012246789999999999999999976654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-28 Score=250.92 Aligned_cols=207 Identities=19% Similarity=0.193 Sum_probs=153.7
Q ss_pred ceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEec----CCeeEEEEecCCCCCHH
Q 038002 449 RKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHR----SSKKLLVYEFMSKGSLA 497 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~----~~~~~lV~e~~~~gsL~ 497 (702)
+.||+|++ ||++.... ..||+| |++++.++.. +...++||||+++++|.
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 103 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHH
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHH
Confidence 56888877 88876643 567776 7777877766 78899999999999999
Q ss_pred HHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC---CCcEEEecccceeecCCCCCceeec
Q 038002 498 DLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD---SWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 498 ~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++....
T Consensus 104 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--------- 171 (299)
T 3m2w_A 104 SRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--------- 171 (299)
T ss_dssp HHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------
Confidence 9998764 3589999999999999999999999 9999999999999988 7889999999987532
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLE 653 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 653 (702)
+..++.++||||||+++|||++|+.||............ ......... ..........+.
T Consensus 172 --------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~~~ 231 (299)
T 3m2w_A 172 --------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQY--EFPNPEWSEVSE 231 (299)
T ss_dssp --------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS----CCSSCTTCC--SSCHHHHTTSCH
T ss_pred --------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH----HHHHhhccc--cCCchhcccCCH
Confidence 234678999999999999999999999654211100000 000000000 000000122456
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHH--HHhCCcCCC
Q 038002 654 RMVKTGLLCIQDEPNLRPSMKNVIL--MLEGTMEIP 687 (702)
Q Consensus 654 ~l~~li~~cL~~dP~~RPt~~evl~--~Le~~~~~~ 687 (702)
.+.+++.+||+.||++|||++|+++ .+.+....+
T Consensus 232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~ 267 (299)
T 3m2w_A 232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 267 (299)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcChhhcccccCC
Confidence 7899999999999999999999997 344444333
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=279.53 Aligned_cols=200 Identities=24% Similarity=0.274 Sum_probs=148.1
Q ss_pred eeeEEEEEec------CCeeEEEEecCCCCCHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 471 ISSLLVYKHR------SSKKLLVYEFMSKGSLADLLFNLET--RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 471 i~~l~~~~~~------~~~~~lV~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
|+++++++.. ++..++||||+++|+|.+++..... .+++..+..++.||+.||+|||++ +|+||||||+
T Consensus 74 IV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~ 150 (676)
T 3qa8_A 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPE 150 (676)
T ss_dssp BCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCST
T ss_pred CCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHH
Confidence 6667666554 7888999999999999999987543 588999999999999999999999 9999999999
Q ss_pred cEEEeCCCc---EEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCC
Q 038002 543 NILIDDSWR---AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVS 619 (702)
Q Consensus 543 NIll~~~~~---~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 619 (702)
||+++.++. +||+|||++....... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||.....
T Consensus 151 NILl~~~g~~~~vKL~DFG~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~ 228 (676)
T 3qa8_A 151 NIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228 (676)
T ss_dssp TEEEECCSSSCEEEECSCCCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH
T ss_pred HeEeecCCCceeEEEccccccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc
Confidence 999997765 9999999998764333 23446789999999999999999999999999999999999999964311
Q ss_pred Ccc------hhhhHHHHHHhhhccc--ccccc--ccccCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038002 620 TAD------EVLLSTWVYNCFVAGE--FNKLV--EEEVDKITLERMVKTGLLCIQDEPNLRPSMKN 675 (702)
Q Consensus 620 ~~~------~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~e 675 (702)
... ..............+. +.... ........+..+.+++.+||+.||++|||++|
T Consensus 229 ~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp HHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000 0000000000000000 00000 11344557889999999999999999999977
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4e-28 Score=252.18 Aligned_cols=201 Identities=12% Similarity=0.053 Sum_probs=154.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
.+++..+.||+|++ ||++.... ..||+| |+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 45666788888877 88887653 566766 888999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||++|++|.+++.. .....++..++.||+.||+|||++ ||+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999954 346667889999999999999999 99999999999999999999998443
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
|++| ++.++||||||+++|||++|+.||............. . ...+... ......
T Consensus 175 -----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~-~~~~~~~--~~~~~~ 229 (286)
T 3uqc_A 175 -----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----R-DTAGQPI--EPADID 229 (286)
T ss_dssp -----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----B-CTTSCBC--CHHHHC
T ss_pred -----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----H-HhccCCC--Chhhcc
Confidence 3333 6899999999999999999999997652211100000 0 0000000 000122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...++.+.+++.+||+.||++| |++|+++.|+.+..
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 3345678999999999999999 99999999987543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=7e-28 Score=280.50 Aligned_cols=208 Identities=18% Similarity=0.225 Sum_probs=161.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh---hhhHhh----------------------------eeeEEEEEecCCe-----e
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF---LCFLIA----------------------------ISSLLVYKHRSSK-----K 484 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~---~~~avk----------------------------i~~l~~~~~~~~~-----~ 484 (702)
..++..+.||+|++ ||++.... ..|||| |++++.++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45666778899887 88887642 556766 7888888776555 7
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
||||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+|||++.+ .+||+|||+++...
T Consensus 160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~ 232 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN 232 (681)
T ss_dssp EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence 999999999999988754 689999999999999999999999 99999999999999886 89999999998764
Q ss_pred CCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
.. ....||+.|+|||++.+.. +.++||||||+++|+|++|..||....... +. .
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------~~---~ 286 (681)
T 2pzi_A 233 SF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LP---E 286 (681)
T ss_dssp CC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------CC---T
T ss_pred cC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------cc---c
Confidence 33 3456899999999887654 899999999999999999998886321100 00 0
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHhCC
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPS-MKNVILMLEGT 683 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt-~~evl~~Le~~ 683 (702)
..........+.+++.+||+.||++||+ ++++...|.+.
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011123467889999999999999995 66666666543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=245.14 Aligned_cols=173 Identities=13% Similarity=0.079 Sum_probs=133.5
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhh-hcCCCCeEecCCCCCcEEEeCCC---------
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLH-DECEVQIIHCDIKLRNILIDDSW--------- 550 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~dlkp~NIll~~~~--------- 550 (702)
++..||||||+++|++.+.+.+ ..+++.++..++.||+.||+||| ++ +|+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~ 208 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLN 208 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEET
T ss_pred cCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeecc
Confidence 6899999999999977776644 36899999999999999999999 89 999999999999999887
Q ss_pred -----------cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHh-HHHhhhCCcCCcCCC
Q 038002 551 -----------RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV-LLEIICCRSNFEVNV 618 (702)
Q Consensus 551 -----------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi-l~elltG~~Pf~~~~ 618 (702)
.+||+|||+++..... ...||+.|+|||++.+.. +.++||||++++ .+++++|..||...
T Consensus 209 ~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~- 280 (336)
T 2vuw_A 209 GKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV- 280 (336)
T ss_dssp TEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-
T ss_pred CccccccCCCceEEEeeccccEecCCC------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-
Confidence 8999999999876432 347999999999998766 899999998766 88899999998421
Q ss_pred CCcchhhhHHHHHHhhh-ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038002 619 STADEVLLSTWVYNCFV-AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677 (702)
Q Consensus 619 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl 677 (702)
........... ................++.+.+|+.+||+.| |++|++
T Consensus 281 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 281 ------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp ------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ------hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 00000111111 1111111112234567889999999999976 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-24 Score=240.64 Aligned_cols=135 Identities=19% Similarity=0.120 Sum_probs=101.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|++++.++++++..||||||++|++|.++|...+ .++.. +|+.||+.||+|||++ |||||||||+|||+++++
T Consensus 304 i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg 376 (569)
T 4azs_A 304 APAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQ 376 (569)
T ss_dssp CCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTS
T ss_pred eeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCC
Confidence 7899999999999999999999999999998765 56544 5889999999999999 999999999999999999
Q ss_pred cEEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCC
Q 038002 551 RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNF 614 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf 614 (702)
++||+|||+|+....... .....+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 377 ~vKL~DFGlAr~~~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 377 HARLIDFGSIVTTPQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CEEECCCTTEESCC---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CEEEeecccCeeCCCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 999999999987644332 2345679999999998875 4567899999999999988776654
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=165.54 Aligned_cols=110 Identities=18% Similarity=0.240 Sum_probs=94.8
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
+++|.+||.|.++ ++|+ ++|.|+|+|+.+||. |+|+ ..++||.||++.+ +.++.|+|+.||||||+|.
T Consensus 1 ~d~l~~g~~L~~g--~~l~-~~~~~~l~~~~dGnl----vl~~---~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTG--HSLE-VGPSYRLIMQGDCNF----VLYD---SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTT--CEEE-ETTTEEEEECTTSCE----EEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCC--CEEE-ECCCEEEEEcCCCcE----EEEE---CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECC
Confidence 3789999999987 7899 999999999988874 5676 3799999999865 4568999999999999999
Q ss_pred CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCc
Q 038002 107 ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPT 151 (702)
Q Consensus 107 ~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PT 151 (702)
++.++|+|.+....+..+++|+|+|||||++. .+||||+||.
T Consensus 69 ~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP---VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEEECSCCC-
T ss_pred CCcEEEecCCCCCCCCEEEEEeCCccEEEECC---CEecCCCcCC
Confidence 89999999876555667899999999999974 7999999983
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=163.34 Aligned_cols=105 Identities=15% Similarity=0.277 Sum_probs=89.8
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
.++|.+||.|.++ ++|+| |.|.|.|+.++|. .++. ..++||+|||+.|. ...+.|+|+.||||||+|.
T Consensus 1 kn~L~~g~~L~~g--~~L~s--g~y~l~~q~DgNL---vly~----~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~ 68 (105)
T 4h3o_A 1 RNILDNNEGLYAG--QSLDV--EPYHFIMQDDCNL---VLYD----HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDS 68 (105)
T ss_dssp CCEECTTEEECTT--CEEEE--TTEEEEECTTSCE---EEEE----TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECT
T ss_pred CCCcCCCCEEcCC--CEEEE--CCEEEEECCCCeE---EEEE----CCEEEEEecCCCCC-CccEEEEEeCCccEEEECC
Confidence 3789999999987 78988 7899999998873 3433 36899999999886 4568999999999999999
Q ss_pred CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeee
Q 038002 107 ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146 (702)
Q Consensus 107 ~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqS 146 (702)
+++++|+|++......++|+|+||||||||+. .||||
T Consensus 69 ~~~~vWss~t~~~~~~~~l~L~ddGNlVly~~---~~W~S 105 (105)
T 4h3o_A 69 SGRSLWASHSTRGSGNYILILQDDGNVIIYGS---DIWST 105 (105)
T ss_dssp TCCEEEECCCCCCSSCEEEEECTTSCEEEEES---EEEEC
T ss_pred CcEEEEEecCCCCCCCEEEEEeCCCeEEEECC---cEecC
Confidence 99999999886556678899999999999964 69998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=2.4e-20 Score=165.47 Aligned_cols=106 Identities=14% Similarity=0.202 Sum_probs=93.1
Q ss_pred ccccCCCCccccCCCCeeE--cCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEE
Q 038002 27 KSTISLGSSLSPSGQHSWN--SSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILK 104 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~--s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~ 104 (702)
.++|.+|++|.++ ++|+ |++|.|+|+|+.+|+. +||++ +++||.||++.+ +.++.|+|+.||||||+
T Consensus 8 ~~~l~~g~~L~~g--~~l~~~S~~g~~~L~~~~dgnl----vly~~---~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~ 76 (119)
T 1b2p_A 8 QPDDNHPQILHAT--ESLEILFGTHVYRFIMQTDCNL----VLYDN---NNPIWATNTGGL--GNGCRAVLQPDGVLVVI 76 (119)
T ss_dssp CSSSCCCCEEETT--CEEEEEETTEEEEEEECTTSCE----EEEET---TEEEEECCCTTS--CSSCEEEECTTSCEEEE
T ss_pred CcccCCCCEEcCC--CEEEEeCCCCCEEEEEecCCCE----EEEEC---CEEEEeCCCccC--CCceEEEEccCCEEEEE
Confidence 4899999999987 7999 9999999999998873 57875 799999999865 55689999999999999
Q ss_pred cCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeee
Q 038002 105 TEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146 (702)
Q Consensus 105 ~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqS 146 (702)
|.++.++|+|.+....+...++|+|+|||||++ .++|||
T Consensus 77 d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~---~~~W~S 115 (119)
T 1b2p_A 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWAT 115 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEEC
T ss_pred eCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC---ccEeCC
Confidence 998999999987544567789999999999997 389998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=1.3e-19 Score=160.14 Aligned_cols=110 Identities=19% Similarity=0.310 Sum_probs=92.8
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
.|+|.+||+|.++ ++|+ +|.|+|+|+.++|.. +|. ..++||.||++.| +.++.|+|+.||||||+|.
T Consensus 2 ~dtl~~gq~L~~g--~~L~--~g~~~L~~~~dgnlv----ly~---~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHAD--HSLQ--AGAYTLTIQNKCNLV----KYQ---NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETT--EEEE--ETTEEEEECTTSCEE----EEE---TTEEEEECSCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCC--CEEE--CCCEEEEEcCCCcEE----EEe---CCEEEEeCCCCCC--CCceEEEECCCCcEEEECC
Confidence 3899999999987 7888 899999999888642 354 3789999999877 4568999999999999998
Q ss_pred CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcc
Q 038002 107 ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTD 152 (702)
Q Consensus 107 ~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTD 152 (702)
++.++|+|.+....+..+++|+|+|||||++. ++||||.+++.
T Consensus 69 ~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~---~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWGDNGKYALVLQKDGRFVIYGP---VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCCSSSCCEEEECTTSCEEEECS---EEECSSTTCBC
T ss_pred CceEEEEcCCCCCCCCEEEEEeCCCeEEEECC---CEEECCCCCCc
Confidence 88999998875444567899999999999964 89999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=159.57 Aligned_cols=110 Identities=17% Similarity=0.313 Sum_probs=93.2
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
+|+|.+||+|.++ ++| ++|.|+|+|+.+++. +||.+ .++||.||+..+ +.++.|+|+.||||||+|
T Consensus 1 tdtl~~gq~L~~g--~~L--~~~~~~L~~~~dgnl----vl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTG--GSL--AEGGYLFIIQNDCNL----VLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTT--CEE--EETTEEEEECTTSCE----EEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCC--CEE--eCCCEEEEEcCCCcE----EEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999987 788 589999999998874 24654 689999999753 456899999999999999
Q ss_pred CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCC
Q 038002 107 ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTP 150 (702)
Q Consensus 107 ~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~P 150 (702)
++.++|+|.+....+..+++|+++|||||++..+.++||||++.
T Consensus 67 ~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCC
T ss_pred CCEEEEECCccCCCCCEEEEEeCCCcEEEECCCCceEEECCCcc
Confidence 78899998875445567899999999999987788999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-18 Score=149.43 Aligned_cols=103 Identities=17% Similarity=0.292 Sum_probs=86.5
Q ss_pred cccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcCC
Q 038002 28 STISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEE 107 (702)
Q Consensus 28 ~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~~ 107 (702)
++|.+||.|.++ ++|+ +|.|+|+|+.+||.. | |.. .++||.+|+..+ +.++.|+|+.||||||+|.+
T Consensus 2 ntL~~gq~L~~g--~~L~--~g~~~L~~q~dGnLv-l---y~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 2 NILYSGETLSPG--EFLN--NGRYVFIMQEDCNLV-L---YDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CEEETTEEECTT--CEEE--ETTEEEEECTTSCEE-E---EET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEeCCC--CEEE--CCCEEEEEcCCCcEE-E---EeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 689999999877 7886 799999999888742 2 543 589999999865 45689999999999999988
Q ss_pred CCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeee
Q 038002 108 SKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146 (702)
Q Consensus 108 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqS 146 (702)
+.++|+|++.......+|+|+||||||||++ +||||
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~---~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT---ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES---CCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC---CEEeC
Confidence 8999999875444457899999999999974 89998
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=2.4e-19 Score=202.06 Aligned_cols=130 Identities=18% Similarity=0.242 Sum_probs=109.4
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW 550 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~ 550 (702)
|+++..++..+++.||||||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++.
T Consensus 401 Iv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~-- 466 (540)
T 3en9_A 401 IPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK-- 466 (540)
T ss_dssp CCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--
T ss_pred cCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--
Confidence 55445555577788999999999999999975 568999999999999999 9999999999999998
Q ss_pred cEEEecccceeecCCCCCce------eeceeccccccCcccccC--CCCCccccccchhHhHHHhhhCCcCC
Q 038002 551 RAKISDFGLAKLLMPNQTGI------VAGVRGSRGYMAPEWQNS--GLITVKSDVYSFGVVLLEIICCRSNF 614 (702)
Q Consensus 551 ~~kl~Dfg~a~~~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltG~~Pf 614 (702)
.+||+|||+++......... .....||+.|+|||++.. ..|+...|+|+..+-..+.+.++.+|
T Consensus 467 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 467 DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99999999999875432211 235679999999999876 56888899999999998888777766
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.5e-17 Score=143.91 Aligned_cols=105 Identities=18% Similarity=0.174 Sum_probs=86.1
Q ss_pred ccccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEE
Q 038002 25 QLKSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILK 104 (702)
Q Consensus 25 ~~~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~ 104 (702)
+++++|.+||.|..+ ++|+| |.|.|-|+.+|| |.+ |.. ++||.+|+... +..+.|+|+.||||||+
T Consensus 4 ~~~dtL~~gq~L~~g--~~L~s--g~~~L~~q~dGn---Lvl-~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 4 FTNNLLFSGQVLYGD--GRLTA--KNHQLVMQGDCN---LVL-YGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CBTTEEETTCEEETT--EEEEC--SSCEEEECTTSC---EEE-ECS----SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred cccCEECCCCEecCC--CEEEe--CCEEEEEcCCCe---EEE-ECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 567999999999977 78998 459998877776 333 443 48999999753 45679999999999999
Q ss_pred cCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeee
Q 038002 105 TEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146 (702)
Q Consensus 105 ~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqS 146 (702)
|.++.++|+|++....+.++|+|+||||||||+ ..||+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~---~~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG---PAIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec---CCEecC
Confidence 998999999987544455789999999999997 489997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=6.4e-17 Score=142.24 Aligned_cols=94 Identities=27% Similarity=0.439 Sum_probs=78.1
Q ss_pred CCCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEE
Q 038002 88 PSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLL 167 (702)
Q Consensus 88 ~~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~ 167 (702)
+...+|.|+.||||+|++. ++++|++++.......+|+|+++|||||++ ++.++||||+
T Consensus 18 ~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~~~~W~S~~------------------- 76 (112)
T 1xd5_A 18 EGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GSRAIWASNT------------------- 76 (112)
T ss_dssp ETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TTEEEEECCC-------------------
T ss_pred CCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CCEEEEECCc-------------------
Confidence 4567899999999999987 789999987533345789999999999999 7889999994
Q ss_pred eeccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcccc
Q 038002 168 SSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTDIQ 213 (702)
Q Consensus 168 S~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~~~ 213 (702)
+|++|.|++.|+++|++++|.. ...+||+++++++
T Consensus 77 ------~~~~g~~~l~l~~dGnlvl~~~-----~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ------NRQNGNYYLILQRDRNVVIYDN-----SNNAIWATHTNVG 111 (112)
T ss_dssp ------CCSCCCCEEEECTTSCEEEECT-----TSCEEEECCCCCC
T ss_pred ------cCCCCCEEEEEeCCCcEEEECC-----CCceEEECCCccC
Confidence 4467899999999999888731 2468999998854
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.69 E-value=2.2e-16 Score=138.72 Aligned_cols=107 Identities=11% Similarity=0.207 Sum_probs=87.6
Q ss_pred cccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEc
Q 038002 26 LKSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKT 105 (702)
Q Consensus 26 ~~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~ 105 (702)
..++|.+||.|.++ +.|. +|.|.|-|+.+|| |.++.. ...++||.+|+..+ +.++.|+|+.||||||+|
T Consensus 5 ~~~tL~~gq~L~~g--~~L~--~g~~~L~~q~dGN---LvL~~~--~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 5 VRNVLFSSQVMYDN--AQLA--TRDYSLVMRDDCN---LVLTKG--SKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CSSEEETTCEEETT--CEEE--ETTEEEEECTTSC---EEEEET--TTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred cCCEeCCCCEECCC--CEeE--cCCEEEEEcCCCE---EEEEEC--CCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 45899999999987 7786 4889999988886 333322 13689999999864 456899999999999999
Q ss_pred CCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeee
Q 038002 106 EESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146 (702)
Q Consensus 106 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqS 146 (702)
.++.++|+|++....+.++|+|+||||||||+ ..||+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~---~~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYG---PAVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEEC---SEEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEec---CCEecC
Confidence 98899999987544455789999999999997 689998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=1.4e-16 Score=139.39 Aligned_cols=90 Identities=22% Similarity=0.412 Sum_probs=75.9
Q ss_pred CCCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEE
Q 038002 88 PSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLL 167 (702)
Q Consensus 88 ~~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~ 167 (702)
+...+|.|+.||||||++ .+++||++++......++++|+++|||||++.++.++||||.
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~~~~~W~S~t------------------- 78 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQSNRVIWQTKT------------------- 78 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECCC-------------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCCCcEEEecCC-------------------
Confidence 446789999999999998 578999998753344578999999999999988899999993
Q ss_pred eeccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 168 SSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 168 S~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
++++|.|+++|+++|++++|. . +||++++.
T Consensus 79 ------~~~~g~~~l~l~~dGnlvl~~-------~-~~W~S~~~ 108 (110)
T 3a0c_A 79 ------NGKEDHYVLVLQQDRNVVIYG-------P-VVWATGSG 108 (110)
T ss_dssp ------CCSSSCCEEEECTTSCEEEEC-------S-EEEECSCC
T ss_pred ------CCCCCCEEEEEeCCccEEEEC-------C-CEecCCCc
Confidence 456799999999999988872 1 69999865
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.66 E-value=1.9e-16 Score=138.05 Aligned_cols=108 Identities=16% Similarity=0.200 Sum_probs=87.3
Q ss_pred cccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEc
Q 038002 26 LKSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKT 105 (702)
Q Consensus 26 ~~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~ 105 (702)
+.++|.+||.|.++ +.| .+|.|.|.|+.+||.-. |.. +|.+|+..+ +.++.|+|+.||||||+|
T Consensus 2 ~~dtL~~gq~L~~g--~~L--~~g~~~L~~q~dGNLvl----~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 2 GTNYLLSGQTLDTE--GHL--KNGDFDLVMQDDCNLVL----YNG------NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCSEEETTCEECTT--CEE--EETTEEEEECTTSCEEE----ETT------TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCcCCCCCcCCC--CEe--ECCCEEEEEecCCeEEE----EeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 56999999999877 677 57999999988887522 221 699998754 457899999999999999
Q ss_pred CCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCC
Q 038002 106 EESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGG 157 (702)
Q Consensus 106 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpg 157 (702)
.++.++|++++.......+|+|+||||||||+ ..+|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~---~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG---PSVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEEC---SEEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe---cCEECC-----CCccCC
Confidence 98899999887544456789999999999997 689998 555554
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.64 E-value=5.6e-16 Score=137.29 Aligned_cols=89 Identities=22% Similarity=0.328 Sum_probs=75.2
Q ss_pred CCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 89 ~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
...+|.|+.||||+|++. +++||++++........|+|+|+|||||++.++.++||||
T Consensus 30 g~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~~~~lW~S~--------------------- 87 (119)
T 1b2p_A 30 HVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSP--------------------- 87 (119)
T ss_dssp EEEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECS---------------------
T ss_pred CCEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCCCcEEEcCC---------------------
Confidence 356899999999999987 7899999875334457899999999999998899999999
Q ss_pred eccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
++|++|.|+++|+++|+++++. .+||++|+.
T Consensus 88 ----~~~~~g~~~l~l~~~Gnlvl~~--------~~~W~Sg~~ 118 (119)
T 1b2p_A 88 ----VAGKAGHYVLVLQPDRNVVIYG--------DALWATQTV 118 (119)
T ss_dssp ----CCCCSSCEEEEECTTSCEEEEE--------SEEEECCCC
T ss_pred ----CCCCCCCEEEEEECCCcEEEEC--------ccEeCCCCC
Confidence 3457899999999999988873 279999863
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=1.6e-15 Score=133.95 Aligned_cols=91 Identities=21% Similarity=0.396 Sum_probs=76.5
Q ss_pred CCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 89 ~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
....|.|+.||||+|++ .++++|++++......+.++|+++|||||++.++.++|||||+|
T Consensus 20 g~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~~~~vW~S~~~~------------------ 80 (115)
T 2dpf_A 20 GAYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG------------------ 80 (115)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTTCCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCCceEEEEcCCCC------------------
Confidence 35689999999999998 57899999875333457899999999999998888999999983
Q ss_pred eccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcccc
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTDIQ 213 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~~~ 213 (702)
++|.|++.|+++|++++|. . .||++++|..
T Consensus 81 -------~~g~~~l~l~~dGnlvl~~------~--~~W~S~~~~~ 110 (115)
T 2dpf_A 81 -------DNGKYALVLQKDGRFVIYG------P--VLWSLGPNGC 110 (115)
T ss_dssp -------SSSCCEEEECTTSCEEEEC------S--EEECSSTTCB
T ss_pred -------CCCCEEEEEeCCCeEEEEC------C--CEEECCCCCC
Confidence 5688999999999988872 1 6999999844
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=9.2e-16 Score=158.37 Aligned_cols=114 Identities=11% Similarity=-0.036 Sum_probs=89.0
Q ss_pred ccceEEEeEE--EEEeeee-hhhhHhheeeE------------------------------------------EEEEecC
Q 038002 447 DKRKLLTVLA--GCLGSIT-FLCFLIAISSL------------------------------------------LVYKHRS 481 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~-~~~~avki~~l------------------------------------------~~~~~~~ 481 (702)
..+.||+|.+ ||++... ...||+|+.+. ...+ +.
T Consensus 94 ~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~-~~ 172 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY-AW 172 (282)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE-EE
T ss_pred ecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEE-ec
Confidence 3477888876 8888763 26778776532 2222 23
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
+..++||||++|++|.+ +.. .+...++.|++.||+|||++ ||+||||||+|||++ ++.+||+|||++.
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCE
T ss_pred cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCe
Confidence 56799999999999998 522 23457999999999999999 999999999999999 9999999999987
Q ss_pred ecCCCCCceeeceeccccccCccccc
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQN 587 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~ 587 (702)
. +..+.|||++.
T Consensus 241 ~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 241 E--------------VGEEGWREILE 252 (282)
T ss_dssp E--------------TTSTTHHHHHH
T ss_pred E--------------CCCCCHHHHHH
Confidence 4 34578888764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=125.62 Aligned_cols=103 Identities=14% Similarity=0.127 Sum_probs=82.4
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
+++|.+||.|.++ +.| .+|.|.|.|+.+||.-. |.. .. ||.+|+..+ +..+.|+|+.||||||+|.
T Consensus 2 ~~~l~~gq~L~~g--~~L--~~g~~~L~~q~dGnLvl----~~~---~~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTD--NQL--SYESAAFVMQGDCNLVL----YNE---AG-GFQSNTHGR--GVDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTT--CEE--EETTEEEEECTTSCEEE----ECS---SC-CEECCCTTS--CSSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCC--CEE--ecCCEEEEEccCCeEEE----ECC---CC-EEECCcccC--CcCEEEEEcCCCcEEEEeC
Confidence 4789999999887 677 47899999988887522 332 23 999998765 4568999999999999998
Q ss_pred CCC-eeeeeccc--cCCcceeEEEecCcCEEEeecCCceEeee
Q 038002 107 ESK-EKPIADLV--FDEPASFASMLDSGNFVLYSNRSGIIWES 146 (702)
Q Consensus 107 ~~~-~~w~~~~~--~~~~~~~~~l~d~Gnlvl~~~~~~~~WqS 146 (702)
++. ++|+|++. ......+++|++|||||||+ ..+|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~---~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG---PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC---SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec---cCEEcc
Confidence 876 59998853 22356789999999999997 689998
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=120.98 Aligned_cols=94 Identities=19% Similarity=0.288 Sum_probs=74.4
Q ss_pred CCCCCCCceEEEccCCcEEEEcC-CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCC
Q 038002 84 EQPMPSNATLALTMDGKLILKTE-ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLEN 162 (702)
Q Consensus 84 ~~~~~~~~~l~~~~~g~L~l~~~-~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~ 162 (702)
.|+.+...+|.|+.||||||++. .+.++|++++........++|+++|||||++.++.++|||=.+
T Consensus 19 ~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~~~iW~S~t~------------- 85 (113)
T 3mez_B 19 AQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRLNTVFVSNTV------------- 85 (113)
T ss_dssp CEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECSCC-------------
T ss_pred CEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCCCEEEECCCc-------------
Confidence 34445567999999999999988 4789999987533346789999999999999888899998211
Q ss_pred CCeEEeeccCCCCcccceEeeeccCCceeeeeccccccccceeecCCc
Q 038002 163 GEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGT 210 (702)
Q Consensus 163 ~~~L~S~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~ 210 (702)
...|.|.+.|+.||++++|. .+.|++++
T Consensus 86 ------------~~~~~~~~~L~~dGnlvly~--------~~~W~s~~ 113 (113)
T 3mez_B 86 ------------GQEGDYVLILQINGQAVVYG--------PAVWSTAA 113 (113)
T ss_dssp ------------CSSSCCEEEECTTSCEEEEC--------SEEEESCC
T ss_pred ------------CCCCCEEEEEcCCceEEEec--------CCEecCCC
Confidence 01356899999999999982 36798874
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.44 E-value=2.4e-13 Score=118.79 Aligned_cols=91 Identities=16% Similarity=0.271 Sum_probs=72.3
Q ss_pred CCCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCc-eEeeecCCCcccccCCCccCCCCeE
Q 038002 88 PSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSG-IIWESFSTPTDTILGGQSLENGEHL 166 (702)
Q Consensus 88 ~~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~-~~WqSFd~PTDTlLpgq~l~~~~~L 166 (702)
.....|.|+.||||||++.++ +|++++........++|+++|||||++.++. ++|||.-+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~----------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPVWVYPRS----------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSCSSCSEEESSS-----------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-----------------
Confidence 456789999999999998776 9999875333457999999999999998765 59999521
Q ss_pred EeeccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 167 LSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 167 ~S~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
.....|.|.+.|+.||++++|. .++|++++.
T Consensus 80 ------~~~~~~~~~l~Lq~dGNlvly~--------~~~W~s~t~ 110 (111)
T 3mez_A 80 ------VNTVRGNYAATLGPDQHVTIYG--------PAIWSTPAA 110 (111)
T ss_dssp ------CCCCSSCCEEEECTTSCEEEEC--------SEEEECCCC
T ss_pred ------cCCCCcCEEEEECCCCeEEEec--------cCEEccCCC
Confidence 1123578999999999999983 478998863
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.36 E-value=2.4e-12 Score=112.15 Aligned_cols=89 Identities=29% Similarity=0.432 Sum_probs=71.5
Q ss_pred CCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 89 ~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
....|.|+.||||+|++. +.++|++++........++|+++|||||++.++.++|||....
T Consensus 19 g~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~~~~W~S~t~~------------------ 79 (109)
T 3dzw_A 19 GRYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG------------------ 79 (109)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTSCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCCCEEEECCCCC------------------
Confidence 357899999999999987 6899999875333457899999999999998888999984211
Q ss_pred eccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
..+.|.+.|+.+|++++|. .+.|++++.
T Consensus 80 -------~~~~~~~~L~ddGNlvly~--------~~~W~s~t~ 107 (109)
T 3dzw_A 80 -------ENGNYVCVLQKDRNVVIYG--------TARWATGTN 107 (109)
T ss_dssp -------SSSCEEEEECTTSCEEEEE--------SCCCCCCCC
T ss_pred -------CCCCEEEEEeCCCEEEEEC--------CCEEeCCCc
Confidence 2357899999999999983 257988864
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.7e-12 Score=111.94 Aligned_cols=87 Identities=23% Similarity=0.339 Sum_probs=69.7
Q ss_pred CCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 89 ~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
....|.|+.||||+|++. .++|++++........++|+++|||||++.++.++|||-.+-
T Consensus 24 g~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~~~iW~S~t~~------------------ 83 (110)
T 3r0e_B 24 KNHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDFKTIWSSRSSS------------------ 83 (110)
T ss_dssp SSCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTCCEEEECCCCC------------------
T ss_pred CCEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCCCEEEEcCCcC------------------
Confidence 357899999999999976 589999875433457899999999999998889999993210
Q ss_pred eccCCCCcccceEeeeccCCceeeeeccccccccceeecCCc
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGT 210 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~ 210 (702)
..|.|.+.|+.||++++|. .+.|++++
T Consensus 84 -------~~~~~~~~L~~dGNlvly~--------~~~W~t~~ 110 (110)
T 3r0e_B 84 -------KQGEYVLILQDDGFGVIYG--------PAIFETSS 110 (110)
T ss_dssp -------SSSCCEEEECTTSCEEEEC--------SEEEESCC
T ss_pred -------CCCCEEEEEcCCccEEEec--------CCEecCCC
Confidence 1356899999999999983 26798874
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.31 E-value=8.4e-12 Score=127.16 Aligned_cols=110 Identities=14% Similarity=0.212 Sum_probs=84.0
Q ss_pred ccccccCCCCc----cccCCCCeeEcCCCeEEEEEEe-----CCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEE
Q 038002 25 QLKSTISLGSS----LSPSGQHSWNSSSGLFQFGFYK-----QGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLAL 95 (702)
Q Consensus 25 ~~~~~l~~g~~----l~~~~~~~~~s~~g~f~lgF~~-----~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~ 95 (702)
.++|||.||+. |..+ +.|+|+ .+++-|+|. .++ +++ |.+ ..+++|.+++..+ +. ..|.|
T Consensus 134 ~ptdtlLpg~~~~~~l~~g--~~L~S~-~dps~G~fsl~l~~dGn-lvL---y~~--~~~~yW~Sgt~~~--~~-~~l~l 201 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPG--SELVQG-VVYGAGASKLVFQGDGN-LVA---YGP--NGAATWNAGTQGK--GA-VRAVF 201 (276)
T ss_dssp CTTSCCCCSCTTCEEECSS--EEECTT-CEEEETTEEEEECTTSC-EEE---ECT--TSSEEEECCCTTT--TC-CEEEE
T ss_pred ccccccccccccccccccC--cccccC-CCCCCceEEEeecCCce-EEE---EeC--CCeEEEECCCCCC--cc-EEEEE
Confidence 57899999999 7655 567654 355555544 443 333 332 3589999998865 33 78999
Q ss_pred ccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCC
Q 038002 96 TMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149 (702)
Q Consensus 96 ~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~ 149 (702)
+.+|+|+++|.++..+|.+.+.. ....+|+|++|||||||+. .++||||||
T Consensus 202 ~~dGnLvl~d~~~~~vWsS~t~~-~~~~rl~Ld~dGnLvly~~--~~~Wqsf~~ 252 (276)
T 3m7h_A 202 QGDGNLVVYGAGNAVLWHSHTGG-HASAVLRLQANGSIAILDE--KPVWARFGF 252 (276)
T ss_dssp CTTSCEEEECTTSCEEEECSCTT-CTTCEEEECTTSCEEEEEE--EEEEESSSC
T ss_pred cCCCeEEEEeCCCcEEEEecCCC-CCCEEEEEcCCccEEEEcC--CCeEEccCc
Confidence 99999999998888999988753 3458999999999999976 689999997
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=108.08 Aligned_cols=87 Identities=16% Similarity=0.279 Sum_probs=70.0
Q ss_pred CCCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEE
Q 038002 88 PSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLL 167 (702)
Q Consensus 88 ~~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~ 167 (702)
+....|.|+.||||||+++ +|++++........++|+++|||||++.++.++|+|= |
T Consensus 20 ~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~~~vWss~-----t-------------- 76 (109)
T 3r0e_A 20 NGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDGSTVWKSG-----A-------------- 76 (109)
T ss_dssp ETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTSCEEEECC-----C--------------
T ss_pred CCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCCCEEEcCC-----C--------------
Confidence 4567899999999999974 7999875434467899999999999998888999871 1
Q ss_pred eeccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 168 SSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 168 S~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
....+.|.+.|+++|++++|. .+.|+++++
T Consensus 77 ------~~~~~~~~~~L~~dGNlvly~--------~~~W~s~t~ 106 (109)
T 3r0e_A 77 ------QSVKGNYAAVVHPDGRLVVFG--------PSVFKIDPW 106 (109)
T ss_dssp ------CCSSSCCEEEEETTTEEEEEC--------SEEEEECTT
T ss_pred ------cCCCcCEEEEEcCCCeEEEEe--------cCEECCCCc
Confidence 012467899999999999983 467999887
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=6.8e-12 Score=127.56 Aligned_cols=72 Identities=28% Similarity=0.337 Sum_probs=60.3
Q ss_pred eeEEEEecCCC-C----CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhh-hcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 483 KKLLVYEFMSK-G----SLADLLFNLETRPLWRDRVRIALDVARGLLYLH-DECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 483 ~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
..+|||||+.+ | +|.++... .++.++..++.|++.+|+||| +. +|+||||||+|||++. .++|+|
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp~NILl~~--~~~liD 212 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSEYNIMYID--KVYFID 212 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCSTTSEEESS--SEEECC
T ss_pred CCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEEcC--cEEEEE
Confidence 45899999942 3 77776543 234567889999999999999 88 9999999999999988 999999
Q ss_pred ccceeec
Q 038002 557 FGLAKLL 563 (702)
Q Consensus 557 fg~a~~~ 563 (702)
||++...
T Consensus 213 FG~a~~~ 219 (258)
T 1zth_A 213 MGQAVTL 219 (258)
T ss_dssp CTTCEET
T ss_pred CcccccC
Confidence 9999764
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.20 E-value=6.8e-11 Score=101.99 Aligned_cols=78 Identities=26% Similarity=0.498 Sum_probs=63.9
Q ss_pred CceEEEccCCcEEEEcCCCCeeeeecccc-CCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 90 NATLALTMDGKLILKTEESKEKPIADLVF-DEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 90 ~~~l~~~~~g~L~l~~~~~~~~w~~~~~~-~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
.-+|.|+.||||||++. +++||++++.. ....+.+.|+++|||||++.++.+||+|=.
T Consensus 20 ~y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~~~vWss~t-------------------- 78 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSGRSLWASHS-------------------- 78 (105)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECTTCCEEEECCC--------------------
T ss_pred CEEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECCCcEEEEEecC--------------------
Confidence 35799999999999974 57899998753 234578999999999999999999999711
Q ss_pred eccCCCCcccceEeeeccCCceeee
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLY 193 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~ 193 (702)
....|.|.+.|+.+|++++|
T Consensus 79 -----~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 -----TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp -----CCCSSCEEEEECTTSCEEEE
T ss_pred -----CCCCCCEEEEEeCCCeEEEE
Confidence 11346789999999999998
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.19 E-value=6.3e-11 Score=118.47 Aligned_cols=88 Identities=22% Similarity=0.357 Sum_probs=71.0
Q ss_pred CCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 89 ~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
....|.|+.||||+|++. +++||.+++... ..+.++|+++|||||++.++.+||+|+++.
T Consensus 26 g~f~l~f~~~gnl~ly~~-~~~vW~an~~~~-~~~~l~l~~dGnLvl~d~~~~~vW~s~~~~------------------ 85 (236)
T 1dlp_A 26 SSFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRAVLQSDGLLVILTAQNTIRWSSGTKG------------------ 85 (236)
T ss_dssp TTEEEEECTTSCEEEEES-SSEEECCCCCSC-SCCBCCBCSSSCBCCBCTTTCCSCCCCCCC------------------
T ss_pred CCEEEEECCCCcEEEEEC-CEEEEECCCCCC-CCeEEEEcCCCcEEEEcCCCcEEEeCCccc------------------
Confidence 346788899999999985 689999887433 567899999999999999899999998751
Q ss_pred eccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
+.|.|.+.|+.+|+++++. ..||++...
T Consensus 86 -------~~~~~~~~l~d~Gnlvl~~--------~~~W~S~~~ 113 (236)
T 1dlp_A 86 -------SIGNYVLVLQPDRTVTIYG--------PGLWDSGTS 113 (236)
T ss_dssp -------CSSCCEEEECSSSCEEEEC--------SEEEECSCC
T ss_pred -------cCCcEEEEEeCCCCEEEec--------CCEEECCCC
Confidence 2467899999999999872 157887654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.09 E-value=3.3e-11 Score=128.06 Aligned_cols=110 Identities=16% Similarity=0.086 Sum_probs=81.5
Q ss_pred ccccceEEEeEE--EEEeeeeh-hhhHhheeeEE-----------EEEec------------------------------
Q 038002 445 VNDKRKLLTVLA--GCLGSITF-LCFLIAISSLL-----------VYKHR------------------------------ 480 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~-~~~avki~~l~-----------~~~~~------------------------------ 480 (702)
+...+.||+|.+ ||++.... ..|||||.+.. .+...
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 445578899987 88887654 78888864421 00000
Q ss_pred ------CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC----
Q 038002 481 ------SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW---- 550 (702)
Q Consensus 481 ------~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~---- 550 (702)
....+|||||++|++|.++... .+...++.||+.+|.+||++ |||||||||.|||+++++
T Consensus 177 vp~p~~~~~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 177 VPEPIAQSRHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CCCEEEEETTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSC
T ss_pred CCeeeeccCceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccc
Confidence 1122699999999988765421 23456889999999999999 999999999999998776
Q ss_pred ------cEEEecccceeecC
Q 038002 551 ------RAKISDFGLAKLLM 564 (702)
Q Consensus 551 ------~~kl~Dfg~a~~~~ 564 (702)
.+.|+||+-+....
T Consensus 247 ~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp TTSEEEEEEECCCTTCEETT
T ss_pred ccccccceEEEEeCCcccCC
Confidence 38999999887643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.1e-06 Score=88.71 Aligned_cols=87 Identities=15% Similarity=0.117 Sum_probs=68.2
Q ss_pred heeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC-------------------
Q 038002 470 AISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC------------------- 530 (702)
Q Consensus 470 ki~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~------------------- 530 (702)
.+.+++.+..+++..|+||||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 71 ~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~ 144 (263)
T 3tm0_A 71 PVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDY 144 (263)
T ss_dssp CCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHH
T ss_pred CCCeEEEEEecCCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHH
Confidence 356777778888999999999999999887421 1223467889999999999810
Q ss_pred -------------------------------------CCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 531 -------------------------------------EVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 531 -------------------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
...++|+|++|.||+++++..+.|+||+.+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 145 LLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13699999999999998766667999987653
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.10 E-value=4.5e-06 Score=83.81 Aligned_cols=83 Identities=16% Similarity=0.147 Sum_probs=62.8
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC--------------------
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-------------------- 530 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------------------- 530 (702)
+.+++.+...++..++||||++|.+|. ... .+ ...++.++++.|+.||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~ 147 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTR 147 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHH
Confidence 466777777788899999999998884 211 11 2356778888888888742
Q ss_pred -----------------------------------CCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 531 -----------------------------------EVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 531 -----------------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 148 MEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.2e-06 Score=90.73 Aligned_cols=128 Identities=22% Similarity=0.199 Sum_probs=84.6
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC--------------------------------
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-------------------------------- 530 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------------------------------- 530 (702)
..|+|||+++|.+|.+.... .++..++..++.++++.|+.||+..
T Consensus 90 ~~~~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp CSCEEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred cceEEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 45899999999888764331 4677778888888888888888610
Q ss_pred -----------------------CCCeEecCCCCCcEEEeC--CCcEEEecccceeecCCCCCce--ee-----------
Q 038002 531 -----------------------EVQIIHCDIKLRNILIDD--SWRAKISDFGLAKLLMPNQTGI--VA----------- 572 (702)
Q Consensus 531 -----------------------~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~--~~----------- 572 (702)
...++|+|++|.||++++ ...+.|+||+.+..-.....-. ..
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence 136899999999999998 5568899999887542211000 00
Q ss_pred ceeccccccC-cccccCCCCCccccccchhHhHHHhhhCCcCCc
Q 038002 573 GVRGSRGYMA-PEWQNSGLITVKSDVYSFGVVLLEIICCRSNFE 615 (702)
Q Consensus 573 ~~~gt~~y~a-PE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 615 (702)
......+... |+.... .....+.|+++.++|.+.+|..+|.
T Consensus 247 ~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0000001111 221111 1123689999999999999998873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.02 E-value=9.4e-06 Score=86.10 Aligned_cols=89 Identities=19% Similarity=0.248 Sum_probs=70.3
Q ss_pred eeeEEEEEecC---CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----------------
Q 038002 471 ISSLLVYKHRS---SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC----------------- 530 (702)
Q Consensus 471 i~~l~~~~~~~---~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~----------------- 530 (702)
+.+++.+..+. +..|+||||++|..+.+.. ...++..++..++.++++.|+.||+..
T Consensus 100 vP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3dxp_A 100 VAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQ 176 (359)
T ss_dssp CCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHH
T ss_pred CCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchH
Confidence 56777777665 5589999999998875422 124678888899999999999999731
Q ss_pred --------------------------------------CCCeEecCCCCCcEEEeCCCc--EEEecccceee
Q 038002 531 --------------------------------------EVQIIHCDIKLRNILIDDSWR--AKISDFGLAKL 562 (702)
Q Consensus 531 --------------------------------------~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~a~~ 562 (702)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 177 RQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999987753 68999998875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00075 Score=64.83 Aligned_cols=103 Identities=11% Similarity=-0.007 Sum_probs=69.5
Q ss_pred CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeec
Q 038002 494 GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573 (702)
Q Consensus 494 gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 573 (702)
-||.++|...+..+++++++.++.|.+.+|.-+-.+. .-..+=+.|..|++..+|.+...+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 4899999988889999999999999999988762210 111333567999999999888764 1110
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhhCCcC
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSN 613 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~P 613 (702)
.....+.|||... ...+.+.-|||||+++|..+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123567888653 3456889999999999999854443
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0004 Score=70.03 Aligned_cols=87 Identities=16% Similarity=0.155 Sum_probs=65.9
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC--------------------
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-------------------- 530 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------------------- 530 (702)
|.+++.+.++++..++|||+++|.++.+..... ..+...+..++++.|+.||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~ 156 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSR 156 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHH
Confidence 577788888899999999999999888765432 1233456667777777777521
Q ss_pred -----------------------------------CCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 531 -----------------------------------EVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 531 -----------------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
...++|+|+.+.||++++++.+-|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 157 MNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11489999999999999887778999997764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0019 Score=66.50 Aligned_cols=89 Identities=19% Similarity=0.159 Sum_probs=60.7
Q ss_pred eeeEEEEE-ecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhc--------------------
Q 038002 471 ISSLLVYK-HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDE-------------------- 529 (702)
Q Consensus 471 i~~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-------------------- 529 (702)
|.+.+.+. ...+..++|||+++|.+|.+.... .++..+...++.++.+.|+.||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~ 150 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKIL 150 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHH
Confidence 44555444 356678999999999888764221 234555555666666666655542
Q ss_pred -------------------------------------CCCCeEecCCCCCcEEEeC---CCc-EEEecccceee
Q 038002 530 -------------------------------------CEVQIIHCDIKLRNILIDD---SWR-AKISDFGLAKL 562 (702)
Q Consensus 530 -------------------------------------~~~~ivH~dlkp~NIll~~---~~~-~kl~Dfg~a~~ 562 (702)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 151 LLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1225799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0023 Score=67.35 Aligned_cols=31 Identities=19% Similarity=0.322 Sum_probs=26.5
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++|+|++|.||+++++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4899999999999999654578999998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=93.03 E-value=0.1 Score=53.85 Aligned_cols=30 Identities=17% Similarity=0.207 Sum_probs=27.3
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 489999999999999888899999999765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=92.47 E-value=0.24 Score=50.27 Aligned_cols=30 Identities=30% Similarity=0.440 Sum_probs=25.7
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 36999999999999 6667889999988764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=92.21 E-value=0.24 Score=50.82 Aligned_cols=27 Identities=15% Similarity=0.193 Sum_probs=23.8
Q ss_pred CCCeEecCCCCCcEEEeCCCcEEEeccc
Q 038002 531 EVQIIHCDIKLRNILIDDSWRAKISDFG 558 (702)
Q Consensus 531 ~~~ivH~dlkp~NIll~~~~~~kl~Dfg 558 (702)
...++|+|+.+.|++++.++ +.|+|+.
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 45899999999999999887 8899973
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=91.58 E-value=0.32 Score=51.52 Aligned_cols=29 Identities=24% Similarity=0.374 Sum_probs=25.5
Q ss_pred CeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.++|||+.|.||+++.+ .++|+||..+..
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 89999999999999876 489999987764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=90.57 E-value=0.24 Score=53.05 Aligned_cols=76 Identities=9% Similarity=0.031 Sum_probs=46.0
Q ss_pred CeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeecee--ccccccCcccccCC---CCCccccccchhHhHHHh
Q 038002 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR--GSRGYMAPEWQNSG---LITVKSDVYSFGVVLLEI 607 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~---~~~~~~DiwSlGvil~el 607 (702)
.++|||++|.||+++.++ ++|+||+.+..-..... ..... -...|.+|+..... ......++.+....+|+.
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 899999999999998876 99999998875321110 01111 01345666544311 111234455777777777
Q ss_pred hhCC
Q 038002 608 ICCR 611 (702)
Q Consensus 608 ltG~ 611 (702)
..+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.53 E-value=0.39 Score=49.09 Aligned_cols=30 Identities=23% Similarity=0.283 Sum_probs=26.1
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.+++|+|+++.||+++++..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 389999999999999987666899998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=86.45 E-value=0.75 Score=47.25 Aligned_cols=31 Identities=32% Similarity=0.395 Sum_probs=27.4
Q ss_pred CCeEecCCCCCcEEEeCC----CcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILIDDS----WRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~----~~~kl~Dfg~a~~ 562 (702)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 389999999999999874 6899999998875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=84.77 E-value=0.33 Score=51.69 Aligned_cols=30 Identities=23% Similarity=0.360 Sum_probs=25.1
Q ss_pred CeEecCCCCCcEEE------eCCCcEEEecccceee
Q 038002 533 QIIHCDIKLRNILI------DDSWRAKISDFGLAKL 562 (702)
Q Consensus 533 ~ivH~dlkp~NIll------~~~~~~kl~Dfg~a~~ 562 (702)
.++|+|+.+.||++ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4466799999988764
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.75 E-value=2.5 Score=40.48 Aligned_cols=74 Identities=11% Similarity=0.101 Sum_probs=57.0
Q ss_pred EEecCCeeEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-hhhhcCCCCeEecCCCCCcEEEeCCCcEEE
Q 038002 477 YKHRSSKKLLVYEFMSK-GSLADLLFNLETRPLWRDRVRIALDVARGLL-YLHDECEVQIIHCDIKLRNILIDDSWRAKI 554 (702)
Q Consensus 477 ~~~~~~~~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~-~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 554 (702)
...+++.+.+.++.-++ -++..+ + ..+..++++++.+|+.... +++.+ +|--|+|+||+++.++.++|
T Consensus 56 I~~~eD~~~i~y~~~~~~~~f~~i-~----~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f~~~~~p~i 125 (219)
T 4ano_A 56 IDVSEDEVKVVIKPPSSFLTFAAI-R----KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMFNRALEPFF 125 (219)
T ss_dssp EEECSSEEEEEEECCTTCEEHHHH-H----TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEECTTCCEEE
T ss_pred EEEeCCEEEEEEEcCcccCcHHHH-H----hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEEeCCCcEEE
Confidence 34667888887877644 344433 2 5778999999999998888 67654 78899999999999999999
Q ss_pred ecccce
Q 038002 555 SDFGLA 560 (702)
Q Consensus 555 ~Dfg~a 560 (702)
.-.|+-
T Consensus 126 ~hRGi~ 131 (219)
T 4ano_A 126 LHVGVK 131 (219)
T ss_dssp SCCEET
T ss_pred EEcCCc
Confidence 876653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=83.66 E-value=0.92 Score=46.34 Aligned_cols=29 Identities=28% Similarity=0.245 Sum_probs=25.2
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3799999999999998 4 899999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=81.45 E-value=1.3 Score=45.79 Aligned_cols=31 Identities=26% Similarity=0.347 Sum_probs=27.6
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4899999999999999888899999987654
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=80.11 E-value=0.82 Score=36.34 Aligned_cols=31 Identities=19% Similarity=0.383 Sum_probs=26.7
Q ss_pred CCHHhhhhhccCCceeeEEEec--CCceeeccc
Q 038002 375 VSKKDCSKSCLNDCYFGAAFYS--DGACSKHKF 405 (702)
Q Consensus 375 ~s~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 405 (702)
.++++|+..|+.+=.|.||.|+ ...|+.+..
T Consensus 30 ~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 30 SSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp SSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred CCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 4899999999999999999994 567988653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 702 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-37 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-36 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-36 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-36 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-35 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-35 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-34 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-33 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-33 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-32 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-31 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-31 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-29 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-28 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-26 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-26 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-24 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-23 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-22 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-21 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-19 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-19 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-19 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-18 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-18 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-17 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-17 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-17 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 5e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 1e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 8e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 6e-05 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-13 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-12 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-07 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-12 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 8e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-11 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 1e-10 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 7e-06 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-10 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-44
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+V ++ SL L +ET+ + IA A+G+ YLH + IIH D+K NI
Sbjct: 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNI 135
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEW---QNSGLITVKSDVYSF 600
+ + KI DFGLA + + GS +MAPE Q+ + +SDVY+F
Sbjct: 136 FLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAF 195
Query: 601 GVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGL 660
G+VL E++ + + N++ D+++ V +++ + +K+ + M +
Sbjct: 196 GIVLYELMTGQLPYS-NINNRDQIIF--MVGRGYLSPDLSKVRSN-----CPKAMKRLMA 247
Query: 661 LCIQDEPNLRPSMKNVILMLE 681
C++ + + RP ++ +E
Sbjct: 248 ECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-39
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
++ E+M GSL D L L + +A +A G+ ++ + IH D++ N
Sbjct: 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAAN 139
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+ D+ KI+DFGLA+L+ N+ G + + APE N G T+KSDV+SFG++
Sbjct: 140 ILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGIL 199
Query: 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCI 663
L EI+ ++ + V + E + + LC
Sbjct: 200 LTEIVTHGRIPYPGMTNPE------------VIQNLERGYRMVRPDNCPEELYQLMRLCW 247
Query: 664 QDEPNLRPSMKNVILMLE 681
++ P RP+ + +LE
Sbjct: 248 KERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 50/215 (23%), Positives = 91/215 (42%), Gaps = 15/215 (6%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ L + LV+EFM G L+D L + + LDV G+ YL + C
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+IH D+ RN L+ ++ K+SDFG+ + ++ +Q G + + +PE +
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
+ KSDV+SFGV++ E+ N S ++ V + + ++
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------------VVEDISTGFRLYKPRL 226
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
+ + C ++ P RP+ ++ L E
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-37
Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 18/213 (8%)
Query: 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQII 535
+ L+V +M G L + + N P +D + L VA+G+ + +
Sbjct: 96 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLASKKFV 152
Query: 536 HCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV---AGVRGSRGYMAPEWQNSGLIT 592
H D+ RN ++D+ + K++DFGLA+ + + V G + +MA E + T
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652
KSDV+SFGV+L E++ + +V+T D + + G +
Sbjct: 213 TKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGR-----RLLQPEYCP 260
Query: 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
+ + + L C + +RPS ++ +
Sbjct: 261 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-36
Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 16/198 (8%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
+V E+MSKGSL D L + L V +A +A G+ Y+ +H D++ N
Sbjct: 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAAN 143
Query: 544 ILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
IL+ ++ K++DFGLA+L+ N+ G + + APE G T+KSDV+SFG++
Sbjct: 144 ILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGIL 203
Query: 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCI 663
L E+ + + V + + E + C
Sbjct: 204 LTELTTKGRVPYPGMVNRE------------VLDQVERGYRMPCPPECPESLHDLMCQCW 251
Query: 664 QDEPNLRPSMKNVILMLE 681
+ EP RP+ + + LE
Sbjct: 252 RKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (344), Expect = 2e-36
Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 19/221 (8%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ L +S+ +++ EFM GSL L + + V + +A G+ YL D
Sbjct: 89 VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN 148
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI----VAGVRGSRGYMAPEWQ 586
+H D+ RNIL++ + K+SDFGL++ L + + G + + APE
Sbjct: 149 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 587 NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646
T SDV+S+G+V+ E++ +++ D V N +
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-------VINAIEQDYRLPPPMDC 258
Query: 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687
+ + L C Q + N RP ++ L+ + P
Sbjct: 259 P-----SALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 5e-36
Identities = 40/211 (18%), Positives = 87/211 (41%), Gaps = 15/211 (7%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ L + ++ E+M+ G L + L + R + + + DV + YL +
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+H D+ RN L++D K+SDFGL++ ++ ++ G + + PE
Sbjct: 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
+ KSD+++FGV++ EI + ++ A + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------------TAEHIAQGLRLYRPHL 225
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
E++ C ++ + RP+ K ++ +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-36
Identities = 52/207 (25%), Positives = 80/207 (38%), Gaps = 20/207 (9%)
Query: 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQI 534
V +V E+M+KGSL D L + L ++ +LDV + YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 124
Query: 535 IHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVK 594
+H D+ RN+L+ + AK+SDFGL K Q + + APE + K
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTK 180
Query: 595 SDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLER 654
SDV+SFG++L EI + D V G + +
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY-----KMDAPDGCPPA 228
Query: 655 MVKTGLLCIQDEPNLRPSMKNVILMLE 681
+ + C + +RPS + LE
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 6e-36
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 6/164 (3%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I + + + E M GSL +L R + ++++ V +GL YL ++
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+I+H D+K NIL++ K+ DFG++ L+ + G +R YM+PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG---TRSYMSPERLQGTH 179
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF 634
+V+SD++S G+ L+E+ R + E++ V
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 223
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 48/218 (22%), Positives = 76/218 (34%), Gaps = 24/218 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ-----IIHCDIK 540
LV ++ GSL D L +++AL A GL +LH E I H D+K
Sbjct: 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLK 135
Query: 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGIVA---GVRGSRGYMAPEW------QNSGLI 591
+NIL+ + I+D GLA I G++ YMAPE
Sbjct: 136 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 195
Query: 592 TVKSDVYSFGVVLLEIICCRSNFEVNVSTAD---EVLLSTWVYNCFVAGEFNKLVEEEVD 648
++D+Y+ G+V EI S ++ +++ S + + +
Sbjct: 196 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP 255
Query: 649 KIT-----LERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
L M K C R + + L
Sbjct: 256 NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (338), Expect = 1e-35
Identities = 51/235 (21%), Positives = 86/235 (36%), Gaps = 39/235 (16%)
Query: 475 LVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL-----------------------WRD 511
L L++E+M+ G L + L ++ + +
Sbjct: 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141
Query: 512 RVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571
++ IA VA G+ YL E + +H D+ RN L+ ++ KI+DFGL++ +
Sbjct: 142 QLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 198
Query: 572 AG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWV 630
G +M PE T +SDV+++GVVL EI ++ + V
Sbjct: 199 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE-------V 251
Query: 631 YNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
G E + LC P RPS ++ +L+ E
Sbjct: 252 IYYVRDGNILACPENCP-----LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 2e-35
Identities = 51/194 (26%), Positives = 82/194 (42%), Gaps = 18/194 (9%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+LV E M+ G+L L + + + +GL +LH IIH D+K NI
Sbjct: 88 VLVTELMTSGTLKTYLKRFKVMK-IKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNI 145
Query: 545 LIDD-SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
I + KI D GLA L + V G+ +MAPE DVY+FG+
Sbjct: 146 FITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPE-MYEEKYDESVDVYAFGMC 201
Query: 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCI 663
+LE+ + + + V + F+K+ EV +I +E CI
Sbjct: 202 MLEMATSEYPYS---ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI-IEG-------CI 250
Query: 664 QDEPNLRPSMKNVI 677
+ + R S+K+++
Sbjct: 251 RQNKDERYSIKDLL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-35
Identities = 44/204 (21%), Positives = 76/204 (37%), Gaps = 17/204 (8%)
Query: 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDI 539
++ +LV E G L L + + V+ G+ YL ++ +H D+
Sbjct: 79 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDL 135
Query: 540 KLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA--GVRGSRGYMAPEWQNSGLITVKSDV 597
RN+L+ + AKISDFGL+K L + + A + + APE N + +SDV
Sbjct: 136 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDV 195
Query: 598 YSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVK 657
+S+GV + E + + + V G+ + E +
Sbjct: 196 WSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMECPPE-----CPPELYA 243
Query: 658 TGLLCIQDEPNLRPSMKNVILMLE 681
C + RP V +
Sbjct: 244 LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-35
Identities = 43/213 (20%), Positives = 83/213 (38%), Gaps = 20/213 (9%)
Query: 471 ISSLLVYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPL---WRDRVRIALDVARGLLYL 526
+ R++ L +V E+ G LA ++ +R+ + L
Sbjct: 66 VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 527 HD--ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE 584
H + ++H D+K N+ +D K+ DFGLA++L + + G+ YM+PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPE 184
Query: 585 WQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644
N KSD++S G +L E+ F + G+F ++
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIPY 236
Query: 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
D+ L ++ + + RPS++ ++
Sbjct: 237 RYSDE--LNEIIT---RMLNLKDYHRPSVEEIL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 131 bits (330), Expect = 1e-34
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 16/212 (7%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDE 529
+ LL R ++ EFM+ G+L D L + + + +A ++ + YL +
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSG 589
IH D+ RN L+ ++ K++DFGL++L+ + AG + + APE
Sbjct: 135 N---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN 191
Query: 590 LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649
++KSDV++FGV+L EI + + + VY E +
Sbjct: 192 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKD-----YRMERPE 239
Query: 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
E++ + C Q P+ RPS + E
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-34
Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 17/211 (8%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
+ +++ E+M G+L L + V + +A G+ YL + +H D
Sbjct: 79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRD 135
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQTGI--VAGVRGSRGYMAPEWQNSGLITVKSD 596
+ RNIL++ + K+SDFGL+++L + +G + + APE + T SD
Sbjct: 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASD 195
Query: 597 VYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMV 656
V+SFG+V+ E++ +S + V N +
Sbjct: 196 VWSFGIVMWEVMTYGERPYWELSNHE------------VMKAINDGFRLPTPMDCPSAIY 243
Query: 657 KTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687
+ + C Q E RP +++ +L+ + P
Sbjct: 244 QLMMQCWQQERARRPKFADIVSILDKLIRAP 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-33
Identities = 50/201 (24%), Positives = 75/201 (37%), Gaps = 18/201 (8%)
Query: 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542
+LV E G L L ++ + + V+ G+ YL + +H D+ R
Sbjct: 81 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAAR 136
Query: 543 NILIDDSWRAKISDFGLAKLLMPNQTGIVA--GVRGSRGYMAPEWQNSGLITVKSDVYSF 600
N+L+ AKISDFGL+K L ++ A + + APE N + KSDV+SF
Sbjct: 137 NVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSF 196
Query: 601 GVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGL 660
GV++ E + ++ V GE M
Sbjct: 197 GVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGCPAG-----CPREMYDLMN 244
Query: 661 LCIQDEPNLRPSMKNVILMLE 681
LC + RP V L L
Sbjct: 245 LCWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 3e-33
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 32/230 (13%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL---------------WRDRVRI 515
I +LL L E+ G+L D L + +
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 516 ALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR 575
A DVARG+ YL + Q IH D+ RNIL+ +++ AKI+DFGL++ + R
Sbjct: 133 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GR 187
Query: 576 GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFV 635
+MA E N + T SDV+S+GV+L EI+ ++ A+ +Y
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYEKLP 240
Query: 636 AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
G E + + C +++P RPS +++ L +E
Sbjct: 241 QGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 3e-33
Identities = 45/208 (21%), Positives = 83/208 (39%), Gaps = 17/208 (8%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ ++ + + L E+ S G L D + + D R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEW-QNS 588
I H DIK N+L+D+ KISDFGLA + N + + G+ Y+APE +
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
DV+S G+VL ++ ++ + S W + K+ +
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWD--QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNV 676
+ + + P+ R ++ ++
Sbjct: 239 LLH---------KILVENPSARITIPDI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 5e-33
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 32/233 (13%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL-----------------WRDRV 513
I +LL L++ E+ G L + L + D +
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 514 RIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG 573
+ VA+G+ +L + IH D+ RNIL+ KI DFGLA+ + + +V G
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 574 -VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYN 632
R +MAPE + + T +SDV+S+G+ L E+ S+ + +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK------ 259
Query: 633 CFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
+ F L E M C +P RP+ K ++ ++E +
Sbjct: 260 -MIKEGFRMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 5e-33
Identities = 50/212 (23%), Positives = 90/212 (42%), Gaps = 24/212 (11%)
Query: 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIK 540
+S L+ + M G L D + + + + + +A+G+ YL D +++H D+
Sbjct: 82 TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLA 138
Query: 541 LRNILIDDSWRAKISDFGLAKLLMPNQTGIVA-GVRGSRGYMAPEWQNSGLITVKSDVYS 599
RN+L+ KI+DFGLAKLL + A G + +MA E + T +SDV+S
Sbjct: 139 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198
Query: 600 FGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE----EVDKITLERM 655
+GV + E++ S Y+ A E + ++E+ I +
Sbjct: 199 YGVTVWELMTFGSKP----------------YDGIPASEISSILEKGERLPQPPICTIDV 242
Query: 656 VKTGLLCIQDEPNLRPSMKNVILMLEGTMEIP 687
+ C + + RP + +I+ P
Sbjct: 243 YMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-32
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 37/234 (15%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL---------------------- 508
I +LL S L++E+ G L + L + +
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162
Query: 509 WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568
+ D + A VA+G+ +L + +H D+ RN+L+ KI DFGLA+ +M +
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219
Query: 569 GIVAG-VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLS 627
+V G R +MAPE G+ T+KSDV+S+G++L EI N +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYK- 278
Query: 628 TWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
+ + EE+ I C + RPS N+ L
Sbjct: 279 --LIQNGFKMDQPFYATEEIYII--------MQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-32
Identities = 45/209 (21%), Positives = 86/209 (41%), Gaps = 25/209 (11%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I L Y H +++ L+ E+ G++ L ++ + ++A L Y H +
Sbjct: 68 ILRLYGYFHDATRVYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSK- 125
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
++IH DIK N+L+ + KI+DFG + ++ + G+ Y+ PE +
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC---GTLDYLPPEMIEGRM 180
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVN--VSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
K D++S GV+ E + + FE N T + + + FV L+
Sbjct: 181 HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR--- 237
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVI 677
++ P+ RP ++ V+
Sbjct: 238 -------------LLKHNPSQRPMLREVL 253
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 124 bits (313), Expect = 4e-32
Identities = 44/210 (20%), Positives = 76/210 (36%), Gaps = 24/210 (11%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
R LV E+ + L + + + + +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQ-EVEIAAVTHGALQGLAYLHSH- 134
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW---QN 587
+IH D+K NIL+ + K+ DFG A ++ P + G+ +MAPE +
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMD 187
Query: 588 SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647
G K DV+S G+ +E+ + + L N A + E
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYHIAQNESPALQSGHWSEYFR 244
Query: 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
+ + C+Q P RP+ + ++
Sbjct: 245 NFV---------DSCLQKIPQDRPTSEVLL 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 6e-32
Identities = 40/212 (18%), Positives = 74/212 (34%), Gaps = 20/212 (9%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I LL + + ++ EF + G++ ++ LE + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH--- 127
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW----- 585
+ +IIH D+K NIL K++DFG++ G+ +MAPE
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCET 186
Query: 586 QNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645
K+DV+S G+ L+E+ +L +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPPHH---ELNPMRVLLKIAKSEPPTLAQPSRWSS 243
Query: 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
L++ C++ + R + ++
Sbjct: 244 NFKDF-LKK-------CLEKNVDARWTTSQLL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-31
Identities = 46/198 (23%), Positives = 74/198 (37%), Gaps = 16/198 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E GSL D L + L R A+ VA G+ YL + IH D+ RN+L
Sbjct: 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLL 143
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVA--GVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
+ KI DFGL + L N V + + APE + + SD + FGV
Sbjct: 144 LATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVT 203
Query: 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCI 663
L E+ + ++ + + + E+ + + + C
Sbjct: 204 LWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGERLPRPEDCP----QDIYNVMVQCW 252
Query: 664 QDEPNLRPSMKNVILMLE 681
+P RP+ + L
Sbjct: 253 AHKPEDRPTFVALRDFLL 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-31
Identities = 44/201 (21%), Positives = 73/201 (36%), Gaps = 15/201 (7%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
++ E + G L L + + A ++ L YL + +H DI RN+
Sbjct: 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNV 139
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVL 604
L+ + K+ DFGL++ + + + + +MAPE N T SDV+ FGV +
Sbjct: 140 LVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCM 199
Query: 605 LEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQ 664
EI+ V D V GE + + C
Sbjct: 200 WEILMHGVKPFQGVKNND-------VIGRIENGERLPMPPN-----CPPTLYSLMTKCWA 247
Query: 665 DEPNLRPSMKNVILMLEGTME 685
+P+ RP + L +E
Sbjct: 248 YDPSRRPRFTELKAQLSTILE 268
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 4e-31
Identities = 52/226 (23%), Positives = 89/226 (39%), Gaps = 30/226 (13%)
Query: 476 VYKHRSSKKLLVYEFMSKGSLADLLFNLETRPL---------------WRDRVRIALDVA 520
+++ EF G+L+ L + + + + VA
Sbjct: 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVA 144
Query: 521 RGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRG 579
+G+ +L + IH D+ RNIL+ + KI DFGLA+ + + + G R
Sbjct: 145 KGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 201
Query: 580 YMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEF 639
+MAPE + T++SDV+SFGV+L EI ++ V +E
Sbjct: 202 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR-----------RL 250
Query: 640 NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
+ T M +T L C EP+ RP+ ++ L ++
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 8e-30
Identities = 48/207 (23%), Positives = 83/207 (40%), Gaps = 17/207 (8%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I + L + +V E+++ GSL D++ ET + + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN- 135
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
Q+IH DIK NIL+ K++DFG + P Q+ V G+ +MAPE
Sbjct: 136 --QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKA 192
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
K D++S G++ +E+I + + L N + + +
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYL---NENPLRALYLIATNGTPELQNPEKLSAIFRDF 249
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVI 677
L R C+ + R S K ++
Sbjct: 250 -LNR-------CLDMDVEKRGSAKELL 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 31/224 (13%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPL---------------WRDRVRIALDVARGL 523
+ ++ E+ SKG+L + L L +D V A VARG+
Sbjct: 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 148
Query: 524 LYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA-GVRGSRGYMA 582
YL + + IH D+ RN+L+ + KI+DFGLA+ + R +MA
Sbjct: 149 EYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMA 205
Query: 583 PEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKL 642
PE + T +SDV+SFGV+L EI + V ++ G
Sbjct: 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------ELFKLLKEGHRMDK 258
Query: 643 VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686
+ C P+ RP+ K ++ L+ + +
Sbjct: 259 PSNCT-----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 25/217 (11%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETR---------PLWRDRVRIALDVARGLLYLHDE 529
+ L++ E M++G L L +L P +++A ++A G+ YL+
Sbjct: 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN 152
Query: 530 CEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEWQNS 588
+ +H D+ RN ++ + + KI DFG+ + + G +M+PE
Sbjct: 153 ---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
G+ T SDV+SFGVVL EI +S V + G +
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGLLDKPDN--- 259
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
+ + + +C Q P +RPS +I ++ ME
Sbjct: 260 --CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 114 bits (287), Expect = 2e-28
Identities = 45/209 (21%), Positives = 87/209 (41%), Gaps = 17/209 (8%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ +L ++ +++YEFMS G L + + + + + V V +GL ++H+
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 531 EVQIIHCDIKLRNILI--DDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS 588
+H D+K NI+ S K+ DFGL L P Q+ V G+ + APE
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEG 199
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
+ +D++S GV+ ++ S F DE L + + + + E+
Sbjct: 200 KPVGYYTDMWSVGVLSYILLSGLSPFGGE--NDDETLRNVKSCDWNMDDSAFSGISEDGK 257
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVI 677
+ + + +PN R ++ +
Sbjct: 258 DF-IRK-------LLLADPNTRMTIHQAL 278
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 109 bits (273), Expect = 1e-26
Identities = 45/194 (23%), Positives = 81/194 (41%), Gaps = 17/194 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
L+ EF+S G L D + + + + + GL ++H+ I+H DIK NI+
Sbjct: 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIM 159
Query: 546 ID--DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
+ + KI DFGLA L P++ V + + APE + + +D+++ GV+
Sbjct: 160 CETKKASSVKIIDFGLATKLNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 217
Query: 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCI 663
++ S F E L T EF++ V + + +
Sbjct: 218 GYVLLSGLSPFA------GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKN----LL 267
Query: 664 QDEPNLRPSMKNVI 677
Q EP R ++ + +
Sbjct: 268 QKEPRKRLTVHDAL 281
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (268), Expect = 2e-26
Identities = 45/198 (22%), Positives = 83/198 (41%), Gaps = 22/198 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV++ M KG L D L T ++ +I + + LH I+H D+K NIL
Sbjct: 87 LVFDLMKKGELFDYLTEKVTLS-EKETRKIMRALLEVICALHKLN---IVHRDLKPENIL 142
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW------QNSGLITVKSDVYS 599
+DD K++DFG + L P + + V G+ Y+APE N + D++S
Sbjct: 143 LDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 200
Query: 600 FGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTG 659
GV++ ++ F ++ + Y F + E++ + D ++
Sbjct: 201 TGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDTVKDLVS-------- 251
Query: 660 LLCIQDEPNLRPSMKNVI 677
+ +P R + + +
Sbjct: 252 -RFLVVQPQKRYTAEEAL 268
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 35/209 (16%), Positives = 69/209 (33%), Gaps = 23/209 (11%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
L K + G L + + + A + L
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC----TRFYTAEIVSALEYLH 125
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAG-VRGSRGYMAPEWQNSG 589
IIH D+K NIL+++ +I+DFG AK+L P A G+ Y++PE
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 590 LITVKSDVYSFGVVLLEIICCRSNF--EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647
SD+++ G ++ +++ F +++ + + + LVE+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK-- 243
Query: 648 DKITLERMVKTGLLCIQDEPNLRPSMKNV 676
+ + R + +
Sbjct: 244 --------------LLVLDATKRLGCEEM 258
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 8e-26
Identities = 39/199 (19%), Positives = 80/199 (40%), Gaps = 19/199 (9%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPL-WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
L+V E + G L + + + R+ I + + YLH I H D+K N
Sbjct: 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPEN 141
Query: 544 ILIDDSW---RAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSF 600
+L K++DFG AK + + + Y+APE D++S
Sbjct: 142 LLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLGPEKYDKSCDMWSL 199
Query: 601 GVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKIT--LERMVKT 658
GV++ ++C F N + +S + G++ + E +++ ++ +++
Sbjct: 200 GVIMYILLCGYPPFYSN----HGLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRN 254
Query: 659 GLLCIQDEPNLRPSMKNVI 677
++ EP R ++ +
Sbjct: 255 ---LLKTEPTQRMTITEFM 270
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (263), Expect = 3e-25
Identities = 45/204 (22%), Positives = 78/204 (38%), Gaps = 19/204 (9%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I + H K + + M+ G L L D A ++ GL ++H+
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRF 127
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+++ D+K NIL+D+ +ISD GLA + G+ GYMAPE G+
Sbjct: 128 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SVGTHGYMAPEVLQKGV 181
Query: 591 -ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649
+D +S G +L +++ S F + + + + E E+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV---ELPDSFSPELRS 238
Query: 650 ITLERMVKTGLLCIQDEPNLRPSM 673
+ LE +Q + N R
Sbjct: 239 L-LEG-------LLQRDVNRRLGC 254
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 103 bits (258), Expect = 7e-25
Identities = 42/209 (20%), Positives = 83/209 (39%), Gaps = 17/209 (8%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I +L L+ + +S G L D + + RD R+ V + YLHD
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
V L +D+ + ISDFGL+K+ P ++ G+ GY+APE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLAQKP 185
Query: 591 ITVKSDVYSFGVVLLEIICCRSNF--EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
+ D +S GV+ ++C F E + +++L + + ++ + + ++ +
Sbjct: 186 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVI 677
++ +P R + + +
Sbjct: 246 H------------LMEKDPEKRFTCEQAL 262
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-24
Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 19/208 (9%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
++ + V E+++ G L + + A ++ GL +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD-LSRATFYAAEIILGLQFLHSKG 123
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
I++ D+KL NIL+D KI+DFG+ K M G+ Y+APE
Sbjct: 124 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-KTNTFCGTPDYIAPEILLGQK 179
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
D +SFGV+L E++ +S F DE L + + + +E+E +
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFH----GQDEEELFHSIRMDNP--FYPRWLEKEAKDL 233
Query: 651 TLERMVKTGLLCIQDEPNLRPSMKNVIL 678
L + EP R ++ I
Sbjct: 234 -LVK-------LFVREPEKRLGVRGDIR 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 100 bits (251), Expect = 3e-24
Identities = 40/189 (21%), Positives = 79/189 (41%), Gaps = 16/189 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V E++ +L D++ + + + D + L + H IIH D+K NI+
Sbjct: 88 IVMEYVDGVTLRDIVHTEGPMT-PKRAIEVIADACQALNFSHQNG---IIHRDVKPANIM 143
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIV--AGVRGSRGYMAPEWQNSGLITVKSDVYSFGVV 603
I + K+ DFG+A+ + + + A V G+ Y++PE + +SDVYS G V
Sbjct: 144 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 203
Query: 604 LLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCI 663
L E++ F + + V + ++ + ++D + + + +
Sbjct: 204 LYEVLTGEPPFTGD--SPVSVAYQHVREDPIPPSARHEGLSADLDAV-VLK-------AL 253
Query: 664 QDEPNLRPS 672
P R
Sbjct: 254 AKNPENRYQ 262
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 7e-24
Identities = 40/210 (19%), Positives = 81/210 (38%), Gaps = 21/210 (10%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I L + ++++EF+S + + + R+ V V L +LH
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH- 121
Query: 531 EVQIIHCDIKLRNILID--DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNS 588
I H DI+ NI+ S KI +FG A+ L P + + + Y APE
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQH 177
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNF--EVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646
+++ +D++S G ++ ++ + F E N + ++ + + ++ E + +
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNV 676
VD+ + E R +
Sbjct: 238 VDR------------LLVKERKSRMTASEA 255
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 8e-24
Identities = 42/209 (20%), Positives = 72/209 (34%), Gaps = 28/209 (13%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ LL + R +L+ E V + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 531 EVQIIHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW-QNS 588
++H DIK NILID + K+ DFG LL G+R Y PEW +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIRYH 184
Query: 589 GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
+ V+S G++L +++C FE +E++ + V+ E L+
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFE----HDEEIIRGQVFFRQRVSSECQHLIR---- 236
Query: 649 KITLERMVKTGLLCIQDEPNLRPSMKNVI 677
C+ P+ RP+ + +
Sbjct: 237 ------------WCLALRPSDRPTFEEIQ 253
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 4e-23
Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 18/205 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV+E + + L E + + RGL +LH ++H D+K +NIL
Sbjct: 92 LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 148
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+ S + K++DFGLA++ + V + Y APE D++S G +
Sbjct: 149 VTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206
Query: 606 EIICCRSNFEVN-----VSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKT-- 658
E+ + F + + +V+ + + +E+ V
Sbjct: 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 266
Query: 659 ----GLL--CIQDEPNLRPSMKNVI 677
LL C+ P R S + +
Sbjct: 267 ELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 95.7 bits (237), Expect = 3e-22
Identities = 36/222 (16%), Positives = 65/222 (29%), Gaps = 23/222 (10%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I ++ ++V E + SL DL + + + +A + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--- 120
Query: 531 EVQIIHCDIKLRNILI---DDSWRAKISDFGLAKLLMPNQTGIVA------GVRGSRGYM 581
IH D+K N L+ I DFGLAK +T + G+ Y
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 582 APEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNC--FVAGEF 639
+ + + D+ S G VL+ ++ +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 640 NKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681
K E L C + +P + +
Sbjct: 241 CKGYPSEFATY-LNF-------CRSLRFDDKPDYSYLRQLFR 274
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 92.9 bits (230), Expect = 2e-21
Identities = 32/225 (14%), Positives = 64/225 (28%), Gaps = 24/225 (10%)
Query: 474 LLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ 533
+ Y + ++ + SL DLL + + A + + +H E
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKS 121
Query: 534 IIHCDIKLRNILIDD-----SWRAKISDFGLAKLLMPNQTGIVA------GVRGSRGYMA 582
+++ DIK N LI + + DFG+ K T + G+ YM+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 583 PEWQNSGLITVKSDVYSFGVVLLEIICCRSNF--EVNVSTADEVLLSTWVYNCFVAGEFN 640
+ + D+ + G V + + + + + E
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 641 KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685
EE K + P + + +E
Sbjct: 242 AGFPEEFYKYM--------HYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.5 bits (229), Expect = 5e-21
Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I + + + ++ +++ G L LL + P + A +V L YLH +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK-FYAAEVCLALEYLHSKD 124
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
II+ D+K NIL+D + KI+DFG AK + + G+ Y+APE ++
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKP 177
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFE 615
D +SFG+++ E++ + F
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFY 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-20
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 20/223 (8%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I LL H +K LV+EF+ + + + T + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSG 589
++H D+K +N+LI+ K++DFGLA+ V + Y APE
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV-VTLWYRAPEILLGCK 178
Query: 590 LITVKSDVYSFGVVLLEIICCRSNFE------------VNVSTADEVLLSTWVYNCFVAG 637
+ D++S G + E++ R+ F + T DEV+
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 638 EFNKLVEEEVDKI--TLERMVKTGLL-CIQDEPNLRPSMKNVI 677
F K ++ K+ L+ ++ L + +PN R S K +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.9 bits (222), Expect = 3e-20
Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 6/145 (4%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I LL S LV++FM ++ + L +GL YLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSG 589
I+H D+K N+L+D++ K++DFGLAK V +R Y APE +
Sbjct: 121 ---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 590 LITVKSDVYSFGVVLLEIICCRSNF 614
+ V D+++ G +L E++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFL 201
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 1e-19
Identities = 41/211 (19%), Positives = 83/211 (39%), Gaps = 20/211 (9%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ +L + +L+ E ++ G L D L + + + G+ +
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGV---YYLH 130
Query: 531 EVQIIHCDIKLRNILIDD----SWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQ 586
+QI H D+K NI++ D R KI DFGLA + + G+ ++APE
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIV 188
Query: 587 NSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646
N + +++D++S GV+ ++ S F + T V EF
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFL------GDTKQETLANVSAVNYEFEDEYFSN 242
Query: 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVI 677
+ + + + + +P R ++++ +
Sbjct: 243 TSALAKDFIRR----LLVKDPKKRMTIQDSL 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.4 bits (218), Expect = 2e-19
Identities = 46/207 (22%), Positives = 80/207 (38%), Gaps = 10/207 (4%)
Query: 479 HRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCD 538
K + + + L LL + RGL Y+H ++H D
Sbjct: 80 IEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSA---NVLHRD 134
Query: 539 IKLRNILIDDSWRAKISDFGLAKLLMPNQT--GIVAGVRGSRGYMAPE-WQNSGLITVKS 595
+K N+L++ + KI DFGLA++ P+ G + +R Y APE NS T
Sbjct: 135 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 194
Query: 596 DVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERM 655
D++S G +L E++ R F D++ + + N ++ + L
Sbjct: 195 DIWSVGCILAEMLSNRPIFPGK-HYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLP 253
Query: 656 VKTGLLCIQDEPNLRPSMKNVIL-MLE 681
K + + PN +++ ML
Sbjct: 254 HKNKVPWNRLFPNADSKALDLLDKMLT 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.1 bits (215), Expect = 3e-19
Identities = 36/145 (24%), Positives = 60/145 (41%), Gaps = 5/145 (3%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+++L + V E+ + G L L +R R A + L
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEYLH 122
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+++ DIKL N+++D KI+DFGL K + + + G+ Y+APE
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFE 615
D + GVV+ E++C R F
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFY 206
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 4e-19
Identities = 42/211 (19%), Positives = 73/211 (34%), Gaps = 24/211 (11%)
Query: 486 LVYEFMSKGSLADLLFNLETRPL--WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543
LV +++ + + + R L Y+H I H DIK +N
Sbjct: 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQN 152
Query: 544 ILID-DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAP-EWQNSGLITVKSDVYSFG 601
+L+D D+ K+ DFG AK L+ + + SR Y AP + T DV+S G
Sbjct: 153 LLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 602 VVLLEIICCRSNFE-----------VNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
VL E++ + F + V + + +F ++ K+
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270
Query: 651 TLERMVKTGL----LCIQDEPNLRPSMKNVI 677
R + ++ P R +
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 1e-18
Identities = 28/134 (20%), Positives = 51/134 (38%), Gaps = 8/134 (5%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV++F LL N+ + + R+ + GL + +I+H D+K N+L
Sbjct: 94 LVFDFCEHDLA-GLLSNVLVKFTLSEIKRVMQMLLNGL---YYIHRNKILHRDMKAANVL 149
Query: 546 IDDSWRAKISDFGLAKLLMPNQTG---IVAGVRGSRGYMAPEW-QNSGLITVKSDVYSFG 601
I K++DFGLA+ + + Y PE D++ G
Sbjct: 150 ITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 209
Query: 602 VVLLEIICCRSNFE 615
++ E+ +
Sbjct: 210 CIMAEMWTRSPIMQ 223
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 83.8 bits (206), Expect = 2e-18
Identities = 41/223 (18%), Positives = 75/223 (33%), Gaps = 21/223 (9%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
I L H + +LV+E + + L E L + G+ Y HD
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
++H D+K +N+LI+ KI+DFGLA+ + S
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650
+ D++S G + E++ F VS AD+++ + + + + E
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFP-GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 651 TLERMVKTGLL----------------CIQDEPNLRPSMKNVI 677
++ +PN R + K +
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 32/145 (22%), Positives = 57/145 (39%), Gaps = 8/145 (5%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ L +S +V E+++ G + L + A + YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFS-EPHARFYAAQIVLTFEYLHSL- 160
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
+I+ D+K N+LID +++DFG AK + + G+ +APE S
Sbjct: 161 --DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKG 214
Query: 591 ITVKSDVYSFGVVLLEIICCRSNFE 615
D ++ GV++ E+ F
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFF 239
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.8 bits (198), Expect = 2e-17
Identities = 34/216 (15%), Positives = 67/216 (31%), Gaps = 20/216 (9%)
Query: 477 YKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIH 536
H K LV+EF + + +GL + H ++H
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124
Query: 537 CDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSD 596
D+K +N+LI+ + K+++FGLA+ A V + L + D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184
Query: 597 VYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMV 656
++S G + E+ D++ + ++ + + K
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244
Query: 657 KTGLL----------------CIQDEPNLRPSMKNV 676
T L+ ++ P R S +
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 80.3 bits (197), Expect = 6e-17
Identities = 42/216 (19%), Positives = 80/216 (37%), Gaps = 19/216 (8%)
Query: 476 VYKHRSSKKL-LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQI 534
+ K S+ LV+E ++ L L D ++ + L Y H I
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRFYMYEILKALDYCHSMG---I 150
Query: 535 IHCDIKLRNILID-DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPE-WQNSGLIT 592
+H D+K N++ID + + ++ D+GLA+ P Q V SR + PE + +
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV--RVASRYFKGPELLVDYQMYD 208
Query: 593 VKSDVYSFGVVLLEIICCRSNFEVNVSTAD------EVLLSTWVYNCFVAGEFNKLVEEE 646
D++S G +L +I + F D +VL + +Y+
Sbjct: 209 YSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFN 268
Query: 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL-MLE 681
R + +++ + P + + +L
Sbjct: 269 DILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 9e-17
Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 16/205 (7%)
Query: 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC 530
+ +L +K L+ ++++ G L L E + + V +L L
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE----VQIYVGEIVLALEHLH 146
Query: 531 EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGL 590
++ II+ DIKL NIL+D + ++DFGL+K + ++T G+ YMAP+ G
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 591 --ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648
D +S GV++ E++ S F V+ + +S + + + +
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP--PYPQEMSALAK 264
Query: 649 KITLERMVKTGLLCIQDEPNLRPSM 673
+ ++R + +P R
Sbjct: 265 DL-IQR-------LLMKDPKKRLGC 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.8 bits (188), Expect = 9e-16
Identities = 39/130 (30%), Positives = 59/130 (45%), Gaps = 11/130 (8%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV FM G+ L + + + +GL Y+H IIH D+K N+
Sbjct: 100 LVMPFM--GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLA 153
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW-QNSGLITVKSDVYSFGVVL 604
+++ KI DFGLA+ TG V +R Y APE N T D++S G ++
Sbjct: 154 VNEDCELKILDFGLARQADSEMTGYV----VTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209
Query: 605 LEIICCRSNF 614
E+I ++ F
Sbjct: 210 AEMITGKTLF 219
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.9 bits (163), Expect = 5e-14
Identities = 30/149 (20%), Positives = 53/149 (35%), Gaps = 36/149 (24%)
Query: 125 ASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNM 184
+ ++GN +LYS + T+ QSL + L+M
Sbjct: 3 VVVANNGNSILYST------QGNDNHPQTLHATQSL---------------QLSPYRLSM 41
Query: 185 QEDGNIVLYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFR 244
+ D N+VL+ R+ + W+ T + + L PNG + +L+ ++
Sbjct: 42 ETDCNLVLFDRD------DRVWSTNTAGKG---TGCRAVLQPNGRMDVLTNQN--IAVWT 90
Query: 245 SSYSLKSMNETVIYRTTLDSDGILRLYSH 273
S S + Y L D L +Y
Sbjct: 91 SGNSRSAGR----YVFVLQPDRNLAIYGG 115
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 59.9 bits (145), Expect = 1e-11
Identities = 23/142 (16%), Positives = 42/142 (29%), Gaps = 34/142 (23%)
Query: 66 IWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFA 125
I T N T + + S L++ D L+L + + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL-FDRDDRVWSTNTAGKGTGCRA 70
Query: 126 SMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQ 185
+ +G + +N++ +W S + S GR+ +Q
Sbjct: 71 VLQPNGRMDVLTNQNIAVWTSG-------------------------NSRSAGRYVFVLQ 105
Query: 186 EDGNIVLYPRNMLNKALEAYWA 207
D N+ +Y A W
Sbjct: 106 PDRNLAIYGG--------ALWT 119
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 71.2 bits (173), Expect = 7e-14
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 12/162 (7%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
+V+E + + LA + +I+ + GL Y+H C IIH DIK N+L
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVL 158
Query: 546 ID------DSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYS 599
++ + + KI+D G A + T +R Y +PE +D++S
Sbjct: 159 MEIVDSPENLIQIKIADLGNACWYDEHYTN----SIQTREYRSPEVLLGAPWGCGADIWS 214
Query: 600 FGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641
++ E+I FE + + + GE
Sbjct: 215 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.2 bits (161), Expect = 8e-14
Identities = 28/142 (19%), Positives = 49/142 (34%), Gaps = 32/142 (22%)
Query: 132 NFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIV 191
N +++S + + +SLE T + MQ D N+V
Sbjct: 1 NNIIFS------KQPDDNHPQILHATESLE-----------ILFGTHVYRFIMQTDCNLV 43
Query: 192 LYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKS 251
LY N WA T + L P+GVL +++ +++S + K+
Sbjct: 44 LYDNN------NPIWATNTG---GLGNGCRAVLQPDGVLVVITNEN--VTVWQSPVAGKA 92
Query: 252 MNETVIYRTTLDSDGILRLYSH 273
+ Y L D + +Y
Sbjct: 93 GH----YVLVLQPDRNVVIYGD 110
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.8 bits (95), Expect = 6e-05
Identities = 23/140 (16%), Positives = 40/140 (28%), Gaps = 36/140 (25%)
Query: 73 NITVVWTANRDEQPMPSNATLALTM--DGKLILKTEESKEKPIADLVFDEPASFASMLDS 130
N + A + + M D L+L + + + A +
Sbjct: 12 NHPQILHATESLEILFGTHVYRFIMQTDCNLVL-YDNNNPIWATNTGGLGNGCRAVLQPD 70
Query: 131 GNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNI 190
G V+ +N + +W+S G + L +Q D N+
Sbjct: 71 GVLVVITNENVTVWQSP-------------------------VAGKAGHYVLVLQPDRNV 105
Query: 191 VLYPRNMLNKALEAYWANGT 210
V+Y A WA T
Sbjct: 106 VIYGD--------ALWATQT 117
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (170), Expect = 2e-13
Identities = 32/129 (24%), Positives = 52/129 (40%), Gaps = 9/129 (6%)
Query: 486 LVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNIL 545
LV E M + L+ + + G+ +LH IIH D+K NI+
Sbjct: 99 LVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIV 151
Query: 546 IDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLL 605
+ KI DFGLA+ + + +R Y APE D++S G ++
Sbjct: 152 VKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 606 EIICCRSNF 614
E++ + F
Sbjct: 210 EMVRHKILF 218
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 61.9 bits (150), Expect = 2e-12
Identities = 25/145 (17%), Positives = 43/145 (29%), Gaps = 35/145 (24%)
Query: 66 IWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFA 125
I S + T + + S+ + D L+L +S + A A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLF--DSDVRVWASNTAGATGCRA 60
Query: 126 SMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQ 185
+ G V+ + ++ I W S T S G + L +Q
Sbjct: 61 VLQSDGLLVILTAQNTIRWSSG-------------------------TKGSIGNYVLVLQ 95
Query: 186 EDGNIVLYPRNMLNKALEAYWANGT 210
D + +Y W +GT
Sbjct: 96 PDRTVTIYG--------PGLWDSGT 112
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 48.0 bits (114), Expect = 2e-07
Identities = 29/151 (19%), Positives = 47/151 (31%), Gaps = 37/151 (24%)
Query: 132 NFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIV 191
N +L+ + T+ QSLE F MQ D N+V
Sbjct: 1 NNILFGLSHE------GSHPQTLHAAQSLELS---------------SFRFTMQSDCNLV 39
Query: 192 LYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKS 251
L+ + WA+ T + + L +G+L +L+ I + S
Sbjct: 40 LFDSD------VRVWASNTAGAT----GCRAVLQSDGLLVILTAQN--TIRWSSGTK--- 84
Query: 252 MNETVIYRTTLDSDGILRLYSHHFKNDGNST 282
Y L D + +Y + G S
Sbjct: 85 -GSIGNYVLVLQPDRTVTIYGPGLWDSGTSN 114
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 61.1 bits (148), Expect = 3e-12
Identities = 20/122 (16%), Positives = 40/122 (32%), Gaps = 15/122 (12%)
Query: 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQP 86
++ ++ G L + + F + + LV + T VW +N
Sbjct: 1 RNLLTNGEGLYAGQ----SLDVEPYHFIMQEDCN-------LVLYDHSTSVWASNTG-IL 48
Query: 87 MPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146
L DG ++ E + + V + + GN V+Y + IW +
Sbjct: 49 GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD---IWST 105
Query: 147 FS 148
+
Sbjct: 106 GT 107
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 54.6 bits (131), Expect = 8e-10
Identities = 27/122 (22%), Positives = 44/122 (36%), Gaps = 23/122 (18%)
Query: 152 DTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211
+ + G+ L G+ L + MQED N+VLY + + WA+ T
Sbjct: 2 NLLTNGEGLYAGQSL---------DVEPYHFIMQEDCNLVLYDHS------TSVWASNTG 46
Query: 212 IQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLY 271
I + K L +G + RS ++ S+ Y L DG + +Y
Sbjct: 47 ILGKKGC--KAVLQSDGNFVVYDAE------GRSLWASHSVRGNGNYVLVLQEDGNVVIY 98
Query: 272 SH 273
Sbjct: 99 GS 100
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.8 bits (154), Expect = 2e-11
Identities = 33/132 (25%), Positives = 57/132 (43%), Gaps = 10/132 (7%)
Query: 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNI 544
+ + + L +++ + + + RGL Y+H IIH D+K N+
Sbjct: 98 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNL 152
Query: 545 LIDDSWRAKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEW-QNSGLITVKSDVYSFGVV 603
+++ KI DFGLA+ TG +R Y APE N D++S G +
Sbjct: 153 AVNEDCELKILDFGLARHTDDEMTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCI 208
Query: 604 LLEIICCRSNFE 615
+ E++ R+ F
Sbjct: 209 MAELLTGRTLFP 220
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 56.6 bits (136), Expect = 1e-10
Identities = 29/123 (23%), Positives = 51/123 (41%), Gaps = 24/123 (19%)
Query: 152 DTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211
+ + G++L GE L + G F MQED N+VLY + + WA T
Sbjct: 2 NILYSGETLSTGEFL---------NYGSFVFIMQEDCNLVLYDVD------KPIWATNTG 46
Query: 212 IQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLY 271
S + L++ +G L + + + K ++ S+ ++ N Y L D + +Y
Sbjct: 47 GLSRSCF---LSMQTDGNLVVYNPS--NKPIWASNTGGQNGN----YVCILQKDRNVVIY 97
Query: 272 SHH 274
Sbjct: 98 GTD 100
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 43.5 bits (102), Expect = 7e-06
Identities = 19/121 (15%), Positives = 39/121 (32%), Gaps = 16/121 (13%)
Query: 28 STISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPM 87
+ + G +LS + G F F + + LV +W N +
Sbjct: 2 NILYSGETLSTGEFLN----YGSFVFIMQEDCN-------LVLYDVDKPIWATNT--GGL 48
Query: 88 PSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESF 147
+ L++ DG L++ +K ++ + N V+Y W +
Sbjct: 49 SRSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD---RWATG 105
Query: 148 S 148
+
Sbjct: 106 T 106
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 56.7 bits (136), Expect = 2e-10
Identities = 27/123 (21%), Positives = 49/123 (39%), Gaps = 25/123 (20%)
Query: 151 TDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGT 210
+D + G L+ G L G + +Q D N+VLY N A WA+GT
Sbjct: 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN------RAVWASGT 45
Query: 211 DIQSEYPYSVKLNLSPNGVLQLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRL 270
+ ++ L + +G L + SG++ ++ + + Y L D + +
Sbjct: 46 NGKAS---GCVLKMQNDGNLVIYSGSRA-------IWASNTNRQNGNYYLILQRDRNVVI 95
Query: 271 YSH 273
Y +
Sbjct: 96 YDN 98
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 50.6 bits (120), Expect = 2e-08
Identities = 21/124 (16%), Positives = 40/124 (32%), Gaps = 14/124 (11%)
Query: 29 TISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMP 88
++ G L G + G + F + LV N VW +
Sbjct: 3 RLNSGHQLDTGGS----LAEGGYLFIIQNDCN-------LVLYDNNRAVWASGT--NGKA 49
Query: 89 SNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFS 148
S L + DG L++ + ++ + + N V+Y N + IW + +
Sbjct: 50 SGCVLKMQNDGNLVIYSGSRAIW-ASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHT 108
Query: 149 TPTD 152
+
Sbjct: 109 NVGN 112
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.2 bits (119), Expect = 1e-07
Identities = 8/53 (15%), Positives = 19/53 (35%), Gaps = 4/53 (7%)
Query: 509 WRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561
+ + + + + I+H D+ N+L+ + I DF +
Sbjct: 102 VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 702 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.98 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.83 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.81 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.78 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.7 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.63 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.53 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.44 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.34 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.27 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.23 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.2 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.14 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.07 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.02 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 93.17 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 89.03 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 83.51 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 80.19 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=338.92 Aligned_cols=222 Identities=21% Similarity=0.222 Sum_probs=178.9
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+.++..+.||+|+| ||++.... ..|||| |+++++++++++..|||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 456677789999988 88887653 678887 8999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC-
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT- 568 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 568 (702)
|+++|+|.+++.... .+++.++..++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 999999999997654 799999999999999999999999 999999999999999999999999999997644332
Q ss_pred ceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... .. ........ ..
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~--~~-----~~~~~~~~----~~ 228 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SD-----WKEKKTYL----NP 228 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH--HH-----HHTTCTTS----TT
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH--HH-----HhcCCCCC----Cc
Confidence 23445789999999999987765 678999999999999999999997542221111 11 11111100 11
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
....++.+.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1223567788999999999999999999875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-41 Score=340.48 Aligned_cols=225 Identities=23% Similarity=0.278 Sum_probs=172.3
Q ss_pred ccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCCCC
Q 038002 445 VNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSKGS 495 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~gs 495 (702)
++..++||+|+| ||++.... ..|||| |+++++++..++..++||||+++|+
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~ 86 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCc
Confidence 445678999998 99998765 568888 9999999999999999999999999
Q ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeecee
Q 038002 496 LADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR 575 (702)
Q Consensus 496 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 575 (702)
|.+++......+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..............
T Consensus 87 L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 163 (263)
T d1sm2a_ 87 LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 163 (263)
T ss_dssp HHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence 9999988776799999999999999999999999 9999999999999999999999999999877554444444567
Q ss_pred ccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHH
Q 038002 576 GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERM 655 (702)
Q Consensus 576 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 655 (702)
||+.|+|||++.+..++.++|||||||++|||+|+..|+..... . .... .....+. ....+...++++
T Consensus 164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~--~~~~----~~i~~~~-----~~~~p~~~~~~l 231 (263)
T d1sm2a_ 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-N--SEVV----EDISTGF-----RLYKPRLASTHV 231 (263)
T ss_dssp -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-H--HHHH----HHHHHTC-----CCCCCTTSCHHH
T ss_pred cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-H--HHHH----HHHHhcC-----CCCCccccCHHH
Confidence 89999999999999999999999999999999996444432211 1 1111 1111111 111223345678
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 656 VKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 656 ~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+++.+||+.||++|||++||+++|+++.
T Consensus 232 ~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 232 YQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-40 Score=337.09 Aligned_cols=228 Identities=23% Similarity=0.294 Sum_probs=175.9
Q ss_pred cccccceEEEeEE--EEEeeeehhhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 444 KVNDKRKLLTVLA--GCLGSITFLCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
.+...++||+|+| ||+|.... .|||| |++++++. .++..++||||++
T Consensus 9 ~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~-~~~~~~lv~Ey~~ 86 (276)
T d1uwha_ 9 QITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCE 86 (276)
T ss_dssp CCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCC
T ss_pred cEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE-eccEEEEEEecCC
Confidence 3455678999998 99886543 47776 88888876 4567899999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC-cee
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT-GIV 571 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~ 571 (702)
+|+|.+++...+..+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 87 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 87 GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9999999987776899999999999999999999999 999999999999999999999999999987644332 234
Q ss_pred eceeccccccCcccccC---CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 572 AGVRGSRGYMAPEWQNS---GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
....||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... .............+.. ...+
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~p~~-----~~~~ 235 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIFMVGRGYLSPDL-----SKVR 235 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHHTSCCCCG-----GGSC
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCCCcc-----hhcc
Confidence 45679999999998864 35899999999999999999999999754211 1111111111111111 1233
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
...++.+.+++.+||+.||++|||++||+++|+.+.
T Consensus 236 ~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 236 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 345678999999999999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=335.11 Aligned_cols=214 Identities=23% Similarity=0.318 Sum_probs=177.8
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+...+.||+|+| ||++.... ..||+| |+++++++++++..|+|||
T Consensus 7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4555678999988 88887654 667777 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++|+|.+++.... .+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 87 y~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred ecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999999998655 799999999999999999999999 99999999999999999999999999998654332
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .. ....+..... ..+.
T Consensus 161 -~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~-~~-----~~~~i~~~~~------~~p~ 225 (263)
T d2j4za1 161 -RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--Y-QE-----TYKRISRVEF------TFPD 225 (263)
T ss_dssp -CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--H-HH-----HHHHHHTTCC------CCCT
T ss_pred -ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--H-HH-----HHHHHHcCCC------CCCc
Confidence 334679999999999999999999999999999999999999996431 1 11 1111111111 1223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..++.+.+++.+||+.||++|||++|+++
T Consensus 226 ~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 34567889999999999999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=332.82 Aligned_cols=220 Identities=21% Similarity=0.235 Sum_probs=180.4
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEec
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
.+++...++||+|+| ||++.... ..||+| |+++++++++++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 346777789999998 99988653 778887 99999999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+++|+|.+++.+. .+++.++..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.+..... .
T Consensus 99 ~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~ 172 (293)
T d1yhwa1 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (293)
T ss_dssp CTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred cCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence 9999999988754 599999999999999999999999 999999999999999999999999999997644332 3
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ... ......... ... ..+..
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~----~~~~~~~~~-~~~---~~~~~ 241 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRA----LYLIATNGT-PEL---QNPEK 241 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHH----HHHHHHHCS-CCC---SSGGG
T ss_pred ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHH----HHHHHhCCC-CCC---CCccc
Confidence 3456799999999999999999999999999999999999999964311 111 111111111 111 12233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.++.+.+++.+||+.||++|||++|+++
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 4667899999999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=334.83 Aligned_cols=217 Identities=17% Similarity=0.238 Sum_probs=176.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..+.||+|+| ||++.... ..|||| |+++++++++++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 45667789999998 99988653 678887 899999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+++|+|.+++...+ .+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 9999999999987665 799999999999999999999999 999999999999999999999999999998754332
Q ss_pred -ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 569 -GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 569 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... ....+..... ..
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~-----~~~~i~~~~~------~~ 229 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN---EYL-----IFQKIIKLEY------DF 229 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHHHTTCC------CC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC---HHH-----HHHHHHcCCC------CC
Confidence 23345679999999999999999999999999999999999999997431 111 1111222211 12
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVI 677 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl 677 (702)
+...++.+.++|.+||+.||++|||++|++
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 233456789999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.2e-40 Score=338.41 Aligned_cols=226 Identities=24% Similarity=0.304 Sum_probs=185.4
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
.++..++||+|+| ||++.... ..|||| |+++++++.+++..++||||+++
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 3444578899988 99998764 678888 99999999999999999999999
Q ss_pred CCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 494 GSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 494 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|+|.+++... ...+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 98 g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~ 174 (287)
T d1opja_ 98 GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 174 (287)
T ss_dssp CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred cchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence 9999999764 34689999999999999999999999 9999999999999999999999999999877655554555
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
...|++.|+|||++.+..++.++|||||||++|||++|..|+...... ... ......+ . ....+...+
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---~~~----~~~i~~~-~----~~~~~~~~~ 242 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQV----YELLEKD-Y----RMERPEGCP 242 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHH----HHHHHTT-C----CCCCCTTCC
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---HHH----HHHHhcC-C----CCCCCccch
Confidence 667899999999999999999999999999999999987776433111 111 1111111 1 112233456
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
+++.+++.+||+.||++|||++||+++|+.+.
T Consensus 243 ~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 243 EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 68999999999999999999999999998764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-39 Score=338.14 Aligned_cols=223 Identities=25% Similarity=0.304 Sum_probs=180.0
Q ss_pred cccccceEEEeEE--EEEeeeeh-------hhhHhh-----------------------------eeeEEEEEecCCeeE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF-------LCFLIA-----------------------------ISSLLVYKHRSSKKL 485 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~-------~~~avk-----------------------------i~~l~~~~~~~~~~~ 485 (702)
.++..+.||+|+| ||++.... ..||+| |+++++.+.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 3445678999988 88887543 246665 999999999999999
Q ss_pred EEEecCCCCCHHHHhhcCCC----------------------CCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCc
Q 038002 486 LVYEFMSKGSLADLLFNLET----------------------RPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRN 543 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~N 543 (702)
+||||+++|+|.++|..... .+++.+++.++.||++||+|||++ +|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhc
Confidence 99999999999999976532 378899999999999999999999 99999999999
Q ss_pred EEEeCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCc
Q 038002 544 ILIDDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTA 621 (702)
Q Consensus 544 Ill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~ 621 (702)
||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.......
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~ 274 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876544432 3345778999999999999999999999999999999998 899997542211
Q ss_pred chhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 038002 622 DEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLE 681 (702)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le 681 (702)
.+... ...+ . ..+.+...++.+.+||.+||+.||++|||++||+++|.
T Consensus 275 ---~~~~~----~~~~-~----~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 275 ---NFYKL----IQNG-F----KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp ---HHHHH----HHTT-C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---HHHHH----HhcC-C----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 11111 1111 1 11223344568999999999999999999999999995
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=333.68 Aligned_cols=224 Identities=25% Similarity=0.351 Sum_probs=180.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..++||+|+| ||+|.... ..|||| |+++++++. ++..++||||+++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~ 91 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMEN 91 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCC
Confidence 34455678999998 99998765 678998 889998775 4567999999999
Q ss_pred CCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 494 GSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 494 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|+|.+++.... ..+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+++...........
T Consensus 92 g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~ 168 (272)
T d1qpca_ 92 GSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168 (272)
T ss_dssp CBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred CcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence 99999886543 2589999999999999999999999 9999999999999999999999999999987655444445
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
...||+.|+|||++.+..++.++|||||||++|||+||..|+....... . .......+. ....+...+
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~----~~~~i~~~~-----~~~~p~~~~ 236 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---E----VIQNLERGY-----RMVRPDNCP 236 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H----HHHHHHTTC-----CCCCCTTCC
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---H----HHHHHHhcC-----CCCCcccCh
Confidence 5678999999999998899999999999999999999766654331111 1 111111111 112223345
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
+.+.+++.+||+.||++|||++||+++|+.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 678999999999999999999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-39 Score=337.31 Aligned_cols=225 Identities=23% Similarity=0.309 Sum_probs=172.9
Q ss_pred ccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 445 VNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
++..+.||+|+| ||+|.... ..|||| |+++++++.+++..++|||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~E 107 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITE 107 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEE
Confidence 445678999998 99987643 246666 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++|+|.+++......+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 108 y~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp CCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred ecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 9999999999988776799999999999999999999999 9999999999999999999999999999876543321
Q ss_pred e----eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 570 I----VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 570 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
. .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... . ..+. ..+..+. .
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~--~~~~----~~i~~~~-----~ 251 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--N--QDVI----NAIEQDY-----R 251 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--H--HHHH----HHHHTTC-----C
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--H--HHHH----HHHHcCC-----C
Confidence 1 123457899999999999999999999999999999998 899996431 1 1111 1111111 1
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...+...++.+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 12233456678999999999999999999999999988643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-39 Score=340.52 Aligned_cols=230 Identities=22% Similarity=0.275 Sum_probs=177.2
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+.++..++||+|+| ||++.... ..||+| |++++++++++++.|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456777789999998 99988653 678877 8999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
|+++|+|.+++.+.+ .+++.++..++.||+.||+|||+ + +|+||||||+|||++.++.+||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999998655 79999999999999999999996 6 89999999999999999999999999998653222
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhh-------------
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFV------------- 635 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~------------- 635 (702)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||........+............
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 23467999999999999999999999999999999999999999764322111110000000000
Q ss_pred ---------cccccccc-------ccc-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 636 ---------AGEFNKLV-------EEE-VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 636 ---------~~~~~~~~-------~~~-~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
........ .+. .....+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000000 000 01123467889999999999999999999987
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-39 Score=330.97 Aligned_cols=221 Identities=20% Similarity=0.161 Sum_probs=178.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.++..++||+|+| ||++.... ..||+| |+++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 44566788999988 99988654 678887 999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCcee
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIV 571 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 571 (702)
++|+|.+++.+....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 99999999877665799999999999999999999999 99999999999999999999999999997643211 122
Q ss_pred eceeccccccCccccc-----CCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 572 AGVRGSRGYMAPEWQN-----SGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 572 ~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
....||+.|+|||++. ...++.++|||||||++|||++|+.||..... .+ .+. .......... .
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--~~-~~~-----~i~~~~~~~~---~ 236 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--MR-VLL-----KIAKSEPPTL---A 236 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--GG-HHH-----HHHHSCCCCC---S
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--HH-HHH-----HHHcCCCCCC---C
Confidence 3467999999999873 45688999999999999999999999965421 11 111 1111111111 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.+...++.+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12344668899999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-39 Score=330.87 Aligned_cols=222 Identities=18% Similarity=0.199 Sum_probs=165.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEe--cCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKH--RSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~--~~~~~~lV 487 (702)
+.++..+.||+|+| ||++.... ..||+| |+++++++. .++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 45666789999998 99887654 678887 888988774 45678999
Q ss_pred EecCCCCCHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHhhhhcC--CCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 488 YEFMSKGSLADLLFNL---ETRPLWRDRVRIALDVARGLLYLHDEC--EVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~--~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
|||+++|+|.+++.+. ...+++.+++.++.||+.||+|||++. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 346999999999999999999999971 01399999999999999999999999999987
Q ss_pred cCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccc
Q 038002 563 LMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKL 642 (702)
Q Consensus 563 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 642 (702)
+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . . . ....+..+...
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~-~-~----~~~~i~~~~~~-- 232 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--Q-K-E----LAGKIREGKFR-- 232 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--H-H-H----HHHHHHHTCCC--
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--H-H-H----HHHHHHcCCCC--
Confidence 643322 2345679999999999999999999999999999999999999996431 1 1 1 11122222221
Q ss_pred cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 643 VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 643 ~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+...++++.+++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 233 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 123344668899999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-39 Score=325.26 Aligned_cols=222 Identities=21% Similarity=0.294 Sum_probs=185.4
Q ss_pred cccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCCCCH
Q 038002 446 NDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 446 ~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~gsL 496 (702)
+..++||+|+| ||+|.... ..|||| |+++++++.+++..++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 44578999988 99999765 578888 99999999999999999999999999
Q ss_pred HHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeeceec
Q 038002 497 ADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVRG 576 (702)
Q Consensus 497 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 576 (702)
.+++......+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++..............|
T Consensus 87 ~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 163 (258)
T d1k2pa_ 87 LNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF 163 (258)
T ss_dssp HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCC
T ss_pred HHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCC
Confidence 999888777899999999999999999999999 99999999999999999999999999998765554444455678
Q ss_pred cccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHHH
Q 038002 577 SRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERM 655 (702)
Q Consensus 577 t~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 655 (702)
|+.|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+ ....+..+.. ...+...++.+
T Consensus 164 t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~~------~~~~i~~~~~-----~~~p~~~~~~l 230 (258)
T d1k2pa_ 164 PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSE------TAEHIAQGLR-----LYRPHLASEKV 230 (258)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHH------HHHHHHTTCC-----CCCCTTCCHHH
T ss_pred CCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--HHH------HHHHHHhCCC-----CCCcccccHHH
Confidence 999999999999999999999999999999998 899996542 111 1111122111 11223345688
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 656 VKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 656 ~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.+++.+||+.||++|||++||++.|..+
T Consensus 231 ~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 231 YTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 9999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-39 Score=329.36 Aligned_cols=234 Identities=24% Similarity=0.298 Sum_probs=180.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMSK 493 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~~ 493 (702)
+.++..++||+|+| ||+|.... ..|||| |+++++++.+ +..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCC
Confidence 45666788999998 99998766 568888 9999998854 568999999999
Q ss_pred CCHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 494 GSLADLLFNL-ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 494 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
|+|.+++... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...........
T Consensus 96 g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 172 (285)
T d1fmka3 96 GSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 172 (285)
T ss_dssp CBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred CchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence 9999998754 23589999999999999999999999 9999999999999999999999999999876544444445
Q ss_pred ceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 573 GVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
...||+.|+|||++....++.++||||||+++|||++|..|+....... .. ...+..+. ..+.+...+
T Consensus 173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~-----~~~i~~~~-----~~~~~~~~~ 240 (285)
T d1fmka3 173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EV-----LDQVERGY-----RMPCPPECP 240 (285)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HH-----HHHHHTTC-----CCCCCTTSC
T ss_pred cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HH-----HHHHHhcC-----CCCCCcccC
Confidence 5678999999999999999999999999999999999777765432111 11 11111111 112333445
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCCCCCCCC
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEIPILAFP 692 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~~~p~~P 692 (702)
+++.++|.+||+.||++||++++|+++|+....-..|+.+
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~ 280 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCC
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCC
Confidence 6889999999999999999999999999997655444433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-39 Score=330.27 Aligned_cols=227 Identities=22% Similarity=0.306 Sum_probs=177.4
Q ss_pred ccccceEEEeEE--EEEeeeeh------hhhHhh----------------------------eeeEEEEEecCCeeEEEE
Q 038002 445 VNDKRKLLTVLA--GCLGSITF------LCFLIA----------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~------~~~avk----------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+...+.||+|+| ||+|.... ..|||| |+++++++.+++..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 456678999998 99887653 357777 999999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+.+++|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 89 e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 89 EYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp ECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 99999999999988777899999999999999999999999 999999999999999999999999999987644332
Q ss_pred c--eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 569 G--IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 569 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+...... .+ ....+..+. ...
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~------~~~~i~~~~-----~~~ 233 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HE------VMKAINDGF-----RLP 233 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HH------HHHHHHTTC-----CCC
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-HH------HHHHHhccC-----CCC
Confidence 1 223456899999999999999999999999999999999977666443211 11 111111111 112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcCC
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTMEI 686 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~~ 686 (702)
.+...+..+.+++.+||+.||++|||++||+++|+.+.+.
T Consensus 234 ~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 2334557789999999999999999999999999986653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.7e-39 Score=334.12 Aligned_cols=221 Identities=22% Similarity=0.273 Sum_probs=165.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+.++..+.||+|+| ||++.... ..|||| |+++++++++++..||||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 44555667788877 77776543 567776 89999999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe---CCCcEEEecccceeecCCCC
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID---DSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~ 567 (702)
++||+|.+++...+ .+++.++..++.||+.||+|||++ +|+||||||+||++. +++.+||+|||+++......
T Consensus 89 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 89 VSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp CCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred cCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 99999999997654 799999999999999999999999 999999999999994 57899999999998654332
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... ....+...... .....
T Consensus 165 --~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----~~~----~~~~i~~~~~~--~~~~~ 232 (307)
T d1a06a_ 165 --VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN----DAK----LFEQILKAEYE--FDSPY 232 (307)
T ss_dssp ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS----HHH----HHHHHHTTCCC--CCTTT
T ss_pred --eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC----HHH----HHHHHhccCCC--CCCcc
Confidence 2345679999999999999999999999999999999999999996431 111 11111121111 11122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....++.+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 23456788999999999999999999999983
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-38 Score=327.60 Aligned_cols=217 Identities=24% Similarity=0.266 Sum_probs=174.7
Q ss_pred cceEEEeEE--EEEeeeeh----hhhHhh-----------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 448 KRKLLTVLA--GCLGSITF----LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~----~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
.++||+|+| ||+|.... ..|||| |++++++++++ ..+|||||++
T Consensus 12 ~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 467999988 88887543 467777 88899888654 5789999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce--
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI-- 570 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-- 570 (702)
+|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 91 ~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 91 LGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp TEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 999999998765 799999999999999999999999 99999999999999999999999999999875444322
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.... .. . ....+..+.. ...+.
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~--~----~~~~i~~~~~-----~~~p~ 233 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GS--E----VTAMLEKGER-----MGCPA 233 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HH--H----HHHHHHTTCC-----CCCCT
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--HH--H----HHHHHHcCCC-----CCCCc
Confidence 234568999999999999999999999999999999998 899997431 11 1 1111222211 12233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhC
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILMLEG 682 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~ 682 (702)
..++.+.+++.+||+.||++|||+++|+++|+.
T Consensus 234 ~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 445688899999999999999999999998875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=322.11 Aligned_cols=213 Identities=24% Similarity=0.289 Sum_probs=168.6
Q ss_pred ccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEec----CCeeEEEEe
Q 038002 447 DKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHR----SSKKLLVYE 489 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~----~~~~~lV~e 489 (702)
-.++||+|+| ||++.... ..||+| |+++++++++ +...|+|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEe
Confidence 3457999988 89887654 567776 8889887754 567899999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC--eEecCCCCCcEEEe-CCCcEEEecccceeecCCC
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQ--IIHCDIKLRNILID-DSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~--ivH~dlkp~NIll~-~~~~~kl~Dfg~a~~~~~~ 566 (702)
|+++|+|.+++.+.. .+++.++..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+++.....
T Consensus 93 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 93 LMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp CCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred CCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 999999999997654 789999999999999999999998 7 99999999999996 5789999999999864332
Q ss_pred CCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .. .......+..+...
T Consensus 169 ---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~---~~----~~~~i~~~~~~~~~--- 234 (270)
T d1t4ha_ 169 ---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA---AQ----IYRRVTSGVKPASF--- 234 (270)
T ss_dssp ---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH---HH----HHHHHTTTCCCGGG---
T ss_pred ---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH---HH----HHHHHHcCCCCccc---
Confidence 2345679999999998865 5899999999999999999999999643111 11 11222222211112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+...++++.+++.+||+.||++|||++|+++
T Consensus 235 -~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 -DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 2223456889999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=328.50 Aligned_cols=217 Identities=23% Similarity=0.253 Sum_probs=176.3
Q ss_pred eEEEeEE--EEEeeeeh----hhhHhh----------------------------eeeEEEEEecCCeeEEEEecCCCCC
Q 038002 450 KLLTVLA--GCLGSITF----LCFLIA----------------------------ISSLLVYKHRSSKKLLVYEFMSKGS 495 (702)
Q Consensus 450 ~l~~g~~--v~~~~~~~----~~~avk----------------------------i~~l~~~~~~~~~~~lV~e~~~~gs 495 (702)
+||+|+| ||+|.... ..|||| |++++++++. +..||||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence 5899987 88886543 357777 8899988865 46899999999999
Q ss_pred HHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce--eec
Q 038002 496 LADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI--VAG 573 (702)
Q Consensus 496 L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~ 573 (702)
|.+++...+..+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.+....... ...
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~ 171 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccc
Confidence 9999887766899999999999999999999999 99999999999999999999999999999875543322 234
Q ss_pred eeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHH
Q 038002 574 VRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITL 652 (702)
Q Consensus 574 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 652 (702)
..||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+ ....+..+.. .+.+...+
T Consensus 172 ~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~------~~~~i~~~~~-----~~~p~~~~ 238 (285)
T d1u59a_ 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PE------VMAFIEQGKR-----MECPPECP 238 (285)
T ss_dssp SCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HH------HHHHHHTTCC-----CCCCTTCC
T ss_pred cccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HH------HHHHHHcCCC-----CCCCCcCC
Confidence 568999999999998999999999999999999998 9999975421 11 1111222221 12233455
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 653 ERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 653 ~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
+.+.+++.+||+.||++|||+.+|++.|+..
T Consensus 239 ~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 7889999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-38 Score=334.72 Aligned_cols=221 Identities=21% Similarity=0.245 Sum_probs=180.6
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
.+...+.||+|+| ||++.... ..|||| |+++++++++++..||||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4556788999998 99988653 678888 8999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe--CCCcEEEecccceeecCCCCCce
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID--DSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
||+|.+++.+....+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~-- 181 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-- 181 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC--
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccc--
Confidence 9999999977666799999999999999999999999 999999999999995 467899999999998654332
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ...+ ..+...... ........
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~-~~~~-----~~i~~~~~~--~~~~~~~~ 251 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--D-DETL-----RNVKSCDWN--MDDSAFSG 251 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--H-HHHH-----HHHHHTCCC--SCCGGGGG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--H-HHHH-----HHHHhCCCC--CCcccccC
Confidence 345679999999999999999999999999999999999999996431 1 1111 111111110 11112233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.++.+.++|.+||+.||++|||++|+++.
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 45678999999999999999999999884
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.1e-38 Score=334.52 Aligned_cols=222 Identities=21% Similarity=0.225 Sum_probs=183.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------eeeEEEEEecCCeeEEEEecC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------ISSLLVYKHRSSKKLLVYEFM 491 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------i~~l~~~~~~~~~~~lV~e~~ 491 (702)
+.++..+.||+|+| ||++.... ..|||| |+++++++++++..||||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 45677789999998 99988653 778888 999999999999999999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe--CCCcEEEecccceeecCCCCCc
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID--DSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~--~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+||+|.+++.....++++.+++.++.||+.||+|||++ ||+||||||+|||++ .++.+||+|||+|..+....
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-- 183 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-- 183 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--
Confidence 99999999887776799999999999999999999999 999999999999997 67899999999999875433
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .... ...+...... .......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~-----~~~i~~~~~~--~~~~~~~ 253 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLET-----LQNVKRCDWE--FDEDAFS 253 (352)
T ss_dssp CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHH-----HHHHHHCCCC--CCSSTTT
T ss_pred ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHH-----HHHHHhCCCC--CCccccc
Confidence 2445679999999999999999999999999999999999999996431 1111 1111111111 1112233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
..+..+.+||.+||+.||++|||++|+++.
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 456788999999999999999999999873
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=327.48 Aligned_cols=216 Identities=20% Similarity=0.241 Sum_probs=178.7
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.++..+.||+|+| ||++.... ..||+| |++++..+++++..|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 4566788999988 88887643 677777 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|++||+|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+...... .
T Consensus 86 y~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~-~ 160 (337)
T d1o6la_ 86 YANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-A 160 (337)
T ss_dssp CCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT-C
T ss_pred ccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCC-c
Confidence 999999999998765 789999999999999999999999 99999999999999999999999999998654322 2
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .. .......... ..+.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~-----~~~~i~~~~~------~~p~ 226 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ER-----LFELILMEEI------RFPR 226 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HH-----HHHHHHHCCC------CCCT
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH---HH-----HHHHHhcCCC------CCCc
Confidence 34557899999999999999999999999999999999999999975421 11 1111122211 1233
Q ss_pred HHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
..+.++.+||.+||+.||++||+ ++|+++
T Consensus 227 ~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 45667899999999999999995 788876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2e-37 Score=329.99 Aligned_cols=217 Identities=20% Similarity=0.161 Sum_probs=175.6
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------------eeeEEEEEecCCeeEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------------ISSLLVYKHRSSKKLL 486 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------------i~~l~~~~~~~~~~~l 486 (702)
.++..+.||+|+| ||++.... ..|||| |++++.++++++..|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 3556678999998 88887653 667776 7888899999999999
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
||||+++|+|.++|.+.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus 85 vmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 999999999999997754 788999999999999999999999 9999999999999999999999999999976543
Q ss_pred CCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 567 QTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 567 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||........ .. ........ ..
T Consensus 161 ~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~----~~~~~~~~------~~ 226 (364)
T d1omwa3 161 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE----IDRMTLTM------AV 226 (364)
T ss_dssp C---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HH----HHHHSSSC------CC
T ss_pred c---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HH----HHHhcccC------CC
Confidence 3 234579999999998864 5789999999999999999999999975422211 11 11111111 11
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPS-----MKNVIL 678 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt-----~~evl~ 678 (702)
..+...++.+.++|.+||+.||++||| ++|+++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 122334567899999999999999999 688875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-38 Score=328.61 Aligned_cols=214 Identities=21% Similarity=0.210 Sum_probs=174.2
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
.+...++||+|+| ||++.... ..|||| |+++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4666788999998 99987654 678887 8999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
||++|+|..++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC----
Confidence 999999987766544 799999999999999999999999 999999999999999999999999999986532
Q ss_pred eeeceeccccccCcccccC---CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 570 IVAGVRGSRGYMAPEWQNS---GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
.....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .+ ..............
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--~~------~~~~i~~~~~~~~~--- 235 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MS------ALYHIAQNESPALQ--- 235 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HH------HHHHHHHSCCCCCS---
T ss_pred -CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH--HH------HHHHHHhCCCCCCC---
Confidence 234569999999998853 4689999999999999999999999964311 11 11111122221111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
+...++.+.+++.+||+.||++|||++|+++
T Consensus 236 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 -SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2234567899999999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=327.58 Aligned_cols=227 Identities=25% Similarity=0.303 Sum_probs=170.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh-------hhhHhh-----------------------------eeeEEEEE-ecCCe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-------LCFLIA-----------------------------ISSLLVYK-HRSSK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk-----------------------------i~~l~~~~-~~~~~ 483 (702)
+.++..++||+|+| ||+|.... ..|||| |+.++..+ ..++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 44556688999998 88887542 356776 56666554 45667
Q ss_pred eEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC
Q 038002 484 KLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD 548 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~ 548 (702)
.++||||+++|+|.++|.... ..+++.+++.++.||++||+|||++ +|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 999999999999999997532 2478999999999999999999999 9999999999999999
Q ss_pred CCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCC-cCCcCCCCCcchhhh
Q 038002 549 SWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCR-SNFEVNVSTADEVLL 626 (702)
Q Consensus 549 ~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~-~Pf~~~~~~~~~~~~ 626 (702)
++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|. .||...... +. +
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~--~ 246 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EE--F 246 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HH--H
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH-HH--H
Confidence 999999999999876444332 234567999999999999999999999999999999999975 567543211 11 1
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
. .....+.. ...+...++++.+++.+||+.||++|||++||+++|+.+.
T Consensus 247 ~----~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 247 C----RRLKEGTR-----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp H----HHHHHTCC-----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHhcCCC-----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1 11111111 1222334567899999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-38 Score=323.44 Aligned_cols=221 Identities=22% Similarity=0.256 Sum_probs=178.2
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh---------------------------------eeeEEEEEecCCee
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA---------------------------------ISSLLVYKHRSSKK 484 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk---------------------------------i~~l~~~~~~~~~~ 484 (702)
.+.++..+.||+|+| ||++.... ..|||| |+++++++++++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 345666788999988 88887653 667776 88999999999999
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC----cEEEecccce
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW----RAKISDFGLA 560 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~----~~kl~Dfg~a 560 (702)
||||||+++|+|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhh
Confidence 99999999999999997755 799999999999999999999999 999999999999998776 5999999999
Q ss_pred eecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc
Q 038002 561 KLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640 (702)
Q Consensus 561 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (702)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . ... ...+......
T Consensus 165 ~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~-~~~-----~~~i~~~~~~ 234 (293)
T d1jksa_ 165 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--K-QET-----LANVSAVNYE 234 (293)
T ss_dssp EECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--H-HHH-----HHHHHTTCCC
T ss_pred hhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--H-HHH-----HHHHHhcCCC
Confidence 8764333 2344578999999999999999999999999999999999999997431 1 111 1111111110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 641 KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 641 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.........+..+.+++.+||+.||++|||++|+++
T Consensus 235 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 --FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112234567889999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-38 Score=322.41 Aligned_cols=225 Identities=21% Similarity=0.243 Sum_probs=170.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEecCCeeEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~~~~~~~lV 487 (702)
+.++..+.||+|+| ||+|.... ..|||| |+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 45666788999998 88887542 345665 999999885 5778999
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++......+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~ 162 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162 (273)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCc
Confidence 999999999999887776799999999999999999999999 99999999999999999999999999998765544
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEE 646 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 646 (702)
........||+.|+|||.+.+..++.++|||||||++|||++ |..||...... + ....+..+... .
T Consensus 163 ~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~------~~~~i~~~~~~-----~ 229 (273)
T d1mp8a_ 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--D------VIGRIENGERL-----P 229 (273)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--G------HHHHHHTTCCC-----C
T ss_pred ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH--H------HHHHHHcCCCC-----C
Confidence 444455678999999999999999999999999999999998 89999654211 1 11111222111 2
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 647 VDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 647 ~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.+...++.+.++|.+||+.||++|||++||++.|+.+.
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 23345678999999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=326.44 Aligned_cols=225 Identities=19% Similarity=0.179 Sum_probs=175.7
Q ss_pred ccccc-ceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEec----CCeeEEEEecC
Q 038002 444 KVNDK-RKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKHR----SSKKLLVYEFM 491 (702)
Q Consensus 444 ~~~~~-~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~~----~~~~~lV~e~~ 491 (702)
.++.. +.||+|+| ||++.... ..|||| |+++++++++ +...|+|||||
T Consensus 12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 44443 45899998 99988654 778888 8888887765 67899999999
Q ss_pred CCCCHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC---CCcEEEecccceeecCCCC
Q 038002 492 SKGSLADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD---SWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 492 ~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~---~~~~kl~Dfg~a~~~~~~~ 567 (702)
+||+|.++|.+.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++. .+.+||+|||+++......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence 9999999998753 4689999999999999999999999 9999999999999975 5679999999998765433
Q ss_pred CceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccccccc
Q 038002 568 TGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEV 647 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (702)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ............ .....
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~~~i~~~~~~--~~~~~ 240 (335)
T d2ozaa1 169 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQYE--FPNPE 240 (335)
T ss_dssp C--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCSSS--CCTTH
T ss_pred c--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHHHHHhcCCCC--CCCcc
Confidence 2 345679999999999999999999999999999999999999997542221110 011111111110 01111
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 648 DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 648 ~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
....++++.+|+.+||+.||++|||++|+++.
T Consensus 241 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp HHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 23456789999999999999999999999883
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.8e-37 Score=316.47 Aligned_cols=221 Identities=20% Similarity=0.240 Sum_probs=176.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------------eeeEEEEEec
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------------ISSLLVYKHR 480 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------------i~~l~~~~~~ 480 (702)
.+++...+.||+|++ ||++.... ..+||| |+++++.+++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 356667788888887 88776543 566665 7888899999
Q ss_pred CCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccce
Q 038002 481 SSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLA 560 (702)
Q Consensus 481 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a 560 (702)
++..||||||+++|+|.++|.... .+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999999999998755 799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCCceeeceeccccccCcccccC------CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh
Q 038002 561 KLLMPNQTGIVAGVRGSRGYMAPEWQNS------GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF 634 (702)
Q Consensus 561 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 634 (702)
+.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... ... ....+
T Consensus 158 ~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~-----~~~~i 227 (277)
T d1phka_ 158 CQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QML-----MLRMI 227 (277)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHH-----HHHHH
T ss_pred eEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHH-----HHHHH
Confidence 98754332 345679999999998753 457889999999999999999999997541 111 11112
Q ss_pred hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 635 VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+... .........++++.+++.+||+.||++|||++||++
T Consensus 228 ~~~~~~--~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNYQ--FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCCC--CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCCC--CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 222111 111122245678999999999999999999999875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=324.63 Aligned_cols=215 Identities=21% Similarity=0.261 Sum_probs=176.0
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------eeeEEEEEecCCeeEEEEe
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
+...+.||+|+| ||++.... ..|||| |+++++.+++++..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 445678889888 88887654 667776 9999999999999999999
Q ss_pred cCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 490 FMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 490 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
|+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...... .
T Consensus 84 y~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~-~ 158 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-A 158 (320)
T ss_dssp CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred ecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhccccc-c
Confidence 999999999998655 789999999999999999999999 99999999999999999999999999998654332 2
Q ss_pred eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCH
Q 038002 570 IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDK 649 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 649 (702)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .. .......+. ...+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--~-~~-----~~~~i~~~~------~~~p~ 224 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--E-EE-----LFHSIRMDN------PFYPR 224 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--H-HH-----HHHHHHHCC------CCCCT
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--H-HH-----HHHHHHcCC------CCCCc
Confidence 3345679999999999999999999999999999999999999997431 1 11 111111111 12223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 038002 650 ITLERMVKTGLLCIQDEPNLRPSMK-NVIL 678 (702)
Q Consensus 650 ~~~~~l~~li~~cL~~dP~~RPt~~-evl~ 678 (702)
..+..+.+|+.+||+.||++||+++ |+++
T Consensus 225 ~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 3456789999999999999999996 6753
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-37 Score=318.25 Aligned_cols=236 Identities=20% Similarity=0.179 Sum_probs=177.7
Q ss_pred ccceEEEeEE--EEEeeeehhhhHhh--------------------------eeeEEEEEecC----CeeEEEEecCCCC
Q 038002 447 DKRKLLTVLA--GCLGSITFLCFLIA--------------------------ISSLLVYKHRS----SKKLLVYEFMSKG 494 (702)
Q Consensus 447 ~~~~l~~g~~--v~~~~~~~~~~avk--------------------------i~~l~~~~~~~----~~~~lV~e~~~~g 494 (702)
..++||+|+| ||+|......|||| |+++++++..+ ...++||||+++|
T Consensus 7 l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g 86 (303)
T d1vjya_ 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86 (303)
T ss_dssp EEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred EEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCC
Confidence 3467999998 99998877888888 88888776543 3689999999999
Q ss_pred CHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC-----CCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc
Q 038002 495 SLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-----EVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 495 sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-----~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+|.++|++. .+++.+++.++.|++.||+|||+.+ ..+|+||||||+||||+.++.+||+|||+++........
T Consensus 87 ~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~ 164 (303)
T d1vjya_ 87 SLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164 (303)
T ss_dssp BHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTE
T ss_pred CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcc
Confidence 999999764 5899999999999999999999621 239999999999999999999999999999987544322
Q ss_pred ---eeeceeccccccCcccccCC------CCCccccccchhHhHHHhhhCCcCCcCCCCCcc---hh----hhHHHHHHh
Q 038002 570 ---IVAGVRGSRGYMAPEWQNSG------LITVKSDVYSFGVVLLEIICCRSNFEVNVSTAD---EV----LLSTWVYNC 633 (702)
Q Consensus 570 ---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~---~~----~~~~~~~~~ 633 (702)
......||+.|+|||++.+. .++.++|||||||++|||+||..||........ .. .........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T d1vjya_ 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244 (303)
T ss_dssp ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH
T ss_pred eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHH
Confidence 23356799999999988654 257799999999999999999988854321110 00 001111112
Q ss_pred hhcccccccc-ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 634 FVAGEFNKLV-EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 634 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
.........+ ......+....+.+++.+||+.||++|||+.||+++|+++.
T Consensus 245 ~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2222221111 11223456678999999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-37 Score=319.57 Aligned_cols=212 Identities=23% Similarity=0.241 Sum_probs=176.2
Q ss_pred ccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEEec
Q 038002 445 VNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
++..+.||+|++ ||++.... ..|||| |+++++++++++..|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 455678999988 88888653 677877 89999999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
++||+|..++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred cCCccccccccccc-cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 99999999998765 788899999999999999999999 9999999999999999999999999999876432
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .. ....+..+.. ..+..
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~-~~-----~~~~i~~~~~------~~p~~ 223 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--T-MK-----TYEKILNAEL------RFPPF 223 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--H-HH-----HHHHHHHCCC------CCCTT
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--H-HH-----HHHHHHcCCC------CCCCC
Confidence 234679999999999999999999999999999999999999996431 1 11 1111112211 12233
Q ss_pred HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
.++.+.+++.+||+.||.+|| |++++++
T Consensus 224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 456788999999999999996 8999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-36 Score=321.52 Aligned_cols=214 Identities=20% Similarity=0.193 Sum_probs=178.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCCeeEEEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSSKKLLVY 488 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~~~~lV~ 488 (702)
+.++..+.||+|+| ||++.... ..|||| |++++..+.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 56677789999998 99988653 678887 899999999999999999
Q ss_pred ecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCC
Q 038002 489 EFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQT 568 (702)
Q Consensus 489 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 568 (702)
||+.+|+|.+++.+.+ .+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999997765 799999999999999999999999 9999999999999999999999999999976432
Q ss_pred ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 569 GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 569 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ... ....+..+.. ..+
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~----~~~~i~~~~~------~~p 258 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ----PIQ----IYEKIVSGKV------RFP 258 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS----HHH----HHHHHHHCCC------CCC
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC----HHH----HHHHHhcCCC------CCC
Confidence 234679999999999999999999999999999999999999996431 111 1111111111 112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 649 KITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
...+..+.+++.+||+.||.+|+ |++|+++
T Consensus 259 ~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 33456788999999999999994 8999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-37 Score=321.39 Aligned_cols=221 Identities=19% Similarity=0.205 Sum_probs=179.9
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
+++...+.||+|+| ||++.... ..||+| |++++++++++++.|||||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 45667789999998 89887654 678887 9999999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC--CCcEEEecccceeecCCCCCce
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD--SWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
||+|.+++......+++.++..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||++....... .
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~ 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--c
Confidence 9999999987766799999999999999999999999 9999999999999975 4589999999998764332 3
Q ss_pred eeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHH
Q 038002 571 VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKI 650 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (702)
.....+++.|+|||.+.+..++.++|||||||++|||++|..||..... .. ....+...... .+......
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~---~~-----~~~~i~~~~~~--~~~~~~~~ 229 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQ-----IIENIMNAEYT--FDEEAFKE 229 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH---HH-----HHHHHHHTCCC--CCHHHHTT
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH---HH-----HHHHHHhCCCC--CChhhccC
Confidence 4456789999999999999999999999999999999999999965411 11 11111111111 11111112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 651 TLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 651 ~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
.++++.+++.+||+.||++|||++|+++
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 3567899999999999999999999997
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.6e-37 Score=317.51 Aligned_cols=228 Identities=20% Similarity=0.231 Sum_probs=173.7
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh------------------------------eeeEEEEEecCC----e
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA------------------------------ISSLLVYKHRSS----K 483 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk------------------------------i~~l~~~~~~~~----~ 483 (702)
.++++..+.||+|+| ||++.... ..|||| |+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 456677789999988 99998653 778887 788887766543 4
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.||||||++|++|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||.+...
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhh
Confidence 899999999999999987765 799999999999999999999999 9999999999999999999999999998865
Q ss_pred CCCCC--ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 564 MPNQT--GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 564 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+ ............
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~-----~~~~~~~~~~~~- 233 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVS-----VAYQHVREDPIP- 233 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHH-----HHHHHHHCCCCC-
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--HHH-----HHHHHHhcCCCC-
Confidence 43322 23345679999999999999999999999999999999999999996431 111 111111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhCC
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRP-SMKNVILMLEGT 683 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-t~~evl~~Le~~ 683 (702)
........++.+.+++.+||+.||++|| |++++++.|.++
T Consensus 234 --~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 --PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp --GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1112233456889999999999999999 899999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=316.73 Aligned_cols=223 Identities=22% Similarity=0.207 Sum_probs=170.8
Q ss_pred ccccceEEEeEE--EEEeeeeh-----hhhHhh------------------------------eeeEEEEEecCCeeEEE
Q 038002 445 VNDKRKLLTVLA--GCLGSITF-----LCFLIA------------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~-----~~~avk------------------------------i~~l~~~~~~~~~~~lV 487 (702)
++..++||+|+| ||+|.... ..|||| |+++++++.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 445567888887 77776532 245665 8999998865 467899
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
|||+++|+|.+++......+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 999999999999887666799999999999999999999999 99999999999999999999999999999875544
Q ss_pred Cce--eeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccc
Q 038002 568 TGI--VAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVE 644 (702)
Q Consensus 568 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 644 (702)
... .....|+..|+|||.+.+..++.++||||||+++|||++ |+.||.... . ... . ..+......
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--~--~~~---~-~~i~~~~~~---- 233 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--G--SQI---L-HKIDKEGER---- 233 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--H--HHH---H-HHHHTSCCC----
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--H--HHH---H-HHHHhCCCC----
Confidence 322 234567889999999999999999999999999999998 899996431 1 111 1 111111111
Q ss_pred cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 645 EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 645 ~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.+.+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 122233456789999999999999999999999999764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-37 Score=319.32 Aligned_cols=227 Identities=26% Similarity=0.308 Sum_probs=180.2
Q ss_pred cccccccceEEEeEE--EEEeeeeh---------hhhHhh-----------------------------eeeEEEEEecC
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF---------LCFLIA-----------------------------ISSLLVYKHRS 481 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~---------~~~avk-----------------------------i~~l~~~~~~~ 481 (702)
++.+...+.||+|+| ||++.... ..|||| |+++++.+.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 355566788999998 98887533 246776 99999999999
Q ss_pred CeeEEEEecCCCCCHHHHhhcCC---------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEE
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLE---------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILI 546 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll 546 (702)
+..++||||+++|+|.++|.... ..+++.+++.++.||+.||+|||++ +|+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceee
Confidence 99999999999999999997553 3489999999999999999999999 99999999999999
Q ss_pred eCCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchh
Q 038002 547 DDSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEV 624 (702)
Q Consensus 547 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~ 624 (702)
+.++.+||+|||+++........ ......+++.|+|||.+.++.++.++||||||+++|||++ |..||.... ..+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~~- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEE- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHH-
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC--HHH-
Confidence 99999999999999877543322 2345678999999999999999999999999999999998 688886431 111
Q ss_pred hhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 625 LLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
....+..+. ....+...++++.+++.+||+.||++|||++||+++|+++.
T Consensus 246 -----~~~~i~~~~-----~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 246 -----LFKLLKEGH-----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp -----HHHHHHTTC-----CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHcCC-----CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 111222221 11223334567899999999999999999999999998864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-37 Score=319.54 Aligned_cols=227 Identities=23% Similarity=0.287 Sum_probs=180.6
Q ss_pred ccccccceEEEeEE--EEEeeeeh-------hhhHhh----------------------------eeeEEEEEecCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-------LCFLIA----------------------------ISSLLVYKHRSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk----------------------------i~~l~~~~~~~~~~~ 485 (702)
+.+...++||+|+| ||+|.... ..|||| |+++++++.+++..+
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 45666789999998 99987542 457776 788899999999999
Q ss_pred EEEecCCCCCHHHHhhcCC-----------------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCC
Q 038002 486 LVYEFMSKGSLADLLFNLE-----------------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLR 542 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~ 542 (702)
+||||+++|+|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEccc
Confidence 9999999999999996432 2378899999999999999999999 9999999999
Q ss_pred cEEEeCCCcEEEecccceeecCCCCC-ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCC-cCCcCCCCC
Q 038002 543 NILIDDSWRAKISDFGLAKLLMPNQT-GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCR-SNFEVNVST 620 (702)
Q Consensus 543 NIll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~-~Pf~~~~~~ 620 (702)
|||++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++|. .||... .
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~--~ 247 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--A 247 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS--C
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC--C
Confidence 99999999999999999986643332 2234567899999999999999999999999999999999996 566533 1
Q ss_pred cchhhhHHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 621 ADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
..+ ....+..+... +.+...+.++.+|+.+||+.||++||||.||+++|+++.+
T Consensus 248 ~~e------~~~~v~~~~~~-----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 248 HEE------VIYYVRDGNIL-----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp HHH------HHHHHHTTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred HHH------HHHHHHcCCCC-----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 11112222221 2233345678999999999999999999999999998753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-37 Score=313.13 Aligned_cols=220 Identities=24% Similarity=0.257 Sum_probs=171.1
Q ss_pred ccccceEEEeEE--EEEeeeehhhhHhh-------------------------eeeEEEEE-ecCCeeEEEEecCCCCCH
Q 038002 445 VNDKRKLLTVLA--GCLGSITFLCFLIA-------------------------ISSLLVYK-HRSSKKLLVYEFMSKGSL 496 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~~~~avk-------------------------i~~l~~~~-~~~~~~~lV~e~~~~gsL 496 (702)
++-.++||+|+| ||++......|||| |+++++++ ++.+..++||||+++|+|
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L 88 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 88 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCH
Confidence 445577999988 99998877888988 88999877 455678999999999999
Q ss_pred HHHhhcCC-CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceeecee
Q 038002 497 ADLLFNLE-TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVAGVR 575 (702)
Q Consensus 497 ~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 575 (702)
.++|.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 89 ~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~~~~~ 161 (262)
T d1byga_ 89 VDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGK 161 (262)
T ss_dssp HHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------------
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----Ccccc
Confidence 99997643 2489999999999999999999999 9999999999999999999999999999865332 23346
Q ss_pred ccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccCHHHHHH
Q 038002 576 GSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVDKITLER 654 (702)
Q Consensus 576 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (702)
+++.|+|||++.+..++.++||||||+++|||+| |+.||.... ..+ ... .+..+. ..+.+...+++
T Consensus 162 ~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~--~~~----~i~~~~-----~~~~~~~~~~~ 228 (262)
T d1byga_ 162 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKD--VVP----RVEKGY-----KMDAPDGCPPA 228 (262)
T ss_dssp CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGG--HHH----HHTTTC-----CCCCCTTCCHH
T ss_pred ccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHH--HHH----HHHcCC-----CCCCCccCCHH
Confidence 7899999999998999999999999999999998 677775431 111 111 111111 12233344568
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHhCCc
Q 038002 655 MVKTGLLCIQDEPNLRPSMKNVILMLEGTM 684 (702)
Q Consensus 655 l~~li~~cL~~dP~~RPt~~evl~~Le~~~ 684 (702)
+.+++.+||+.||++|||+.+|+++|+.+.
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 889999999999999999999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=315.59 Aligned_cols=222 Identities=20% Similarity=0.167 Sum_probs=167.2
Q ss_pred ceEEEeEE--EEEeeeeh--hhhHhh--------------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 449 RKLLTVLA--GCLGSITF--LCFLIA--------------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 449 ~~l~~g~~--v~~~~~~~--~~~avk--------------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
+.||+|+| ||++.... ..|||| |+++++++.++++.|+||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 46777766 77776543 556666 8889999999999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCceee
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGIVA 572 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 572 (702)
++++..++.. ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 84 ~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 84 TDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp EEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred chHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 8877766543 44789999999999999999999999 999999999999999999999999999987644332 233
Q ss_pred ceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc---cccc--------
Q 038002 573 GVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA---GEFN-------- 640 (702)
Q Consensus 573 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~-------- 640 (702)
...||+.|+|||++.. ..++.++|||||||++|||++|..||...... ..+.. +...... ..+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~-i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTR-IFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH-HHHHHCCCCTTTSSSTTSSTTC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHH-HHHhcCCCChhhccchhccchh
Confidence 4578999999998764 56799999999999999999999999654211 11111 1110000 0000
Q ss_pred ----cccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 641 ----KLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 641 ----~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ........+.+.+|+.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000 01112345689999999999999999999999873
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-36 Score=314.46 Aligned_cols=227 Identities=22% Similarity=0.308 Sum_probs=179.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh-------hhhHhh-----------------------------eeeEEEEEecCCee
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-------LCFLIA-----------------------------ISSLLVYKHRSSKK 484 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk-----------------------------i~~l~~~~~~~~~~ 484 (702)
+.+...++||+|+| ||+|.... ..|||| |+++++.+.+++..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 33444678999998 88886532 456776 88999999999999
Q ss_pred EEEEecCCCCCHHHHhhcCC-----------------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe
Q 038002 485 LLVYEFMSKGSLADLLFNLE-----------------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID 547 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~ 547 (702)
++||||+++|+|.+++.... ..+++.++..++.||++||+|||++ +|+||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999997543 2478999999999999999999999 999999999999999
Q ss_pred CCCcEEEecccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhh
Q 038002 548 DSWRAKISDFGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLL 626 (702)
Q Consensus 548 ~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~ 626 (702)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+|+..|+.......+. +
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--~ 257 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--F 257 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--H
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--H
Confidence 9999999999999977544432 334578999999999999999999999999999999999955444332222211 1
Q ss_pred HHHHHHhhhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 627 STWVYNCFVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.... ..+ . ....+...+..+.+||.+||+.||++|||++||+++|+++
T Consensus 258 ~~~i----~~~-~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 YKMI----KEG-F----RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp HHHH----HHT-C----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH----hcC-C----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111 111 1 1122233456799999999999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=316.35 Aligned_cols=223 Identities=27% Similarity=0.300 Sum_probs=176.3
Q ss_pred ccccceEEEeEE--EEEeeeeh----hhhHhh-----------------------------eeeEEEEEecCCeeEEEEe
Q 038002 445 VNDKRKLLTVLA--GCLGSITF----LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYE 489 (702)
Q Consensus 445 ~~~~~~l~~g~~--v~~~~~~~----~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e 489 (702)
++..+.||+|+| ||+|.... ..|||| |+++++++.+++..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 344578999988 88887654 245555 8999999999999999999
Q ss_pred cCCCCCHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEE
Q 038002 490 FMSKGSLADLLFNL---------------ETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKI 554 (702)
Q Consensus 490 ~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl 554 (702)
|+++|+|.++|... ...+++.++..++.||++||.|||++ +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999999754 24689999999999999999999999 9999999999999999999999
Q ss_pred ecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCc-CCcCCCCCcchhhhHHHHHHh
Q 038002 555 SDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRS-NFEVNVSTADEVLLSTWVYNC 633 (702)
Q Consensus 555 ~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~~~~~~ 633 (702)
+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||... . ... ....
T Consensus 169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--~--~~~----~~~~ 238 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--T--CAE----LYEK 238 (309)
T ss_dssp CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--C--HHH----HHHH
T ss_pred cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--C--HHH----HHHH
Confidence 99999986532222 234568999999999999999999999999999999999765 56432 1 111 1111
Q ss_pred hhccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 634 FVAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...+. ..+.+...++++.++|.+||+.||++||||+||++.|+++.+
T Consensus 239 i~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 239 LPQGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp GGGTC-----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhcC-----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22211 112233456789999999999999999999999999988653
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-36 Score=315.01 Aligned_cols=223 Identities=23% Similarity=0.285 Sum_probs=176.5
Q ss_pred cccccceEEEeEE--EEEeeeeh--h----hhHhh----------------------------eeeEEEEEecCCeeEEE
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--L----CFLIA----------------------------ISSLLVYKHRSSKKLLV 487 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~----~~avk----------------------------i~~l~~~~~~~~~~~lV 487 (702)
.++..+.||+|+| ||+|.... . .||+| |+++++++.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4666789999998 88887543 2 36665 88999888765 56788
Q ss_pred EecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCC
Q 038002 488 YEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 488 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 567 (702)
||++.+|+|.+++......+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 999999999999988877899999999999999999999999 99999999999999999999999999999875444
Q ss_pred Cc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhh-CCcCCcCCCCCcchhhhHHHHHHhhhcccccccccc
Q 038002 568 TG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIIC-CRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEE 645 (702)
Q Consensus 568 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (702)
.. ......||+.|+|||++.++.++.++|||||||++|||+| |..||..... .+ +.. ....+.. .
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--~~--~~~----~i~~~~~-----~ 232 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SE--ISS----ILEKGER-----L 232 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--GG--HHH----HHHHTCC-----C
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH--HH--HHH----HHHcCCC-----C
Confidence 32 2334568999999999999999999999999999999998 7888865421 11 111 1111111 1
Q ss_pred ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 646 EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 646 ~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
..+...++.+.+++.+||+.||++|||+.||++.|+.+
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 22333456789999999999999999999999998764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=314.83 Aligned_cols=223 Identities=23% Similarity=0.374 Sum_probs=177.9
Q ss_pred cceEEEeEE--EEEeeeeh-----hhhHhh----------------------------eeeEEEEEe-cCCeeEEEEecC
Q 038002 448 KRKLLTVLA--GCLGSITF-----LCFLIA----------------------------ISSLLVYKH-RSSKKLLVYEFM 491 (702)
Q Consensus 448 ~~~l~~g~~--v~~~~~~~-----~~~avk----------------------------i~~l~~~~~-~~~~~~lV~e~~ 491 (702)
.++||+|+| ||+|.... ..|||| |+++++++. .++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 457999998 99988644 247777 888887754 567899999999
Q ss_pred CCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCc--
Q 038002 492 SKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTG-- 569 (702)
Q Consensus 492 ~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-- 569 (702)
++|+|.+++.......++.+++.++.|+++||.|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999988777788999999999999999999999 9999999999999999999999999999876543321
Q ss_pred -eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccccccccccC
Q 038002 570 -IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLVEEEVD 648 (702)
Q Consensus 570 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (702)
......||+.|+|||.+....++.++||||||+++|||++|..||.......+ .... ...+.. ...+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~~~~----i~~g~~-----~~~p 256 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVY----LLQGRR-----LLQP 256 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---------CHHH----HHTTCC-----CCCC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---HHHH----HHcCCC-----CCCc
Confidence 22345689999999999999999999999999999999998888865422211 1111 111111 1112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 649 KITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 649 ~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
...++.+.+++.+||+.||++||+++||++.|+++..
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2335678899999999999999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-36 Score=308.43 Aligned_cols=209 Identities=22% Similarity=0.263 Sum_probs=167.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------------eeeEEEEEecCCe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------------ISSLLVYKHRSSK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------------i~~l~~~~~~~~~ 483 (702)
.+++..+.||+|+| ||++.... ..|||| |+++++++++++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 44556677888876 77776543 556665 7788899999999
Q ss_pred eEEEEecCCC-CCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCC-CcEEEeccccee
Q 038002 484 KLLVYEFMSK-GSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDS-WRAKISDFGLAK 561 (702)
Q Consensus 484 ~~lV~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~-~~~kl~Dfg~a~ 561 (702)
.++||||+.+ +++.+++.... .+++.+++.++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccce
Confidence 9999999976 68888887654 799999999999999999999999 99999999999999854 799999999998
Q ss_pred ecCCCCCceeeceeccccccCcccccCCCC-CccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc
Q 038002 562 LLMPNQTGIVAGVRGSRGYMAPEWQNSGLI-TVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640 (702)
Q Consensus 562 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (702)
...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||... +. ......
T Consensus 160 ~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~----------i~~~~~- 221 (273)
T d1xwsa_ 160 LLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EE----------IIRGQV- 221 (273)
T ss_dssp ECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HH----------HHHCCC-
T ss_pred eccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hH----------Hhhccc-
Confidence 754322 345679999999999877655 67789999999999999999999632 11 011110
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 641 KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 641 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
..+...++++.+++.+||+.||++|||++|+++
T Consensus 222 -----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112223567899999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-36 Score=309.74 Aligned_cols=229 Identities=20% Similarity=0.170 Sum_probs=173.1
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
.++..++||+|+| ||++.... ..|||| |++++.+++++++.|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 4566788999988 88887654 678877 89999999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+.++.+..........+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 83 ~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-~~ 158 (298)
T d1gz8a_ 83 LHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RT 158 (298)
T ss_dssp CSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-BC
T ss_pred cCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-cc
Confidence 976555544455555799999999999999999999999 99999999999999999999999999998764333 22
Q ss_pred eeceeccccccCcccccCCC-CCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh--hc-----------
Q 038002 571 VAGVRGSRGYMAPEWQNSGL-ITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF--VA----------- 636 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~----------- 636 (702)
.....||+.|+|||.+.... ++.++|||||||++|+|++|+.||...... + .+........ .+
T Consensus 159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~--~-~~~~i~~~~~~~~~~~~~~~~~~~~ 235 (298)
T d1gz8a_ 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--D-QLFRIFRTLGTPDEVVWPGVTSMPD 235 (298)
T ss_dssp TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--H-HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH--H-HHHHHHHhcCCCchhhccccccccc
Confidence 34457999999999876554 588999999999999999999999754111 1 1111000000 00
Q ss_pred --ccccccccc---ccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 637 --GEFNKLVEE---EVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 637 --~~~~~~~~~---~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
......... ......++.+.+++.+||+.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000 1122345678999999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-36 Score=310.50 Aligned_cols=230 Identities=19% Similarity=0.153 Sum_probs=174.3
Q ss_pred cccccccceEEEeEE--EEEeeeeh---hhhHhh--------------------------------eeeEEEEEe-----
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF---LCFLIA--------------------------------ISSLLVYKH----- 479 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~---~~~avk--------------------------------i~~l~~~~~----- 479 (702)
.++++..++||+|+| ||++.... +.|||| |+++++.+.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 456677788999987 88887542 457877 666776653
Q ss_pred cCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccc
Q 038002 480 RSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGL 559 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 559 (702)
.+...+++|||++++.+..........+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhh
Confidence 35688999999999888777666666799999999999999999999999 999999999999999999999999999
Q ss_pred eeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhh--cc
Q 038002 560 AKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFV--AG 637 (702)
Q Consensus 560 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~ 637 (702)
+...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+......... ..
T Consensus 163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCCCCGG
T ss_pred hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhhCCCchh
Confidence 8864322 234456799999999999999999999999999999999999999975421 1111111100000 00
Q ss_pred ccc--------------cccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 638 EFN--------------KLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 638 ~~~--------------~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.+. ...........++.+.+|+.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 000001223345678899999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=309.23 Aligned_cols=227 Identities=25% Similarity=0.377 Sum_probs=181.4
Q ss_pred ccccccceEEEeEE--EEEeeeeh-------hhhHhh----------------------------eeeEEEEEecCCeeE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-------LCFLIA----------------------------ISSLLVYKHRSSKKL 485 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-------~~~avk----------------------------i~~l~~~~~~~~~~~ 485 (702)
+.+...++||+|+| ||+|.... ..|||| |+++++.+..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 44556688999998 99887642 467877 999999999999999
Q ss_pred EEEecCCCCCHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEec
Q 038002 486 LVYEFMSKGSLADLLFNLE---------TRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISD 556 (702)
Q Consensus 486 lV~e~~~~gsL~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~D 556 (702)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEee
Confidence 9999999999999986421 2468899999999999999999999 999999999999999999999999
Q ss_pred ccceeecCCCCCc-eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCC-cCCcCCCCCcchhhhHHHHHHhh
Q 038002 557 FGLAKLLMPNQTG-IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCR-SNFEVNVSTADEVLLSTWVYNCF 634 (702)
Q Consensus 557 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~ 634 (702)
||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+||. .||... . ..+ .....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~-~~~------~~~~i 248 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-S-NEQ------VLRFV 248 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-C-HHH------HHHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC-C-HHH------HHHHH
Confidence 9999876443322 223456899999999999999999999999999999999985 666432 1 111 11112
Q ss_pred hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCCcC
Q 038002 635 VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGTME 685 (702)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~~~ 685 (702)
..+... ..+...+..+.++|.+||+.||++|||+++|+++|++..+
T Consensus 249 ~~~~~~-----~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEGGLL-----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTTCCC-----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhCCCC-----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222211 1223345689999999999999999999999999998755
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-35 Score=303.05 Aligned_cols=231 Identities=17% Similarity=0.127 Sum_probs=178.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
++++..+.||+|+| ||+|.... ..|||| |..+..++.+++..++||||+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 35667789999998 99998653 788998 566667788899999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEe---CCCcEEEecccceeecCCCCCc
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILID---DSWRAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~ 569 (702)
+++|.+.+......+++.++..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+++.+......
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 86 GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 5677777776666899999999999999999999999 999999999999985 4557999999999987543321
Q ss_pred ------eeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccccc
Q 038002 570 ------IVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNKLV 643 (702)
Q Consensus 570 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 643 (702)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||.................. .....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~-~~~~~----- 236 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-KMSTP----- 236 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH-HHHSC-----
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc-cCCCC-----
Confidence 233567999999999999999999999999999999999999999765322221111111110 00000
Q ss_pred ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 644 EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 644 ~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
.+......++++.+++.+||+.||++||+++++.+.|+..
T Consensus 237 ~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0111223456788999999999999999999998888764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.1e-34 Score=297.93 Aligned_cols=231 Identities=15% Similarity=0.106 Sum_probs=182.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh--------------------------eeeEEEEEecCCeeEEEEecCC
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA--------------------------ISSLLVYKHRSSKKLLVYEFMS 492 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk--------------------------i~~l~~~~~~~~~~~lV~e~~~ 492 (702)
.+++..++||+|+| ||++.... ..|||| |+.++.++..+...++||||+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 35566788999998 99998654 778888 777888999999999999999
Q ss_pred CCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeC-----CCcEEEecccceeecCCCC
Q 038002 493 KGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDD-----SWRAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 493 ~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~-----~~~~kl~Dfg~a~~~~~~~ 567 (702)
+++|.+++......+++.++..++.|++.||+|||++ ||+||||||+|||++. ++.+||+|||+++......
T Consensus 84 ~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 84 GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 7899999988777899999999999999999999999 9999999999999964 5789999999999865332
Q ss_pred C------ceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcccccc
Q 038002 568 T------GIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFNK 641 (702)
Q Consensus 568 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (702)
. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.............. ...........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~-i~~~~~~~~~~- 238 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER-IGEKKQSTPLR- 238 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH-HHHHHHHSCHH-
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH-HHhccCCCChH-
Confidence 2 123356799999999999999999999999999999999999999976533322211111 11111111111
Q ss_pred ccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhCC
Q 038002 642 LVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILMLEGT 683 (702)
Q Consensus 642 ~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~Le~~ 683 (702)
+.....++++.+++..|++.+|++||+++.+.+.|+.+
T Consensus 239 ----~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 239 ----ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp ----HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ----HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 11222345788889999999999999999998888764
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-34 Score=298.96 Aligned_cols=227 Identities=19% Similarity=0.194 Sum_probs=170.5
Q ss_pred ccccccceEEEeEE--EEEeeeeh-hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF-LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~-~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
++++..++||+|+| ||++.... ..|||| |++++..+.+++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 35566788999987 99987654 778888 88999999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+.++.+..+.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||.+........ .
T Consensus 82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 9887666665544 4799999999999999999999999 999999999999999999999999999987643322 2
Q ss_pred eeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhc---cccc---c--
Q 038002 571 VAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVA---GEFN---K-- 641 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~---~-- 641 (702)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... .+. +.. ....... .... .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~--~~~-~~~-i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE--ADQ-LMR-IFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHH-HHH-HHHHHCCCCTTTSTTGGGST
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH--HHH-HHH-HHHhhCCCChhhccchhhhh
Confidence 334568999999998765 4678999999999999999999999964311 111 111 0000000 0000 0
Q ss_pred -c---c-------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 642 -L---V-------EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 642 -~---~-------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
. . ........++.+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 00112334568899999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-34 Score=298.05 Aligned_cols=223 Identities=22% Similarity=0.212 Sum_probs=177.1
Q ss_pred cccccccceEEEeEE--EEEeeee-----hhhhHhh--------------------------------eeeEEEEEecCC
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSIT-----FLCFLIA--------------------------------ISSLLVYKHRSS 482 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~-----~~~~avk--------------------------------i~~l~~~~~~~~ 482 (702)
-+.++..++||+|+| ||++... ...||+| |++++..+++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 355667789999988 8887542 2457776 888888999999
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
..++||||+.+|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999998765 678899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeceeccccccCcccccCC--CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc
Q 038002 563 LMPNQTGIVAGVRGSRGYMAPEWQNSG--LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN 640 (702)
Q Consensus 563 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 640 (702)
+............|++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+. ......
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~----~~~~~~--- 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS----RRILKS--- 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH----HHHHHC---
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HhcccC---
Confidence 755544445567799999999988654 56889999999999999999999997653322111111 111111
Q ss_pred cccccccCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038002 641 KLVEEEVDKITLERMVKTGLLCIQDEPNLRP-----SMKNVIL 678 (702)
Q Consensus 641 ~~~~~~~~~~~~~~l~~li~~cL~~dP~~RP-----t~~evl~ 678 (702)
....+...+.++.+++.+||+.||++|| |++|+++
T Consensus 252 ---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 ---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ---CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 1122334577899999999999999999 4788886
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-34 Score=300.56 Aligned_cols=227 Identities=20% Similarity=0.135 Sum_probs=167.7
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------eeeEEEEEe------cCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------ISSLLVYKH------RSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------i~~l~~~~~------~~~~~~lV~e~ 490 (702)
.++..+.||+|+| ||++.... ..|||| |++++.++. ++.+.+|||||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey 100 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDY 100 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEEC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEec
Confidence 3556678999988 99998764 778888 777776663 34568999999
Q ss_pred CCCCCHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC-cEEEecccceeecCCCC
Q 038002 491 MSKGSLADLLF--NLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW-RAKISDFGLAKLLMPNQ 567 (702)
Q Consensus 491 ~~~gsL~~~l~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 567 (702)
++++.+..+.. .....+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.......
T Consensus 101 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~ 177 (350)
T d1q5ka_ 101 VPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177 (350)
T ss_dssp CSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred cCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence 98764444332 2344699999999999999999999999 999999999999999775 89999999998764433
Q ss_pred CceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH----------Hhh--
Q 038002 568 TGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY----------NCF-- 634 (702)
Q Consensus 568 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~----------~~~-- 634 (702)
. .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ..+..... ...
T Consensus 178 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~---~~l~~i~~~~g~~~~~~~~~~~~ 252 (350)
T d1q5ka_ 178 P--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEIIKVLGTPTREQIREMNP 252 (350)
T ss_dssp C--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCCCHHHHHHHCC
T ss_pred c--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH---HHHHHHHHHhCCChHHhhhhhcc
Confidence 2 334578999999997754 57899999999999999999999999654211 11111000 000
Q ss_pred --hcccccccc----ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 635 --VAGEFNKLV----EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 635 --~~~~~~~~~----~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
......... ........++.+.+|+.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000 00112334667899999999999999999999996
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-33 Score=294.31 Aligned_cols=232 Identities=16% Similarity=0.153 Sum_probs=166.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEec--------C
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHR--------S 481 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~--------~ 481 (702)
.+++..++||+|+| ||++.... ..|||| |++++..+.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 56677789999988 99988653 778888 5566655433 5
Q ss_pred CeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 482 SKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 482 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.+.++||||+.++.+.... .....+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceee
Confidence 6789999999877665444 4444789999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---ceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcc
Q 038002 562 LLMPNQT---GIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG 637 (702)
Q Consensus 562 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 637 (702)
.+..... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.............. ........
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~-~~~~~~~~ 244 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ-LCGSITPE 244 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCTT
T ss_pred ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH-hcCCCChh
Confidence 7654332 122345699999999988654 689999999999999999999999964321111001100 00000000
Q ss_pred cccc------------cccccc-------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 638 EFNK------------LVEEEV-------DKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 638 ~~~~------------~~~~~~-------~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
.... ...... .......+++|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 000000 01124467789999999999999999999964
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-33 Score=290.27 Aligned_cols=230 Identities=17% Similarity=0.095 Sum_probs=175.4
Q ss_pred cccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCCeeEEEEec
Q 038002 444 KVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSSKKLLVYEF 490 (702)
Q Consensus 444 ~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~~~~lV~e~ 490 (702)
+++..++||+|+| ||++.... ..|||| |++++.++.+....++|+|+
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~ 82 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeee
Confidence 5667789999998 99988754 678888 88889999999999999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCCCCce
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPNQTGI 570 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 570 (702)
+.+++|..++...+ .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... .
T Consensus 83 ~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~ 157 (292)
T d1unla_ 83 CDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-C 157 (292)
T ss_dssp CSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-C
T ss_pred cccccccccccccc-ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-c
Confidence 99999988876554 789999999999999999999999 999999999999999999999999999998644332 2
Q ss_pred eeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhccccc---cc----
Q 038002 571 VAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAGEFN---KL---- 642 (702)
Q Consensus 571 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---- 642 (702)
.....+++.|+|||.+... .++.++|||||||++|||++|+.||.......+.................. ..
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 2334578889999988665 468999999999999999999999854322111111100000000000000 00
Q ss_pred ---------cccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 643 ---------VEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 643 ---------~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
-.........+.+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000123344567889999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-33 Score=294.25 Aligned_cols=228 Identities=19% Similarity=0.203 Sum_probs=172.2
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------eeeEEEEEe--cCCeeEEEEec
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------ISSLLVYKH--RSSKKLLVYEF 490 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------i~~l~~~~~--~~~~~~lV~e~ 490 (702)
.+.++..++||+|+| ||++.... ..||+| |++++..++ .....++||||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~ 113 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence 355677789999998 99988653 778888 888888876 45679999999
Q ss_pred CCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCC-cEEEecccceeecCCCCCc
Q 038002 491 MSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSW-RAKISDFGLAKLLMPNQTG 569 (702)
Q Consensus 491 ~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~ 569 (702)
+++++|..+. ..+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++........
T Consensus 114 ~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 114 VNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC-
T ss_pred cCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc-
Confidence 9999998764 3689999999999999999999999 999999999999998655 699999999987654332
Q ss_pred eeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH------Hhhh-------
Q 038002 570 IVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY------NCFV------- 635 (702)
Q Consensus 570 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------~~~~------- 635 (702)
.....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.......+......... ....
T Consensus 186 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 264 (328)
T d3bqca1 186 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264 (328)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence 3455789999999987654 579999999999999999999999975532221111100000 0000
Q ss_pred -----------ccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038002 636 -----------AGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL 678 (702)
Q Consensus 636 -----------~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~ 678 (702)
................+.++.+||.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111111122334567899999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.3e-33 Score=296.24 Aligned_cols=234 Identities=20% Similarity=0.163 Sum_probs=170.5
Q ss_pred cccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEecCC------
Q 038002 442 NDKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHRSS------ 482 (702)
Q Consensus 442 ~~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~~~------ 482 (702)
++.++..++||+|+| ||++.... ..|||| |++++.++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 456777789999999 99998653 778887 778888877654
Q ss_pred eeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 483 KKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 483 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
+.|+||||+ +.+|..+++.. ++++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceec
Confidence 579999999 66888887653 699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHH-------HHHhh
Q 038002 563 LMPNQTGIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTW-------VYNCF 634 (702)
Q Consensus 563 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~-------~~~~~ 634 (702)
.... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||............... .....
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 6432 234578999999998865 46789999999999999999999999654211100000000 00000
Q ss_pred ----------hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCCcC
Q 038002 635 ----------VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGTME 685 (702)
Q Consensus 635 ----------~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~~~ 685 (702)
..................+.+.+|+.+||+.||++|||++|+++. ++++.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 000000000011223345678899999999999999999999985 666543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4e-33 Score=295.29 Aligned_cols=235 Identities=19% Similarity=0.205 Sum_probs=167.8
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh----------------------------eeeEEEEEecCC----eeEE
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA----------------------------ISSLLVYKHRSS----KKLL 486 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk----------------------------i~~l~~~~~~~~----~~~l 486 (702)
.+++..++||+|+| ||++.... ..|||| |++++..+.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 45677789999998 99987653 778888 666776665433 2345
Q ss_pred EEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecCCC
Q 038002 487 VYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLMPN 566 (702)
Q Consensus 487 V~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 566 (702)
+++++.+|+|.+++... ++++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 88 l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 55667799999999754 689999999999999999999999 9999999999999999999999999999876443
Q ss_pred CC--ceeeceeccccccCcccccC-CCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhh---------
Q 038002 567 QT--GIVAGVRGSRGYMAPEWQNS-GLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCF--------- 634 (702)
Q Consensus 567 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--------- 634 (702)
.. .......||+.|+|||++.. ..++.++||||+||++|||++|+.||....... ............
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHHTCC
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-HHHHHhhhccCCChhhhhhhh
Confidence 22 12345679999999998854 567899999999999999999999996542111 100000000000
Q ss_pred ---------hccccccccccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhCC
Q 038002 635 ---------VAGEFNKLVEEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM--LEGT 683 (702)
Q Consensus 635 ---------~~~~~~~~~~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~--Le~~ 683 (702)
.................+.++.+++.+||+.||++|||++|+++. |+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 000000000001112234578899999999999999999999975 5544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-32 Score=289.53 Aligned_cols=225 Identities=20% Similarity=0.196 Sum_probs=161.7
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEe------cCCe
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKH------RSSK 483 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~------~~~~ 483 (702)
++++..++||+|+| ||++.... ..|||| |++++..+. +..+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 45777789999998 99998653 778887 777777775 4578
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.|+||||+.++.+. .+. ..+++.+++.++.||+.||+|||++ ||+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~-~~~---~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ---MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHH-HHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHH-hhh---cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhcc
Confidence 99999999765544 442 2589999999999999999999999 9999999999999999999999999998865
Q ss_pred CCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHH------------
Q 038002 564 MPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVY------------ 631 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~------------ 631 (702)
.... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||..... .........
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHHHTT
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCCHHHHHH
Confidence 4332 23456789999999999999999999999999999999999999964421 110000000
Q ss_pred -----Hhhhcc-------cccccc-------ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038002 632 -----NCFVAG-------EFNKLV-------EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNVILM 679 (702)
Q Consensus 632 -----~~~~~~-------~~~~~~-------~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~~ 679 (702)
...... ...... ........+..+.+|+.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000 000000 011234567789999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.3e-32 Score=286.08 Aligned_cols=229 Identities=17% Similarity=0.168 Sum_probs=166.3
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-----------------------------eeeEEEEEec-----CCee
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-----------------------------ISSLLVYKHR-----SSKK 484 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-----------------------------i~~l~~~~~~-----~~~~ 484 (702)
++++..++||+|+| ||++.... ..|||| |++++..+.. +...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 45677788999988 99987653 778887 6677777653 3344
Q ss_pred EEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeecC
Q 038002 485 LLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLLM 564 (702)
Q Consensus 485 ~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~~ 564 (702)
++||+++.+|+|.+++... ++++.++..++.||+.||+|||++ ||+||||||+|||++.++.+|++|||++....
T Consensus 98 ~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred EEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccC
Confidence 6677788899999999643 699999999999999999999999 99999999999999999999999999997542
Q ss_pred CCCCceeeceeccccccCcccccCC-CCCccccccchhHhHHHhhhCCcCCcCCCCCcchhhhHHHHHHhhhcc------
Q 038002 565 PNQTGIVAGVRGSRGYMAPEWQNSG-LITVKSDVYSFGVVLLEIICCRSNFEVNVSTADEVLLSTWVYNCFVAG------ 637 (702)
Q Consensus 565 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------ 637 (702)
. ......|++.|+|||...+. .++.++|||||||++|+|++|+.||...... .............
T Consensus 173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~----~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCCCCHHHHT
T ss_pred c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCChHHhh
Confidence 2 23345689999999976654 5689999999999999999999999654211 1111010000000
Q ss_pred ------------ccccccc---cccCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhCCc
Q 038002 638 ------------EFNKLVE---EEVDKITLERMVKTGLLCIQDEPNLRPSMKNVIL--MLEGTM 684 (702)
Q Consensus 638 ------------~~~~~~~---~~~~~~~~~~l~~li~~cL~~dP~~RPt~~evl~--~Le~~~ 684 (702)
....... .......+..+.+||.+||+.||++|||++|+++ .+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 0000000 0111223567889999999999999999999997 455543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=2e-29 Score=268.63 Aligned_cols=248 Identities=19% Similarity=0.097 Sum_probs=171.1
Q ss_pred ccccccceEEEeEE--EEEeeeeh--hhhHhh-------------------------------------eeeEEEEE--e
Q 038002 443 DKVNDKRKLLTVLA--GCLGSITF--LCFLIA-------------------------------------ISSLLVYK--H 479 (702)
Q Consensus 443 ~~~~~~~~l~~g~~--v~~~~~~~--~~~avk-------------------------------------i~~l~~~~--~ 479 (702)
.+++..++||+|+| ||++.... ..|||| |++++.++ +
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 35777899999988 99997653 677877 44445444 3
Q ss_pred cCCeeEEEEecCCCCCHHHH--hhcCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCeEecCCCCCcEEEeCCCc-----
Q 038002 480 RSSKKLLVYEFMSKGSLADL--LFNLETRPLWRDRVRIALDVARGLLYLHD-ECEVQIIHCDIKLRNILIDDSWR----- 551 (702)
Q Consensus 480 ~~~~~~lV~e~~~~gsL~~~--l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~~ivH~dlkp~NIll~~~~~----- 551 (702)
.....+++|+++..+..... ........++..+..++.||+.||+|||+ . ||+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 45667777777755443222 22334468899999999999999999998 6 9999999999999976653
Q ss_pred -EEEecccceeecCCCCCceeeceeccccccCcccccCCCCCccccccchhHhHHHhhhCCcCCcCCCCCcch---hhhH
Q 038002 552 -AKISDFGLAKLLMPNQTGIVAGVRGSRGYMAPEWQNSGLITVKSDVYSFGVVLLEIICCRSNFEVNVSTADE---VLLS 627 (702)
Q Consensus 552 -~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~---~~~~ 627 (702)
++++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||......... ..+.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 999999999865322 23456899999999999899999999999999999999999999754221110 0010
Q ss_pred HHHHH-------hhhc--------------cccccc--------c--ccccCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 038002 628 TWVYN-------CFVA--------------GEFNKL--------V--EEEVDKITLERMVKTGLLCIQDEPNLRPSMKNV 676 (702)
Q Consensus 628 ~~~~~-------~~~~--------------~~~~~~--------~--~~~~~~~~~~~l~~li~~cL~~dP~~RPt~~ev 676 (702)
..... .... ..+... . ...........+.+|+.+||+.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 00000 0000 000000 0 002346678899999999999999999999999
Q ss_pred HHH--HhC---CcCCCCCCCCCCCCC
Q 038002 677 ILM--LEG---TMEIPILAFPPLSHV 697 (702)
Q Consensus 677 l~~--Le~---~~~~~~p~~P~~~~~ 697 (702)
++. ++. ..++..|+.|-...-
T Consensus 326 L~Hp~f~~~~~~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 326 VNHPWLKDTLGMEEIRVPDRELYGSG 351 (362)
T ss_dssp HTCGGGTTCTTCTTCCCTTSCTTCBS
T ss_pred hcCcccCCCCCcccCCCCCcccCCCC
Confidence 984 543 334555665554433
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=9.9e-22 Score=170.82 Aligned_cols=112 Identities=19% Similarity=0.342 Sum_probs=95.8
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
+|+|.|||.|.++ ++|+ +|.|+|+|+.+|| |.|+. ..++||.|+++.+ ..++.|.|+.||+|+|++.
T Consensus 1 tDtL~~gq~L~~g--~~l~--~g~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTG--GSLA--EGGYLFIIQNDCN---LVLYD----NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTT--CEEE--ETTEEEEECTTSC---EEEEE----TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCC--CEEE--ECCEEEEEcCCCC---EEEEc----CCcEEEEccCccC--CCCcEEEEeccccEEEEec
Confidence 4899999999987 7887 4889999999997 34444 3689999999876 5567899999999999986
Q ss_pred CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcc
Q 038002 107 ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTD 152 (702)
Q Consensus 107 ~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTD 152 (702)
+..+|++++....+..+|+|+|+||||||+.++.++|||+.+|+|
T Consensus 68 -~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNAIWATHTNVGN 112 (112)
T ss_dssp -TEEEEECCCCCSCCCCEEEECTTSCEEEECTTSCEEEECCCCCCC
T ss_pred -CCeEEEEeeccCCCceEEEEcCCCCEEEECCCCcEEecCCCccCC
Confidence 567888887655667899999999999999999999999999985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.83 E-value=1.1e-20 Score=162.62 Aligned_cols=107 Identities=18% Similarity=0.250 Sum_probs=91.3
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
+++|.+||.|.+| ++|. +|.|.|.|+.+|| |.||. ..++||.||++.| +..+.|.|+.||+|+|+++
T Consensus 1 ~~~L~~g~~L~~G--~~l~--ng~~~l~~q~DGN---Lvly~----~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTG--EFLN--YGSFVFIMQEDCN---LVLYD----VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTT--CEEE--ETTEEEEECTTSC---EEEEE----TTEEEEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCC--CEEE--cCCEEEEECCCCe---EEEEe----CCceeeEeCCCCC--CCccEEEEeccceEEEECC
Confidence 3789999999877 7775 6999999999997 45554 3578999999876 6677899999999999999
Q ss_pred CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCC
Q 038002 107 ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149 (702)
Q Consensus 107 ~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~ 149 (702)
+|.++|+|++.......+|+|+||||||||+. .+||||+|
T Consensus 68 ~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~---~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTGGQNGNYVCILQKDRNVVIYGT---DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCCCSCSCEEEEECTTSCEEEEEC---CCCCCCCC
T ss_pred CccceEEccccCCCCcEEEEEcCCCCEEEeCC---CcccCCCC
Confidence 99999999876556677899999999999964 59999987
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.81 E-value=6.2e-20 Score=157.80 Aligned_cols=107 Identities=18% Similarity=0.275 Sum_probs=90.4
Q ss_pred cccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcCC
Q 038002 28 STISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEE 107 (702)
Q Consensus 28 ~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~~ 107 (702)
++|.+||.|.++ ++|+ +|.|.|+|+.++|. .++. ..++||.||++.|. ...+.|.|+.||+|+|+|.+
T Consensus 2 ~~L~~g~~L~~g--~~l~--~g~~~l~~q~dgnL---vl~~----~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 2 NLLTNGEGLYAG--QSLD--VEPYHFIMQEDCNL---VLYD----HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CEEETTCEEETT--CEEE--ETTEEEEECTTSCE---EEEE----TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred CCccCCCEEeCC--CEEE--eCCEEEEecCCCeE---EEEe----CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence 789999999987 7776 48899999998874 3332 35899999999886 56788999999999999999
Q ss_pred CCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCC
Q 038002 108 SKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFST 149 (702)
Q Consensus 108 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~ 149 (702)
|.++|+|++....+.++|+|+||||||||+. .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~---~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS---DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC---EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC---CEecCCCc
Confidence 9999999876556677899999999999953 69999864
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.78 E-value=2.5e-19 Score=156.57 Aligned_cols=103 Identities=20% Similarity=0.240 Sum_probs=89.8
Q ss_pred EEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEe
Q 038002 65 GIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIW 144 (702)
Q Consensus 65 gIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~W 144 (702)
-|||.++++++.+|+++++.+++....+|.|+.||||+|++. +.++|++++.......+|+|+++|||||++.++.++|
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 389999999999999999999977778999999999999975 6789999876555677899999999999999999999
Q ss_pred eecCCCcccccCCCccCCCCeEEeeccCCCCcccceEeeeccCCceeee
Q 038002 145 ESFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLY 193 (702)
Q Consensus 145 qSFd~PTDTlLpgq~l~~~~~L~S~~s~~dps~G~fsl~l~~~g~~~~~ 193 (702)
|||. +.++|.|.|.|++||++++|
T Consensus 90 ~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 90 TSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp ECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 9974 34578899999999999998
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.70 E-value=3.5e-18 Score=147.56 Aligned_cols=111 Identities=20% Similarity=0.279 Sum_probs=96.2
Q ss_pred EEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEee
Q 038002 66 IWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWE 145 (702)
Q Consensus 66 Iw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~Wq 145 (702)
|||.-.++.+..|..+.+.++.....+|.|+.||||||++ ++.++|++++. +..++.+.|+++|||||++.++.+|||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~-~~~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTA-GATGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCC-SCSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccC-CCCceEEEEeccCCEEEEccCCCEEEE
Confidence 7888888888889999999997778899999999999997 56789999874 456788999999999999999999999
Q ss_pred ecCCCcccccCCCccCCCCeEEeeccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 146 SFSTPTDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 146 SFd~PTDTlLpgq~l~~~~~L~S~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
|+. +.+.|.|.|.|++||++++|- .++|++++.
T Consensus 81 S~t-------------------------~~~~g~y~l~Lq~DGNlvlY~--------~~~Wssgt~ 113 (115)
T d1dlpa1 81 SGT-------------------------KGSIGNYVLVLQPDRTVTIYG--------PGLWDSGTS 113 (115)
T ss_dssp CCC-------------------------CCCSSCCEEEECSSSCEEEEC--------SEEEECSCC
T ss_pred cCC-------------------------CCCCCCEEEEECCCCcEEEeC--------CCeecCCCC
Confidence 863 346899999999999999871 479999875
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.63 E-value=7.1e-16 Score=133.86 Aligned_cols=103 Identities=16% Similarity=0.204 Sum_probs=84.4
Q ss_pred cccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcCC
Q 038002 28 STISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTEE 107 (702)
Q Consensus 28 ~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~~ 107 (702)
.+|.+||+|. ..+..|.|.|.|+.+||. .+ |. ..++||.+|+..+ +..+.|.|+.||+|+|+|.+
T Consensus 15 ~~l~~~q~l~------~~~~~~~y~l~mQ~DGNL---VL-y~---~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESLE------ILFGTHVYRFIMQTDCNL---VL-YD---NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEEE------EEETTEEEEEEECTTSCE---EE-EE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeEE------EecCCceEEEEECCCCcE---EE-EE---CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCC
Confidence 5677777763 457899999999999984 22 22 3678999999765 55689999999999999999
Q ss_pred CCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecC
Q 038002 108 SKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFS 148 (702)
Q Consensus 108 ~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd 148 (702)
|.++|++++....+..+|+|+||||||||+ .++|||-.
T Consensus 80 g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg---~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAGKAGHYVLVLQPDRNVVIYG---DALWATQT 117 (119)
T ss_dssp CCEEEECSCCCCSSCEEEEECTTSCEEEEE---SEEEECCC
T ss_pred CcEEEECCCcCCCCceEEEEcCCCCEEEEC---CCEeccCC
Confidence 999999987655667789999999999995 47999953
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.53 E-value=1.3e-15 Score=145.41 Aligned_cols=99 Identities=13% Similarity=0.097 Sum_probs=72.6
Q ss_pred eEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCeEecCCCCCcEEEeCCCcEEEecccceeec
Q 038002 484 KLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDECEVQIIHCDIKLRNILIDDSWRAKISDFGLAKLL 563 (702)
Q Consensus 484 ~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~~ 563 (702)
.++||||+++..+.+ ++...+..++.|++++|+|||++ ||+||||||+|||++++ .++|+|||.|...
T Consensus 85 ~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG~a~~~ 152 (191)
T d1zara2 85 NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEV 152 (191)
T ss_dssp TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCTTCEET
T ss_pred CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEECCCcccC
Confidence 379999998865543 33445667899999999999999 99999999999999965 5899999999865
Q ss_pred CCCCCceeeceeccccccCc------ccccCCCCCccccccchhHhH
Q 038002 564 MPNQTGIVAGVRGSRGYMAP------EWQNSGLITVKSDVYSFGVVL 604 (702)
Q Consensus 564 ~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwSlGvil 604 (702)
...... .|+.. |. ..+.|+.++|+||+.--+
T Consensus 153 ~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 153 GEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 432211 11111 11 135678899999975443
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.44 E-value=5.4e-14 Score=120.94 Aligned_cols=99 Identities=16% Similarity=0.195 Sum_probs=79.2
Q ss_pred cccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEc
Q 038002 26 LKSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKT 105 (702)
Q Consensus 26 ~~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~ 105 (702)
..++|.+||+|. +|.|.|.|+.+||. .++. ...+||.++... ...+.+.|+.||||||+|
T Consensus 13 ~~~tl~~~~~l~----------~g~~~l~~q~DGNL---vL~~----~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d 72 (115)
T d1dlpa1 13 HPQTLHAAQSLE----------LSSFRFTMQSDCNL---VLFD----SDVRVWASNTAG---ATGCRAVLQSDGLLVILT 72 (115)
T ss_dssp SCSCCCTTCEEC----------STTEEEEECTTSCE---EEEE----SSSEEECCCCCS---CSCCBCCBCSSSCBCCBC
T ss_pred CcceecCCCcEE----------cCCEEEEECCCCeE---EEEc----CCeeEEEcccCC---CCceEEEEeccCCEEEEc
Confidence 346677777664 46699999999973 3443 357899998753 456789999999999999
Q ss_pred CCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeec
Q 038002 106 EESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESF 147 (702)
Q Consensus 106 ~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSF 147 (702)
.++.++|++.+....+..+++|++|||||||+ ..+|+|-
T Consensus 73 ~~~~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~---~~~Wssg 111 (115)
T d1dlpa1 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG---PGLWDSG 111 (115)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC---SEEEECS
T ss_pred cCCCEEEEcCCCCCCCCEEEEECCCCcEEEeC---CCeecCC
Confidence 99999999988656677789999999999994 4799984
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.34 E-value=1.9e-12 Score=111.83 Aligned_cols=86 Identities=23% Similarity=0.353 Sum_probs=70.6
Q ss_pred eEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEeecc
Q 038002 92 TLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSSVT 171 (702)
Q Consensus 92 ~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S~~s 171 (702)
+|.|+.||||||++. +.++|++++......+.+.|+++|||||++.++.+||+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g~~vWsS~t----------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNENVTVWQSPV----------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEECSC-----------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCCcEEEECCC-----------------------
Confidence 689999999999964 56899998754455688999999999999999999998721
Q ss_pred CCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 172 ETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 172 ~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
.-+.|.|.+.|++||++++|- .+.|++++.
T Consensus 89 --~~~~~~~~l~Lq~DGNlvlYg--------~~~W~S~T~ 118 (119)
T d1b2pa_ 89 --AGKAGHYVLVLQPDRNVVIYG--------DALWATQTV 118 (119)
T ss_dssp --CCCSSCEEEEECTTSCEEEEE--------SEEEECCCC
T ss_pred --cCCCCceEEEEcCCCCEEEEC--------CCEeccCCc
Confidence 124578999999999999982 368998863
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.27 E-value=7.3e-12 Score=106.60 Aligned_cols=87 Identities=29% Similarity=0.447 Sum_probs=70.3
Q ss_pred CceEEEccCCcEEEEcCCCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEee
Q 038002 90 NATLALTMDGKLILKTEESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLSS 169 (702)
Q Consensus 90 ~~~l~~~~~g~L~l~~~~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S~ 169 (702)
.-+|.|+.||||||++ .+.+||++++........++|+++|||||++.++.+||+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g~~vWsS----------------------- 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWAS----------------------- 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTCCEEEEC-----------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCccceEEc-----------------------
Confidence 3579999999999996 5678999987544456789999999999999999999987
Q ss_pred ccCCCCcccceEeeeccCCceeeeeccccccccceeecCCc
Q 038002 170 VTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGT 210 (702)
Q Consensus 170 ~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~ 210 (702)
....+.+.|.+.|+.||++++|- .+.|++++
T Consensus 76 --~t~~~~~~~~l~L~ddGNlVly~--------~~~W~S~t 106 (108)
T d1jpca_ 76 --NTGGQNGNYVCILQKDRNVVIYG--------TDRWATGT 106 (108)
T ss_dssp --CCCCSCSCEEEEECTTSCEEEEE--------CCCCCCCC
T ss_pred --cccCCCCcEEEEEcCCCCEEEeC--------CCcccCCC
Confidence 11224578899999999999982 24688764
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.23 E-value=8.9e-12 Score=107.95 Aligned_cols=98 Identities=13% Similarity=0.212 Sum_probs=75.3
Q ss_pred ccccCCCCccccCCCCeeEcCCCeEEEEEEeCCCceEEEEEeecCCCCeEEEEecCCCCCCCCCceEEEccCCcEEEEcC
Q 038002 27 KSTISLGSSLSPSGQHSWNSSSGLFQFGFYKQGSGYSLGIWLVTSPNITVVWTANRDEQPMPSNATLALTMDGKLILKTE 106 (702)
Q Consensus 27 ~~~l~~g~~l~~~~~~~~~s~~g~f~lgF~~~~~~~~lgIw~~~~~~~~~vW~An~~~~~~~~~~~l~~~~~g~L~l~~~ 106 (702)
..+|.++|+|.+ |.|.|.|..+||. .|+- ...+||.++.... +..+.+.|+.+|||||+|.
T Consensus 23 ~~~l~~~q~l~~----------g~y~L~~q~DGNL---vL~~----~~~~vW~s~t~~~--~~~~~~~l~~~GnLvl~d~ 83 (120)
T d1dlpa2 23 PQTLHATQSLQL----------SPYRLSMETDCNL---VLFD----RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTN 83 (120)
T ss_dssp CCEECSSCCCBC----------SSCEEEEETTTEE---EEEB----TTBCCSCCCCCSS--CSSCEEEEETTTEEEEEET
T ss_pred ccEEcCCCeeEc----------CCEEEEEcCCCcE---EEec----CCcEEEEEccccC--CCcEEEEEeCCeeEEEEcC
Confidence 356677777654 4588888877753 3432 3467899886432 5667899999999999999
Q ss_pred CCCeeeeeccccCCcceeEEEecCcCEEEeecCCceEeee
Q 038002 107 ESKEKPIADLVFDEPASFASMLDSGNFVLYSNRSGIIWES 146 (702)
Q Consensus 107 ~~~~~w~~~~~~~~~~~~~~l~d~Gnlvl~~~~~~~~WqS 146 (702)
++.++|+|.+....+..+++|++|||||||+ ..+|.|
T Consensus 84 ~~~~lW~S~t~~~~~~~~l~Lq~DGnlvlY~---~~~W~t 120 (120)
T d1dlpa2 84 QNIAVWTSGNSRSAGRYVFVLQPDRNLAIYG---GALWTT 120 (120)
T ss_dssp TTEEEEECCCCCSSSCCEEEECSSSCEEEEC---CCCCBC
T ss_pred CCCEEEEeCCCCCCCcEEEEECCCCcEEEeC---CCcccC
Confidence 9999999998655667789999999999994 468876
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.20 E-value=3.5e-11 Score=102.37 Aligned_cols=88 Identities=27% Similarity=0.494 Sum_probs=70.2
Q ss_pred CceEEEccCCcEEEEcCCCCeeeeecccc-CCcceeEEEecCcCEEEeecCCceEeeecCCCcccccCCCccCCCCeEEe
Q 038002 90 NATLALTMDGKLILKTEESKEKPIADLVF-DEPASFASMLDSGNFVLYSNRSGIIWESFSTPTDTILGGQSLENGEHLLS 168 (702)
Q Consensus 90 ~~~l~~~~~g~L~l~~~~~~~~w~~~~~~-~~~~~~~~l~d~Gnlvl~~~~~~~~WqSFd~PTDTlLpgq~l~~~~~L~S 168 (702)
.-.|.|+.||||+|+. ++.+||++++.. ......+.|+++|||||++.++.+||+|=
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~s~--------------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEGRSLWASH--------------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSSCEEEECC---------------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCCcEEEEEe---------------------
Confidence 4678999999999996 567899988753 23467899999999999999999999981
Q ss_pred eccCCCCcccceEeeeccCCceeeeeccccccccceeecCCcc
Q 038002 169 SVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTD 211 (702)
Q Consensus 169 ~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~ 211 (702)
...+.|.|.+.|+++|++++|- .+.|.+++.
T Consensus 78 ----t~~~~~~~~l~L~ddGNlvly~--------~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ----SVRGNGNYVLVLQEDGNVVIYG--------SDIWSTGTY 108 (109)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC--------CEEEECCCC
T ss_pred ----eECCCCCEEEEEeCCCcEEEEC--------CCEecCCCc
Confidence 1113577899999999999982 357988764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.14 E-value=7e-11 Score=101.29 Aligned_cols=111 Identities=24% Similarity=0.425 Sum_probs=79.5
Q ss_pred cccccCCCccCCCCeEEeeccCCCCcccceEeeeccCCceeeeeccccccccceeecCCccccCcCcceeeeeecCCccE
Q 038002 151 TDTILGGQSLENGEHLLSSVTETNSSTGRFCLNMQEDGNIVLYPRNMLNKALEAYWANGTDIQSEYPYSVKLNLSPNGVL 230 (702)
Q Consensus 151 TDTlLpgq~l~~~~~L~S~~s~~dps~G~fsl~l~~~g~~~~~~~~~~~~~~~~yw~~g~~~~~~~~~~~~~~~~~~~~~ 230 (702)
||||+|||.|..++.|++ |.|+|.|+.||++++|. ...++|.+++..... ...+.++.+|.+
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~------~~~~vW~s~~~~~~~---~~~l~l~~dGnL 62 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYD------NNRAVWASGTNGKAS---GCVLKMQNDGNL 62 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEE------TTEEEEECCCTTSCS---SEEEEECTTSCE
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEc------CCcEEEEccCccCCC---CcEEEEeccccE
Confidence 899999999999999964 99999999999999983 235789887653222 235889999999
Q ss_pred EEeecCccceEEeeeeeeeeccCcceEEEEEEccCCcEEEEEecccCCCCcceEEEEeeccccc
Q 038002 231 QLLSGNKTQKILFRSSYSLKSMNETVIYRTTLDSDGILRLYSHHFKNDGNSTVGIEWSALEKQC 294 (702)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~rl~Ld~dG~lr~y~~~~~~~~~~~w~~~w~~p~~~C 294 (702)
.++......... ........++++|++||||++|.- + ....|+...++|
T Consensus 63 vl~~~~~~~w~s-------~t~~~~~~~~l~L~ddGNlvly~~---~-----~~~~W~S~t~~~ 111 (112)
T d1xd5a_ 63 VIYSGSRAIWAS-------NTNRQNGNYYLILQRDRNVVIYDN---S-----NNAIWATHTNVG 111 (112)
T ss_dssp EEEETTEEEEEC-------CCCCSCCCCEEEECTTSCEEEECT---T-----SCEEEECCCCCC
T ss_pred EEEecCCeEEEE-------eeccCCCceEEEEcCCCCEEEECC---C-----CcEEecCCCccC
Confidence 887654332211 112223346899999999999831 1 224688776665
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.94 E-value=0.00081 Score=64.93 Aligned_cols=86 Identities=15% Similarity=0.124 Sum_probs=62.2
Q ss_pred eeeEEEEEecCCeeEEEEecCCCCCHHHHhhcCCCCCCHHHHHHHHHHHHHHHHhhhhcC--------------------
Q 038002 471 ISSLLVYKHRSSKKLLVYEFMSKGSLADLLFNLETRPLWRDRVRIALDVARGLLYLHDEC-------------------- 530 (702)
Q Consensus 471 i~~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-------------------- 530 (702)
+.+++.+.++++..++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~ 145 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL 145 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHH
Confidence 4677777888899999999999988876553211 12334556666666666421
Q ss_pred ------------------------------------CCCeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 531 ------------------------------------EVQIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 531 ------------------------------------~~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
...++|+|+.|.||++++++...|+||+.+..
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 01489999999999999876677999987753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.07 E-value=0.0034 Score=60.01 Aligned_cols=30 Identities=23% Similarity=0.339 Sum_probs=26.0
Q ss_pred CeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.++|+|+.|.||+++++..+-|+||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 489999999999999877778999987653
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.02 E-value=0.0096 Score=36.69 Aligned_cols=33 Identities=30% Similarity=0.659 Sum_probs=27.0
Q ss_pred cccccccCCCCCccccCCCCCCCCCccCCCCCccccC
Q 038002 292 KQCVVKGFCGLNSYCSTSTNISTKGDCHCFRGFNFIN 328 (702)
Q Consensus 292 ~~Cd~~g~CG~~g~C~~~~~~~~~~~C~C~~GF~~~~ 328 (702)
|.|.+-..|| +|-|+. ....-.|.|-.||+|..
T Consensus 2 dECsignpCG-nGTCtN---viGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKN---VIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEE---CSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-Cceeee---cccceEEeecCCcCCCc
Confidence 6899999999 889985 44566799999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=93.17 E-value=0.061 Score=54.70 Aligned_cols=29 Identities=24% Similarity=0.320 Sum_probs=25.6
Q ss_pred CeEecCCCCCcEEEeCCCcEEEecccceee
Q 038002 533 QIIHCDIKLRNILIDDSWRAKISDFGLAKL 562 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~~~~kl~Dfg~a~~ 562 (702)
.++|||+.|.|||++++. ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 699999999999998764 89999988764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=89.03 E-value=0.15 Score=49.76 Aligned_cols=30 Identities=23% Similarity=0.283 Sum_probs=27.3
Q ss_pred CCeEecCCCCCcEEEeCCCcEEEeccccee
Q 038002 532 VQIIHCDIKLRNILIDDSWRAKISDFGLAK 561 (702)
Q Consensus 532 ~~ivH~dlkp~NIll~~~~~~kl~Dfg~a~ 561 (702)
.|+||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 489999999999999998878899999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=83.51 E-value=0.38 Score=48.45 Aligned_cols=17 Identities=29% Similarity=0.487 Sum_probs=13.8
Q ss_pred CeEecCCCCCcEEEeCC
Q 038002 533 QIIHCDIKLRNILIDDS 549 (702)
Q Consensus 533 ~ivH~dlkp~NIll~~~ 549 (702)
.++|+|+.+.||++.+.
T Consensus 219 v~CHnDL~~~NiL~~~~ 235 (395)
T d1nw1a_ 219 TFCHNDLQEGNILLPKA 235 (395)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred eEEecCCCcccEeeccc
Confidence 36799999999999653
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=80.19 E-value=0.24 Score=32.37 Aligned_cols=31 Identities=19% Similarity=0.660 Sum_probs=23.8
Q ss_pred ccccc-ccCCCCCccccCCCCCCCCCccCCCCCcc
Q 038002 292 KQCVV-KGFCGLNSYCSTSTNISTKGDCHCFRGFN 325 (702)
Q Consensus 292 ~~Cd~-~g~CG~~g~C~~~~~~~~~~~C~C~~GF~ 325 (702)
|+|.. ...|..+|.|.. ...+-.|.|++||.
T Consensus 4 deC~~~~~pC~n~g~C~n---~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCIN---TLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEE---CSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeEC---CCCCEEeECCCCCc
Confidence 56775 467999999975 23456899999985
|